The Influence of Psychological Intervention upon Psycho-Neuro ...

The Influence of Psychological Intervention upon Psycho-Neuro ... The Influence of Psychological Intervention upon Psycho-Neuro ...

homepage2.nifty.com
from homepage2.nifty.com More from this publisher
29.01.2013 Views

T h e In fl u en ce o f Psy ch o l og i ca l In t e r v e n t i o n u p o n P s y c h o-Ne u r o-End o c r i o-Immu n n e N e t w o r k A t h e s i s s u b m i t t e d f o r t h e a w a r d o f D o c t o r o f P h i l o s o p h y ( P h . D . ) I m p e r i a l C o l l e g e , F a c u l t y o f M e d i c i n e , L o n d o Aki r a NA ITO M.D. A u g u s t 2 6 0 0 I m p e r i a l C o l l n e d g o e n L o F a c u l t y o f M e d i c i n e D i v i s i o n o f N e u r o s c i e n c e a n d M e n t a l H e a l t h Cha ri ng Cr oss C a mp u s S t . D u n s t a n ’ s R o a d , L o n d o n W 6 8 R P and D e p a r t m e n t o f I m m u n o l o g y C h e l s e a a n d W e s t m i n s t e r C a m p u s 3 6 9 F u l h a m R o a d , L o n d o n S W 1 0 9 - 1 -

T h e In fl u en ce o f Psy ch o l og i ca l In t e r v e n t i o n u p o n<br />

P s y c h o-Ne u r o-End o c r i o-Immu n n e N e t w o r k<br />

A t h e s i s s u b m i t t e d f o r t h e a w a r d o f<br />

D o c t o r o f P h i l o s o p h y ( P h . D . )<br />

I m p e r i a l C o l l e g e , F a c u l t y o f M e d i c i n e , L o n d o<br />

Aki r a NA ITO M.D.<br />

A u g u s t 2 6 0 0<br />

I m p e r i a l C o l l n e d g o e n L o<br />

F a c u l t y o f M e d i c i n e<br />

D i v i s i o n o f N e u r o s c i e n c e a n d M e n t a l H e a l t h<br />

Cha ri ng Cr oss C a mp u s<br />

S t . D u n s t a n ’ s R o a d , L o n d o n W 6 8 R P<br />

and<br />

D e p a r t m e n t o f I m m u n o l o g y<br />

C h e l s e a a n d W e s t m i n s t e r C a m p u s<br />

3 6 9 F u l h a m R o a d , L o n d o n S W 1 0 9<br />

- 1 -


T h i s t h e s i s i s d e m d i y c f a th t e r d : t o<br />

N a g a y o s h i N A I T O<br />

1 9 4 0 - 2 0 0 6<br />

M y r o l e m o d e l a n d m e n t o r<br />

w h o t a u g h t m t h e i mp o rt a n c e o f b e i n g m y se l f<br />

a n d p a s e d a w a y a t t h e e n d o P f h . m D y . c o u . r s e<br />

I t han k hi m f o r h i ts rut hf uln e ss, wa rm un de rstan din g and sp i ri tu al sup po rt .<br />

C y c l a m e n<br />

( 3 1 J a n u a r y 6 2 ) 0 0<br />

T h e l a s t p i e c e o f wo rk i n h i p s r i v a t e l i w f i t e h m y m o t , h e r M a s a k o<br />

- 2 -


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

A b s t r a c t<br />

A gr owi n g b od y o f e vi d en ce s u gges ts th at th ere are cr os s regu lat or y in flu en ces b etween<br />

t h e p s y c h o l o g i c a l , n e u r o l o g i c a l , e n d o c r i n o l o g i c a l a n d i m m u n o l o g i c a l d s to y s t e m s . T h i s h a s<br />

t h e p r o p o s a l o f a -n e p u s r y o-e c h n o d o c r i o-i n mmu n e n et wo rk, in wh ich a ch an ge in o n e p art h as<br />

con s eq u en t i al i n fl u en ces u p on oth er p arts <strong>of</strong> th e n etw or k. Th u s p s ych olo gical s tres s can als o<br />

a f f e c t p h ys i c a l w e l l-b ei n g t h rou gh th e n et wor k.<br />

T h i s t h e s i s i s ed b a on s th e h yp ot h es is th at th e d etrimen tal ef fects o f s tres s u p on th e<br />

n etwork can b e al l evi at ed b y p s ych olo gic al in terven tion . Th e aim <strong>of</strong> th is p roject i s to ex amin e<br />

wh eth er l earn i n g an d p ract i s in g s t r e s s-ma n agemen t s kills i mp ro ves p s yc h o l o g i c a l a n d p h ys i c a l<br />

w e l l -b e i n g.<br />

An i n v i sv tu o d y u s in g u n ivers it y s tu d en ts con firm ed th at e x a m i n a t i s tres o n s p ro vo kes<br />

an xiet y an d in creas es s tres s , an d t h a t s tre s s p ercep tion was as s ociated with N K -c e l l f u n c t i . o n<br />

Immu n e al t er at i on s w e re ob s er ved in vitr o wh en N K -cells an d lymp h o c ytes w ere e xp os ed to<br />

s tres s h orm on es . A n o t h e r i n v i v s o t u d y -in u fect s i ed n p a g t i e n t s H n I o t V r e c e i v i n g a n t i-ret ro viral<br />

t r e a t m e n t s c o n f i r m e d t h a t t h e -ly r m e p h i o c s y t e cou a n t s , t a ne d a th d at y th is d e c l i n e i n<br />

d e c l i n e w a s a s s o c d i a w t i e t h l d i e n c e s in q u a l -o i t f -l y i f e s c s o . r e<br />

T h e ps y c h o l o g i c a l i n t e s r u v s e n d t i n o n t h e p r o j e c t , s -h e l yp f n os is an d J oh rei , a i m e d t o<br />

p r o v i d e a l t e r n a t i v e p e r s p e c t i v e s o f , a n d u n i q u e -h s elp e l f cop in g s trat e gi es f or, s t res s fu l life<br />

even ts . Th es e, p art icu larl y J oh rei , w e r e n s t o h o a l w l e v i o a r t e v e n t o r e v th e r s e ffect e s <strong>of</strong> s tres s<br />

u p o n t h e , i m n c m l u d n i a e n g d e c s r e y a s e N t -c K i e n l l s m i n u n i v e r s i t y s t u d e a n n t d s the<br />

d e c l i n e o -l f y m p C h D o c 4 y t e T s i n -i H n I f e c V t e d p a t i e . n Ne t s i t h e r i n t e r v af e f n e c t e i d o sn tres s<br />

p e r c e p t i o s n i g n i f i n c t a l , y alth ou gh J oh rei a p p e a r e d to i m p r o v e t h e q -o u a f -l l i t f e y s c s. o r e<br />

T h e s e f i n d i n g s s u p p o r a t p r t i o h r e i h yp ot h es is th at p s ych ol o gical in ter ven tion ma y<br />

cou n teract th e d et ri men tal e ffects <strong>of</strong> s t res s on h e a l t an h d p r o m o t e w e l l -b e i n g, an d s u gges t th is<br />

v i e a n i n m g-f o c u s e d c o p i n g . T h e w s a e r r a n t t n e h e d f o r f u r t h e r r e s e a r c h t o e x p l o r e t h e i -n<br />

t e r<br />

d ep end en t rel at ion s h ip s a m o n g s t th e in tegrated p s y c h o-n e u r o-e n d o c r i o-i n m m u n e n e t w , o an r k d<br />

t h e i n f l u e n c e o f J o h r e i u p o .<br />

n t h e n e t w o r k<br />

- 3 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n t e n t s P a g e<br />

Ab s t r a c t 3<br />

Lis t <strong>of</strong> F i g u r e s 6<br />

Lis t <strong>of</strong> T a b l e s 9<br />

Lis t <strong>of</strong> T e xt bo x e s 14<br />

A b b r e v i a t i o n s<br />

A c k n o w l e d g e m e n t s 16<br />

C h ap ter I I n t r o d u c t i o n<br />

Cont ent s o f c h apte r I 18<br />

1.1 P r o j e c t o v e r v i e w<br />

1.2 T h e o r e t i c a l f r a m e w o r k<br />

1.3 A p p r o a c h t a k e n<br />

C h ap ter II M a t e r i a l s a n d M e t h o d s<br />

C h a p t e r I I I R e s u l t s<br />

Contents o f c h apte r I I 51<br />

2.1 Pa r t i c i ts p a w n i t h r e g a r d t o o u t c o m e s a n d m e a s u r e m e n t t i m e p o 53 i n t s<br />

2.2 P s y c h o l o g i c a l i n t e r v e n t i o n<br />

2.3 S e l f-r e p o r t u e s q t i o n n a i r e s<br />

2.4 M a t e r i a l s a n d m e t h o i d n s v i t r o<br />

2.5 S t a t i s t i c a l a n a l y s e s<br />

C o n t e n t s o f c h apte r I I I 79<br />

3.1 T h e i n f l u e n c e o f p s y c h o l o g i c a l i n t e r v e n t i o n u p -re o n la s te t d r e cs ha s nge s<br />

i n u n i v e r s i t y s t u d e n t s f a c i n g a c a d e m i c e x a m i n a t i o n s<br />

3.2 T he inf lu e nc e <strong>of</strong> p s y c h o l o g i c a l i n t e r v e n t per i o ce n ive u d p o s n t r e s s and<br />

q u a l i -<strong>of</strong>-l t y i f and e various imm u n o l o g i c a l d i s -as e a s se oc ia t ed<br />

p a r a m e t e -i r n f s e c t e d i n d i v i H d I u a l V s<br />

3.3 I n v i t inve r o s t iga t io n int o the e ff e ct <strong>of</strong> e xp os ur e t o st re s s hor mo ne s<br />

u p o n N a t u r a l K i l l e r c e l l s<br />

3.4 I n v i t inve r o s t iga t io n int o the e ff e ct <strong>of</strong> e xp os ur e t o st re s s hor mo ne s<br />

<strong>upon</strong> T-l y m p h o c y t e s 151<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 4 - I m p e r i a l C o l l e g e L o n d o n<br />

15<br />

19<br />

22<br />

49<br />

60<br />

63<br />

65<br />

77<br />

83<br />

102<br />

128


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C h a p t e D r i s c I u s V s i o n<br />

Cont ent s o f c h apte r I V 171<br />

4.1 T he in f lu e nc e <strong>of</strong> ps yc hologic a l in t e r ve n t io n up o n s us ta in e d s tr e ss a nd<br />

s t r e s s-a s s oc ia te d c ha nge s in unive rs it y s t u de nt s f a c in g e x a ms a n d in<br />

p a t i e n t -i s n f e w c i t i t o n h H I V<br />

4.2 S t r e s s ho r mone as s oc ia te d c ha nge s i n v i t i n r o i m m u n e c e l l as n a s<br />

e x e m p l a r <strong>of</strong> t he p s y c h o-n e u r o-e n d o c r i -i n o m m u n e n e t w i o r n t k e r a c t i 190 o n<br />

4.3 C o n c l u s i o n<br />

4.4 F u t u r e d i r e c t i o n s<br />

R e f e r e n c e s 200<br />

A p p e n d i c e s<br />

A-1. E t h i c s a p p r o v a l , i n f o r m a t i o n 214 s h e e t a n d<br />

A-2. P s y c h o l o g i c a l t r a i n i n g i n t e r v e n t i o n p r o t o c o l s<br />

A-3. Q u e s t i o n n a i r e s<br />

i . S e l f h y p n o s i s t r a i n i n g<br />

i i . J o h r e i t r a i n i n g<br />

S t r e s s p e r c e ( p St Ti AI o n , I E S a n d P ) S S<br />

287<br />

Qu a lit y o f L i fe a nd s leep qu a lit y ( L o , C MCS and P S Q I ) 290<br />

A-4. S t a n d a r o d p e r a t i n g p r o c e d u r e s (S O P s ) f o r l a b o r a t o r y m e t h o d s<br />

[ 3 H ] -t h y m i d i n e i n c o r p o r a t i o n u s i n g w h o l e b l o o d f o r p r 296 o l i f e r a t i o n a s s a y<br />

F lo w c yt o me t r y a na l ys is o f p r o li f e r a t io n r e s p o ns e in w ho le b lo o d a s s a y p r o t o co l<br />

N K c e l l c y t o t o x i c a c t i v i t y a s s a y b y f l o w c y t o m e t r y 300<br />

A-5. P a p e r s 304<br />

i . Pe e r r e v i e w u e b d l i c p a t i o n s<br />

i i . P r e s e n t a t i o n a n d w o r k s h o p g i v e n<br />

i ii . S u p e r v i s o r f o r r e s e a r c h s t u d e n t s<br />

A-6. A d d i t i o n a l r e s u l t s<br />

A-7. R e s e ar c h p r o p o sa l f or p os t-d o ct or i a l p r oj ec t 316<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

173<br />

198<br />

199<br />

227<br />

253<br />

298<br />

304<br />

305<br />

307<br />

226<br />

286<br />

296<br />

308<br />

- 5 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Fi gu r e 1 : A t yp i c a l N a t u r a l K i l l e r c e l l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

L i s t o f F i g u r e s<br />

Fi gu r e 2 : S c h a e o m f t h e -e n e n u d r o c o r i -immun n o e in te ra c t ion<br />

F i g u r e : 3 N u m b e r s o f s t u d e n t s r e c r u i t e d a n d r e m a i n i n g i n t h e -e s t xa u m d y a t t h e E x a m a n d N o<br />

a s s e s s m e n t t i m e p o i n t s . T h e -o n u m t b e s r t u d o e f n t s d r i o s p a l s o d. i n d i c a t e<br />

Fi gur e 4: T i m i n g o f t h e E x a m -e a x n a d m N a o s e n s s m e n t t i m e p o i wit n t s h r e s pe ct to re c ruit me nt for<br />

i n d i v i d u a l s t u d e n t s i n t h e C o h o r t s A a n d B<br />

Fi gu r e 5 : T i m i n g o f t -ups r and a i da n ta-c i o n l l g e c , t i o n f s o e s l s i l o n o s w ( B and a s e l Ex i n ae ms a s se s s ment<br />

points) and nu m b e r s o f tudent s s a t t he s e s s i s o n<br />

Fi gu r e 6 : Timing <strong>of</strong> t he me as ure me nt c olle ct io n t ime p o i n t s (R e cr u i t m e nt and Af t e r 4 m o n t h s ) a nd the<br />

one-m o n t h b l o c k s (Bas e line , T e r m o n e t o T e r m f o u r ) f o r c l i n i c a l r o u t i n e b l o o d c o l l e c t i o n s<br />

Fi gu r e 7 : T i m i n g o f t w h o e m e a s u r e m e n t p o i n t s Re ( c ruit me nt a n d P o st-i n t e r v tion) e n wit h re ga r d t o t he<br />

pe r iod <strong>of</strong> t r a in ing a nd pr ac t ice o f t he p s yc h o lo gi c a l i n t e r v e n t i o n s<br />

Fi gu r e 8 : T i m e-p o i n t s ( T r a i n i n g t i m e p o i n t r m a n s d a c t c o h r e d i T n e g t o t h e T r a i n i n . g Inte ) r va ls bet we e n<br />

t h e d o t -l e i n d e s r e p r e s e n t o n e t e r m ( o n e m o n t h )<br />

Fi gu r e 9 : C o m p a r i s o n f or m at w i t h r e g a r d t o t h e T r a i n i n g t i m -i n e t er p ve o i n t i o n ( vs P r . e P os t-<br />

i n t e r ve nt i o n ) . I nt e r va l s be t we e n do t-l i n e s r e p r e s e n t o n e t e r m ( o n e m o n t h ) a s i n F i g u r e 8<br />

F i g u r e : 1 F 0 S C v s . S S C d o t t p l o<br />

Fi gur e 11: I n d i v i d u a l c o r t i s o l l e v e l s l t i u n r e t m h e d i u t m i s a s n u d e i n c u p l a s m a f r o m 3 4 v o l u n t e e r s<br />

4 5 6<br />

Fi gur e 12: K5 62 c e ll gr owt h a t s t a r t i n g c e l l c o n c e n t r a , t 1.5x10 i o n s and o f 1.0x10 1 . 5 x 1 0 c e l l s p e r m L<br />

F i g u r e : 1 A 3 c q u i s i o n s e t t i n g s o f a f l o w c y t o m e t r y m e t h o d m e a s u r i n g t h e l e v e l s o f N K c<br />

Fi gur e 14: Ac quis ion s e tt ings <strong>of</strong> t h e f l o w c yt o m e ter in t h e N C R a n a l y s e s<br />

Fi gur e 15: Ac quis ion s e tt ings <strong>of</strong> the f l o w c yt o m e ter i n t Annexin h e V- P I a n a l y s i s<br />

Fi gur e 16: M e a n ( 9 5 % C . I . ) P S S s c o r e -e s xa a m t a nt d h E e xa m N o t i n m e p o i nts<br />

F i g u r e 7: 1 M e a n ( 9 5 % C . I . S ) t a t e a n x i e sc t o y r es in t h e ST AI a t t h Non-e e xa m a n d Ex a m t i m e p o i n ts<br />

F i g u r e 8: 1 M e a n (95% C.I .) NK-c e l l p e r c e n t a g e s i n m a l e a n d f e m a l e s t u d e n t s<br />

F i g u r e 9: 1 M e an ( 95% C.I .) N K C A (% k i l l i n g in ) t he N ot -s t r e s s e a d n d S t r e s s subgroups e d<br />

Fi gur e 20: M e an ( 95% C.I . ) NKCA le ve ls ( % kil lin g) in t he N ot -s t r e s s and e d S t r e s s ma e d le s t u d e n t s<br />

Fi gur e 21: M ea n (95% C.I .) p e r -N K -c e l l c yt o t o x ic ac t ivit y ( c a lc u la te d as a r at io: NK c yt oto xic a ct ivit y<br />

( N K C A ) -c / e l N l K p e r C%) c e ) in n t he a Not-st g e r es s( ed N a K n d S t r e s s subgroups e d<br />

Fi gur e 22: M e an ( 95% C.I .) per-N K -c e l l c y t o t o x i c a c t i v i t y ( -c c e ll a l c u l a t e d a s<br />

p e r c e n t a g e ) in t he N ot -s t r e s s e d a n d S t r m e a s l e s e s d t u d e n t s<br />

F i g u r e 3: 2 M e a n (95% C.I .) C D 4 -c e T l l l e v e ( l % s ) o f m a l e a n d f e m a l e s t u d e n t s<br />

F i g u r e 4: 2 M e a n (95% C.I.) S t a t e a n x i e t y s c o r e s i n t h e S T <strong>of</strong> A I t he t hr ee gr oups at bas e line a nd the<br />

E x a m t i m e p o i nt<br />

F i g u r e : 2 M 5 e a n (95% C.I .) l e v e l -c e s l l s <strong>of</strong> o t he f th re e N gr K oups at bas e lin e a nd the E xa m t i m e p o i nt<br />

F i g u r e : 2 <strong>The</strong> 6 i n d i vi d u a l le ve ls <strong>of</strong> N K -c e l l p e r c e n t a g t e h s e t i h n r g e e r o u s p a t ba s e lin e a nd t he Exa m<br />

t i m e p o i n t<br />

- 6 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

F i g u r e : 2 M 7 e a n (95% C.I .) l e v e l s -c o e f l l s <strong>of</strong> C tD he 4 t hre T e gr oups at ba s e lin e and the Ex a m t ime<br />

point<br />

Fi gur e 28: <strong>The</strong> i n d i vi d u a l l e v e l s -c o e f l l C D p e 4 r c e T n t a g t e h s e t i h n r g e e r o u s p a t b a s e l i n e Exa a n m d t h<br />

t i m e p o i n t<br />

F i g u r e : 2 M 9 e a n (95% C.I .) l e v e l s -c o e f l l s <strong>of</strong> C tD he 8 t hre T e gr oups at ba s e lin e and the Ex a m t ime<br />

point<br />

F i g u r e : 3 <strong>The</strong> 0 i n d i vi d u a l l e v e l s -c o e f l l C D p e 8 r c e T n t a g t e h s e t i h n r g e e r o u s p a t ba se lin e a nd t he Exa m<br />

t i m e p o i n t<br />

F i g u r e : 3 M 1 e a n (95% C.I.) P S S l e v e l <strong>of</strong> s t he N ot -st re sse d a nd S t r e s s subgroups e d a t r ec r uit me nt and<br />

f o u r m o n t h s l a t e r<br />

F i g u r e : 3 M 2 e a n (95% C.I .) le ve ls <strong>of</strong> t he St at e a nx iet y s c or es in th e ST AI <strong>of</strong> t he N ot -s t r e s s and e d S t r e s s<br />

subgroups at re c ruit me nt a nd f o u r m o n t h s l a t e r<br />

F i g ure 33: M e a n (95% C.I .) le ve ls <strong>of</strong> t he I ES in t he Not-s t r e s s and e d S t r e s s ub gr oups a t r e cr uit men t and<br />

f o u r m o n t h s l a t e r<br />

F i g u r e : 3 M 4 e a n (95% C.I .) le ve ls <strong>of</strong> t he Lo C in t he N ot -s t r e s s and e d S t r e s s subgroups e d a t r e cr uit ment<br />

and f o u r m o n t h s l a t e r<br />

F i g u r e : 3 Mean 5 (95% C.I .) le ve ls <strong>of</strong> t he M SC in t he N ot -s t r e s s and e d St re s se d subgroups at re cr uit me nt and f o u r m o n t h s l a t e r<br />

F i g u r e : 3 M 6 e a n (95% C.I .) le ve ls <strong>of</strong> t he P SQI in t he S t r e s s and N ot -s t r e s s subgroups e d a t r e cr uit ment<br />

and f o u r m o n t h s l a t e r<br />

Fi gu r e 3 7 : M e a n ( % 9 5 C. I .) C D 4 gr a d i e nts ( c e l l per s l pe r mo nt h) in the I n c r e a se d co n t r ol ( de cr e as ed<br />

s c o r e s o f t h ) e a n d L D o e C c r e a s c e on d t r o l ( i n c r e a s s c o e r d e s o f t h ) e subgroups L o C<br />

Fi gu r e 3 8 : M e an ( 95 % C. I .) C D 4 gr a d i e nts ( c e l l per s l pe r m o n t h ) i n It mpr h e ove d ps yc hologic a l<br />

functioning (I m p r o v e d : Q o c i r L e n a s e d s c o r e s <strong>of</strong> the M C S ) and De c re a se d ps yc ho lo gic a l<br />

functioning (D e c r e a s e d : Q o d e L c r e a s c e o r d e s <strong>of</strong> t he MCS ) s u b g r o u p s<br />

Fi gu r e 3 9 : M e an ( 95% C.I .) CD 4 gr a d i e nts ( c e l l per s l pe r m o n t h ) i n It mpr h e ov e d s le e p qualit y<br />

( d e c r e a s e d s c o r e s o f t h P e S Q I ) and D e c r e a s e d s l e e p q u a l ( i t i y n c r e a s c s o e r d e s <strong>of</strong> t he P S Q I )<br />

subgroups<br />

F i g u r e 0: 4 M e a n s ( 9 5 % C . I . ) C D 4 g r a d i over e n t s t h e f i v e m o n t h st s udy p e r i o d f r o m t Ba h e s e lin e t o t he<br />

P os t -i n t e r v e n t i m o e n p o i nt<br />

F i g u r e 1: 4 CD4 g r a d i e n t s o f one c o nt r o l s u bj e ct a t t h e P r e-i n t e rve nt ion and P o st -i n t e r v e n t i o n p e r i o d s<br />

F i g u r e : 4 CD4 2 g r a d i e n t s o f one J o hr e i s ub j e c t a t t h e P r -int e e r ve nt io n a n d P os t-i n t e r v e n t i o n p e r i o d s<br />

F i g u r e : 4 I3 ndivid ua l c ha nge s i n CD4 gr a d i en t s ( ce l l c o un ts pe r l p e r m o ) n in t h t h e S e l f-hypnosis,<br />

J o h r e i and D a t a b a s e-c o n t r o l g r o u p b s e t w e e n t h e P r e-i n t e r v e n t i a n o d n P o st -in t er ve nt ion<br />

periods<br />

F i g u r e : 4 M4 e ans ( 95% C.I.) CD4 gr adie nts (c ou nt pe r l p e r m o ) n in t h t h S e e l f-hypnosis and J ohr e i and<br />

D a t a b a s e-control g r o u p s i n t h e P r e- and Post- i n t e r v e n t i o n p e r i o d s<br />

F i g u r e : 4 ( a) 5 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K C A le ve ls a t Tim e 0 a n d a f t e r 2 4 h o u r i n c u b a t i o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 7 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

F i g u r e : 4 ( a) 6 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K -c e l l p e r c e n t a g i e n P B M C s a t T i m e 0 a n o d u rs a f t e r 2 4 h<br />

F i g u r e : 4 ( 7 a ) I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K C A l e v e l wi s t h c o r t i so l at 0, 250 and 2500nM<br />

F i g u r e : 4 ( a) 8 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K -c e l l p e r c e n t a g wit e h c ort is ol at 0, 250 a n d 2500nM<br />

F i g u r e : 4 C 9 o r r e l a t i o -c n y t b e o t m e w t e e r n y f m e l -r t e o l h w e a o s d i n g a m n e t d o h o f d L D H t h e N K C A<br />

F i g u r e : 5 ( a) 0 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K C A (50:1) l e v e l (% s k i l l ) i a t n Ti g m e 0 a n d a f t e r 2 4 h r s<br />

F i g u r e : 5 ( a) 1 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . NKCA ) (25:1) l e v e l s (% k i l l ) i a t n Ti g m e 0 a n d a f t e r 2 4 h r s<br />

F i g u r e : 5 P 2 e r c e n t a -c g e ll e in s t o t o a l f a n N d K e a c h s u b s e t a t T i m e 0 a n d a f t e r 2 4 h o u r s i n c u b a t i<br />

F i g u r e : 5 ( a) 3 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . Nkp46 ) (m.f.i.) a t Ti m e 0 a n d a f t e r 2 4 inc h r uba s t io n<br />

F i g u r e : 5 ( a) 4 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) k p 30 (m.f.i.) a t Ti m e 0 a n d a f t e r 2 4 i h n r c s ub a t ion<br />

F i g u r e : 5 ( a) 5 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K C A (50:1) l e v e l s (% kill ing) o f P B M C s i n c u b wit a t h e d<br />

o r w i t h o u t c l o r t i s o<br />

F i g u r e : 5 ( a) 6 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) K C A (25:1) l e v e l s (% kill ing) o f P B M C s i n c u b wit a t h e d<br />

o r w i t h o u t c l o r t i s o<br />

F i g u r e : 5 M 7 e a n (9 5% C.I .) <strong>of</strong> the NKCA a t T ime 0 a nd aft e r 24 hr s in cu bat io n <strong>of</strong> P BM Cs wit h / out 2 5 0 n M c o r t i s o l i n t h e t a r g e t : e f f e c t o r r a t i o o f 2 5 : 1<br />

F i g u r e : 5 C 8 o r r e l a t i o n s b e t w e e n t h e c h a n g e s a n d d i f f e r e n c e s o f t h e N K % C A killin ( g: be t we e n a t T ime 0<br />

a n d a f t e r 2 4 h r b s a t i o n n c u o f P B M C s w i t h / o u t 2 5 0 n M c o r t i s o l i n t h e r a t i o o f 2 5 : 1<br />

F i g u r e : 5 P 9 e r c e n t a -c g e ll e in s t ota l o a nd f e a ch N K s ubs et in th e P BM Cs a ft er 24 ho urs in cu ba t io n wit h<br />

a n d wi t h o u t 2 5 0 nM c or t i s o l<br />

F i g u r e : 6 ( a) 0 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . Nkp46 ) (m.f.i.) a f t e r 2 4 hr s i nc u b at i o n <strong>of</strong> P BM C s wi t h / o ut<br />

c o r t i s o l<br />

F i g u r e : 6 ( a) 1 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . N ) k p 30 (m.f.i.) a f t er 2 4 hr s i nc u b at i o n <strong>of</strong> P BM C s wi t h / o ut<br />

c o r t i s o l<br />

F i g u r e : 6 M 2 e a n ( 9 5 % C . I . and ) individual expression <strong>of</strong> N k p 4 6 ( m . f . i . -c ) e lls o n t h e c y t o<br />

( C D56 dim C D 1 6 + ) a t T i m e 0 a n d a f t er 2 4 hr s i nc u b at i o n <strong>of</strong> P B M Cs wi t h / o ut 2 5 0n M c o r t i s o l<br />

F i g u r e : 6 M3 ea n (9 5% C.I .) and individu a l le ve l <strong>of</strong> NKCA a t T ime 0 an d af te r 24 hr s in c uba t io n <strong>of</strong><br />

P BM Cs wit h / o ut 250nM c or t iso l a t t a r g e t : e f f e c t o r r a t i o o f 2 5 : 1<br />

F i g u r e : 6 G 4 r ou p s d e f i n e d b y t e r t i a r y s p l i t o f t h e N K C A l e v e l s a f t e r 2 4 h o u r s i n c u b a t i<br />

F i g u r e : 6 M5 ea n (9 5% C.I .) pla s ma le ve ls <strong>of</strong> c ort is ol in t he High , in t e r me diat e ( M id) a n d Lo w NKC A<br />

le ve l gr o u p s a f t e r 2 4 h o u r s i n c u b a t i o n<br />

F i g u r e : 6 M6 ea n (9 5% C.I .) pla s ma le ve ls <strong>of</strong> D H E A -S in t he High , in t e r me diat e ( M id) a n d Lo w NKC A<br />

le ve l gr o u p s a f t e r 2 4 h o u r s i n c u b a t i o n<br />

F i g u r e : 6 M7 ea n (9 5% C.I .) pla s ma le ve ls <strong>of</strong> me la t on in in th e High , in t e r me dia te (M id ) a nd Lo w N KC A<br />

le ve l gr o u p s a f t e r 2 4 h o u r s i n c u b a t i o n<br />

F i g u r e : 6 ( 8 a ) I n d i v i d u a l b) ( M e a n ( 9 5 % C . I . b ) a c k g r o u n d p r o l i f e s r <strong>of</strong> a t P BM i o n Cs c ult ured<br />

F i g u r e : 6 ( a) 9 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) r o l i f e r a t i o n r e s <strong>of</strong> p o P n B s e M C s t o t h e P P D a n t i g e n<br />

F i g u r e : 7 ( a) 0 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) r o l i f e r a t i o n r e s <strong>of</strong> p o Pn BM s e Cs t o t he H e r p e s a nti g e n<br />

F i g u r e : 7 ( a) 1 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) r o l i f e r a t i o n r e s <strong>of</strong> p o Pn BM s e Cs t o t he SEB a t Da y 3<br />

w i t h / o ut co r t i s o l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 8 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

F i g u r e : 7 ( a) 2 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) r o l i f e r a t i o n r e s <strong>of</strong> p o Pn BM s e Cs t o t he P H A a t Da y 3<br />

w i t h / o ut co r t i s o l<br />

F i g u r e : 7 ( 3 a) I nd ivid ua l ( b) M e a n ( 9 5 % C . I . background ) pe r ce nt a g e s o f C D -c 8 e l T l s e x p r e s s i n g C D 9 5<br />

F i g u r e : 7 ( a) 4 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . background ) pe r ce nt a g e s o f C D -c 4 e l T l s e x p r e s s i n g C D 9 5<br />

F i g u r e : 7 ( a) 5 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e l 8 l s p e r x e s s i n g C D 9 5 i n P H A<br />

s t i m u l a whole t e d blood culture in t he a bs e nc e o f co r t i s o l<br />

F i g u r e : 7 ( a) 6 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 4 l l s e x p r e s s i n g C D 9 5 i<br />

s t i m u l a whole t e d blood culture in t he a bs e nc e o f co r t i s o l<br />

F i g u r e : 7 7 ( a ) I n ad l i ( v b) i M d u e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 8 l l s e x p r e s s i n g C D 9 5 i<br />

s t i m u l a whole t e d blood culture in t he p r e se n ce o f c o r t i s o l<br />

F i g u r e : 7 ( a) 8 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 4 l l s e x p r e s s i n g C D 9 5 i<br />

s t i m u l a whole t e d blood cultur e i t he n p r e se n ce o f c o r t i s o l<br />

F i g u r e : 7 M 9 e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f P H A s t i m u T-c l a et lls e d e xpr C D es 8 s ing CD95 a ft e r<br />

( a ) 2 4 h ou r s , ( b ) 48 h o ur s o f i n cu b at i o n wi t h a n d wi t h o u t c o r t i s o l<br />

F i g u r e : 8 M 0 e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f P H A s t i m u T-c l a e t lls e d e xpr C D es 4 s ing CD95 a ft e r<br />

( a ) 2 4 h ou r s , ( b ) 48 h o ur s o f i n cu b at i o n wi t h a n d wi t h o u t c o r t i s o l<br />

F i g u r e : 8 1 I n d i v i d u a l p e r c e n t a g e s -c e o l f l s a p ( o b -c p ) t e lls o in t C cD i u4 bc at eT d ( 3 a da ) ys wit C D h 8 T<br />

a n d wi t h o u t c o r t i s o l<br />

F i g u r e : 8 ( a) 2 I nd ivid ua l ( b) M e a n C . ( I . ) background 9 5 % pe r ce nt a g e s o f C D -c 8 e l T l s e x p r e s s i n g C D 2 5<br />

F i g u r e : 8 ( a) 3 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . background ) pe r ce nt a g e s o f C D -c 4 e l T l s e x p r e s s i n g C D 2 5<br />

F i g u r e : 8 ( a) 4 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 8 l l s e x p r e s s i n g C D 2 5 i<br />

s t i m u l a whole t e d blood culture in t he a bs e nc e o f co r t i s o l<br />

F i g u r e : 8 ( a) 5 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 4 l l s e x p r e s s i n g C D 2 5 i<br />

s t i m u l a whole t e d blood culture in t he a bs e nc e o f co r t i s o l<br />

F i g u r e : 8 ( a) 6 I nd ivid ua l ( b) M e a n ( 9 5 % C . .) I p e r c e n t a g e s o f T-c C D e 8 l l s e x p r e s s i n g C D 2 5 i<br />

s t i m u l a whole t e d blood culture in t he p r e se n ce o f c o r t i s o l<br />

F i g u r e : 8 ( a) 7 I nd ivid ua l ( b) M e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f T-c C D e 4 l l s e x p r e s s i n g C D 2 5 i<br />

s t i m u l a whole t e d blood culture in t h e p r e s e n f c e o r t o i s o l<br />

F i g u r e : 8 M 8 e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f P H A s t i m u T-c l a et lls e d e xpr C D es 8 s ing CD25 a ft e r<br />

( a ) 2 4 h ou r s , ( b ) 48 h o ur s o f i n cu b at i o n wi t h a n d wi t h o u t c o r t i s o l<br />

F i g u r e : 8 M 9 e a n ( 9 5 % C . I . p ) e r c e n t a g e s o f P H A s t i m u T-c l a et lls e d e xpr C D es 4 s ing CD25 a ft e r<br />

( a ) 2 4 h ou r s , ( b ) 48 h o ur s o f i n cu b at i o n wi t h a n d wi t h o u t c o r t i s o l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

L i s t o f T a b l e s<br />

T ab l e 1 : C l a s s i f i c a t i o n o f t h ma e in c ompo ne nt s <strong>of</strong> t h e i m m u n e s y s t e m<br />

T able 2: C D e x p r e s s -c ei lls o a n d lymphoc b y yt N e s<br />

K<br />

- 9 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T ab l e 3 : D e f i n i t i o n s o f v a r i o u s e n d o g e molec n o u s ule s<br />

T able 4: N u m b e r a n d p e -i r c n f e n c t a e d g e i n o d i f v i H d I u a V -c l es ll c ou w nh ts o c he h c a t d t he C D 4 T<br />

m o n t h l y t i m e p e r i o d s f r o m t h e R e c r u i t m e n t t o f o u r m o n t h s a f t e r t h e r e c r u i t m e n t ( T e r m 4 )<br />

T ab l e 5 : N u m b e r an d m o nt h <strong>of</strong> su b j e ct s wh o st a r t ed a nt i-r e t ro vir a l me d ic a t io n a n d d r op p e d f rom t he<br />

s t u d y ( N B : T e r m X r e p r e s e n t s t h a t X m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t )<br />

T ab l e 6 : M e a n p e r c e n t a g e s a n d c o u n t s ( s t a n d a r d d e v i a t i o n : S <strong>of</strong> D N ) K -c e l l s, C D 4 and C D 8 T-c e lls and<br />

t ota l lymp ho c yt e c ount s u s i n g a s i n lunt g l e e r v o ( 9 t ube s colle c t ed a nd a ve r a ge d on th r ee<br />

s e p a r a t e o c c a s i o n s )<br />

T able 7: M e a n ( 9 5 % C . I . ) P S S s c o r e -e s xa a m t and t h E e x a N m o n t i m e p o i n t s<br />

T able 8: M e a n ( 9 5 % C . I . ) S t a t e a n x i e t y s c o r e s i n -e xa t m h e and S T E A x a I m a t i m t e h p e o i n N t o s n<br />

T able 9: M e an ( 95% C.I .) N K -c e l l p e r c e n t a g e s i n m a l e a n d f e m a l e s t u d e n t s<br />

T able 10: M e an ( 95% C.I .) l e v e l s o f N K C A ( % k i l l i n i g n ) the N ot -s t r e s s and e d S t r e s s s e d u bg r o u p s<br />

T able 11: M e a n ( 95% C.I .) le ve ls <strong>of</strong> NKCA ( % killin g) in t he N ot -s t r e s s and e d S t r e s s e m d a l e s t u d e n t s<br />

T able 12: M e a n ( 9 5 % C . I . ) r -c a et ll in i t ho e s N ot -s o tr ef ss e d and N K C S A t r e t s s o s e t d u d e N n K t s<br />

T able 13: M e a n ( 9 5 % C . I . ) r -c a et ll in i t ho e s N ot -s o tr ef ss e d and N K C S A t r e t s s o m e a d l e N s K t u d e n t s<br />

T able 14: M e an ( 95% C.I .) C D 4 -c T e l l l e v e l s ( % ) o f m a l e a n d f e m a l e<br />

T a ble 15: T h e n u m b e r s o f p a r t i c i p a n t i n t h e t h r e e g r o u p s -hypnos ( S e l f is , J oh r e i and Re la xa t io n c ont ro l)<br />

in the N ot -s t r e s s e d a n d S t s r u e b s gr s o e up d s bas e d on t he P SS s c o r es at t he E xa m t i m e p o i nt<br />

T able 16: M e an ( 95% C.I .) S t a t e a n x i e t y s tc he o r S e s l f-hypnos i n is , J ohr e i and Re la xa t io n c ont r ol groups at b a s e l i n and e t h e Ex a m t i m e po i n t<br />

T able 17: N u m b e r s o f p a r t i c i p a nt s i n t h e t hr e e gr o u p s a t t h e Ex a m t i m e p o i n t<br />

T able 18: M e an ( 95% C.I .) l e v e l -c s e l l o f ( % t he ) N S K i e l n f-h yp no s is , J ohr e i and Re la xa t io n c ont ro l<br />

groups at b a s e l i n and e t h e Ex a m t i m e po i n t<br />

Table 19: P e r c e n t a g e s ( n u m b e r -c es ll c) ou nt s o ma f int a ine s u d or b j inc e re ac se t d s w h o s e N K<br />

(Ma i n t a i n ) e a d n d d e c r e a s e d (D e c r e a s e ) d i n t h e S e -hypnosis l f and Johrei and Re la xat io n<br />

c o n t r o l g r o u p s f o r t h -t e o-t I r n eat t e an n at lys i o is n ( mis s ing da ta we r e ad de d int o t he nu mb er in<br />

t he D e c r e a s e group) d<br />

T able 20: M e an ( 95% C.I .) l e v e l s o -c f e l l C D 4 ( % ) t T h e S i e n l f-hyp no s is , Johre i a nd Re la xat io n c on tr ol groups at b a s e l i n and e t h e Ex a m t i m e po i n t<br />

T able 21: M e an ( 95% C.I .) le ve ls o f C D -c 8 e l T l ( % t he ) S i e l n f-h yp no s is , Johre i a nd Re la xat io n c on tr ol groups at b a s e l i n and e t h e Ex a m t i m e po i n t<br />

T able 22: M e dia ns , me ans and st an dar d de via t io ns <strong>of</strong> t he P SS <strong>of</strong> t h e u n i v e r s i t y s t u d e -e n xa t s m a t n o n<br />

a nd e xa ms an d <strong>of</strong> t h e -i n H f I e c V t individuals e d a t rec r uit me nt a nd f o u r m o n t h s l a t e r<br />

T able 23: M e an ( 95% C.I .) l e v e l s o f t h e the P S N S ot -s i t n r e s s e d a n d S t subgr r e s s oe ud ps at t he<br />

r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

T able 24: M e d i a n , m e a n a n d s t a n d a r d d e v i a t i o n o f a n t x i h e t S y t a s t c <strong>of</strong> o e r t e h e u n i ve r s i ty s tude nt s a t<br />

non-e xa m an d e xa ms and <strong>of</strong> t h e -i n H f I e c V t individuals e d a t rec r uit me nt a nd f o u r m o n t h s l a t e r<br />

T able 25: M e an ( 95% C.I .) l e v e l s o f t h e S t a t e a n x i e t y s c o the r e Not-st o f rt es h se e d S a T n d A I S t i r n e s s e d<br />

subgr ou ps at t h e r e cr u i t m e nt and four months l a t e r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 1 0 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 26: M e an ( 95% C.I .) l e v e l s o f t h e the I subgr E S i ou n ps <strong>of</strong> t he N ot -st re s se d and S t r e s s at e d t he<br />

r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

T able 27: M e an ( 95% C.I .) l e v e l s o f t h e t he L o N C ot -s i tr n es s ed a nd S t r e s s subg e d r o u p s a t t he<br />

r e cr u i t m e nt and four m o n t h s l a t e r<br />

T able 28: M e an ( 95% C.I .) l e v e l s o f t h e the M C N S ot -st i re n ss e d and S t r e s s subgr e d ou ps at r e cr u i t me n t<br />

and f o u r m o n t h s l a t e r<br />

T able 29: M e an ( 95% C.I .) l e v e l s o f t h e t he P S Q N I ot -s i t n r e s s and e d S t r e s s subgr e d ou ps at r e cr u i t me n t<br />

and four months l a t e r<br />

T able 30: C o r r e l a t i o n b e t w e e n t h e C D 4 g r a d i e n t pe ( r c e l pl es r m o n t h ) a n d t h e c h a n g e s c o r e s o f<br />

p e r c e i v e d q u a -<strong>of</strong>-l l i t i f y e s c a l e s<br />

T able 31: M e an ( 95% C.I .) C D 4 -c T e ll c han ge ove r t he f ive mont h (c e lls per l p e r m o -n<br />

t h ) i n H I V<br />

inf e ct e d in dividua ls <strong>of</strong> t he I n c r e a s e c d o nt ro l a n d De cr e as e d c ont r ol subgroups<br />

T able 32: M e an ( 95% C.I .) C D 4 -c T e ll c han ge ove r t he f ive mont h (c e lls per l p e r m o -n<br />

t h ) i n H I V<br />

inf e ct e d in dividua ls <strong>of</strong> t he I m p r o v e QoL d a nd D e c r e a s e d subgroups Q o L<br />

T able 33: M e an ( 95% C.I .) C D 4 -c T e ll c han ge ove r t he f ive mont h (c e lls per l p e r m o -n<br />

t h ) i n H I V<br />

i n f e ct e d in dividua ls <strong>of</strong> t he I m p r o v e d s l e e p q u a l and i t y D e c r e a s e d s l e e p q u a l subgroups i t y<br />

T a b l e 34: M e an ( 95% C.I .) l e v e l s o f t -i n h d i e v i d u a I l s E i S n t h e i S -hypnosis, n e l f t h e Johrei H and I V<br />

Control groups a t t h e B a s e l i and n e P o st -i n t e r v e n t i o n t i m e p o i n t s<br />

T able 35: S u m m a r y o f t h e n u m b e r -i s n d i v i ( d u p a l e s r w h c o s e n c h t a n g a in e s g t he e LoC s ) o f t h e H I<br />

b e t we e n t h e Ba s e l i n e a n d po s t-in te r ve nt io n e it h er d ec re a se d ( Ga in e d s e n se <strong>of</strong> c on tr o l) or<br />

i n c r e a s e d ( L o s t s e n s e o f c o n t r o l ) i n t h e -h S e y l p f n o s i s , J o h r e i a n d C o ps n t r o l g r o u<br />

T a b l e 36: S u m m a r y o f t h e n u m b e r -i s n d i v i ( d u p a l e s r w h c o s e n c h t a n g a in e s g t he e Ms CS ) o f t h e H I<br />

b e t we e n t h e Ba s e l i n e a n d po s t-in te r ve nt io n e it h er in c re a se d ( I mpr o ve d me nt a l q ua lit y o f lif e )<br />

o r d e c r e a s e d ( D e c r e a s e d m e n t a l q u a l i t y o f l i f e ) i n t h -hypnos e S e l f is , J oh re i a nd Contr ol<br />

groups<br />

T a b l e 37: S u m m a r y o f t h e n u m b e r -i s n d i v i ( d u p a l e s r w h c o s e n c h t a n g a in e s g t he e Ps SQI ) o f t h e H I<br />

b e t we e n t h e Ba s e l i n e a n d po s t-in te r ve nt io n e it h er d ec re a se d (I mp ro ve d s le e p q u a lit y) or<br />

i n c r e as e d ( D e cr ea s ed s l e ep q ua l i t y) i n th e S e l f-hypnosis, Johrei and Control groups<br />

T able 38: M e an ( 95% C.I .) le ve ls <strong>of</strong> C D 4 gr ad ie nts (c o u n t s per l per month) i n H I -inf V e c te d<br />

i n d i v i d u a l s i n t h e S -hypnosis, e l f J o h r e i and Control groups<br />

T able 39: P er ce nta ge s (number s) o f p a r t i c i p a n t -c s e ll cw oh un o ts s ma e inta C D ine 4 d or T de c re a se d ove r<br />

t he f ive mo nt hs in t h e S e l f-h yp n o s i s a n d J o hr e i and C o nt r o l groups f o r t h e I n t e -t n t o-t i r eat o n<br />

a na lys is ( mis s ing da t a we r e a d d e d i n t o t h e n u m t b e h r e D i e n c r e group) a s e d<br />

T able 40: M e an ( 95% C.I .) le ve ls <strong>of</strong> C D 4 -ce T l l (c o u n t s per l) i n H I -inf V e ct e d in dividua ls in t he<br />

g r o u p s o f t h e S e -hypnosis, l f J oh r e i and D a t a b a s e-c ont ro ls a t t h T e r a i n i n g p e r i o d<br />

T able 41: M e an ( 95% C.I .) C D 4 gr a die nt s i n -individuals H I V in the S e l f-hypnos is , J ohr e i a nd Da ta bas e<br />

control gr ou ps , a nd i n a l l the 96 in d i v i d u a l s ( A L L ) a t -i t h n e t e P r v e e n t i o n p e r i o d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 1 1 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T a b l e 42: P e r c e n t a -i g n e d i v s i d u a l o s f i n t h H e I S -h e V l y f p n o s i s , J o hr e i a n d D a t a b as e co n t r o l g r o u p s<br />

w h o s e c h a n g e s i n C D 4 g r a d i e n t s b e t w e e n -i t n h t er e ve P n r t e i o n a n d P os t-inte r ve nt io n per io ds<br />

w e r e e i t h e r i n c d r , e a s e t a y e d t h e s a m e o r w i d t e h c r a e a j s u e d g e m e n t t h a t a <strong>of</strong> c fh our a n g oe f<br />

l e s s c e l l pe s r l pe r mo nt h wa s de f ine d a s t h e s a m e c h a n g e ( S t a y e d t h e s a m e s u b g r o u , p mor ) e<br />

t h a n f o u r i n c r e a s ( e I m p r o v i n g s u b g r o u p ), a nd m o r e t h a n f o u r d e c r e a s e ( W o r s e n i n g s u b g r o u p )<br />

T a b l e 43: M e an ( 95% C.I .) C D 4 gr a die nt s i n -individuals H I V in the S e l f-h y p n o s i s , J o h r nd e i Da a ta bas e<br />

control g r o u p s at t h e P r -i e n t er ve n t i o n an d P ost-i n t e r v e n t i o n p e r i o d s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

Ap p e n d i x 6<br />

T able A-1: M e an ( 95% C.I .) P SS le ve ls <strong>of</strong> t h e C o h o r t s A and B a t t h e -exam N o n and E x a m t i m e p o i n t s<br />

T able A-2: M e an ( 95% C.I .) St a te a nx ie t y le ve ls <strong>of</strong> the Cohorts <strong>of</strong> A and B a t t h e -exam N o n and Exa m<br />

t i m e p o i n t s<br />

Ta b l -3: e M A e a n ( 9 5 % c y t C o t . o x I i c a . c t ) i v i t N y K i Cohorts n t h e A a n d B a t Non-e t h e x a m a n Exa d m<br />

t i m e p o i n t s<br />

T able A-4: M e a n ( 9 5 % -c e ll C p . e r c I e n . t a g ) e s in the N K C o h o r t s A a n d B a t t h -e e x a N m o n a n Exa d m<br />

t ime points<br />

T able A-5: M e a n ( 9 5 % C . -c I e . l ) l e r p C c D 4 e n T t a g e s i n t at h the e Non-ex C o h ao m r at nd s A a n d B<br />

E x a m t i m e p o i n t s<br />

T able A-6: M e a n ( 9 5 % 8 T-c C e. ll pI e rc . e nt ) a ge s C in D the Cohor ts A and B at the Non-ex a m a nd<br />

E x a m t i m e p o i n t s<br />

Table A-7: M e a n ( 9 5 % C A . I l e . v e ) l s a N t K -e t xa h e m and N o n E x a m t i m e p o i n t s<br />

T a b l e A-8: M e a n ( 9 5 % -c C . e l I l . ) a n d N K C D 4 -c a e l n l d ( C % D ) 8 a T t -e t xa h m e and N o n Ex a m t ime<br />

points<br />

T a b l e A-9: Numbe r <strong>of</strong> st ude nts in th e N ot -s tr e ss e d and S t r e s s se ubgr d ou ps wit h r e g a r to d gender who<br />

f i l l e d i n th e P S S a n d h a d b l o o d c o l l e c t i o n f o r l a n y d m p N h K o c C y A t e l e v e l a n a l y s e s<br />

T able A-10: M e an ( 95% C.I .) N K -c e l l p e r c e n t a the g e s Not-s i n tr e ss e d and S t r e s s subg e d r o u p s<br />

T able A-11: M e a n ( 9 5 % -c C e. ll pe I r. ce nt ) a ge s N in K the Not-s tr e ss e d and S t r e s s m e d a l e s t u d e n t s<br />

T able A-12: M e a n ( 9 5 % -c C e. ll pe I r. ce nt ) a ge s N in K the Not-s t r e s s e a d n d S t r e s s f e m d a l e s t u d e n t s<br />

T a b l e A-13: M e a n ( 95% C.I .) le ve ls <strong>of</strong> NKCA ( % killin g) in t he N ot -s t r e s se d and S t r e s s f e ma d le<br />

s t u d e n t s<br />

T able A-14: M e a n ( 9 5 % C . I . ) l e v e l s o f N K C A ( % k i l l i o n f g ) m a l e a n d f e m a l e<br />

T able A-15: M e a n ( 9 5 % C . I . ) r -c a et ll in i t ho e s N ot -s o tr ef ss e d and N K C S A t r e t s s fo e ma d le N K<br />

s t u d e n t s<br />

T able A-16: M e a n ( 9 5 % C . I . ) r -c a e t l l i n o m s a l e o a n f d f e m N a K l C e A s t u d t e n o t s N K<br />

T a b l -17: e MA e an ( 95% C.I .) C D 4 a n d C -c D e 8 l l T l l e s v e ( % ) i n the N ot -s t r e s s e a d n d S t r e s s e d<br />

subgroups<br />

- 1 2 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-18: M e a n ( 9 5 % C . I . ) C D -c 4 e ll le a ve n ls d ( %) C D in 8 the T N ot -s tr e ss e d and S t r e s s ma e d le<br />

s t u d e n t s<br />

T able A-19: M e a n ( 9 5 % C . I . ) C D -c 4 e ll le a ve n ls d ( %) C D in 8 the T N ot -s tr e ss e d and S t r e s s f e ma d le<br />

s t ud e n t s<br />

T able A-20: M e an ( 95% C.I .) C D 8 -c T e l l l e v e l s ( % ) o f m a l e a n d f e m a l e s t u d e n t s<br />

T a b l e A-21: M e a n ( 95 % C. I .) P SS l e ve l s i n t h e t h r e e gr o up s at t h e E xa m t i m e p o i nt<br />

T able A-22: M e a n ( 95 % C. I .) P SS s c o r e s i n ma l e s u bj ec t s i n t h e t h r e e gr o up s a t t h e E x a m me t i point<br />

T able A-23: M e a n ( 95 % C. I .) P SS s c o r e s i n f e m a l e s u bj e ct s i n t h e t hr e e gr ou p s a t t h e E x a m t i m e p o i n t<br />

T able A-24: M e an ( 95% C.I .) S t a t e a n x i e t y s c t o h r e m e s a l e i s n u b j e c t s o f t h e S -hypnos e l f is , J oh re i a nd<br />

R e l a x a t i o n c o n t r o l g r o au t p b s a s e l i n and e th e E x a m t i m e p o i nt<br />

T able A-25: M e an ( 95% C.I .) S t a t e s c o r e t s h e f i e n m a l e s u b j e c t s S i e n l f-hyp t h e no s is , J ohr e i a nd<br />

Re la xa t io n c ont rol gr oup at b a s e l i n and e t h e E x a m t i m e p o i nt<br />

T able A-26: M e a n ( 95% C.I .) NKCA le ve ls ( % kil lin g) in t h e t hr e e gr ou p s a t t h e E x a m t i m e p o i n t<br />

T able A-27: M e a n ( 95% C.I .) NKCA le ve ls ( % kil lin g) in ma le s u bj e ct s in t h e t hr e e gr o u ps a t t he Ex a m<br />

t i m e p o i n t<br />

T able A-28: M e a n ( 95% C.I .) NKCA le ve ls ( % kil lin g) in f e ma le su b je ct s in t h e t hr e e gr ou ps a t t he<br />

E x a m t i m e p o i nt<br />

T able A-29: M e an ( 95% C.I .) l e v e l -c s e l l o f ( % ) N K o f m a l e ts he t gr u d oe up n t s s o f t i h n e S e l -hypnos f is ,<br />

J o h r e i a n d C o n t r o at l s b a s e l i n and e t h e Ex a m t i m e p o i n t<br />

T able A-30: M e an ( 95% C.I .) l e v e l -c s e l l o s f ( % t N ) h K e f e i m n a l e s u b j e c t s i n t h e S -hypnos e l f is , J ohr e i<br />

a n d R e l x a t i o n c o n t r o l g r o at u p b s a s e l i n ae nd t h e Ex a m t i m e p o i n t<br />

T able A-31: M e an ( 95% C.I .) l e v e l s o -c f e l l C D 4 ( % ) T o f m a l e t s h t e u S d e l f-hypnosis, n t s i n Johrei and<br />

R e l a x a t i o n c o n t r o l g r o au t p b s a s e l i n and e t h e E x a m t i m e p o i nt<br />

T able A-32: M e an ( 95% C.I .) l e ve l s o f C -c D e 4 l l s T ( % the ) f e i m n a l e s t u d e n t s i n t h e S -hypnosis, e l f<br />

J o h r e i a n d R e l a x a t i o n c o n t r o l g ar t o b u a p s e l i n and e t he E x a m t i m e p o i nt<br />

T able A-33: M e an ( 95% C.I .) l e v e l s o -c f e l l C D 8 ( % ) T o f m a l e t s h t e u S d e l f-hypnosis, n t s i n Johrei and<br />

R e l a x a t i o n trol c o groups n a t b a s e l i n and e t h e E x a m t i m e p o i nt<br />

T able A-34: M e an ( 95% C.I .) l e v e l s o -c f e l l C D s 8 ( % the T ) f e i m n a l e s t u d e n t s i n t h e S -hypnosis, e l f<br />

J o h r e i a n d R e l a x a t i o n c o n t r o l g ar t o b u a p s e l i n and e t he E x a m t i m e p o i nt<br />

T able A-35: Co r r e la t ion be t we e n t he CD4 g r a d i e n t ( c e l per l s l pe r m o n t h ) a n d t st h re e s s pe r ce pt ion<br />

s c o r e s a n d t h e p e r c e i v e d q u -<strong>of</strong>-l a l i f t e y a t r e c r u i t m e n t t i m e p o i n t ( p r e ) a n d -mont f o u r hs<br />

a f t e r t h e r e c r u i t m e n t ( p o s t )<br />

T able A-36: C o r r e l a t s i b o e n t w e e n t h e C D 4 g r a d i e n t pe ( c e r l l s pe r m o n t h ) a n d t h e c h a n s g c e o r e s <strong>of</strong><br />

s t r e s s p e r c e p t i o n s c a l e s<br />

T able A-37: Numbe r <strong>of</strong> H I V-i n f ec t e d i n d i vi d u a ls who had vi r a l l o a d l e ve l c h e c k a t th e mo nt hly t ime<br />

pe r i o d s f r m o t h e R ec r u i t me n t to four mont hs a f te r t he r ec ru it me nt (Te r m 4)<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

- 1 3 - I m p e r i a l C o l l e g e L o n d o n


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-38: Co r r e la t ion be t we e n t he vi r a l l o a d l e ve l gr a d i e n ts (log-t r a nsf o r med vir a l c o p ies p er l p e r<br />

m o n t h ) a n d t h s e t r e s s p e r c a e n p d t i t o h n e p e r c e i v e d q u -<strong>of</strong>-l a l i t f e y s c o r e at s re c ru it me nt t ime<br />

p o i n t ( p r e ) a n d f o u r m o n t h s l a t e r ( p o s t )<br />

T able A-39: Cor re la t ion be t we e n t he vi r a l l o a d l e ve l g r a d i e n t log-t ( r a nsf or me d copie s pe r l pe r mon t h)<br />

a n d t h e a n c g h e s c o r e s o f p e r c e i v e d s t r e s s a -<strong>of</strong>-l n d i q f u e a l s c i o t r e y s<br />

T able A-40: Cor re la t ion be t we e n t he N K g r a d i e n t ( c e pe l l r s l pe r m o n t h ) a n d t st h re es s pe rc e pt ion<br />

s c o r e s a n d t h e p e r c e i v e d q u -<strong>of</strong>-l a l i f t e y a t r e c r u i t m e n t t i m e p o i n t ( p r e ) a n d -mont f o u r hs<br />

a f t e r t r h e c r u i t m e n t ( p o s t )<br />

T able A-41: Cor re la t ion be t we e n t he N K g r a d i e n t ( c e pe l l r s l pe r m o n t h ) a n d t h e c h a n g e s c o r e s o f<br />

p e r c e i v e d s t r e q s u s a l a i n -<strong>of</strong>-l t d y i f e s c o r e s<br />

Table A-42: M e an ( 95% C.I .) le ve ls <strong>of</strong> t he St at e a nx iet y a n d P S s S c o r e s -individ i n ua t ls h in e the H I V<br />

S e l f-h y p n o s i s , J o h r e wa i i t-l a n i d s t co e d nt r o l gr o u p s at t h e B as e l i n e an d t h e P o s t-<br />

i n t e r v e n t i o n t i m e p o i n t s<br />

T able A-43: M e an ( 95% C.I .) le ve ls <strong>of</strong> t he L o C , M C S a n d P S Q in I the HIV-i n d i v i d u a l s i n t h e S -e<br />

l f<br />

h yp n o s i s , J oh r e i an d wa i t-l i s t e d c o n t r o l g r o au t p t s h e B a s e l i and n e P o st -in t er ve nt ion t ime<br />

points<br />

T able A-44: M e an ( 95% C.I .) le ve ls <strong>of</strong> r e g r e s s i o n g r a d i v e i n r t a s l i l n o a d l e v -t e rl a nsf s or ( me L o g d ) i n<br />

H I V-i n f e c t e d i n d i v i d u a l s i n t h e S -hypnosis, e l f J o hr e i a nd wa i t -l i s t e d c o n t r o l g r o u p s<br />

T able A-45: M e a n ( 5% 9 C.I .) le ve ls <strong>of</strong> r e gr e ss ion gr a die nts in N K -c e l l (counts pe r l p e r m o n ) t i h n<br />

H I V-i n f e c t e d i n d i v i d u a l s i n t h e S -hypnosis, e l f J ohr e i a nd wa i t -l i s t e d c o n t r o l g r o u p s<br />

Text box 1: Pr o j e c t s y n o p s i s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n<br />

Li s t <strong>of</strong> T e x t b o x es<br />

Text box 2: Ap p r a i s a l o f a r s t r e s s o<br />

38<br />

Text box 3: El e m e n t s o f c o p i n g wi t h a t h r e at 38<br />

Text box 4: Ps yc ho l o gi c a l i n t e r ve n t i o n s i n t h i s p r oj ec t 43<br />

Text box 5: Su m m a r y o f h y p o t h e s e R s e : S t r e -re s s la te d cha nge s <strong>of</strong> e ndoc r ine s ys te m wh ic h ma y<br />

c o n t r i b u t e t o s u p p r e s s c e l l u l a r i m d m e r u n s e u s t r a e i n s e p d o n s t e r s e s s u n<br />

- 1 4 - I m p e r i a l C o l l e g e L o n d o n<br />

21<br />

48


P s yc h o l o g i c a l i n t e r v e n t p i s o y n c h -n o a e n u d r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

A C T H : a d r e n o c o r t i c o t r o p h i c h o r m o n e<br />

A N O V A : a n a l y s i s o f v a r i a n c e<br />

A P -1: a c t iva t io n pr ot e in 1<br />

ART : a n t i -r e t r o vi r a l t r e at m e nt<br />

C B G : c o r t i s o l b i n d i n g g l o b u l i n<br />

C D : c l u s t e r s o f d i f f e r e n t i a t i o n<br />

C F S E : c a r b o x y f l u o r e s c e i n m i d s y u l c c e s i t n e r<br />

c p m : c o u n t p e r m i n u t e<br />

C R F : c o r t i c o t r o p h i n r e l e a s i n g f a c t o r / ( h o r m o n e )<br />

C R P : -r e C a c t i v e p r o t e i n<br />

C S F : C o l o n y s t i m u l a t i n g f a c t o r<br />

C T L : ( c y t o t o x i c / c y t o l i t i c T l y m p h o c y t e )<br />

C V : c o e f f i c i e n t o f v a r i a t i o n<br />

D H E A (-S ) : d e h y d r o e p i a n d r o s t e r o n e ( s u l p h a t e )<br />

A b b r e v i a t i o n s<br />

EE G : e l e c t r o e n c e p h a l o Q o g L : r q a u a m l i t y o f l i f e<br />

E : T r a t i o : E f f e c t o r v s . T a r g e t r a t i R o C T : r a n d o m i c s o e nt d r o l l e d t r i a l<br />

F I T C : f l u o r e s c e i n i s o t h i o c y a n a t e<br />

F C S : f o e t a l c a l f s e r S A u M : m s y m p a t h e t i c -m a e d r u e l n l o a<br />

G A B A : g a m m a a m i n o b u t y r i c a c i d<br />

G C R : g l u c o c o r t i c o i d r e c e p t o r<br />

H I V : h u m a n i m m u n o d e f i c i e n c y v i r u s<br />

H P A : h y p o t h a l a m u s p i t u i t a r y a d r e n a l ( a x i s )<br />

H S V : h e r p e s s i m p l e x v i r u s<br />

I E S : I m p a c t o f E v e n t S c a l e<br />

I L : I n t e r l e u k i n<br />

I F N : i n t e r f e r o n<br />

I T A M / : i m I m u T n o I r e c M e p t o r t y r o -bas s i n ee d<br />

a c t i v a t / i o n h i b i t o m r o y t i f s<br />

K I R : k i l l e r i m m u n o g l o b u l i n l i k e r e c e p t o r<br />

KP SS: K e s s e l e r P er c e i ve d So c i a l Su p p o r t<br />

Lo C : Lo c u s o f C on trol<br />

L P S : l i p o p o l y s a c c h a r i d e<br />

M C R : m i n e r a l c o r t i c o i d r e c e p t o r<br />

M H C : m a j o r h i s t o c o m p a t i b l i t y c o m p l e x<br />

NCR: n a t u ra l c yt otoxic re c ept or s<br />

N F B: n u c l e a r f a c t o r k a p p a B<br />

N K c e l l : N a t u r a l K i l l e r c e l l<br />

N K C C : N a t u r a l k i l l e r c y t o t o x i c a c t i v i t y<br />

P B L : p e r i p h e r a l b l o o d l y m p h o c y t e<br />

P B M C s : p e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s<br />

P B S : p h o s p h a t e b u f f e r s a l i n e<br />

P E I : P e r s o n a l i s e d E m o t i o n a l I n d e x<br />

P F A : p a r a f o r m a l d e h y d e<br />

P H A : p h y t o h a e m a g g l u t i n i n A<br />

PI: propidium iodide<br />

P N I : p s y -n c h e o u r o-immunology<br />

P P D : p u r i f i e d p r o t e i n d e r i v a t i v e<br />

P S S : P e r c e i v e d S t r e s s S c a l e<br />

P S Q : P e r s o n a l i t y S y n d r o m e Q u e s t i o n n a i r e<br />

P S Q I : P i t t s b u r g h S l e e p Q u a l i t y I n v e n t o r y<br />

R E M : r a p i d e ye m o ve m e n t<br />

S A S : S t a t i s t i c a l A n a l y s i s S o f t w a r e<br />

S D : s t a n d a r d d e v i a t i o n<br />

S E B : S t a p h y l o c o c c a l E n t e r o t o x i n<br />

SI BS: S p i r i t u a l I n v o l v e m e n t a n d B e l i e f s S c a l e<br />

SoC : s e n s e o f c o h e r e n c e<br />

S O P s : s t a n d a r d o t p i e n r g a p r o c e d u r e s<br />

S P S S : S t a t i s t i c a l P a c k a g e f o r S o c i a l S c i e n c e s<br />

S T A I : S t a t e a n d T r a i t A n x i e t y I n v e n t o r y<br />

T C I : T e m p e r a m e n t a n d C h a r a c t e r I n v e n t o r y<br />

T C M : t i s s u e c u l t u r e m e d i u m<br />

T h . : H e l p e r T l y m p h o c y t e<br />

T N F : T u m o u r n s e i c s r f a o c t o r<br />

T-r e g : r e g u l a t o r y h e l p e r c y t T e l y m p h o<br />

T U N E L : T -m d T e d i a t e d d U T P n i c k e n d l a b e l l i n g<br />

W H O : W o r l d H e a l t h O r g a n i s a t i o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 5 - I m p e r i a l C o l l e g e L o n d o n


P s yc h o l o g i c a l i n t e r v e n t p i s o y n c h -n o a e n u d r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

A c k n o w l e d g e m e n t s<br />

I wis h t o t ha n k a ll t he pa rt ic ipa nt s wh o t oo k p a r ts in th e pr oj e ct as st u d y s u bj ec ts .<br />

T he wor k in t his t he s is wa s funded by t he Jo hr e i A c a d e m y and J oh r e i As s o c i a t i . o n m I os t gr a at m ef ul t o<br />

t he m f or t he ir g e n e r o s i and t y f o r t h e i r k i n d support i n d e v e l o p i n g m a t e r i a l s o t f h Je ohr e i in te r ve nt ion.<br />

I would li ke t o give s pe c ia l thanks to D r . D o n C . H e n f d o e r r h s i o s n e n d u ra b l e c los e s upe r vis io n a nd Pr <strong>of</strong> .<br />

John H. Gruze lie r f or a llowing me t o s t ar t a nd c o n du ct t he pr o je ct . T he y h a ve gi ve n me ins pir at io n to s ee<br />

the pr oj e ct through. D r . T a n n i s M . L a i d l a w , D r . P r a b u d h a D w i v e d i a n d e M d r . B r y a n B e n n e t t w<br />

t o g e t h e r w i t h m e a s a r e s e a r c h t e i a m n f v st o i r udie v o t h s. e I a m v er y gr a t e ful t o t he m. One <strong>of</strong> th e<br />

ps yc holo gic a l int e r ve nt ions , the Se l f-h y p n o s i s t r -up a i s en s si io ns n , g wa s pla a nned n d a nd f o l l o w<br />

c onduc te d by Dr . La idla w. T h e m o c k n e u -f r e o e d b a c k s e s s i o n s ( r e l a x a t i o n c o n t r o l we ) r e c on du ct e d by Dr .<br />

D w i ve d i . M r . B e n n et t wa s in charge <strong>of</strong> pa t i e n t r e c r u i t m e n t a n d o r e g d a n m i e s e t i n g s f o r the pa rt ic ip a nts .<br />

Without any <strong>of</strong> the m, t h i s p r o j e c t w o u l d u n d o u b t e d l y h a v e n e v , e r o r b e v n e n c o s m . t p I a l ar m e t e d<br />

mos t in deb te d to t h e i r gr ea t c o n t r i b u t s, i pe o n rs on a l he lp a nd wa r m supp or t .<br />

My s p e c i l a tha nks a ls o go to P r o f . A d r i a n P . B u r g e s s a n d D r . M a r t i n R . G o . o Th d i e y r g a v e m ve e r y<br />

us e ful a n d e n c our a ging input s a t t h e tr a n sf er e x a m to P h . D. f ro m M .P h il. Dr . Ala n W. St e el contributed t o<br />

the i n v i vo H I V-s t u d y a s a n i n d e p e n d e n t r e s e a l r e c h t e r c a t s o e m controls. a t c h e d D r . S i m o n E . B a r t o n<br />

k i n d l p y e r m it t e and d ga ve support t o r e -pa c t ie r nt u s in i his t c linic H I . MV r . M oha me d Sh amj i he lp e d me<br />

t o st ar t t he i n v i et xpe r o r ime nt s be fore t he pr oj e ct co mme nc ed . I a m in de bt e d t o t he ir kin d he lp a nd w a r m<br />

s uppor t . I a p p r e c i a t M e .Sc . st u d e n t r e s e a r c h e rs, I j e o m U a g w u-Onuoha a n d A l e x G , a al nd e B. Sc . s t udent r e s e a r c h e r s, L i n d a F a r a h a n i , C a t r i n a L y n c h , r N i s c t k i E n n e z o B r , i n C c h a t , T and o m He F le r ne a n c h<br />

M a r c o ne l l , f or t he ir c ont r ibut ion t o t he s tu dies . I a p r ep c iat e t he s e cr et ar ia l a s s ist anc e give n by M r s . Ann<br />

E b b e r s o n t h r o u g h o u t m y P h . D . . T c o h u a n r k s e a l s go o t o a ll t he r es e ar c h st a ff / c lin ic a l la bo r at or y st af f /<br />

s t u d e n t s a t C h a r i n g C r o s s N e u r o s c i e n c e D i v i s i o n , a t C h e l s e a a n d W e s t m i n s t e r nt I m m u n o l o g y D e p a r<br />

a n d S t . S t e p h e n ’ s A I D s T r u s t K o b w l h e r o C k e n p t r e m e g o i n g w h e n I w a . s s t r u g g l i n g<br />

I n a d d i t i o n m , ve I r y a gr a t ef ul t o P r o f . M a r k J , e Pn r<strong>of</strong> s e . n Y u k i h i s a K u r a s a w a, D r . ieson, G r a Dr h . a m J a m<br />

G e r a l d S , t Pr e i <strong>of</strong> n . Fr a nc es Got c h, Dr . N a t h a l i Fouquet, e Dr . Philippe Dona t ie n , Dr . Da vid V e r n o n, Dr.<br />

M a l c o l m H a w , k e n P r o f . T o m and S e n s k P y r o f . J u f o l r t he i r a c o m m B en u t s c o n k t he i m n a n g u sc h r i a pt. m I<br />

would l ike t o thank my e xa mine rs , P r o f . P h i l E v a n s ’d a n P d r o R f e . v Goulding, N i c k f or t heir t houghtf ul<br />

a n d u s e f u l e s tu ions g g . To t he a f o r e m e n t i o n a e n d m a n y o t h e r u n n a m e d c o l l e a g a u n e d s f r i e n , d who s<br />

ha ve a ls o h e lpe d t owa r ds t he c o mp let io n o f t his t h es is , I e xt e n d my s in c er e t ha n ks .<br />

A k i r A a I T O N<br />

London, August, 2006<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 6 - I m p e r i a l C o l l e g e L o n d o n


Chapter I<br />

Introduction<br />

- 1 7 -


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

CO NTENTS O F CH APTER 1<br />

1 . 1 P r o j e c t o v e r v i e w<br />

1 . 2 T h e o r e t i c a l f r a m e w o r k<br />

1 .2 .1 I m m u n e s y s t e m<br />

I n t r o d u c t i o n<br />

1 . 2 . 1 . 1 I n n a t e a n d a d a p t i v e i m m u n i t y<br />

1 .2 .1 .2 C o m m u n i c a t i o n b e t w i e m e m n u n e c e l l s<br />

1 .2 .2 N e u r o-e n d o c r i n -i o m m u n e i n t e r a c t i o n<br />

1 .2 .2. 1 B r a i -t n o-i m m u n e p at h w a y 30<br />

1 .2 .2. 2 I m m u n e-to-b r a i n p a t h w a y<br />

1 .2 .2 . 3 C i r c a d i a n n t h e r -e n h e n u d y r o c o t r i h n -i o m m u n e n e t w o r k<br />

1 .2 .2 . 4 C i r c a d i a n r h y t h m a n ud b jecti s ve w e l l -b e i n g 35<br />

1 .2 .3 P s y c h o l o g i c a l i n p u t i n -n t e h u e r o-e p s n d y o c c h r o i n -i o m m u n e n e t w o r k<br />

1 .2 .3. 1 Str e s s o r 36<br />

1 .2 .3. 2 St r e s s p e r c e p t i o n<br />

1 .2 .3 . 3 P s y ch o l o g i c a l t r a i n i n g i n t e r v e n t i o n<br />

1 .2 .4 St r e s s-a s s o c i a t e d c h a n g e s<br />

1 . 2 . 4 . 1 C h r o n o l o g i c a l d e f i o n f i s t i r e o s n s r e s p o n s e<br />

1 .2 .4 . 2 A c u t e s t r e s s r e s p o t n h s e s n e -e i u r n d o c r i n -i o m m u n e n e t w o r k 44<br />

1 .2 .4 . 3 Su s tai n ed s tres s and ch an ges in th e p s y c h o-n e u r o-e n d o c r i n - o<br />

1 . 3 A p p r o a c h t a k e n<br />

i m m u n e n e t w o r k<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 8 - I m p e r i a l o C n o d l o n l e g e L<br />

22<br />

27<br />

32<br />

33<br />

37<br />

39<br />

43<br />

46<br />

19<br />

22<br />

30<br />

36<br />

43<br />

49


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1.1 Th e p r o j e c t o v e r v i e w<br />

S t r e s s i s i n e v i in t a e b v l e r y d a y l i a n f d e it a f f e c t s m e n t a l a n d p h ys i c a l w e l l-b ein g b oth<br />

b e n e f i c i a l l y a n d d e t r i m e n t a l ly [ C o h e n & H e r b e r t , 1 9 9 6 ; E v a n s e t a l . , 2 0 0 0 ; M a r m o t , . 2 Th 0 0 is 4 ]<br />

p roject i s b as ed on t h e h yp oth es is th at th e d etrimen tal ef fect s o f s t res s u p o n p s yc h o l o g i c a l w e l l-<br />

b e i n g a n d g e n e r a l h e a l t h iate c a n d b y e p sa ych l l ol e ogi v c al i n t e r v e n t [T i e o x n t b o x ]. 1<br />

P s y c h o l o g i c a l i n t e r v e n t i o n i n t h e -s c o om n t ati e x c t m ed o f ici np e s [ y Wal c h o d s tein e t al.,<br />

2 0 0 1 ; W a l k e r e t a l . , 1 9 9 h 9 a ] s b o t h r a i n i n g a n d p r a c t i c e a s , p b e c t o s t h o f to p ro w vi h d e i c h a i m<br />

o t h e r p e r s p e c t i v e s o f l i f e e v e n t s ( p s e t r e c s e s p t ) i an o d n cop in g s ki ll s (s tres s man ag emen t) in<br />

o r d e r t o r e d u c e le t vels h e o f s tres s . T w o p s y c h o l o g i c a l i tions n t e r u s v e d n i n is t p roject h we re<br />

Self-h yp n os is an d J oh rei , a J ap an es e s ys t em e n c o m p a s s i g n s tres s man age men t . Th es e<br />

i n t e r v e d n to t e n c i o u o r a g n e s t h e p a r i t i c m i p a n t s t o s e c u r e t h e i r o w n t i m e f o r with t h e m s e l v e s<br />

r e l a x a t i o n t e c h n i q u as e s well as to r e d u c e s t s r s e b y p r o v i d i n g a l t e r n a t i v e p e r s p e c t i v e , s o a f n d<br />

c o p i n g s t r a t e g i fo e s r, s t r e s sf u l l i f e e v e . n t s<br />

Th e f i e l d s o f p ‘ s y c h o-n e u r o-e n d o c r i n o l o g ’ y [ d e K l o e t , 2 0 0 0 ; S a p o l s k y e t a l . , 2 an 0 0 d 0 ]<br />

‘p s y c h o-n e u r o-i m m u n o l o g ’ y [ A d e r & C o h e n , 1 9 9 3 ] a r e b as ed on th e con cep t <strong>of</strong> Descartes'<br />

‘m i n d a nd b o d y ’ or ‘t h e w a y w ith th e b o d y -m i n d’ [ Y u a s a & K a s u l i s , 1 9 8 . 7 A ] g ro wi n g b od y <strong>of</strong><br />

evid en ce s u gges t s t h at t h ere are cros s reg u lator y in flu en ces b etween ps ych ol ogic al, n eu rological ,<br />

en d ocri n ol ogi c al an d i mmu n ol ogical s ys t ems . Th is h as led in ves tigat ors t o p rop os e th e<br />

e x i s t e n c e o f a n i g n r t a e t e d p s y -n c e h o u r o-e n d o c r i n -i o m m u n e n et work , in wh ich a ch an ge in on e<br />

facet h as con s eq u en t i al i n fl u en ces up on oth er p arts <strong>of</strong> th e n etw or k. Th e p rimar y m ed iators in th e<br />

n e t w o r k i n c l u d e c a t e c h o l s a m f i r n o e m t h e s y m p a t -a h d e t r i e c n o-m e d u l l a ( S AM ) s ys t e m , a d r e n a l<br />

h o r m o n e s f r o m t h e h y p o t h a l a -pituitary-ad m u s ren al ( HP A) a xi s an d a m yriad <strong>of</strong> c o mp on en ts <strong>of</strong><br />

t h e i m m u n e s y s t e m , i n c l u d i n g i n d i v i d , u cell a l c se ul rface l s recep to rs , an d in tracell u lar an d<br />

in tercel l u l ar mes s en gers (c yt okin es ) .<br />

Th e fiel d <strong>of</strong> s t res s res ea rch h as n ot yet ag reed u p on a definition o f s tr es s th at i s u s ed in all<br />

s t u d i e s . Fo r e x a m p l e , th e d i s t i n c t i o n b e t w e e n a c u t e a n d s u s t a i n e d s t r e s s i s a m b i g u o u s a ies n d v a r<br />

f r o m s t u d y t o s t e u d c y u . r r e I n n t t h h e , s acu i s te or s u s tai n ed s tres s was d is tin gu is h ed on th e<br />

ba s is <strong>of</strong> t i m e i n a b i o l o g i c a l c y c l s t e . r e s A s c s u w t d a e f i n e d a s w h e n e f f e c t o f s t or r e s tres s<br />

r e s p o n s e i s c o n t a i n e d w i t h , i n i . o e n e a d a y s i n g l . e In c on c tras i t , r s u c s t a i n d e d i s t a r e n s s r h y t h<br />

was d efi n ed as s tres s th at th e effect l a s t s f o r m o r e t e h a d n a . y T o n h i s lead s to a wo r ki n g<br />

h yp oth es is th at s u s tai n ed s tres s is as s ociated with altere d c i r c a d i a n p a t t e r n s p o s f y c h t o-<br />

h e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

n e u r o-e n d o c r i n -i o m m u n e n et wor k. Si n ce th e p s ych ol ogical in terven tion s u s ed in the p roject<br />

r e q u i r e w k e s e o f t r a i n i n g a n d i p r s a i c n t v i e s c e t , i g a t f t h o i c u o se n d o n t h se u s tain ed st res s .<br />

P r e v i o u s r e s e a r c h h a s s h o w n t h a t th e s t r e s -as s s oci at ed i n a p p r o p r i a t e r e s p o n s e o th f e<br />

immu n e s ys tem h as b een s h own to c o m p r i s : e<br />

1 . Im p a i r e d c e l l u l a r i m m u n e r e s p , o n w s e h s i c h a l d e t o a n i n c r e a s e i n s u s c e p t i b i l it y t o<br />

in fection an d mal i gn an c y [ G a r s s e n , 2 0 0 4 ]; a n d<br />

2 . Ex c e s s i v e i n f l a m m a t o r y r e a c t , i w o n h s i c h m a y b e d u e t o i m p a i r e d s u p p r e s s i v e -s<br />

e l f<br />

r e g u l a t , i o r n o v e r-p r o d u c t i o n o f -i n p f r l o a m m a t o r y c y t o k i n de in s g l to e a an<br />

au gmen t ed s everi t y <strong>of</strong> s ymp to ms o f aller g y or au toim mu n e d is eas es [ C l e a r e , 2 0 0 3 ].<br />

T h i s p r o j e c t f o n c u t h s e d f i r s t p t a - r th e s t r e s s-i n d u c ed i m p e n a t i o f r m c e l l u l a r . i m m u n i t y<br />

T h e e f f e c t s o f s t r e s s a n d p s yc h o l o g i c a l i n t e r v e n t i o n u p o n th e p s y c h -n o e u r o-e n d o c r i -n<br />

o<br />

i m m u n e n et wor k we re in ves tig ated i n v i in v o u n ivers it y s tu d en ts faci n g ex ams as a n examp le <strong>of</strong><br />

individ u al s wi th time-limited s u s t a i n e d s t r , e s s a n d -in i fected n a H d I u l t V s as an exa mp le <strong>of</strong><br />

i n d i v i d u a l s o w n i g o t i h n , g life-lo n g , d i s e a s -a e s s o c i a t e d s t r e s s . Ge n e r a l a n d m e n t a l w e l l-b ein g<br />

w e r e i n v e s t i g a t e d t h r o u g h q u e s t i o n n a i r e s d e s i g n e d t o m e a s u r e p e r c e iv e d s tres s , an x iet y, q u a l -i<br />

t y<br />

o f -li fe, an d s leep q u al it y. Th e e ffects <strong>of</strong> s t res s u p on th e p s y c h o-n e u r o-e n d o c r i n -i o m m u n e<br />

n etwork were exa mi n ed t h rou gh im mu n e p r<strong>of</strong>iles in clu d i n g d i s eas e p arameters . As s ociation s<br />

b e t w e e n t h e m e d i a t o r s p o s f y c t h o-n e e u r o-e n d o c r i n -immu o n e n et work were al s o i n v e s t i g a t ed<br />

i n v i in t r ord o er t o d em o n s t r a t e a n y d i r e c t s bl etween i n k h orm on e level s an d immu n e<br />

p aramet ers .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

! " #<br />

T e x t b o x 1 : P R O J E C T S Y N O P S I S<br />

" " $ % % % & '<br />

) * # + # " )<br />

!<br />

( &<br />

" # $ %<br />

#<br />

# & '<br />

) * &<br />

* # + ' * ,(<br />

& # - .<br />

% % (<br />

% % (<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1.2 T h e o r e t i c a l f r a m e w o r k<br />

1 . 2 . 1 I m m u n e s y s t e m<br />

H u m a n s a r e c o n s t a n t l y p r o s n (vi e ru s es t , b act o eri a, i n f e c t i o<br />

f u n g i , a n d m u l t i-c e l l u l a r p a r a s i ) t a e n s d t o m a l i g n a n c y t h r o u g h m u t a t i o n s f r o s e m l f ’. ‘ It is th e<br />

f u n c t i o n a l r e s p o n s i b i l i t y o f t h e i m m u n e s y -s s el t f e an m d a t l o t e r e -s e c elf d o g an n i d s te o n o n<br />

p r o d u c e a n a p p r o p r i a t e i m m u n e r r e m e s o v p e o n i t s i e n o t r o d e r to m a i n t th a i e n gen e ral h eal th <strong>of</strong><br />

t h e b y. o d An y i m m u n e r e s p o n s e i n v o l v e s , f i r s t, r e c o g n i t i o n o f t h e p a t h o g e , n an o d r m u t a t i o n<br />

th en s e c o n d, a r e a c t i o n t o e l i m i n a te it.<br />

1 . 2 . 1 . I 1 n n a t e a n d a d a p t i v e i m m u n i t y<br />

T h e i m m u n e s y s t e m h a s b e e n c l a s s c i o f m i p e o d n e n i t s n : t ( o 1 ) i t n w n o a t e ( i n b o -r<br />

n : n o n<br />

s p e c i f i c ) i m m u n i ; an t y d ( 2 ) a d a p t i v e ( a c q u i r e d : -s p a p t e h o c g e n i uf n it i y [T c a b ) l e ]. i 1 m m<br />

I n n a t e i m m u n i t y<br />

I n n a t e i m m u n i s t y -s n o pn ecifi c an d is d e f i n e d a s -b t h orn e di efen n ce mech an is m o f th e<br />

b o d y . T h e i n n a t e i s p n r e a s e t n t u r a t a i s b l r i e s r p t o n h i s ib a m ln e m d for u tn h e e earl y s / y s t e m<br />

i m m e d i a t e d e f e n c e a g a i n s t a n i d n f m e a c l t i g o n . n a Alth n c y ou gh th is fo rm <strong>of</strong> i m mu n it y h as n o<br />

m e m o r y o f -s n o e n l f , t h e s e c e l l s a r e a b l e -s elf t o rgan r e c is o ms g n i (t s u mou e n r o n c el ls or<br />

i n f e c t e d c e l l s ) b y m ‘ i s s i n g s e l f’-s i g n a l [ M o r e t t a e t a l . , 2 0 0 , 2 ] a n d d e f e n d t h , e e v b e o n d y w h e n<br />

the t r i g g e r i s n o t s u f f i c i e n t t o a c t i v a t e t h e a d a p t i v e i m m u n e s y s t e m . T h e r e a to r e t w o e l e m e n t s<br />

i n n a t e i m m , u i.e. n i t h y u m o r a l a n d c e l l-m e d i a t e d i m m u : n i t y<br />

1 . H u m o r a l i m m u n : i the t y s e c r e te d m o l e c u l e , s wh ich in cl ud e comp lemen t , l ys oz o me,<br />

f i b r o n e c t i n , a c u t e p h a s e p r o t e ( i n e s -r . e g a . c t e d C p r o (C t R e i P ) n ), ei cos an oi d s , n at u r al<br />

a n t i b o d i e s a n d p -in r o fla mmat or y c yt o ki n es (e. g. I n t e r l e u s k ( i I L n s ), I n t e r f e r o n s ( I s), N F<br />

c o l o n y s t i m u l a t i n g f a c t ( o r C s S s) F an d t u m o u r n e c r o s i s f a c s t o ( r T N Fs)) .<br />

2 . Cellu la r im mu ni ty : t h e p r i n c i p a l c e l al re p h agoc t y yt es p e s i n i<br />

(e.g . ma cr op h ages , m on oc yt es an d gran u loc ytes in clu d in g n eu trop h ils ) an d n atu ral<br />

killer (N K) cel l s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 2 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Ad a p t i v e i m m u n i t y<br />

A d a p t i v e i m m u , n i o n t y t h t e h e o r h a , n d i s t h e d th e at f rec e ogn n ic s es e a n d m e c h a n i s m<br />

figh ts agai n s t s p eci fi c in fect i ou s or gan is ms an d d e v e l o p s m e m o f r y s p e c i f i c a n t i g o e f n s s u c h<br />

p a t h o g e n s. T h i s a l l o w s a l l s u b s e q u e n t r e s p o fecti n s e on s t o o p r oceed t h e mor s a m e e rap i id n l y<br />

an d effect ivel y. T h i s a d a p t i v e i m m a u l n s i o t h s y a h u m o r a l a n d c e l lu l a r c om p o n e n t s .<br />

1 . H u m o r a l i m m u n i t s y m e d i a t e d b y a v a s t a m o u -s n t p ecifi o f c an p a ti t b od h o ig es e n<br />

p r o d u c e -l d ymp b h oc y yt es B . An ti b od ies p r o v i d e p r o t e c tion f r o m ath p ogen s b y<br />

n eu trali s i n g t oxi c c omp on en ts o f p ath oge n s , b y c oatin g p ath o gen s an d th ereb y<br />

t a r g e t i f n g o r d i s p o s p a h l a g o b c y yt e s ( t h i s i s k n o w n a s o p s o n isation), an d b y acti vat in g<br />

c o m p l e m e n t t o t r i g g e r e l s y s a n d i n g e s t i o n o f p a t h o g e b n y s p h a g o c y t e . s Sp ecifi c<br />

m o l e c u l e s p r o d u c e d b y i m m u lls n e (n c ae mel y, Th .1 an d Th .2 cy t o k i n e s) [s ee als o<br />

T a b l e ] als 1 o p la y a maj o r r ol e in re gu lati on <strong>of</strong> th e ad ap tive im mu n e s ys te m as me d ia<br />

o f c e l l-c e l l c o m m u n i c . a t i o n<br />

2 . Cellular immunity i s b a s e d o n t h e a c t i v i t i e s m o p f h o t c w y o t e - y s p e a , s n -d<br />

o T f B l y<br />

l y m p h o c y t s. e Each l ymp h oc yt e can s p eci ficall y reco gn is e an d react with on e <strong>of</strong> th e<br />

th ou s an ds <strong>of</strong> f orei gn p rot ei n s , i.e . an tigen ic ep itop es fou n d on / in p ath ogen s .<br />

T h e -l ym B p h o c yt e s a r e r e s p o n s i b l e f o r t h e p r o d u c t i o n o f s p e c i f i c a n t i b o d ie s , an d<br />

h ave B-c e l l a n t i g e n r e c e p t o r ( B C . R ) T h e B C R i s a m e m -b b r ou a n ne d for m <strong>of</strong> th e<br />

a n t i b o d y -ly t m h p h a o c t y t e w t i l h l e s e c r e B t e a f t e r f o l l o w a i c n t i g v a ti o n b y s p eci fi c<br />

an tigen a n d d i f f e r tiation e n int o p las ma ce ll s .<br />

T h e -l T y m p h o c y t e s h a v e b e e n s u b d i t v o i d t e w d o -p i s n op u b u lat ion s acc ord in g to t h e i r f u n s, c t i.e. i o t n h e c y t o -l t y o m x p i h c o c T y t e ( C T L ) a n -l d ymp t h oc h yt e h e l p e r T<br />

( T h . ). Both s u b s e t s e x p r e s s T-c e l l a n t i g e n r e c e p t s o r ( T C R ). Th e TC R is s p eci al l y<br />

a d a p t e d t o d e t e c t a n t i g e n s d e r i v e d f r o m f o r e i g n a n p d r po at t e hi ogen n s s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I N N A T E<br />

A D A P T I V E<br />

T a b l e 1: C l a s s i f i c <strong>of</strong> a t he i o ma n in c ompone nt s o f the i m m u n e s y s t e m<br />

H U M O R A L C E L L U L A R<br />

C y t o k i n e s -i ( n P f l r a m o m a t o r y )<br />

A c u t e p h a s e p r o t e i n s<br />

C o mp le me nt<br />

L y s o z o m e<br />

N a t u r a l a n t i b o d i e s<br />

C y t o k i n e s<br />

A n t i b o d i e s<br />

( I m m u n o g l o b u l i n )<br />

Na t u r a l K i l l e r ( N K ) c e l l s<br />

T h . 1<br />

( c e l l u l a r )<br />

T h . 2<br />

( h u m o r a l )<br />

IgM<br />

IgG<br />

I gA<br />

IgE<br />

Nat u ra l K i lle r ( NK ) cell s<br />

P h a g o c y t e s<br />

T-l y m p h o c y t e s<br />

M a c r o p h a g e s<br />

M o n o c y t e s<br />

Gr anu lo c yt e s<br />

C yt o t o x ic T-c e lls ( C T L )<br />

He lp er T-c e lls<br />

B-l y m p h o c y t e s ( a n d P l a s m a c e l l s )<br />

C yt ot o xic N K -c e l ls<br />

R e g u l a t r y o N K -c e l ls<br />

N e u t r o p h i l s<br />

E o s i n o p h i l s<br />

B a s o p h i l s<br />

T y p e I ( T h . 1 )<br />

T y p e I I ( T h . 2 )<br />

Reg u lat o r y ( T-re g )<br />

Th e Nat u ral Ki l l e r ( N K ) c e l on l s e <strong>of</strong> a r t he e p ri n ci p al cel l t yp es in th e in n ate cellu lar<br />

i m m u n e . T s h e y a s r e t l a r e g e m g r a n u l a r l y m p h o c y [ t F e i s g u r e 1 ], wh ich d evel op fr om c o mm on<br />

l y m p h o i d p r o g e n i t o r c e l l s . T h e y m -1 a 5 k % e <strong>of</strong> u tp h e a mb on o u on t u cl 5 ear cel l fra ction in<br />

n ormal p eri p h eral b l o od .<br />

Fi gur e 1 : A t yp i c a l N a t u r a l K i l l e r c e l l<br />

[T a k e n fr o m Wa s a t c h H e a lt h G r o u p : ht t p : / / w ww . w a s a t c h he a lt h . c o m / -c P e a l l. g ht ml] e s / N K<br />

Th ere are two s u b s et s <strong>of</strong> N K -c e l l s [ C o o p e r , F e h n i g e r & C a l i g i u r i , 2 0 , 0 1 ] i . 0-2 e 1 0 % <strong>of</strong><br />

re g u l a t o r y N -c K e l l s u b s e t (c yt o ki n e p rod u cin g s u b s et [ C o o p e r , F i e g h e r n , T u r n e r e t a l . , 2 0 ) 0 1 ]<br />

a n d 8 0-9 0 % <strong>of</strong> cyt ot o xi c N K -cell s u b s et [ J a c o b s e t a l . , 2 0 0 , 1 ] w h i c h h a two s p os s ib le ki ll in g<br />

m e c h a n i s m s :<br />

1 . Cytolitic g r a n u l e s ma ke a h ol e in th e me mb ran e <strong>of</strong> t a r g e t c e l ls c au s in g n e c r o s i s; a n d<br />

2 . Gr a n u l e s o r a c e l l-c e l l c o n t a c t ( e.g . Fas - F a s-l i g a n c d o n t a c t) t ri g gers a cas cad e f or<br />

‘p r o g r a m m e d c e l l ’ d (kn e a own t h as ap op tos is ) [ O p f e r m a n & K o r s m e y e r , 2 0 0 3 in ] th e<br />

t a r g e t c e l l.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e c y t o l i t i c g r a n u l e e p a m t p h l w a o y y e d b y -cells c is y th t e s o ame t killing o x i c N K<br />

mech an i s m as t h at a p p l i ed b y c ytot oxic T-c e l l s (C T L) . C ytot oxic gr an u les , wh ich con tain<br />

P erfori n an d Gr an z yme A / B, are releas e d on to th e s u rface <strong>of</strong> th e b ou n d t a r g e t c e l l, an d th e<br />

P e r f o r i n m a k e s a h o l e t o d e s t r o y t h e c e l l m e m b r a n e a n d G r a n z y a m p o e p t i o n s d i u s. c Th e s is s e c r e t i o n o f g r a n u l e s w i t h c o r n g t e a t c t c e t l o l s t a t a k e w s s a e c o f n e d s a n d i s k n o w n a s t h kis e ‘ s o f<br />

d e a t h’ [ T r a m b a s & G r i f f i t h s , 2 0 0 . 3 A ] p o p t o s i s i s e s s e n t i a l in t h e c e l l c to y c m l a e i n t a i n cel lu lar h omeos tas is [ O p f e r m a n & K o r s m e y e r , 2 0 0 3 . ] Th e F a s -r e c e p t o r [ H i n g o r a n i e t a l . , 2 0 0 w 0 ] a s<br />

sh o w n t o t r i g g e r a n -cellu i n t lar r a cas cad e i n d u c i n ap g op tos is wh en th e F a s -l i gan d f rom oth er<br />

cells con tact s [ A l e n z i & W a r r e n s , 2 0 0 . 3 ]<br />

T a r g e t re c o g n i t -cells i o n b y N K<br />

Th e mai n r ol e <strong>of</strong> N K -c e l l s i s t o r e c o g n i s e a n d k i l l v i r a l i l n y f e ct e d-cel ls a n d t u m o u r-c ells<br />

b oth <strong>of</strong> wh i ch h ave es cap ed re co gn ition a n d d eath b y oth er i mmu n e c o m p o n e n t s. T h e ex a ct<br />

m e c h a n i s m o f t h e r e c o g n i t i b o n y -c e l N l K s i s u n c l e a r , b r u e t h a t s h e b e e n a h y p o t h e s i t s h a - t N K<br />

c e l l s dc etect a n ‘m i s s i n g s e l f’ [ M o r e t t a e t a l . , 2 0 0 . 2 In ] oth er w ord s , N K -c e l l s l a c k a n t i g e n<br />

s p e c i f i c i t y b u t a r e a b l e t o i d e n t n i f o y n -s ‘ e l f ’. Al l h u man cel ls e xp res s th e maj or<br />

h i s t o c o m p a t i b l i l i t y c o m p l e x ( M H c C l a ) s s I m o l e c u l e s o n t h e c e l l-s u r f a c e. Th e le ve ls <strong>of</strong><br />

exp res s ion <strong>of</strong> th is M HC d e c r e a s e w h e n c e l l s a r e i e n c f t e d o r t u r n i n t o t u m o this u r c e l l s , a n d<br />

d ecreas e <strong>of</strong> th e M HC cl as s I m olecu le is c a l l e t d h e ‘m i s s i n g s e l f’ [ M o r e t t a e t a l . , 2 0 0 . 2 ]<br />

R ecogn i t i on <strong>of</strong> t a r g e t c e l ls b y N K -c e l l s is ach ieved b y c omb in ation o f tw o cate go ri es <strong>of</strong><br />

r e c e p t o r s, i . . activat e in g an d in h ib it or y re cep tor g rou p s [ M i d d l e t o n e t a l . , 2 0 . 0 Recogn 2 ] it ion <strong>of</strong><br />

‘m i s s i -s n e g l f ’ m e a s n t h a t b a l a n c e b e t w e e n a c t i v a t i itor n g y a s in gn d al i s n wei h i gh b s toward activati on d u e to a l a c k o f t h e M H C c l a s s I . R e c o g n i t i o n s e o l f ’ th ‘ r ou gh n orm al e xp res s ion <strong>of</strong><br />

M H C C l a s s I t r i g g N e K r s -c e l l i n h i b i t o r y s i g , n w a l h s i c h s wi tch <strong>of</strong>f act i vat in g s i gn als .<br />

N K -c e l l r e c e p t o r s<br />

Th e N K -c e l l s u rfa ce re cep tors c o m p r i s e t w o f a m i l : i e s<br />

1 . Im m u n o g l o b u l i n s u p e r , f i a m n c i l u y d i n g k i l l e r i m m -l u i n k o e g l r e o c b e u p l t o i r s n ( K I R ; )<br />

a n d<br />

2 . C-t yp e l ect i n l i ke recep t o rs in clu d in g NKG2 D a n d n a tu r a l c y t o t o x i c r e c e p t o r s ( N C R )<br />

A s in gl e s ign al f ro m on e <strong>of</strong> th es e recep to rs is n ot s u f f i c t i t o e n t r i g g e r e i t h e r th e b e gi n n in g<br />

o r t h e e n d o N f K -c e l l act i vat ion . In s tead , th e t r i g g e r i s t h e r e s u l o t m b o i f n e c d s i g n a l <strong>of</strong> s th es e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

N K -c e l l r e c e p t o [ r B s i a s s o n i e t a l . , 2 0 0 1 ; M a n d e l b o i m & P o r g a d o r , . 2 0 T 0 h 1 e ] m e c h a n i s m s o f<br />

the i n t -c r e a l l u l a r s i g n a ls cas cad es are co m p l e x [ M i d d l e t o n e t a l . , 2 0 0 an 2 ] d n ot cl earl y d efi n ed .<br />

Mid d let on et al . [2 0 0 2 ] h a v e r e c e n t l y d e s c r i b e d o n e m o d e l, w h i c h i s b a s t e h d e i o n n t -c r ellu a lar<br />

s t r u c t u r o e f the s e t w o f a m i ly r e c e p t o r , s i. e. th e i m m u n o-r e c e p t o r t y r o -b s i as n ed e in h ib it or y<br />

motifs ( IT IM) an d t h e i m m u -r n e o c e p t o r t y r o -b s i a n s e d a c t i v a t i o n m o t i f s ( I T A M [Bak ) ker et al . ,<br />

2 0 0 0 ] .<br />

Th e IT IM a r e t h e r e c e p t o r motifs wi th lo n g c yt op las mic tails th at are res p on s ib le f or th e<br />

i n h i b i t o r y s i g n a l s a s s o c i a t e d w i t h r e c o g n i t i o n o f M H s, C w c l h e a r s e s a ts hI e IT m o AM l e c au re l e<br />

t h e r e c e r p m t o t i f s w i t h s h o r t c y t o p l a s m g i v c e r t i s a e i to l s t h a e n d a c t i v a t n als i o . n Al s l i g<br />

reaction s s eem t o b e t h e res u lt <strong>of</strong> th e b alan ce b etween th es e in h ib itor y an d activati on s ign als .<br />

M i d d l e t o n e x ined p l a th e regu lat ion b y m ean s <strong>of</strong> th e l e n g t h o f t h e i r c y t o p l a s m i . c I t TAM a i l s , i . e<br />

h a s s h o r t IM e r h a s a l o n d g e r / d I e T e p e r c yt o p l a s m i c t a ils. Acti vation s ign als can b e b locked b y<br />

i n h i b i t o r y s i g n a l er s or i mo n re d e pe eri p p h eral level s <strong>of</strong> intra-cellu lar cas cad e wh e n th ere are<br />

en ou gh in h ib it or y s i gn al s fr om th e IT IM to o verc o me acti vation s ign als f r o m . t B y h e I T A M<br />

t h e se c o m p l e x m u s , th t e u N K a -c l e l l m a intains m e c h i t a s n b a i l a b s n e c t e w m e e n i n s u f f i c i e n t<br />

reaction a g a i n s t t h e t a r g e -s t e l f ( n o r n a l t -s e l r f) e a d n d o v e r-r e a c t i ext o n en d in g to th e ‘s e l f ’.<br />

T-l y m p h o c y t e s<br />

T h e -l T y m p h o c y t e s a r e o n e o f t h e p r i n c i p t a h l e a d c a p e t l i l v e t c y e p l e l s u l i a r n i m m u n e<br />

s y s t e m . T h e y m a k e u p 0-85% a b o u <strong>of</strong> t t h6 e mon on u cl ear cell fra ction in n or mal p erip h eral<br />

b l o o d ( p e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s : P B M . C s ) T h e r e a r e t w -l o y m p s h o u c b y t s e e s: t s o f T<br />

35-80 % o f a r e t h e l h p e r T-l m y m p h o c y t s e ( T h . ) w h i c h o r c h e s t r a te b o t h c e l l r u an l d a h u moral<br />

immu n ol o gi cal res p on s es b y p r od u cin g c yt o k i n e s a n d b y c e l l-cell c on tacts v i a -c e l T l r e c e p t o r<br />

(T C R ); a n 20-6 d 5 % <strong>of</strong> th em are c yt ot o xi c T-ly m p h o c y t es ( C T L ).<br />

T h e h e l -l p ymp e r h oc T yt es h a ve b een fu rt h er su b d i v i d e d i n t o t h r e e p e s p (T h e a n b o l t e y 1 ):<br />

1 . T yp e I h el p er T-l ymp h oc yt e (Th .1 );<br />

2 . T yp e II h e l p e -l r ymp hT oc yt e ( T h . 2 ); an d<br />

3 . R e g u l a t -l o r y m p h T o c y -r t e g e ) ( T<br />

accord in g t o th ei r rol es in d efen ce [ J o n u l e i t & S c h m i t t , 2 0 0 3 ; M c H u g h & S h e v a c h , 2 . 0 0 2 ]<br />

Th e Th .1 cel ls p ri n ci p al l y orch es trate cell u lar immu n it y, th e T h . 2 c e l l ab s le e h un moral<br />

i m m u n i t t y o r e a c t a g a i n s t s, an p a d t th h e o g T-re e n g cel ls mai n l y r egu late t o s u p p res s exces s ive<br />

in flammat or y rea ct i on s i n cellu lar im mu n it y.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n c o n t -cells r a wh s t ich can t at o tack N ‘n K o n -s e l f ’ i n a -s n o pn ecifi c m an n er as d es cri b ed<br />

a b o v e , each T-l y m p h o c y t e h a s a u n i q u e r e c o g n i t i o n a g a i n s t a s p e c i f i c a n t i . g Th e n is s p eci fi ci t y<br />

o f a n a n t i g e n w o u r s k i s n g th b e y M HC cl as s I (f or c yt ot o xic T-l y m p h o c y t ) e o r clas s I I (fo r<br />

he l p e -l r ym p T h o c yt e) m ol ecu les . Becau s e an y ‘n o n -s e l f ’ p a r t i c l e s c a n b e , a th n e total a n t i g e n<br />

p op u lat ion <strong>of</strong> T-l y m p h o c y t e s c o l l e c t i v e l y b e a r s a h u g e r e p e r t o i r e o f , an r e d c e mos p t o t r <strong>of</strong> s th em<br />

in c i r c u l a t i a r o n e i n a c t i v e o . r T h e r s e s r t e p i e n r g t o i r e a s r e t h e r e s u l t <strong>of</strong> s th e h igh le vel o f<br />

d i v e r s i t y i n p r t o t h o e t y p e a n t i g e n r e c e p t . o r T h i s m he an c is m in p rod u ct ion <strong>of</strong> h u ge variet y o f<br />

a n t i g e n s -cell p e c recep i f ti o rs c is sT imi la r to th e mech an is m in p rod u ction o f a wi d e ran ge o f<br />

a n t i g e n s p e c i f -c i ells c an a d pn las t ma i b cel o ls d . i e s b y B<br />

R e c o g n i t i a n o d n e l i m i n a t i o n o f s p e c i f i c p a t h o b g e y -l n s y T m p h o c yt e s<br />

T h e r o l -l e y m o p f h o c y T t e s i s t o r e c o arra g n i n s g e , a n e d i t h e r , d i r e c t l y o r i n d i r e c t l y t o<br />

elimin at e f orei gn p at h ogen s . Th is rec ogn i tion <strong>of</strong> p r e-e x p o s e d a n t i g (rec e n all a n t i g ) e is n b as ed<br />

o n a h u g e v a r i e t y o f a n t i g e n r e c e p t o r s , <strong>of</strong> a n p d a t h t o h g e n e d ep l i en m di s n on a t th i e o ab n ilit y<br />

<strong>of</strong> rap id p rol i ferat i on o f on e s p ecificall y r ecogn is ed s et o f l ym p h oc ytes . T h e p r o l i f e r a t iv e<br />

res p on s e o f -l ym T p h oc yt es c o n s i s t s o f f o u r p r o c e s s e s :<br />

1 . Re c o g n i t i o n e o f o r t e h i g n p a t h o t g e o n m a t a p c r h e-exp os ed / r e c a l l a n ; t i g e n<br />

2 . Act i v a t i n g c e l l -S-G c y c l 2 e -M ) ( G p 1 r o g r e s s o i f o n t h e o t yp n e o f c e l l m a t c h ; e d<br />

3 . Ac t u a l c e l l d s i an v d i p s r i o l n i f e r a ; t i a o n n d<br />

4. Ap o p t o s i s o f e x c e s s i v e c e l l s g e n e r a t e d t a h b r o v u e g h p r t h o e l i f e . r a t i o n<br />

T h i s p r o c -l e s y m s p h o c f y t e T p r o l i f e r a t w i n o n t o i o s c c u k r n a o l s in o p eri p h eral<br />

l ymp h oc yt es b ot h i n v i an v o d e x v i , v o p a r t i c u s l i g a n r i f l i c a y n t in r e s p o n s e t i o n v i s timu t r o lat ion w i t h a m i t o g e n , a s u p -a e n r t i g e n , o r s p e c i f r i e c a l l an ti g en s [A n t i a e t a l . h med 2 0 0 3 ; K a e<br />

2 0 0 3 ; S e d e r a n d A h m e d ]. 2 0 0 3<br />

1 .2 .1 .2 C o m m u n i c a t i o n b e t w i e m e m n u n e c e l l s<br />

Immu n e cells (e.g . N K -cells, l y m p h o c y t e s a n d p h a g o c y t e ) s c om mu n icat e wi th eac h ot h er<br />

e i t h e r d i r e c t l y b y c e l l-c e l l c o n t a c t, o r i n d i r e c t l y v i a v a r i o u s s e c r e t e d m , o wh l e ich c u l ie ns teract with cel l s u rface mol ecu les o r i n t -c r e a l l u l a r ( c y t o p l a s m i c o r n u c l e a recep r ) tors .<br />

Man y s u rface mar kers (rec ep tors ) h a ve b een id en tified an d n amed accord in g to th e<br />

c l u s t e r s o f d i f f e r e n t i a t i o n ( C D ) s ys te m [T a b l e ]. 2 Th is al lows cel l t yp es (p h en ot yp e s ) to b e<br />

i d e n t i f a i c e c d o r d i n g t eir o e x t p h r e ss i o n o f c e l l s u rface mar kers , e. g. he l p e -l r y m p T h o c y t e s<br />

( C D 3 + C D 4 + ), c y t o t o -l x i y m c p h o T c y t e (C D 3 + C D 8 + ) , -cells B ( C D 1 9<br />

+ ) , -cells N K ( C D 3<br />

- C D 5 6 + )<br />

an d N K T -cells ( C D 3<br />

+ C D 5 6 + ). T h i s i d e n t i f i c a t i o n c yt c o m a e n t er<br />

b e p e r f o<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 7 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

w h i c h d e t e c ts fl u ores cen t l y con ju gated s p ecific an tib od ies b ou n d to u n iqu e C D m a r k e r s /<br />

m o l e c u l e s e x p r e s s e d o n t h e c e l . l s u r f a c e<br />

Fo r e xamp l e, N K -c el l s are ch a racteris ed b y th e e xp res s ion o f C D5 6 mol ecu les on th e<br />

s u r f a c e a n d t h e a b s e n c e o f a c o m m o n l y m p h o c y t e m a r ( k e r C D3 ) w h i c h d i s t i n e s g u i t i fro s h m<br />

a n o t h e r c y t o t o x i l c y m p h o c y t e -p s o p u u b l a t i o n (N K T -cel ls : C D 3 + C D 5 6 + l ymp h oc yt es ) [Sea man ,<br />

2 0 0 0 ] . Fu rt h er C D 1 6 c a n b e u s e d t o u d i s t h i n g b e -cell t w se u be s et n s , i .e. N t K h e c y t - o t o x i c N<br />

Di m Br i g h t<br />

c e l l s ( C D ) 5 6 e xp res s C D1 6 wh il e t h e r e g -c u e l l s a (C t D 5 o 6 r y ) a r N Ce K D1 6 n egat ive [s e e a l s o T a ]. b l e 2<br />

T able 2: C D e x p r e s s i o n N K b -c y e l l s and lymphoc yt es<br />

N K -c e lls C D 3 (-) & C D 5 6 +<br />

T-l y m p h o c y t e s C D 3 +<br />

B-l y m p h o c y t e s C D 1 9 +<br />

C D 3 + +<br />

& C D 5 6<br />

C y t o t xi o c C D 5 6 D i m & C D 1 6 +<br />

R e g u l a t o r y<br />

N K T -c e l l<br />

C y t o t o x i c<br />

C D 5 6 B r i gh t & C D 1 6 (-)<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 8 - I m p e r i a l o C n o d l o n l e g e L<br />

C D 8 +<br />

H e l p e r C D 4 +<br />

Th e s ecret ed m ol ecu les wh ich act as intra-c e l l u l a r m e s s e n g e br etween s im mu n e cel ls are<br />

k n o w n as c yt o ki n es . C yt o k i n es con s is t <strong>of</strong> t h r e e g rou p s [s e e a l s o T a ]: b ( l 1 e ) p 1 r -i o n flammat or y<br />

( I -1 L , -6 I , L T - N F , I - N F e t ); c ( 2 ) T h . 1 -2 , ( I -1 I 2 L L e t c . ); an d (3 ) T h . 2 -4 ( , I -1 L I 0 L e t c . )<br />

c y t o k i n e s. Th e y h a v e b e e n c l a s s i f i e d i n ct yto o ki t h n e f a m i l i e s u c h a s In t e r l e u k i n ( s IL) ,<br />

In t e r f e r o n s (IN F), Co l o n y s t i m u l a t f i a n c g t o r s ( C S F ), Tu mo u r n ecr o s is fa cto r s ( T N F ) a n d a<br />

ran ge <strong>of</strong> c h e m o k i n e f a m i l s i [ J e a n e w a y e t a l . , 2 0 0 . 1 ]<br />

As n e w c y t o k i n e s w e r e d i [ s J a c n o e v w e a r y e d e t a l . , 2 0 0 , 1 th ] e d is ti n ct ion s b et ween<br />

v a r i o u s t y p e s o f e n d o g e n o u s m o l e c , u w l h e i s c h a r e u t i l i s e d f o r c e l l-c e l l c o m m u n i c , a bt ecame i o n<br />

in creas in gl y a mb igu ou s d u e to o v e r l a p p i n g f u n c t s i [T o n a b l e ]. 3 In i t ia l l y th e s e m l ecu o les were<br />

c o n s i d e r e d t o b e p r o d u c e d b y s p e c i f i c an c d e l to l s af fect s p e c i f i c c e l l o s n l y i n e a c h . o r g a n<br />

Recen t e v i d e n c e, h owev er, h as reveal ed t h a t t s h e m o l e c u l e s c a n b e p r a o d v u a c r i e d t y <strong>of</strong> b y<br />

d ifferen t c e l l s tha a n d t t h e i r recep to rs a r e e x p r es e d b y a vas t r a n g e o f t yp es <strong>of</strong> cel l s in d ifferen t<br />

org an s ys t ems [ Han s en et al ., 1 9 9 8 ; Marz et al., 1 9 9 9 ; Miller et al ., 1 9 9 4 ; Tu rn b u ll & R ivie r,<br />

1 9 9 9 ] .


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

H o r m o n e s<br />

T able 3: D e f i n i t i o n s o f v a r endogenous i o u s m o l e c u l e s<br />

Ch e m i c a l s u b s t a n c e produce s d i n a r n g a n o o r g l a n d i n t h e b o d y t h a t a r e<br />

s e c r e t e d into t h e b l o o d a n d c a r r i e d t o o t h e r o r g a n s o r p a r t s o f t h e<br />

N e u r o t r a n s m i t t e r s<br />

Ch e m i c a l s u b s t a n c e s r e l e a s e d f r o m n a p n s e u s r o t n s h a t i tn o b i s n y d<br />

( C a t e c h o A c l e t a y l m c i li h n o e n ) e s c o r r e s & p o nd ing r e c e p t o r s o n ne a r b y c e ll s u r f a c e s o r a c t iva te s e c o n a d r y<br />

m e s s e ng e r c a s c a d e, i . e c h a n n e l s , p u m p s , k i n a s e s , o r p r o t e a s e s<br />

C y t o k i n e s<br />

P rot ein s t hat ar e t he co r e o f co mmu nicat io n bet ween im mu ne ce lls<br />

t h e m s e l s , v a n d w i t h c e l l s b e l o n g i n g t o o t h e r t i s s u e t y p e s<br />

���� .<br />

C h e m o k i n e s<br />

P rot ein s t hat sig na l leu ko c yt es t o mo ve in a spec if i c d ir ect io n; in o t her<br />

���� . w o r d s , a c l a s s o f c h e m o t a c t i c c y t o k i n e s<br />

E i c o s a n o i d s<br />

B i o s y n t h e s i m s o e l d e c u l e s f r o m a r a c h i d (p o o n i l c y-u nsat a c i ur d at ed<br />

( A r a c h i d o n i c a c i d d e r i v a t i v e s ) f a t t a c y i ), d i . e . p tr agla o s nd in s, pr o st ac yc lin s, t hr ombo xa ne s,<br />

leuk o t r ie nes et c. ; i n o t h e r w o , r a d cs las s o f o xyg e nat ed hyd r o pho bic c y t o k i n e s<br />

C o m m u n i c a t i o n a n d i n t e r a c t i o o r n g a s n y b s e t t e m w s e e n<br />

Th e p ri mar y o r g a n s y s t e m s wh ich are d i s t r i b u t e d t h r o u g h o u t an d t h in e wh b io ch d y<br />

me d i a t o rs a r e n o t-r e s t r i c t e d i n ar l e o th c e a t n ervou i o n s s ys te m, th e en d ocrin e s ys te m an d th e<br />

i m m u n e . Th s e y ar s e con t se id m ered to f o r m u l a t in e d ep en d en t c e l l -cell c o mmu n ication<br />

ne t w o r s k b y va ri ou s s ign al tran s p ort ati on s ys te ms ( e.g . e l e c t r i c a l s ign als an d m o l e c u l e s ), an d<br />

th es e com mu n i cat i on n et works are s h o w n to h ave th eir own in d ep en d en t regu latory<br />

m e c h a n i s m s i n ing c l u c d o u n t e r r e g u l a t i o n , b u f f i e s r m i s n a g n d m / o e r c h f a e n e d b a c k m e c h a n i . s m s<br />

F o r e x a m p l , e in th e au ton omi c n erv ou s s y s , t h e m s y m p a t h e t i e c p aras a n d ymp t h at h et ic s y s t e m s h a v e o p p o s i t e e f f ; e th c t e s s y m p a t h e t i c n e r v o u s s y s t e m s u p e p s r e th s s e p arasym p at h et ic n ervou s s ys t em an d vi ce vers a [ B o e r e e , 2 0 0 2 ].<br />

In th e en d ocri n e s y s , t h e m h y p o t h a l a m -pituitary-ad u s ren al ( HP A) axi s h as the<br />

i n t e r a c t i m v o e d u l a t i , o n n a m e ‘c l o y r t i c o t r o -r p h e i l n e a s -fact i n g or (C R F) – a d r e n o c o r t i c o t r o p -h<br />

i c<br />

h o r m o n e ( A C T H ) – g l u c oc o r t i c o i d ( c o r t i s o l )’ i n m od h u um lat a in on . Th is ‘C R F -A C T H-c o r t i s o l ’<br />

mod u lat i on h as feed b ack mech an is ms , b y wh ich in creas ed level s o f c o r t i s o l s ec rete d fro m<br />

a d r e n a l g l a n d s s u p p r e s s e s p r o d u c t i o n o f C R F a n d [Ts A ig C os T H & Ci hn rou t sh os e , b r a i n<br />

2 0 0 2 ] . T h i s m o d u l a t i o n a l s o c o n t a i n s b u f f e r i n g m e c w h a h n e i r s e th m e s le vel s o f f r ee co rt is ol can<br />

b e m a i n t a i n e d i n a n a r r o w w i n d o w r a n g e w i t h a m i n i m u m a s t i i n m t e h e o f o v e r f l u c t u<br />

f o l l o w i n . g Th e l e m v e l c o f h f r e a e c n o r t i s o s l i n m s e r u m d e p e n d s o n t h e r a t o i o f c ort is ol t o<br />

c o r t i s o l b i n d i n g ( g C l B o G b u ) sl o i th n at a s u dd en ch an ge <strong>of</strong> f ree c ortis ol level can b e b u ffered<br />

b y c h a n gi n g i t s h c o r t i s o l-C B G rat i o, i . e. p e r c e n t a g e s o f c o r t i s o l w h i c b h i n d to th e C B G<br />

[ M c E w e n e t a l 7 . ] .<br />

, 1 9 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

In th e i mmu n e s y s , t c o u e n t m e r-r e g u l a t o r y m e c h a n i s m s o T f h . t 1 h c e l l s a n d t h e T c h e l . l 2 s<br />

wor k to mai n tai n lon g ter m b alan ce b etween t h [ e K i m d d , 2 0 0 3 ], i . . Th e .1 (cel lu lar ) c yt oki n es<br />

c a n s u p p r e s s T h . 2 ( h u m o r a l ) c y t o k i n e p r o d u c t i o n . a n d v i c e v e r s a<br />

F u r t h e rm ore , it h a s b e e n r e v e a l e d t h a t c e a l so s c o m m u n i c a te ove r th es e d iffer en t org an<br />

s y s t e m s [s ee b el ow 1 . 2 . 2 f o r t ne h e u r o-e n d o c r i n -i o m m u n e i n t e r a ], c an t i d o it n ha s b e e n<br />

s u gges t ed t h at t h es e n ervou s , en d ocrin e a n d immu n e s ys te ms h ave mu tu al regu lato r y<br />

m e c h a n i s m s b e t w e e n t h e m s e l v e s a s a n i n t n e r u a r -e c o t n i d v o e c r i n -im o mu n e axi s [ El en ko v et al .,<br />

2 0 0 0 ; H a a s & S c h a u e n s t e i n , 2 0 0 1 ; M c E w e n e t a l . , . 1 9 9 7 ]<br />

1 . 2 . 2 N e u r o-e n d o c r i n -i o m m u n e i n t e r a c t i o n<br />

T h e interact ive n e u r o-e n d o c r i n -i o m mu n e axi s h as <strong>of</strong>t en b een d is cu s s ed in th e con text o f<br />

s tres s res p on s es [ B e s e d o v s k y & d e l R e y , 2 0 0 1 ; B i o n d i , 2 0 , 0 1 n a ] d i t h as b een p rop os ed th at<br />

p s y c h o l o g i c a l s t r e s s c a n m o d u l a t e t h e i m m u n e v a s r i y s o t u s in e m teract v i ia ve mec h an is ms in this n e u r o-e n d o c r i n -i o m m u n e a x i s [ M o y n i h a n & S t e v e n s , 2 0 0 1 [ ] F i g u r e 2 ].<br />

F i g u r e 2 : S c h e m a o f -e t nd h o e c r in n e o u -im r o mu ne int er act io n.<br />

( H P A : h y p o t h a l a m -p u s i t u i t -a a d r y e n a l a x i s , S A M : s y m p -a a t d r h e na t i l-m c e d u l l a m o d u l a t i o n )<br />

1 .2 .2. 1 B r a i -t n o-im m u n e p a t h w a y<br />

I n re c e n t d e c a d s, e t w o m a j o r a x h e s a v e b een p r o p o s e d a s a n i m p o r t a n t s p i a n t h w e a y<br />

s t r e s s r e s p o : n s ( 1 e ) t h e sy m p a t h e t i c -a d r n e e n o-med r v u ll o a (S u AM) s a n s d (2 y ) s th e t e m<br />

h yp o t h a l a m u s -pituitary-a d r e n a l ( H P A ) s a [d x e Kl oet , 2 0 0 0 ; d e Kl oet et al., 1 9 9 8 ; Down in g &<br />

M i y a n , 2 0 0 0 ; e r s , 2 H 0 0 e 3 ; u Y s a n g e & r G l a s & e r , 2 L 0 0 a [ 2 F ] i m g m u r e 2 ]. Th is s e ct ion in trod u ces th e p a t h w a y f ro m th e b rai n to th e immu n e s ys tem [Elen k ov et al. , 2 0 0 0 ; Lawren ce &<br />

K i m , 2 0 0 0 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e ‘f i g h t o r f l i g h t’ res p on s e [C an n on , 191 4 ; C ann on , 1 9 32 ; C a n n o n , 1 9 3 4 ] an d emoti on s<br />

like an xi et y an d / or fear [ L e D o u x , 1 9 9 8 ] are k n o w n t o b e a s s o c i a t i n e c d r e a w s e i d t a h c t i v i ty in<br />

t h e s y m p etic a t h n e r v o . u h s e T r e s a r y e s t p t r w i o e m a m pr ath y wa ys b y w h i c th h e s ymp at h et ic s ign als are c on ve yed t o ta rget or gan s [ E l e n k o v e t a l . , 2 0 0 . 0 ] O n e p a t h w a is y d i r e c t ura n e l<br />

c o n n e c t i o n s, w h e r e n o r e p i n e p h r i n f u e n c t io n s a s a n e u r o t r a n s m a i ne t u r t a l e t r e r m i n a l. Th e<br />

o t h e r i s k n o w n a s t h e s y m -a p a d t r h e n t o-m i c e d u l l a ( S A M ) p a , t wh h w ere a y e p i n e p h r i n (as e a<br />

r e s p o n s e t o t h e s y m p a t h e t i c n e u r a l a c t i v i t y ) r e l e a s e d f r o m t h e a t d r e a n v a e l l g s l a n t d h s r t o h u e g h<br />

b lood s t r a e n d a c m t s a s a h o r m i n o n v e a r i o u s o r g a s. n F o r e x a m p l , e th e symp at h et ic n eu ral<br />

fib res d e s c e n d f r o m t h e b r a n i e n u ral i tn ermi t o n al b ot h in th e p rima r y l ymp h oid ti s s u es (b on e<br />

m a r r o w a n d t h y m u s ) t h se a econ n d d ar y l ym p h oi d ti s s u es (s p leen an d l ymp h n od es ) [ Felten &<br />

F e l t e n , 1 9 9 4 . ] I m m u n e c e l l s t h e elves m s h ave al s o b een r e p o r t e d t o e x p r e catech s s o lami n e<br />

r e c e p t o r s, b u t th ei r p r o f i s l a e r e u n i q u e, i . . N e K -c e l l s h a v e h i -d g e h n s i t y a n d -a h f i f g i h n i t y -2- b e t a<br />

a d r e ner g i c r e -c c e l p l t s o h r a v s e -d , h i e g n B h s i t -affin y it b y, u an t d T-c l e l l o s w h a v -d en e s it y l o w<br />

a n d -a f l f o i n w �[ i t A y n s t e a d e t 9 9 a 8 l ] . . T , h i s 1 i s i n l i t n h e fin e dw in i gs t h th at c a t e c h o l a m i s, n e<br />

n o r e p i n e p h r i n e a n d e p i n e p h a r c i t n i e v a t e t h e i m m u n e r , e in s p clu o n ds ie n g an in creas e <strong>of</strong> N K -<br />

c e l l s a n d -cells c y t o i t n o c x i r c u l [ H T a e t n i n i o g n e t a l . , 2 0 0 an 0 ] d an in creas e <strong>of</strong> p r o-<br />

in f l a m m a t o r y c y t o k pi rod n e u ct ion [ E l e n k o v e t a l . , 2 0 0 . 0 T ] h i s se r i e s o f e v i d e sn tron c e gl y<br />

s u g g e s t s that th e s ymp at h et ic n erv ou s s ys tem ( p a r t i c u l a r l t y h e w S i A t M h a x ) i ds ire ctl y<br />

c o m m u n i c a t s e w i t h i m m u n e c e in l l th s e b r a i -t n o-i mmu n e p at h wa y.<br />

O n t h e o t h e r h o a r m n d o , n e s h i n t h e h y p o t h a l a -pituitary-a m u s d r e n a l ( H P A ) a x i s ha ve als o<br />

b e e n con s id ered to p l a y a i m n p o r t a n t r o l e a s c o n n e c t o r s o mr od u lat ors b et ween th e b r a i n a n d<br />

immu n e s ys tem [ F l i e r & U n d e r h i l l , 1 9 9 5 ; R e i c h l i n , 1 . 9 Cortis 9 3 ] ol , th e mai n s ecret ed h ormon e<br />

t o t h e b l o o d s t r e a m i n t h e H P , is A a b x e i l s i e v e d t o m b e a j o a r st r e s s-r el a t e d h o r m o n e<br />

[ H u c k l e b r i d g e e t a l . , 1 9 9 8 ; R o h l e d e r e t a l . , . 2 It 0 ha 0 1 s ] b e e n d emon s trat ed th at th e maj or<br />

immu n e or gan s , i .e . s p l een an d th ymu s , a n d immu n e cells th ems elves ar e rich in c orti s ol<br />

recep tors [ M i l l e r e t a l . , 1 9 . 9 T 4 ] h e e f f e c t o r f t i s c o l u p on in d ivi d u al t a r g e t c e l , l hs o wever , is<br />

s u g g e s t e d v a t r o y f r o m s u p p r e s s i v e t o , s i t . . si ue m p pu res l a st ive, o r py rep arat iv e, pe r m i s s i v e a n d<br />

s t i m u l a t o r y a c t i [ o S n a s p o l s k y e t a l . , 2 0 0 . 0 T ] h e v a r i o u s facto rs c o n t r i b u t ing to th is d ifferen ti at ion i n c l u d : e<br />

Ty p e s o f r e l t e t a v r a g n e t c e l l s a n d t h e i r c o r t i s o l r e c e p t r o r f i s; l e<br />

Timing o f s e c r e t , i do un rati on <strong>of</strong> e x p o s u r e, a n d c o n c e n t r a o t f c i o r t n i s o l; a n d<br />

Com b i n at i o n w i t h c a s c a d i n g s e c r e t i o n s oth o f er m o l ecu les (h or mon es an d<br />

c y t o k i n e s ).<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n a d d i t i t o n t h i s c o m , p l t e h e x e x i a t c t y mech an is ms a t t h g e n e l e v e l a re al s o yet to b e<br />

mad e cl ear . Fo r e xamp l e, co rtis ol is kn o wn to b e an tag on is tic a g a i n s t th e n u c l e a r f a c t o r k a p p<br />

( N F B ) [ C h r o u s o s , 1 9 9 5 ; G o u l d i n g , 2 0 0 , 4 ] w h i is c h a k n o w n act i vat o r f or th e tra n s crip tion <strong>of</strong><br />

pr o-inf l a m m a t o r y c y t o k i n ( e s I -1 L , -6 I a nL d T N F - ) [ B a r n e s , 1 9 9 7 ] as well as a g e n o m i c<br />

inhibitor a g a i n s t t h a e p o p t o t i c c a s s c a [ d K e a r i n & L i n , 2 0 0 . 2 B] y c on tras t , th e c o r t i s o l -i n d u ced<br />

g e n e p r o d u c t s a r e k n o w n t o c o m a vp as r i t ran s e ge <strong>of</strong> p r o t e i n s i in n c g l th u e d An n exi n I, wh ich h as comp reh en s ive a n t i -i n fl am mat or y intra-c e l l u l a r s a c [ G t o i u o l d n i n g , 2 0 0 4 . ] N e v e r t h e l e s s , t h<br />

evid en ce s t r o n g l y u s p p o r t s t h e c o n c l u t s h a i t o t n h e m e d i a t o or f s th e HP A axi s (p art icu larl y<br />

cortis ol ) can e xert d irect in fl u en ce u p on i m m u n e c e l l s i n t h e -t b r o-i a mmu i n n e p at h wa y.<br />

F u r t h e rm ore , i n v i v l o a b o r a t o r y s t r e s s s t u d i e s t h a h v a e t t i h l e l r e u c s o i t n s r i s a t e t n e t d<br />

o r d e r <strong>of</strong> res p on s es in th e ch an ge levels <strong>of</strong> m e d i a t o r s b etwe en t h e S A M a n d t h e H P A , a x e i s . . an e<br />

in creas e <strong>of</strong> co rt i s ol l e vel s was ob s erved a fter an in creas e <strong>of</strong> catech ola min e level s [ C low et al . ,<br />

1 9 97 ; C l ow et al ., 2 0 0 0 ; Hu ckleb rid ge et al., 1 9 9 8 ; Mad d en , 20 01 ; R oh led er et al., 2 0 01 ;<br />

U c h i n o e t a l . , 2 0 0 . 1 T ] h i s su g g e s t s t h a t c a t e c h o l a s m ma i n y e p r om ot e c ort is ol s ecr etion , s o that<br />

t h e s e t w o m a i n a x o e f s t h e b r -t a i o-i n m m u n e p a t h w a y i n t h -n e e p u s r y o-e c n h d o o c r i n -im o mu n e<br />

n etwork ma y al s o co mmu n i cate with eac h oth er.<br />

1 .2 .2. 2 I m m u n e-to-B r a i n p a t h w a y<br />

R e c i p r o c a , l it l has y b een d i s c o v e r th e d at t h e p -i r n o f l a m m a t o r y c y t o k i n e s I ( L-1, I -6 L an d<br />

T N F - ) c a n a c t i v a t e t h e S A M a n d H P A [ B a e x s e s d o v sk y & d el R e y, 2 0 0 0 ; Bu cki n gh am et al. ,<br />

1 9 9 6 ; P e r l s t e i n e t a l . , 1 9 9 3 ; T u r n b u l l & R i v i e r , 1 9 9 9 ; W a n g & D u n . n Th , e 1 9 9 b 9 l ] o -b o d r a i -n<br />

b a r r i e r g e n e r a l l y p r e v e n t s t h e t r a n s p o r t a ti on <strong>of</strong> lar ge m olecu les f ro m b lo od to th e b rain , h owev er,<br />

th e p r o-i n f l a m m a t o r y in c es y t (p o art k icu la rl y I L-6) we r e s h own t o b e cap ab le o f in c reas in g<br />

p e r m e a b i l i t y o f t -b h r a e i n b l a o r r o i d e r [ C a s t e l n a u e Bu t ckin gh a al m, . 1 9 9, 9 ; 1 9 9 8 ; M u<br />

T u r n b u l l & R i v i e r , 1 9 9 . 9 Fu ] rth er mo re, c yt o ki n es h ave b een s h own to b e r eleas ed f r , an o d m<br />

a f f e c t , i p n e g r i p h e r a l r v n e s a n d t h e b r a i n a s w e pl erip l a hs eral im mu n e cel ls [ Han s en et al.,<br />

1 9 9 8 ; M a r z e t a l . , 1 9 9 . 9 Th ] e p r -infla o m mat o r y c yt oki n es (IL-1 i n p a r t i c u l a r ) w e r e ls a o<br />

d e m o n s t r a t e d t o i n s i t c k i n a e t s e s b e h a v i o u r e ( . g . f e v e r , f a t i g u e , s l e e p a i n d e an s s orexi a)<br />

[ D a n t z e r , 2 0 0 4 ; K e l l e y e t a l . , 2 0 0 3 ; V o -C l l m o n e n r a , 2 0 0 1 ; W a t k i n s & M a i e r , 1 9 . 9 With 9 ] th e<br />

f i n d i n g t -1 h a recep t to t rs h he ave I al sL o b een fou n d on n eu ron s an d glial cells , p articu larl y<br />

d e n s e i n e ht ip h p ocamp u s [ Cu n n i n g h a m & D e S o u z a , 1 9 9 , 3 i ] t w a s su gges ted th at th ere is a<br />

d irect in teract ion b et ween th e im mu n e cells a n d t h e b r i n a i t n h e i m m -to-b u n e rai n p at h wa y<br />

[ B e c h e r e t a l . , 2 0 0 0 ; M a i e r & W a t k i n s , 1 9 i 9 n 8 ] t h e p -n s y e c u h r o o-e n d o c r i n -i o m m u n e n e t w o r k<br />

[ F i g u r e 2 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 2 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e h i p p o c a m p u s a n d th e a m yg d a la, wh i ch p la y a co re role in le arn in g, mem or y a n d<br />

cogn iti on [ B l a n k e t a l . , 2 0 0 , 2 are ] als o k n o w n t o h a v e n imp a o rt an t r ol e in th e s tres s res p on s e<br />

[ d e K l o e t , 2 e 0 r s , 0 2 0 0 3 ; ]. Th e H h ie p p ocamp u s e u s r h a s & b e e s n L ho a w n m t m o b rich e in<br />

c o r t i s o l r e c e p t o r [ s d e K l o e t e t a l . , 1 9 9 8 ; D o w n i n g & M i y a n , 2 0 0 0 ; M i l l e r e t a , l a . n , d 1 9 9 4 ]<br />

c o r t i s o l was s h own to en h an ce mem or y b y me an s <strong>of</strong> th e g l u c o c o r t i c o i d r e c e p t o r s G ( C R s ) in th e<br />

h ip p ocamp u s [ d e K e l t o e t a l . , 1 9 9 . 9 In ] a d d i t i o n , th e GC R s in h ib ition (b y an tag on is ts ) in th e<br />

a m y g d a l a w a s a l s r o e p o r t e d t o i m p a i r m e m o r y i c n o c n l s u o d l i n i g d a s t r i e o s s n f u l m e m . o Th r i is e s<br />

imp airmen t o f mem or y c on s olid ation w a s s u gges ted to res u lt in d ecreas in g th e leve l s <strong>of</strong> fear an d<br />

an xiet y [ M c G a u g h o o z e & n d a a R l , 2 0 0 2 ; R o o z e n d a a l , 2 0 0 . 0 F ] u r t h e r m o r , e it has b een<br />

d emon s t rat ed t h at t h e s ymp ath etic n erv ou s s ys te m an d th e HP A a xis man a ged to p r ov oke<br />

an xiet y [ T a n a k a e t a l . , 2 0 0 . 0 ]<br />

H e n c e , it w a s s u g g e s t ed t h a t t h e i m -to-b m u n r e a i n p a t h [ w M a y i e r , 2 0 0 3 ] c a n e x t to e n d<br />

p s y c h o-b e h a v i o u r a l r n s e s p or o ‘m i n d-b o d y ’ in teract ion [ Y u a s a & K a s u l i s , 1 9 8 7 as ] in th e<br />

p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w . o r k<br />

C on s eq u en tl y, it is p r o p o s e d t h a t t h e s e i n -c t e r l l u l a r i n t e r a c t i o n s -cellu a n d i lar n t r a<br />

m e c h a n i s m s each i n level <strong>of</strong> t h e p s y c -n h e o u r o-e n d o c r i n -im o mu n e n et work en ab le th e immu n e<br />

s y s t e m t o m a i n t a i n h o m e o s t , a i.e. s i s t h i be alan n h ce e a <strong>of</strong> l t r eact h ion s b et ween in co mp eten t<br />

immu n e res p on s es , wh i ch ma y lead to ma lign an c y o r in fection , an d exces s ive in fla mmati on ,<br />

wh ich m a y l e a d t o -i mmu a u t no e d is eas e or al le rg y.<br />

1 .2 .2 . 3 Ci r c a d i in a th n e n e u r o-e h n d y o c t r i h n -i m o m m u n e n e t w o r k<br />

Ea c h o r g is a kn n o wn to s f y o s l t its l e o w m w n h o m e o s t a t r i e c s t-a l e r t c ycl es . <strong>The</strong>se r e s t-<br />

alert c y c l e s s y n c h r o n i with s e t h e s l e -w e p a k e c y c l [L e a v i e , 2 0 0 1 ]. Th e y h a v e b e e n o b served as<br />

d i u r n a l v a r s i [C a t leri i o ci n et al ., 1 9 9 7 ; Gl as er et al. , 2 0 0 1 ; Mas ch ke & Hech t, 2 0 0 4 ; Saka mi et<br />

a l . , 2 0 0 2 ] o r h a d th ei r own ci rcad ian p a t t e s r [ n Folka rd , 1 9 9 0 ] i n t h e l e v e l s o f t h e i r m . e d i a t o r s<br />

T h e b i o l o g i c a l -wa s ke l e ce ycl p e, a ci rcad ian rh yth m , is origin all y d riven fro m a<br />

p h ys i o l o g i c a l c yc l e o f c h a n g e s i n b o d y t e m p e r a t u r e , i . e . o n e c yc l e o f d i u r n a l c h a n g e s i n t h e s -e<br />

t<br />

p oin t temp erat u re [ F o s t e r & K r e i t z m a n , 2 0 0 . 4 O ] n e e x a m p l e e o f o b t s h e r v e c d i r c a d i a n p a t t e r n s<br />

i n t h e n -e e u n r d o c r i n -i o m m u n e n e t w a o r e k t h e sh ifts in d o m i n a n e c i n t h e b a l <strong>of</strong> a n c e<br />

i n t e r a c t i o n within s each n e r v ou s , e n d o c r i n e [ La yc oc a k n & d Wi s e i , 2 0m 0m 3 ; u n e s y s t e m<br />

M a r s h a l l & B o r n , 2 0 0 :<br />

2 ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 . Th e p a r a s ym p a t h e t i c i s d o m i n a n t o v e r t h e s ym p a t h e t i c a t n i g h , t an d vi ce vers a<br />

d u r i n g t h e d a ; y i n t h e n e r v o u s s y s t e m<br />

2 . A p ea k s ecr et i on o f mel at on in p reced es s leep [ L a v i e , 2 0 0 1 ] an d a cortis ol s u r ge<br />

p reced es waki n g [ B o r n e t a l . , 1 9 -S 9 c 9 h ; w a S l b p e a t e t h a l . , 1 9 9 ; 2 ] a n d<br />

3 . T h . 1 c y t o k i n -2 e ) s are h( igh e . er g at . n i gh I t tL h an d u rin g th e d a y [ B orn et al .,<br />

1 9 9 7 ] a n d t h e y c a n c e n h s l e e i p n d u c t i o w n h i l e T h . 2 c y t -4 o k a i n -d<br />

e s L ( e . g . I<br />

1 0 ) s u p p r e s s s i l n e d e u p c t i o n a n d d t i h s e t s l u e p r e b p r o c e s s [ M a r s h a l l & B o r n , 2 0 0 . 2 ]<br />

It ha s a l s b o e e n s h own th at th e ci rcad ian p at tern s <strong>of</strong> th es e s e c r e t e d m o l e c u l e s i n - t h e n e u r o<br />

e n d o c r i n -im o mu n e n et work con tri b u te to th e s l e e -wa p ke c ycl e b y p r o mot in g or in h ib itin g s leep<br />

[ M o l d o f s k y , 1 9 9 5 ]. For e xa mp le, pr o-i n f l a m m a t o r y c y t o k i n e s e. ( g. T N F- I -1 L a n d -6) I as L<br />

w e l l a s m e in l are a t o kn n own to in d u ce s leep [Kr on fol & R emic k, 2 0 0 0 ; Kru eger & Majd e, 1 9 9 4 ,<br />

2 0 0 3 ] . In ad d it ion , c o r t i s o l a -i n d n f l p r a o m m a t o r t o y k i c n e y a n t a g o n i s t s e. ( g. I -1 L r a ) a s w e l l as<br />

n egative mo od (e. g. a n x i e t a y n d ep res s ion ) can in h ib it s leep [ S a k a m i e t a l . , 2 0 0 . 2 ]<br />

R ecip rocal l y, d i s o r g a n i z a t i o n o f -w t a h k e c s y l c e l e p h a s b e e n s h ow n t o i n d u c e<br />

al t e r a t i o : n s<br />

1 . In th e le vel s o f th e n e u r o-en d ocrin e h or m on es [ v a n R e e t h e t a l . , 1 9 9 in 4 ] clu d in g<br />

imp airmen t o f mel at on in s ecreti on [ S u z u k i e t a l . , 1 9 9 ; 3 an ] d<br />

2 . In i mmu n e p aramet ers [ C r u e s s e t a l . , 2 0 0 3 ; M o l d o f s k y , 1 9 in 9 5 clud ] in g s h ift in g the b a l a n c e o f T h . 1 / T h . 2 c uy ctio t o k n i toward n e p r Th o d .2 d omi n an ce [S aka mi et al .,<br />

2 0 0 2 ] .<br />

T h e s e a l t e r a t i o n s m a y b e a s s o c i a t e d w i t h e a c h o t h e r s i n c e m e l r a t e o p n o i r n t o w e d a s<br />

s timu lat e Th .1 c yt o ki n e p rod u ction [ G a r c i -M a a u r i o n e t a l . , 1 9 9 9 ; I n s e r r a e t a l . , . 1 It 9 9 h8 as ]<br />

als o b een s h own t h at s l eep d ep rivation , p articu larl y th e rap id e ye mo vem en t (R EM ) s leep<br />

d ep rivat ion , imp ai rs i mmu n e res p on s es [ C a s e y e t a l . , 1 9 7 . 4 Th ] e ‘s l e e p e f f i c ie n c y ’ , i .e. th e<br />

p ercen tage o f t ot al s leep am ou n t in a v a i l a b l e -time s l e e (i p n cl u d in g awake ti me in b ed ), was<br />

s h o w n t o c o r r e l n e a t g a e t i v e l w y i t h t h e c l i n i c a l p a r a m e st en e tin r s g r d e is p eas r e e s ev eri ti es b oth in<br />

c y s t i -fib c r os is p at ien ts [ M i l r o s s e t a l . , 2 0 0 2 ] a n d -i i n f n e c t e H d I p a V nt ts i [ e C r u e s s e t a l . , 2 0 0 . 3 ]<br />

T h e s l e e p e f f i was c i e al n sc o y r e p o r t to e d b e s ign ifi can tl y d ecreas ed in recu rr en t d ep res s ive<br />

p atien ts , an d t h e p ercen t age <strong>of</strong> th e R EM s leep was in creas ed with in th e d ecreas ed time o f s leep<br />

[ T h a s e e t a l . , 1 9 9 . 5 Th ] is s u g g e s t s t h e i m p o r t a n h c e a l t o h i n m a i an n t ap a i pn rop i n ri g at e<br />

a m o u n t o f t Rh EM e s leep .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

In p atien ts wi th d ep res s ion , wh o o f t e r n e p o r t s leep p rob lems , mel at on in s ecretion is<br />

rep orted to b e imp ai red , an d ex o gen ou s melaton in ha s b e e n s h own to res to re s lee p q u al it y an d<br />

mo od [ L e p p a m a k i e t a l . , 2 0 0 . 3 Ex ] ogen o u s mel at on in was als o s h own t o imp r ove mo od an d to<br />

inc r e a s e t h e R E M s l e e p i n d e p d r e ps atien s ts d u ri n g th e n ext d a y <strong>of</strong> ad min is tration [Bau e r et al .,<br />

1 9 9 5 ; S p a -S t c h w a l b e e t a l . , 1 9 9 a 8 l ] t h o u g h t i h m e p r o v em e n t mi n ood an d in crea s ed amou n t <strong>of</strong><br />

th e R E M s l e e d p i s a p p e a r i e n d t h e f o l l o w . i Fu n g rth er, d a y a h igh c ort is ol t o melato n in ratio<br />

( c a u s e d b y i m p a i r m i e g n h t -t i m o f e m n e lat on in s ecret ion ) ha s a l s b o e e n s h own to correl at e wi th imp aired c e l l -med i at ed i mmu n e res p on s e s an d with an in creas e in d ep res s ive moo d [ Fi orin a et<br />

a l . , 1 9 9 9 . ] H e n c e m e l a t , o a n s i w n e l l a s c o r t i s o l a p p e a r e to d h a ve an i mp ort an t r ol e regard in g<br />

s l e e p r e g u l a t i o n i n -n t e h u e r o-e p s n d y o c c h r o i n -i o mmu n e n et wo rk.<br />

C o n s e q u e n t l it y has b e e n s u g g e s t e d t th h a e s l e e p p r o c e s s itself p la ys a n i m p o r t a n t r o l e i n<br />

in teract ion s in th e p s y c h o-n e u r o-e n d o c r i n -im o mu n e n e t w o r [ k Kru eger et al . , 2 0 0 3 ; Mars h all &<br />

B o r n , 2 0 0 2 ].<br />

1 .2 .2 . 4 Ci r c a d i a n d n s u b r j e c h t w i y v e e l t l-b h e i m n g<br />

P s y c h o l o g i c a l l y , t -wak h e e s cl ycl e e p is a rob u s t regu lat or <strong>of</strong> h u man ale rtn es s [ Hu ll et al.,<br />

2 0 0 3 ] . At t h e b e gi n n i n g <strong>of</strong> s leep , th e b od y red u ces th e in p u t <strong>of</strong> exte rn al s timu li (n e u ral s en s or y<br />

in p u ts ) an d t h ere i s al s o l es s p h ys ical m o vemen t (n eu ral mot or ou tp u t s ). Th is s leep in du ction<br />

a n d i t s m a i n t be o e n h el a p fu n l c for e c o n a s o l r i d a e ting mem k n o or y w in th e awa k e learn in g<br />

p r o c e s s, s o th at e f f e c t i v e c o g n i t i v e f d au yti n c me t i co an n bi e n p res erved [S tic k gol d et al., 2 0 0 1 ;<br />

S t i c k g o l d & W a l k e r , 2 0 0 5 ; W a l k e r e t a l . , . 2 Al 0 0 5 e ] r t n e s s th a e n c d o g n i t ive e ffect i ven es s in<br />

f u n c t i o n v h e a b e e n d i s c u in s s r e d l a tion to su b j e c t i v w e e l l-b e i n g r a t i n g a s n d q u a l i t y o f l i f e<br />

d u rin g th e d a y t i m e a n d t o s u b s e q u e n t s leep q u a l i t a t y n i g h t. T h e m o s t c o m m o n l y u s e d s e -l<br />

f<br />

rep ort meas u re <strong>of</strong> s leep q u al it y i s t h P e i t t s b u r g h S leep Qu al it y In d ex (P SQI) [ Bu ys s e et al.,<br />

1 9 8 9 ] .<br />

Sl e e p q u a l , as i t meas y u red b y th e P SQ I, h as b een r e p o r t e d ith t am o ou nc t <strong>of</strong> o r r e l a t e w<br />

s leep , n amel y th e s l e e p e f f c i y , c i a n e d n w i t h t h e p e r c e n t a g e s o f R E s l M e e p i n t h e t - o t a l s l e e p<br />

time [ M i l r o s s e t a l . , 2 0 0 . 2 Sleep ] q u al it y h as al s o b een s h own to r e p o r t e d t o c o r r e l t a h t e e w i t h<br />

q u a l i -o t f y -l i f [ e C o h e n e t a l . , 1 9 9 , 8 a ] n d it has b een s u gges ted th at imp roved s leep q u alit y ma y<br />

c o n t r i b u t e t o b e t t -o e f r -li fe q u [ Ma l ye i rs t & y Bad ia, 1 9 9 5 ] . R e c i p r o c a l l a yti y , me d r el axat ion exercis e has s h own to imp r ove th e s leep q u alit y [ S h a p i r o e t a l . , 2 0 0 . 3 It ] ha s a l s b o e e n<br />

d e m o n s t r a t e d t h a ut b jects s wi th a h i g h a m p l i t u d e o f a l p h a d a w y t a i v e m bs e rain i n waves , wh ich r e p r e s e n t s a c a l m e r o r r f e mi l a n d x e , sd leep s t sa ign t e ifi can o tl y l on ger an d d eep er [Eh lers et al. ,<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 9 9 8 ] . O n t h e o t h e r , h a d i n d s o r g a n i z a t i o n o -w f ake t h e c ycl s e l w e a e s p f o u n d t o i m p a i r t h e<br />

q u a l i -o t f y -li fe [ E d e l l -Gu s t a f f s o n , 2 0 0 2 ; E d e l l-Gu s t a f f s o n & He t ta , 2 0 0 1 ].<br />

C o l l e c t i , v th e ere l y m a y b e an i n t e g r a t r e l d a t i o n b s e t h w i e p e n n i g h t t i m e w e l l-b e i n g (s leep<br />

q u a l i t y ) a n d d a y t i m e w e l l-b e i n g (q u a l i -o t f y -l i f ), e a n th d e d a yt i me w e l l -b e i n g ma y con trib u te to<br />

th e n i g h t t i m e w e l l-b e i n g a n d v i c e v e r i s a n t h e p -ne s y c u h r o o-e n d o c r i n -i o m m u n e n e t w . o r k<br />

1 .2 .3 P s y c h o l o g i c a l i n p u t i n -n t h e u r p o-e s y n c d h o o c r i n -i o m m u n e n e t w o r k<br />

T h e w o r d ‘S t r e s s’ w a s d e f i n e d b y H a n s S , a e l py he ys ici an an d en d ocri n ol ogis t wh o<br />

in s tigat ed s tres s res earch , a s “ t h e -s n p o e n c i f i c r e s p o n s e o f t h e b o d y to an y d e man d ” [Sel ye ,<br />

1 9 3 6 ] . S e l y e a l s o e m p h ed a s i th s e d is ti n cti on b et ween ‘St r e s s o r’ (th e cau s e) an d ‘St r e s s’ (th e<br />

effect) [ S e l y e , 1 9 7 5 a ].<br />

1 .2 .3. 1 S t r e s s o r<br />

Li fe e ven ts (s u c h a s t r a u m a , d i s e a s e , e x e r a c n i d s l -c i f h e a n g i n g e x p e r i e n c e ) s c h a l l e n �g<br />

e<br />

a n i n d i v i d u a l ’ s c a p a c i t y t o a d a p t t o i n n e r a n d o u s t e r c h d a e l m l a e n s d g s e ma . y T bh e<br />

p h y s i o l o g i c a l l y a r a n o d u / s o i r e n m g o ti o n a l l y t a x i n g , a n d t h e s e e v e n t s m a y l e a d t o c o g n i ive t an d<br />

b eh avi ou ral res p on s es .<br />

P h ys iol ogi cal s tres s o rs (i n c l u d i n g t r a u m a , i n f e c t i o n ) a ffect n d s h ut man a r v a o rgan t i o n<br />

s ys te ms d i rect l y t h rou gh cat ab oli c ch an g es (en erg y c on s u min g ch an ges ). P s ych olo gical<br />

s t r e s s o r s�(s t i mu l i wh i ch arou s e h u man emoti on s ) can als o a ffect h u man or gan s ys tems th rou gh<br />

t h e e f f e c t s o f p s y c h o l o g i c a l s t r e s s , b o t h -n e d i u r o-e e c n t d o l c y r i v n -i i o a m m t u h n e p s y c h o<br />

n e t w o r k (i .e. a p p r a i s a l o f s t r e s s o r a c ts as an i n p u t i n t h e n e ) t w a o n r d k mod b y u lat ion <strong>of</strong> h u man<br />

b e h a v i o u r i n c l u d i n g e a t i n g h a b i t s , e x e r c i s e , s m o k i n g a n -med d s e l icat f ion .<br />

S t r e s s r e l a t e d -e v l e i n t f s e h ave <strong>of</strong>t en b een examin ed eith er in h ealth y p op u lation s u s in g<br />

a c a d e m i c e x a m i n a t i o n s w h e r -cells e , iN n K p art icu lar, were meas u red as a s t r e s s-r e l a t e d m a r k e r<br />

[Dein zer & S ch u l l er, 1 9 9 8 ; Glas er et al., 1 9 85 ; Gru zelier, Le v y et al. , 2 0 0 1 ; Gru ze lier, Smith et<br />

a l . , 2 0 0 1 ; Ki e c o l t-G l a s e r e t a l . , 1 9 8 6 ; Ki e c o l t-G l a s e r e t a l . , 2 0 0 [ 1 s ] e e a l s o 1 . 2 . 4 . 2 a n d 1 . 2 . , 4 . 3 ]<br />

o r i n p a t i e n t p o p u l a t i o n i.e. s ( clin ical l y s t res s ed in d ivi d u als ) wh o are p ers is ten tl y e xp os ed to th e<br />

p r e s e n c e o f l -lon i f g e d is eas es . T h e s e life-l on g d is eas es <strong>of</strong>ten u s ed in th e literatu re i n clu d e<br />

malign an c y (b reas t can cer i n p articu lar ) [ An t o n i et al ., 2 0 0 1 ; Baid er et al ., 2 0 0 3 ; Bakke et al . ,<br />

2 0 0 2 ; S p i e g e l e t a l . , 1 9 8 9 a ] n d i n f e c t i o n s ( p a r t i c u l a r l y w i t h t e h he u man<br />

h e p a t i t i s v i r u s o r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

i m m u n o d e f i c i e n c y v i : r u s H I ) [ An V t on i et al ., 2 0 0 2 ; An ton i et al. , 2 0 0 0 ; C arb on e et al., 2 0 0 0 ;<br />

C r u e s s e t a l . , 2 0 0 3 ; C r u e s s e t a l . , . 1 T 9 9 h 9 e ] HIV in fect i on is a l i -th f e reaten in g d is eas e d irect l y<br />

r e l a t e d t h t e o i m m u e n c e l l , s p a r t ic u la r l y C D 4 -c ells T , s o it ma y b e c on s id ered as a go od<br />

examp le <strong>of</strong> a life-l o n g s t r e s s o r t o b o t h ’s o n b e i o l o y g an d p s y c h o l o y. g In ad d it ion , s t r e s s has<br />

b e e n s h o w to n d e t r i m e n t a l l y af f e c t th e HIV d i s e a s e p r o g r e [C s s atalan i o n et al . , 1 9 9 5 ; C ol e et al.,<br />

2 0 0 3 ; C o l e e t a l . , 1 9 9 7 ; C o l e e t a l . , . 1 9 9 6 ]<br />

He n c e , th e t w o s u b j e c t g r o u p s ed s for i n v i in v ves o ti gat ion in th is p roj ect were :<br />

1 . Un i v e r s i t y s t u d e , n t f s a c i n g a c a d e m i c e x a m i n a t , i as o n an s exa mp le o f in d ivi d u als<br />

with time-l i m i t e d s u s t a i n e d s , t a r e s n s d t h e p r i m a r y o -c u e l t l s; c o m e m e a s<br />

a n d<br />

2 . H I V-i n fect ed a d u lts, n ot rec eivin g a n t i -re trociral m e d i c a t i , a o s n an ex amp le <strong>of</strong><br />

indi v i d u a l with s o n -goi n g d i s e a s e-a s s o c i a t e d s t r e , s an s d th e p ri mar y ou tco me<br />

m e a s u r e w a s -cells. C D 4 T<br />

1 .2 .3. 2 St r e s s p e r c e p t i o n<br />

On e in d i vi d u al ’s p ercep t i on <strong>of</strong> a p articu la r s tres s or will d iffe r f ro m an oth er’s . Fact ors<br />

a f f e c t i n g s t r e s s p e r c e p t i o n c a n b e c l a s s ifi ed in to th ree cate gori es [ F o l k m a n & M o s k o w i t z , 2 0 0 4 ]<br />

S t r e s s o r-r e l a t e d : i n h e r e n t q u a l i t y ( t y p e ) , i n ; t e n s i t y a n d f r e q u e n c y<br />

E n v i r o n m e n t -r e l a t e d : p h ys i c a l a n d s o c i a l r e s o u r c e s; a n d<br />

In d i v i d u a l -rel at ed : c ogn i t i ve ap p rais al, co p in g s kills , an d p ers on alit y.<br />

A m o n g t h e s thr e e e fact ors , th e i n d i v i d u a l-r e l a t e d f a c t o ar re s th os e m os t d irect l y<br />

s u s cep t ib l e t o p s ych ol o gi cal in flu en ces [ H a n , 2 0 0 2 ]. An in d ivid u al’s ap p rais al <strong>of</strong> a s t r e s so r h as<br />

two ele men ts [ L a z a r u s & F o l k m a n , 1 9 8 4 : ]<br />

1. Pr i m a r y a p p r a l i (p s erc a ep ti on <strong>of</strong> a d e m a n d, th reat o r s t i m u lu s ); a n d<br />

2. Se c o n d a r y a p p r a i s a l (j u d ge men t in on e’s cap ab ilit y o f c o p in g w i t h a t h r e a . t )<br />

P rimar y ap p rai s al can b e ei th er n eu tral, b en ign o r t h r e a n t i e n g [Te x t b o x ]. W 2 h en th e<br />

p r i m a r y a p p r a i s a l o f a s t r e s s o r w p a s e r c e i v e d a s th reat , th en con s eq u en tl y t h e s e c o n d a r y<br />

a p p r a i s a l w o u l for d mu lat e an d r e s u l t a cop i n in g a c t i o [ n Laza ru s , 1 9 9 9 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 7 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T e x t b o 2: x APP RAI SAL O F A S T R E S S F U L L I F E E V E N T<br />

# & / 0<br />

1 #& / 0 2 3<br />

. # 4 / 05 + 6 7 8 9 :<br />

%<br />

; <<br />

2 3 2 3 =<br />

T w o t y p e s o op f in c g wi th a th reat h a v e b e e n h y p o t h e s i s e d : ( 1 ) e m o t i -f o o n c us ed and (2 )<br />

p r o b -f o l c u e s e m [ d F o l k m a n & M o s k o w i t z , 2 0 0 . 4 ] T h e s ma e y b e m a i n l y a s s o c i a t e th d e w i t h<br />

levels o f p ri ma r y an d s econ d ar y ap p rais al , res p ectivel y. R e c e n t l y , n a d d i nt al i o in d ep en d en t<br />

c o p i n g s t r a t e g y , -makin m e a n i g n fg ocu s ed , h as b een p rop os ed [ T e x t b o x 3 ]. T e h m e a n i -n<br />

g<br />

m a k i n g-f ocu s ed el emen t was p rop os ed as an in d ep end en t cop in g s t rateg y in wh ich th e p ers on<br />

w e i g hs v a l u e s , b e l i e f s a n d g o a l s t o m o d i f y t h e m e a n i n g s f o u f l a t s t r a e s n s a [F c r t a n i k o l n , 1 9 7 0 ],<br />

p a r t i la c r u l y u n d er s u s t a i n se tres d s th at ma y n ot b e a men ab le to the f i r s t t w e o l e m e n t s [P ark &<br />

F o l k m a n , 1 9 9 7 ]. Fo r e x a m p l e , the m e a n i -m n g a k i n g c o p i was n g i l l u s t r a t e d a s trateg t h e y<br />

caregi vers mos t freq u en t l y rep o rted to em p lo y wh en th e y h ave to c o p e with b eh avi ou rs <strong>of</strong><br />

d e m e n t e d c a r -r e c i p i e n t [ s G i g n a c & G o t t l i e b , 1 9 9 . 6 ]<br />

Text box 3: E L E M E N T S O F C W O I P T I H N G A T H R E A T<br />

%, . ><br />

# '<br />

) # +<br />

-%, .<br />

1 # ><br />

# )<br />

%, .<br />

# ?<br />

<<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 8 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e s e t h r e e c o p i n g s t r a t e g i e s h a v e b e e p n a r i a n p t h r e a g r s into a e t d e th d e con a n d cep t <strong>of</strong> th e<br />

s e n s e o f c o h e r e n oC c e ) [ A ( n S t o n o v s k y , 1 9 9 3 ], in w h ich s tres s fu l p e r c e p t i c o a n b e al tered an d<br />

r e d u c e d t h r o u g h th ree co mp on en ts [ G e y e r , 1 9 9 7 ]:<br />

1 . C o m p r e h e n s i b i : l To i t m y a k e a s t r e s so r r a t i o n a l, u n d ers tan d able a n d / o r p r e d i c t a . b l e<br />

2 . M a n a g e a b i l : i t y T o b e c o m e c a p b a l e o f i n f l u e ing n c d irect l y u p on a n d taki n g in<br />

c o n t r o l o f h i s / h e r s t r e s s-rel at ed e n v i ro n m e n t .<br />

3 . M e a n i n g f u l n e s : s To ob tai n wort h y a w a r e n e s s c b o y m m i t m e n t in a n d i n v e s t m e n t <strong>of</strong><br />

h is /h er own exi s t i n g r e s o u r c es.<br />

It h as b een s u g g e s t e d t h a omp t c reh en s ib il it y can b e con s tru cted t h r o u g h t i h n e d i v i d u a l’s<br />

own th ou gh ts an d th eori es , d e s p i t e a n i n s e c u ituation; r e s that man ageab il it y can b e ach ieved b y<br />

a c t i v e i n f o r -s m e a e t k i n o g n s t r a t e g i e s , b y s o c i a l s u p p o r t a n d b y p o s i t i v e r e in terp ret ation <strong>of</strong> th e<br />

s itu ation ; an d that me a n i n g f u l n e s s c a n b e creat ed b y a c l o s e-r e l a t s i h o i n p an d a faith (or a b el ief a n d c o n f i c d e n i n o n s e l f / a o n r d s o m e t h i n g g r e a te r ) [ F r a n k l , 1 9 7 0 ] a s w e l l ba y s a b e h a v i o u r a l<br />

c o m m i t m e n t / e f f o r t [ S t r a n g & S t r a n g , 2 0 0 . 1 ]<br />

1 .2 .3 . 3 P s y c h o l o g i c a l t r a i n i n g i n t e r v e n t i o n<br />

S i n c e p s y c h o t h e r a p y b e g a n t o r a as p p a e fo a rmal l y re co gn is ed in terven tion with in<br />

med ici n e (p a r t i c u l a r l y m a m e n o t n a g l h e a l t h p r o f e s s ), i o hn us n d red s <strong>of</strong> fo rms <strong>of</strong> p s ych oth erap ies<br />

h ave b een in trod u ced [ R o t h & F o n a g y , 1 9 9 6 . ] In recen t d ecad es , th e s t yl e o f p s yc h oth erap y h as<br />

s h i f t e d i n i ts mai n focu s fr om a p a t e r n a l i s t i c s t y l e a t h ( e r i a . p i e s t-o . ri g en i tv at i ed n g th erap y t o a<br />

c l i e n t / p a t i e n t ) to a n e mp owerin g s t yle (i .e. train in g or p r ovid in g a c l i e n t / p a t i e n t w s e i l f-h t h e l p<br />

/ s e l f-a d m i n i s t r tech a t e nd iq u es in clu d in g s ki ll s to get s u p p ort s o th at th e y can man age s tres s b y<br />

th ems el ves ).<br />

Th e latt er t yp e <strong>of</strong> p s ych ol o gical in ter ven t ion h as focu s ed u p on a t rain in g as p ect , i .e .<br />

t e a c h i n g s p e c i f i c s k / i t l e l c s h n i q u e s a n d e n c o u r a g i n g c l i / e pn atien t s ts to u s e th es e i n d ai l y li fe<br />

[ B a i d e r e t a l . , 2 0 0 1 ; B a t e y e t a l . , . 2 T0 h0 is 0 ] t yp e <strong>of</strong> in ter ven ti on aims t o h elp p atien ts red u ce<br />

s t r e s s l e v e l s a n d i m p e r w o v e l l-b ei n g th ro u gh th e mod ificati on <strong>of</strong> b eh aviou r, co gn ition , o r<br />

emoti on [ M i l l e r & C o h e n , 2 0 0 . 1 Th ] is t yp e <strong>of</strong> in ter ven ti on in clu d es s tres s man age men t<br />

( b e h a v i o u r t h e r a /or p y c a o n g d n i t i -b v eh e a vi ou ral th erap y [ An ton i et al., 2 0 0 0 ; C ru es s et al.,<br />

1 9 9 9 ; C r u e s s e t a l . , 2 0 0 ), 0 relaxat ] i on me th od s [Gi ll an i & Smith , 2 0 0 1 ; Gru zelie r, Le v y et al .,<br />

2 0 0 1 ; K e e f e r & B l a n c h a r d , 2 0 0 , 2 ] s e l f-h yp n os is or vi s u al is at ion [ Gru zelier, Lev y e t al., 2 0 0 1 ;<br />

G r u z e l i e r , S m i t h e t a l . , 2 0 0 1 ; W h i t e h o u s e e t a l . , an 1 d 9 9 b6 i<strong>of</strong>eed ] b ack or c on d it ion in g<br />

in terven ti on s [ M i l l e r & C o h e n , 2 0 0 1 ; R a y m o n d e t a l . , 2 .<br />

0 0 5 ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Bas ed on th e a p p r a i s a l t h e o ies r o u t l i n e d a b , o it v c e a n b e h yp o t h e s i s e d t h a t p s ych ol ogical<br />

t r a i n i n g an d p ract ice can al ter s t r e s s f u l p e rc e p t i o ( p n r i m a r y a n d s e c o n d a r y a p p r a i s a l s ) b y<br />

p r o v i in d g altern at i ve or s u p p lemen tal p ers p ectives an d co p i n g s k i l l f s o r s t r e s s f u l l i f e e . v e n t s<br />

Primar y ap p rai s al m a y b e a l t e r e d f r o m a t h r e a t t o a n e u t r a l o r a b e n i g n s t imu lu s b y ad ju s tin g<br />

i n d i v i d u a l r , se in a l ce i on t e’s y p ercep ti on is b as ed on on e’s p ers p ectives a n d exp eri en ce. Th e<br />

se c o n d a r y a p p r a i s a l m a y b e a l t e r e ne d w cop b y in l g e sa ki r ln ls i n g ord er t o s tren gt h en on e’s<br />

cop in g ab il it y t o the s t r e s s f u l p e . r c e p t i o n<br />

Self-h y p n o s i s<br />

A m o n g t h e m a n y p s y c h o l o g i c a l i n t e s r for v e s n e t l f-a i o d n m i n i s t r a t e d s tres s man age men t,<br />

on e ap p roach c o m m o n l y u se d i n c l i n i c a l s t u d i e s i n self-h v o l v e y s p n o s i s t r a i a n i d n g p r a c t i c e<br />

[ Ki e c o l t -G l a s e r & Gl a s e r , 1 9 9 2 ; Ki e c o l t-G l a s e r e t a l . , 2 0 0 . 1 H] yp n os is (b ot h wi th an d wi th ou t<br />

s e l f-h y p n o s i s t r a i n i n g is ) ar gu ab l y on e <strong>of</strong> th e more accep ted th erap ies with in comp l emen tar y<br />

m e d ici n e [ A f a r i e t a l . , 1 9 9 9 ; S t e w a r t , 2 , 0 0 a 5 n ] d self-h y p n o s i s h as b een s tu d ied as a fo rm <strong>of</strong><br />

p s ych ol ogi cal i n t erven t i on for d ecad es [ Gru zelie r, 2 0 0 2 a; Gru zelier , Le v y et al ., 2 0 01 ; Sch u lz,<br />

2 0 0 1 ; S p ie g e l e t a l . , 1 9 8 9 ; W h i t e h o u s e e t a l . , . 1 9 9 6 ]<br />

On e o f t h e u n i q u e p e r s p e c t i v e s i n h y p n is o s th i s e con cep t <strong>of</strong> th e ‘h y p n o t i c s t ’, a t i.e. e a<br />

state o f m i n d i n w h i c h a p e r s o n ' s n o r m a l c r i t i c a l o r [ G r u s z k e l p i e t r i , c 1 9 9 n 8 a . ] t u r e i s b y p a s<br />

Th e h y p n o t i c s t is a t e u s u a l t l a u y g h t as a n a l t e re d l e v e l o f a w a r e n e s s or a s t a t e o f m i n d w h e r e<br />

on e can gai n mor e c on trol ove r him- o r h ers elf an d on e’s c o g n i t i s o ab n ou t or p erce p ti on s <strong>of</strong><br />

‘reality’. Th is ma y in creas e th e c o m p r e h e n s i b i i l n i t h e y c o p i n g s t r a t e g i e ss ee [ ab o ve 1 .2 .3 .2 ].<br />

Self-h yp n os is t yp i cal l y i n c l u d e s a f o c u s in g <strong>of</strong> at ten ti on , f ol low ed b y men tal an d p h ys ical<br />

r e l a x a t , i a n o d n m e n t a l i m a g e r y o f d e ‘ e p e n i n ’ g in and ‘a b s o r p t i ’ o into n a h yp n ot ic state. As a<br />

‘s u g g e s t i ’ o in n a h yp n ot ic state, at ten ti on f o c u se d o n e x e r c i s e s o f -c on a n trol x i , e gt uy id ed<br />

i m a g e r y o f h e a l nt d h th e a f e e l i n g s o f c o n f i d e n c e a n d h a p p s , i i.e. n e s an in creas e in i n n e r s e n s e o f<br />

e m p o w e r m e t. n Th is p ro ces s a i m s t p o r o v i d e p in c g o s ki ll s to i n c r e a s e t h e m a n a g e a b i l i t y<br />

[ 1 . 2 . 3 . 2 . ] F o r t h e p u r p o s e o e f n h a n c ing the man age ab il it y, s o me skills f r o m t co h e g n iti ve<br />

b eh avi ou ral th erap y (C BT ) we re als o p ro vid ed as a s u p p l e m e n t a r t e y c h n i q u in e thi s p r o j e c t<br />

[A p p e n d -2i]. i x A<br />

J o h r e i<br />

T h e o t h e r t r a i n i n g i n t e r f or v e n a t s e i l f-a o n d m i n i s t r s a t r e d a t e g a y p p l i in e d this p r o j e c t s w a<br />

J oh rei, a J a p a n e s e n o n-con tact h e a l i n g h i m c h e l t o o s h k o s i d m i l w a r t o -o t n h -o e f -h l a n y d i s<br />

n g<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

t e c h n i q u e s. J oh rei is cl as s ifi ed u n d er s u b tle en erg y m ed ici n e a n d a s categ a or y o f<br />

comp lemen tar y med ici n e [ C l a r k e , 2 0 0 0 ] b e c a u s e i t d e a l s w i er t y h <strong>of</strong> ‘h i m e a l g i n -light’ g or<br />

u n d i s c o v e r ‘vital e d e n e r g y’. Du ri n g a J oh rei s es s ion , th e p ractition er vis u alizes a s p iritu al<br />

h e a l i -l n g i g h t c o m i n g f r o m a n i m a g i n a r ( a y s s i f o u l r i g c h e t c o m e s f r o m t h e S a u n d ) t r a n s m its<br />

th is to th e reci p ien t th rou gh th e p alm <strong>of</strong> h i s / h e r o u t s t r e t c h e . d As h a wit n d h ot h er s u b tl e en erg y<br />

m e d i c i n e m e t h o d s l Th i erap k e eu ti c tou ch [ M e e h a n , 1 9 9 8 ; O ' M a t h u n a e t a l . , 2 , 0 Ki 0 2 [C ] h an g,<br />

2 0 0 3 ] or Sp iri tu al h eal in g [ P a t t e r s o n , 1 9 9 8 , ] J oh rei h as it s own p h il os op h ical b ack grou n d , in<br />

o t h e r w o r d , s J o h r e i p r o v i d an e s alte rn at iv e p ers p ect ive o f s tres s fu l life even ts .<br />

Th e phi los op h ical b ackgr ou n d o f J o h r e i i n c l u d e k s e y p t r w i o n c i p l e s a i m i pn l y g t o s u p<br />

altern at i ve p ers p ect i ves :<br />

1 . ‘P r o c e s s o f P u r i f ’ i c w a h t i c o h n e n c o u r a g e s in g c o h n a e n ’s g p ers p ect ives d u ri n g<br />

s t r e s s f u l a n d / o r d i f f i c u l t p , se hr i iftin o d s g fro m f ocu s in g on n e g a t i v i t i e o s f th e mo m en t<br />

to f ocu s i n g u p on fu t u re ou t com es wh en t h e p r o b l e m p e r i o d is o v e r; a n d<br />

2 . ‘I Z U N O M E’ w h i c m h e a n s a d yn ami c s tat e <strong>of</strong> h arm on y in a p p r o p r i a t e t an i d m i n g<br />

b a l a n ce b e t w e e n t w o d i c h o t o m i s e d c o n c / e p a t t s t i t u , d e.g. e s b e t w e e e n n d e a v o u r t o<br />

p e r s i s t m a k i n you g r own d es ti n y wi th ‘M a k o t o’ ( s i n c e r i t y , i n t e g r i t y , t r u t h a n d l o v e<br />

u s e d f o r o ’s n e s e l f a w a r e n e s s ) [ H a r d a c r e , 1 9 8 8 ] an d d e t a c h m e n t ‘l t e o t ’ g (tru o s t in n atu ral t i me cou rs e wh i ch is b e y o n d o n e’s c o n t r o l ).<br />

‘J o h r e i ’ literally m e a n s “ p u r i f i c a t i o n o f , s the p o i r i a t p ” p r o a c ma h y al s o p r o v i d e a n<br />

a l t e r n a t i o v r e a d d i t i o n a l p e r s p e c t i n v lif e e even o ts wi th th e con cep t o f s p i r i t u a [ Seaward l i t y ,<br />

2 0 0 0 ] . E x p e r i e n c e o f J o h r e i l i f-c s on a tai s ne ed ti me wh en on e can q u i e t l y, m i n d f u ll y an d kin d l y<br />

con cen trat e u p o n t h e r e c i p i e n t ’ s b e n e f i t, a s w e l l a s h i , s s / i h n e c r e t o h w e n J o h r e i p r a c t i c e i s<br />

b as ed u p o n t h e c o n c e p t t o h n a e t c a “ n h e a l o n e s e l f b y h e a l i n g ” o [ t N h a e i r t s o , 2 0 0 3 . ]<br />

H e n c e , J o h r e i d i f f e r s f r o m s e -h l f y p n o s i s i n a i t n l y h i a n t p a , i alth r s i o ut gh i s p r a c<br />

s e l f-J oh rei an d d is tan t J oh rei t e c h n i q u s e c a n b e p r o v i , d a e n d i n f a c t, w e r e p r o v i d e d a t th e en d<br />

o f t r a i n i n g s e i s n s i t o n h e c u r r e . n I t n s a t d d u i d y t i o n , t e a c h i n g a p p r e c i n a d t i i n g o s n an d o f s u r r o u<br />

h u m a n r e l a t i o s n (n s h amel i p y ‘Spiritua l C o s’) r d is g i v e n a s a o n e o f m a j o r fi ve p r i n c i p s l to e<br />

p r a c t i se J o h r e i [A p p e n d -2ii]. i x Th es A e c on cep ts m a y b e c ollecti vel y a b l e i t n o c r e a s e a s en s e <strong>of</strong><br />

r e c e i v i n g s u p p o r t (m a n a g e a b i l ) i a t n d y to en h an ce th e m e a n i n gf u l n e s, b o t h o f w h i c h a n<br />

p r o m o t e c op in g ability [1 . 2 . 3 ].<br />

. 2<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P o s s i b l l e t a e r a t s in i o the n neu ra l pa rt o f t h e n e t w o r k<br />

H y p n o s i s , b y d e f i n i t i o n , c o m p t r h i r e s e s i n t e -lin r ked p r oces s es [ S t e w a r t , 2 0 0 5 : ]<br />

1 . Fo c u s e d a t t e n , t i o n<br />

2 . In d u ct i on <strong>of</strong> a h yp n ot i c state, a n d<br />

3 . Re c e p t i v en e s s t o s u g g e s . t i o n<br />

P os itive emi s s i on top o grap h y (P ET) s tu d ies h ave imp lied th at th es e p roces s es o f h yp n os is<br />

a r e n o t p r o c e s s o f s i m p l y f o l l o w i n g i n s t r u c t i o n s b u t t h e y i n v o e l a v ch an ge <strong>of</strong> p er cep ti on in th e<br />

b r a i , n s u c h a s in vi s u al p ercep ti on [ K o s s l y n e t a l . , 2 0 0 0 a ] nd in p a i n s e n s a t [ i Fa o n ym on vi ll e et<br />

a l . , 2 0 0 0 ]. P a r t i c u l a r l y in i p ercep n p a ti on , it w a s s u g g e s t e d t h a t is t h a e s r t e r o n r g e l a t i o n s h i p<br />

b etween th e p s yc h o l o g i c a l s t a te o f m i a n d n e u r o l o g i c a l r e s p t o n s p e a i n s t i m , u i.e. l u s a p ai n<br />

s timu lu s was s h own to cau s e d ifferen t n eu rolo gical res p on s es w h e t h e r n a in creas e or a d ecreas e<br />

i n b l , o d o e d p e n d f i g n l u p o n w t h e s t a t e o f m i n ‘h d y p i n o t i h c e s t ’ a [Mon t e tg ome r y et al .,<br />

2 0 0 0 ; P a t t e r s o n & J e n s e n , 2 0 0 . 3 ] H e n c e, i t w a s s u g g e s t e d t h a t self-h yp n os is ma y d irectl y b e<br />

a b l e t o a l t e r t h ap e p rais p r i al m at a tr h y e u n c o n s c i o u s l e v e l as well as at th e c o n s c i o u s l e v e l.<br />

O n t h e t h o e r h a n d , f e w s t u d i e s h a v e th e i pn hv ys e s iol t oi gi g cal a t p e r d o c e s se s as s oci ated<br />

w i t h a J o h r e i s e . s s wi o T o pn rel i mi n ar y s t u d i e s h ave d emon s trated th at exp erien ced p ractition ers<br />

w e r e s h o w n t o i n c r e a s e t h e h a p o w a e v r e s, o w f h i a c l h p i n d i s c a t a e n e x p e r i e n c e o f r e , l a x a t i o n<br />

d u r i n g t h e J o h r e i [Dwived s e s s i o et n al . i n p r e p a r a ]. t Single-b i o n l i n d e d s ies t u c d o m p a r ing a<br />

J o h r e i s e s s i ( recei o n ver was s it ti n g wi th e yes cl os ed , s ep arated b y a cu rtain f r the o m p ract it ion er ,<br />

a n d g iv e n J o h r e i f r o m b e h i mock n d ) s a e n s d s i o (th n e s ame s et ti n g wi th th e s ame ar m<br />

mo vemen ts <strong>of</strong> th e s am e p ractition e r b u t with n o in ten tion b y t h pe ractiti on er to p r act is e J oh rei)<br />

h a s d e m o n s t r a t h t a t e d s i m u l t a n e o u s l y r e c o r d e d b r a i n w a v e s f r o m b o t h n d p r e a c e t i v e t r i o n e r a<br />

e x h i b i t se ign d ifi can tl y in cre as ed level s <strong>of</strong> ‘m u t u a l i n f o r m ’ a in t i t o h n alp e h a wave b an d (an<br />

exp erien ce o f rel axat i on ) i n t h e J o h r e i , bs ue t s ns ot i in o n th e moc k c on d it ion [Dwi ved i et al. in<br />

p r e p a r a t ]. i T o n h i s i n d i c a t e s a y in t creas h e a their t l e v t e l s h <strong>of</strong> e rela xation J o . h r e i s e s s<br />

C o n s e q u e n t , l i t y w a s s u g g e s t e d t h a t th e p r a c t i c o e f J o h r e i m a y d i r e c t l y b e a b l e t ed o ur ce s tres s<br />

l e v e l s.<br />

I n s u m m a r y , t h w e po s ych ol ogi cal trai n i n g in terven tion s , self-h yp n os is an d J oh rei , were<br />

i n t e n d e d t o p r o v i d u e b j e s c t s w i t h t e c h n i q u e s t o a l t e h r pe erc ep ti on <strong>of</strong> s tres s ors , to en h an ce<br />

cop in g s ki ll s an d to p r ovi d e p r <strong>of</strong>ou n d rel axation [T e x t b o x ], a 4 n d t h e r e b t y o r e d u ce t h e e f f e c t s<br />

o f s t r e s s u p o n t h -n e e u p r s o-e y c n h d o c r i n -im o mu n e n et wor k.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 2 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Text box 4: SYCHOLOGI P C AL I N T E R V E N T I O N S I S I P N R O J T E H C T<br />

# , ,<br />

6 3 @ A 3 @ 8 3<br />

.<br />

6 A 8 )<br />

,% B* < &<br />

1 .2 .4 St r e s s-a s s o c i a t e d c h a n s g e<br />

/*<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 3 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

&<br />

B* <<br />

P u b l i s h e d f i n d i n g s r e g a r d i n g -as s t r se oc s s iat ed ch an ges are c omp lex an d d ifficu lt to<br />

s u mmari ze b ecau s e o f t h e h u g e v a r i e t y o f s t r e s , s b o i r s o l o g i c a l m a r k e , r tim s , e p oi a n nd ts at<br />

wh ich ch an ges ar e o b s e r v e d o r i n v e s t h t a i t g h a a t v e d b e e n u s e d i n t h e s e . s t Th u d is i e lat s ter d i f f e r e n c e i n p u b l i s h ed s t u d i e s i s p a r t i c u la r l y i m p o r t a n t w i t h r e g a r d t o t h e c u r r e n t p r o ect. j It is n e c e s s a r y, th e r e f o r , e t o b e ve r y s p eci fi c r egard in g th e timin g o f c h a n g e s i n s t r e s s r s e s that p o n s e<br />

w i l l b e m e a . s u r e d<br />

1 . 2 . 4 . C 1 h r o n o l o g i c a l d e f i o n f i s t i r e o s n s r e s p o n s e<br />

T h e ch ron ol o gi cal d e fi n it ion a n d d i s t i n c o t f i s t o r n e s s r e s p o n s e s a r e a m b i ou g u s an d h ave<br />

v a r ied f r o m s t u d y t , o e v s e t n u d t y h o u Han g h s Sel ye in trod u ced a c on cep t t h a t d e f i th n ree e d<br />

p h as es <strong>of</strong> s t r e s s r e s p o n s e s a s t h e n a m e o th f e ‘g e n e r a l a d a p t a t i o n s y n d ’ r [ o S m e l e y e , 1 9 7 5 b ]:<br />

1 . Ala r m s ta g e: t r i g g e r d i u n r g i n g w h i c h m a r s h a lled r e s o u r c e s a r e o ; r g a n i s e d<br />

2 . Res is ta n ce s tag e: ad a p t a t i d o u n r i n g w h i c h r e s i s t a n c e t o a l a r m r i s e s a b o v e n o r m a ; l<br />

a n d<br />

3 . Ex h a u s t i o n s t a g e : wh en ad ap tat ion en ergy is u s ed u p .<br />

R ecen tl y, it ha s b een d e m o n s t r a t e d b y u s i n a g m e t a-a n a l y si s s t r a t h t a e t g y S e l y ’s e t h ree<br />

c a t e g o ri e s o f s t r e s s r e s ma p o y n hs ae ve c o u n t e r p ar t s w i t h i n t , an h d e ma y i m m u n e s y s t<br />

r e p r e s e n t th ree d ifferen t i mmu n olo gical m o d i f i c a t s i [ S o e n g e r s t r o m & M i l l e r , 2 0 0 : 4 ]<br />

1 . Up-re gu l at i on <strong>of</strong> i n n at e i m mu n it y an d s up p res s ion <strong>of</strong> ad ap tive im mu n it y b y s h o r t -<br />

lasting ( s e c o n d s t o m i n u t e s ) s t r e s ; s<br />

2 . Cy t o k i n e s h i f t f r o m T h [ E . l 1 e n k t o o v & T h C . h 2 r o u s o s , 1 9 9 9 witho ] u t con s is ten t<br />

ch an ges in cel lu lar immu n it y b y t e m p o r a l ( h o u r s t o d a y s s ) t r e s s; a n d<br />

3 . Gl o b a l i m m -s u u n p o p r e s s i o n l b o y n -l g a s t g i (wee n ks , m on th s to years ) s t r e s s.


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

In c o n t r a s t , t h e r e i s a w e l l-u s e d d i c h o t o m i s e d c h r o n o l o g i c a l d i s t i n c t i o n , i n i . . s acu t e r e te s s<br />

an d s u s tain ed or ch ron ic s tres s . In te rms <strong>of</strong> th e g e n e r a l a d a p t a t i o n s y n d , r o cu a m te, e m omen tar y<br />

o r s h o r t l a s t i n g s t r e fs orth s ( acu h e n tc e s t res s ) is d efi n ed con cep tu all y as th e s tres s th at falls in<br />

th e p eri od fr om th e a l a r m s t a to g e t h r e e s i s t a n c e s t . a Su g e s tai n ed or ch ron ic s t res s (s u s tain ed<br />

s t r e s s t h ) r e e s i s i t a s n c e s f t to a r g e t o h e m x h a u s t i o n s t . a g e<br />

C o n s i d e r i n t g h s e l e e -w p a k e c yc l e a s a b i o l o g i c a ll y f u n d a m e n t a l , p e a r c u i t o e d o r s u s t a i n e d<br />

s t r e s s i n t h i s t h e is s i s de f i ed n on th e b as is <strong>of</strong> t h i s c y c . l T e h a t i s cu , te a s tres s is d efi n ed as s tres s<br />

th at h as it s effect s w i t h i n o n e d a y o r , i n o t h e r w o r d s , a s i n g l e c i r on c a tras d i a t, n r h y t h m . I n c<br />

s u s tain ed s tres s is d efi n ed as s tres s th at has its effects f o r m o r e t h a n , o n e i . . od ver e a y mo re th an<br />

on e circad ian rh yt h m. Th is can b e c o n s t r u e d a s “Su s tai n ed s tres s al ters ci rcad ian p attern s <strong>of</strong> th e<br />

p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w o rk.”<br />

D u e t th o e n a t u r e o f p s y c h o l o g i c a l in i n wh t e ich r v te rai n t n i n g o n a n d p r a c t i c e o c c u r ove r<br />

a p r o t r a c t e d p e r i o d d ( a y s , w e e k s a n d m o n t h s ), th e effects <strong>of</strong> s u s tain ed s tres s u p on med iators in<br />

t h e p s y c -n h e o u r o-e n d o c r i n -i o m mu n e n et wor k are th e cen tral f ocu s o f in teres t i n t h i s t h e . s Th i s e<br />

wor kin g h yp ot h es i s i n t h e p roject is that su s tain ed s tres s dis tu rbs p s ych olo gical b al an ce with<br />

c o n s e q u e n t i a l i n f l , a u n d e t n h e c d e t a s i l e d u c h p a n g o e b s n s e r v t e u nd dh er e i m m u n e<br />

s u s tain ed s tres s s u pp ort in g th is wor kin g h yp oth es is a r e e x p l ained b e l o w i n j u c n o c t i o n w the i t h<br />

s t r e s s r e s p o n s e in s th e p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w . o r k<br />

1 .2 .4 . 2 A c u t e s t r e s r s e s p o n s e s t i h e n n e u -e r n o d o c r i n -i o m m u n e n e t w o r k<br />

In th e p s y c h o-n eu ral p a rt o f th e p s y c h o-n e u r o-e n d o c r i n -im o mu n e n et work , th e p r i mar y<br />

a p p r a i s a l o f a sc tres u t e s , p art i cu larl y rew ard an d f e a r r e a c t i o , n a s r e b i-d i r e c t i o n a l l g y u l r a e t e d v i a<br />

n e u r o-h orm on al s ecret i on s [ C h a r n e y , 2 0 0 4 ]. In th e n erv ou s s ys te m, acu te s tres s is s h own to<br />

a c t i v a t e t h e r s e y c r e n t o e u r o n s t h r o u g -er h gic in a n ervat m i in on e s ir n tg h e i c a n d G A B A<br />

au ton omi c n er vou s s ys te m [ C o l e & S a w c h e n k o , 2 0 0 2 . ] This a m i n e r g i c p a t ha h s w a b y e e n<br />

r e p o r t e d p r t o j o e c t d i r e c t l o y t h e C R F n e u r o n s i n t h e y H P o f A , t h o b e t h u e t r n eu m ral a n<br />

n e t w o r k s utilise n e u r a l s yn a p t i c s i g n a l s v ia a n i n h i -e b rgic i nt et wo or r k y [ d e K G l A o e B t , A 2 0 0 3 ]<br />

i n c l u d i n eu g ron n s in th e SAM. Fo r e x a m p l e , th e e x c i t a t o r y i n p u t s f r o m -c or l tical i m b regi i c on s<br />

m o d u l a t e -e r t g i c h i e n t e r-n G eu A r on B A al n et work [C ol e & Sawch en ko , 2 0 0 2 ; Her man et al.,<br />

2 0 0 2 ] . T h i s a s h b e e n s u gges ted to p r o v i e d a s t r e s s o r a s p e c i f i c -ch n e emi u r o cal s ig n at u re to th e<br />

s ecretor y n eu ron s [ P a c a k & P a l k o v i t s , 2 0 0 .<br />

1 ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

In th e n e u r o-e n d o c r i n e p a r t o f t h , e i t n e w t a w r s o e r c k e n t d l i s y c o v e re d that th ere ar e b oth<br />

m i n e r a l o c o r t i c o i d r e c e p t o r s ( M C R s ) a n d g l u c o c o r t i c o i d r e c e p t o r s ( G C in R th s ) e b rai n [d e Kl oet ,<br />

2 0 0 0 ] as wel l as i n t h e en d ocrin e or gan s . H e n c e , d e Kloet [2 0 0 3] h a s h yp o t h e s i s e d t h a t t h e<br />

M C R s a n d G C R s h a v e i n t -c e r omp lemen t ar y e ffect s a gai n s t s tres s res p on s es in th e cen tral<br />

n e r v o u s s y s t e m s. S p e c i f i c a l l y , i t w a s h y p o t h e s i z e d t h a th t e ( 1 s) ymp at h et ic n eu ron s an d MC R s<br />

r e s p o n d t o a c u t e s t ; r e a s n s d t h e n t h a t ( 2 ) s o o n aft e r th is res p on s e, th e p aras ymp ath etic n eu ron s<br />

a n d G C R s f a c i l : i t a t e<br />

1 . Re c o v e r y o f s t r e -i s s n d u c e d a c u t e i m m u n e r e s p o n ; s e s<br />

2 . C o n t r o l o f e n e r g y in th m e e n t d o a c r i b n e o s ys l t e i m ; an s d m<br />

3 . P r o m o t i o n o f i n f o r m a t i o n s t o t r h a be rain g e [ i d n e K l o e t , 2 0 0 3 . ]<br />

I n t h ie mmu n e s ys tem , it ha s b e e n e l u c i d a t via e d m e t a-a n a l y s i s th at acu te s tres s in creas es<br />

t h e n u m b -c e l r l s o i f n t h N e K b l o o d Ns K t r c yt e a ot m oxi a c n act d ivi t y, b u t th a t th er e is n o<br />

con s is ten t effect u p o n t h e n u m -c b e r l l o -c s f ells o T [ S r e g e r B s t r o m & M i l l e r , 2 0 0 . 4 ] In a d d i t , i o n<br />

it ha s b een s h o w n t h a t t h e a c u t e s -i t r n e d s s u c e d i n c r e a s e d N K c y t o t o , x mi eas c ua red c t i in v i t y<br />

p e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s ( P B M C , was s ) n ot d u e to an in creas e in t h e p e r-N K -cell<br />

c y t o t o x i c a c t i v i t y s b u t d w u a e t o a n i n c r -cells e a s in e P BMC i s n [S ege p rs te ro r m c e n t a g e s<br />

& M i l l e r , 2 0 0 4 . ] F u r t h e rm o r e, i n t h e i n t e r a c t i o n b e t w e e n t h e e n d o c r i n e a n d i m m u , n e s y s t e m s<br />

th e acu te s t r e s s-i n d u ced ch an ges in immu n e cell d is trib u ti on were s h own to b e a s s o c i a t d e with<br />

th e exp res s ion <strong>of</strong> th e GC R s in mice [ D h a b h a r e t a l . , 1 9 9 . 6 ] D i u r n a l es c h in a n ad g ren al s teroi d s<br />

w e r e kn own to b e a s s o c i a t d e w i t h c h a n g e s o f te l de is u tri k o bc uy ti on , i .e. th e d iu rn al p eak in<br />

glu coco rt i coi d (co rt i s ol ) l evels c oin cid ed with a d iu rn al trou gh in the n u mb er <strong>of</strong> p e rip h eral<br />

b lood l ymp h oc yt e an d vi ce ve rs a [ M c E w e n e t a l . , 1 9 9 . 7 ]<br />

Acu te s tres s a c t i n g t h r o t u g h e S A M a n d H P A a x e s o f -e n t d o h c e r i n e n -im u o r mu o n e<br />

n etwork ha s b een s h ow n t o h a v inter-c e o m p l e m e n t a r y e f f e c t s a g a i n s t s t r e s s r e s , p i.e. o n s t e s o<br />

p rom ot e o r t o s u p p r e s s i n f l a m t m o r a y r e a c t i o n [ s C h r o u s o s , 1 9 9 5 ; H u e t h e r , 1 9 9 : 6 ]<br />

1 . Pr o m o t ing i n fl a mmat i on as th e alar m or ‘f i g h t o r flig h t ’ r e s p o n s e [C an n on , 1 91 4 ;<br />

G o l i g o r s k y , 2 0 0 1 ]: t h e S A M a x i s i s s t i m u l a t e d t o p r o d u c e s wh c a t ich e c h o l a m i n e<br />

a c t a s im mu n ol ogi cal ‘a l a r m s i g n a ls’ b y p r o m o t i n g s e c r e t -in i o flam n o mat f op r y o<br />

c yto kin es [ E l e n k o v e t a l . , 2 0 0 0 b ] y m a i n l y s t i m on u l oc a t yt e es d [S trau b , M a ye r e t<br />

a l . , 2 0 0 0 ]; a n d<br />

2 . Su p p r e s si n g in fl ammat i on a s a r e s p o n s t e o t h e a l a r m ( r t e h a e c t r i e s o i n s t a s n t c a e g e<br />

in the g e n e r a l a d a p t a t i o n s y n d r t h o e m o e r y ): ac u t e s t r e s is s kn own t o in creas e th e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

l e v e l s o f c o r t i s o l [ R o h l e d e r e t a l . , 2 0 0 2 w ] h i c h c a n c o u n t e ra c t th e al arm s ign al an d<br />

s u p p r e s s a ct ivat ion o f th e i mmu n e s ys tem [ M c E w e n e t a l . , 1 9 9 . 7 ]<br />

H i s t o r i c , a t l h l e y c o n c e p t o f t h i s c o u n t e r a c t i n g m e c h a n -i i mmu s m ni e n t h e e n d o c r i n o<br />

p a t h w a y i t n h e a c u t e s t r e s r s e s p o n s e w a s o r i g i n a p rop l l os y ed b y B e s e d o v s k y & S o r k in [1 9 7 7 ] . It<br />

w a s t h e pn arap h ras ed b y M u n c k e t a l . [ 1 9 8 , 4 ] w h o h y p o t h e s th i at s e th d e s t r e s s-i n d u ced in creas e<br />

i n c o r t i s o l l e s e v n e o l t s p r o d t e o c t a g a i n s t t h e s o u r c e o f s t r e s s , i t b s u e t l f r a t h e r a g a i n s t t h e b o s d y ’<br />

n o r m a l r e s p o n s e s t o s t . r Th e s s is p roces s was s u gges ted to p r e v e n t t h o s t e r e s s r es p on s es from<br />

exces s ive ov ers h oot in g p roces s es th reate n in g h omeos tas is [ M u n c k e t a l . , 1 9 8 . 4 ]<br />

Al t h o u g h t h e w h o l e p i c t u r e o f t h e m e c h a n i s m o f t h i s c o r t i s o -in l d u ced s u p p res s ive immu n e res p on s e is yet to b e in ves ti gated [ S a p o l s k y e t a l . , 2 0 0 , 0 ] ortis c ol h as b een con s id ered<br />

a s a m a i s n t r e s s h o rm on e wh ich can s u p p r e s s t h immu e n e res p on s e b y a f f e c t ing t a r g e t s m a i n ly<br />

t h r o u g h i t s e p r t o e r c (G C R s ) . Th is is con s id ered t o o c c u r p r i m a inhibiting r i l y b y the N F B’s<br />

gen omi c f u n c t i o n s t o p r o m -s o pt ecif e in c o i n fl amm at ion an d to in h ib it a p o p t osis [Ka rin & Lin ,<br />

2 0 0 2 ] . In c o n t r a s t t o c o r t i s o l , a n o t h e r a d r e n a l h o r m o n e i n t h e HP A a x s i , d eh yd r oe p ian d ros teron e<br />

( D H E ; A an d it s s u lp h at e D H E A -S), h as comp licated ef fects . D HE A ha s b e e n rep or ted to s t i m u l a t e T h . 1 c y t o ( k -2 i I n L e t c . ) p r od u ct ion [C leri ci et al., 1 9 9 7 ; Cu tolo et al. , 2 0 0 0 ; Loria,<br />

2 0 0 2 ] a n d t o b e h a v e a s a n a n t a g o n i s t t o c o r t i s o l in th is Th .1 / Th .2 re gu lat ion [ Wo l f &<br />

K i r s c h b a u m , 1 9 9 9 ]. D H , hE owev A er, h a s al s o b een s h own to h ave a s imila r an d /o r s y n e r g i s t i c<br />

e f f e c t w it h c ort is ol , i .e . inhibiting t h e N F B a c t i v a t i o n s u p a p n r d e s si n g p r o-i n fl am mat o r y<br />

c yto kin es [ S t r a u b , S c h o l m e r i c h e t a l . , 2 0 . 0 0 ]<br />

C ollecti vel y, it ha s b e e n s u gges ted th at a d ren al h ormon es (co rtis ol in p articu lar an d<br />

comb in ed with D H E A/ -S ) p l a y a n i m p o r t a n t r o l e i -i n m t m h u e n e e n i d n o t c r e r i a n with c o t i o n<br />

regard t o acu te s t r e s s r e s p o n s in e th e p s y c h o-n e u r o-e n d o c r i n -im o mu n e n et work .<br />

1 . 2 . 4 . Su 3 s tai n ed s tres s a n d c h a n g e s th i e n p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w o r k<br />

S u s t a i n e d s t r e h s s a s b e e n d e m o n s t r a t e d to in d u ce vari ou s c h a n g e s th i n e p s y c h o-n e u r o-<br />

e n d o c r i n -i o m m u n e n e t w . o In r k t h e n e -i u r m o u n e b i-d irect ion al in teracti on [ La wr en ce & Ki m,<br />

2 0 0 0 ] , t h e b -b l r o a o d i -b n ar rier p e r m e a b i l i a w t s y f ou n d to b e in creas ed u n d er Gu lf War s t res s<br />

[ F r e e d m a n e t a l . , 1 9 9 . 6 ] It has al s o b een s h own th at i n h i b i t -e o r r g i y c n e G r A v B o u A s a c t i v i t y<br />

was a t t e n u a t d e u nd er s u s t a i n e d s t r e [ s V s e r k u y l e t a l . , 2 0 0 . 4 ] T ese h f i n d i n g im s p l y t h a t t h se tres s<br />

r e s p o n s e s i n t h e n e u r a l l e v e l u n d e r s tres s u s can t a i bn e more h yp e ractive a n d t h e b n e c o m e<br />

d i f f i c u l t t o s w i t c h , o w f f h i c h m a y r e s u l t i n m a i n t ing a i n a v i c i o u s c y c o l f e s t r e s s r e s p o n .<br />

s e s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t h e i m m u n e s y s t e m u s, tain s ed s tres s h as b een d emon s trated to alter tis s u e s p ecific<br />

d i s t r i b u t i o n o f l y m p h s o u c -p b y op t e u lat io n s i n v i [ v S o u d o e t a l . , 1 9 9 . 7 S ] p e c i f i a c l l y , erip p h eral<br />

N K -cell l e v e l s h a v e b e e sn h own to d ecre as e u n d er s u s tain ed s tres s [Bor ella et al ., 1 9 99 ;<br />

G r u z el i e r , S m i t h e t a l . , -Sa 2 0 0 ku 1 ; rai I et n o al u ., e 2 0 0 0 ; Maes et al., 1 9 92 ; Segers trom & Mille r,<br />

2 0 0 4 ] . In c on t ras t , t h e e ffect s <strong>of</strong> s u s tain ed s tres s u p on in vivo d i strib u tion <strong>of</strong> l ymp h oc ytes ar e<br />

n o t c l e a r-cu t an d are in con s is ten t in t h e l i t e r a , t u i r . e e . s i n o v m e e s t i g a t o r s r e p o r t in c reas es an d<br />

oth ers rep o rt d ecreas es in th e s u b-p o p u l a t i o n c o u n ts ( e . g . h e l p e r T-l y m p h o c y t s e [d e Gu ch t et al .,<br />

1 9 9 9 ; M a e s , V a n B o c k s t a e l e e t a l . , 1 9 an 9 d 9 ] c yt ot o xi c T-l y m p h o c y t s e [ Gru zel ie r, Smi th et al . ,<br />

2 0 0 1 ; M a e s , L i n e t a l . , 1 9 ). 9 Non 9 ] et h el es s , in fu n ct ion al i n v i meas t r o u res <strong>of</strong> th e i mmu n e<br />

s ys te m, su s tai n ed s tres s has b e e n s h o w n to s u p p res s cellu lar i m m u n e r s e p o n s es [B au er et al .,<br />

2 0 0 1 ; B o n n e a u e t a l . , 1 9 9 8 ; D h a b h a r & M c E w e n , 1 9 9 7 ; K o h , 1 9 9 8 ; S e g e r s t r o m & M i l l . e r , 2 0 0 4 ]<br />

H e n c e , s u s t a i n e d s t re s s h as b een b elieved to cau s e a d etri men tal ef fect u p on im mu n e cells in<br />

v i v o r e s u l t i n g i n a n i d n c s r u e s a s c e p t i b i l mali i t gn y an t co y [ G a r s s e n , 2 0 0 4 ] a n d i n f e c n t [C i oh o en<br />

& He r b e r t , 1 9 9 6 ; Ki e c o l t-G l a s e r & G l a s e r , 1 9 9 . 9 ]<br />

N o t a bl y, t h e r e w a s a r e p o r t [ B o n n e a u e t a l . , 1 9 9 8 ] d e m o n s t r a t i h a n t g a d r e n a l e c in t o m y<br />

m i c e p r e v e n t e d t h e s u p p r e s s iv e e f f e c t o f s u s t a i n e d s t r e s u s p o n th e a c u t e s t r e -in s s du ced immu n e<br />

activation (meas u red b y i n v i c t y r t o t o x i c a c t i v i c y t o y k i a n e n d p r o d u c t i o n . ) H e n c e , ad ren al<br />

h orm on es were s u g ges ted to p la y an e s s e n t i a l r o l e i n t h e o-s i u p m p m r e u s n s i v e e f f e c t <strong>of</strong><br />

s u s tain ed s t res s . Fu r t h e r , t h e r e a r e c o n t r a d i c t i v e c l i n i c a l f i n d i n g s w i t h r e g a r d to c o rtis ol le vels<br />

u n d er s u st ai n ed s t res s , i .e. cortis ol le vels are h igh in p atien ts with th e p os t trau matic s t res s<br />

d i s o r d e r ( P T S D ) a (k n d n o w d n e p r a e s s a i ) o in h n p ati , y en p to s a wi c n th d o r l t o i w s o l i s m<br />

s o m a t o f o r m d i s o r d e ( r s c h r o n i c f a t i g u e s y n d r o m al e , gia, f bi u rn b r ou o m t sy yn d ro me et c.) [ Heim<br />

e t a l . , 2 0 0 . 0 Th ] ere h a v e b e e n two in terl i n ked h yp ot h es es r e g a r d i th n g e mech an is ms w h i c h<br />

c o n t r i b u t e t o s u p p r e s s c e l l u l a r i m m u e n s e p o r n s e s u n d e r s u s t a i n e d s t r [T e s e s x t b o x ]: 5<br />

1 . Su s t a i e d n exp os u re to h igh l e v e l s <strong>of</strong> c o r t i s o l ; a n d<br />

2 . At t e n u a t e d r e s p o n s e s c a u s e bd y h a b i t ation u t o r e p e t i t i v e s t i m u la t i . o n<br />

Th e p r i m a r m y e c h a n i s m o f f t i r h s e t h y p o t h is, e s s u s t a i n e x d p o s u r e t o h i g h l e v e ls o f<br />

c o r t i s o l , i s t h a t t h e s t r e s s r e a c t i o n i n t h e H P A a x i s i f s t c a o y p s i n a g c t w i i v t e h s t lls r e us ns d er f a<br />

th e s u s t ai n ed s t res s , t h erefore t a r g ets are exp os ed to el evated le vels o f c o r t i s o l f or a p rolon g ed<br />

time [ d e K l o e t , 2 0 0 3 . ] Th is ma y b e a s s o c i a t d e with mu lt ip le p os it ive feed b ack l oop s in th e HP A<br />

axis [ G o l d e t a l . , 2 0 0 , 2 t ] h e n t h i s s u s t a i n e d h i g h l e v e l s ex acerb o f c at o e r t ht e i is mb o l al an m ce a y<br />

o f i n t e r a c t i o n s w i t h i -n n e u t r h o-e e n d p o s c y r c i h o n -i o m m u n e n e t w [ o d r e k K l o e t , 2 0 0 3 , ] in clu d in g<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 7 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

l o s s o f n e u r on s i n t h e h i p p o a c m p u s [ S a p o l s k y , 2 0 0 0 ]. Fu r t h e r , it i s w e l l-kn o wn th at mos t<br />

p atien ts wi th d ep res s ion h ave ch an ged cir cad ian p a t t e s r in n t h e n e t w o r k , p a r t i c o c r u t i l s o a l r l y i n<br />

levels , i.e . el e vat ed tr ou gh an d flatten ed p e a k l e v e l s w i t h a n r a r n r g o e w e o d f f l u c t u a t i o n<br />

[ G o l d s b y e l t . , a 2 0 0 2 ; W e b e r e t a l . , 2 ; 0 as 0 0 ] w e l l a evid s en ce <strong>of</strong> s y m p a t h e t i h c y p e r a c t i v i t y<br />

[ B e l a n o f f e t a l . , 2 0 0 2 ; C h r o u s o s & G o l d , 1 9 9 2 ; Go d l & C h rou s os , 1 9 9 9 ; Hol s b oe r, 2 0 01 ;<br />

S c h a t z b e r g e t a l . , 1 9 8 . 5 F ] u r t h e r m o r e , g r o w i n g e v i d e n uc gges e s ts th at th e med iat o rs <strong>of</strong> th e S AM<br />

a n d H P A a x s e are r e p e a t e d l y e l e und v a t er e sd u s tai n ed s tres s and <strong>of</strong>ten fail t o s h u t <strong>of</strong>f p romp tl y<br />

b e f o r e xp eri en ci n g an ot h er r e p etitive ch allen ge b y a s t res s or [ M c E w e n e t a l . , 1 9 9 . 7 ]<br />

Th e lat er m e c h a , a n t i t e s n u a m t r e d s p o n s e c a u s e d b y a h b i t u a t [ i Kirs o n ch b au m et a l .,<br />

1 9 9 5 ; S c h o m m e r e t a l . , 2 0 0 , 3 is ] als o k n o w n a s a p r o g r e s s i v e d i m i n u tion o f t h e r e s p o n s e<br />

again s t r e p e t i t i v e s t i m u l ation [ H e i m e t a l . , 2 0 0 . 0 Th ] e at ten u at ed res p on s e in h ormon al s ecretion<br />

h a s b e e n o b s e r v e b o d t h i th n e ne u r a l l e v e l (a m y g d a l a) [ C a r t e r e t a l . , 2 0 0 an 4 ] d th e H P A a x i s<br />

[ G a a b e t a l . , 2 0 0 2 ; J o h n & B u c k i n g h a m , 2 0 0 3 ; P a r i a n t e & M i l l e r as , 2 well 0 0 1 ] as th e c yt o ki n e<br />

level [ G a ab e t a l . , 2 0 0 . 5 It ] ha s a l s b o e e n d e m o n s t r a t e d t h a t s u s t a i n e t d t s e n t u r a e t s e s t h a acu e te<br />

s t r e s s re s p o n s es in th e en d ocrin e an d immu n e s ys te ms . A s a c o m m e n c i n g c o n d i t cu i o te n , s tres a s<br />

i n c r e a s e g l u c o c o r t i c o i d s a n d a l t e r l y m p h o c y t e d i s d t s tream r i b u t o f i r at o n s . Th i n e t h e b l o o<br />

g r e a t e s t c h a n g e s i sn e, glu t h e coc ort ic oi d level s an d a l t e r a t i o n o lf ymp h oc yt e d i s t r i b u , t were i o n<br />

s e e n o n D a y 1 , b u t t h e r e a f t w e i r t h r e p e a t e d e x p o s u r e t o t h e s a m e a c u t , e th s e t cr he an s s ges<br />

d ecreas ed an d reach ed th ei r lowes t at Da y 3 5 [ D h a b h a r & M c E w e n , 1 9 9 7 . ] A c c o r d i ln y, g it is<br />

h y p o t h e s i s e d t h c a t c a u m u l a t e d n e g r e a p e t i t i v i e r v e s e p o n s e s f i n e b o e th d th e b SAM a c k s f r o m<br />

a n d HP A a x e s r e s u l t in imp aired r eaction s in th eir h o r m o n e s e c r e s. t i o n<br />

Text box 5: S U M M A R Y O F H Y P O T H E S E R S e : S t r e -r s s e l a t e d c h a n g whic e s h ma o y f e n d o c r<br />

/ (<br />

c o n t r i b u t su e p p t r o e s s c e l l u l a r e r i e m s p m o n u s n e s under s u s t a i n e d s t r e s s<br />

+<br />

( *<br />

Th es e ma y b e ab l e t o rep res en t th e d iffer en t s tages <strong>of</strong> th e s u s tain ed s tres s , i.e. th e r es i s tan t<br />

a n d t h e e x h a u s t i s t o n a g e s i n t h e ’s S e gl en y e eral ad ap tat ion s yn d r ome . It s h ou ld b e n oted ,<br />

h owever , th at th ere remai n s c o n f u s i o ab n ou t th e mech an is ms t h a t u n d e r l s i u s e t a i n e d s t r , e s s a n d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 8 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

wh eth er th es e ma y be b e s t t h o u g h t , o f as two c on s ecu ti ve s tages th at occu r a f t e r a n o t h e r, or as<br />

t w o d i s t i n c t res p on s es th at occu r in p arall el. O t h e r f a c t o r s l i k e g d e i n f e t f e i r c e n s c ( e e.g. gen d er)<br />

ma y a l s o c o n t r i b u te to th is con fu s ion , b u t rep orts s till remain in con s is ten t [ Lu n d b erg, 2 0 0 5 ;<br />

S a u r o e t a l . , 2 0 0 . 3 N ] o n e t h e l e s s , t h e c e l l u l a r i m m u n e r e s p o n s e s a r e b e l i e v e d t o b e i<br />

m a i n l y b y e i t h e r o r b o a t b oh ve m e c h a s n i n s t h m e p -n s y e c u h r o o-e n d o c r i n -i o m m u n e n e t w . o r k<br />

H e n c e , t h i s p r o j e c t f e o d c u s o n t h e h yp o t h e s i s t h a t p s yc h o l o g i c a l i n t e r v e n t i o n c a n c o u n t e r a c t, o r<br />

at leas t b u ffer, th e n e gat ive e f f e c t s o f s u s t a i n e d s t r e s s u p o -n n e u t r h o-e e n d p o s c y r c i h o n -im o mu n e<br />

ne t w o r k , p a r t i th c u e l im a r mu l ny e s ys te m.<br />

1.3 Ap p r o a c h t a k e n<br />

T h i s t h e s i s i s b a s e e hd yp ot u p ho es n is t h at p s ych ol ogi cal in terven tion actin g th ro u gh th e<br />

p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w o w r i k l l c o u n t e r a c d t e t r t i m h e n t a l e f f e c t o f s tres s on th e<br />

i m m u n e sy s t .�In e v e m s t i g a t i o n w a s p e r b f y uo sr in m g e a d s e ri es o f i n v i an v o d i n v i st tud r o ies .�<br />

Th e p s ych ol ogi cal i n t erv en t ion s u s ed to cou n teract s tres s were Self-h yp n os i s an d J oh rei,<br />

b o t h o f w h i c h p r o v i d e t r a i n i n g a n d p r a c t i c e o f -h s e l f p s t r e s s m a n a g e m ne iq n ut es .� t e c h<br />

U n i v e r s i t y s t u d e n t s f a c i n g e x a m i n a t i o n w e r e u s e d a s a n e x a m p l a e t i o m f -l e i m i t e d s t r f e u s l s<br />

s i t u a t i o n , a n d th e p r i m a r y o u e t r e c N o -c K m e l e l p e m r c e n a t a s g e u s r a n d e N s K C A w l .� e v e l s<br />

H I V-in fect ed p at ien ts were u s ed as an ex amp le <strong>of</strong> o n g o i n g d i s e a -a s s e s o c i a t e d s t r e f s u s l s itu at ion ,<br />

an d t h e p r i m a r y o u t c o m e m e a s u r e s w C a D s 4 -c e T l l c t o u s n . uA mb n er <strong>of</strong> val id at ed<br />

q u e s t i o n n a i r e s w a s u s e d t o d e m o n s t r a t e t h a t s e a x n a d m -g o i n o n i a n t g i o d n i s e a s b e o t in h du ce<br />

s t r e s s, a n d t o e x p l o r e t h e e f f e c t s o f t h e en p tion s y c s h uo pl on o g si tres c a s l p ercep i n t te ion r v .<br />

In ad d it ion , i n v i exp t r o eri men ts were p er for med to exp lo re th e d irect in flu en ce o f t h e<br />

s tres s h orm on e, co rt is ol , on th e p erip h era l N K -c e l l s -l a y m n p d h o c T y t e s.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 4 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Chapter II<br />

M a t e r i a l s a n d M e t h o d s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C O N T E N T S O F C H A R P T E 2<br />

M a t e r i a l s a n d M e t h o d s<br />

2 . 1 P a r t i c i p a n t w s i t h r e g a r d s t o o u t c o m e s a n d m e a s u r e m e n t t i m e p o i n t s<br />

2 . 1 . 1 S t u d e n t v o l u n t e e r s<br />

2 . 1 . 2 P a t i e n t v o l u n t e e r s<br />

2 . 1 . 3 C a s e m a t c h e d p a t i e n t s f r o m d a t a b a s e<br />

2 . 1 . 4 L a b o r a t o r y v o l u n t e e r s<br />

2 . 2 P s yc h o l o g i c a l in t e r v e n t i o n<br />

2. 2 . 1 Self-h y p n o s i s t r a i n i n g<br />

2 . 2 . 2 J o h r e i t r a i n i n g<br />

2 . 2 . 3<br />

M o c k i n t e r v e n ( t C i o n o t n r o l s f o r t h e p s y c h o l o g i c a l t r a i n i n g s )<br />

2 . 3 S e l f-r e p o r t u e s q t i o n n a i r e s<br />

2 . 3 . 1 S t r e s s p e r c e p t i o n<br />

2 . 3 . 2 . 1 State an xi et y s c ore in th e State a n d T r n a x i e t y I n A v e n t o r y<br />

2 .3 .2 .2 I m p a c t o f E v e n t S c a l e ( I E S )<br />

2 .3 .2 .3 P e r c e i v e d S t r e s s S c a l e ( P S S )<br />

2 .3 .2 P e r c e i v e d q u a l i t y o f l i f e<br />

2 . 3 . 2 . 1 L o c u s o f C o n t r o l s c a l e ( L o C )<br />

2 .3 .2 . 2 M e n t a l C o m p o n e n t S u m m a r y i n th e S -3 F 6 (M C S ) 64<br />

2 .3 .2 . 3 P i t t s b u r g h e S p l Q e u a l i t y I n d e x ( P S Q I )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 1 - I m p e r i a l o C n o d l o n l e g e L<br />

63<br />

63<br />

63<br />

63<br />

64<br />

53<br />

56<br />

58<br />

60<br />

60<br />

61<br />

62<br />

63<br />

63


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . 4 M at eri a ls an d met h od s i n v i t r o<br />

2 . 4 . 1 M a t e r i a l s a n d e x p e r i m e n t k i t s<br />

2 .4 .1. 1 C h e m i c a l s a n d r e a g e n t s<br />

2 . 4 . 1 . 2 B i o l o g i c a l r e a g e n t s<br />

2 . 4 . 1 . 3 F l u o r e s c e n t l y c o n j u g a t e d a n t i b o d i e s f o r f l o w c y t o m e t r y 65 a n a l y s e s<br />

2 .4 . 1 . 4 C omme rci al l y av ai lab le lab orat or y kits fo r col ori metri c a n a l y s e s 66<br />

2 . 4 . 2<br />

E q u i p m e n t s u s e f d o r i n v i i t n r v o e s t i g a t i o n s<br />

2 . 4 . 2 . 1 F l o w c y t o m e t r y<br />

2 . 4 . 2 . 2 C o l o r i m e t e r 68<br />

2 .4 .3 Met h od s i n v i t r o<br />

2 . 4 . 3 1 P r e p a r a t i o n o f or cell t cu i lt us re s i n u v e i t r c o u 69 l t u r e m e d i<br />

2 .4 .3 .2 NK c yt ot o xi c acti vit y m e a s u r e bd y f l o w c y t o m e t r y<br />

2 .4 .3 .3 N K -cel l ch aract eris tics d u rin g N KC A as s a y m eas u red b y fl ow<br />

c y t o m e t r y<br />

2 . 4 . 3 . 4 P rol iferat ive res p on s e m e a s u r e bd y [ 3 H ] -t h y m i d i n e i n c o r p o r 74 a t i o n<br />

2 .4 .3 .5 T-cel l ch ara ct eris tics afte r i n v i t i r n o c u b a t i o n m e a bs y u fl r ow e d<br />

c y t o m e t r y<br />

2 .5 S t a t i s t i c a l a n a l y s e s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 2 - I m p e r i a l o C n o d l o n l e g e L<br />

64<br />

65<br />

66<br />

70<br />

73<br />

75<br />

64<br />

66<br />

69<br />

77


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2.1 P a r t i c i p a n t s w i t h r e g a r d o s u t c t o o m e s and me asur e me nt ti me<br />

p o i n t s<br />

2 . 1 . 1 S t u d e n t v o l u n t e e r s<br />

Un i v e r s i t y s t u d e n t s f a c i n g t h e a c a n d e p m eri i od c were e x a m recru i n a it t ed i t o in ves tigate<br />

th e effect s <strong>of</strong> a time-l i m i t e d s u s t a i n e d s t r e s acad s ( emi c e x a inations m ) u p on th e p ercep ti on <strong>of</strong><br />

s t r e s s a n d a s s o c i a t e d c h a n g e s i n i m m u n o l o g i c a l p a , r a m e t p e r a s r t i -cell c u p ercen l a tage r l an y d N K<br />

N K C A l e v e l . s T h e y w e r e r ite e c d r th u rou gh p os ters d is p la yed in Imp erial C ollege Lon d on an d<br />

b y w o r d-o f -m ou t h con t act s u s in g s tu d en t res earch as s is tan t s (P s ych olo g y BS c s tu d en ts ). Eth ical<br />

ap p roval was gran t ed f ro m t h e R ive rs id e R es earch Eth ics C om mittee an d all v olu n teers were<br />

g i v e n d e ta i l e d i n f o r m a t i o n s h e e t s , i n t e r v i e w e d a n d n a s k i e n d f o t r o m cs e on i d sg en n t a for m [s ee<br />

Ap p en d i x 1 ] . Al l s u b j ect s were as ked to f as t ove rn igh t b efo re g i ving a m orn in g b lo od s amp le<br />

(b etween 8 :0 0 an d 9 :0 0 a.m . in o rd er to min imis e d iu rn al effects [ M c G l o n e e t a l . , 1 9 9 ), 1 an ] d<br />

g i v e n a s i mp l e b reak fas t aft e r th eir b lo od collection . At th e en d <strong>of</strong> th e s tu d y, e ach p articip an t<br />

r e c e i v e d £ 3 0 f o el r e xp t en r a s es v an d in con ven ien ce.<br />

In t otal, 4 8 u n ivers it y s tu d en ts were rec ru ited p rior to their e x a m i n a t s. i Th o n e med i an age<br />

was 2 1 yea rs an d the r a n g e w a -2 s 3 1 ye 9 ars wi th on e p art ici p an t <strong>of</strong> 3 7 years . Th er e were 2 6<br />

m a l e s a n d 2 2 f e m a . l T e s h i r t y n i o n f e t h p e a r t i c i p a n t w s e r e m e d i c a l s t u d e n a t s I m p e r i a l C o l l e g e<br />

(fr om f i r s t t o f i f t h y e a r : s p e f c i t f h e i c o u y r e w s a e r e s n o t r e c o r d e d ) a n d t h e r e m a in in g n in e<br />

w e r e o n o t h e r U n i v e r s i t y o f L o n d o n c o u r s e s ( w s p a e s c n o i t f r i e c o r d i e n d f ). o r m a t i o n<br />

T h e r e w e r e t w o e x a m i n a t i o n p e r i a o n d d, s f o r t h e E x a m a s s e s s m e n t p o i n t , s t were u d e n t s<br />

a s s e s s e d w i t h in f i v e d a ys p r i o r to t h e i r e x a m i n a t i [ o F n i s g u r s e 3 a n ]. d C 4 o n t r o l ( -exa N o n m)<br />

p e r i o d s f o r c o m p a -p r e riod i s were o n ch os w en i as t fol h l ows : e f or x s o a m e m s t u d e n t s (C oh ort<br />

A) , i t w a s f o u r w e e k s a f t e r e x a m i n a , t an i o d n for s t h e r e m a i n d e r (C o h o r ) , t it was B f ou r wee ks<br />

after recru it men t (w h i c h w a s f o u r t o e i g h t w e e k Ex s a b m e s f ). o r Se tu d en ts were fre e to with d raw<br />

f r o m t h e s t u d y a t a n y t i m e w i t h o u t g i v i n g a n y s p e c i f i c r e a , s o n a s n a d total <strong>of</strong> 2 1 s t u d e ts n<br />

w i t h d [ r F i e g u s w r e 3]. B l o o d s a m p l e s w e r e t a k e n a n d q u e s t i o n n a i r e at s th w e e r e c o m p l e t e d<br />

recru it men t an d at th e Ex a m a n d N -exa o n m as s es s men t p oi n ts .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

R e c r u it m e n t �<br />

(48)<br />

W i t h d r e w ( 1 0 )<br />

W i t h d r e w ( 1 ) W i t h d r e w ( 1 0 )<br />

Fi gur e 3: N u m b e r s o f tudents s r e c r u i t e d a n d r e m in a t i he n si t ud n g y a t t he Exa m a nd Non-e x a m<br />

a s s es s m en t t i m e p o i n ts . T h e n u m b e r o -out f d s tr ud o p e nt s is a ls o indic at e d.<br />

Weeks from the Recruitment<br />

1 2<br />

Fi gur e 4: T iming <strong>of</strong> the Ex a m a n d n-e N o xam a s s es s me nt t i m e p o i n ts wit h r e sp e ct t o re cru it me nt f or<br />

i n d i v i d u a l s t u d the e n t Cohorts s i n A and B<br />

Bef ore co mb in in g C oh ort s A an d B to tes t th e h yp oth es es th at (1 ) acad emic e x a m i n a t i s o n<br />

c a u s e s t r e s s in u n i v er s i t s t y u d e n t ; s an d ( 2 ) p s y c h o l o g i c a l i n t c e a r n v e r n e t d u i c so e tn res s effect s ,<br />

comp arab il it y o f t h e t w o g r o x a u m p s a nd a N t o n-e x t a m h t e i m e E p o i n ts w a s ed bc y o n f i r m<br />

s t a t i s t i c a l a n a l y cs oe mp s ari n g C o h o r t s A a [ n A d p p e n B d i x 6 : T s a b l -1 A e t -6 o ] . T h e A l e v e l f s o<br />

th e P SS and t h e S t at e an xi et y s c ore <strong>of</strong> th e ST AI, l ymp h oc yte s u b s ets d is trib u tion an d NK<br />

c ytot oxi c act i vi t y (N KC A) w ere c omp ar e d . Th e levels <strong>of</strong> th es e meas u res were n ot d ifferen t<br />

b etween th e t w o c o h o r t at s t h e N -exa o n m time p o i n t s, s o th e two c o h o r t s were co m b in ed into a<br />

s in gle gr ou p i n ord er t o e xamin e ch an ges in th e levels <strong>of</strong> t h es e meas u re men t s .<br />

A t o t a l o f 2 7 s t u d e n t s w e r e s t u d i e d , b u t n o t a l l o f t h e p a r t i c i p a n t s p r o v i d e d c o<br />

s ets . Some d at a were in comp lete b ecau s e <strong>of</strong> t e c h n i c al f a i l u r e e w a i n t a l h y s e t s an h d b ecau s e<br />

s t u d e n t s d i d rn n uo t p to t pu rovi d e s amp l es or failed to co mp lete q u es tion n aires . C on s eq u en tly,<br />

t h e n u m b e r s i n e a c h a n a l y t s i o s t e s t fi rs t h h e yp o t h e s i s t h a t acad emic e x a m i n a t i s cau o n s e s tres s<br />

in u n i v e r s i s tu t dy en ts w e r e :<br />

8<br />

4<br />

0<br />

4 w e e k s 4-8 w e e ks<br />

C o h o r t A<br />

E x a m<br />

E x a m s<br />

[Co h or t A (21)]<br />

Non-e x a m<br />

[Co h or t B (26 ) ]<br />

Non-e x a m<br />

R e c r u i t m e n t R e c r u i t m e n t<br />

1 2<br />

8<br />

4<br />

0<br />

C o h o r t B<br />

E x a m<br />

Non-e x a m<br />

Non-e x a m<br />

[ G r o u p A ( 1 1 ) ]<br />

Exa ms<br />

[ G r o u p B ( 1 6 ) ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P ercei ved s t res s s cal e (P S S ) an al ys is : 2 2 s t u d e n t s<br />

State an xi et y s c ore an al ys i s : 2 5 s t u d e n t s<br />

N K c yt o t o x i c a c t i v i t y a n a l ys i s : 2 1 s t u d e n t s<br />

C D 4 a n d C -c D 8 e l T l s -cell a an n al d ys es : N K<br />

2 6 s t u d e n t s<br />

In ord er t o tes t th e s ec on d h yp oth es is th at p s y c h o l o g i c a l i n t e r c a v n e n r t e i d o u n c e s tr es s<br />

e f f e c t s, th e s a m e 4 8 u n i v e r s i t y s t u d , e as n t ds es cri b ed a b o v e , w e r e e a c h r a n d o m l y a s s i g n e d t o<br />

o n e o f t h r e e g r o u : p s<br />

R e l a x a t i o n o n c t r o l g r o u p : e xp eri en ci n g m o c k n e u r -f o e e d b a c k s e s s i o n s,<br />

Self-h y p n o s i s g r o u p : t a u g h t a n d p r a c t i s i n g S -h e yp l f n o s i s wi th i m a g e r y , o r<br />

J o h r e i g r o u p : t a u g h t a n d p r a c t i s . i n g a n o v<br />

F o r b o t h C o h o r t s A a , n train d in B g an d p ract ice <strong>of</strong> ei th er in terven tion c om men ced at<br />

r e c r u i t m e n t a n d w a s e n c o u r a g e d t o c o n t i n ir u e x u a n m t i n l a t i t o n h s e , t h ef e r ore , f or C oh ort A,<br />

train in g an d p ract ice las ted fou r w eeks an d , for C oh ort B , ei gh t to twel ve w eeks . F o r a n a l y s e , s<br />

b o t h i n a t e i x o n a d m a t w a e r e c o m b i n e d [ F ]. i g u r e 5<br />

B a s e l i n �e<br />

(48)<br />

T r a i n i n -s g e s s i o n<br />

W i t h d r e w 1) ( 1<br />

Fi gur e 5: T i m i n g o f t -ups r and a i d a n ta-c i o n l l g e c , t i o n f s e i o s o n l s l ( B o a s w e l and i n e Ex a ms a s s es s ment<br />

points) and nu m b e r s o f tudent s s a t t he s e s s i s o n<br />

Of 4 8 s t u d en ts recru i t ed , 1 1 with d rew fro m th e s tu d y. C o mp lete d atas ets were n ot<br />

o b t a i n e d f o r t h e 3 7 s t u d e n t s r e m a i n i n g . H e n c e , t h e n u m b e r o f s u b j e lc ys t s is v a r i e d f o r e a c h<br />

comp ari n g b et ween th e p s ych ol o gical in terven tion grou p s an d t h e R e l a x a t i o n c o n t : r o l g r o u p<br />

PSS 3 2 s t u d e n t s<br />

S t a t e a n x i e t y s c o r e i n t h e S T A I<br />

N K c y t o t o x i c a c t i v i t y<br />

Practice & follow-ups<br />

4 w e e k s 4-8 w e e ks<br />

Exa ms<br />

(21)<br />

3 5 s t u d e n t s<br />

3 1 s t u d e n t s<br />

L y m p h o c y t e s -p u b o p u l a t i -c o e n l l s a n 3 d 4 s t u N d K e n t s<br />

E x a m s<br />

(16)<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . 1 . 2 P a t i t e n v o l u n t e e r s<br />

Af t e r a p p r o v a l f r o m t h e R i v -in e fected r s i p at d ie ne ts wh R o e s e a r c h<br />

were n ot recei vi n g a n t i -r e t r o v i r a l t r e a t m e n t (treatmen t n a ï v e H I -p a V t i e n t s ) w ere re cru it ed to i n v e s t i g a t ( 1 e ) t h e e f f e c t -goin s o g f d i o s n e a s e ( H -i I n f V e c t n ) i uo p on s tres s p ercep ti on an d<br />

a s s o c i a t e d c h a n g e s i n i m m u n o l o g i c a l p a r a m e t e r s, C D -c 4 e l l T c o u n t i s n p a r t i c u l ; a r an d (2 )<br />

w h e t h e r p s y c h o l o g i c a l i n t e r c v a e n t r i e d o u n c s e t r e s s e f f e c . t T s h e cl in ical im mu n ol ogi cal data<br />

w e r e o b t a i n e d f r o m t h e p a t i e n as t e at r te hc e o Cr hd el sd ea a t an a d b Wes t min s ter Ho s p ital.<br />

A t o t a l -i n f o e c f t e d i 6 n 3 d i v i d H u I a l V s i n c l u d i n g t h r e e , f with e m a a l e med s ian a g e <strong>of</strong> 3 7<br />

y e a r s (r a n g e -5 2 7 8 y e a r s) wh o w e r e r e g u l a r a t t e n d e e s t o t h ’s e c S l t i . n i c S t a t e p t h e n C ea h e l s<br />

an d Wes t mi n s ter Hos p it al , w e r e recru ited b y a r e s e a r c h a s s t i a s n t , M r . B r y a n M . B e n n e t t , a n d<br />

res earch n u rs es accord i n g t o th e in clu s ion criteria : (1 ) n o t r e c e i v i n g a n t i-ret ro viral t r e a t m e n t , ( 2 )<br />

n o s y m p t o m r -i e n f g e c a t r i o d n i ( 3 a ) n md ore g th H an I 2V 0 0 cel ls p er L o f C -cells’ D 4 T in t h e i r p e r i p h e r a . l T h b e l o o -in d H fected I V p art ici p an ts were giv en d etailed in formati on s h eets an d<br />

e a c h g a v e s i g n e d i n f o r m e d c o n s e n t. T h e y p a r t i c i p a t e d f o r m o r e t h a n f i v e , m o n t h s i n t h e s<br />

d u rin g Au gu s t 2 0 0 3 t o Decemb er 2 0 0 4 .<br />

F o r e t h s t u d i n y v e s t i g a t in g t h e e f f e c t s -g oin o f g d o i n s e a s e ( H -in I fecti V on ) u p on s tres s<br />

p ercep ti on an d as s oci at ed ch an ges in d i s e a se p a r a m e t e r s, t h e r a t e o f -cell d e c o l u n i t n e i n C D 4<br />

was cal cu lat ed b e t w e e n t h recru e it men t ti me p oi n t a n d f o u r m o n t h s l a t e as r the p ri mar y ou tc ome<br />

m e a s u r e o f t h e . T h s e t u t d y i m i n g o f c l e i c k-u n i p c s a l w i c t h r e g a r d t o w o t h t e i m e p o i for n t s th e<br />

p s yc h o l o g i c a l a s s e s s m e n t (t h e R ecru itme n t an d After 4 mon th s ) was as foll ows [ Fi gu re 6 ] :<br />

- Recruitment<br />

-<br />

Ba s e l i n e<br />

Fi gur e 6: T iming <strong>of</strong> t he m e as u r e m e nt c olle ct io n t ime p o i n t s (R e cr u i t m en t and Af t e r 4 m o n t h s ) a nd t he<br />

one-m o n t h b l o c k s (Bas e line , T e r m o n e t o T e r m f o u r ) f o r c l i n i c a l r o u t i n e b l o o d c o l l e c t i o n s<br />

Un f o r t u n a t , e n ot l y all <strong>of</strong> th e p at ien ts recr u ited h ad th eir C D4 T-cell c o u n t s meas u red a t<br />

e a c h T e r m [T a b l e ]. 4<br />

T e r m o n e<br />

T e rm t w o T e rm t h r e e<br />

4 m o n t h s<br />

- After 4 months -<br />

T e r m f o u r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 4: Numb er a nd per c ent a ge <strong>of</strong> H I V-i n f ec t e d i n d i vi d u a ls who had CD4 T-ce l l counts ch e c k a t t he m o n t h l y t i e m r i e o d s p f r m o t h e Re c r u i t m e nt to four mont hs a ft er th e r e cr uit men t (T er m 4)<br />

N u m b e r s o f p a t i e n t s ( T o t a l N = 6 3 )<br />

V a l i d n u m b e r M i ss i n g<br />

N P er ce n t N P er ce n t<br />

T e r m 4 ( f o u r m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 23 36.5% 40 63.5%<br />

T e r m 3 ( t h r e e m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 18 28.6% 45 71.4%<br />

T e r m 2 ( t w o m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 19 30.2% 44 69.8%<br />

T e r m 1 n e ( o m o n t h a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 14 22.2% 49 77.8%<br />

B a s e l i n e ( 2 w e e k s b e f o r e a n d a f t e r t h e r e c r u i t m e n t ) 22 34.9% 41 65.1%<br />

T h e r a t e o f d e c l i n e Ci D4 n T-c t h e l l c o u n ts ( C D 4 g r a d i e n t ) was th eref ore cal cu lat ed fro m<br />

t h o s e i n d i v i d u a l s w h o h a sd t two a t me l e as a u remen ts mad e in th e as s es s men t p erio d . Of t h 6e 3<br />

p a r t i c i nts p a r e c r u i , on t e l y d 3 8 p a t i ) h ad e sn u ffi t ci en s t d at a ( from 6 0 wh . ich 3 to % c alcu late th e<br />

rate o f d ecl i n e i n t h e C D 4 T-cells d u rin g th e fou r mon th p lu s on e mon th (fi ve mon th s<br />

a l t o g e t h e r ) t u s d y p e ri o d , a n d i t r h e d a t w a e r e u s ed to i n v e s t i g a th t e a s s o c i a t i o n b e st tres w e s e n<br />

p e r c e p t i o n da is n eas d e p rogres s ion .<br />

T h e s a m e 6 3 -in H I fe V cted i n d i v i d u a l s were r a n d o m l y a s s i g n e d t o o n e o f t h r e e g r o u p s :<br />

C o n t r o l (wait-listed c o n t r o l: w a i t i n g f o r f o u r m o n th s b efore b ein g ran d oml y<br />

a s s i g n e d t o t h e S e -h l f yp n o s i s o r J o h r e i) g rou p ,<br />

Self-h y p n o s i s t r a i a n i d n g p r a c t i c e g r o u p , a n d<br />

J o h r e i t r a an i n d i pn ract g ice grou p .<br />

R an d omi s at i on u t i l i s ed ran d om n u mb ers gen erated b y a res earch er b lin d with a co mp u ter.<br />

I t w a s p e r f o rm e d b y u s in g s tu d y n u m b e r s a t r e c r u i t m e n t, an d t h e n t h e s a e n o n ym i s e d<br />

p articip an t s were as s i gn ed t o on e <strong>of</strong> th e g r o u ps. Alth ou gh th e in itial n u mb er <strong>of</strong> p eo p le in each<br />

g r o u p at ran d omi s at ion g e n e r a t e d b y a c o m p u t e was r al m os t eq u al , s o me s u b jects with d rew<br />

b e f or e t h e t r a in i n g s e s s was i o n s tart ed (i . e. th e y d id n ot tu rn u p th e firs t s es s ion ) re s u ltin g in<br />

d i f f e r e n t n u m b e r s o f p a r t i c i p a n . t T s h e r i e n w e r a e c 23 h p art g r ici o u p an ts in th e Self-h yp n os is<br />

a n d 16 pa r t i c i p a n t s i n t h e J o h r e i a n d 24 in th e w a i t -listed c o n trol gr ou p s . T h e p s yc h ological<br />

in terven ti on s were ad mi n is tered t o s ev en Self-h y p n o s i s an d eigh t J oh rei t r a i n i c on hg ort s .<br />

A t r e c r u i t m e n t ( B a s after e l i the n e ) i a n n t d e r v e n p t e i r o i n o (a d f t e r 4 m o n t ) h s [ F i g u r ], e th e 7<br />

p a r t i c i p a n t s w e r e a s k e d t o c o logical m p l e qt ue es tp ion s y nc ai h res o . Of 6 3 p atien ts , a total <strong>of</strong><br />

t w e l v e p a t i e n t s e i t h with e r d rew f r o m t h e s ot r failed u d y t o c omp let e s ome <strong>of</strong> q u es tion n aires<br />

b e f o r e t h e e n d o f o n e t -mon h e th t r a i n i n g s e s s i o . n Hen s ce, a tot al o f 51 s u b ject s ( 2 1 i n S e l -f<br />

h y p n o s i s , 1 2 i n J o e h i r a n d 1 8 i n w a i t-l is te d con trols ) c o mp leted q u es tion n aires . Lymp h oc yte<br />

s u b p o p u l a t i o n a n d H I V v i r a l l o a d d a t a w e r e o b t a i n -e e d xis f tin r g o m p at t ien h e t dp at r ab e as e, a n d<br />

o n l y 3 8 s u b j e c t s ( 1 5 i n S -h e l yp f n o s i s , 1 0 i n J o h r e i a n d 1 3 i n w a i -l t i s t e d c o n t r o l g r o ) u hp ad<br />

s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 7 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

s u f f i c i e n t d a t a f r o m w h i c h t o c a r l a c t u e l a o t f e d t e h c e l i n e Ci D4 n T-c t h e l l s d u ri n g th e s tu d y<br />

p eriod .<br />

- Recruitment - - Post-intervention -<br />

B a s e l i n e T e r m o n e<br />

T e r m f o u r<br />

T r a i n i n g<br />

1 m o n t h<br />

F i g u r e 7: T i m i n g o f t w h o e m e a s u r e m e n t p o i n t s R ( e cr u i t m en t a n d P o st-i n t e r v e n t i o n ) wit h r e ga r d t o t he p e r i o d o f t r a i n i n g a n d f t he p r p a s yc c t h i o lo c e gi c o a l i n t e r v e n t i o n s<br />

2 . 1 . 3 C a s e m a t c h e d p a t i e n t s f r o m t h e d a t a b a s e<br />

Th e s a m e H I -in V fected i n d i v i d u a l s r e c r u i t e d t o t h e a b o v e w R e r C e an T al s ys t eu d iy n<br />

th is cas e con trol led s tu d y. T h e p r e v i o u s R C T s t u d y ed u a s w a i t -listed c o n t r o l g r o u p , s f o t e r a t h e<br />

f o u r mon th s <strong>of</strong> th e wai ti n g p e r i o , d th e y w ere ran d o ml y as s i gn ed to eith er t h e l f-h S yp n os is or<br />

J o h r e i t r a i g n r i o n u o g p v e r t h e A u g p u s e t r 2 0 i 0 3 o t d o D f e c r e m o b . e Th m r is 2 in 0 creas 0 4 ed th e<br />

n u m b e r i n t h e t w o g r o u p s :<br />

Self-h y p n o s i s: 3 4 s u b j e c t c s o n s i s t in g o f s e v e n t r a i n i n g c o h o r ts<br />

J o h r e i : 2 9 s ub j ects con s is tin g <strong>of</strong> eigh t t rain in g co h orts<br />

In ad d it ion to th es e p art ici p an ts , 5 8 m a t c h e d d a t a b a s con e trol p at ien ts were s el ect e d<br />

b l i n d l y f r o m t h e s a m e H I V p a t i e n with t d pa ermi t a b a s s ie on fr om th e Et h i c s c o m m i t te e . Th is<br />

s election was p erf or med b y a n i n d e p e n d e n t lan r W . e s S t e a e l r th , c e w h i t h d o c t o r , D<br />

f o l l o w i n g i n c l c u r s i t o e : r n i a<br />

1 . C D4 T-c e l l c o u n t s > 2 0 0 c e l ls / L<br />

�� �� �� Practice & Follow-ups<br />

2 . HIV vi ral l oad > 1 0 0 0 v i r a l c o p i e s / m l<br />

3 . Stu d y p eri od – s a m e 1 2 m o n t h s s p r e a d t o m i n i m i s e s e a s o n a l variati on ; an d th i s<br />

r e s u l t s i n e i g h t c o n t r o l c o h o r t s w i t h r e g a r d t o c o m m e n c i n g m o n t h f o r a n a l y s i s<br />

4 . Eq u ival en t m e a n C D 4 -l y m T p h o c y t e s c o u n t with s tha t <strong>of</strong> p art ici p an ts at th e<br />

com men ci n g m on t h <strong>of</strong> t rai n in g in terven ti on .<br />

3 m o n t h s<br />

C D 4 -c T ell c ou n ts an d vi ral load le vels w ere ob tain ed fr om th e p atien t d atab as e. Th e<br />

T r a i n i n g t i m e p o i n t w a s s e t a s t n h e -m m o n i t d h p to rai i n it n g io nf terven t h e ti on o s an d<br />

s u b s eq u en t t erms were n amed aft er th e n u mb er <strong>of</strong> m on th s fro m th e Tr ain in g time p oin t (e.g.<br />

T e r m o n e i s o n e m o n t h f r o m t h e a i T n r i n g t i m e p o i n t Figu ) [ re 8].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 8 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Training<br />

B a s e l i n e T e r m o n e<br />

T r a i n i n g<br />

1 m o n t h<br />

3 m o n t h s<br />

Fi gur e 8: Ti m e-points (Tr a inin g t ime point and the T e r m s a cc or din g t o th e T r a i n i ). n g<br />

In t e r v a l s b e t w e e n t -l h i e n e s d o r e t p e r e d s e n t o n e t e r m ( o n e m o n t h )<br />

Th e C D4 ch an ge grad ien ts were co mp are d b e t w e en t h e i n t e r n v e n g t r i o o u p elf- s ( S<br />

h yp n os is an d J oh rei ) an d t h e d a t a b a s e c o n t r o l g r o u p . F o r e a c h i Cn D4 d i v di ecl d u ia nl e , a<br />

g r a d i e n t (cel ls p er l p e r m o n t h ) was c a l c u l a t retros e d p ect ivel y f ro m th e p reced in g 1 2 m on t h s’<br />

d ata h el d on th e p at ien t record d atab as e (P r e-i n t e r v e n t i o n ) . T h e -in s e ter p ven r e ti on C D4<br />

g r a d i e n t s w e r c o e m p a r ed b e t w e e t n h e t h r g e r e o u p s. S i m i l a r l y, a p o s t-i n t e r v e n t i o n C D 4 g r a d i e n t<br />

w a s p r o s p e c t i v e l hy e C D4 c a gl rad c ien u l ts a in t th e d 1 2 . mon T th p eriod s p rior to an d after th e<br />

T r a i n i n ( g P r -i e n t e r v e n t vs i . o P n o s t-i n t e r v e n t i o n ) [ F i 9] g were u r e co mp ared wi th in an d b etween<br />

th e th ree gr ou p s .<br />

Training<br />

Pre-i n t e r v e n t i o n<br />

4 m o n t h s<br />

Fi gur e 9: C o m p a r i s o n f or m a t wi t h r e ga r d to t h e T r a i n i n g t i m e p o -i i n t t e rve ( n P t i r o e n vs . P o s t-<br />

int e r ve nt io n ) . Int e r va l s be t we e n do t-l i n e s r e p r e s e n t t o e n e r m ( o n e m o n t h ) a s i n F i g u r e 8<br />

Seven p a t i e n t s t h i Self-hy e n p n o s i s grou p , ten p at ien ts in th e J o h r e i g p r an o u d n in e<br />

p a t i e n t s i n D a t -c a b o a n s t e r ls o were excl u d ed b ecau s e n o rou tin e b lood s amp les wer e taken<br />

d u r i n g t h e 1 2 m o n t h s e i t h e r p r i o r t o o r a f t e r . In i th n es t e r exc v e ln ut d ed i o pn at ic en o m ts , m e n c e d<br />

s e v e r a l p a t i e n t s c o m ed m e a n c t i -r e t r o v i r a l m e d di uc rin a t g i th o e n P o s t -i n ter ven ti o n p eriod , an d<br />

the y were d r op p ed fro m t h e s tu d y. Tab le 5 s h ows th e n u mb ers <strong>of</strong> p atien t s wh o s tar ted d ru g<br />

th erap y i n e ach gr ou p .<br />

�� �� �� Practice & Follow-ups<br />

T e r m f o u r<br />

Post-i n t e r v e n t i o n<br />

T able 5: N u m b e r and month <strong>of</strong> su bje ct s wh o s ta rt e d a nt i -r e tr ovir a l m e d i c a t i ao nd n dr oppe d fr om the<br />

s t u d y ( N B : T er m X r ep r e s e nt s t ha t X m on t hs a f te r t he R e cr u i t m en t t i m e p o i n t )<br />

T e r m 2 T e r m 5 T e r m 8 T e r m 1 1 Total<br />

D a t a b a s e c o n t r o l s 0 1 3 3 7<br />

S e l f-hypnosis 0 0 2 4 6<br />

J o h r e i 1 0 1 1 3<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 5 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . 1 . 4 L a b o r a t o r y v o l u n t e e r s<br />

T h i r t y o h n e a l t h y v o l u n te e r s, o f wh o m 2 1 were mal es an d 1 0 f e m a l e , s with a n a g e r e a n g<br />

<strong>of</strong> 2 1 -6 0 y e a r s, were recru i t ed to d on ate b lood in o rd er to in ves tigate th e eff ects o f i n v i t r o<br />

e x p o s u r e t o t h e s t r e s s -c e l h l o s r -l m a y o m n p n d h e o c T y , t s. e c o r t i s o l , u p o<br />

Th is recru it men t was t h r o u g h w o -o r f d -m o u t h c o n t a c t s w i t h t h e a u t h a o n r d c o l l a g e u es<br />

f r om th e Dep art men t o f Immu n olo g y an d th e Di v i s i o n o f N e u r o s c i e n c e a n d M . All e n t a l H e a l t h<br />

b lood s amp l es were col l ect ed b etween 9 :3 0 an d 1 1 :3 0 a.m . to elimin ate th e e ffects <strong>of</strong> d iu rn al<br />

variati on [ M c G l o n e e t a l . , 1 9 9 a 1 n ] d t h e n e i t h e r i s o l a t p e r d i p h e r a l b l o o d m o n o n u c ells l e a r c<br />

(P BMC s ) or wh ol e b l o od wer e a s s a yed s t raigh t afte r c ollection .<br />

2.2 P s y c h o l o g i c a l in t e r v e n t i o n<br />

2 . 2 . 1 S e l f-h y p n o s i s t r a i n i n g<br />

T h e s e l f-h yp n os is trai n in g, d es ign ed an d c o n d u c t e bd y an exp eri en ced cl in ical h yp n otis t<br />

D r . T a n n i s M . L a i d l a w , c o n s i s t e d o o u f r f w e e k l y s e s s i o n ( s t w o h o u r s e a c h . )<br />

T h e p a r t i c i p a n t s l e a r n t f i r s t a S p i e g e l-t y p e e y -roll e in d u ct ion (s yn ch r on is in g u p ward e y e -<br />

r o l l s w i t h a d e e p i n s p i r a t i o n f , r o f m o l t l h o e w e n d o s e b y h o t l h d be i reath n g fo r a f e w s e c s, o n d<br />

t h e n e y -r e o l l s d o w n w i t h ti e on x p i fr r om a th e mou th ) f o r ‘ i n s t a n t r .’ e Th l a e x y a t w i e o r n e a l s o<br />

t a u g h t a s l o w e r r -t e yp l e a x in a dt ui ct o ion n tech n iqu e to ach ieve gettin g in to a s tate o f min d ,<br />

‘h y p n o t i c s t .’ a t A e l l p a r t i c i p a n t s w e r e p r o v i d e d w i -rec t h ord a in s g t [Ap a n p d e a n r d i x a 2-i] u d i o<br />

w h i c h p r o v i d e d i n s t r u c t i o n s f o r b o t h i n d . u Pc reviou t i o n s res ear ch h as s h own th at u n ivers it y<br />

s tu d en ts p ract i s i n g i mmu n e s tren gth en im ager y in th e self-h yp n os i s t rain in g h ad les s cold<br />

s y m p t o m s d u r i n g i r t h e a c a d e m i c e ination x a m p e r i o d t h a n s t u d e p n r t a s c t i s i n g r e laxa ti on ima ger y<br />

[ Gru zel ier, L e v y e t a l . ]. It 2 0 w 0 1 a s a l s ho own in p at ien ts wi th gen ital h erp es th at s elf h yp n os is<br />

c o n t r i b u s t e t o a r e d u c t i o n i n -relat d i s ed e a s se ymp toms [F o x e t a 9 l 9 9 . ; 1 G r u z e l i e r e t ]. a l . 2 0 0 2<br />

H e n c e , the i n d u c t i o n t e c h n i q u e w mb a s in l ed a wi t e th r a sc po eci fi c ima ger y <strong>of</strong> i mm u n e<br />

s t r e n g t h e n , i wh n g ich p art ici p an ts were to ld to p r a c t i s u e n d e r t h e h ‘ y p n o t i c s t ’. a t Fu e rth er, al l<br />

p a r t i c i p a n t s w e r e t a a n x u i g e h t t y m t a n w a o g e m e n t t e c h n i q u e s :<br />

1 . How t o u s e b reat h in g tech n iq u es to con tr ol acu te an xi et y [ L a i d l a w , 1 9 9 4 ; ] an d<br />

2 . Th e I n t e ru p t Di s tract ion P roced u re ( IDP ) [ L ai d l a w , 1 9 9 9 ] for w orri es an d b el ief c h a n g e .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Each p art ici p an t wa s r e q u e s t e d to p r a c t i s e l f-h yp n o s i s d a i ly t o learn an d fa miliar is e<br />

th ems el ves wi th t h e t e c h n i q [ u G e r u z e l i e r e t a l . , 1 9 9 . 8 D ] u r i n g o n -mon e th trai n in g p eri od , each<br />

p a r t i c i p a n t a t t e n d e d f o u r g r o u p s e s s i o n s w i t h t h e h y p n o t i s t a n d e a c h w a s e x p e c t e d m, t o at p e r f o r<br />

l e a s t , m o r e t h a n t e n s -h e l yp f n os is s es s ion s . Diar i e s w e k r e p t b y t h e p a r t i c i p a n t s t o r e c o r d t h e i r<br />

p r a c t i c e f r e q at u e hn ome c y . Aft e r th e f ou r wee kl y t rain in g s es s ion s , m o n t h l y -u p f g r o u l p l o w<br />

s es s ion s were c o n t i n e d u f o r a t l e a s t f o u r m o n b t h y s -inf H e I c t V e d i n d i v i d u . a l s<br />

2 . 2 . 2 J o h r e i t r a i n i n g<br />

Th e J oh rei trai n in g was p lan n ed an d c o n d u c t e bd y th e au th or wh o is a t rai n ed p ractition er<br />

with more t h an 2 0 yea rs o f p ractice an d wh o is als o med icall y q u ali fied . O rigin al teach in g<br />

t e x t b o o k s a n d s u p p o r t w id e ed r e b y p t hr e o Jv oh rei Acad em y [h t t p : / / w w w . j o . h r u e k/] i an . d o r g<br />

J o h r e i A s s o c i a t i o n h [ t t p :/ / w w w . j o h r e ia s s o c i ation.co. u k/] s o t h a t t h au e th or cou ld t each , ed it an d<br />

a d j u s t for each g rou p o f p art icip an ts in th e s tu d ies [Ap p e n d i x 2-ii] [ See al s o th e J o h rei<br />

F o u n d a t i , o h n t t p :/ / w w w . j o h r e i f o u n d a t i o n . o r g /; I z u n o m e, h t t p : / / w w n w . o i m z u e . o r g ; / j o h r e i .<br />

a n d J o h r e i i n s t , i h t t p u :/ t / e w w w . j o h r e i-i n s t i t u t e . o r g / o u r p ] e o p l e . a s p<br />

Th e J oh rei i n t erv en t i on con s is ts <strong>of</strong> fou r w eekl y train in g s es s ion s (tw o h ou rs each )<br />

i n v o l v i n g c o r e p r in c i p l e s n e e d e d t o t p i r s a e c J o h r e i t e c h n i q u e s s h u e c a h l i a g s n o n“ es el f b y<br />

h e a l i n g o t h e ”; r s s tate <strong>of</strong> h a r m o n y, b al an ce an d timin g (I Z U N O M E), an d an in trod uction to the<br />

th ree fou n d at i on s <strong>of</strong> J oh rei p h ilos op h y w h ich emp h as is es imp ortan ce <strong>of</strong> :<br />

1 . Aw a r e n e s s o f s p i r i tu a l w e l l-b e i n g (Ar t o f livin g / Ar t o f He a l i n ); g<br />

2 . Ap p r e c i a t i o n o f a e s t h e t i c A s r ( t a n d B e a ) u t ; y a n d<br />

3 . Ap p reci at ion <strong>of</strong> Na t u r e i n c l u d i n g f a r m i n g p r a c t i c A e r ( t o f N a t ). u r e<br />

I n J o h r e i p r a c t i , c e t h e p r a c t i t i o n e r i m a g n i n e t e h s e r e a l ‘h e a l i n -light’ g e n t e r i n g dh y i s b o<br />

an d b e i n g t r a n s m i t t e d t h r o u g h h i s / h e r h a n d s t o w a r d s t h e r tition e c i p er i , e wi n t t. h ou T t h e p r a c<br />

tou ch in g a reci p i en t , s l owl y mo ves h is /h er h an d s from th e h ead d own t o th e kid n e y area, fr on t<br />

an d b ack. Th e p roced u re t a kes ap p ro xima tel y 1 5 min u tes in s ilen ce. Th e p articip an ts were<br />

r e q u e s t e d t o p r a c t i s e J o h r e i d a i l y w i t h a p a r t n e r , b u t a t t h e e n d o f t r a i n i n g p -J e r oh i o rei d , an s e d l f<br />

d is tan t J oh rei t e c h n i q u s e we r e in trod u ced as s u p p l e m e n t a r y t o o l s s o t h a articip t p an ts cou ld p ractice w h e n a p a r t n e r w a s n o le.<br />

t a v a i l a b<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

As in th e h yp n os is gr ou p , it w a s r e q s t u e d t h a t e a c h p a r t i c i p a n t p ractis e J oh rei at l eas t<br />

f o u r t i m e s a t o lea w e rn e k an d fami li ari s e th ems elves with t h e t e c h n i q . u Diaries e w ere u s ed to r e c o r d p r a c t i c e f r a e t q u h e o n m . c Grou y e p mo n t h l y -u p f s e o s s l s i l were o n o w c o n t i n ed u for at<br />

leas t fou r mon t h s .<br />

2 . 2 . 3 M o c k i n t e r v e n t i o n ( C o n t r o l s f o r t h e p s y c h o l o g i c a l t r a i n i n g s )<br />

T h is m o c k n e u r -f o e e d b a c k c o n d i was t i o ai n med to p r o v i e d a c o n t r o l a g a i n s t p o s s i b l e<br />

p l a c e b o e f f e c ts f r o m p a r t i c i p a ’ n t e s x p e c t a t a i n d o n a g a i n s t fa c t o rs o f at ten tion give n an d<br />

e x p e r i e n c e o f r e l a x a d t u i r o i n th n g eir trai n in g s e s s i o n s s in ce th is p roced u re w a s s h own to<br />

gen erat e a rel a xat ion r es p on s e wh en u s ed as a c on trol c on d ition [ E g n e r e t a l . , 2 0 0 . 2 ]<br />

T h i s c o n d i t i o n a p p e a b e r e h d i g -t t h ech o , wi th two c omp u ters an d electrod es fi xed to<br />

e a r l o b es a n d t h e c e n t r e o f , an t d h wi e th s c au a dl it p or y rel a xi n g feed b ack s ou n d s (b ab b lin g<br />

b roo k an d ocean wa ve) h eard o ver h ead p h on es . Th e s ou n d s were s u p p os ed ly rep re s en tin g alp h a<br />

a n d t h e t a w a v e eed f b ack fr om th e p art ici p an t ’s own b rain waves as s ociated with r elaxation .<br />

Alth ou gh t h e p ro ced u re was real , th e feed b acks were fals e as th e s ou n d s were r eco r d ed<br />

p r e v i o u s l f r y o m a n o t h e r s e s s ion .<br />

T h e pa r t i c i p a n t s is g i r n o u p t h a d e i g h t m o c -f k e n e e d b u a r ck o s e s s i o n s o v e r o n , e m o n t h<br />

an d th es e s es s i on s were p erfor med b y Dr . Dwived i, a q u alified clin ical p s ych ol ogis t, with valid<br />

n e u r o-feed b ack eq u i p men t .<br />

2.3 S e l f-r e p o r t u e s q t i o n n a i r e s<br />

P r i m a r y a p p r a i s a l i n s t r e s s p e r c e p t i o n ( a n x i e t y l e v e l a n d i m p a c t es o f s fu a l s et r ven t ),<br />

s e c o n d a r y a p p r a i s a l en , s e o f ‘t a k i n g c o n t r o l o ’s f o w n e n l ’, i f pe s ych ol o gi cal fu n ct ion in g<br />

(m e n t a l q u a l i t y ) o f a n l d i f s e l e e p q u a l i t y w e r e m e a s u t r h e f o d ll owi b y n g u s pi u bn lg is h ed<br />

q u es tion n ai res .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 2 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . 3 . 1 S t r e s s p e r c e p t i o n<br />

2 . 3 . 1 . State 1 a n xi e t y s c o r e i n t h e a S n t d a t T e r a i t A n x i e t y [S I p n i v e l n b t e r o g r e r y e t a l . , 1 9 7 0 ]<br />

T h e S t a t e a n d T r a i t A n x i e t s y c a l I e w n v a e s n d t e s o i r g y n d e t o m e a s u r e t h e l e v e l s o a f n x i e t y<br />

b o t h a t t h e e x a c t t i h m qe ue es tion n ai re w as fi ll ed in (s tate an xiet y) an d as a gen era l ten d en c y<br />

(t r a i t a n ). x State i e t y an xi et y le vel w as me as u red an d an al ys ed in th e cu rren t p roject . High s co res<br />

a r e a s s o c i a t e d w i t . h a n x i e t y<br />

2 .3 .1 . 2 I m p a c t o f E v e n t S c a l e ( I E S [Hor ) owi tz et al ., 1 9 7 9 ; J os ep h , 2 00 0 ; Sun d in & Hor o witz,<br />

2 0 0 2 ]<br />

Th e Imp act <strong>of</strong> Even t S cal e ( IES) meas u re s th e amou n t <strong>of</strong> s t res s wh ich res u lt s fro m a<br />

p s ych ol ogi cal l y tr au mat is in g e ven t, s u ch as a d iagn os is o f H I V i n f e c . t High i o n s co res are<br />

as s ociat ed wh en e v e nt b e i pn ercei g v ed as a s tres s or . Th is IES was meas u red an d an al ys ed in th e<br />

s t u d y u -in s fect i ed n g in d ivi H dI u al V s in th is cu rren t p roject. Hi gh s cores are as s oci ated with<br />

h igh i m p a c t o f t h e e v e n t.<br />

2 .3 .1 .3 P e r c e i v e d S t r e s s S c a l e ( P S S [ ) C o h e n e t a l . , 1 9 8 3 ]<br />

Th e P e r c e i v e d S t r e s s S c a l e PSS) ( is a s ca le d es ign ed to meas u re th e s e c o n d a r y ap p rais al<br />

<strong>of</strong> s tres s ove r a p eri od (t w o wee ks or a m on th ) with t h e d e f i n i t i o n p er t ceived h a t “ st r es s is th e<br />

d e g r e e t o w h i ch s i t u a t i o n s i n o n e ’ s l i f e a r e a p p r a i s e d a s s t r e s s fu l (un pr ed ict ab le, un co n tro ll ab le<br />

a n d o v e r l o a d .” i n H g i g h s c o r e a s r e a s s o c i a t e d w i th s t r e s . s<br />

2 .3 .2 P e r c e i v e d q u a l i t y o f l i f e<br />

2. 3. 2 . 1 L o c u s o f C o n t r o l s c a l e ( L o C [ F ) u r n h a m & S t e e l e , 1 9 9 3 ; W a l l s t o n e t a l . , 1 9 7 8 ]<br />

Th e L o c u s o f C o n t r o l s c a l e L ( o C) meas u res th e p ercep ti on o f c a ability p o f c o n t r o ll i n a g<br />

e v e n t [ S c h m i t z e t a l . , 2 0 0 . 0 Low ] s c o r e s are as s oci at ed with h igh s en s e o f takin g c on trol <strong>of</strong><br />

o n e ’s own li f e, as s a l ed f r o m 0 ( t o ter t a n l a l ) y t i o n 2 4 ( t o t e r a n l a l ) y [ R o e t x t e r , 1 9 6 7 : ]<br />

I n d i v i d u a l s w h o h a v e i n a t e n r n a l l o c u s o f c o n t r o l b el ieve th at even ts res u lt p rimari l y<br />

f r o m th ei r own b eh avi ou r an d action s .<br />

T h o s e wh o h a v e a e n x t e r n a l l o c u s o f c o n tr o l b e l i e v e t h p a o w e r f u l o t h e r p a r t n e r s , f a t e<br />

o r c h a n c , e p ri mari l y d et er mi n e even ts . H i g h s c o r e s a re as s o ci at ed wi th low con tr ol.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 .3 .2 . 2 Men tal C omp on en t Su mma r y in th e S F -3 6 ( M C S ) [ W a r e e t a l . , 1 9 9 * 4 ]<br />

T h e S -3 F 6 is a s cal e d evel op ed t o m e a s u r e t h e l e v o e f l s q u a l i t y o f . Th l is i f c e o n s i s t s o f<br />

two s u b s et s , i .e. Ph ys i cal an d Men tal h eal th clu s ters as s c a l e s <strong>of</strong> th e P h ys ical C omp on en t s<br />

S u m m a r y ( P C S ) t a n h d e<br />

M e n t a l C o a m r p y o ( n M e C S n ) . t s H s c i o r g e h s iS n eac u m h m s u bs et are<br />

a s s o c i a t e d a w h i igh t h p ercei ved q u a l i t y o f p l h i y s f i e c al l y ( P C S ) a n d m e n t a l l y ( M C , S )<br />

r e s p e c t i . v e l T y h e M C S w a s m e a s u r e d a n d -in fecte a n d a il n d iy vi ds u als e d i n t h e<br />

in th is cu rren t p roj ect . H i g h s c o r e s a re as s oci at ed wi th h igh p s ych ol ogi cal fu n ction in g.<br />

2 .3 .2 . 3 P i t t s b u r g h S l e e p Q u a l i t y I n d e x ( P S Q [ B I ) u y s s e e t a l . , 1 9 8 9 ]<br />

T h e P i t t s b u r g h S l e e p Q SQI) u a l i s t a y s I c a n l d e e d x e v e ( l P o p e d t o m t e h a se s u br ject e ive q u a l i t y o f c s o m l b e i e n p e d w i t h b e h a v i o u r a l i t e m s, e . g . s l e e p . d H u r i g a h t i s c o n r are e s<br />

a s s o c i a t e d low w i t s l h e e p q u a l . i t y<br />

All s e l f-rep o rt d at a a n o n ym i s e d a n d d e p e r s o n a l i t o s p e r d o t e c t t h e c o n f i d e n t i a l i ty <strong>of</strong> th e<br />

s tu d y p art ici p an ts . Al l d a t a c o l l e an c t d i en o n tr y was p e r f o r m e d b y r e s e a r c h a s s i s t a bn lin t s d to t h e t r e a t m e n t c o n d i t i o n s o f t h e s t u d y p a . r t i c i p a n t s<br />

* N o t e : T h -3 e 6 sS cal F es , in cl u d in g t h e M e n t a l C o m p o n e n t S (MC u m m S) a r , ar y e<br />

s c o r e d s u c h t h a t r h i s cores g h e rep res en t b et ter fu n ction in g (in th is cas e, h igh er<br />

p s ych ol ogi cal fu n ct i on i n g), an d low er s c ores r ep res en t p oore r fu n ction in g. In all o f<br />

t h e o t h e r a s m u e r em e n t s u s e d i n t h i s s t u d y , h i g h e r s c re o r e s f u r n e c p t r i e o . s n e i n t g p o o<br />

2.4 M ater i al s a n d m e o t d h s f o r i n v i t i r n o v e s t i g a t i o n<br />

2 . 4 . M 1 a t e r i a l s a n d e x p e r i m e n t k i t s<br />

2 .4 .1 .1 C h e m i c a l s a n d r e a g e n t s<br />

Th e fol l owi n g M a t e r i a l s w e r e<br />

h t t p :/ / w w w . s i g m a a l d r i c h . c o m /)<br />

R P M I 1 6 4 0<br />

1 % g l u t a m i n e ( 2 0 0 m M )<br />

p u r c h S a i s g m e a (D d ors et , f U . r K., o m<br />

1 % p en i ci l l in (5 0 00 IU/ ml ) / s t r e p t o m y c i n ( 5 0 0 0 m c g / m l )<br />

1 % H e p e s b u f f e r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 % n o n-e s s e n t i a l a m i n o a c i d s ( 1 0 0 x )<br />

1 % s od i u m p yru v at e (1 0 0 mM) .<br />

F o e t a l c a l f s e r u m ( F C S )<br />

P h o s p h a t e b u f f e r s a l i n e ( P B S )<br />

L y m p h o p r e p® (f o r p e r i p h e r a l b l o o d m o n o n u c l e a r c ) e l l s s e p a r a t i o n<br />

P a r a f o r m a l d e h y d e ( P F A )<br />

0 .0 5 % E o s i n d y e<br />

P r o p i d i u m i o d i d e ( P I )<br />

P h y t o h a e m a g g : l m u i t i o ) g e n i n ( P H A<br />

S t a p h y l o c o c c a l e : n s t u p e r r a n o t i t g e o n ) x i n B ( S E B<br />

H y d r o c o r t i s o n e<br />

R a d i o a c t i v e [<br />

3 H] th ymi d in e w a s p u r c h a s e d f r o m Am t h ers e h am [Ame rs h am P h armacia<br />

B i o t e , c B h u c k i n g h a m s h i , r U e . K., h t t p :/ / w w w 6 . a m e r s h a m b i o s c i e n c e s . c o m /]<br />

2 . 4.1 . 2 B i o l o g i c a l r e a g e n t s<br />

T h e a n t i g e n s o f p u r o i t e f i n e d e r p i v a t i ( v e P : t P u b D e r c u l o s i s a n t i ) g e an n d Herp es<br />

S i m p l e x v i r u s c o m m o n a n t i g e n ( H e r p e s ) w e r e p r o olo v i gd y e cl d in b ical y lt ab h orat e I or m y m u n<br />

at C h el s ea an d Wes t mi n s t er hos p ital.<br />

Th e K 5 6 2 c e l l l , a i n e hu man ch r on ic m ye logen ou s leu kae mia cell lin e f or N K c yt o toxic<br />

a c t i v i t y m e a s u r e m e n t, was p u rch as ed fro m th e E u r o p e a n c o l lection <strong>of</strong> cell cu ltu res [E C A C C ,<br />

Salis b u r y, U. K. ].<br />

2 . 4.1 . 3 F l u o r e s c e n t l y c o n j u g a t e d a n t i b o d i e s f o r f l o w c y t o m e t r y a n a l y s e s<br />

An t i b o d y c o c k t a i l s -F o f I T C C/ D C 4 D 5 3-P E / C D 4-C y -C h r o m e/ C D 8-A P C a n d C D -4<br />

5<br />

F I T C/ C D 3-P E / C D 1 9-C y -C h r o m e/ C D 5 6-AP C , stan d ard p an els <strong>of</strong> flu ores cen tl y co n ju gated<br />

a n t i b o d y c o c k t a i l s f o r t e l s y u m b p o h p o u c l y a t i o n a n a l y , s we e s re p u rch as ed fro m B e c k m a n<br />

C o u l t e r [B e c k m a n C o u l t e r, B ed ford s h ire, U. K., h t t p :/ / w w w . b e c k m a n c o u l t e r . c o m /]<br />

In d i v i d u a l a n t i b ies o d o f C D 3 , C D 4 , C D 8 , C D 4 5 9 5 , N k C p 0 D 3 , 5 6 , C D 1 6 ,<br />

N k p 4 6 a n d A ( n c o n j e u g x a t i e n d w i V t h F I T -C C , h r o P m E e , o C y r A P C ) w e r e p u r c h<br />

B e c t o n D i c k i n s o n [B e c t o n D i c k i , n Os xo ford n , U . K., h t t p :/ / w w w . b d . c o m /] .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . 4.1 . 4 C o m m e r c i a l l y a v a i l a b l e l a b o r a t o r y k i t s f o r c o l o r i m e tr i c m e a s u r e m e n t<br />

T h e C y t o T o x ®, 9 6 a kit me as u ri n g N K c yt ot o xic a c t i v i t y , Pw ro a mega s p u r c h a s<br />

[P romeg a U. K., h t t p :/ / w w w . p r o m e g a . c o m /]. T h i s C y t o T o ® x 9 a 6 n a l y sis i n c l u s d e m e a s u r em e n t s<br />

o f r e l e a s ed L a c t a t e d e h y d r n o a g s e ( L D H ) in t h e s u p e r n a n t o f t h e c u i l u t m u r ( e a d f t -h m e ou e r d r 4<br />

i n c u b a t i o n o f mix ed K 5 6 2 c e l l s a n d P B M C s ) w h i c h c o n t a i certain n s level s o f LD H fr om d ead<br />

cells. Th is ki t was u s ed i n o r d e r t o a v o i d u -active s i n g sr u ba sd tan i o ce wh ich is requ ired in th e<br />

gold s tan d ard met h od , th e 5 6 C r -r e l e a se a s s a [ y P r om e g a , 2 0 0 4 ].<br />

E L I S A k i t s f o r m e a s u r i n g -S an t d mel h e at on il n were e v pe u rch l as s ed o f c o r t i<br />

fro m i DS [iDS U . K., h t t p :/ / w w w . i d s l t d . c o m /].<br />

2 . 4 . E 2 q u i p m e n ts u s e fo d r i n v i i t r n v o e s t i g a t i o n<br />

2 . 4 . 2 . F 1 l o w c y t o m try e<br />

Fl ow c yt o met r y i s a meth od f or q u an titatin g co mp on en ts or s t ru ctu ral f eatu res o f c ells<br />

p rimari l y b y op ti cal mean s . F l o w c y t o m e m t e r a y s u r e s on e c el l at a ti me, b u t it can p roces s<br />

t h o u s a n d s o f c e l l s i n a f e w s e c o n d s . T h e c e l l s -f a r i l e p t h a rou s s gh e d a s las i n er g l be eam b y<br />

con tin u ou s fl ow o f a fi n e s t ream o f th e s u s p en s ion . Each cell s catters s o me <strong>of</strong> th e l as er ligh t,<br />

a n d a l s o e m i t s f l u o r e s c e n t l i g h t e x c i t e d b y t h e cl oa me s e r f ro m th e lab el led fl u ores cen t<br />

c o n j u g a t e d a n t i b o d i e s d e s i g n e d t o b o n d r s t p i e c i l f e i c o n p a t h e c e l l s u r f a c e o r i n . t h e c y t o p l a s m a<br />

T h e f i v e m a i n c o m p o n e n t s o f f l o w c yt o m e t r y a r e :<br />

1 . Fl ow cel l - l i q u i d s t ream (s h eath flu id ) ca rries an d align s th e c e l l s s o t h a t t h e y p a s s i n<br />

s i n g l e f r i l o e u t g h h t h e l i g h t b e a m<br />

2 . Li gh t s ou rce - c om mon l y u s ed is h i g h p o w e r w a t e -c r o o l e d a r g o n a n d / o r k r y p t o n l a s e r<br />

3 . El e c t r o n i c d e t e c t o r w h i c h c a n q u a n t i t a t e t h e f a i n t f l a s h e s o f s c a t t e r e d a n d f l u o r e s c e n t l i g h t<br />

4 . A n a l o g u e t o D i g i n vers t a l i on C ( o ADC ) s ys te m wh ich g e n e r a t es f o r w a r d s c a t t e r (FSC)<br />

an d s i d e s c a t t e r SSC) ( s i g n a ls as wel l as l ab el led f l u o r e s c e n c e s i g n a l s<br />

5 . Comp u ter f or an al ys is <strong>of</strong> th e s i gn als , an d to r e c o r d ata d for th ou s an d s <strong>of</strong> cel ls p er s amp le,<br />

an d to d i s p l a y t h e d a t a g r a p n h d i c n a u l m l e r y i c a l l y<br />

6 . Stat is ti cal an al ys is c an b e d on e s i m u l t a n e o u s o l r y a f t e r w a r d u a s n i a l n g y s i a s n p r o g r a m m e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

D a t a a c q u i s i t i o n<br />

Th e c yt o met e r t yp i cal l y m eas u res s ever al p aramete rs s imu ltan eou s l y f or e ach cell :<br />

Lo w a n g l e f o r w a r d s c a t t e (F r S C ) in ten s it y, p r op ort i on al to cell d iameter<br />

Or t h o g o n a l ( 9 0 d e g r e e ) s c a t t e r i n t e n s i t y orti , on a p al p r to o tx hi e m q ua an t e ti l ty y o f p r o p<br />

g r a n u l a r s t r u c t u r e s w i t h i n t h e c e l l ( S S C )<br />

SS C<br />

Fl u o r e s c e n c e i n t e n s i t i e s a t s th e v s e r a l w a v e l e n g<br />

(each FL-1 , -2 F , L -3 F L a n d s o as o sn ocia te wi th a<br />

d efin ed s t ru ct u re i d en t i fi ed b y a f l u o r e s c e n t p r o b e )<br />

L i g h t s c a t t e r a l o n e ( F S C a n d S S C a p g h r : e . g . F i g 1 u 0) r e<br />

is com mon l y u s ed t o ex cl u d e d ead cells , cell ag gre gates , an d<br />

cell d eb ri s fro m t h e fl u o res cen ce d ata. It i s s u fficien t to<br />

d i s t i n g u i s h l y m p h o c y t e s f r o m m o n o an c y d t e gran s u loc yt es in Debris<br />

Granulocytes<br />

Lymphocytes<br />

Monocytes<br />

b lood leu koc yt e s a mp les . F i g u r e : 1 FS 0 C v s . S S C d o t p lo t<br />

Flu or es cen ce i n t en s i t i es are t yp icall y mea s u red at s everal d i f feren t wa velen gth s<br />

s imu ltan eou s l y fo r each cel l . Flu ores cen t p rob es are u s ed to r ep ort th e q u an tities <strong>of</strong> s p ecific<br />

c o m p o n e n t s o f t h e c e l l s . F l u o r e s c e n t a n t i b o d i e s a r e o f t e n d en u s iti e d es t <strong>of</strong> o s pr eci e p o fi r c t t h e<br />

s u rface recep t o rs , an d t h u s t o d is tin gu is h s u bp op u lation s <strong>of</strong> d ifferen t cell t yp es .<br />

G a t i n g a n d d a t a a n a l y s i s<br />

I n o r d e r t o a n a l h y a r s a e c t c e r i s t i c s o f s p e c i f i c i m m u n -p e op c ue lat l il on , s u el b ect io n <strong>of</strong> th e<br />

c e l l s n e e d s t o b e p r e c i fficien s e a n t. d Th e is s el ect ion is p erfo rmed b y ma kin g a gat e <strong>of</strong> re gion in<br />

a d o t-p l o t d u r i n g f l o w c yt o m e t r y a n a l ys e s , f o r e x a m p l e :<br />

1 . Aft er s et ti n g u p fl ow c yto meter f or acq u is ition , c r eate a d o t p l o t th w e i X-axi t h s as<br />

f o r w a r d s c a t t e r ( F S C ) a n -a Y d xis t h as e s i d e sc a t t e r (SSC).<br />

2 . A c q u i r e d a t a f r o m c , e l l a s n d r a w cir a cl e arou n d a re gi on <strong>of</strong> th e l ymp h oc ytes b as ed<br />

o n t h e i r l i g h t s c a t t e r c h a r a c s t on e r i t s h t e i p c l o t ( F S C . SSC v s ). Th is b ecomes a re gi on<br />

1 (R 1 ), t h e red ci rcl e <strong>of</strong> l ymp h o c yte in th e Fi gu re 1 0 fo r e xamp le.<br />

3 . F o r fu rt h er a n a l y ses , c reate an oth er d ot p l ot th at en co mp as s es th e c e l l s f r o m Rt 1 h in e<br />

t h e p l o t w i t h f l u o r e s c e n t s ( F L 1 v s . S S C o r F L 1 v s . F L . 2 e t c . )<br />

P r e c i s i o o f pe n rcen ta g e in ly m p h o c y t e -p s o u p b u l a t i mea o n s ure d by f l o w c y t o m e t r y<br />

Meth od ol o gi cal vari at i on i n l ymp h oc yte p ercen tages was as s es s ed in th ree p relimi n ar y<br />

b lood s amp l es fr om on e vol u n teer. Nin e s amp le tu b es <strong>of</strong> b lo od were t aken at each t ime p oin t ,<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 7 - I m p e r i a l o C n o d l o n l e g e L<br />

F S C


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

a n d a s s e s s e d f o r p e r c e n t a g e s o f c e l l s e x p r e C s D s i 4 5 n g<br />

+ C D 3 - C D 5 6 + (h e n c e f -cells) o r t an h d N K<br />

C D 4 5 + C D 3 + C D 4 + + + +<br />

( 4 C D T-cells) a n d C D C 4 5 D 3 C D 8 ( C D 8 T-cells).<br />

F l u o r e s c e n t l y c o n j u g a t e d s D8 i n , Cg D4 l 5 e , C D5 a 6 n an t d i C D1 b o 6 d i e s o f C D<br />

[Bect on Di cki n s on , Oxf ord , U. K. ] wer e u s ed t o d e t e r m i N n K e c e l l (C s yt ot oxi c an d R egu lat or y<br />

N K -c e l l s u b s e t s )<br />

a n d -l y m T p h o c y t e s ( 4 C D -c T e l l s a n -c d e l l C s ). D C8 el l sT amp les were<br />

m e a s u r e b d y a FAC SC al ib u r fl o w c yt o m eter [B e c t o n D i c k i ] n s a o n d th e d at a gen erat ed b y fl ow<br />

c y t o m e t e r w e r a e n a l y s e d b y a C e l l Q u e s t . s o f t w a r e<br />

M e a n s a n d r a n g e s w e r e w i t h i n n o r m a l [ H l i a m n n i e t s e t a l . , 1 9 9 an 2 ] d s tand ard d evi at ion s<br />

were cal cu lat ed in in d ivi d u al o c c a s i o an n d in tot al [T a b l e 6].<br />

Table 6: M e a n p e r c e n t a g e s a n d c o u n t s ( s t a n d a r d d e v i a t i o n : S <strong>of</strong> D N ) K -c e l l s, C D 4 and C D 8 T-ce lls and<br />

t ota l lymp ho c yt e c ount s us ing a s in gle vo lu nt e e r ( 9 t ube s co lle c t ed a nd a ve r a ge d on 3 s e p a r a t e o c c a s i o n s )<br />

NK % C D 4 % C D 8 % N K count CD4 count CD8 count T ot a l l ym p h c o u nt<br />

( S D ) ( S D ) ( S D ) ( S D ) ( S D ) ( S D ) ( S D )<br />

T ime 1.<br />

T ime 2.<br />

T ime 3.<br />

T o t a l m e a n<br />

( S D )<br />

9.7<br />

(0.54)<br />

8.3<br />

(1.31)<br />

14.3<br />

(0.72)<br />

10.77<br />

(0.86)<br />

48.1<br />

(0.97)<br />

46.8<br />

(0.89)<br />

44.4<br />

(0.52)<br />

46.4<br />

(0.79)<br />

29.6<br />

(0.73)<br />

28.8<br />

(0.33)<br />

28.2<br />

(0.60)<br />

28.9<br />

(0.55)<br />

94.8<br />

(9.3)<br />

65.6<br />

(12.6)<br />

130.3<br />

(8.7)<br />

96.9<br />

(10.2)<br />

438.4<br />

(12.7)<br />

346.1<br />

(10.7)<br />

381.0<br />

(36.4)<br />

388.5<br />

(19.9)<br />

270.0<br />

(11.3)<br />

894.3<br />

(32.0)<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 8 - I m p e r i a l o C n o d l o n l e g e L<br />

213.4<br />

(9.8)<br />

249.3<br />

(11.6)<br />

244.2<br />

(10.9)<br />

712.6<br />

(36.2)<br />

859.2<br />

(33.6)<br />

822.0<br />

(33.9)<br />

H e n c e , l a l c h a n g e s i n p e r c e n t a g e s o f N K c e l -cells l s , a n d C C D D 4 8 -c T e T l l s mo r e th an<br />

twice <strong>of</strong> s tan d ard d evi at ion s in total mean s , i.e. 1 . 9 0 , 1 . a n 5 d 1 8 . 1 res 0 p ect ivel % y, were<br />

con s id ered as in o u t o f t h e 9 5 % c o n f id e n t i n t e r v a l. C h a n g e s i n e a c h -p c op e l u lat l ion s u mb ore<br />

t h a n t h e s e p e r c e n t a g e s a r e c o n s i a d e dr ifferen e d a ce b et ween s amp les , an d th e s tatis tical<br />

a n a l ys e s a r e p e r f o r m e d w i t h t h i s c o n s i d e r a t i o n i n t h e c u r r e n t p r o j e c . t<br />

2 . 4 . 2 . C 2 o l o r i m e t e r<br />

T h e c o l o r i m e t e r i s a n a p p a r a t u s t h a t a l lo ws th e ab s orb an ce <strong>of</strong> li gh t at a p arti cu lar w a v e -<br />

len gth or f r e q u e n c y lour) ( c o o f vi s u al li g h t to b e d etermin ed . Dif feren t ch emi cal s u b s tan ces<br />

ab s orb var yi n g f req u en ci es <strong>of</strong> th e vis ib le s p ectru m. C olo ri mete rs rel y on th e p rin cip le th at th e<br />

a b s o r b a n c e o f a s u b s t a n c e i s p r o p o r t i o n a l t o i t s c o n c e n t r a t i o n , i . e . a m o olu r e tion c o n c e n t r a t e d s<br />

gives a h i gh er ab s orb an ce r ead in g.<br />

A q u an t i t at i ve r ead i n g f or t h e c on cen tration <strong>of</strong> a s u b s tan ce can b e fou n d b y makin g u p a<br />

s eries <strong>of</strong> s ol u t i on s <strong>of</strong> kn own c on cen tratio n <strong>of</strong> th e ch emical u n d er s tu d y, an d p lottin g a grap h o f


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

a b s o r b a n c e a g a i n s t c o n c e tion n t r . a B y r ea d in g th e ab s orb an ce <strong>of</strong> th e s p ecimen s u b s tan ce on th e<br />

grap h , a val u e f or i t s c on cen tration is f ou n d .<br />

M e t h o d o f t h n e z y e m e l i n k e d i m -s m o u r n b o a n t a s s a y ( E L I S A ) [ V o l l e r , 1 9 7 8 ]<br />

T h e E L I S A i s i d e a l l y s u i t e d t o a s s a y i n g p r o t e i n f a s c t b o ur t can s e . b e g . ad ap h o tr ed m o n e<br />

to me as u re s mal l mol e cu l es as well. In t h e c u r r e n t p r o j e c t, v ariou s c om merciall y a vailab le<br />

E L I S A k i t [iDS s U. K. , h t t p :/ / w w w . i d s l t d . c o m /] a n d C y t o T o x ® 9 6 [P rome ga U . K.,<br />

h t t p :/ / w w w . p r o m e g a . c o m /] were p u rch as ed an d u s ed for meas u remen ts <strong>of</strong> th e h o r mon e le vels<br />

an d LD H l e vel s t o d et er mi n e th es e con ce n tration s .<br />

2 . 4 . 3<br />

M e t h o d s in vitro [S e e a l s o A p p e n 4. d i f o x r d e t a i l e d p r o c e d u r e s ]<br />

2 . 4 . 3 1 P r e p a r a t n i o f t i s s u e c u l t m u r f or e cel m e l d cu i lu tu re i n v i t r o<br />

T i s s u e c u ( T l C M t ) wa u s r u s e d f o m r i n e c u d b a i t i o n u o m f c e l l s i n t h e p r o j e c t. It c o n s is ts<br />

<strong>of</strong> R P M I 1 6 4 0 s up p l emen t ed with 1 % glu tamin e (2 0 0 mM), 1 % p en icillin (5 00 0 IU/ml)/<br />

s t r e p t o m y c i n ( 5 0 0 0 m c g / m l ) , 1 % H e p e s -es sb en u f ti f al e ami r , n o 1 % aci dn s o (1 n 0 0 x), 1 %<br />

s od iu m p yru vat e (1 0 0 mM).<br />

Co r t i s o l l e l v in th e t i s s u e c u l t u r e m e d i u m<br />

In ord er t o s u p p l y es s en t i al n u trition for c ell cu ltu re, 1 0 % Fetal C al f Seru m ( FC S :<br />

S i g m a ® ) w a s a d d e d ( T C i M n ) wh en t cel i ls s were s u in cu e b ated c i u n l v i t . t r u o r e m e d i u m<br />

E LI S A a s s a ys s h o w t h a t t h e t i s s u e c u l t u r e m e d i u m c o n tai n in g 1 0 % FC S con tain s 5 .9 n M<br />

c o r t i s o l ; a n d t h i s w s m a s a l l i n c o m p a r i s o n t o t h e a m o u n t o f c o r t i s o l in f o th u e n d 3 4 i n p l a s m a<br />

volu n teers (2 9 .5 - 265 . 8 n M ; m e a n 1 3 1 . 8 , S D = 5 0 [Fi . 3 ) gu re 1 1 ].<br />

3 0 0<br />

2 5 0<br />

2 0 0<br />

1 5 0<br />

1 0 0<br />

5 0<br />

0<br />

F i g u r e 1 1: I n d i v i d u a l c o r t i s o l l e v e l s i n t h e t i s s u e c u l t u r e m e d i u<br />

m ( l e f t : 5 . 9 n M )<br />

an d in p l as ma from 3 4 vol u n teers ( righ t : 2 9 .5 - 265 . 8 n M)<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 6 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

Th e l e v e l o f c o r t i s o l i T n was C t M h e low , an d th ereaft er in th is th es is , TC M on l y was<br />

con s id ered to b e c o r t i s o l e. f r e<br />

2 .4 .3 .2 N K c y t o t o x i c a c t m i e a v i s u t r y e d f b y l o w to metr c y y [ G o d o y-R a m i r e z e t a l . , 2 0 0 0 ]<br />

De t a i l e d p r o c e d u r are e s giv en in th e Ap p en d ix 4 .<br />

E ffect or cel l s (P B M Cs ):<br />

P e r i p h e r a l v e n o u s s b a l m o p o l s d e w e r e c o l l ue s in c t g e Vacu d tai n ers [Bect on Dickin s on ,<br />

Oxf ord , U. K.]. Hep ari n i zed b lood was c e n trifu ged (1 5 0 0 rp m for 1 0 min u tes at r oo m<br />

temp erat u re). Th e p l as ma w as re mo ved a n d th e b lood p ell et recon s titu ted b y th e a d d ition <strong>of</strong><br />

R P M I 1 6 4 0 . T h i s w t a h e n m i x e d a n d o v e to r Lymp l a i d h op o n rep . P B MC were rec ove red fr om<br />

th e in terface aft e r cen t ri fu gi n g (1 5 0 0 rp m) f or 3 0 min s at r oo m te mp eratu re [ B o y u m , 1 9 7 4 ].<br />

Viab ilit y was as s es s ed an d ad ju s ted b y d ye ( Eos in 0 .0 5 % ) exclu s ion .<br />

Th e s ep arat ed effect or cel ls (P BMC s ) b y L y m p h o P r e ® p were was h ed twi ce an d<br />

s u s p e n ded in th e TC M ; t h 1e 0 n l o f a n t i-h u man C D4 5 mon ocl on al an tib od y d irec tl y<br />

c o n j u g a t e d w i t h f l u o r e s c e i n i ns at o t e h ( FITC i o c y a ) was ad d ed an d i n c u b a t e d f o r minut 2 0 e s.<br />

T h e s e c e l l s w e r e w a s h e d after a g a i th n e , las t a was n d h , con cen tration <strong>of</strong> cells was as s es s ed b y<br />

6<br />

cou n tin g cel ls wi th d y e e x c l u s , i o a n d t h e c e l l c o n c e n t r a t i o n a d j c u e s l t l / s e ml d bt y o 5 x 1 0<br />

ad d in g TC M p r i o r t o m i x i n g w i t h t a r g , e t i c e . l e l . s K 5 6 2 c e l l s , f o r . t h e N K C A a s s a y<br />

T a r g e t 5 6 2 c e l l l i n l e ) : s ( K<br />

K5 6 2 h aemat op oi et ic tu mou r c ells s erv ed as th e target cell f o r d e t e r ing m i Nn K c yt ot o xi c<br />

a c t i v . i t K y 5 6 2 c e l l s a r e e a r y t h u h m r o a m n y e l o c y t i c l e u k a cell e m i lin a e, wh ich ma y tran s fo rm if<br />

a l l o w e to d o v e r g r o w r e s u l t i n g i n l o s i n g t h e i r s e n s i t i v i ty t o b e -cells k i . l Hen l ce, e td h e b y N K<br />

K5 6 2 cel l l i n e s h ou l d b e ren ewed ever y o n e to two m on th s , b y s tartin g with a n ew b atch <strong>of</strong><br />

frozen c el l s fr om t h e l i q u i d n itrogen freez er.<br />

In o r d e r t o m a i n t a i n a r e a d y s u p p l y o f c e l l s i n t h e o p t i m a l g r o w t h p h a s e f o r h e t N KC A<br />

a s s a y , o p t i m a l d u r a t i o n a n d c o n c e n t r a t i o n o f K 5 6 2 c e l l s d u r i n g c e l l c u l t u r e<br />

d e t e r m ing i n th e gr owt h ch aract e ri s ti cs <strong>of</strong> th is cell lin e.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 0 - I m p e r i a l o C n o d l o n l e g e L


Cell numbers per mL (in Log-scale)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

G row th ch a ra cteri s ti cs <strong>of</strong> K 5 6 2 cell line u s e d a s t a r g e t s f o r a s s e s s i n<br />

K5 6 2 cel ls s h ou ld b e i n t h e l o g a r i t h m i c g r o w fo t r h p e t h a s e u s e o as sf a y, as N cel K C ls A<br />

i n t h e e a r l y ( d e v e l o p i n g ) a n d l a t e ( s a t o u f r t a h t e i e r d ) e v p e h l o a p s m e e n t ar e res is ta n t to killin g.<br />

K5 6 2 cel ls (r e c o v e r e d f r o m f s a r m o p z l e n ) w e r e c u l t u r t e v d a r a i o u s s e e d i n g c o n c e n t r a tion s <strong>of</strong><br />

4 5 6<br />

1 . 5 x , 1 0 1 . 5 x a 1 n 0 d 1 . 0 x c e 1 l 0 l ps er ml in 1 0 ml fl as ks wi th tis s u e cu ltu re m ed iu m, an d<br />

o<br />

each f l a s k w a s p l a c e d C a t i 3 7 n a 2 h u mid 5 % ifi ed C in O cu b at or fo r 3 d a ys . Th e K5 6 2 viab le<br />

cell con cen t rat i on i n each fl as k w as as s es s ed on Da y 0 , 1 , 2 , an d 3 an d s imu ltan eou s l y th e<br />

p e r c e n t a g e o f d e a d c e l l s w [ a Figu s m re e 1 a 2 s ]. u r e d<br />

1 00 00 00 0 0<br />

1 0 00 00 0 0<br />

1 00 00 0 0<br />

10 00 0 0<br />

1 00 0 0<br />

F i g u r e 12a: T h e g r o w t h r a t e c u r v e o f K 5 6 2 c e Fi l l gu s r e 12b: T h e de a d c e l l % o f K 5 6 2 c e l l s<br />

( T h e r e d l in i n F e i g u r e b 1 i 2 n d i c ates th e ma ximum a c c ept ab le le ve l <strong>of</strong> dead K562 cell s)<br />

4 5 6<br />

Fi gur e 12: K5 62 ce ll gr owt h a t s t a r t i n g c e l l c o n c e n t r a , t 1.5x10 i o n s and o f 1.0x10 1 . 5 x 1 0 c e l l per s mL<br />

Fi gu re 1 2 a s h ows th at fr om Day 0 t o 3 , t h e K 5 6 2 c e l l s w -g e rowth r e i pn h as t e h e l o g<br />

r e g a r d l e s s o f s e e d i n g c o n c e n t r a t i o n . T h e t cell h i g h con e s cen trat ion s wer e ob tain ed with a<br />

5<br />

s e e d i n g c o n c e n t r a t i o n o f c e 1 l . l ps 5 er x mL. 1 0 F i g u r e 1 2 b i l l u s t s r th a t at e th e lowes t<br />

5<br />

p e r c e n t a g e d e a d c e l l s w a s o b t a i n e d w i t h a s e e d i n g c o c n e l c l e ps n er t r mL. a t i o n o f 1 . 5 x 1 0<br />

H e n c e , i t c a n c o n b c e l u d e d t h a t t h e c e ls s h ou ld b e p as s ed ever y two t o th ree d a ys a t<br />

5<br />

a p p r o x i m a t e l y 1 . 5 cells x p1 er 0 ml o f c u lt u re in TC M s u p p lemen ted with 1 0 % foetal cal f<br />

s eru m.<br />

K562 growt h curve i n cul t ure<br />

N K C A as s ay proc e du re:<br />

1.5x10^4 cells/ml<br />

1.5x10^5 cells/ml<br />

1.0x10^6 cells/ml<br />

da y0 da y1 da y2 da y3<br />

Dead cell percentages<br />

D e a d K5 6 2 % i n c u l t u r e c o n d i t i o n<br />

Effect or an d target c el ls , i .e. f r e s h P B M C s a n d K 5 6 2 c e l l s , w e r e a d d e d 12 i n d u p l i c a t e<br />

x 7 5 m m r o -b u n otto d m tu b es [Bec k Di c k in s on , Oxf ord , U. K.] t o yield th e Ef fecto r to T arg et<br />

(E :T) rat i o o f 5 0 :1 , 2 5 :1 , 1 2 .5 :1 in 2 0 0 l. C on trol tu b es were s et u p with o n l y ta rg et or effe ctor<br />

cells for d e t e r m ing i n s p o n t a n e o u s c e l l r a d t e a s. t h T u b e ix s ed b y w gen e tl r y te ap p in g, m an d<br />

1 00<br />

80<br />

60<br />

40<br />

20<br />

0<br />

1.5x10^4 cells/ml<br />

1.5x10^5 cells/ml<br />

1.0x10^6 cells/ml<br />

Da y 1 Da y 2 Da y 3<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

in cu b at ed at 37 °C for t h ree h ou rs (in th e u n ivers it y s tu d en t s tud y) or f ou r h ou rs . After<br />

in cu b at i on , t h e t ub es were p laced on ice u n til an al ys ed . Twen t y mic roliters <strong>of</strong> p ro p id iu m iod id e<br />

( P I ) , w h i c h s t a i t n h s e n u c l eu s o f d e a d c e l ls , w e r e a d d e d t o e a c -1 h 5 min t u b ue tes 1 b0 efore<br />

acq u is it i on .<br />

F l o w c y t o m e t r i c a c q u i s i t i o n :<br />

Fl ow c yt o met r y was p er for med with a FAC S C alib u r c yt om eter [B e c k D i c k i n ]. s o Th n e<br />

i n s t r u m e n t w a s s e -c t o l f o u r t a w n a o l y s i s u s i n g F A C S c o m p s n o f j t w u a n r e c ith t i n i c o n w<br />

C alib rit e b ead s [B e c k D i c k i n ]. s o D n a t a w e r e c o l l e c t e d i n l i s t m o d e a n d a n a l y s i s w or a s med p e r f<br />

u s in g C el lQu es t s <strong>of</strong>t ware [B e c k D i c k i n ]. s o A n re gi on was s et on a d ot p lot <strong>of</strong> SSC vs .<br />

f l u o r e s c e n c e 1 (FL-1 : C D 4 5 ) a r o u n d t h e c l u s t e r o f t a r in g e th t e con c e l trol l s a mp i d e le n t i f i e d<br />

t u b e s a n d p e r c e n t a g e s o f P -s I t a i n e d c e l l n u m b e r<br />

calcu lat ed b y s u b t ract i on <strong>of</strong> ta rget total fr om in d ivid u al totals [Fi gu re 1 3 ].<br />

i n t h e r e g i C o A n was w e r e c o u n t e d<br />

Fi gur e 13a: K 5 6 2 c e l only l s t ub e a c qu is it ion Fi gu r e 13b: P B M C s o n l y t u b e a c q u i s i t i o n<br />

Fi gu r e 13d: K 5 6 2 h i s t o g r a m b y P I s t a i n i n g<br />

(M 1 : P I s t a i n i n g p o s i t i v e c e l l s )<br />

Fi gur e 13c: t e s t i n g t u b e ( m i x e d w i t h K 5 6 2 a n d P B M C s ) a c q u i s i t i o n<br />

Fi gur e 13: A c q u i s i o n s e t t i n g s f o l o f w t c h yt e o m e te r f o r m e a s u r i n g t h e f l e v e C N l A K s o<br />

A r e gio n s e t t in g ( R1) f or K562 [Figu r e 13a,b] and a p r o c e s s o f d e a d K 5 6 2 [Figur d e t e e c t 13c] i o n<br />

f o l l o we d b y h i s t o gr a m p e r c e nt a ge a na l ys i s ( co u n t in g PI st a ine d ce ll n u mb e rs ) [Figu r e 13d]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 2 - I m p e r i a l o C n o d l o n l e g e L<br />

M 1


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P recis ion <strong>of</strong> le vel s in th e N K c y t o t o x i c a c t m i e v a i s u t r y e d b y fl o w c y t o m e t r y<br />

Meth od ol o gi cal vari at i on i n N K c ytot oxi c activit y was as s es s ed in p relimin ar y b l o od<br />

s a m p l e s f r o m t h r e e v o l u n t e e r s , . an d al T l nh in r e e e s a m p<br />

s amp les were d u p li cat ed to meas u re N K c ytot oxic activit y. Ch a n g e s i n t h v e e l s e o f N K C A<br />

mor e th an t w i c e o f s t a n d a r d d e v i a t % i o k n i s l ) l ( we i 1 . r n e g 4 4 c o n s i d e r e d a o s u t o f t h 9e 5 %<br />

c o n f i d e n t i n t e r v a l. C h an ges in N KC A l e v e l m o r e t h 1 a . n 4 w 4 e r e c on s id ered as a d ifferen ce<br />

b e t w e e n s a m p s l , e a n d r e s u l t s f r o m t h a e l y s t e a s t i w s e t r i e c a e l x a m a n i n e d w i t h t . h i s d e f i n i t i o n<br />

2 .4 .3 .3 N K -ce l l c h a r a c t e r i s t i d c u s r i n g N K C A a s m s e a y s u r e d b y f l o w c y t o m e t r y<br />

E xpr es s ion o f Na t u r a l c y t o t o x i c r e c e p t o r ( N C R m ) e a s u r e d b y f l o w c y t o m e t r y<br />

Ce l l s u r f a s pc erf e or med s t b y a in cu i bn at i n g n with g 5 w l <strong>of</strong> p articu lar mon oclon al<br />

an tib od i es for 1 5 mi n at r oo m te mp eratu r e in th e d ark. T h e a n a l y s i s o f n a t u r a l c yt o toxic recep to r<br />

(N C R s : N k p 3 0 o r N ) k w p a 4 s 6 p e r f o r m e d u s i n g f o u -c r olo r fl ow c yt o met ri c acq u is ion an d<br />

Flo w J o ® f l o w c y t o m e t r y a n a l y [Figu s e s r e 1 4 ].<br />

FL-3: CD56-CyChrome staining<br />

Whole<br />

lymphocytes<br />

Gated NKC<br />

sample<br />

C D 3 - C D 5 6 +<br />

( N -c K e l l s )<br />

F L -4 : C D -A 3 P C s t a i n i n g<br />

F i g u r e 1 4 : a C D 3 - C D 5 6 + N K -cells in dot plot<br />

N C R s ( + ) %<br />

F L -1 : C D 1 -F 6 I T C s t a i n i n g<br />

Fi gur e 14: Ac quis ion s e tt ings <strong>of</strong> t h e f l o w c y t o m e t e in r t h e N C R a n a l y s e s<br />

C D 5 6 b r i g h t C D 1 6 -<br />

R e g u l a t -c e o ll s r y N K<br />

C D 5 6 dim C D 1 6 +<br />

C y t o t o -c x e l i l s c N K<br />

F L 2 : N k p 3 0 o r N k -P p 4 E 6 s t a i n i n g F i g u r e 1 : 4 NK-s b ub s et s <strong>of</strong> C y t o t o x i c a n -c d e l l s R i n e d o g t u p l ot l a t o r y N K<br />

F i g u r e c 1 : 4 P p e r c e n t a g e o f N C R e x p r e s s i o n s<br />

A regi on was s et on a d ot p l ot o f FL-3 (C D5 6 ) vs . FL-4 (C D3 ) to t arg et C D 3 - C D 5 6 + N K -<br />

cells [F i g u r e a], 1 4 an d fu rt h er re gi on s f or N K s u -p b o p u l a t i o n s e w r e d e t e r m in ed b y a d ot p lot <strong>of</strong><br />

FL-3: CD56-CyChrome staining<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

d i m<br />

FL-3 (C D5 6 ) vs . FL-1 ( C D 1 6 ) [Fi gu re 1 4 b : C D 5 6 C D 1 6 + Cyt ot oxi c an d C D 5 6 b r i g h t C D 1 6 -<br />

Re g u l a t -c o e l r l s y u b s e N ]. t s K Th e p ercen tage e xp res s ion s <strong>of</strong> NC R s were th en me as u red as a<br />

p ercen tage o f FL-2 ( N C R s ) p o s i t i v e c e l l s w i t h i <strong>of</strong> n a t s el h ect e ed p o re p u gi l oa n t (C i o yt n ot oxic<br />

o r R e g u l -c a e l t l s o ) r h is b y to y gra N m K [Fi gu re 1 4 c : p e r c e n t a g e o f c e l l s N e C x R p r s]. e s s i n g<br />

2 .4 .3 .4 P rol iferat ive res p on s e m e a s u r e d b [ y<br />

3 H ] -t h y m i d i n e i n c o r p o r a t i o n<br />

P B M C c u l t u r e s w i t h s t i m u l u s :<br />

P e r i p h e r a l b l o o d m o n o n u c l e a r c (P e l BMC l s s ) were cu lt u red wi th microb acte rial p rotein<br />

(p u rified p rot ei n d eri vat i ve : P P D) an d Herp es an tigen (me mo r y recall an ti gen s ) f or 6 d a ys in<br />

t i s s u e c u l t u r e m e d i u m ( T C M : c o n t a i n i n g 1 0 % f e t a l calf s e ru m) with /ou t co rtis ol [h yd r oc orti s on e,<br />

S i g m ] a t ® o m e re a s l ymp u h oc yt e p rol ife r at ive res p on s es . In ad d ition , T h r e e d a y c u l t u s r with e 1 )<br />

Staphy l o c o c c a l e n t e r o t o x i n B ( S E B u ) s e d a s a s t i m nt, u l a s u p e r a n t , wh i g ich e n ca n s ti mu lat e<br />

b o t h n a ï v e a n d m e m o r y c ; e l a l n s d 2 ) P h yt oh aema ggl u ti n in A (P HA) ch os en as a mi togen wh ich<br />

s t i m u l a t -cells e s an a d l th ereb l y T a ct s as a p os itive c on trol fo r p roli ferati ve res p on s es .<br />

Whole B loo d C e l l c u l t u r e ws ith s ti mu l us [ H u t c h i n s o n e t a l . , 1 9 9 [See 9 ] al s o Ap p e n d i x 4 ]:<br />

T h e w h o l e b l o o d a s r s meas a y uf ri o n g p r o li ferat iv e res p on s es was ap p lied in ord er t o<br />

red u ce cel l h an d l i n g an d man ipu lation . In b rief, wh ole b lood (d ilu ted 1 /4 ) was in cub ated for 3<br />

d a ys wi th 1 2 .5 g / m l o f SE B, s u p e r-a n t i g , e or n 1 2 .5 g/ ml <strong>of</strong> P H A, m i t o , g to e n m eas u re<br />

l ym p h o c yt e p r o li f e r a t i v e r e s p o n . s e Ps HA or S E B were in cu b at ed with 1 :1 0 d ilu ted b lood with<br />

o r w i t h o u t 2 5 0 -s h a n p e M d w c e l o l r p s l t in a t i tot e s al o am l ou n t <strong>of</strong> i 2n 0 0 9 L, 6 a n d in U cub ated<br />

0 , 2 4 a n d 4 8 h o u r s f ol l o w e d t b h y e [ 3 H ] -t h ymi d in e in corp orati on as s a y.<br />

[ 3 H ] -t h y m i d e i n i n c o r p o r a t i o n<br />

T h e p l a t e s w e r e i n n c a u b 2 ha 5 u mid t % e ifi d C ed O at a mos t p h3 ere, 7 ° an C d th e cells were<br />

p u ls ed wi th 1 C i t r i t i u m [ m e h yl- 3 H ] T h y m i d i n e ( [<br />

3 H ] -T d R ) p er w e l l f o r las t h t e f ou r h ou rs o f<br />

in cu b at ion . Th e s u p ern at an ts were h arves ted u s in g a S k a t n r AS o Har ves ti n g s ys te m [S h atr on ,<br />

3<br />

S u f f o l ] k a n d t h e a m o u n t o f H] [ in corp o r at ed wi th th e cells d etermin ed on a Walla c 1 2 0 5 Liq u id<br />

scintillati on C ou n ter [P h a r m a c i a , B e c ]. k s R es u lt s were p res en ted as cou ts p er min u tes (cp m).<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 4 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 .4 .3 .5 T-ce l l c h a r a c t e r i s t i c s te a f r i n v i t i r n o c u b a t i o n m e a s u r e d b y f l o w c y t o m e t r y<br />

C e l l p r e p a r a t i o n f o r p r o l i f e r a t i o n a n a l y s e s<br />

5<br />

P r e v i o u s l y t i t r a t e d c o n c e n t r a t i o n o f P P D o r H e r p e s a n t i g e n w a s i n c u b a t e d<br />

cells p e r m L P B M C s in total a mou n t o f 1 .2 m L p e r w e l l 2 4 i wel n l cu lt u re p l a t e s /ou w i t 2h 50<br />

n M c o r t i s o l. 1 2 .5 g / m L o f P H A o r S E B w e r e i n c u 1 b : a 1 t 0 e d i w l i u t h e d b l /ou o o t d 2 50 w i t h<br />

n M cort is ol in 2 4 -s hU ap ed w e l l p l s a in t e tot al a mou n t 1 .2 m L, an d in cu b ated f o r 0 , 2 a 4 n d 4 8<br />

h ou rs . T h e p l a t e s w e r e i n c 2 u h u b m i a d t i f e i e d a t a m o t s p a h n e d 3 r , e th 7 e n ° cel C ls i n a 5 % C<br />

were a l l o c a t d e i n t FAC o S 1 2 x 7 5 r ou n d b ot tom tu b es [Bec k Dic kin s on , Ox ford , U. K.] b ef ore<br />

f o l l o w i n g p r o c e d u . r e s<br />

S t a i n i n g c e l l s u r f a c e m a r k e u r p s o n T-l y m p h o c y t e -p s o p u b l a t i s o n<br />

Ce l l s u r f a s p c e r e f o r m e s d t b y a in cu i bn at i n g n with g 5 w l <strong>of</strong> p articu lar mon oclon al<br />

a n t i b o d i e s f o r 1 5 m i n a t r o o m t e m p e r a t wh u r ol e e bi ln o od t as h e s a y, d a er r yt k . h roc I ytes n<br />

were l ys ed for 2 0 mi n wi th 1 ml <strong>of</strong> 1 0 x d ilu ted l ys in g s ol u tion [B e c t o n D i c k i ] n in s o th n e d ark.<br />

I n b o t h m e t h o d s , c e l l s w e r e w a s times h e d wi t h tr h e te h e TC M an d fi xed in 1 0 0 l <strong>of</strong> 4 % o f<br />

p a r a-f o r m a l d e h y d e i n P B S ( f i x a . t i o n b u f f e r ) f o r 2 0 m i n<br />

E x p r e s s i o n o f C D 2 5 -l y o m r p h o C c y D t 9 e 5 s m u e p a s o u n r e d T b y f l o w c y t o m e t r y<br />

C e l l s a m p l e s w e r e r u n o n a F A C S C a l i b u r f l o w c y t o m ) e an t d e r ( B e c t o n D i c k i n s o<br />

an al ys ed b y C el lQu es t s o ft ware . C D 3 -C y -C h r o m e ( -3 F L ) a n d C D -A 8 P C ( -4 F L ) fl u ores cen t<br />

c o n j u g a t e d a n t i b o d i e s w e r e u s e d t o l a b -p e l o p u l y a t m i p o h n o ( s c C y D t 3 e s u b<br />

+ C D 8 + T-c e l l s an d<br />

C D 3 + C D 8 - +<br />

T-c e l l s a s C D T-c 4 e l l s ). At l e a s t 5 0 0 0 e v e n t s i n t h e l i g h t-s c a t t e r ( FSC /SS C )<br />

l ymp h oc yt e re gi on we re acq u ired . E a c h ly m p h o c y t e s -p u o b p u l a t i o n a w s i d e n t i f bi y e a d g a t e on<br />

FL-3 vers u s FL-4 d o t p l o t s , -C i . D e 8 . s c a C t D t e 3 r d o t p . l T o t h s e F -f I l u T o C r e s c e n c e i n t e n s i t i e s<br />

(FL-1 ) o f C D o2 r 5 C D 9 5 -l ab el led l ymp h oc yte p op u lation s an d is ot yp e c on trol s w ere d is p la yed<br />

a n d d e t e r m i n e d a s m e a n c h a n n e l v a l u e s o n a -d f o e u c r a d e l o g s c a l e i n h i s t o g r a m . p l o t s<br />

T h e r e l a t i v e q u a n t i t oy r Co D9 f 5 C exp D 2 5 res s ion was calcu lated b y th e p ercen ta ge o f<br />

c e l l n u m b e r s i n t h e p o s i t i v e i n t e n s i t y n flu a r or e a es , cen a n ce d im n te en a s it y (m. f.i. ) was<br />

c a l c u l a t e d a s t h e d i f f e r e n c e b e t w e e n m e oa r n C D9 v a 5 l an u e d s is ot o f yp e C cD on 2 t5 rol lab elled<br />

T M<br />

s a m p l e s . T h e i n s t r u m e n t c a l i b r a t i o n w a s p e r f o r m e d b y C e l l<br />

b ead s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

E xpr es s ion o f Annexin V- PI o n -l y T m p h o c y t e s m e a s u r e d b y f l o w c y t o m e t r y<br />

Th e A n n -F e I x i T C n ( -1 F L ) V a n t i b o d y & p r o p i d i u m i o d i n e : ( P I -3) F L s tai n in g met h od for<br />

d etecti on <strong>of</strong> ap op tos is was u s ed to d eter m in e th e effect <strong>of</strong> c ortis ol u p o n a p o p t o t i c p r o c e s . s e s<br />

Fo u r -c o l o r f l o w c y t o m e t i r s i c o n a c q lo a u n w d J o ® F f l o w c y t o m e t r y a n a l y s w e e s r e p e r f o . r A m e d<br />

r e g i o n w a s et on a d ot p lot <strong>of</strong> SS C vs . FL-2 ( C D -P 3 E ) t o t -l a ymp r g he oc t yt es T , a n d fu rt h er<br />

p e r c e n t a g e s o f n e c r o t i c c e l l s , a p o p t o t i c c e l l s a n d l i v e d c e bl y l a s d ow t e pr lot e <strong>of</strong> d e FL- t e r m i n e<br />

3 (P I) vs . FL-1 ( An n exi n V) [Figu re 1 5 ].<br />

Side Scatter (SSC)<br />

W h o l e l y mp h o cytes<br />

F L -2 : C D 3 s t a i n i n g<br />

F L -3 : P I s t a i n i n g<br />

Fi gur e 15b: s e t t -up i n a g re gio n f or a popt ot ic c e lls<br />

u s i n g n e ga t i ve i s o t yp e c o nt r o l i n a d ot p l o t<br />

Fi gur e 15: Ac quis ion s e tt ings <strong>of</strong> the f l o w c yt o m e ter i n t Annexin h e V- P I a n a l y s i s<br />

A regi on was s et on a d ot p lot o f FL-2 ( 3) C vs D . SSC t o tar get T-cells ( F i g u r e a ) fr 1 om 5<br />

w h o l e l ym p h o c yt e s g a te d b y t -S C h C e p l F o S t C p r e v i , an o u d s fu l y rt h er r e g i o n s f o r a p o p t o t i c<br />

cell s u bs e t s e w r e d etermi n ed b y a d ot p lo t <strong>of</strong> FL-3 (P I ) vs . FL-1 (A n n e x ) i ( Fig n u re V 1 5 c:<br />

FL-1: Annexin V staining FL-1: Annexin V staining<br />

( g a t e d b -S y S C t p l o h t ) e F S C<br />

T-l y m p h o c y t e s<br />

Fi gur e 15a: a r e g i -c o e n l l s i f n a o d r ot p T l ot<br />

Ne gati ve c ont r ol<br />

( f o r g a t i n g p u r p o s e )<br />

Apopt ot i c<br />

c e l l s<br />

L i v e c e l l s<br />

Apopt ot i c<br />

cel l s<br />

L i v e c e l l s<br />

N e c r o t i c c e l l s<br />

E x p e r i m e n t s a m p l e s<br />

N e c r o t i c c e l l s<br />

F L -3 : P I s t a i n i n g<br />

F i gur e 15c: a r e gi o n f o r a p op t ot i c ce l l s i n a do t p l o t<br />

+ - +<br />

ap op tot ic ( A n n e x & i P n I ) a n V d n e c r o t i c c e l l ( P ) I s u b s et s i n t -l h y e m p h T o c y t e s ). F i g u r b e 1 5<br />

s ho w s t h e m e t h o d -u s e p t for t i th n e g re gi o n <strong>of</strong> ap op tot ic cells b y u s in g n egati ve is ot yp e con tr ols .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2.5 S t a t i s t i n c a l ys e s a<br />

All p s ych ol o gi cal an d p h ys iol o gical lab o r ator y s amp les we re a n o n ym i s e an d d p roc es s ed<br />

u s i n g a n a ss ign ed s tud y n u m b e r to e n s u r that e t h e a n a l y s e ws ere p e r f o r m e d b l i n terms d l y <strong>of</strong> i n<br />

t h e g r o u p s a s n u d b gr o u ps t w o h i c h t h e s a m s p b l e l o n g . t o<br />

T o e x a m i n e t h a e p r i o r i h yp ot h es is th at p s ych olo gical in ter ven tion ma y c ou n teract th e<br />

d e t r i m e n t a l e f f e c t o f s t r e s s o n w e l l-b e i n g , -t o r e n a t m e n t a n a l ys is (a n a l ys i s <strong>of</strong> res u lts fr om on l y<br />

th os e wh o co mp let ed th e tri al) was p erf or med . W h e n statistical d i f f e r e es n c w e r e f o u n d in th e<br />

p r i m a r y o u t c o m e m e a s in u r u e n i v a r i a t a e n a l y s e s , I n -t t e o-t n r t e i a t o n a n a l y s w i s a s p e r f o r m in e d<br />

o r d e r t o c o n f i r m t h e r e s u l t s . T h e i n te n t i o -t n o-t reat is th e an al ys is <strong>of</strong> res u lts fro m e v er y s u b ject<br />

en rolled i n t h e t ri al re gard l es s o f wh eth er th e y co mp leted th e trial, an d all in d ivid u al s wh o<br />

w i t h d r e w w e r e c o u n t e d i n t h e n u m b e r o f s u b jects wh o failed th e h yp oth es is .<br />

Un i v a r i a t s t e a t i s t i c a l an a l y s e s w e r e r m p e r d f t o t e s t s p e c i f i c h y p o t s h t a e t s e d s a t each<br />

p o i n t i n t h e r e s u l t s s e c t io n [3 .1 a n d 3 . 2 i n v i sv tu o d ies ; an d 3 .3 an d 3 .4 in vir to e x p e r i m e n t s].<br />

S a m p l e s i s z <strong>of</strong> e each grou p were rel at i vel y s mall in th e i n v i an v o al ys es [3 .1 an d 3 .2 ], an d<br />

t h e r e f o re e s s e n t i a l l y m u l t i v s a e r s i a t r e a u n a l i t y ach k o e l ie y ve mean in gfu l res u lt s . If<br />

mu ltivari at e an al ys es were p erf or med , s t a n d a rd e r r o r s w o u l d b e r e l h a givi t i nv g e ver l y y h wi i dg e<br />

9 5 % c o n f i d e n ti a l i n t e r v a ls (C . I.) in d icating a l ot <strong>of</strong> u n certain t y in fin d in gs . Fo r th is reas on , it<br />

was felt i n a p p r o p r i a t o e p erf or m mu lt iv a ri at e an al ys es .<br />

Th e S t a t i s t i c a l P a c k a g e o f S o c i a l S c i e n c e v e r s i o n 1 1 . 0 ( S P [ S F S i e ® l ) d , 2 0 0 3 ] was u s ed<br />

with a p val u e o f les s th an 0 .0 5 con s id ered as a s t a t i s t i c a l l y s i g n i f i , c an a n d t a v p a val l u e u e o f<br />

l e s s t h a n 0 . 1 0 a s h a e S tu s d y t Sa ize t i Det s er t mi i nc at a ion l (SSD) t r pe ro n gra d . mm e T [ Leh man n ,<br />

2 0 0 1 ] w a s u s e d f o r amp s le s ize cal cu lat io n a t t h e 5 % s i g n i pf ower. i c a n c e<br />

Fo r in d ep en d en t n ormal l y d i s trib u ted d ata, a n a l y s e s o f v a ri a n c e ( A N O V A ) w e r e p e r f o r m e d<br />

f o l l o w e d b y p o s t-h o c St u d en t t-t e s t e p s e a . t e -meas d R u res AN O V A w a s u s e d f o r l o n g i t u d i n a l<br />

d a t a n ormal l y d is tri b u ted [ T a b a c h n i c k & F i d e l l , 1 9 9 . 6 For ] n o n-n o rmal l y d i s t r i b u dt ata, e d<br />

r e p e a t -m e d e a s u r e A N O V A f o l l o w e d b y 1t 0 h % e tri mmi n g m et h od [ W i l c o x , 1 9 9 7 ]<br />

p e r f o r m e trim d mi . n g met T h od h we as ap 1 p li ed 0 in % ord er to r em ove o u t l iers s o t h at th e<br />

ANO V A m et h od can b e ap p lied . T o c o n f i r m t h e f i n d i n g f r A o m N O t V h A e f i o n g l th e l 1 0 o % w<br />

trimmi n g met h od , t h e N -p o n a r a m e t r i c A N O V A th ( e K r u s k a l -Wallis r a n k t e s ) t wa s s u s e d<br />

[ T a b a c h n i c k & F i d e l l , 1 9 9 . 6 ] T h e W i l c o x o n r a n k t e s t s w e r e u s e d n-n f or o mal r p l y a i r e d a n d n o<br />

d is trib u ted d at a [ A j e t u n m o b i , 2 0 0 2 .<br />

]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 7 - I m p e r i a l o C n o d l o n l e g e L<br />

a w s


Chapter II I<br />

Results<br />

- 7 8 -


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

CO NTENTS O F CH APTER 3<br />

R e s u l t s<br />

3. 1 Th e i n flu en c e <strong>of</strong> p s yc h o l o g i c a l i n t e r v e n t i o n u p o n s -rela t r e s s t ed ch an ges i n<br />

u n i v e r s i t y s t u d e n t s f a c i n g a c a d e m i c e x a m i . n a t i o n s<br />

3.1. 1 V a l i d a t i o n o f a c a d e m i c e x a m i n a t i o n a s a s t r e s s i n d u c e r f o r u n i v e r s 83 i t y s t u d e n t s<br />

3.1. 1. 1 Im p a c t o f a c a d e m i c e x a m pi on n a pt s ych i o n ol ou gi cal meas u res o f<br />

s t r e s s a n d a n x i e t y<br />

3.1. 1. 2 Imp act o f acad e mi c e xamin ation u p on i m m u n e p a r a m e t e r s<br />

3.1.2 D i f f e r e n c e s in th e le vel s o f l ym p h oc yt e s u b s ets and NK c ytot oxic act ivit y<br />

( N K C A ) b et ween u n ivers it y s tu d en ts w i t h h i g p e h rc e i v a e d n s d t r e s s l e v o e l w s 85<br />

3.1.2 . 1 D i f f e r e n c i e n t h e p e r -cells c e an n d t th e a level g e s <strong>of</strong> No K f N K<br />

c y t o t o x i c a c t i v i t y ( N K C A b etween ) u n iv ers it y s tu d en ts with h igh<br />

a n d l o w p e r c e i v e d s t r e s s l e v e l s<br />

3.1.2 . 2 D i f f e r e n c i e n t h e p e r c -cells e n t b a e g t w e e e n o f u n i rs T v it e y s tu d en ts w i t h h i g h a n d l o w p e r c e i v e d s t r e s s l e v e l s<br />

3 . 1.3 T h e in fl u en ce <strong>of</strong> p s ych ol ogical i n t e r v e n t u i p o n s t r e -rel s s ated ch an ges in u n i v e r s i t y s t u d e n t s f a c i n g a c a d e m i c e x a m i n a t i o n s<br />

3.1.3 .1 E f f e c t o f p s y c h o l o g i c a l i n t e r v e n t i o n u p o n s t r e s s cep p e tion r in u n ivers i t y s t u d e n t s a n t i c i p a t i n g a c a d e m i c e x a m i n a t i o n s<br />

3.1.3 .2 E f f e c t o f p s y c h o l o g i c a l i n t e r v e n t i o n u p o -related n s t r e s s<br />

l y m p h o c y t e -p s u op b u lat ion s in u n ivers it y s t u d e n t s anticip atin g<br />

a c a d e m i c e x a m i n a t i o n s<br />

3.2 T h e i n f l u e n c e o f p s y c h o a l o g i c n t e r v e n t i o n u p o n p e r c e i v e d s t -o r f -e<br />

s s a n d q u a l i t<br />

l i f e a n d v a r i o u s i m m u n o l o g i c a -a l s d i s e o a s c e i a t e d p -i n a fec r ted a m e t e r s i n<br />

i n d i v i d u a l s<br />

3 . 2.1 D i s e a s e-a s s o c i a t e d a n d s t r -r e s s e l a t e d c -in h fected a n g in e d is vi d u al i s i n H I V<br />

p s ych ol og y i m m u n o l o g i c a l p a r am e t e r s 102<br />

3.2.1 .1 P s y c h o l o g i c a l -in p fecte r o d if n d i ivi l d u als e s recru o it ed f t h e H I V<br />

into the s t u d y<br />

3.2 .1 .2 S t r e s s-r e l a t e d p e r c e p t i d o i n s a n e d a s e p r o g r e -s<br />

s i o n m a r k e r s<br />

i n f e c t i o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 7 9 - I m p e r i a l o C n o d l o n l e g e L<br />

83<br />

84<br />

86<br />

91<br />

93<br />

95<br />

103<br />

110<br />

93


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 2.2 Th e in fl u en ce <strong>of</strong> p s yc h o l o g i c a l i n t e r v e n t i o n u p o n d i p s r e a o r s g e s s i o n<br />

p a r a m e t e -in r fected s i n dn ivi d u al H s I (r V an d omis ed con trolled trial f or fou r<br />

m o n t h s p e r i o d ) 117<br />

3.2.2.1 Effect <strong>of</strong> p s yc h o l o g i c a l in ter ven tion u p on p erceived s tres s an d<br />

a n x i e t -i y n f e c i t e n d i n d H i I v i V d u a l s<br />

3.2.2 .2 Effect <strong>of</strong> p s yc h o l o g i c a l int e r v e n t i o n u -cell p o n c ou nC ts D i4 n T<br />

H I V-i n f e c t e d i n d i v i d u a l s<br />

3.2.2.3 Effect <strong>of</strong> p s yc h o l o g i c a l in ter ven tion u p on oth er i mmu n olo gical<br />

m a r k e r s ( -t l r a o n g s f o r m e d v i r a l l o a d l a e v n e l d s -c e N l l K c o u n t s ) in<br />

H I V-i n f e c t e d i n d i v i d u a l s<br />

3.2 .3 T h e i n f l u e n f c p e s y c o h o l o g i c l a in terven ti on u p on d is eas e p rogres s ion m ark er,<br />

C D 4 -c T e l l s -in , fected i n in d ivi H d uI al V s (cas e con tr olled s tu d y o ver 2 4<br />

m o n t h s p e r i o d ) 122<br />

3 . 2 . 3 . 1 A n a l y s i s o f b a s e l i n e d i f f e r e n c e s b e -cell t w e e n t h e t h r<br />

c o u n t 122<br />

3.2 .3 .2 An al ys is o f t h e r a t e o f -c c e l h l a c o n u g n t e ( C i D 4 n g r a C d D i e 4 n t 123 ) T<br />

3.3 In vi t ro i n vesti ga ti on i nt o th e effec t <strong>of</strong> exp osu re t o st ress h ormon es up on<br />

N a t u r a l K i l l e r c e l l s<br />

3 . 3.1 D e v e l o p m e n t a n d o p t i m i s a t ion o f a flow c yto met ric meth od f o r meas u rin g<br />

N K C A 128<br />

3.3.1 . 1 N K C A a f t e r i n c u b a t i o n o f P B M C s f o r 2 4 h o u r s<br />

3.3.1 .2 N K -c e l l p e r c e n t a g e i n P B M C s a f t e r 2 4 h o u r s i 129 n c u b a t i o n<br />

3 . 3 . 1 . 3 N KC A a f t e r 2 4 h r s i n c u b a t i o n o f P B M C s w i t h c o r t i s o l 131<br />

3.3.1 .4 N K -c e l l p e r c e n t a g e i n P B M C s a f t 2 e r 4 h o u r s ith i n c u b a t i o n w<br />

c o r t i s o l 132<br />

3 . 3.2 C o m p a r i s o n o f t w o m e t h o d s f o r m e a s u r i n g N K c y t o t o x i c a c t i v i t y ( N : K - C A )<br />

3 . 3 . 3<br />

t h e f l o w c y t o m e t r i c m e t h o d a n d t h e c o ( l C o y r t o i T m o x e 9 t 6 r ® i ) c m e t 133 h o d<br />

I n v e s t i g -cell a t pi r<strong>of</strong>i o les n a n d o f N K C N (c A K o l o r i m e t r i c ) m e t h o d 134<br />

3 . 3 . 3 . 1 NKC A, as s es s ed b y c ol orim etric meth od , after in cu b ation o f<br />

P B M C s f o r 2 4 h o u r s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 0 - I m p e r i a l o C n o d l o n l e g e L<br />

117<br />

119<br />

121<br />

128<br />

134


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .3 .3 .2 R e p e a t a s s e -cell s s p ercen m e tn ag t e an d o exami f n ation N K <strong>of</strong> N K<br />

s u b p o p u l a t i o n s i n P B M C s a f t e r 2 4 h o u r s i n c u b a 135 t i o n<br />

3 .3 .3 .3 E x p r e s s i o n o f N a t u r a l C y t o t o x i c R e c (Nkp e p t o r 4s 6 an d Nkp 3 0 ) b y<br />

c y t o t o -c x e l i l c s ( -C C N D K 3 5 6 d i m C D 1 6 + ) p r e a n d p o s t 2 4 h o u r s<br />

i n c u b a t i o n<br />

3 .3 .3 .4 NKC A, as s es s ed b y c ol orim etric meth od , after 2 4 h ou rs in cu b ation<br />

o f P B M C s w i t h 2 5 0 n M c o r t i s o l 138<br />

3 .3 .3 .5 N K C A l e v e l s b e t w e e n p r e a n d p o s cu t b ation 2 4 h wi o u th r or s i n<br />

w i t h o u t 2 5 0 n M c o r t i s o l 139<br />

3 .3 .3 .6 C D 5 6 -cell N K s u b s et p r<strong>of</strong>i les in P BMC s after 2 4 h ou rs in cu b ation<br />

w i t h 2 5 0 n M c o r t i s o l 141<br />

3 .3 .3 .7 Exp res s i on o f Natu ral C ytot oxic R ecep to rs (Nkp 4 6 an d Nkp 3 0 ) b y<br />

- +<br />

c y t o t o x i c N -c K e l l s ( C D 5 3 6 d i m C D 1 6 ) a f t e r 2 4 h ou rs<br />

i n c u b a t i o n w i t h o r w i t h o u t 2 5 0 n M c o r t i s o l 142<br />

3 .3 .3 .8 N k p 4 6 e x p r e s s i o -cells n po re n an d pc os y t 2t 4 ho ou t rs o x i c N K<br />

i n c u b a t i o n w i t h o r w i t h o u t 2 5 0 n M c o r t i s o l 143<br />

3 .3 .3 .9 N K C A a n d N k p 4 6 e x p r e s -cells s i p re o an n d p os o t n c y t o t o x i c N<br />

2 4 h o u r s i n c u t i b o a n w i t h o r w i t h o u t 2 5 0 n M c o r t i s o l 144<br />

3 .3 .4 E n d o g e n o u s s t r e s s h o r m l o e n v e ls a n d N K C A ( c o l o r i m e t r i c m e t h o d )<br />

3 .3 .4. 1 E n d o g e n o u s h o r m o n e l e v e l s a n d N KC A a t T i m e 0 p o i n t<br />

3 .3 .4.2 En d ogen ou s h orm on es levels an d th e in creas ed levels o f N KC A<br />

a f t e r 4 h ou 2 rs in vi tr o in cu b at ion <strong>of</strong> P B M C s with ou t exo gen ou s<br />

c o r t i s o l 146<br />

3.4 In vi t ro i n vesti ga ti on i nt o th e effec t <strong>of</strong> exp osu re t o st ress h ormon es up on<br />

T-l y m p h o c y t e s<br />

3 . 4.1 T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o n s e s a g a i n s t c o m m o n a n t i g e n s<br />

3.4.1 . 1 T-l y m p h o c y t e p r olife rat ion a ft er in cu b at ion <strong>of</strong> P BMC s fo r s ix d a ys<br />

w i t h a n d w i t h o u t e x o g e n o u s c o r t i s o l 152<br />

3.4.1 . 2 T-l ymp h oc yte p r olife rative res p on s e ag ain s t p u rified p rotein<br />

d erivati ve (P P D) aft er i n cu b ation <strong>of</strong> P BM C s for s i x d a ys with or<br />

w i t h o u t e x o g e n o u s c o r t i s o l 153<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 1 - I m p e r i a l o C n o d l o n l e g e L<br />

136<br />

146<br />

145<br />

151


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3.4.1 . 3 T-l ymp h oc yte p r olife rative res p on s e ag ain s t Herp es an tigen aft er<br />

in cu b at i on <strong>of</strong> P BMC s for s i x d a ys with a n d with ou t exogen ou s<br />

c o r t i s o l 154<br />

3 . 4.2 T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o n s e s a g a i n s t s u -a p e n r t i g e n a n d m i t o g e n 155<br />

3.4.2 . 1 T-l y m p h o c y t e r olife p rat ive res p on s es aga in s t s tap h yl ococ cal<br />

en terot o xi n B (S E B) aft e r i n cu b ation <strong>of</strong> d ilu ted wh ole b lood fo r<br />

t h r e e d a ys w i t h o r w i t h o u t e x o g e n o u s c o r t i s o l 156<br />

3.4.2 . 2 T-l ymp h oc yte p r olife rative res p on s es aga in s t p h yt oh aema gglu tin in<br />

A ( P H A) a f t e r i n c u b a t ion <strong>of</strong> d ilu ted wh ole b lood f or th ree d a ys<br />

w i t h o r w i t h o u t e x o g e n o u s c o r t i s o l 157<br />

3 . 4.3 C e l l s u r f a c e m n a r p k r o e l r i f s e r a t o in g T-l y m p h o c y t s e f ollo wi n g s ti mu lat ion w i t h P H A<br />

3.4.3 . 1 E x p r e s s i o n o f a n a p o p t o s i s ( C D 9 5 : - F a s ) c e l l s u r f<br />

l y m p h o c yt es i n v i t r d o u r i -in n dg u ced P pH rol A iferat i on wi th an d<br />

w i t h o u t e x o g e n o u s c o r t i s o l 158<br />

3.4.3 . 2 E x p r e s s i o n o f c e l l-s u r f a c e A n n e -V x i an n d c yt op las mi c P rop id iu m<br />

i o d i n e ( -l P ymp I ) h o c yt i es n a ft T er in cu b at ion with P HA f or th ree<br />

d a ys w i t h o r w i t h o u t c o r t i s o l 163<br />

3 . 4 . 3 . 3 E x p r e s s i o n o f a n a c -2 t i re cv ep a t or ) i ce o ll n s urf ( a ce C D ma 2 5 r ker : I L<br />

byT-l y m p h o c y t e s -induc d eu d pr r oi life n r at g ion wit P H h A a nd wit ho ut e x o ge n o u s c or t i s o l 164<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 2 - I m p e r i a l o C n o d l o n l e g e L<br />

158


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 1 T h e i n f l u e n c e o f p s y c h o l o g i c a l i n t e r v e n t i o n u p o -r n e l s t a r t e s d s c h a n g e s i n<br />

3 . 1 . 1<br />

un i v e r si t y s t u d e n t s f a c i n g a c a d e m -e i c x s. a m<br />

V a l i d a t i o n o f a c a d e m i c e x a m i n a t i o n a s a s t r e s s u n i n v d e u r c s i e r t y f s o t r u d e n t s<br />

Th is s t u d y was d es i gn ed t o e xamin e th e h yp oth es is th at an ticip atin g an acad emic<br />

e x a m i n a t i o n i n d u c e s s t r e s s a n d -r s t e r l e s a s t e d c h a n s g in e u n ivers it y s tu d en ts . Th e le vels o f s tres s<br />

p e r c e p t i ( o P n e r c e i v e d S t r e s s S c o r e a n d S t a t e a n x i e t y s c o r a e n ) d N K -cel l p e r c e n t a g e s a n d N K<br />

c y t o t o x i c a c t w i e r v e i t e x y a m i n e d i n u n i v e r s i t y s t u f d a e c n t i s n g a c a d e m i c e x a m (E i n xams a t i ) o n<br />

an d comp ared wi th res u lt s o b t a i n e d i n t -e h x e a m n o n p e r i o d s o f u n i v e r s i t ( y N o -e l n i x a f m e ) in o r d e r t -s o tres s d as e s oci t at e ed c ch t a n ges . e In x ad a d ition m , C D 4 a n d C -cell D 8 p ercen T tages were e xami n ed .<br />

3 .1 .1. 1 Im p a c t o f i a n a c t i a o n d u e p o m n i p s c y c h o l e o g x i c a l m m e a s u r e s o f n s x t i r e s t s y a n d a<br />

P ercei ved s tres s l e v e l s ( P S S )<br />

Th ere was a s i g n i f i c a n t i n c r e a s (t e = 2 , . d1 f = 2 1 , p = 0 . 0 4 5 ) in th e level s o f th e P SS at th e<br />

E x a m s c o m p a r e d t o t h -e e x a N m o n t i m e p o i n t [T a b l e 7 a n d F i g u 6]. r e 1<br />

T able 7: M e a n ( 9 5 % C . I . ) P S S s c o r e -e s xa a m t a n t d h E e x a N m o t n i m e p o i n ts<br />

P S S<br />

Non-e x a m Ex ams<br />

Me a n s c o r e 21.5<br />

26.2<br />

( 9 5 % C . I . ) (18.6 - 24.5) (22.8 – 29.6)<br />

n 22 22<br />

Mean (95% C.I.) Perceived Stress Scores<br />

Mean (95% C.I.) <strong>of</strong> PSS score<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

2 2<br />

Non-exams<br />

p = 0 . 0 4 5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 3 - I m p e r i a l o C n o d l o n l e g e L<br />

2 2<br />

Exams<br />

F i g u r e 6: 1 M e a n ( 9 5 % C s . c o I r . e s at ) the P S Non-e S x a and m E x a m t i m e p o i n ts


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

Pe r c e i v ed s t r e s s level s we re in creas ed i n u n i v e r s i t y s t u d e n w t h s e n f a c e d academi w i t h c<br />

e x a m i n a t i s. o n<br />

S t a t e n x a i e t y l e v e l s<br />

T h e s t u d e n ts w e r e s h o w n t o mo b e re a n x i o u s (t = 2 .1 , d f = 2 4 , p = 0 . 0 4 8) at th e Ex am<br />

t i m e p o i n t t h a n at th e N o n -e x a t i m e p o i n t [Tab le 8 a n d F i g u 7]. r e 1<br />

T able 8: M e a n ( 9 5 % C . I . ) S t a t e a n x i e t y s c o r e s i n -e xa t m h e and S T E A xa I m a t i t me t p o h i e n ts N o n<br />

S t a t e a n x i e t y i n t h e S T A I<br />

Non-e x a m Ex ams<br />

Me a n s c o r e 36.6<br />

41.8<br />

( 9 5 % C . I . ) (32.7 - 40.5) (38.5 – 45.1)<br />

n 25 25<br />

Mean (95% C.I.) <strong>of</strong> State score in STAI<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

2 5<br />

Non-exams<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 4 - I m p e r i a l o C n o d l o n l e g e L<br />

2 5<br />

Exams<br />

Fi gur e 17: M e a ( n 9 5 % C . I . S ) t a t e a n x i e sc t o y r es in t h e ST AI a t t h Non-exam e and E xa m t im e p o i n ts<br />

C o n c l u s i o n :<br />

Mean (95% C.I.) State Scores in the STAI<br />

p = 0 . 0 4 8<br />

Ac a d e m i c e x a m i n s a t i n i c o r e n a sed a n x i e t l y e v e l in s u n ivers it y s tu d en ts .<br />

3 .1 .1.2 Im p a c t o f inations a c a d u p e o n m i m m c u n e e p a r x a m a e t m e r s<br />

Previou s r e s earch s u g g e s t e d t h a t t h e l e v e l s o f N K c ( N y t K o C t A o ) x an i d c N a K c -cel t i ls v i t y<br />

ma y b e a s s o c i a t d e w i t h p s y c h o l o g i c a l s t r e s s , i . e . t h e es h y a p r o e t h t e s h a -in t d u ced e s tx res a s m<br />

d e c r e a s e s t h e N K c y t o t o -c x e l i l s c i n a t h c e t u n i v e r i s i n t ts y . y Hen s t u ce a d e n d t h e l<br />

th is s tud y was d es i gn ed t o ex amin e th es e h yp oth es es with an ad d ition al exp lorat or y<br />

in ves ti gat ion o f th e ef fect s u p on th e level s <strong>of</strong> C D4 an d C D 8 -cells T .


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

N K C A l e v e l s<br />

T h e N K c yt ot oxi c act ivi t y le vels were n o t s t a t i s t i c a l l y ds if i feren g n i f t (t i c = a 0 n . t 2, l dy f =<br />

2 0 , n s) b et ween th e N o n -e xam an d E x a m t i m e p o i n ts [Ap p e n d i x 6 : T a b l -7]. e A<br />

C o n c l u s i o n :<br />

A n t i c i p a t i o n o f a c a d e m i c e x a m i s n da id t i no ot n a f f e c t th e l evel s <strong>of</strong> N KC A.<br />

N K -c e l l -c a e l l n l d e v e l T s<br />

Th e res u lt s f r o m 2 s tu 6 d en ts sh ow th at n on e <strong>of</strong> th e -cell N K ( t = 0 . 3 , , d f n s), = 2 C 5 D -4<br />

T<br />

cell (t =0.6, d f = 2 5 , n s) o r C -c D e 8 l l (t T =0.2, d f = 2 5 , n s) p e r c e n t a g e s w e r e s ign if ican tl y<br />

di f f e r t be etween n th e N o n -e xam an d E x a m t i m e p o i n ts [Ap p e n d i x 6 : Tab le A-8].<br />

C o n c l u s i o n :<br />

p ercen t age.<br />

S u m m a r y :<br />

An t i c i p a t i o n o f a c a d e m i c e x a m i s n da id t i no ot n a f f e c t N K -c e l l a n d C D 4 a n -c d e l l C D 8 T<br />

T h e d a t a i n d i d c a th t at e an an ti ci p at ion <strong>of</strong> acad emic e xamin ation s in d u ces s tres s an d<br />

p r o v o k e s a n x i e t u ny ivers i n it y s tu d en ts . Howev er, th e acad emic e xa min ation s d id n ot ap p ear to<br />

affect t h e l e K-c v e l l s , o f C D 4 N -cells a n d o r NC K D 8 c yt ot T o xi c act i vi t y in th e u n ivers it y<br />

s t u d e n t s, i n t h i s s tu d y.<br />

It is con cl u d ed t h at acad emi c ex ams a re a valid s tres s fu l li fe e ven t (s tr es s or) to in cr eas e<br />

s t r e s s a n d a n x i e t y l e v e l s f o r u n i v e r s i t y s t u d e n t s ; b u t th at acad emic exams d id n ot a p p ear to<br />

p r o v i d e c o n c u r r e n t c h s a in n g e i m m u nol o gi cal p ara met ers , i.e. le v e l s -c e o l f l -cells s , N K an T d<br />

NK c yt ot o xi c act i vi t y.<br />

3 .1 .2 D i f f e r e n c s e in the le vel s <strong>of</strong> ly m ph ocy te s u b s e t s a n d NK c y t o t o x i c a c t i v i t y ( N K C A )<br />

b e t w e e n<br />

u n i v e r s i t i y t h s t h i u d g e percei h n t a ve s n d d s tres w l s l o e v w e l s<br />

Th e p revi ou s s ect i on s u g ges ted th at an an ticip ation <strong>of</strong> ac ad emic e xamin ati on s d id not<br />

a f f e c t t h e l e v e l s i mmu o f t nh e e p aramet er s . H o w e v e r , a d s e s c r i b e d i n t h e i n t r o d u c t i o 1 n .2 .3 [ .2<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

a n d 1 . 2 . ], 4 i . n d 3 i v i d u a l ’s p ercep ti on <strong>of</strong> s t r e s s h as b een s h own to b e m o r e a s s o c i a d t with e<br />

i m m u n e p a r a m e t e r s, p a r t i -cell c u p r<strong>of</strong>i l la es r , th l an y a s t r e N s s K f u l l i f e e v e n t i t s . e Hen l f ce, in this<br />

s e c t i , o i n m m u n e p a r a m e t e r s ( -c N K e l l s [ 3 -l . y m 1 . p h 2 o c . y t 1 e s ] [ , 3 . 1 . T 2 . 2 ] ) w e r e c o m p a red in two s u b grou p s <strong>of</strong> s tu d en ts a s s e s s e t d o b s tres e s ed an d n o t -s tres s ed indi v i d u a l accord s in g to th ei r<br />

P S S s c o r e s. T h e u n i v e r s i t y s t u d e n ts , wh o filled th e P SS qu es tion n ai res an d h a d b lood collecti on<br />

fou r wee ks a ft er recru i t men t , w e r e d i v i d e d i n t o two s u bg r o u p s o n t h e b a s i s o f the PSS (Med ian<br />

= 2 2 .5 , Mean = 2 3 .1 , St a n d a r d d e v i a t i o n = 7 . an 7 ) d lab el led as N o t -s t r e s s and e d S t r e s s e d<br />

i n d i v i d u a l in s t h i s s tu d y:<br />

S t r e s s e i d n d i v i d u a l s : P S S s c o r e w a s m o r e t h a n o r e q u a l t o 2 2<br />

N o t -s t r e s s i e n d i v i d u a l s : P S S s c e o r w a s l e s s t h a n 2 2<br />

Th ere was n o s t at i s t i cal l y s i gn ifican t d iff eren ce in th e n u mb ers <strong>of</strong> S u b j e c t s b etwee n th e<br />

N o t -s t r e s s e d a n d S t s r u e b s g s r o e u d p s w i t h r e g a r d t o g e n d e r d i s t r i b u t i Ap o n p [ e n d i x 6 : T a b l -9]. e A<br />

3 .1 .2 .1 D i f f e r e n c e s in th e p e r c e n t a g e o f N -cells K an d th e level o f N K c yt oto xic acti vit y<br />

( N K C A ) b e t w e e n u n i v i e t r h s i h t i y g p ercei h s ved t a u n s tres d e s l n l e v t e o l s w w<br />

Re s e a r c h a s s u g g e s t ed t h -c a e t l l s N a K r e a f f e c t e d b y s t r [1 e .2 s .3 s .2 p an e r d c e p t i o n<br />

1 . 2 . 4 ]. . 3 A c c o r d i n g l y , t h i in e s if, in s u nt ivers u id t y sy tu d en w ts a , s p e r f o r m e<br />

p erceived s t res s l ev el i s as s ociated with<br />

1 . o w L N -c K e l l p e r c e n t a g e<br />

2 . Low N K c yt o t o x i c a c t i v i t y l e v e l, a n d<br />

3 . L o w p e r-N K -c e l l c y t o t o x i c . a c t i v i t y<br />

In ad d it ion , t h e i n f l u e n c e o f g e n d e r u p o n t h e s e p a r a m e t e . r s w a s i n v e s t i g a t e d<br />

NK-c e l l l e v e l s<br />

<strong>The</strong>re was n o s i gn ifi can t d i f f e r e n c be etw een th e S t r e s s a e n d d N o n -s t r e s s e u d b gr o u p s in th e p ercen tages <strong>of</strong> N K -c e l l s (t = 0 . 7 , d f = 3 9 , [Ap n s ) p e n d i x 6 : T a b le A-1 0 ].<br />

G e n d e r d i d n o t a p p e a to r aff ect th e res u lt s . T h e r e w a s n o s i g n i f i c n a d n e t r v g s e . s t r -e<br />

s s<br />

p e r c e p t i o t n e r i a c n t i o n ( F = 1 . 7 , d f = ; m 3 a 9 l , e : n t s = 1 .1 , d f = 1 8 , n s ; an d female : t = 1 .5 , d f =<br />

1 8 , n s ) [Ap p e n d i x 6 : T a b l es -1 A 1 a n d ]. 1 2 Hen ce, it was c on cl u d ed th at th ere was n o gen d er<br />

b i a s w i t h r e g a r d t o t h e r e s u l t al f r ys o is m b et c ween o m p a tr h e i S s t o n r e s a s n an e d N o t -s t r e s s e d<br />

s u b grou p s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 6 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

With reg ard t o gen d er d i ffe ren ce, h o w e v e r , ma l e s t u d e n t s<br />

h a d a t r e n d - t o w a r d s<br />

c e l l p e r c e n t a g e th s an fe mal e s tu d en ts (t = 1.9, d f = 3 8 , p = 0 .0 6 6 ) [Tab le 9 a n d F i g u 8]. r e 1<br />

C o n c l u s i o n :<br />

T able 9: M e a C.I n .) N K ( -c e 9 l l 5 p e % r c e n t a g e s i n m a l e a n d f e m a l e s t u d e n t s<br />

N K -c e l l (%)<br />

Ma l e Fe m a l e<br />

Me a n l e ve l 11.0<br />

8.0<br />

( 9 5 % C . I . ) (8.5 – 13.5) (6.1 – 10.0)<br />

n 20 20<br />

Mean (95% C.I.) NK-cell (%)<br />

1 5<br />

1 0<br />

5<br />

0<br />

m a l e f e m a l e<br />

Fi gur e 18: M e a n (95% C.I .) NK-c e l l p e r c e n t a g e s i n m a l e a n d f e m a l e s t u d e n t s<br />

Th e r e w a s i n o f d f e r e -c n e c l l l e v e l s i b e n t w e e n N s K t r e s s e d a n d n o t-s tres s ed s tu d en ts .<br />

M a l e s t u d e n t s a p p -c e l a l r p e e r c e d n t a g t e t s h o a n f h e m a l v , e bs e u t th ih s d i ifferen g h ce e r N K<br />

was n ot s t at i s t i cal l y s i gn i fi can t.<br />

Na tura l K i l l er cy toto xi c a cti vity (NK C A) l e v e l s<br />

p = 0 . 0 6 6<br />

<strong>The</strong> S t r es s e d s t ud en ts h ad s i gn ifican tl y lo wer N KC A le vel s c omp ared t o th e N o n -s t r e s s e d<br />

s tu d en ts (t = 2.4, d f 9 = , p 3 = 0 . 0 ) 2 [T 3 a b l e 1 0 a n d F i g u 9]. r e 1<br />

T able 10: Me a n ( 95% C.I .) l e v e l s o f N K C A ( % k i l l i n i g n ) the Not-s t r e s s and e d S t r e s s e s d u bgroups<br />

N K C A (% ki l l in g )<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 12.0<br />

5.8<br />

( 9 5 % C . I . ) (7.7 – 16.3) (2.8 – 8.7)<br />

n 20 21<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 7 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

NKCA levels (95% C.I.) at Time point 1<br />

20<br />

15<br />

10<br />

5<br />

0<br />

N =<br />

2 0<br />

Non- s t r e s s e d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 8 - I m p e r i a l o C n o d l o n l e g e L<br />

2 1<br />

St r e s s e d<br />

Fi gur e 19: M ea n (95% C.I .) N K C A (% k i l l i n g i ) n t he N ot -s t r e s s e a d n d S t r e s s subg e d r o u ps<br />

Ge n d e r d i d n o t a p p e a r t o a f f e c t th e res u lt s . T h e r e w a s n o s i g n i f i c a n t g e n d e r v s . - s t r e s s<br />

p ercep ti on in teract ion ( F = 0 .6 , d f = 3 9 , n s ). Th is was c on fi rmed wh en th e S t r e s s an e d N o t -<br />

s t r e s s e s u d b g r o u p s w e r e c o m p a r e d i n e a c h g e n d e r . <strong>The</strong> s e p S a t r a e t s e s l male e y d s t u d en ts h ad<br />

s i g n i f i c a n t l y r l No KC w e A level s c o mp ar ed to th e N o n -s t r e s s male e d s t u d e n t s (t = 2 .2 , d f = 1 9 , p<br />

= 0 . 0 3 8 ) [Tab le 1 1 a n d F i g u r e ]. Th 2 0 e s ame tren d was s h own in fe male s tu d en ts , b u t it d id n ot<br />

a c h i e v e s t a t i s t i c a l s i g n i f i c a n c t e = ( 1 . 1 , d f = 1 8 , [Ap n s ) p e n d i x 6 : T a b l -13] e . Wi A t h regard t o<br />

d ifferen ce b et ween mal e an d female s tu d en ts , t h e r e w a s n o s i g n i f i c a n t d i n f th f e r le evel n c e s <strong>of</strong><br />

t h e N K C A (t = 0 .1, d f = 3 9 , n s) b e t w e e n m a l e a n d f e m a l e s t u d e n Ap t s p [ e n d i x 6 : T a b l -14]. e A<br />

T a b l e 11: M e a n ( 9 5 % C . I . ) l e v e l s o f N K ) C in A the ( Not-st % k i r es l se l d i and n g S t r e s s m e a d l e s t u d e n t s<br />

N K C A (% k i l l ) i n g<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 12.9<br />

4.7<br />

( 9 5 % C . I . ) (6.6 – 19.2) (1.2 – 8.2)<br />

n 11 10<br />

NK cytotoxic activity (%killing)<br />

NK cytotoxic activity (%killing)<br />

Mean (95% C.I.) NKCA in male (%killing)<br />

2 0<br />

1 5<br />

1 0<br />

Fi gur e 20: M e a n ( 9 5 % C . I . )<br />

5<br />

0<br />

p = 0 . 0 2 3<br />

p = 0 . 0 3 8<br />

N o t - s t r e s s e d S t r e s s e d<br />

N K C le A ve ls ( % ki llin g) in t he N ot -s t r e s s e a d n d S t r e s s m e a d l e s t u d e n t s<br />

Hen ce, i t was c on cl u d ed t h at th ere was n o gen d er b ias with re gard t o th e res u lt f ro m<br />

comp ari s on an al ys is b et ween th e S t r e s s an e d N o t -s t r e s s su e d b grou p s .


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

St r e s s e d s t u d en t s h a d l o w e r l e v e l s o f N K C A c o m p a r e d t o t h e n o -s t t r e s s e d s t n u t d s. e<br />

NKC A l evel s we re n ot s i gn i fican tl y d iff e ren t b etween male an d fe male s tu d en ts .<br />

P e r -N K -c e l l c y t o t o x i c a c t i v i t y l e v e l s<br />

It is kn own t h at N K c yt ot o xic a ctivit y (N KC A) is related t o th e n u mb er o f N K -c e l l s an d<br />

th e p r o m i s c u i -cells. t y T o h i f s p t r o h m i t e i y s i s c u d N e K p e n d e n t u p o n f a c t o r s l i k e :-<br />

1. R el at ive c o n c e n t r a t s i o o n f -cells, N K tar g et cel ls a n d ot h er is olated p e r i p h e r al m o n -o<br />

n u c l e a r c e l l /or s ; a n d<br />

2 . Pe r -c e l l c y t o t o x c i c t a i v i t y o -cells f . i n d i v i d u a l N K<br />

Th e firs t h yp ot h es is was e xamin ed u s in g a c o r r e l a an t al i o ys n is b e t w e e -c e n l l N K<br />

p e r c e n t a g e a n d C A N l K e v e l , a n d s h o w e d t h a t t h se tr r on e g w an a s d sa tat is ti cal l y s i gn ifican t<br />

p os itive a s s o c i a t (r i o = n 0 .5 2 , p = 0 . 0 0 1 , n = 4 . 4 ) H e n c e , i t w a s c o n c l u d e d t h a t t h e n u m a n b d e r<br />

c o n c e n t r a t i o n f -cells N K wer e on e <strong>of</strong> th e m o s t i m p o r t a n t f a c t f o r s t h e N K C A l e . v e l s<br />

Ha vin g d em on s t rat ed t h i s p os itive c orrela tion , th e s econ d h yp oth es i s th at low le vel s <strong>of</strong><br />

p e r -N K -c e l l c y t o t o x i c a c t i v i t y a s s o c i a t e w i t h h i g h s t r e s s p e r c e p t i o n w a s e x a m i n e d . - T h i s p e r<br />

N K -c e l l c y t o t o x i c , a c w ich t h i was v i t cal y cu lat ed as a f i g u r e o f a r a -cell t i o o f t h e<br />

p e r c e n t a g e a s w a s s u g g e s t e d i n -a t n h a e l y m s i e t s o a f S e g e r s t r o m a n d M i l l e r [ 2 0 0 , 4 were ]<br />

comp ared b et ween th e S t r e s s an e d N o t -s t r e s s se tud d en ts . Th e r e s u l t s s h o w t h a t the St r e s s e d<br />

s t u d e n t s a h t a r d e n d t o w a r d l s o w e r le vel s o f p e r-N K -c e l l c yt oto xic acti vit y (calcu la ted as a ratio<br />

o f N K C A -cell t o p e r c e N n K t a g e) co mp ar ed to th e No n -s t r e s s e tu d e n ts (t = 2.0 , d f = 3 9 , p =<br />

0 . 05 6 ) [Tab le 12 a n d F i g u r 2 e 1].<br />

T able 12: M e a n ( 9 5 % C . I . ) r a t i o s NK-c o f eN ll K in C A t he t Not-st o re s se d and S t r e s s e t d u d e n t s<br />

N K C A to NK-c e l l r a t i o<br />

Not-s t r e s s e d St re s se d<br />

Me a n r a t i o 1.29<br />

0.64<br />

( 9 5 % C . I . ) (0.74 – 1.84) (0.25 – 1.02)<br />

n 20 21<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 8 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Per-NK-cell cytotoxic activity<br />

Mean (95% C.I.) ratios <strong>of</strong> NKCA to NKC %<br />

2 . 5<br />

2 . 0<br />

1 . 5<br />

1 . 0<br />

0 . 5<br />

0 . 0<br />

N o t - s t r e s s e d S t r e s s e d<br />

Fi gur e 21: M ea n (95% C.I .) p e r -N K -c e l l c yt ot ox ic ac t i vi t y ( c a l c u l a t e d as a r at i o : NK c yt oto xic a c t i v i t y<br />

( N K C A ) / NK-c e l l p e r c e n t a g e ( C%)) N K in t he Not-st r es s ed a n d S t r e s s subgroups e d<br />

Gen d er ap p eared n o t t o i n f l u e n c e t h e r e s s u l i t g s n i f i c . Th a n t ere l y was n o s i gn ifi can t<br />

g e n d e r v s . s t r -p e s e s r c e p t i o n i n t e r a c t i o n ( F = 1 . 4 , d f = 3 9 , n s ) . T h s i w a s c o n f i r m e d th e w h e n<br />

S t r e s s and e d N o t -s t r e s s e s u d b g r o u p s w e r e c o m p a r e d i n e a c h g e n d e r . Th s e p St a r a e t s e s l e y d<br />

male s t u d e n t s l h o a w d e r p e r -N K -c e l l c y t o t o x i c a c l t e i v e v l i co s t mp y ared to th e No n -s t r e s s e d<br />

m a l e s t u d e n ts (t = 2 .3 , d f = 1 9 , p = 0 . 0 3 5 ) [ T a b l e 1 3 a nd F i g u r e ]. Th 2 2 ere was , h o wever , n o<br />

s tatis tical l y s ign ifi can t d ifferen ce b etwee n th e N o t -s tr es s ed a n d S tr es s ed f e m a l e s t u d e n t s t ( = 0 .5 ,<br />

d f = 1 8 , n s ) Ap [ p e n d i x 6 : Tab le A-1 5 ] . With reg ard to d ifferen ce b etween male a n d female<br />

s t u d e n ts , th e r e w e r o e s i g n i f i c a n t d i f f e r e n c e s b e t w e e n m a l e a n d f e m a l e s t in u d th e n e t rat s ios o f<br />

t h e N K t C A o -c e l l N p K e r c e n t a g e (t = 0 . 1 , d , f n = s) [Ap 4 0 p e n d i x 6 : Tab le A-1 6 ] .<br />

T able 13: M e a n ( 9 5 % C . I . ) r -c a et ll in i t ho e s Not-st o re f s se d and N K C S A t r e t s s o m e a d l e N s K t u d e n t s<br />

N K C A to NK-c e l l r a t i o<br />

Not-s t r e s s e d St re s se d<br />

Me a n r at io 1.38<br />

0.33<br />

( 9 5 % C . I . ) (0.53 – 2.24) (0.14 – 0.52)<br />

n 11 10<br />

Per-NK-cell cytotoxic activity<br />

Mean (95% C.I.) ratios <strong>of</strong> NKCA to NKC % in male students<br />

2 . 5<br />

2 . 0<br />

1 . 5<br />

1 . 0<br />

0 . 5<br />

0 . 0<br />

p = 0 . 0 5 6<br />

p = 0 . 0 3 5<br />

N o t - s t r e s s e d S t r e s s e d<br />

Fi gur e 22: M ea n (95% C.I .) p e r -N K -c e l l c yt ot ox ic ac t ivit y ( c a lc ula te d as a r at io : N K C A / NK-c e ll<br />

p e r c e n t a g e) in t he N ot -s t r e s s e d a S n t r e s s m e a d l e s t u d e n t s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 0 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Hen ce, i t was c on cl u d ed t h at th ere was n o gen d er b ias with re gard t o th e res u lt f ro m<br />

comp ari s on an al ys is b et ween th e S t r e s s an e d N o t -s t r e s s su e d b grou p s .<br />

C o n c l u s i o n :<br />

I t a p p e a r s t h a t r e s s e d s t u d e n t m s a y h a v e l o w e r l e v e l s o f p -N e r K -cel l c yt ot oxi c act ivi t y<br />

c o m p a r e d t o t h e n o t-s t r e s s e d s t u d e n , t s a n d p o s s i b l y , b e c a u s e o f t h e s m is a l l s a m p l e s i z e ,<br />

a c h i e v e d s t a t i s t i c a l s i g n i f ican ce on l y f or male s tu d en ts .<br />

3 . 1 . 2 . Differen 2 ces in th e p e r c e n t a g es o f T-cells b etween u n ivers it y s tu d en ts with h i g h a n d l o w<br />

p erceived s t res s l e v e l s<br />

As s ociat i on s b et ween s tres s p e r c e p t i o n a T-cells n d h a v e b een in con s is ten tl y rep ort ed<br />

[1 . 2 . 3 . 2 a n d 1 ]. . Hen 2 . 4 ce, . 3 th is s tu d y w as p erfor med to d etermin e i f th ere a re an y as s ociati on s<br />

b etween p ercei ved s tres s level a n d C D -c 4 e T l l a n d / -c o e r l l p erc C D en 8 tages T in u n ivers it y<br />

s tu d en ts . In ad d i t i on , t h e i n flu en ce <strong>of</strong> gen d er u p on th es e p arameters was in ves ti gat ed .<br />

<strong>The</strong>r e w a s s i n g o n i f i c a n t d i f f e r e n bc etw e een th e S t r e s s a e n d d N o n -s t r e s s i e n d i v i d u a l in s<br />

t h e C D 4 o r C D 8 T-c e l l l e v e l (C s D 4 -cel T ls : t = 1 .4, d f 9, = n 3 s; C D -cells 8 T : t = 0 .8 , d f = 3 9 ,<br />

n s ) [Ap p e n d i x 6 : T a b l -1 e 7 ]. T h A e r e w a s n o s i g n i f i c a n t g e n d e r v s . -p er s t cep r e s ts io n in teract ion ( C D 4 -c T e l l s : F = 0 . 8 , d f -c e l = l s : 3 F 9 , = 0 . n 5 s , ; d f = a n 3 d 9 , n C s D ) . 8 con T h T firm i s w ed a s<br />

w h e n th e S t r e s s an e d N o t -s t r e s s e s u d b g r o u p s were co mp ared in each g en d er s ep aratel y. Th ere<br />

wa s n o s ign ifi can t d i f f e r e n c be etween th e N o t -s t r e s s and e d S t r e s s e s t d u d e n t s ( m a l e : C D 4 - T<br />

c e l l s : t = 1 . 1 , d f = 1 ; 8 C , D n 8 s -c T e l l s : t = 1 .1 , d f = 1 8 , n s [Ap p e n d i x 6 : T a b l -1 e 8 ]; an A d<br />

f e m a l e : C D 4 -c e T l l : t = 1 . 7 , d f = 1 ; 8 CD , n 8 s -c T e l l : t = 1 .1 , d f = 1 8 , n s [Ap p e n d i x 6 : T a b l - e A<br />

1 9 ]). Hen ce, i t was con cl u d ed th at th ere was n o gen d er b ias with re gard t o th e res u lt fro m<br />

comp ari s on an al ys is b et ween th e S t r e s s ed an d N o t -s t r e s s su e d b grou p s .<br />

G e n d e r a p p e a r e d t o i n f l u e -cells n c e ( F t = h 6 .0 e , d f r = e 1 s , p u = l 0 t .0 1s 9), bo uf t C D 4 T<br />

n o t C D -c 8 e l T l s ( F = 0 . 0 3 , d f = 1 , n s ) . -cell F e m p er a cen l e tages s t th an u d e n t s h a v e<br />

male s tu d en ts (t = 2.4, d f = 3 8 , p = 0 .0 2 0 ) [Tab le 1 4 an d F i g u r e 23]. Th e r a e s n o s w i g n i f i c a n t<br />

d ifferen ce b et ween m a l e a n d f e m a l e s t u d e n t s C i D n 8 t -c h e T l l p e r c e n t a g e (t s = 0.4, d f = 3 8 , n s )<br />

[Ap p e n d i x 6 : T a b l -2 e 0 ] .<br />

A<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 1 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

T able 14: Me a n ( 95% C.I .) C D 4 -c T e l l l e v e l s ( % ) o f m a l e a n d f e m a l e<br />

CD4 T-c e ll (%)<br />

Ma l e Fe m a l e<br />

Me a n l e ve l 43.2<br />

48.7<br />

( 9 5 % C . I . ) (39.9 – 46.4) (45.5 – 52.0)<br />

n 20 20<br />

Mean (95% C.I.) CD4 T-cell (%)<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

m a l e f e m a l e<br />

F i g u r e 23: M e a n (95% C.I .) C D 4 -c e T l l l e v e ( l % s ) o f m a l e a n d f e m a l e s t u d e n t s<br />

Th e r e w a s s i n g o n i f i c a n t d i f f e r e n c e i n o r C D C D 4 8 T-c e l l l e v e l s b en e t sw tres e s ed an d<br />

n o t -s t res s ed s tu d en ts . F e m a l e s t u d e n t s s h o w -c e ell d p ercen h i tg ages h e r th an C mal D 4 e T<br />

s tu d en ts i n t h i s s tu d y.<br />

S u m m a r y :<br />

CD4 T-cell percentages<br />

p = 0 . 0 2 0<br />

T h e a n a l y s e <strong>of</strong> N KC A a n d p e r-N K -cel l c ytot oxic activit y l e v e l s s u g g e s te d that the<br />

s tu d en ts wi th h igh s tres s p ercep tion ( t h e s t r e s s e d i n d i v i d u a ls ) m a y h a v e l o w e r l e v e l s o f<br />

a n d p e r-N K -c e l l c y t o t o x i c ca omp c t ai red v i t to y th e s tu d en ts wh o exp res s ed a l o w l e v e l o f s t r e s s<br />

( t h e n o t-s t r e s s e d i n d i v i d u a l s . ) Th ere were n o s ign ifi can t d iffe ren ces b etween th e s tres s ed an d<br />

n o t -s t r es s e d s t u -c d e l n l t s o r i C n D 4 -c N a e K l n l d p C e D r 8 c e n t T a g e th s es , e res a n ud lt s h ad n o<br />

g e n d e r b i a s l ; t a h o u g m h a l e s t u d e n t -c s e l l h a a d n d h l i o -c g w e h l e l e r r p cen e C D tages N 4 K tT h an<br />

f e m a l e s. He n c e , i t i s s u g g e s t e d t h a t g e n d e r m a y n o t n e e d t b o e s e p a r a t e l y a n a lys ed wh en th e<br />

l e v e l s o f t h e N K C -c A e l o l r s a p n e d r c C D e 4 n -cells t a n a ad re g ce oC mp D s 8 ared o T if n N K<br />

r e l a t i o n s h i p w i t h t h e l e v e l s o . f s t r e s s p e r c e p t i o n<br />

T h i s s t u d y h a s s h o w t n t h e a r e a r e a s s o c i a t i o n s b e t ’s w pe ercei e n o vn ed e s tres s lev el an d<br />

o n e ’s l e v el s f o N K C A ; a n d se t h f e i n d i n g s u p p o r t p r e v i o u s r e p o [ r I t n s t r o d u c t i o n : 1 . 2 . 4 . that 3 ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 2 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

th ere are i n t e r a c t i o n s a m o n g t h e p r o p o s e d i n -n t e u g r o-e a t n e d d o c r p s i y n -i c o h m o m u n e n e t w , o r k<br />

an d that it is warran t ed t o i n ves tig ate th is n etwork fu rth er [3 .3 an d 3 .4 ].<br />

3 . 1 . 3 T he in fl uen ce <strong>of</strong> ps y ch ol og ica l interven tion u p o n s t r e s s-rela te d cha ng es in<br />

u n i v e r s i t y s t u d e n t f s a c i n g a c a d e m i c e x a m i n a t i o n s<br />

Th e ob j ect i ve <strong>of</strong> this s eri es o f in ves tigati on s was to d eter min e if th e p racti ce o f<br />

p s yc h o l o g i c a l c o p i n g s k i l l s w o u l d r e d u c e :<br />

1 . I nc r e a s e d l e v e l erc s eived o f s p t r e s s ( P S S ) an d an xiet y ( S t a t e s c o r e o f t h e S T A , I )<br />

2 . S t r e s s-r e l a t e d l o w N K C A l e , v e l a s n d<br />

3 . St r e s s-rel at ed d ecreas e in N K -c e l l p e r c e n t a s g e<br />

in u n ivers i t y s t u d en t s faci n g acad e mic e x amin ation s . Th e le vel s w e r e c o m p a r e d b e t w e e n th e<br />

recru it men t b a s e l i n e t i m e p o i n t an d th e E x a m t i m e p o i n t. Psych ol ogical in terven tio n was given<br />

p rior t o t h e ex ami n at i on s . In a d d i t i o n , t h e e f f e c ts <strong>of</strong> p s ych olo gical in ter ven tion u p on C D4 , C D8<br />

T-c e l l p e r c e n t a g e s w e r e e eth x od p . l o r e d b y u s i n g<br />

3.1 . 3 . 1<br />

Ef f e c t o f p s y c h o l o g i c a l i n t u p e on r v se tn res t i s po ercep n ti on in u n ivers it y s tu d en ts<br />

a n t i c i p a t i n g a c a d e m i c e x a m i n a t i o n s<br />

P e r c e i v e d S t r e s s l e v e l s ( P S S )<br />

Th e P S S q u es t i on n ai re was n ot read y fo r u s e wh en th e s tud en t s were recru ited for t h e<br />

b a s e l e i n a s s e s s m e n t s. H o w e v e r , 3 2 p a r t i c i p a n t s c o m p l e t ne aire d t at h te h e q Exa u e s m t i ime o n<br />

p o i n t . A N O V A s h owed th at th ere w as n o s tatis tical d ifferen ce b etween t h e t h r e e s g (F r o u = p 0 . , 5<br />

d f = 2 9 , n s ), a n d e x p l o r a t o r y p o s t-h o c t-tests s h owed n o s i g n i f i c a n t d n i c f e s f e (R r e el axat ion c o n t r o l vs . S e l f-h yp n o s i s : t = 0 .6 , d f = 1 9 , n s; R elaxation con t r ol vs . J oh rei : t = 0 .3 , d f = 1 8 , n s )<br />

[Ap p e n d i x 6 : T a b l -2 e 1 ]. F A u r t h e r , t h e r e w a s n o s i g n i f i c a n t d i in f f e th r e n Pc Se S s level s<br />

b e t w e e n th e t h r e e g r o u p s w i t h r e g a r d t o ;-<br />

Distri b u ti on <strong>of</strong> n u mb ers <strong>of</strong> the p articip an ts in th e N o t -s t r e s s e a d n d S t r e s s e d<br />

s u b grou p s ( N o d i f f e r e n c e s : P e a r s o are n ' : s R e l C a h x i a t i s o q n u n t r c o l s v s . S e -l<br />

f<br />

h y p n o s i s = 0 .2 ; R e l a x a t i o n o n c t r o l s v s . J o h r e i = 2 . [ 6 T ) a b l e ] 1 ; 5 a n d<br />

Gen d er bias [Ap p e n d i x 6 : T a b l es -2 A 2 a n d A-2 3 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 15: T h e n u m b e r s o f p a r t i c i p a n t i u n p s t ( S h e l f-h t y h p r n o e s e i s g , r o J o h r e i a n d R e l a x ontrol) a t i o n in c<br />

t he N ot -s t r e s s e d a n d S t sr ubgr e s s oe up d s ba s ed on the P SS s c or es at th e E xa m t i m e po i n t<br />

C o n c l u s i o n :<br />

Group<br />

Not-s t r e s s e d<br />

S t r e s s e d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 4 - I m p e r i a l o C n o d l o n l e g e L<br />

T ot a l<br />

S e l f-hy p nos i s 5 7 12<br />

J o h r e i 7 4 11<br />

C o n t r o l s<br />

3 6 9<br />

T ot a l 15 17 32<br />

St u d e n t s p r a c t i s i n g p s y c h o l o g i c a s l p rior i n to t e acad r v e emi n t c i exa o n ms d id n ot s h ow an y<br />

s ign ifican t d i f f e r e n c e s i n p e r c e si tres v e s d level s at th e E x a m t i m e p o i n t wh en co m p ared with<br />

s t u d e n t s i n t h e R e l a x a t i o n . c o n t r o l g r o u p<br />

Sta te a n x i e t y l e v e l s<br />

Th i r t y f i p v a e r t i c i p a n t s c o m p l e t e d t h e S t a t e s c o r e o f t h e S T A I q s elin u e s e t i o n n a i r e s a t b a<br />

an d th e E x a m t i m e p o i n t, al l owin g fo r an an al ys is <strong>of</strong> an xiet y l evels in th e th ree gr o u p s b efore<br />

t h e p ch s y ol ogi cal in terven ti on p eri od an d later at th e exa m s tres s p eri od .<br />

An x i e t y l e v e l s i n c r e a s e d s i g n i f i c a n t l y a t t h e E x a m s s t r e s s t i m e p o i n t c o m p a r e d t o b a s e l i n e<br />

in all th ree gr ou p s ( F = 1 1 .0 , d f = 3 2 , p = 0 .0 02 ). Alth ou gh rep eated meas u re ANO VA s h owed<br />

that there was n o s i gn i fi can t d iff eren ce in th e State an xiet y s co res in th e ST AI b etween th e th ree<br />

g r o u p s a t b a s e l i n e a n d E x a m t i m e p o i n t, i .e. th ere w as n o time x g r o u p i n t e r a c t (F i = o n 0 .0 2 , d f<br />

= 3 2 , n s ), p os t h oc t-t e s t s s h o w e d t h a t th e i n c r e a s e s w e r e s t ticall a t i s y s ign ifi can t fo r th e<br />

R e l a x a t i o n o n c t r o l (mean ch an ge = 6 .8 , t = 3 .3 , d f = 9 , p = 0 .0 2 7 ) a n d S e l f-h yp n os i s (mean<br />

ch an ge = 4 .9 , t = 3 .3 , d f = 1 2 , p = 0 . 0 ) 0 g 6 r o u p s b u t n o t f o r t h e J o h r e i (mea g r o u n p ch s an ge =<br />

4 .2 , t = 1 . 1 , d f , n = s) 1 [ Tab 1 le 1 6 a n d Fig u r e 24]. An al ys es <strong>of</strong> th e d ata b y gen d er s h owed th e<br />

s a e m t r e n d s [ A p p -2 e 4 n a n d i ]. 2 x 5 6 : T a b l e s A<br />

T able 16: Me a n ( 95% C.I .) S t a t e a n x i e t y s the c o r S e s l f-hypnosis, i n Johrei and Re la xa t io n c on tr ol groups at b a s e l i n and e t he Ex a m t i m e po i n t<br />

S t a t e s c o r t h e e i S T n A I<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 37.3 34.8 31.5 42.2 39.0<br />

38.3<br />

( 9 5 % C . I . ) (34.0 - 40.6) (29.7 – 40.0) (28.5 - 34.5) (39.1 - 45.4) (33.9 – 44.1) (31.9 - 44.7)<br />

N 13 12 10 13 12 10


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) State scores in the STAI<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

S e l f - h y p n o s i s J o h r e i C o n t r o l s<br />

B a s e l i n e<br />

E x a m s<br />

Fi gur e 24: M e a n (95% C.I .) S t a t e a n x i e t y s c o r e s i n t h e S T <strong>of</strong> A I t he t hr e e gr oups a t ba se line and the Ex a m<br />

t i m e p o i n t<br />

C o n c l u s i o n :<br />

A n x i e t y l e v e l s i n d c r e i a s n e u n i v e r s i t y s t u d e n t s f a c i n g a c a , d an e m d i th c e e x a m i n a t i o n<br />

train in g an d p ract ice <strong>of</strong> J oh rei a p p e a r ed t o h e l p s t u d e n t s t o c o n t se r o pl ro vo t h ked e level s o f<br />

a n x i e t alth y ou gh th is a n t i -an xi et y ef fect d i d n o t a c h i e v e a s t a t i s t i c a l . s i g n i f i c a n c e<br />

3 .1 .3 .2 Effect s o f p s y c h o l o g i c a l i n t e r v e s n t r i e s o s-r n e l a u t p e d o n ly m p h o c y t e s u -p b o p u l a t i s o in n<br />

u n i v e r s i t y s t u d e n ts a n t i c i p a t i n g a c a d e m i c e x a m i n a t i o n s<br />

NK cy toto xi c a cti vi ty (NK CA ) l e v e l s<br />

N K C A l e v e l s w e r e d e t e r m i n e d i n p e r i p h e r pa artici l b pl an o to s d at f th r e o Exa m m 3 1 ti me<br />

p o i n t s . Du e to tech n ical d i f f i c u l t i , t e s h e N K C A l e v e cl ou s ld n ot b e col lect ed at th e b as elin e. T h e<br />

mean level o f th e N KC A in th e R e l a x a t i o n c o n t r o l were g r no ot u p s i gn ifi can tl y d if feren t fr o m<br />

t h o s e l e v e l s i n t h e S -h e l yp f n os is an d th e J oh rei g rou p s (R e l a x a t i o n c o n t r o l v s . S e l -h f yp n os is : t =<br />

1 . 3 , d f , = n ; s 1 R 8 e l a x a t i o n c o n t r o l vs . J o h rei : t = 0 . 2 , 1 d 8, f n s) [Ap = p e n d i x 6 : T a b l e -2 A 6 ].<br />

G e n d e r d i d n o t a p p e a r t -2 o 7 i a n -2 n f 8 ] d l . I u t A e w co n a s nc firmed e [ th at A p p e n d i x 6<br />

th ere was n o g e n d e r b i a . s<br />

C o n c l u s i o n :<br />

p = 0 . 0 0 6<br />

P s y c h o l o g i c a l i n t e r v e n t o t i o a n p p e d a i r d t o i n f l u e n c e N K C A l e v e l s o f u n i v e r s i t y s t u d e n t s<br />

facin g acad emi c e xami n at i on s .<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

p = 0 . 0 2 7<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 5 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P eriph era l N K -c e l l a n d C D 4 a n -c d e l l C p D e r 8 c e n t T a g e s<br />

P e r i p h -c e r l a l a n N d K C D 4 -c a e l n l p d e r c C e n D t 8 a g es we T re d et er min ed for 34<br />

p articip an ts ( 1 9 m a l e a n d 1 5 f e ) m a [ l T e a b l ] e at 1 b7 as el in e an d th e E x a m t i m e p o i n ts a l l o w i n g<br />

an al ys is <strong>of</strong> th e in fl u en ce o f p s yc h o l o g i c a l i n t e r v e n -s tres t i s as o s oci n at ed u ch p an o ges n . e x a m<br />

T able 17: Number s <strong>of</strong> pa rt ic ipa nt s in t h e t hr ee gr o u p s a t t he E x a m t i m e p o i n t<br />

N K -c e l l p e r c e n t a g e s<br />

G r o u p<br />

S e l f-h y p n o s i s J o hr e i<br />

Re la xat io n<br />

co n t r o l s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 6 - I m p e r i a l o C n o d l o n l e g e L<br />

T o t a l<br />

m a l e 7 7 5 19<br />

f e m a l e 5 4 6 15<br />

T o t a l 12 11 11 34<br />

<strong>The</strong>r e w a s n o d i f f e r e n c e b e t w e e n -c t ell h pe ercen t ta ges h r at e e g r o u p s<br />

b a s e l i n e ( S e l f-h y p n o s i s a n d R e l a x a t i on o trol n c : t = 0.5, d f , = n 2 ; s 1 J oh rei an d R el axat ion c o n t r o l : t = 0.7, d f , = s). 2 n 0<br />

R e p e a t e d m e a s u s r e AN OV A s h owed th at th ere is a s ign ifican t d if feren ce in th e ch an ges<br />

fro m b as el i n e t o t h e Exa ms as s es s men t p oin t am on g th e t h ree gr ou p s ( F = 5 .8 , d f = 3 1 , p =<br />

0 .0 07 ). A t t h e E x a m s p e r i o d , -c e l l t p e r h c e n t a r g e i n th e w Ra el s axation a d e c r e a s e<br />

c o n t r o l g r (mean o u p ch an ge = 2 .1 , SD = 4 .7 , t = 1 . 5 , d f , = n s), b1 u0 t th is d id n ot ach ieve s t a t i s t i c a l s ig n i f i c a n c e . Ho w e v e r , th e c h a n g e -cell i p erc n en tages t h in e th e pN sK ych ologic al<br />

in terven t i on gr ou p s were s i gn ific an tl y d i f f e r e n t , i . e . th ere w as a s ign i fican t time x g r o u p<br />

i n t e r a c t ( i F o n = 5 . 8 , d f , p = = 3 1 0 . 7 0 ). Th i s w a s c o n f i r m e d b y f o l l o w i n g p o s t-h o c t-tes ts .<br />

Th e r a e s n o s w i g n i f i c a n t c h a n g e i n -c e l l t p e h r c e n t a g m e e i n a t n h e S -h e N l yp f K n o s is grou p<br />

(mean ch an ge = 1 .0 , t = 0 . 7 , S D , = d 4 f . 5 , = 1 n 1 s), b u t th ere wa s a s ign ifi can t in cre as e in th e<br />

J oh rei gr ou p (me an ch an ge = 3 .2 , t = 6 .9 , SD = 1 .7 , d f =1 0 , p < 0 . 0 0 1 ) at th e E x a m t i m e p o i n t<br />

[Tab le 1 8 an d Fi gu re 25]. A n a l y s e s o f t h e d a t a b y g e n d e r s h o w e d tren t h de s [ s Ap a m pe en d ix 6 :<br />

T a b l -29 e s a n d A ]. 3 0<br />

T able 18: Me a n ( 95% C.I .) l e v e l -c s e l l o f ( % the ) N S K i e l n f-hypnosis, Johrei and Re la xa t io n c ont ro l<br />

( Contr ols) groups at b a s e l i n and e the E xa m t im e p o i n t<br />

N K -c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r l o s<br />

Me a n l e ve l 9.6<br />

7.6<br />

8.8<br />

8.6<br />

10.8<br />

6.7<br />

( 9 5 % C . I . ) (7.7 - 11.5) (4.9 – 10.3) (6.3 - 11.3) (5.7 - 11.5) (8.1 – 13.6) (4.7 - 8.7)<br />

n 12 11 11 12 11 11


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

NK cell percentages (95% C.I.)<br />

2 0<br />

1 5<br />

1 0<br />

5<br />

0<br />

N =<br />

1 2<br />

H y p n o s i s<br />

1 2 1 1 1 1 1 1<br />

J o h r e i<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 7 - I m p e r i a l o C n o d l o n l e g e L<br />

1 1<br />

C o n t r o l ( r e l a x a t i o n )<br />

B a s e l i n e<br />

E x a m s<br />

Fi gur e 25: M e a n (95% C.I .) l e v e l -c e s l l s <strong>of</strong> o t he f t hr ee N gr K oups at bas e lin e a nd t h e E xa m t i m e p o i n t<br />

Fi gu re 26 s h o w s e t h c h a n g e s f -c r e o l l m p e r c b e n a t a s g e s to e th l at i at n th e E xa N m K ti me<br />

p o i n t for i n d i vi d u al s t u d en t s in each grou p . In th e J oh rei g rou p , th ere w as a clea r i n creas in g<br />

tren d wi th e i g h t in d ivi d u al s i n c r e a s e w d h i l th e ree s ta yed th e s am e (l es s th an 2 .6 % ch an ges : 9 9 %<br />

Co n f i d e c n e In ter val <strong>of</strong> th e meas u re in N K -cell %). T h e r e w a s n o c l e a in r the t r Re el n axat d i on<br />

c o n t r o l g r with o u p two in d ivi d u al s in creas ed , f o u r s t e a d y th e s a me an d fi ve d ecrea s ed . In th e<br />

Self-h y p n o s i s , t h in r e creas e ed , f i v e s ta ye d th e s ame an d th ree d ecreas ed .<br />

NK-cell percentage<br />

20<br />

15<br />

10<br />

5<br />

0<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

B a s e l i n e E x a m<br />

20<br />

15<br />

10<br />

5<br />

0<br />

p < 0 . 0 0 1<br />

B a s e l i n e E x a m<br />

p = 0 . 0 2 5<br />

N o t s i g n i f i c a n t<br />

2 0<br />

1 5<br />

1 0<br />

5<br />

0<br />

B a s e l i n e E x a m<br />

Self-hy p n o s i s J o h r e i R e l a x a t i o n o n c t r o l<br />

Fi gur e 26: <strong>The</strong> i n d i vi d u a l le ve ls <strong>of</strong> N K -c e l l p e r c e n t s a g e i t n h e t h r g e e r o u s p at ba s e lin e a nd t he Exa m<br />

t i m e p o i n t


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h i s f i n d i n g w a s i n v e s t i g a t e d -to-t b y r t e h a e t a I n n a t l y e s co n i t s mp i o ari n n g p erc en tages o f<br />

i n d i v i d u a l s b e t w e e n t h e t w o g r o -c u el p l level s s ( an d M a i n t a i n d<br />

D e c r e a s -ce e l l d l e v e N l s . K ) All th e d at a fr om th e s u b jects wh o with d rew we re ad d ed in to th e<br />

n u m b e r i n t h e g r o u p i n w h -cells i c [Tab h le t 1 9 h ]. e s u b j e c t s d e c<br />

T a b l e 19: P er c enta ge s ( numbe rs ) <strong>of</strong> s u b j e ct s wh os e N K -c e l l c o u n t s m a i n t a i n e d o i r n c r e a (M s e a d i n t a i d) n e<br />

and de c r e a s e (D d e c r e a s e ) d in t h e S e l f-hypnosis and Johrei and R e l a x a t i o on n t r c o l groups f o r the<br />

I n t e n t -t i o o-t n r e at a na lys is ( mis s ing da t a we r e a d d e d i n t o t h e n u m the b e D r e c i r n e a s e d g r o u ) p<br />

G r o u p Ma i n t a i n e d N -cells K D e c r e a s e d N -cells K T o t a l<br />

Self-h yp n o s i s 4 4 % ( 7/1 6 ) 5 6 % ( 9/1 6 ) 1 6<br />

J o h r e i 7 5 % ( 1 /1 2 6 ) 2 5 % ( 4 /1 6 ) 1 6<br />

C o n t r o l s<br />

3 8 % ( 6 /1 6 ) 6 2 % ( 0/1 1 6 ) 1 6<br />

T o t a l 2 5 2 3 4 8<br />

Th e p ercen t age <strong>of</strong> t h e s t u d en ts wh o main tain ed th e N K -cell cou n t s at th e E xam ti m e p oin t<br />

i n t h e J o h r e i ( g 7 r 5% ) o u w p a s h i g h e r t h a n t h a t <strong>of</strong> R elax ation c o n t r o l g r o 8% u p ) ( ( 3 P e a r s ’s o n<br />

c h i -s q u are = 4 .6 , p = 0 .0 3 3 ).<br />

C o n c l u s i o n :<br />

A s h as b een s h own in th e l i t e r a t u [ s r e e a l s o I n t r o d u c t i o n : 1 . 2 . 4 b. u3 t ] n ot in th is s tu d y<br />

[3 .1 .1.4 ] , e x a m s t r e s s a to p p res e a ur lt e in d a d ecreas e in p erip h eral b lood N K -cell p ercen tage in<br />

u n i v e r s i t y s t u d e n t i s n t h e R e l a x a t i o n c o alth n t r ou o l gh tg hr is o du ecreas p e d id n ot ach ieve<br />

s t a t i s t i c a l s i g n i . f Ho i c weve a n c e r, t rai n in g in an d p ractis e <strong>of</strong> J oh rei re vers ed th is e f f e c t an d led to<br />

an ove ral l i n c r e a s e<br />

i n -c e l N l K p e r n c t a g es . In con tras t , t rai n in g a n d p r a c t i c e o f S e -h l f yp n os is d id n ot s ign ifi can tl y c h a n g e t h e -cells l . e v e l s o f N K<br />

C D 4 -c T e l l p e r c e n t a g es<br />

T h e r e s u l t s s h o w er e t h w a t s n o t d ih f fere n ce b et ween th e th ree gr ou p s in th e level s <strong>of</strong><br />

C D 4 -c T ell p ercen tages a t b a s e l i n e Self-h ( y p n o s i s a n d R e l a x a t on i o trol n c : t = 0.2, d f , = n 2 ; s 1<br />

J oh rei an d R e l a x a t i o n c o n t r o l: t = 0.5, d f 0, = n 2 s).<br />

R e p e a t e d m e a s u s r e AN OV A s h owed th at th ere is a tr en d toward d iffe ren ce in th e c h an ges<br />

fro m b as el in e to th e Exa ms as s es s men t p oin t b e t w e e the n th ree gr ou p s ( F = 3 .2 , d f = 3 1 , p =<br />

0 .0 54 ). A t t h e E x a m s p e r i o d , t h e r e -cell w a p ercen s a tage n in i th n e c Rr el e axati a s on e i n C D 4 T<br />

c o n t r o l g r (mean o u p ch an ge = 1 .6 , t = 1 . 2 , S D = 4 . 5 , n s), d f b u t = th is 1 0 d id n ot ach ieve s t a t i s t i c a l s i g n i f i a c n a n g c e . i T n h e t c -c h ell e p ercen C D 4 tages T in th e p s ych ol ogi cal<br />

in terven t i on gr ou p s h ad t ren d s toward s d ifferen t ch an ges f ro m th at <strong>of</strong> the R ela xatio n con t rol<br />

g r o u p ( F 3 = . 2 , d f , p = = 3 1 0 5 . 4 0 ). T h e r as e n o w c h a n g e i n t h -cell e m p ercen e a n tage C iD n 4 T<br />

t h e S e l f-h y p n os is gr ou p (mean ch an ge = 0 .1 , t = 0 . 1 , S D = 3 . 5 , n s), d f a = n th d 1 ere 1 was a<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 8 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

t r e n d t o w da ecreas r d e in th e J oh rei g rou p (mean ch an ge = 3 .4 , t = 1 .8 , SD = 6 .2 , d f =1 0 , p =<br />

0 . 0 9 4 ) [Tab le 2 0 a n d F i g u r 27]. e A n a l y s e s o f t h e d a t a b y g e n d e r s h o w e d t r h d e s n s a m e<br />

[ A p p e n d i x -3 6 1 : a n -32]. T d a b A l e s A<br />

T able 20: Me a n ( 95% C.I .) l e v e l s o -c f e l l C D 4 ( % ) t T h e S i e n l f-hyp no s is , J ohr e i a nd Re la xa t io n co ntr ol ( Contr ols) groups at b a s e l i n and e the E xa m t im e p o i n t<br />

CD4 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 45.6 46.5 45.3 45.8 43.1<br />

46.9<br />

( 9 5 % C . I . )<br />

n<br />

(42.4 - 48.9)<br />

12<br />

(42.8 – 50.3)<br />

11<br />

(41.8 - 48.7)<br />

11<br />

(41.1 - 50.4)<br />

12<br />

(37.7 – 48.6)<br />

11<br />

(38.5 - 51.1)<br />

11<br />

Mean (95% C.I.) levels <strong>of</strong> CD4 T-cells (%)<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

p = 0 . 0 9 4<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

S e l f - h y p n o s i s J o h r e i C o n t r o l s<br />

B a s e l i n e<br />

E x a m s<br />

Fi gur e 27: M e a n (95% C.I .) l e v e l s -c o e f l l s <strong>of</strong> C tD he 4 t hr T e e gr oups a t ba se lin e and t h e Ex a m t i m e p o i nt<br />

Fi gu re 28 s h o w s e t h c h a n g e s f r o m b -c a e s l l e p l e r c i e n t e a g e s tC o D th 4 at at T th e Exa m<br />

t i m e p o i n t f o r i n d i v i d u a ls in each gr ou p . Th ere ap p eared t o h a ve n o cl ear t ren d .<br />

I n t h e J o h r e i g r o u p indi , v o i n d e u a l i n c r e a s , e f d i v e s ta yed th e s ame (l es s th an 2 .4 %<br />

ch an ges : 9 9 % con fi d en t in terval <strong>of</strong> th e m eas u re in C D 4 -cell T % ) a n d f i v e d e c r e a s , e d w h i in l e<br />

th e R el axat ion c on trol g rou p , f i v e i n d i v i d u a l s i n c r e a s e d , f o u s r t e a d y th e s am e an d t w o d e c r e a s . e d<br />

I n t h e l e f-h y S p n o s i s g r o u , p t h r in e e creas e d , s e v e n s ta yed th e s ame an d two d e c r e a s . e d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 9 9 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

6 4<br />

5 8<br />

5 2<br />

4 6<br />

4 0<br />

3 4<br />

2 8<br />

B a s e l i n e E x a m<br />

6 4<br />

5 8<br />

5 2<br />

4 6<br />

4 0<br />

3 4<br />

2 8<br />

B a s e l i n e E x a m<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 00 - I m p e r i a l o C n o d l o n l e g e L<br />

6 4<br />

5 8<br />

5 2<br />

4 6<br />

4 0<br />

3 4<br />

2 8<br />

B a s e l i n e E x a m<br />

Self-hy p n o s i s J o h r e i R e l a x a t i o n o n c t r o l<br />

Fi gur e 28: <strong>The</strong> i n d i vi d u a l l e v e l s -c o e f l l C D p e 4 r c e T n t a g t e h s e t i h n r groups e e at bas e line and t he Exa m<br />

t i m e p o i n t<br />

C o n c l u s i o n :<br />

CD4 T cell percentage<br />

E x a m s t r e s s d i d n o t a f f e c -cell t pp ercen e r ti ages p h . e In r ad a dl it ion b , nl eith o o er d <strong>of</strong> C D 4 T<br />

t h e p s y c h o l o g i c a l i n t s e a r f f v e c e te n t d i o C n D 4 -c e T l l p e r c e n t a g e s i g n i f i c . a n t l y<br />

C D 8 -c T e l l p e r c e n t a g es<br />

T h e r e s u l t s s h o w er e t h w a t s n o t s i h g n i f i c a n t d ifferen ce b etween th e th ree gr ou p s in th e<br />

l e v e l s o -c f e l l C p D e r 8 c e n t T a g e s a t b a s e l i n e ( S -h e l yp f n os is an d R e l a x a t i o n on c trol : t = 0.8, d f =<br />

2 1 , n ; s J oh rei an d R e l a x a t i o n c o n t r o l: t = 0.2, d f 0, = n 2 s).<br />

Th ere was n o s i gn i fi can t d i fferen ce s t a t i s t i c a l l y in th e ch an ges b etween th e th ree g r ou p s<br />

( F = 2 .3 , d f = 3 1 , n s ). At th e E x a m t i m e p o i n ts , t h e r e w s a i g s n i f n i c o a n t c h a n g e i -cell n C D 8 T<br />

p ercen tage in th e R e l a x a t i o n on c tr ol a n d J o h r e i g rou p s . Howe ver , an e xp lorat or y a n al ys is with<br />

p aired t-t e s t s s h owed th at t h e C D -c 8 e l l T p e r c e n t a g e s i n c d r i e n a s t e h e S e -h l f y p n o s i s g r o u p<br />

(mean ch an ge = 2 .5 , t = 3 . 1 , S D = 12 1 , . p 8 = , 0 . 0 d 1 f 0 ) [T = a b l e 1 2 a nd F i g u r e ]. An 2 9 al ys es o f<br />

t h e d a t a b y g e n d e r s d h o t w h e s a m e t r e n d s [ A p p e n d i x s 6 : -3 T 3 A a b l a e n -3 d 4 ]. A<br />

T able 21: Me a n ( 95% C.I .) l e v e l s o -c f e l l C D 8 ( % t he ) T S i e l n f-h yp no s is , J ohr e i a nd Re la xa t io n co ntr ol ( Contr ols) groups at b a s e l i n and e the E xa m t im e p o i n t<br />

CD8 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p nosis J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 25.1 26.8 27.2 27.6 27.6 26.8<br />

( 9 5 % C . I . ) (20.9 - 29.4) (24.0 – 29.6) (24.4 - 30.1) (24.0 - 31.2) (24.3 – 30.9) (23.9 - 29.8)<br />

N 12 11 11 12 11 11


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) levels <strong>of</strong> CD8 T-cells (%)<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

S e l f - h y p n o s i s J o h r e i C o n t r o l s<br />

B a s e l i n e<br />

E x a m s<br />

F i g u r e 29: M e a n (95% C.I .) l e v el s o f -c C e l D l 8 s <strong>of</strong> tT he t hr e e gr oups a t ba se lin e and t h e Ex a m t i m e p o i nt<br />

Fi gu re 3 0 s h o w s e t h c h a n g e s f r o m b -c a e s l l e p l e r c i e n t e a g e s tC o D th 8 at at T th e Exa m<br />

t i m e p o i n t f or in d ivi d u al s tu d en ts in e a c h g r o u p . I n t h e S e -h l f yp n os is gr ou p , th ere was an<br />

i n c reas in g tren d wi th s e v e n in d ivid u als i n c r e a s , e f o d u r s ta yed th e s am e (l es s th an 1 .7 % ch an ges :<br />

9 9 % con fi d en t in terval <strong>of</strong> th e meas u re in C D 8 -c T e l l % ) an d o n e d e c r e a s . Th e d ere was n o cl ear<br />

t r e n in d th e J o h r e i with f o u r in creas ed , f i v e s ta yed th e s a me an d two d e c r e a s ; e d a n in d th e<br />

R elaxat ion c on trol gr ou p s , t w o i n d i v i d u a l s i n c r e s a t s e a e d y d th , e ss a me i x an d t h r e e d ecreas ed .<br />

CD8 T cell percentage<br />

40<br />

34<br />

28<br />

22<br />

16<br />

B a s e l i n e E x a m<br />

4 0<br />

3 4<br />

2 8<br />

2 2<br />

1 6<br />

B a s e l i n e E x a m<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 01 - I m p e r i a l o C n o d l o n l e g e L<br />

4 0<br />

3 4<br />

2 8<br />

2 2<br />

1 6<br />

B a s e l i n e E x a m<br />

S e l f-hypnosis J o h r e i R e l a x a t i o n o nt c r o l<br />

Fi gur e 30: <strong>The</strong> i n d i vi d u a l l e v e l s -c o e f l l C D p e 8 r c e T n t a g t e h s e t i h n r groups e e at bas e line and t he Exa m<br />

t i m e p o i n t<br />

C o n c l u s i o n :<br />

N o t s i g n i f i c a n t<br />

p = 0 . 0 1 0<br />

N o t s i g n i f i c a n t<br />

N o t -significant<br />

N o t -significant<br />

Exa m s tres s d id n ot ap p ear to a f f e c t p e r i p h e r -cell a l p ercen b l to ages o d . H C o w D e 8 v e r , T<br />

t h e S e l f-h y p n o s i s a p p e a r e d t o i n c r C e a D s 8 e -c e T l l p ercen ta ges .


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S u m m a r y :<br />

Pr a c t i s i n g S e l -h f yp n os is or J oh r ei p ri o r to acad emic e xa ms , wh en co mp ared with th e<br />

p a s s i v e r e l a x a t i o n e x p e r i e n c e , d i d n o t a p p e a r t o a f f e c t p e r c e i v e d in s t ur ne ivers s s l ie t y v e l s<br />

s tu d en ts faci n g acad emi c exa ms . J o h r e i , h owever , a p p e a r e d t o d e c r e a s e i t n h c r e e a sed a n x i e t y<br />

l e v e l s i n u n i v e r s i t y s t u d e n t s f a c i n g a e t x a m a c s. a d e m i c<br />

N K C A l e v e l s i n t h e u n i v e r s i t y s t u d e n t s p r a c t i s i n g e i t h e -h r yp S e nl f os is or J oh rei at<br />

a c a d e m i c e x a m s w e r e s i m i l t a r h e t l o e v e l t s h e i s n t u s d f e o l n l o w i n g t h e c o n tr o l rel axation<br />

e x p e r i e n c e s. O n t h e o t h e r h c a a n d e , m i a c e x a m s tr e s s ap p eared to b e as s ociated wi th a d ecreas e<br />

i n -c e N l K l l e v e in l s u n ivers it y s tu d en t wi th relaxati on exp erien ce alth ou gh th is d ec reas e d id n ot<br />

a c h i e v e s t a t i s t i c a l s i g , n i f a i n c d a n c i e n t e gl r y e th s t is i d n e c r e a s e w a s er rs e ed v in th e s tu d en ts t r a i n in e d a n d p r a c t i s i n g oh J r e i . S e l f-h yp n os is d id n ot ap p ear to d iffer s i gn ifican tly f ro m<br />

Relaxat ion c on trol in th e e ffect on N K -c e l l l e v e . l O s n t h i s o c c a s i xam o n , se tres s w as n ot fou n d<br />

t o a f f e c t th e le vel s o f C D 4 a n d -cells, C D 8 a n d T th e level s <strong>of</strong> th es e cells were n ot affected b y<br />

J o h r e i i n t e r v wh e n ile t i Se o n l f-h y p n o s i s i n c r e a d s e C D 8 -c e T l l p e rcen tages wh en s tu d en ts faced<br />

a c a d e m s. i c e x a m<br />

T h e s e f i n d i n g s p a r t i a l l y s u p p o r t e d t h e h y p o t h e s i t s e r v t e h n a t n t i ma o p y s y c h o l o g i c a l i n<br />

c o u n t e r a c t t h e f f e c t o f s t r e s s u p o n t h e p r o p o s e d -n e i u n r t o-e e n g d r o a c t r i e n o d -i mp s mu y c nh e o<br />

n e t w o r k ; a n d w a r r a n t t h e n e e d t o i n v e s t i g a t e t h i s h y p o t h e s i s f u , r in t h a e r p a t i e n t p o p u . l a t i o n<br />

H e n c e , t h e n e x t s t u d y e m p l o H y s I -i n V f e c t e d i n d i v i d u [ a 3 l . s 2 ].<br />

3 . 2 T h e i n f l u e n c e o f p s y c h o l o g i upo c a l n per i ce n t i ve e r d v str e n e t ss i a nd o n<br />

q u a l i -o t y f -l i f e a n d v a r i o u s i m m u n o l o g i c a l -a d sso i s e cia a s te e d pa ra me te r s i n<br />

H I V-i n f e c t e d i n d i v i d u a l s<br />

T h e o b j e c t i v e o f t h i s s t u d y w a s t o d e t e r m i n e i f t h e ot f r pa si ych n i n ol g ogi a n cal d p r a c t i c<br />

s t r e s s c o p i n g s k i l l s w o u l d i n f l u e n c as e well s t r as e s i mmu s p ne ol r c o e gi p cal t i po ar n ameters<br />

p a r t i c u l the a r l d i y s e a s e p r o g r e s m s a i r e o k r n , C D4 T-c e l l c o u n , t s i n -in fected H I V in d ivi d u al s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 02 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 2 . 1<br />

Di s e a s e-a s s o c i a t a e n d s t r e s s-rel a te d c ha ng es i n -in H I fecte V d i n d i v i d u a l s<br />

Th is p a r t i n v e s t i g a t e s t h e p r o p o s e d i -n n t e u e r g o-e r a n t d o e c d r i p s n -im o y c mu h o n e n et wor k<br />

b y e xa mi n in g p s ych ol o gi cal an d i m m u n e ( d i s e a s e ) p a r a m e t e r s a n d a s s o c i a t i o n s b e th t e w e e n<br />

p a r a m e t e r s, i .e. b et ween th e l e v e l s o f st r e s s p e r c e p t ion an d p erceived q u a l i -o t f y -l i f e a n d C -D<br />

4 T<br />

c e l l c o u n t a s s p r i m a r y o u t c o m e m e a s . u r e s<br />

3 .2 .1 .1 P s ych ol o gi cal p r <strong>of</strong>i les <strong>of</strong> th e H I V-i n f e c t e d i n d i v i d u a r l s e c r u i t e d i n t o t h e s t u d y<br />

T h e -i H n I f e V c t e d i n d i v i d u a l s r e c r u i t e d i n t o t h e s t u d y w e r fou e r a s k e d a t r e c r u<br />

m o n t h s l a t e r t o c o m p s y l c e h t o l e o g t i c h a e l q p u e s t i o n n a i r e l s i s t in e ord d er t b o e a s l s e s o s th w ei r<br />

l e v e l s o f st r e s s p ercep ti on an d p erceiv ed q u a l i -o t f y -l i f e :<br />

Ge n e r a l a n d -i H n I f e V c t i o n r e st l r e a s t s p e d r c e p t i o n<br />

P e r c e i v e d S t r e s s o r e S c ( P S S ) : s e c o n d a r a y i s a l p p s c a l e<br />

State an xi et y in th e St at e T r a i t A n x i e t y I n v e n t o r y ( S T A : I ) a n x i e t y s c a l e<br />

I m p a c t E v e n t S c a l e ( IE S ) : p r i m a r y a p p r a i s a l a g a i n s t a s t r e s s o r s c a l e<br />

Q u a l i -o t f y -life ( Q o L ) p e r c e p t i o n<br />

Lo c u s o f C o n t r o l ( Lo C ) : s en s e <strong>of</strong> takin g c o n t r o l o f o ’s n e o w n l i s ca f e l e (recal l :<br />

in n er o r o u t e r l o c u s o f c o n t r o l = l o w o r h i g h s c o r e )<br />

M e n t a l C o m p o u n m e m n t a r y S i n t S h F e -3 6 ( M C S ) : m e n t a l -o q f u -l a l i f i e t y s c a l e<br />

P i t t s b u r g h S l e e p Q u a l i t y I n v e n t o r y ( P S Q I ) : s l e e p q u a l i t y s c a l e<br />

W i t h ll a o f t h e s e q u e s t i o n n a i r e s , e x c M e p C t S, lo t w h e r s c o r es m e a n b e t t e r fu n c t i o n i . n g<br />

A n a l y s e s o f t h e s e d a t a i n v o l v e d irs , t, f a c omp ari s on <strong>of</strong> th e P SS an d th e State an xie t y s co res o f<br />

th e p art i ci p an t s i n t h is s t ud y with th os e <strong>of</strong> th e u n ivers it y s tu d en t s in th e p reviou s s tu d y. Sec on d ,<br />

t h e o t h e r p s yc h o l o g i c a l p r <strong>of</strong>i les c ollected s p ecificall y to th i s s tu d y we re an al ys ed b y c o m p a r in g<br />

t h e t w o s t r -r e s e s l a t e d s u b g r o u p s lab ( elled as N o t -s tr es s ed a n d S t r e s s s e d u b g r o u p s ) d e f b y i n e d<br />

t h e m i d l i n e s p l i t o f t h e P S S a t r e c r u i t m e n t , i . e . i n d e i Pv SS i d were u a l s s c o r i n g m o r<br />

p laced in th e S t r e s s se ub d grou p an d in d ivi d u al s s corin g eq u al to o r b elow 3 1 were p laced in to<br />

th e N o t -s t r e s s se ud b grou p .<br />

P ercei ved stres s l e v e l s ( P S S )<br />

T h e -in H fected I V in d ivi d u al s h ad h igh er P SS s cores (mean d iffe ren ce = 7 .2 , t = 4 .5 , d f =<br />

8 1 , p < 0 . 0 0 1 ) t h a n th e u n i v e r s i t y s t u d e n t s f a c i n g e x a m i n a t i o n s , a n d th e P S S s c o r e s d n i ot d<br />

ch an ge s ign ifi can tl y ( F = 2, 0 . 0 d f = , n 4 s) 6 f recru r o it m en t to th e f ou r mon th s later time p oin t<br />

i n -in H fected I V in d ivi d u al s [T a b l e 1].<br />

2<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 03 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 22: Me dia ns , me a ns and st a nda rd de viat io ns <strong>of</strong> th e P SS <strong>of</strong> t h e u n i v e r s i t y s t u d e -exam n t s and a t n o n<br />

e xa ms a nd <strong>of</strong> t h e -i n H f I e c V t individuals e d a t re cr uit me nt and f o u r m o n t h s l a t e r<br />

U n i v e r s i t y s t u d e n t s<br />

H I V-i n f e c t e d i n d i v i d u a l s<br />

Non-e xa m E x a m s R e c r u i t m e n t A f t e r 4 m o n t h s<br />

M e d i a n<br />

22 25 32 31<br />

M e a n 23.3 24.4 31.6 31.7<br />

S D 8.8 7.5 7.0 5.6<br />

n 34 32 51 51<br />

C o n c l u s i o n :<br />

P atien ts wi t h HIV h ave h i gh er s tres s p erc ep tion th an u n ivers it y s tu d en t s facin g exa ms .<br />

Th e s u b grou p s <strong>of</strong> N o t -s t r e s s an e d S t r e s s e w d e r e d e f i n e d b y t h e j u d g e m mi e n dt lin o e f a<br />

s p l i t o f t h e P S S s c o r e a t r e c r u Si tr t es m se ed n t s . u b T g h r e o u p h a 26 d s ub ject s (i n cl ud in g two females ) a n d t h N e o t -s t r e s s e s d u b g r o u p h 2a 5 d s ub ject s (on e femal e). Th e res u lts f rom 5 1<br />

s u b j e c t s ( t h r e e f e m a l e s a n d 4 8 m a l t e s s ) f r o a m n d 4 8 t h m s e u a b l r j e e c s t u s o n rl e y s imil a ar an d<br />

t h e y h a v e t h e s a m e t r e n d , s o r o e n s l u y l t s h e f r o m 4 8 m a l e s re u b pj res e c en t s ted a .<br />

T h e r e s u l t -i n f e r c t o e m d m 4 a l 8 e i H n I d i V v i d u a l s er s e h o w e s r e t d i h f a f t e r e t n c h e s<br />

b etween th e S t r e s s a e n d d N o n -s t r e s s e u d bgr o u p s i n t h vels e l e o f P SS at recru it m e n t an d fou r<br />

mon th s l at er [ Tab l e 23].<br />

T able 23: Me a n ( 95% C.I .) l e v e l s o f t h e the P S Not-s S i t n r e s s e d a n d S t s r u e bgr s s oe ud ps a t the<br />

r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

P S S l e v e l s<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Me a n s c o r e 26.0<br />

36.8<br />

27.4<br />

35.5<br />

( 9 5 % C . I . ) (24.6 – 29.5) (34.9 – 38.6) (25.8 – 28.9) (33.2 – 35.5)<br />

n 24 24 24 24<br />

Th e r e e r e s i g w n i f i c a n t d i f f e r e n s c be etween th e two s u bgrou p s b oth at r e c r u i t m e n t t ( = 9.2 ,<br />

d f = 4 6 , p < 0 . 0 0 1 ) a n d f uo r m o n t h s l a t e r (t = 5.9, d f 6, = p < 4 0 . 0 0 1 ). T h e r e w a s s ign a ifi can t<br />

time x s u b g r o u in p teract ion ( F = 5.8, d f 9, = p 4 = 0 . 0 ), 2 b 0 u t th e P SS s cores d id n ot ch an ge<br />

s ign ifican tl y o ver th e fou r m on th s s tu d y p eriod in th e No t -s t r e s s (t e d = 1.2, d f = 2 3 , n s) or in th e<br />

S t r e s s su e d b grou p (t = 1 .6 , d f , = n 2 s) 3 [Fi gu re 31].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 04 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) PSS levels<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

A ft er 4<br />

m o n t h s<br />

Fi gur e 31: M e a n (95% C.I .) P S S l e v e l <strong>of</strong> s the Not-s tr e ss e d and S t r e s s se ubgr d oup s at r e cr uit me nt and<br />

f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

P S S l e v e l s<br />

i n -i n f H e I c t e V d i n d i v i d u a d l i s d n o t ge c h sa ign n ifi can tl y ove r th e f ou r mon th s<br />

o f t h e s t u d y , p an e d r th i o is d con s is ten c y i n th e levels <strong>of</strong> P SS s cores w a s a l s o s h w o h w e n th e<br />

S tr es s ed o r N o t-s tr es s ed s u b g r o u ps w e r e s e p a r a t e l y . c o m p a r e d<br />

Sta te a n x i e t y l e v e l s<br />

I n c o n t r a s t t o t h e P S S , a n x i t e t h y e -i n l f e c H v t e I e l d s V i n d i n v i d u a l s w e r e s i m i tl o a r th e<br />

levels o f th e u n ivers it y s tu d en ts ( m e a n d i f f e ren ce = 1 .1 , t = 0 . 4 , d , f n = s) , 8 5 a n s d t a t an e xiet y<br />

l e v e l i -in fected n t in h d ivi e d u al H s I d id V n ot ch an ge s ign ifican tl y ( F = 0 . 7 , d , f n s) = fro m 4 6<br />

recru it men t to f o u r m o n t h s l a t e [T r a b l e 4]. 2<br />

T able 24: M e d i a n , m e a n a n d s t a n d a r d d e v i a t i o n o f a n t x i h e t S y t a s t c <strong>of</strong> o e r t e h e u n i ve r s i t y s t u de nt s at<br />

non-e xa m an d e xa ms and <strong>of</strong> t h e -i n H f I e c V t individuals e d a t rec r uit me nt a nd f o u r m o n t h s l a t e r<br />

U n i v e r s i t y s t u d e n t s H I V-i n f e c t e d i n d i v i d u a l s<br />

Non-e xa m E x a m s R e c r u i t m e n t A f t e r 4 m o n t h s<br />

M e d i a n<br />

37 40 36 38<br />

M e a n 37.9 39.7 38.9 40.8<br />

S D 9.4 8.3 12.5 14.4<br />

n 37 36 51 51<br />

C o n c l u s i o n :<br />

N o t -significant<br />

p < 0 . 0 0 1<br />

p < 0 . 0 0 1<br />

N o t -significant<br />

T h i s r e s u l t s u g g e s t e d t h a t th ere was little d i f f e r e n c in e th e St at e an xi et y s c o r es in H IV-<br />

i n f e c t e d i n d i v i d u a l s c o m p a r e d w u n i t v h e r s t i h t e y s t u d e facin n t s g acad emi c exa ms .<br />

W h e n c o m p a r i s o n s w e r e m a d e b e t w e e n 4 t 8 h e -in H fected I V mal e in d ivi d u al s in the N o t -<br />

s tr es s ed and S t r e s s grou e d p s b as ed on a med ian s p lit <strong>of</strong> t h e P S s S c o r , e t h e i n d i v i d u a l s in th e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 05 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S t r e s s su e d b grou p h ad s ign ifi can tl y h igh e r an xiet y lev els th an th e in d ivid u als in th e N o t -<br />

s t r e s s e u d b g r o u p b o t h a t r e c r u i t m e n t t = ( 7 .0 , d f = 4 9 , p < 0 . 0 0 1 ) a n d f o u r m o n t h s l a t e = r ( 6 .1 ,<br />

d f = 4 9 , p < 0 .0 0 1 ). Th ere was n o s ign ific an t time x s u b g r o up i n t e r a c t i o n .7 , ( F d f = , = 1 n s 4 ), 9<br />

a n d th e St at e an xi et y s c o r e s d i d n o t c h a s n g i e g n i f i c a o n v t e l r y t h e s t u d y in p th e r No i o t d -<br />

s tr es s ed su b grou p (mean ch an ge = 2 .2 , t = 1 . 1 , d , f n = s) or 2 in 3 th e S t r e s s se ud b grou p (mean<br />

ch an ge = - 0 .3 , t = 0 . 3 , d , f n s) = [ 2 T 3 a b l 5 e a 2 n d F i g u r 32]. e<br />

T able 25: Me a n ( 95% C.I .) l e v e l s o f t h e S t a t e a n x i e t y s c o the r e Not-st o f re t sh se e d and S T A S I t r i e n s s e d<br />

subgr ou ps at t h e r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

St a t e an xie t y s c o r e o f t h e S T A I<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 30.2<br />

49.6<br />

30.5<br />

47.4<br />

( 9 5 % C . I . ) (26.9 – 33.4) (45.1 – 54.1) (27.6 – 33.3) (42.6 – 52.2)<br />

n 24 24 24 24<br />

Mean (95% C.I.) State anxiety scores<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

a fte r 4<br />

m o n t h s<br />

Fi gur e 32: M e a n (95% C.I .) le ve ls <strong>of</strong> t he St a te a nx iet y s c or e s in t he ST AI <strong>of</strong> t he N ot -s t re s s e d and S t r e s s<br />

subgroups at re c ruit me nt a nd f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

N o t -significant<br />

p < 0 . 0 0 1<br />

p < 0 . 0 0 1<br />

N o t -significant<br />

H I V-in fect ed in d ivi d u al s rep ortin g l ow le vels o f stre s s a l s o r e p o r t l o w e r s c o r s e <strong>of</strong> t h e<br />

State an xi et y t h a n i n d i vi d u al s rep ortin g h igh levels <strong>of</strong> s tr es s .<br />

P rima ry a ppra i s a l a g a i n s t a s pecific lif e even t l e v e l s ( I E S )<br />

T h e p r i m a r y a p p r a i s a l -in o fe f cti on t was h e meas a u red w a b y r th e n e s s o f c<br />

IES. Th e m e a n I E S s c o r e s o f S t r h e s s in e d ivid u al s were s ign ifi can tl y h igh er th a n th e levels<br />

fo r th e N o t -s t r e s s e i d n d i v i d u a l s itment a t r e (t c = r 3.2, u d f = 2 3 , p = 0 . 0 0 3 ) an d aft er f ou r m on th s<br />

(t = 3.2, d f = 2 3 , p = 0 . 0 0 3 ). T h e I E S s c o r e s d e s c i r g e n a i s f e i d c ove a n t r th l y e s tu d y p eri od ( F =<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 06 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 8 .8 , d f = 4 6 , p < 0 . 0 0 1 ), a n th d is was o b s e r v ed i n b o th t e h S tr es s ed s ub grou p (me an ch an ge =<br />

7.3, t = 3 .5, d f = 2 3 , p = 0 . 0 0 ) 2 a n d th e N o t -s t r e s s e s d u b g r o u p ( m e a n 6.2, c h t a = n 2.7, g e d f =<br />

2 3 , p = 0 . 0 1 ), 3 b u t th ere was n o s ign ifi ca n t time x s u b g r ou p i n t e r a c t i 0 o .5 n , ( d f F , = n 4 s ) 9<br />

[T a b l e 6 2 a n d igu F re 33].<br />

T able 26: Me a n ( 95% C.I .) l e v e l s o S f i the n t subgr h e ou I pE s <strong>of</strong> t he Not-st r es s ed a nd S t r e s s at e d t he<br />

r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

I E S<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Me a n 16.5<br />

31.4<br />

10.4<br />

24.2<br />

( 9 5 % C . I . ) (10.0 – 23.1) (24.7 – 38.1) (5.9 – 14.8) (16.6 – 31.7)<br />

n 24 24 24 24<br />

Mean (95% C.I.) IES levels<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

A fter 4<br />

m o n t h s<br />

Fi gur e 33: M e a n (95% C.I .) le ve ls <strong>of</strong> t he I ES in t he N ot -s t r e s s and e d S t r e s s subgroups at r ec r uit men t and<br />

f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

p < 0 . 0 0 1<br />

p = 0 . 0 0 3<br />

p = 0 . 0 0 3<br />

p = 0 . 0 0 2<br />

T h e i m p a c t i n t h p e r i m a r y a p p r a i s a l f r o m d i a g n o s e d a s<br />

c a r r y -i i n f n e c g t i o n H I d e as c V r ed e<br />

o v e r t h e s t u d y . Alth p e r ou i o gh d th e d ecre as ed levels o f imp act in th e H I V-in fected in d ivid u als<br />

w e r e n o t d i f f e r e n t th e b se tres t w se ed e n a n d n o t-s tres s ed s u bg r o u ps, i n d i v i d u a l w s i t h a h i g h<br />

p e r c e i v e d s t r e s s l e v e l c o n s i s t e n t l y s h o w e d h i g h e r l e v e l s i o m f p act th an th e in d ivi du al s in th e<br />

n o t -s t res s ed s u bg r o u p b ot h at r e c r u i t m e n t a n d f o u r m o n t h s l a . t e r<br />

L ocus <strong>of</strong> con trol (L oC : S e n s e o f c o n t r o l o f ’s o n w e n l i f e l e ) v e l s<br />

Th e s en s e <strong>of</strong> ta ki n g c on trol <strong>of</strong> o n e ’s o w n l i was f e meas u red b y u s in g th e LoC . Th e Lo C<br />

s c o r e re e s ign ifi w can tl y h i g h e r i n S t h r e e s s in e d ividu al s th an th e N o t -s t r e s s ind e d ivid u al s at<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 07 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

recru it men t (t = 2.8, d f = 2 3 , p = 0 . 0 ) 0 an 7 d fou r m on th s lat er (t = 1.0, d f = 2 3 , p = 0 . 0 0 ), 2 b u t<br />

th ere was n o s ign ifi can t time x s u b g ro up i n t e r a c t i o n ( F 4 9, = n s ), 0 . an 1 d , th e sd cores f = d id n ot<br />

c h a n g e s ign ifi can tl y ove r th e s tu d y p eri o d ( F = 0 . 4 , d , f n s) = [ T 4 a 6 b l e 2 a 7 n d F i g u 4]. r e 3<br />

T able 27: Me a n ( 95% C.I .) l e v e l s o f t h e the L o N C ot -s i tr n e ss e d and S t r e s s subg e d r o u p s a t t he<br />

r e cr u i t m e nt and f o u r m o n t h s l a t e r<br />

Lo C s c o r e<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 9.3<br />

12.6<br />

8.7<br />

12.6<br />

( 9 5 % C . I . ) (5.9 – 14.8) (11.0 – 14.2) (7.5 – 11.0) (11.0 – 14.2)<br />

n 24 24 24 24<br />

Mean (95% C.I.) LoC levels<br />

1 5<br />

1 0<br />

5<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

A fte r 4<br />

m o n t h s<br />

Fi gur e 34: M e a n (95% C.I .) l e ve l s o f t h e Lo C i n the N ot -s t r e s s and e d S t r e s s subgroups e d a t r e cr uit ment<br />

and f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

N o t -significant<br />

p = 0 . 0 0 7<br />

Th e locu s <strong>of</strong> con t r ol d i d n ot ch an ge s ign if ican tl y o ver th e s tu d y p eri od , an d les s s t res s ed<br />

H I V-i n f e c t e d i n d i v i d u rep a l s orted th e lo wer s co res (a h igh er s en s e <strong>of</strong> t a k i n c g o n t r o l o f o ’s n e<br />

o w n l i ) f th e an d id h igh er s t r e s s e d i n d i v i d u . a l s<br />

N o t -significant<br />

p = 0 . 2<br />

0 0<br />

M enta l a s p e c t o f q u a l i t y o f l i f e l e v e l s ( M C p S s : y c h o l o g i c a l f u n c t ) i o n i n g<br />

T h e p s ych ol ogi cal fu n ct i on i n g in th e H I V-i n f e c t e d i n d i v i d u a l s n o t r e c e i v i n g a n t i-<br />

r e t r o v i r a l m e d i c a t i o n a n d n o t e x i p e r n c i n g d i s e a s -related e s ym p to ms in th is s tu d y was<br />

examin ed b y meas u ri n g m en tal as p ect <strong>of</strong> q u alit y <strong>of</strong> lif e, i.e . th e MC S s c ores . Th e M C S s c o r e s<br />

w e r e s i g n i f i c a n tl y h i gh er in th e N o t -s tr es s ed i n d i v i d u a l s t h a n S i t n r t e s h e s in e d ivid u al s at<br />

recru it men t (t = - 5.8, d f = 2 3 , p < 0 . 0 0 1 ) a n d f o u r m s o later n t h (t = - 4.6, d f = 2 3 , p < 0 .0 0 1 ),<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 08 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

b u t th ere was n o s ign ifi can t time x s u b g r o u p i n t e r a c t i o n .2 , ( F d f = = , 1 4 n 9 s ) , th e a n s cores d d id n ot ch an ge s ign ifi can tl y ov er th e s tu d y p eriod ( F = 0 .8, d f , = n 4 s) 6 [ T a b l e 28 an d Fi gu re 35].<br />

T able 28: Me a n ( 95% C.I .) l e v e l s o f t h e the M C N S ot -s i tr n es s ed and S t r e s s subgr e d ou ps a t r e cr u i t m en t<br />

and f o u r m o n t h s l a t e r<br />

M C S s c o r e<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Me a n 51.8<br />

35.3<br />

52.1<br />

37.6<br />

( 9 5 % C . I . ) (48.7 – 54.8) (30.5 – 40.1) (48.8 – 55.4) (32.2 – 42.9)<br />

n 24 24 24 24<br />

Mean (95% C.I.) MCS levels<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

Af te r 4<br />

m o n t h s<br />

Fi gur e 35: M e a n (95% C.I .) le ve ls <strong>of</strong> t he M SC in t he N ot -s t r e s s and e d Str e ss e d subgroups a t r e cr uit me nt<br />

and f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

P s y c h o l o g i c a l f nu in n c g, t as i o meas u red b y th e men tal h e a l t h c o m p o n e n t -3 6 o f t h e S F<br />

( M C S ) , d id n ot ch an ge s i gn ifican tl y o v e r t h e s t u -in d fected y p in e d ir vi di u al o s d in , th e a n d H I V<br />

s tres s ed s u b grou p r e p o r t e d l o w e r l e v e sl ych s olo o f gi cal p fu n ct ion in g th an in d ividuals in th e<br />

n o n -s t r e s s e d s u b g r o u p b a o t r h e c r u i t m e n t a n d f o u r m o n t h s l a . t e r<br />

Sleep q u a l i t y l e v e l ( P s S Q I )<br />

Th e P SQI s co res <strong>of</strong> th e S t r e s s in e d ivid ual s were s ign ifi c an tl y h igh er th an th at o f t h e N o t -<br />

s t r e s s at e d recru it men t (t = 2 .1 , d f 6, = p 4 = 0 . 30 9 ) an d aft er f ou r m on th s (t = 2.9, d f 6, = p = 4<br />

0 . 0 05), b u t th ere was n o s ign ifican t time x s u b g r o u p i n t e r a c t i o n , ( F d f = 9, = 0 n. s 4 6 ), an d th e<br />

s cores d id n ot ch an ge s i g n i f i c a on ver t l ty h e s tu d y p eri od ( F = 0 .6, d f , = n 4 s) 6 [ T a b l e an 2 9 d<br />

F i g u r e 6]. 3<br />

N o t -significant<br />

p < 0 . 0 0 1<br />

N o t -significant<br />

p < 0 . 0 0 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 09 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 29: Me a n ( 95% C.I .) l e ve l s o f t h e P t he S Q N I ot -s i tr n es s ed and S t r e s s subgr e d ou ps a t r e cr u i t m en t<br />

and f o u r m o n t h s l a t e r<br />

P S Q I<br />

R e c r u it m e n t A f t e r 4 m o n t h s<br />

Not-s t r e s s e d St re s se d Not-s t r e s s e d St re s se d<br />

Mea n<br />

8.1<br />

10.3<br />

7.5<br />

10.2<br />

( 9 5 % C . I . ) (6.9 – 9.4) (8.7 – 11.8) (6.6 – 8.4) (8.6 – 11.8)<br />

n 24 24 24 24<br />

Mean (95% C.I.) PSQI scores<br />

1 2<br />

1 0<br />

8<br />

6<br />

4<br />

2<br />

0<br />

N o t - s t r e s s e d S t r e s s e d<br />

R e c r u i t m e n t<br />

A fter 4<br />

m o n t h s<br />

Fi gur e 36: M e a n (95% C.I .) le ve ls <strong>of</strong> t he P SQI in t he S t r e s s and N ot -s t r e s s e s u d b g r o u p s a t re c r uit me nt<br />

and f o u r m o n t h s l a t e r<br />

C o n c l u s i o n :<br />

p = 0 . 0 3 9<br />

N o t -significant<br />

N o t -significant<br />

p = 0 . 0 0 5<br />

Th e s leep q u al it y s c ores d id n ot ch an ge s i gn ifican tl y o v e r t h e s t u -d<br />

y p e r i o d ,<br />

in fected i n d i vi d u al s in t h e s t res s ed s ub grou p r e p o r t e d wo rs e s leep q u alit y th an H I V-in fe cted<br />

i n d i v i d u a l i s n t h e -s n t o n r e s s e d s u b g at r recru o u p it men t an d f ou r m on th s later.<br />

3 .2 .1 .2 St r e s s-r e l a t e d p e r c e an p t d i d i o s n e a s e p r o g r e s s i o n m a r k e s r o f H I V i n f e c t i o n<br />

C D 4 -c T ell c ou n ts an d HIV vi ral l oad lev els are r ou tin el y m eas u red f o r t h e p u r p o s e o f<br />

c l i n i c a l m l o y n i t o r i n g d i s e a s e p r o g r e s s i o n . T h e r e -cell f o r e , r e l a t i o n<br />

c o u n t s a n d H I V v i r a l l o a d l e v e l s a n d l e tres v e l s s p erc o f ep s ti on were exa mi n ed .<br />

R a t e o f d e c l -c i e l n l e c o u n i t ( n C D 4 C g D r 4 a d i e T n t )<br />

C D 4 -c T e l l c o u n t s f o r m a m a j o r -in fected p a r p a t ti en ts o . f t h e r o<br />

A s d e s c r i b e d i n t h e m e t h o d s s e c t i o n [ 2 . 6 3 1 . p 2 a ] r , t i o c nts f i p t a r h e c r u i , on t e l y d 3 8 p at ien ts ( 6 0 ) h . a d 3 s u f % f i c ie n t d a t a f r o m w h 4 i g rad c ih en ts dt u ri o n g th c e (fou a l r c mon u th l a t e t h e<br />

p l u s o n e m o , n five t h m on th s al toget h er, i . e. B as elin e to T erm f ou r) s tu d y p eriod . W i t h i n t 38 h e<br />

p atien ts , 3 2 p art i ci p an t s (3 0 males an d two fe males ) co mp leted th ei r q u es tion n aires. Th e res u lt s<br />

ob tain ed from 3 2 s u b j ect s and th e res u lts fro m 3 0 male s u b ject s on l y are s i milar an d th e y h a ve<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 10 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

th e s ame t ren d , s o on l y t h e res u lts fro m 3 0 male s u b jects were p res en ted . Mean C D4 grad ien t <strong>of</strong><br />

3 0 mal e s u b j ect s was a d ecl i n e <strong>of</strong> 3 cells p er l p er mon th .<br />

Th e C D 4 grad ien t o ver th e five m on th s w a s i n v e s t i g a t e d b y c o r r e l a t i o n a n a fo l r y s e s<br />

a s s o c i a t i o n with s the l e v e l s o f s t r h e s -r s elated p ercep ti on s (S tat e an xiet y s co re <strong>of</strong> th e STAI,<br />

th e Percei ved St res s Sc o r e: PSS a n d I m p a c t E v e n t S : c I a E l S) e an d the p e r c e i v q e u d a l i -o t f y -life<br />

(Locu s <strong>of</strong> Co n t r o l : L o , C M e n t a l C o m p o n e n t S u m m a -3 r 6 y : M i C S n an t d h P e it ts bS uF rgh Sl eep<br />

Q u a l i t y I : n P d S e Q x I ). Th e C D 4 g r a d i e n t s o v e r t h e f i v e m o n t h s n w o t a s s i g n i f i a c s a s n t o c l i y a t e d<br />

with th e s cores o f St at e an xi et y, I E S o r P S S a t e i t h e r re cru itmen t o r a f t e r t h fe ou r mon th s ti me<br />

p o i n t s, a n d t h a t t h e r e w a s n o s i g n i f i c a n t a s s with o c i a t s i c o n r e s o f th e M C S o r P S Q I a t e i t h e r<br />

recru it men t o r a f t e r f o u r m o n t h s Ap [ p e n d i x 6 : T a b l -3 e 5 ] . here A T was a tren d tow ard s a<br />

p o s i t i v e c o r ti r on e l (r a = 0 .3 2 , n = 3 0 , p = 0 .0 85 ) b etween th e C D4 grad ien ts an d Lo C s cores at<br />

recru it men t , b u t t h i s rel at i on s h ip was n ot s tatis ticall y s ign ifican t at f ou r mon th s aft er th e<br />

r e c r u i t m e n t [Ap p e n d i x 6 : Ta b l -3 e 5 ]. A<br />

C o n c l u s i o n :<br />

Th e s c o r e s o f s t r e s s , p q e u r a c l e i p t y i o o n f l i f e q u a n l d i eith s t l y er e e at p re cru it men t or at<br />

fou r mon th s h a d n o s ign ifi can t a s s o c i a t ion w i t h t h e C D 4 g r a d i over e n t s th e fi ve m on th s p eri od ,<br />

i.e. n o n e o f t h e s c o r e a s t a o n e a s s e s s m e n t p o i n t c o u i l n d t b h e i s u s e s pd t red u t d ict y o or to indicat e th e r a t e o f c h a n g e i n t n h t s e C i D n 4 -in c fected o H u I V p at ien ts n o t r e c e i v i n g a n t i-<br />

retro viral t reat men t .<br />

T h e D 4 C g r a d i e n t r e p r e s e n ts t h e r a t e o f c Ch D4 a n g cou e ni ts n o v e r a f i v e pm eriod o n t , h<br />

t h e r e f o r e c h a n g e s c o r e s o f vari t h ou e s p ercei ved s tres s sc a les (State an xiet y s co res , P SS and<br />

IES) ove r th e s am e p eri od we re a n a l y s ed with th e C D 4 g r a d i e n t. Th e C D 4 g r a d i e n t s h a d n o<br />

s i g n i f i c a n t a s s o c iation wi t h th e State an xi et y, I ES or P SS [Ap p e n d i x 6 : Tab le A-3 6 ].<br />

Fu rth er, c h a n g e s c o r e s o f t h e v a r i o u q s u a l p e i r -o t c f y -l e i v f e d e w e r e a n a l y s i e t d , w a s a n d<br />

fou n d th at th e C D 4 g r a d i e n t s h a d a s i g n i an f i t c n egat ive c or rel at ion with th e ch an ge s cores <strong>of</strong> th e<br />

L o C; an d a s ign ifi can t p o s i t i v c e o r r e l a t ion with th e ch an ge s cores o f th e M C S , while t h e r e w a s<br />

tren d toward s a n egat i ve c o r r e l a t with i o n the c h a n g e s c o r e s o f P t S h Q e I [T a b l e 3 0].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 11 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 30: C o r r e l s a t b e i t o w n e e n t h e C D 4 g r a d i e n t per ( c e l l s pe r m o n t h ) a n d t h e c h a s n c g o e r e s <strong>of</strong><br />

pe r ce ive d q u a l i -<strong>of</strong>-l t y i f e a s l c es i : n<br />

L o C * M C S * P S Q I<br />

R - .40 .44 - .32<br />

2-t a ile d p 0.029 0.015 0.086<br />

N 30 30 30<br />

*: p < 0.05<br />

Th e cor rel at i on s b et ween C D4 gr ad ien t an d th e c h a n g e s c o r e s in th e (1 ) LoC , (2 ) MC S<br />

an d (3 ) P S QI can i m p l y t h a t :<br />

1. In d ivi d u al s wi th an i n c r e a sed s en s e <strong>of</strong> tak in g c o n t r o l o f o ’s n e o w n l i (d f ecreas e ed<br />

t h e i r sc o r e L s) o sC h ow ed an in creas e in t h e i r -c C e D ll 4 c ou nT ts (recal l th at l ow LoC<br />

= i n n e r l o c u s o f c o n t r o l), a n d i n d i v i d u a l s w h o d e c r e s a s e n d s e t h o e f n trol c o<br />

(in creas ed th ei r LoC sc o r e s) s h owed a d e c r e a s e in t h e i r -c e C l l D c 4 o u n t T s ;<br />

2 . I n d i v i d u a l s im w p h r o o v e d t h e i r p s ych ol o gi cal fu n ction in g (in cre as ed MC S levels )<br />

s h o w e d a n i n c r e a s t e h i e n i r -cell C D c ou 4 n tT s , an d in d ivi du al s wh o rep orted a<br />

d e c r e a s e p i s yc n h o l o g i c a l fu n ct ion in g (d e creas ed MC S s c o r es ) s h owed a d e c r e a s e i n<br />

t h e i r -c C e D l 4 l T c o u n t s ; a n d<br />

3. I n d i v i d u a l s im w p i r t o v h em e n t their i n s le ep q u al it y (d ecr eas ed P SQI s c o r es ) s h ow ed<br />

a n i n c r e a s e t i h n e i r -c e C l l D 4 c o u n T t (re s call th at l o w P S Q I = b e t t e r s l e e p ), q u a l i t y<br />

an d in d ivi du al s wh o r e p o r t e d a d e c r e s leep a s e q ui al n it y (i n creas ed P SQI s c o r es )<br />

s h owed a d e c r e a s e in t h e i r -c ell C D co 4 u n tT s .<br />

Th erefo re, fu rt h er an al ys es we re p er for m ed after gr ou p in g th e p atien ts accord in g to<br />

ch an ge sc o r e s o f s t e h p e e r c e i v e d q u a l i ty-o f -l i f e s c a l e ( s i n c r e a s e d o r d e c r e a s e d ), a n similar d<br />

t r e n s d o f a s s o c i a t i o n b s e t w e e n c h a n g e s i n t h e s e s c a l e s C D a n 4 d g r t a d h i e n ts were<br />

d e m o n s t r a t . T e h d e r e w e r e s i g n i f i c a n t d i th f e f C e D r 4 e g n r c a e d s i e n t i w n h e n C D 4 g r a d i e n t s w e r e<br />

c o m p a r ed b et ween the t w so u b grou p s acc ord in g to c h a n g e s c o r e s o f:<br />

1. L o C (t = 2 .1, d f = 3 0 , p = 0 4 . 9 0 ): I n c r e a sed s e n s e o f c o n t r o l o f o ’s n e o w n l i f e<br />

(I n c r e a s e d c o n t r o l: 1 6 in d ivid u als w i t h a creas d e ed LoC s c o r e) an d Decreas ed s e n s e<br />

<strong>of</strong> c on trol (D e c r e a s e d c o n t r o l: 1 4 i n d i v i d u a l s w i t h a n i n c r e a s e d L o C s c o s u r e b ) g r o u p s<br />

[ T a b l e 1 an 3 d Fi gu re 3 7 ] ;<br />

2. M C S (t = 2.4, d f = 3 0 , p = 0 2 . 7 0 ): Imp ro ved p s ych ol o gi cal fu n ction in g (Imp r o ved<br />

Q o L : 1 6 in d ivi d u al s w i t h a n c r e i a s n ed M C S s c o r ) e a n d D e c r e a s e d ch p olo s y gi cal<br />

f u n c t i o n i (D n g e c r e a s e d : Q 1 o 4 L i n d i v i d u a l s w i t h a d e c r e a ) s se ud b grou s c o r pe s [Ta b le 32 an d Fi gu re 3 8 ] ; a n d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 12 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3. P S Q I (t = 2.1, d f = 3 0 , p = 0 4 . 7 0 ): I m p r o v e d s l e e p q u a ( l 2 i 3 t in y d ivi du al s h a d a<br />

d e c r e a s e P d S Q I s c o r ) e an d D e c r e a s e d s l e e p q u a l (7 i ind t y i v i d u a l s h a d a n i n c r e a s e d<br />

s c o r e) s u b g r o u p s [ T a b l e 3 an 3 d Fi gu re 3 9 ] .<br />

T able 31: Me a n ( 95% C.I .) C D 4 -c T e ll c ha nge ove r the f ive mont h ( c e lls per l per month) in HI Vinf<br />

e ct e d in dividua ls <strong>of</strong> t he I n c r e a se d c o nt ro l a n d De cr e as e d c ont r ol subgroups<br />

CD4 T-c e ll c ha nge ( ce lls pe r l pe r month)<br />

I n c r e a se d co n t r ol D e c r ea s e d c o nt ro l<br />

Me a n CD4 gr a die nt<br />

+ 9<br />

- 15<br />

( 9 5 % C . I . )<br />

(- 2.8 t o + 21.7) (- 34.7 t o - 5.2)<br />

n 16 14<br />

Mean (95% C.I.) CD4 gradient (cells/ul/month)<br />

4 0<br />

2 0<br />

0<br />

- 2 0<br />

- 4 0<br />

I n c r e a s e d c o n t r o l D e c r e a s e d c o n tr o l<br />

Fi gur e 37: M ea n ( 9 5% C . I .) C D 4 gr a d i en ts ( c e l l per s l pe r mo nt h) in t he I n c r e a se d co n t r ol ( de cr e as e d<br />

s c o r e s o f t h ) e and D L e o c C r e a s e c d on t r o l ( i n c r e a s s c o e r d e s o f t h ) e subgroups L o C<br />

T able 32: Me a n ( 95% C.I .) C D 4 -c T e ll c ha nge ove r the f ive mont h ( c e lls per l p e r m o -n<br />

t h ) i n H I<br />

inf e ct e d in dividua ls <strong>of</strong> t he Im p r o v e d QoL a nd D e c r e a s e QoL d subgroups<br />

CD4 T-c e l l c h a n g e ( c e l l s p e r l per month)<br />

I m p r o v e d Q o L De c r ea s e d QoL<br />

Me a n C D 4 gr a d i e nt + 11<br />

- 19<br />

( 9 5 % C . I . )<br />

(- 1.4 t o 21.4) (- 40.5 t o + 2.5)<br />

n 16 14<br />

Mean (95% C.I.) CD4 gradient (cells/ul/month)<br />

4 0<br />

2 0<br />

0<br />

- 2 0<br />

- 4 0<br />

p = 0 . 0 4 9<br />

p = 0 . 0 2 7<br />

I m p r o v e d Q o L D e c r e a s e d Q o L<br />

Fi gur e 38: M ea n ( 9 5% C . I .) C D 4 gr a d i en ts ( c e l l per s l pe r m o n t h ) i n It mpr h e ove d me nt a l ps yc hologic a l<br />

f unct ion in g (Im p r o v e QoL: d i n c r e a s e d s c o r e <strong>of</strong> s the M C S ) and De c re a se d p s y c h o l o g i c a l f u n c t i o n i n g<br />

(D e c r e a s e d : d Q e o c L r e a s e s d c o r e s <strong>of</strong> t he MCS ) subgroups<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 13 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 33: Me a n ( 95% C.I .) C D 4 -c T e ll c ha nge ove r the f ive mont h ( c e lls per l p e r m o -n<br />

t h ) i n H I<br />

inf e ct e d in dividua ls <strong>of</strong> t he Im p r o v e d s l e e p q u a l and i t y D e c r e a s e d s l e e p q u a l subgroups i t y<br />

CD4 T-c e ll c ha nge ( ce lls pe r l per month)<br />

I mpr ov e d s l e e p q u a l i t De y c r ea s e d s l e e p q u a l i t y<br />

Me a n C D 4 gr a d i e nt<br />

+ 4<br />

- 26<br />

( 9 5 % C . I . )<br />

(- 8.4 to + 1 8.2) (- 48.9 t o - 1.9)<br />

n 23 7<br />

Mean (95% C.I.) CD4 gradient (cells/ul/month)<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

- 2 0<br />

- 4 0<br />

- 6 0<br />

I m p r o v e d s l e e p q u a l i D t e y c r e a s e d s l e e p q u a l i t y<br />

Fi gur e 39: M e an (95% C.I .) CD 4 gr a d i en ts ( c e l l per s l pe r m o n t h ) i n It mpr h e ove d sl ee p quali ty<br />

( d e c r e a s e d s c o r e s o f t h P e S Q I ) and D e c r e a s e d s l e e p q u a l ( i t i y n c r e a s c s o e r d e s <strong>of</strong> t he P S Q I ) subgroups<br />

C o n c l u s i o n :<br />

p = 0 . 0 4 7<br />

T h e s e f i n d i n g s s u g g e s t t h a t t h e r a t e o f d e c l -c i e n l e l i n c o t -in u h fe e n cted t C D 4 o f T H I V<br />

i n d i v i d u a l is s a s s o c i a with t e d c h a n g e s c o r s e i n t h pe ercei ved con tr ol , p s ych ol ogi cal fu n ction in g<br />

a n d s l e e q p u a l i s t cales y r a t h e r t h a n a c t u a l s c o r es o n o n e o c c a , i s .e. i o th n os e wh o inc r e a s ed C D4<br />

T-c e l l c o u n t o s v e r t h e fi v e m o n t h eriod p i m p r o e v d i n t s h c e o r es <strong>of</strong> L o C, M C S an d P S Q I .<br />

Ra te <strong>of</strong> ch a n g e i n HI V vi ra l loa d ( HI V vira l loa d g r a d i e n t)<br />

V i r a l l o a d l e v e l s a r e a n o t h e r m a j o r p a r t o f t h e r o u t i n e m o n i t o r t i n h g e o H f I -in V fec ted<br />

p a t i e n t s, p art icu larl y wi th reg ard to d ru g t reatmen t. Altho u g h n o n e -in fe o cted f t h e H I V<br />

i n d i v i d u a l s in t h i s s tu d y h a d t a k e n a n y a n t i-retr ovi ral treat men t , th e r ate o f ch an ge in viral l oad<br />

l e v e l s -tran ( l o sg fo rmed fi gu res ) w as calc u lated b e t w e e n t h recru e it men t ti me p oi n t a n d fou r<br />

m o n t h s l a t e r . S i m i l t a o r t h e r e s u lt s o f t -c h e l C D l 4 T b l o o d c o l l -e<br />

c t i o n , n o t<br />

i n d i v i d u a l s r e c r u i t e d h a d v i r a l l o a m d e l a e s v u e r l s e d r i d n u g t h e s t u d y p e r i o d Ap [ p e n d i x 6 : Tab le A-3 7 ]. Of t h e 6 3 p a r t i c i p a n t r s e c r u i , ot ne l y d 3 8 p a t i ) h ad e sn u ffi t ci en s t d ata ( fr om 6 0 wh . ich 3 %<br />

t o c al c u l a t e t h e v i r a l l o -t a r d a n s l f o e r m v e l d ) grad ( l o ien g ts d u ri n g th e s tu d y p eriod . With in th e<br />

a b o v e 3 8 p a t i e n t s , 3 2 p a r t i c i p a n 2 t 9 s ( m a l e s a n d t h females r e e ) co mp let ed th ei r q u es tion n aires .<br />

T h e r e s u l t s o b t a i n e d f r o m 3 2 s u b j e c t s a n d es t h ue lts r fro m 2 9 mal e s u b ject s are s i m ilar an d th e y<br />

h ave th e s ame t ren d , s o on l y th e r e s u l t s f r o m 2 9 m a l e s re u b pj res e c t en s ted a .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 14 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

This viral l oad l evel g rad i en t ove r th e fi v e mon th s w a s in ves tig ated b y co rrelati on<br />

an al ys es fo r as s oci at i on with the s c o r es o f t S h t e a t e a n x i e t c y o s r e , , I P S E S S, L o C, M C S a nd<br />

P S Q I . Th ere was n o s i gn i fi can t co rrelati o n a t e i t h e r r e c r u i t m e n t or a f t e r f o u r m o n t h s t i m e p o i n t s<br />

[Ap p e n d i x 6 : Tab l e A-3 8 ]. S i milar t o th e an al ys es <strong>of</strong> th e C D4 grad ien t , ch an ge s c o res <strong>of</strong> th e<br />

s t r e s s p e r c e p t i o n s ( S t a t res e , Pa Sn S x i an e d t IES y s ) c an o d p erceived q u a l i -o t f y -life s cal es ( LoC ,<br />

M C S a n d P S Q I) o v e r t h e s a m e p e r i o d w e r e c o r r e l a te d with th e viral l oad lev el g ra d ien t.<br />

H o w e v e r , t h e v i r a l l o a d l e v e l g r a d i e n t we s r e n ot s i gn ifi can tl y as s ociated with th e c h an ge s cores<br />

<strong>of</strong> a n y s e l f-r e p o r t v a r i a [Ap b l e p e n d i x 6 : Tab le A-3 9 ].<br />

Co n c l u s i o n :<br />

Viral load l e vel w as n ot s i gn ifican tl y as s ociated with an y <strong>of</strong> th e p ercei ved s t res s o r<br />

q u a l i -o t f y -li fe m e a s u r es u s ed i n t h i s . s t u d y<br />

R a t e o f c -c e h l l a c o n u n g t e ( N K g i r a n d i e n t N ) K<br />

Becau s e N K -c e l l l e v e were l s s h own to b e a s s o c i a t d e with th e s tres s p ercep ti on in th e<br />

u n ivers it y s tu d en ts [ 3 . 1 ], f o r e x p l o r a t o r y p u r s, p o th s e NK grad ien t was al s o calcu lated fro m th e<br />

s a m e b l o o d s a m p l e d -c a t e a l l a s g t r h a e d C i D e 4 n T t s . O n e s - a m p l e d a t<br />

c e l l lcu c a lation . Hen ce 37 s u b j e cts h a d s u f f i c i e n t d a t a gr f ad ien r o ts m w h i c h<br />

d u rin g th e s tu d y p eri od . W i t h i n t h e a 7 b o p v a e t i 3 e n t 1 s p , a r t i 3 c i p a n t s 2 ( 9 m a l e s a n d t w o<br />

females ) co mp let ed th ei r q u es tion n aires . T h e r e s u l t s o b t a i n e d f r o m 3 1 s u b j e c ts a n d t h e r ults e s<br />

fro m 2 9 mal e s u b j ect s are s i milar an d th ey h a ve th e s a me t ren d , s o on l y th e res u lts fro m 2 9 male<br />

s u b ject s were p res en t ed .<br />

T h e N K g rad i en t ove r t h e fi ve mon th s an d th e s cores o f th e p s ych olo gical meas u re s were<br />

fu rth er i n v e s t i g a t e d b y c o elation r r an al ys es for as s oci at i on s with the l e v e l s o f s t r h e s -related s<br />

p ercep ti on s (S t a t e a n x i e t y s , PSS c o r e a n d I E S) an d the p e r c e i v q e u d a l i -o t f y -life an d s leep (L o C,<br />

M C S an d P S Q I ). R es u lt s s h ow t h a t g t r a d h i e n t s o v N e K r f i v e m o n t we h s r e n o t s i g n i f i c a n tl y<br />

a s s o c i a t with e d th e s cores <strong>of</strong> St at e an xiet y, I E S, PSS L o C, M C or S P S Q I a t e i t h e r recru it men t o r<br />

a f t e r f o u r m o n t h s , e x c e p t w i t h t h e P S Q I a t r e c r u i t m e n t [Ap p e n d i x 6 : Tab le A-4 0 ]. Th ere was a<br />

s ign ifican t cor rel at ion ( r = 0 .4 4 , p = 0 . 0 1 7 ) b e t w e e n t h e dN ien K t an g r d a th e P SQI s core at<br />

recru it men t b u t th is correl at i on was n ot r ep licated at th e fou r m o n t h a s s e s s m e n t p o i n t Ap [ p en d ix 6 : T a b l -4 e 0 ]. Si A mi la r to th e an al ys es o f th e C D4 grad ien t, ch an ge s co res o f th e s t res s<br />

p e r c e p t i o n s ( S t a t e a n x i a e n t d I y E S s ) c o a r n d e s q , -o u a f l -l P i S f t S e y s c a l e s Lo ( C , M C S an d<br />

P S Q I) o v e r t h e s a m e p e r i o d w e r e c o r r e l a ted with NK grad ien ts . Howeve r, n on e <strong>of</strong> th es e<br />

c o r r e l a t i o n s w e r e s t a t i s t i c a l l y s i g n i f i c a n t [Ap p e n d i x 6 : Tab le A-4 1 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 15 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

Th e l e v e l s o f o r c h a n g e d l e v e l s o f N -c K e l l c o u n t were n ot s ign ifi can tl y as s ociated with<br />

an y <strong>of</strong> th e s tres s p ercep ti on o r q u alit y o f l ife meas u res u s ed i n t h i s . s t u d y<br />

S u m m a r y :<br />

P a t i e n t s d i a g w n o i s i t hs ave h h igh H er I sV tres s p ercep ti on th an u n ivers it y s tu d en ts facin g<br />

e x a m s , a n d t h e h i g h e r l e v e l s d id n ot ch an ge s ign ifican tl y o ver th e fou r m on th s <strong>of</strong> t h e s tu d y<br />

p eriod . On t h e ot h er h an d , t h ere was little d ifferen ce in th e State an xiet y l evel s b e t w e e n t h e<br />

H I V-in fect ed in d ivi d u al s a n d t h e u n i v e r s i t y s t u d e n t s f a c i n g a c a d e m i , c e a x a n m s d -in fected H I V<br />

individual s wh o r e p o r t e d l ow l e v e l s o f s t r e s s a l s o r e p o r te d l o w e r State an xiet y s c or es t h a n<br />

in d ivid u al s wh o r e p o r t e d h igh levels o f s t res s . Th e imp act o f b ein g d i a g n o s e d a -s<br />

c a r r y i<br />

in fection d ecreas ed o v e r t h e s t u d y p e r i o d . the A l i m t p h a o c u t g h l e v e d l e s c r e a se d , i n d i v i d u a l s<br />

w i t h h i p g e h r c e i v e d s t r e con s s s is ten tl y s h owed h igh er s c o r es o f t h e i m p a c t t h a n t h e i n d i v i d u a l s<br />

w h o r e p o r t e d l o w s t . r e s s<br />

Th e p e r c e i v e d q u a -o l f -l i i t f e y (l ocu s <strong>of</strong> co n trol , p s ych ol ogical fu n ction in g an d s leep q u a l i ) t s y c a l e s d i d n o t c h a n g e s ig n i f i c a n o t v l e r y t h e s t u d y p e r i o d , a n d lo w e r s t r e -s<br />

s e d H I V<br />

in fected in d ivi d u al s con s tant l y r e p o r t e d ing h a v a h igh e r s en s e <strong>of</strong> taki n g con tr ol o f on e’s own<br />

l i f e , b e t t e r p s y c h o l o g i c a l f u n c t i o n i n g a n d b th e e t h t i e g r h e r s l s t e r e p s s d q u a l i t y t h a n<br />

in d ivid u al s .<br />

No t a b l , y i t w a s c o n c l u d e d t h a t th e s c o r e s o f s t r e s s a p e n d r c e p e p t r c i e o i n q v u e a d l -o i t f -life y<br />

s c a l e s at a s i n g l a e s s e s s m e n t p o i n t ( r e c r u i t m e n t o r f o u r m o n t h s l a t e r ) w e r e n o t a s s o c i a t e d w i<br />

t h e r a t e o f c h a n g -in e fected i n p at ien t ts h (n e o t re c C e i D v 4 i n g a n c t i-re o u trovi n t ral s i n H I V<br />

t r e a t m e n t ); b u t th a t t h e r a t e o f d -c e c l l l c o i u n t e o i f n -in fected H t I h V e in dC ivi D d4 u al s T w a s<br />

a s s o c i a t e d w i t h c h a n g e s i p n e r t c h e i v e d q u -o a f l -l i t f y (L e o C , M C S a n d P S Q I s ) c o r e s.<br />

Th es e res u lt s su p p o r t t h e c e n t r a l h y p o t h e t s i h t s a s tres s cau s es d et ri men tal effects u p on<br />

w e l l -b e i n g; an d fu rt h er, t h a t a n i m p r o v e m e n t i n p e r c e i -o v f e -li d fe q mu a y l hi at v e y b e n e f i cial<br />

e f f e c t u p o n d i s e a se p r g o r e s s n i , o i . e . p s y c h o l o g i c a l i m p r b o e v be en m efi e n ci t al f m o a r y h eal th .<br />

Th is lead s on to t h e n e x t ves i ti gat n ion o f p s ych ol ogi cal in terven tion u p on t h e p s y c -n h e o u r o-<br />

e n d o c r i n -im o mu n e n et work , p art icu larl y u p on th e p e r c e i v e d q u a -o l f -li i t fe y s cal es an d th e<br />

d i s e a s e p r o g r e s s i o n m a r k T-c e r l , l c o C u D n t 4 [ 3 . 2 .<br />

2 ]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 16 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 2 . T 2 h e i n f l u e n c e o f ps y c h o l o g i c a l i n t e r v e n t ion u pon d i s e a s e pro g r e s i pa o n ra mete rs in H I V-i n f e c t e d i n s d e d i c v o n i t r d o l u l a e d l t s r i a ( l r o v a p e r n r i o d a ) o f m o u r m o n t h<br />

Th is s t u d y i n ves t i gat es t h e h yp oth es is th a t ps yc h o l o g i c a l i n terv en tion can c o u n t e r a c t<br />

d e t r i m e n t a l e f f e c t o f s t r e s s u p o r n o g d r s i e s i e a o s n, e i . e . d e c l i -cel n e l cou o nf ts , t h e C D 4 T<br />

a c t i n g t h r o u g h t h e p r o p o s e d i n t e -n g e r u a r t o-e e n d d o p c s r y i c h n -i o<br />

mmu n e n et wor k.<br />

3 . 2 . 2 . Ef 1 f e c t o f p s y c h o l o g i c a l i n t e r v e -in n fe cted t i o n u p o n<br />

i n d i v i d u a l s<br />

Th e in fl u en ce <strong>of</strong> th e p s yc h o l o g i c a l i n t e r v e n t m i e o n t a l u w p o e l n l-b ei n g (p ercei ved s tres s<br />

a n d q u a l -o i f t -life y ) w a s e a x m i n e d b y c o m p a r i n g t h e n t s h c e o r s e l -rep s f o rt q u es ti on n ai res<br />

b e t w e e n t h e S e l -h f yp n os is , J oh rei grou p s an d t h e w a i t-l i s t e d on tr c ol grou p .<br />

T h e S t a t e a n x i e t y s c e o s r o r th e P SS s core s d id n ot ch an ge s ign ifican tl y fr o m th e B as elin e<br />

t o t h e P o s t-i n t er ven t i on t i me p oin t (f ou r mon th s after th e Bas elin e) in an y g rou p , an d th e s cores<br />

d i d n o t d i f f e br etween gr ou p s at ei th er as s es s men t p o i n t [Ap p en d ix 6 : Tab le A-4 2 ]. T h e I m act p<br />

Even t Scal e ( IES ) s co res i m p r o v e d s i g n i f tly i c ba et n ween th e p r e- a n d p o s t- i n t e r v e n time t i o n<br />

p o i n t s (F = 1 4 .1, d f = 4 8 , p < 0 . 0 0 1 . ) Th ere w e r e, h o w e v e r , n o s i g n i f i c a n t g r o u es p in d i f f e r e n c<br />

t h i s c h a n , g i.e. e n o s i gn ifi can t time x g r o u p in teraction ( F = 0 . 8, d f = 4 8 , n [T s ) a b l e 4]. 3<br />

T able 34: Me a n ( 95% C.I .) l e v e l s o f t -i h n d e i v i d I u a E l S t s h e i S i n e l -h n f yp n t o s i h s , e J oh r e H i a I nd V wa i tl<br />

i s t e d ontrol c groups a t t h e B a s e l i and n e P o st -i n t e r v e n t i o n t i m e p o i n t s<br />

I E S<br />

B a s e l i n e<br />

P os t -i n t e r v e n t i o n<br />

S e l f-hypnos i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 23.1 23.5 28.4 16.0 20.1<br />

21.2<br />

( 9 5 % C . I . ) (19.2 - 27.0) (18.3 - 28.7) (24.2 - 32.6) (12.3 - 19.7) (15.2 - 25.0) (17.2 - 25.2)<br />

N 21 12 18 21 12 18<br />

Th e o c L u s o f C o n t r o l ( L o C (F ) = 1.1, d f , = n 4 s), 8 M e n t a l C o m p o n e n t s S -u<br />

m m a r y o f S F<br />

3 6 (MC S ) (F = 0.8, d f = , n 4 s) 8 o r P i t t s b u r g h S l e e p Q u a l i t y I n v e n t o r y ( P S (F Q I ) = 1.9, d f , = 4 8<br />

n s ) s c o r e s d i d n ot ch an ge s i gn ifican tl y f r o m t h e B a s e l i n e t o t h e P o s t-in ter ven tion t ime p oin t in<br />

a n y g r o u p , n o r d i d i t d if f e r b e t w e e n g r o u p s a t e i t h e r a s s e s s m e n t p o i n t, i.e. n o s ign ifican time x<br />

g r ou p i n t e r a c s t [Ap i o n p en d ix 6 : T a b l -4 e 3 ]. Hen A ce, it was c on cl u d ed th at p s ych ol ogical<br />

in terven ti on d id n ot affect s tres s p ercep tion or p erceived q u a l i -o t f y -life s i gn ifi can tl y.<br />

Ho we v e r , a v i h n g s h own in th e p re vi ou s s ection th at th e w o r s i n i in n g th e l e v e l s o , f t h e L o<br />

M C S a n d P S Q I o v e r t h e s t u d y w p e r e pi os o itivel d y as s oci at ed wi th th e d e c l i n e i n t h e -<br />

C D 4 T<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 17 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

c e l l c o u n t [ 3 . 2 . 1 . 3 , ] th e d is tri b u ti on s <strong>of</strong> th e n u m b e r f o p e o p l e w h o w e r o e v i n m g p o r w o r s e n i n g<br />

in th e level s <strong>of</strong> ( 1 ) L o [ Tab C le 3 5 ], (2 ) M C S [Tab le 36] an d (3 ) P SQI [Tab le 37] w e r e f u r t h e r<br />

e x a m i n e u d s i n g t h e I n t -t e n o-t t r e i a o t n a n a l y s i s ( T h e p a r t i c i p a n t s w h o f a i l e d t o p r o v i d -rep e s e ort l f<br />

q u e s t i o n n a i r e d a t a w e r e a d d e d i n t h e n u o m f b e t r D h s e c r e a s e d c o n t r o l, D e c r e a s e d o Q r o L<br />

D e c r e a s e d s l e e p q u a l g i r o t u y p s ) f o r t h e e x p l o r a t o r y . p u r p o s e<br />

T able 35: S u m m a r y o f ) t o h f e -i t n d i h n v e i u d u m a l H b s I w e V h o r s e s c h a n g in ( e s the % LoC be t we e n t he<br />

B a s e l i n e a nd p os t-i n t e r v e n t i o n e i t h e r d e c r e a s e d I n ( c re a s e d c o nt r ol: i n c r e a s e d s e n s e o f one’s c o n t r o l i n<br />

o w n l i ) f o e r i n c r e a s e d (D e c r e a s e c d o nt r ol) i t n h e S e l -hypnosis, f Johrei and wait-l i s t e d ontrol c groups<br />

I n c r e a s ed c o n t r o l Decr ea s ed c o n t r o l T o t a l<br />

Self-h y p n o s i s 1 0 / 2 1 ( 4 8 % ) 1 1 / 2 1 ( 5 2 % ) 2 1<br />

J o h r e i 9 / 2 ( 1 7 5 % ) 3 / 1 2 ( 2 5 % ) 1 2<br />

Co n t r o l 1 0 / 1 8 ( 5 5 % ) 8 / 1 8 ( 4 5 % ) 1 8<br />

T o t a l 2 9 2 2 5 1<br />

T able 36: S u m m a r y o f t h e n u m b e r s %) ( o f -i t n d i h v e i d u a l H s I w V h o s e c h a n g in e s the M CS be t we e n t he<br />

B a s e l i n e a nd p os t-int er ve nt ion e it her in cr e as ed (Im p r o v e d : Q o i L m p r o v e d p s y g c i h c o a l o f u n c t i ) or o n i n g<br />

d e c r e a s e d (De cr e as e d Q o L ) i t n h e S e l -h f yp n o s i s , J o hr e i a nd wa i t-l i s t e d ontrol c groups<br />

I m p r o v e d Q o L D e c r e a s e d Q o L T o t a l<br />

Self-h y p n o s i s 11 / 2 1 ( 5 2 % ) 10 / 2 1 ( 4 8 % ) 2 1<br />

J o h r e i 7 / 1 2 ( 5 8 % ) 5 / 1 2 ( 4 2 % ) 1 2<br />

C o n t r o l 7 / 1 8 ( 3 8 % ) 1 1 / 1 8 % ( 6 ) 2 1 8<br />

T o t a l 2 5 2 6 5 1<br />

T able 37: S u m m a r y o f t h e n u m b e r s %) ( o f -i t n d i h v e i d u a l H s I w V h o s e c h a n g in e s the P SQI bet we e n t he<br />

B a s e l i n e a nd p os t-i n t e r v e n t i o n e i t h e r d e c r e a s e d I m ( p r o v e d s l e e p q u a ) l o i r t i y n c r e a s e d (De cr e ase d sl ee p<br />

quality) i t n h e S e l -hypnosis, f J o hr e i a n d wa i t-l i s t e d ontrol c groups�<br />

I m p r o v e d s l e e p q u a l i t D y e c r e a s e d s l e e p q u a l i T t o y t a l<br />

Self-h y p n o s i s 15 / 2 1 ( 7 1 % )<br />

6 / 2 1 ( 2 9 % ) 2 1<br />

J o h r e i 9 / 1 2 ( 7 5 % )<br />

3 / 1 2 ( 2 5 % ) 1 2<br />

C o n t r o l 1 0 / 1 8 ( 5 5 % ) 8 / 1 8 ( 4 5 % ) 1 8<br />

T o t a l 3 4 1 7 5 1<br />

T h e p e r c e n t a s g e o f t -i h n e f e c H I t V e d i n d i v i d u a l . s M C w S h o r o P S Q i I m p r o v e d t<br />

s c o r es i n t h e J o h r e i g r o u a p l l w h e i r g e h e r t h o a s n e i t n h t h w e a i t-l i s t e d on trol c gr ou p , a l t h o u g h<br />

thes e d i f f e r e n t p e r c e n t a g e s b e t w e e n t h e t h r e e g r o u p s d i d n o t a c h i e v e s t a t i s t i c a l s i g n i f i<br />

(Self-h y p n o s i s v s . w a i t-l i s t e d on tr c ol : c h i -s q u are = 0 . , 2 a n J d o h r e i v s . w a i t-l i s t e d o n t c r o l : c h i -<br />

s q u are = 1 .2 f o r t ; h S e l f-h yp L o n o C s i s v s . w a i t-l i s t e d on tr c ol : c h i s q u a r = e 0 . 7, an d J oh rei vs .<br />

w a i t -l i s t e d o n t c ro l : c h i -s q u a r e = 1 .1 f or t h e MC S; an d Self-h y p n o s i s . w v a i t -l i s t e d on trol c : c h i -<br />

s q u a r e = 1 . , 1 a n J d o h r e i v s . w a i t-l i s t e d o n t c r o l : c h i -s q u a r e = 1 .2 f o r t h e P S Q ). I<br />

S a m p l e s i z e c a l c u l a t i o n s h o w s t h a t , i or t 1 3 3 w , o s u l b j d e c ts n e p e r d g r 1 o 2 u 1 p in ord er<br />

t o s t h a h t 7 o 5 %, w or 5 8 % i n t h e J o h r e i , i s g s r i o g u n p i f c a n t l y d iffe ren t to t h e %, 5 5 o in r 3 8 %<br />

th e w a i t -listed c o n t r o l g r , o u r p e s p e c t .<br />

i v e l y<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 18 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

Ne i t h e r S e l f-h yp n os i s n or J oh rei ap p eare d to alter an xiet y or p ercei ved s t res s level s in th e<br />

H I V-in fect ed i n d i vi d u al s (n o t r e c e i v i n g a n t i-r e t r o v i r a l t r e a t m e n ts). Th e i mp act o f b ein g aware<br />

<strong>of</strong> c a r r y i -i n f g e c t i H I o n V d e c r oe ver a s th e d e s tu d y p eri od , b u t n e i t h e r t h e i n t e r v e n t ion <strong>of</strong> th e<br />

Self-h yp n os is n or J oh rei aff ected th e d ecr eas e o ver th at fou n d i n t h e w a i t-l i s t e d o n t c r o l g r . o u p<br />

No n e o f th e LoC , MC S an d P SQI s c o r es c h a n g e d, a n t d h e J o h r e i a n d S e -h l f yp n os i s gr ou p d id n ot alter th es e s co res s ign ifi can tl y o v e r t h e s t u d y , p alth e r ou i gh o d th e J oh rei g r ou p s h owed th e<br />

h igh es t p e r c e n t a g e s imp w h o r ov ed in their s c o r e s all i n t h e p e r c e i d v e q u a l -o i t f -l y i f e s c a l . e s<br />

S a m p l e s e i calcu z lat ion s h owed th at th e n u mb ers in each gr ou p were to o few t o d e mon s trate<br />

s tatis tical l y s i gn i fi can t ch an ges .<br />

3 .2 .2 .2 E f f e c t o f p s y c h o l o g i D 4 c a T-c l e l i l n t e c r o v -in u e n fected n t s i o n i n u p H o I n V C<br />

i n d i v i d u a l s<br />

Th e in fl u en ce <strong>of</strong> p s ych ol ogi cal in terven ti on u p on th e c h a n g e i n t h -cell e co C uD n4 ts T<br />

(C D 4 g r a d i e n t: t h e d i s e a s e p a r a m e t ) e w r a s e x a m i n e in d o rd er to tes t th e h yp ot h es is th at<br />

p s ych ol ogi cal in terven ti on ma y cou n terac t the d e t r i m e n t a l e f f e c t o df is eas s t e r e s s u p o n<br />

p r o g r e s s -i i n f o e c n t e d i n d n i v i d H u . a I l s V<br />

C D4 grad i en t s were c on s t ru cted for 1 5 p articip an ts in the Self-h yp n o s i s , t e n i n t h e J o h r e i<br />

a n d 1 3 in t h e w a i t-l i s t e d o n t c r o l gr ou p s . A mean d ecl in e o f 1 2 cells p er l p e r m o n t h - i n C D 4 T<br />

c e l l c o u n t s w a s s h o w n i n t h e w a i t-lis ted con trol gr ou p . T h e Kr u s k a l -Wallis ran k t e s t sh owed a<br />

t r e n d t o w a r d s d i f f e r e n c e a m o n g t h e t h r e e g r o u c p h s i -s ( q u are = 5 .5 , d f = 2 , Mon te C arlo<br />

s i g n i f i c a n = c e 0 . 064 ) . h e se T d i f f e r e n t s a t m r o e n g d t h e t h r e e g r o u p e w s r e c o n f i r m b y e d<br />

follo wi n g c h i -s q u a r e a n a l y s e . s Th e re was a s ign ifi can t d e c r e a s e i n t h e r a t e - o f d e c l i<br />

cells in p art ici p an ts wh o were t r a i n e d i n a n d p r a c t i s mp i n g ar ed J o wi h r th e i n d ic vi o d u al s in th e<br />

w a i t -l i s t e d o n t c r o l (c h i -s q u a r e = 3 . 9 , d f -tail = ed 1 , p = t w 0 . o 0 7) 4 a n d S e l f-h yp n os is (c h i -s q u are<br />

= 4 . 5 , d f = -tailed 1 , p t w = o 0 . 0 3) gr ou p s . Th ere was , h owe ver, n o d iffe ren ce in C D4 grad ien t<br />

b e t w e e n t h e S e l -h f yp n o s i s a n d w a i t-list e d o c n t r o l g r o u p (c s h i -s q u a r e = 0 . 1 , d f = ) 1 [Tab , n s le 38<br />

a n d F i g u r 0]. e 4<br />

T able 38: Me a n ( 95% C.I .) le ve ls <strong>of</strong> C D 4 gr ad ie nt s (c o u n t s pe r l p e r m o n ) t i h n H I -inf V e ct e d in dividua ls<br />

i n t h e S e l -hypnosis, f J oh r e i and wa i t -l i s t e d ontrol c groups<br />

CD4 gr a die nt (c o u n t s per l p e r m o n ) t h<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n c h a n g e - 9 + 1 7 - 1 2<br />

( 9 5 % C . I . ) (-17 to -1) (+ 6 t o + 28) (- 20 t o - 3)<br />

n 15 10 13<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 19 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

CD4 gradient (95% C.I.) cells/month<br />

50<br />

0<br />

- 50<br />

N =<br />

1 5<br />

Hypnosis<br />

1 0<br />

Johrei<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 20 - I m p e r i a l o C n o d l o n l e g e L<br />

1 3<br />

Control<br />

Fi gur e 40: M e a n s ( 9 5 % C . I . ) C D 4 g r a d o i v e e n r t the s f i v e m o n t h st s udy p e r i o from d the Base line t o t he<br />

P os t -i n t e r v e n t i m o e n p o i nt<br />

Th is fin d in g w a s f u r t h e r i n v e s t i g a t e d b y -to-t t h r e a t I a n n t a e l n y t s c i o s m o n p ari n g<br />

p ercen tages o f in d ivi d u al s b etween th e two grou p s (d ecreas e or m a i n t a i ne d t h e -cell C D 4 T<br />

c o u n t s ). Al l t h e d at a fr o m t h e s u b jects wh o with d rew wer e ad d ed in to th e n u mb er in th e grou p<br />

i n w h i c h t h e s u b j e c ts d e c r e a s e d t -cells h e i [T r ab le C 3 D 9 ]. 4 T<br />

T a b l e 39: P er c enta ge s ( numbe rs ) o f p a r t i c i p a n t -c s e ll cw oh unt o s ma e int C aD ine 4 d or T de c re a se d<br />

ove r t he f ive mont hs in t h e S e l f-h yp n o s i s a nd J o h r e i and wa i t-l i s t e d ontrol c groups f o r t he<br />

I n t e n t -t i o o-t n r e at a na lys is ( mis s ing da t a we r e a d d e d i n t o t h e n u m t b e h r e D i e n c r e a g s r e o d u ) p<br />

G r o u p Ma i n t a i d n e C D 4 -cells T D e c r e a s e d C D 4 -cells T T o t a l<br />

Self-h y p n o s i s 2 9 % (6 /2 1 ) 7 1 % (1 5 /2 1 ) 2 1<br />

J o h r e i 5 8 % ( 7 /1 2 ) 4 2 % (5 /1 2 ) 1 2<br />

C o n t r o l s<br />

3 3 % ( 6 /1 8 ) 6 7 % ( 2/1 1 8 ) 1 8<br />

T o t a l 1 9 3 2 5 1<br />

T h e p e r c e n t -i a n g f e e c t e d o i f n d i v l t i d s u h a e w h o H I m V a i n t a i n -cell e d c o ut n th s e in C D 4 T<br />

t h e J o h r e i ( g 5 r 8 o % u ) p w a s h i g h e r t h a n t h a t o f w a i t-l i s t e d on trol c g rou p (3 3 % ), b u t th e d ifferen t<br />

p ercen t ages b et ween t h e t h ree g rou p s d id n ot ach ieve s tati s tical s ign ifican ce. Th e s amp le s ize<br />

c a l c u l a t i o n s h a o t w i t s w o t u l h d n e e d 8 4 s u b j e c ts p e r g r o u p t o tha s t 5 h 8 % o w in th e J oh rei g rou p<br />

i s s i g n i f i c a n tl y d iffer en t to t h e % 3 3 i n t h w e a i t-listed c o n t r o l g . r o u p<br />

C o n c l u s i o n :<br />

p = 0 . 3<br />

0 3<br />

N o t s i g n i f i c a n t<br />

p = 0 . 7 0 4<br />

As s h own in th e p revi ou s an al ys is [ 3 . 2 . 1 ], C D -c 4 e T l l c o -in u n fected t s in d ivi i dn u al s H I V<br />

w h o w er e n o t r e c e i v i n g a n t i-r e t r o v i r a l t r e a t m e n t i n t d h e c w r a e i t-l a s i e s d t e d on tr c o l gr ou p .<br />

H o w e v e r , t h i s d e c r e a s -c i ell n cou g n t ap r pe eared n d to o bf e reve C rs D ed 4 b y T th e train in g an d<br />

p r a c t i c e o f J o h r e i, a l t h o u g h t h i s w a s n o t s u p p o r t e d -t o-t b y reat t an h e al ys i in s , t wh e n it le i to hn e<br />

����


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

t r a i n i n g a n d p r a c t i c e o f S -h e l yp f n os is d id n ot ap p ear to affe ct th is tren d . S a m p le s i ze calcu lation<br />

s h o w e d t h at t h e n u mb ers <strong>of</strong> each g rou p w ere to o few t o d em on s t rate s tati s ticall y s i gn i fican t<br />

ch an ges .<br />

3 .2 .2 .3 E f f e c t o f p s y c h o l l o in g i ter c a ven ti on u p on o t h e r i m m u n o l o g i c a l m a -r<br />

k e r s ( l o g<br />

tran s for med v i r a l l o a d l e v e ls a n d -c e l l N c K o u n t s )<br />

i n -i n f H e I c t e V d i n d i v i d u a l s<br />

V i r a l l o a d l e -t v r e a l n s f o ( r l m o e d g ) g r a d i e n t s w e r e c o n s t r u c t e d f o r 1 4 p a r t i c i p a n t s i n - S e l f<br />

h y p n o s i s , 1 2 i n J o h r e i a e n w d a i t-l 1 2 i s i t n e d o t n t c h r o l g r o u p s NK ; a gn rad d ien ts were<br />

c o n s t r u c t e d f o r 1 5 p a r t i c i p a n t s i n S -h e y l p f n o s i s , 1 0 i n J o h r e i g r o u p s a n d 1 2 i n th e w a i t-listed<br />

con trol s . T h e v i r a l l o a d l -t e r v e a n l s f ( o r l m o e g d ) d i d n o t c s h a i n g n e i f i c oa ver n t tl hy e fi ve<br />

m o n t h s n o r K g d r a i d i d e n t , s a N n d t h e r e w e nr o e s i g n i f i c a n t d i f f e r e n c be etween th e th ree g rou p s<br />

[Ap p en d ix 6 : T a b l es -4 A 4 a n d -4 5 , A r e s p e c t ]. i v e l y<br />

C o n c l u s i o n :<br />

As s h own in th e p revi ou s an al ys is [3 . 2 . ], 1 n e i t h e r v i r a l l o a d l e v e l n o r N -cell K c ou n t<br />

c h a n g e d s i g n i f i c a n i t l n y -i n f e H c I t e d V i n d i v i d u a l s w h o w e r e n o t r e c e i v i n g a n t i-retr ovir al<br />

t r e a t m e n t , a n d t h e t r a i n i n g a n d p r a c t i c e o f J o h r e i o -h r yp S e nl os f is d id n ot affect th e viral load<br />

l e v e l o r t h e -g r a N d K i e n t .<br />

S u m m a r y :<br />

A l t h o u g h t h e r e s u l t s s h o w e d a p o s s i b i l i t y t h va e t h elp J o h ed r e ti o imp m a ry ove h a<br />

p e r c e i v e d q u a -o l f -life i t y s c o r es , ne i t h e r S e l f-h yp n os is n or J oh rei ap p eared to alte r t h e levels o f<br />

s tres s p ercep ti on or p er cei ved q u a l i -o t f y -l i f s e i g n i f i c a n t i l n y t -i n h f e c t e d H i I n d V i v i d u . a l s<br />

T h e maj o r d i s e a s e p r o g r I e V-in s fect s i on o , C n D 4 m -c T a e l r l k c o e u n r , t was s o s hf own tH o<br />

d e c r e a s e o v e r t h e s t u d y in p th e r w i a o i d t -l i s t e d o n t c r o l g r o a u s p e x p e c . t Th e d t rai n in g an d<br />

p r a c t i c e o f S e l -h f y p n o s i s d ni ot d ap p ear t o af fect th is d e c r e a s e. In c o n t r a s t , th is d ecreas in g tren d<br />

ap p eared to b e re vers ed s i g n i f i c a b n y t l t h y e in t r in a g an d p ract ice <strong>of</strong> J oh rei in th os e in d ivid u als<br />

w h o c o m p l e t e d t h e . Si s gn t ifi u d can y ce w as los t in t h e i n te n t i o -t n o-t r e a t a n a l y s , i bs u t th is was<br />

s u gges t ed t o b e rel at ed t o t h e small s amp l e s ize. Hen ce, th i s cou n teractin g ef f e c t o f J o h r e i on<br />

d ecreas i n g t ren d was fu rt h er in ves ti gated in th e n ext s tu d y [3 .2 .3 ] e xamin in g th e ra te <strong>of</strong> ch an ge<br />

i n C D -cell 4 T cou n ts in t h e 1 2 m o n t h s p e r i o b d o s t h p r i o r t o ( i n o r d e xa r mi t no e b as el in e<br />

d i f f e r e n c e ) an d aft e r p art ici p an ts s t a r t ing e i t h e r o f t h e i r t r a i n (in i n g ord s er t o e xami n e th e effect<br />

o f t h e i n t e r v t e r n a t i n i o n ).<br />

g s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 21 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th es e res u l t s p r o v i d e s u p p ort fo r the h yp oth es is th at learn in g an d p racti s in g p s ych olo gical<br />

i n t e r v e n t i o n , w h i c h p r o v i d e s a l t e r n a t i v e p e r s p e c t i v , e s a n o d f c o p i n g s k i l f o l r, s s tr es s fu l li fe<br />

e v e n t s, i m p r o v e s p s yc h o l o g i c a l a n d p h ys i c a l w e l l-b e i n g.<br />

3 . 2 . T 3 h e i n f l u e n c e o f p s y c h o l o g i c a l i C n D t 4 e -cells r v T e (d n t i i s e o a n s e pr u og p o res n s ion ma r ker) i n -i H n I f e c V t e d i n d i v i d u a l s ( c a s e c o n t r o l l e d s t u d y o v e r 2 4 m o n t h s p e r i o d )<br />

T h i s s t u a d i y m e d t o r e p l i c a t e a n d e x p a l b o r v e f t i n h d e i n g [ s 3 . 2 . 2 . 4 b] y in cre as in g th e<br />

s amp le s ize an d e x t e n d i n g t h e i n v e s t i g a t i o n p e r i o d f r o a tm otal f <strong>of</strong> i v 2e 4 mon m o n th t s h s t o<br />

( C D 4 g r a d i e n t s w e r e c a l c u l a t e d o v e r 1 2 m o n t h s p r i o r gic t al o a n d a f t e r t h e p s y c h o l<br />

interven t i on s com men ced ).<br />

M a t c h e d a n ymis o n ed p at ien ts fro m th e d at ab as e [s ee Meth od s s ection 2 .1 .3 ] we re u s ed as<br />

con trol s f or th is s tu d y. C o m p a r a b i l i w t a y s c o n f i r m e d b y c -cell o m cp oa u nr ts i and n g C D4 C D 4 T<br />

grad ien s <strong>of</strong> th e c o n t r o l s w i t h t h e s t u d y llows g r o [3 u p .2 s .3 .1 a s ]. f o<br />

3 . 2 . 3 . A 1 n a l y s i s o f b a s e l i n e d i f f e r e n c e s b e -c t e l w l e c o e u n t t h e t h r e e g<br />

Th e r e w e r e n o d i f f e r ab e sn olu c e ts e Ci D4 n T-cell c ou n ts b etween th e th ree grou p s at th e<br />

time p o i n t t h e i n t e r v e n t i o n s c o ( m F m e = n c , e 0 d . d f 7 = , 9 4 s; n Self-h y p n o s i s v s . D a t a -b<br />

a s e<br />

con trol : t = 0 . 6 , d , f n = s; J 7 o 4 h r e i v s . D a -c t a on b a trol s e : t = 0 . 9 , d , f n = s) [T 6 a 6 b l e 4 0].<br />

T able 40: Me a n ( 95% C.I .) le ve ls <strong>of</strong> C D 4 -ce T l l (c o u n t s pe r l) i n H I -inf V e ct e d in dividua ls in t he gr ou ps o f t h e S e l -hypnosis, f J oh r e i a nd D a t a b a s e-c ont r ols a t t h T e r a i n i n g p e r i o d<br />

CD4 T-c e lls ( c ounts per l )<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n 397<br />

346<br />

375<br />

( 9 5 % C . I . ) (330 - 464) (278 - 414) (346- 404)<br />

n 27 19 49<br />

F u r t h e r, th e r e e r e n o w statistical d i f f e r e n s c e in C D4 grad ien ts b et ween th e th ree gr ou p s a t<br />

th e P r e-i n t e r v tion e n p eri od ( F = , 0 d. f 2 = 9 3 , n s ; Self-h y p n o s i s v s . d a t a b on a s trol e c : t = 0 , . d 5 f =<br />

7 5 , n ; s J oh rei vs . d a t a b a s e on c trol : t = 0 , . 2 d f = 6 7 , ); n a s n d th e a v e r a g e C D 4 g r a d i e n t o f r all 9 6<br />

H I V-i n f e c t e d i n d i v i d u a l as w s a d ecl in e <strong>of</strong> seven cells p er l p e r m o [T n t a b h l e 1].<br />

4<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 22 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able 41: Me a n ( 95% C.I .) C D 4 gr a die nt s i n -individuals H I V in the S e l f-hypnosis, Johrei and Dat a ba s e<br />

control g r o u p s, a n d i n a l l the 9 6 i n d i v i d u a l s ( A L L ) a -i t n t h e r v P e r n e t i o n p e r i o d<br />

CD4 gr a die nt ( c e lls pe r l p e r m o n t h )<br />

A L L Se l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n - 7 - 7 - 9 - 5<br />

( 9 5 % C . I . ) (- 11 t - o 3 ) (-10 to -3 ) (- 14 t o - 4 ) (- 8 t o - 3 )<br />

n 95 27 19 49<br />

C o n c l u s i o n :<br />

Th e r e w e r ne o s tati s ti cal d iffe ren ces in ab s olu te C D4 T-cell c ou n ts at Mon th 0 an d C D4<br />

grad ien ts d u r i n g t h e P -i r e n t e r v e n t i o n b p e t r i w o e d e n t h e t h r e e g r o . u p s<br />

3 . 2 . 3 . A 2 n a l y s i s o f t h e r a t -c e e o l f l c h c D4 a o n u g r n a e d t i e n i t ) n ( C C D 4 T<br />

T h e o b j e c t i v e o f t h i s s t u d y w a s :<br />

T o e x p l o r e t h e i n f l u e n c e o t f h p e s y c h o l o g i c a l i n t e r v e n t i o n , <strong>of</strong> p J a o r h r t e i , c u l a r l y<br />

u p o n t h e r a t e c l o i f n e d b y c o m p a t r h i e n g C grad D 4 ien ts in each gr ou p b et ween the<br />

p eriod s ove r th e 1 2 mon th s p r i o r t o -i ( nP terven r e ti on ) an d a f t e r th e in t e r v e n t s i o n<br />

c o m m e n c e d ( P o s t-i n t er ven t i on ).<br />

Th e C D 4 g r a d i e n t s f r o m a l l s u b j e c t u s l a w t e r d e s a c d a e l s c c r i b e d i n t d h e s ection m e t h o<br />

[ 2 . 1 . 3 ] . T w o i n d i v i d u a l e x a m p l e s o f C D 4 g r a d i e n t r e g r e s s i o n in l es are p res en ted in Fi gu res 4 1<br />

a n d 4 2.<br />

Fi gu re 41 s h ows t h e C D4 grad ien t <strong>of</strong> on e d atab as e con trol p atien t as an e xamp le <strong>of</strong> th e<br />

n a t u r a l c o u r s e -c e l o l f c o u n t ts h e i C n -i D n 4 f e c H t e T I d in V d i v i d u a l s . Fo r t h i s p a t i e n t , th ere is an<br />

a v e r a g e d e c l i n e o f six (cells p er l p er m o n t h) in th e P r e-i n t e r v e n t i o n p e r f i o o u d r (cells a n d p er<br />

l p er m o n t h) i n t h e P o s t -i n t erv en tion p eriod . T h e S e l f-h yp n os is p articip an ts ga ve s imilar<br />

p r<strong>of</strong>iles t o t h os e s h own f or t h e d atab as e c on trol p atien ts , s o th at an in d ivid u al exa mp le <strong>of</strong> th ei r<br />

C D4 grad i en t reg res s i on l i n es is n ot p res e n ted h ere.<br />

I n c o n t r i gu a s re t 4 , 2 s h F o w s th e C D4 gra d ien t <strong>of</strong> on e J oh rei p articip an t. Th ere is a d eclin e<br />

<strong>of</strong> 1 0 (cells p er l p e r m ) o n i n t th h e P r -i e n terven ti on p eri od , an d an in creas e <strong>of</strong> s e v en (cells p er<br />

l p e r m ) o n i n t h e P o s t-i n t e r v e n t i o n .<br />

p e r i o d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 2 3 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P r e -i n t e r v e n t i o n<br />

M o n t h s (P r e (-) an d P o s t ( + ) f ro m t h e T r a i ) n i n g<br />

P o s t -i n t e r v e n t i o n<br />

M e a n d e c l i n e o f 6 c e l l pe s r l pe r m o n t h M e a n d e c l i n e c o e f l l pe s 4 r l pe r m o n t h<br />

F i g u r e 41: CD4 g r a d i e n t s o f one c o nt r o l s u bj ec t a t t h e P r e-int er ve nt ion and P o st -i n t e r v e n t i o n p e r i o d s<br />

P r e -i n t e r v e n t i o n<br />

Training<br />

Training<br />

M o n t h s (P r e (-) a nd P o s t ( + ) f r t h o T e r m a i n i ) n g<br />

P o s t -i n t e r v e n t i o n<br />

M e a n d e c l i n e o f 1 0 c e l l pe s r l pe r m o n t h M e a n i n c r e a s e o f 7 c e l l pe s r l pe r m o n t h<br />

Fi gur e 42: CD4 g r a d i e n t s o f one J o hr e i su b j ec t a t t h e P r e-int er ve nt ion a n d P o st-i n t e r v e n t i o n p e r i o d s<br />

T h e d i f f e r e n t s t in r C e D n d 4 g r a d i e n ts b e t w e e n P - r a e n d P o s t- in terven ti on p eri od s was<br />

e x a m i n e d b y A N O V A r e -m p e e a t s u e r d e a n a l ys e s f o l lowed b y u s in g th e 1 0 % trim min g m eth od<br />

[ W i l c o x , 1 9 9 7 ] as d es cri b ed in th e Met h od s s ection [2 .5 ]. Th is s u b s equ en t ANOV A in clu d ed 7 8<br />

s u b j e c t s ( 2 0 i n t h e S -h e l y f p n o s i s , 1 4 i n t h e J o h r e i a n d 4 4 i n d i v a s i e-con d u a l tr s ol s ). i n t h e D a t a b<br />

Fi gu re 43 s h o w s t h e i n d i v i d u a l s c in h a t n h g e C D 4 g r a d i e n t s b t e h t e P w r e - e<br />

a n d P o s t-<br />

i n t e r v e n t i o n p e r elf-h i o d yp s n o i s i s n , J o t h r h e i g rou S p s an d D a t a b a s e-c on trol gr ou p s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 24 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

- 1 0<br />

- 2 0<br />

- 3 0<br />

S e l f-hypnosis group ( n = 2 0 ) J o h r e i up g r (n o =14) D a t a b a s e-controls ( n = 4 4 )<br />

F i g u r e 43: I nd ividua l c ha nge s i n CD4 gr ad i e nt s ( c e l l c o un ts per l per month) in t h e S e l f-hypnosis, J o hr e i<br />

and D a t a b a s e-c o n t r o l g r o u p b s e t w e e n t h e P r -i e n t e r v e n t i a n o d n P os t -i n t e r v e n t i o n p e r i o d s<br />

Th ere was a s i gn ifi can t d ecreas e in th e C D4 grad ien ts fro m t h e P r -i e n t e r v e n t i o n to p e r i o d<br />

th e P o s t -i n t e r v e n t i o n p ( e r F i 9 o = . d 4, 1 d f = 7 5 , p < 0 . 0 0 1 ). Th e gr eates t imp r ove me n t in th e<br />

C D 4 g r a d i e n ts w a s s e e n i n t h e J o h a r m e o i n g g t r h o e u p t h r e e g r o ( u p F s = , 2 d. f 4 = 7 5 , p = 0 . 0 9 5 . )<br />

H a v i n g t h i res s u lt, fu rt h er e x p l o r a t i an v e al ys es were p er fo rmed as foll ows . T a b l e 2 4<br />

s h o w s t h e s u m rm y a o f th e in creas in g an d d ecreas in g tren d s in C D 4 g r a d i e n t with s th e<br />

a s s u m p t i t o h n a t a c h a n g e o f fou r or les s i n C D4 g r a d i e n t w a s d e f i n e d a s s t a y i n g s in t ce h e s a m e<br />

f o u r C -cells D 4 ch T an ge p er l p e r m o was n t h wi th in th e 9 5% C .I. o f th e me an in 9 5 p atien ts in<br />

t h e P r -i e n t e r v e n t i o n . p Acc e r i ord o d in gl y, in d ivi d u al s in th e I m p r o v i n s g u bgrou p imp ro ved th e<br />

rate o f d ecl in e m ore th an fou r cells p er l p e r m o n t h i n C D 4 g r a d i e n t b - e t a w n d e e P n o s P t- r e<br />

inter v e n t i o n p e r i o d s , i n d i v i d u a l W s o r i s n e n t i h s n e u g bgrou p i n c r e a s ed t h e r a t e o f d e c r b e y a s e<br />

m o r e t h a n f o u r C D 4 -cells T p er l p er m on th , an d th e res t were in th e S t a ying-the-s a m e<br />

s u bg r o u p.<br />

Gr adient c hanges in Hypnos is<br />

P r e Post<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

- 1 0<br />

- 2 0<br />

- 3 0<br />

Gradient changes in Johrei<br />

P r e Post<br />

Gradient changes in Control<br />

T able 42: P e r c e n t -indivi a g e d s u a l s i o n f t h e S H e -hypnosis, I l f V Joh r ei a n d D a t a b -c a s o e nt r o l groups whose<br />

c h a n g e s i n C D 4 g r a d i e n t s b e t w e e n -i t n h t e r ve P n r t e i o n a n d P o st-int e r ve nt io n per io ds we r e e it her i n c r e a s e d , s t a y e d t h e s a m e w o i r t h d e a c r j u e d a g s e m d e n t t h a t a o f c h f a o n u g r e o f l e c s e s l l pe s r l pe r<br />

month w a s d e f i n e d a t s h e s a m change e (S t a y i -the-s n g a m e subgroup), m o r e t h a n f o u r i n c r e a s (I e mpro v in g<br />

subgroup), and m o r e t h a n f o u r d e c r e a s (W e o r s e n i n subgroup) g<br />

G r o u p I m p r o v i n ( g % ) S t a yi n g-t h e-s a m e ( % ) W ors e ni ng ( % ) Total<br />

S e l f-h y p n o s i s 9 / 20 ( 4 5 % ) 7 / 20 ( 3 5 % ) 4 / 20 ( 2 0 % ) 20<br />

J o h r e i 11 / 14 (79 %) 2 / 14 ( 1 4 % ) 1 / 14 ( 7 % ) 14<br />

Da t a b a s e-control 11 / 44 (25%) 21 / 44 (48%) 12 / 44 (27%) 44<br />

Tot a l 31 30 17 78<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 25 - I m p e r i a l o C n o d l o n l e g e L<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

- 1 0<br />

- 2 0<br />

- 3 0<br />

P r e Post


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h i s 1 1 / 1 4 ( %) 7 9 o f t h I e m p r o v i sn ub g grou p in th e J oh rei gr ou p i s s i g n i f i c a n tl y d ifferen t<br />

to t h e 1 1 / 4 4 %) ( 2 i 5 n t h e t D a a b a s e-c o n t r o l g r o u p (P e a r s o n ' s c h i-s q u a r e = 1 2 . , d9 f = 1 , p <<br />

0 . 0 01) w h i l e t h e 9 / 2 0 ( 4 5 % ) i n t h e -h S e yp l f n os is grou p was n ot s i gn ifican tl y d iff er en t to that in<br />

th e D a t a b a s e-c o n t r o l g r (P o u e a p r s o n ' s c h i -s q u are = 2 .6, d f = 1 , n s).<br />

Ha vin g s h own t h e s e f i n d gs i n u s i n g t r i m m e d s et, d a t f u a r t h e r an a l y s es u s i n g a l l o f t h e 9 6<br />

s u b j e c t s w e r e p e r f o r m e d i n o r d e r t o c o n f i r m t h e r e s u l t s t h a t J - o h r e i m a y<br />

c e l l c o u n . t s T h e a n a l y s e incl s u d e c o m p a r i s o n s b : e t w e e n<br />

1 . T h r e e g r o u p s a t t h e P o s t-i n t e r v e n t i o n r i p o e d ( b y u s i n g t h e Kr u s k a l-W a l l i s r a n k t e s t ; s )<br />

2 . P r e- a n d P o s t-i n t e r v e n t i o n p e r i o d s i n t h e -c D o n a t a r b o a l s e g r (b o y u p u s in g th e<br />

W i l c o x o n S i g n e d R a n k t e s t s ) ; a n d<br />

3 . P r e- a n d P o s t- i n t e r v e n t i o n p e r i o n d s t h e S e l -h f y p n o s i s a n d J o h r e i g r o u (b p y s u s in g<br />

t h i l e c o x o n S W i g n e d R a n k t e s t [Tab s ) le 43 a n d F i g u r 4]. e<br />

T a b l e 43: Me a n ( 95% C.I .) C D 4 gr a die nt s i n -individuals H I V in the Se l f-h y p n o s i s , J o h r e i a n d D a -t<br />

a b a s e<br />

control g r o u p s at t h e P r -i e n t er ve n t i o n an d P ost-i n t e r v e n t i o n p e r i o d s<br />

CD4 gr a die nt ( c e lls pe r l p e r m o n t h )<br />

P r e-i n t e r v e n t i o n<br />

P o s t -i n t e r v e n t i o n<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n - 7 - 9 - 5 - 1 + 3 - 2<br />

( 9 5 % C . I . ) (-10 to -3 ) (- 14 t o - 4 ) (- 8 t o - 3 ) (- 4 t o + 3 ) (- 2 t o + 7 ) (- 5 t o + 1 )<br />

N 27 19 49 27 19 49<br />

Mean (95% C.I.) CD4 gradients (cells/mcl/month)<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

- 1 0<br />

- 2 0<br />

- 3 0<br />

N o t s i g n i f i c a n t<br />

p = 0 . 0 4 0<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

N o t s i g n i f i c a n t<br />

S e l f - h y p n o s i s J o h r e i D at abase<br />

c o n t r o l<br />

Pre<br />

P o s t<br />

Fi gur e 44: Me a ns ( 95% C.I .) CD4 gr a die nt s ( c oun t pe r l per month)<br />

in the S e l f-hypnosis a n d J ohr e i an d D a t a b a s e-control gr ou ps i n t h e P r e- and Post- i n t e r v e n t i o n p e r i o d s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 26 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e C D4 grad ien ts <strong>of</strong> th e i n d i v i d u a l s i n t h e D -c a t o a n b t a r s e o l g r s ho owed u p a d ecl in in g<br />

t r e n d i n b o t h t -i h n e t e P r v r e n t i o n a n d t h e P o s t-i n terven tion p eri od s (z = -1 . 5, d f = 4 8 , n s ). In<br />

c o n t r a s t , t h e d e c l i a n t i n t g h e t -i r P n r e t e n d e r v e n t i o n p w e r a i s o d h a l an t d e d revers ed in th e J oh rei<br />

grou p at the P o s t-i n t e r v e n t i p e o r n i (z o d = - 2 .1, d f = 1 8 , two-t a i l p e d = 0 . 0), 0 4 w h i p l a e t i e n t s in t h e S e l f-hyp n os is gr o u p c o n t i n u e d t o s h o w a d e c l i n i n g t r e z n d = - ( 1 . 1, d f = 2 6 , ). Su n s rp ri s in gl y,<br />

h owever , th ere w as n o statisticall y s i g n i f i c a n t d i f f e r e n c e s yc b h e o t l o w g e i c e a n l t h e p<br />

i n t e r v e n a t a b i a s o e-c n o n s t r o l i n a C n D d 4 g r a D d i e n t s a t t h e 1 2 m o n t h o f t h e P o s -in t terven ti on<br />

p e r i o d ( S e l f-h y p n o s i s v s . D a t a -c b on a s tr e ol : t = 0 , . 2 d f = 7 5 , n s ; J o h r e i v s -con . D tr a ol t : a t b = a s e<br />

1 . 0, d f = 6 7 , n s ).<br />

S u m m a r y :<br />

Th e r e s u l t s s u p p o r t t h e p reviou s fin d in gs th at th ere is a s t ead y d eclin e in p erip h eral b lood<br />

C D 4 -c T e l l c o -in u n fe cted t s in d ivi i dn u al s (n H o I t r V e c e i v i n g a n t i-r e t r o v i r a l t r e a t m e n t); a n that d<br />

the d e c l i n e o f C -c D e 4 l l T c o u n t a s p p e a r e d t o db ecreas e ed o r al le vi at ed b y th e trai n in g an d<br />

p r ac t i c e o f J o h r e i t b, y Self-h b u t yp n o n os is . Hen ce, it was s u g ges ted th at l e a r n i n g a n d p r a c t i s i n g<br />

J oh rei ma y h ave i m p r o v ed d i s e a s e p r o g r e s i s i n o -i n n f H e I c t e V d i n d i v i d u .<br />

a l s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 27 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 3 In v it ro i n v e s t i g a t i o n i n t o t h e p e o f s u f r e c t t str o<br />

e f ss e h x o r m o n e s u p o n<br />

N a t u r a l K i l l e r c e l l s<br />

B a c k g r o u n d<br />

N K -cel l s are i mp o rt an t cel l u lar c omp on e n ts <strong>of</strong> th e i n n a t e immu n e s ys te m in d efen ce<br />

again s t i n fect i on an d m a l i g n a n cy, an d th ey are kn own t o b e a ffected b y s tr es s as s h own in<br />

p r e v i o u s s t u d y .2 ] [ an 3 d . i1 n th e li terat u re [ S e g e r s t r o m & M i l l e r , 2 0 0 . 4 ] Ph armaco logi cal level s<br />

<strong>of</strong> e x o g e n o u s g l u c o c o r t i c o i d are s kn own t o s u p p res s in fl ammation i n v i an v o d to s u p p res s NK<br />

c ytot oxi c act ivi t y i n v i [ t Z r h o u e t a l . , 1 9 9 . 7 ]<br />

In th is s eri es <strong>of</strong> in vi tr o e x p e r i m e n t s , t h e e f f e c t s o f e x p o s u r e t o t h e m s a hj or o r mon s t e, r e s<br />

c o r t i s o l , a n d o t h -S e an r d mel s at on t ir n ), e p art s is cu larl h y with o r in m po h ys n iol e ogi s cal ( D H E A<br />

l e v e l s -cells , w ere o n e xa mi N K n ed .<br />

A i m s<br />

A. T o c o n f i r m th e s u p p res s ive effect <strong>of</strong> a ma jor s tres s h o rm on e, c o r t i s o l , u p o n N K<br />

c y t o t o x i c C A ), a an c d t to i e xp v lor i e t th e y u n d erl ( yin N K g mech an is ms at th e cel lu l ar<br />

level.<br />

B. T o e x a m i n e t h e r e l a t i o n s h i oth p s er en b e dt ogen w e e ou n s s tres s as s ociated h o rm on e s ,<br />

D H E A -S an d mel at on i n , u p on NKC A.<br />

W o r k i n g h y p o t h e s i s<br />

“A n in vi tr o m od el <strong>of</strong> s u s t a i n e s t d r e s s i m p a i rs N K c y t o t o x c i t c i a v i .” t y<br />

In vitr o mod el o f s u s t a i n e s t d r e s s is d efi ned as “m o r e t h a n 2 4 r s h o u o f e x re p o ts o u p p er<br />

p h ys i o l o g i c a l l e v e l s o f c o r t i s o l”.<br />

3 . 3 . 1<br />

D e v e l o p m e n t a n d o p t i m i s a t i o n o f a f l o w c m y t e o t m h e o t f d r o i r c m e a s u r i n g N K C A<br />

3 .3 .1 . 1 N K C A a f t e r C s i f o r n 2 4 c h o u r b s a t i o n o f P B M<br />

T o i n v e s t i g a t e t h e -cells e , Pf BMC f e s we c t re cu lt o u red f fo r c 2 4 o hr ou t rs i s o l u p o n<br />

with cort i s ol . Th ere for e t h i s exp eri men t was d es ign ed to d etermin e i f in cu b ation it s elf <strong>of</strong><br />

p e r i p h e r a l b l o o d m o n o n u c l e a r c e l ( l s P B M C s ) h a d K a n c y t o e t o f x i f c e a c ( t N i K v C i A u t ).<br />

p y o n N<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 28 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e flow c yt omet r y met h od was u s ed . P BMC s f ro m 1 2 h ealth y s u b ject s were in cu b ated for 2 4<br />

h ou rs p ri or t o as s es s i n g t h e N KC A.<br />

Fi gu re 4 5 a an d Fi gu re 4 5 b s h o w m e a n ( 9 5 % C . I i n . d ) i v i d a u n a d l level s <strong>of</strong> N KC A p re an d<br />

p o s t in cu b at i on for 2 4 h ou rs . N KC A l e v e l s w e r e i n c r e a s e d i n s i x i n d i v i d u a ls, d ecre as ed in th ree<br />

an d s ta yed th e s ame in th ree. T h e r e p e a t e d m e a s u ANOV r e A s h owed a t r e n d t o w a r d s i n c d r e a s e<br />

l e v e l s o f t h e = 4 N .3, K C d f A = 1( 1 , F p = 0 .0 6 3 ) wh en P BMC s were in cu b ated i n v i t for r 2o 4<br />

h ou rs .<br />

Individual NKCA levels (% killing at E:T ratio = 50:1)<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

NKCA ( 50: 1 rat i o)<br />

T i me 0 24 hr s<br />

NKCA levels (95% C.I.) by flowcytometry<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 29 - I m p e r i a l o C n o d l o n l e g e L<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 2<br />

Ti me 0<br />

Fi gu r e 45a: Ind i vi d u a l N K C le A ve ls a t Fi gur e 45b: M ea n ( 95% C. I. ) N K C A l e v e l s<br />

T i m e 0 a n d a f t e r 2 4 h o u r i n c u b a t i a t o T n i m e 0 a n d a f t e r 2 4 h o u r i n c u b a t i o n<br />

C o n c l u s i o n :<br />

Th e level s <strong>of</strong> th e N KC A <strong>of</strong> P BMC s afte r 2 4 h ou rs i n v i in t cu r o b at ion sh owed a tre n d<br />

t o w a r d s i n c r e d a s l e v e l s c o m p a r e d w i t h , T i b m u t e t h 0 a t t h e i n c r e a s se h ort w a s o f s tat is ti cal<br />

s i g n i f i c a n t .<br />

3 .3 .1 . 2 N K -c e l l p e r c e n t a g e i n P B M C s a f t e r 2 4 h o u r s i n c u b a t i o n<br />

H a v i n g s h o w n t h a t i n c u b a t i o n o f P B M C s f 2 o 4 r h o u r s r e s u l a t tren e d ti oward n s a n<br />

in creas e in NK c yt ot o xi c act ivit y, th is ex p erimen t w a s p e r f o r m d e to d et er mi n e if t h is was<br />

a s s o c i a t e d w i t h a n i n c r e a s e i n t o t a l N K -c e l l p e r c e n t a , g e p e r h a p s d u e to ad h eren ce or l os s b y<br />

s e l e c t i v e c e l l d e a t h b-p o f p u l o t a t h e i s r o <strong>of</strong> n s Pu BMC s .<br />

L y m p h o c y t e s -p u o b p u l a t i s o n w i t h i n P B M C s w e -c r yto e met ra y n p erfo a l rmed y s e d b y f<br />

p r i o r a t n d o a f t e r 2 4 h ou rs c u l t u r . e<br />

p = 0 . 0 6 3<br />

1 2<br />

24hrs


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual NK-cell percentages in PBMCs<br />

3 0<br />

2 5<br />

2 0<br />

1 5<br />

1 0<br />

Fi gu re 4 6 a s h ows t h at t h ere was n o c on s is ten t ch an ge in i n d ividu al level s o f total N K -c e l l<br />

p e r c e n t a g e s P B i M n Cs a f t e r 2 4 h r s i n v i i t n r c o u b a t , i i.e. o n five in cr eas ed , f ou r d ecr eas ed an d<br />

t h r e e s t a y e d t h e s a m e r e g a r d l e s s o f t h e i r N K C A . Figu c h a n re g e 46b s s h ows th at there was n o<br />

s ign ifican t d i fferen ce i n t h e m e a n p e r c e n t a g e o f N K -c e l l s a fter 2 4 h rs in cu b ation .<br />

5<br />

0<br />

3 0<br />

C D 5 6 N K c e l l %<br />

T i me 0 24hr s<br />

CD56 NK cell% (95% C.I.)<br />

2 0<br />

1 0<br />

0<br />

N =<br />

Fi gu r e 46a : Ind i vi d u a l NK-c e l l p e r c e n t a g e Fi gu r e 46b: M e a n ( 9 5 % C . I . NK-c ) e l l p e r c e n t a g e<br />

i n P B M C s a t T i m e 0 a ours n d a f t e r 2 4 h i n P B M C s a t T i m e 0 a n o d u rs a f t e r 2 4 h<br />

C o n c l u s i o n :<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 30 - I m p e r i a l o C n o d l o n l e g e L<br />

1 2<br />

Ti me 0<br />

Th e t r e n d t o w a r i d s n c r a e n a s e i n N K c y t o ctivit t o x i y c in a P BMC s aft e r 2 4 h ou rs<br />

i n c u b a t i o n w a s n o t a s s o c i a t e d w i t h a n i n c r e t a s e h e p e -c e r l l s c . e n t a g e o f N K<br />

1 2<br />

24hrs


Individual NKCA (% killing at E:T ratio = 50:1)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .3 .1 . 3 N K C A aft er 2 4 h rs i n cub ation <strong>of</strong> P BMC s w i t h c o r t i s o l<br />

T h e a i m o f t h e xp i s eri men t w a s t o e x a m i n e t h e e f f e c t o f 2 4 h o u r o s f M o f C P s i B n c u b a t i o n<br />

with c o r t i s o l a t p h ys i ol o gi cal an d h igh er le v e l s o f N K C A . P B M C s were in cu b at ed wi th two<br />

c o n c e n t r an d a 2 5 t 0 0 n i M ) o n f s c o r t i ( s o 2 l h o 5 f u r o 0 r s n a 2 4 n M d N K C A w a s m e a s u r e d b y<br />

f l -c o yt w omet r y. Du e t tech o n ical p r o b l e m s n , e s o a m p l e f r o m o n e v o l u n t e e was r l o st to th e s tu d y,<br />

s o that res u l t s fr om 1 1 s amp les wer e an al ys ed .<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

Fi gu re 4 7 a s h ows i n each i n d ivid u al th e effect <strong>of</strong> e xp os u re <strong>of</strong> P BMC s t o c orti s ol (2 5 0 an d<br />

2 5 0 0 n M ) on th e level s o f th e N KC A. Fig u re 4 7 b s h o w s a d e c r e a s e i n a t n h l e v m e l e <strong>of</strong> th e<br />

N K C A w h e n c o rt i s o l w a s p r e s e n t. T h e r e p e a t d e meas u re ANOV A s h ow ed a s ign if ican t<br />

d e c r e a s e i n t h e l e v e l s o f N K C A w i t = h 1 c 0 o . r 5 d0 t f = i 1s 0 o , l p = 0 c .0 o 0n 9 c ). e Th n t is r a t i o n ( F<br />

d e c r e a s e w a s c o n f i r m e d b y p o s t-h oc p air ed t-t e s t c o m p a r i s o n s ( m e a n d i f f e r e n c e = 6 . 0 6 , s t a d n d a r<br />

erro r = 1 .7 4 , p = 0 . 0 1 : 8 b e t w e e n th e N K C A w i t h ; an d 0 mean n M d ifferen a ce n = d w i t h<br />

7 .0 2 , s tand ard error , 2 .1 7 , p = 0 . 0 2 : 7 b e t w e e n t h e N K ). C Th A ere w i t h 0<br />

w a s n o s i gn i fi can t d i ffe ren ce b etween N KC A with 2 5 0 n M an d 2 50 0n M.<br />

0<br />

NKCA (50:1 rati o)<br />

0 n M 2 5 0 n M 2 5 0 0 n M<br />

NKCA levels (95% C.I.) by flowcytometry<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

� �<br />

� �<br />

� �<br />

0 n M 2 5 0 2 n 5 M 0 0 n M<br />

Fi gur e 47a : I ndividua l N K C A l e v e l w s i t h c o r t i s o l Fi gur e 47b: M e a n ( 9 5 % C . I . ) N K C A l e v e l s<br />

at 0nM, 250nM, and 2500nM w i t h c o r t i s o l at 0nM, 250nM, and 2500nM<br />

C o n c l u s i o n :<br />

Th e in cu b at i on <strong>of</strong> P BMC s with 2 5 0 n M or m ore c o r t i s o l f or 2 4 h ou rs h a d a s u pp res s in g<br />

effect u p on N KC A.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 31 - I m p e r i a l o C n o d l o n l e g e L<br />

� ��<br />

p = 0 . 0 1 8<br />

p = 0 . 0 2 7


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual NK-cell percentages<br />

3 .3 .1 . 4 N K -c e l l p e r c e n t a g e i n P B M C s a f t 2 e 4 r h o u r s i a n c t u i b o n w i t h l c o r t i s o<br />

3 0<br />

2 5<br />

2 0<br />

1 5<br />

1 0<br />

H a v i n g s h own th at c ort is ol at 2 5 0 o n r M m o r h e ad a s u p p r e s s iv e effect u p on N K C A , th is<br />

exp eri men t was p er fo rmed t o d eter min e if th is su p p res s ive effect was as s o ciated w ith a ch an ge<br />

i n t h e p e r c e n t a g e o N f K -c e l l s i n t h e P B M C . N s K -c e l l s w i t h i n P B M C s w e -r<br />

e a n a l y s<br />

c y t o m e t , r py er fo rmed aft er 2 4 h ou rs in cu b ation with two c ortis ol con cen tration s (0 n M, 2 5 0 n M<br />

an d 2 50 0n M).<br />

Th ere w e r e n o ign s ifican t d if feren ces in t h e N K -c e l l p e r c e n t a g e i n t h e P B M C s a f t e r 2 4 h r s<br />

i n v i in t cub r o at ion wi th cort is ol (0 n M, 2 5 0 n M an d 25 00 n M). Fi gu re 4 8 a an d Figu r e 4 8 b s h ow<br />

i n d i v i d u a l mean a n d s level s o f tot al N K -c e l l p ercen tages in th e P BMC s , res p ectiv ely.<br />

5<br />

0<br />

C D 5 6 N K c e l l %<br />

0 n M 2 5 0 n M 2 5 0 0 n M<br />

CD56 NK cell% (95% C.I.)<br />

3 0<br />

2 0<br />

1 0<br />

1 2<br />

1 2<br />

1 2<br />

0 n M 2 5 0 2500 n nM M cortisol<br />

Fi gur e 48a: Individua l N K -c e l l p e r c e n t a g e Fi gu r e 48b: M ea n ( 95% C. I. ) N K -c e l l p e r c e n t a g e s<br />

wit h c ort is ol at 0nM, 250nM, and 2500nM w i t h c o r t i s o l at 0nM, 250nM, and 2500nM<br />

C o n c l u s i o n :<br />

Th e c o r t i s o l a s s uo pc pi res a t s e ion d <strong>of</strong> N K C A in P B M C s was n ot as s ociated wit h a<br />

c h a n g e i N n K -c e l l p e r c e n t . a g e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 32 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 3 . C 2 o m p a r i s o n o f t w o m e t h o d s f o r m e a s u r i n g N K c y t o t o x i c a c t i v i t y ( N K C A ) :<br />

- the fl ow cy to me tri c meth o d a n d the c olori me tric meth o d (Cy toT o x9 6 ® ) -<br />

T h e f l o w c y t o m e t r i c m e t h o d o f s in a g s s N e s K c y t o t o x i c a c [G t i o v d i o y-R t y ami r ez et al .,<br />

2 0 0 0 ] was in it ial l y ad op ted to a void th e c on ven tion al r a d i -a o c t i v e<br />

5 1 C r -r e l e a se a s s . a Howe y ver,<br />

t h e f l o w metric c y t o met h od is lab ori ou s a n d req u ires a h igh d egree o f s kill . A s imp ler<br />

c o l o r i m e t r i c , m e n t a h m o e d l y t h e C y t ®, o T ho as x 9 b6 een d evel op ed [ P r o m e g a , 2 0 0 4 ]. Th is<br />

m e t h o d m e a s u r e s l e v e l s o f r e l e a d s e l a c t i c d e h y d r o g e n a s e ( L D H f ) r killed o m K 5 6 2 c e l . l Th s e<br />

a m o u n t o f LD H i s p r o p o r t i o n a l t o t h e n u m b e r s o f k lled i K5 6 2 cel ls . Th e LD H le v el can b e<br />

accu rat el y an d s i mp l y meas u red col ori me tricall y.<br />

<strong>The</strong> f l o w y t c o m e t r i an c d th e col ori met ri c as s a ys were co mp ared in th is exp erimen t.<br />

P BMC s were s ep arat ed f ro m 4 5 h ealth y i n d ivid u als and NKC A an al ys ed , in p arall el , b y both<br />

the f -c l y t o m w e t ri c an d the c o l o r i m e t r i c s. m e t h o d<br />

Fi gu re 4 9 s h ows t h e s cat t er g rap h <strong>of</strong> th e c orrelati on b etween th e two meth od s . Th e<br />

P ears on correl at i on an al ys i s s h ows th at th ere is a s i gn ifican t co rrelati on b etween th e two<br />

m e t h o d s ( r = 0 -tailed . 3 6 7 , p = 2 0 .0 1 3 ).<br />

NKCA by CytoTox (LDH) assay<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0 Rsq = 0.1349<br />

0 10 20 30 40 50 60<br />

NKCA b y f l o wc yt o me t r y a s s ay<br />

Fi gur e 49: C o r r e l a t i -c o n y t b o e m e t w e r e y n m f e -r t l e h o l o w e d a s a i n n d g L D m H e t h o d o f t h<br />

C o n c l u s i o n :<br />

p = 0.013<br />

n = 45<br />

r = 0.367<br />

It was d et er mi n ed th at th e levels o f th e N KC A s h o u l d b e meas u red b y th e les s lab o riou s<br />

b u t s t i l l v a l id col ori met ri c meth od in s u b s e q u e n t exp erimen ts an d to rep eat th e p rev iou s<br />

e x p e r i m e n t s w i t h a l a r g e r s a m t p h pe l revi e ou s fi s n d i in gs z . e t o c o n f i r m<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 33 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 3 . 3<br />

In v e s t i g a t i o n o f N -c K e l l p r o f i l ae nd s N K C A (c o l o r i m e t r i c ) m e t h o d<br />

T h e f l o w c y t o m e t Cr A i s h ow c ed a th at s in s cu e b at s ion s m <strong>of</strong> e P BMC n t s fo o r 2f 4 h ou N rs K<br />

res u lted i n i n creas ed NK c yt ot oxicit y. Th is rep eat exp eri men t was p erf or med with P BMC s fro m<br />

a larg er n u mb er <strong>of</strong> vol u n t eers u s in g th e c olori metric meth od with th e ob jective <strong>of</strong> c o n f i r m i n g<br />

th es e res u l t s .<br />

3 .3 .3. 1 N KC A, a s s e s s e d b y c o l o r i m e tri c m e t , h o a d f t e r i n c u b a t i o n o f P B M C s f o r 2 4 h o u r s<br />

P BMC s were ob tai n ed fr om 3 1 h ealth y s u b jects a n d i n c u b a t e d f o r rs 2 p4 rior h o tu o<br />

as s es s in g th e NKC A a t effect or : tar get rat ios o f 5 0 : 1 a n d 2 b 5 y : 1 t h e c o l o r i m e t . r i c a s s a y<br />

I nd ivid u al an d mean ( 9 5 % C . I . ) N KC A l evel s wi th ef fect o r : tar get ratios <strong>of</strong> 5 0 :1 a n d 25 :1<br />

p re an d p os t in cu b at ion are s h own in Fig u re 50 ( a ) , ( b ) an d Fi gu re 51 ( a ) , ( b , ) res p ect ivel y. In<br />

a g r e e m e n t w i t h p r e v i o u s f i n d i n g s , t h e r e w a s a e s mean i g n i Nf KC i c A a n lt e vel i n c r e a s e i n t h<br />

a f t e r i n c u b a t i n g P B M he C s r f e o r p e 2 a 4 t h e o d u r s m . e s a h s T s t o h a u w t r th e e level A s oN f O V A<br />

N K C A w e r e i n c r e a s e d a f t e r 2 4 h r s a 5i 0 n :1 c u rat b a io t ( i mean o n i d in fferen ce = 6 . 3 8 (1 5 .67 to<br />

2 2 .05 ), s d = 1 4 .9 , p = 0 .0 2 4 , t = 2 . 3 8 , d f = 3 0 ) a n d 2 5 1 : rati o ( mean d iffe ren ce = 1 0 .4 7 (8 .78 to<br />

1 9 .25 ), s d = 1 1 .1 , p < 0 .0 0 1 , t = 5 .3 2 , d f = 3 0 ).<br />

Individual NKCA (% killing at E:T ratio = 50:1)<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

Ti me co u r s e o f NKCA 5 0 : 1<br />

T i me 0 2 4 h o ur s i n c uba t i o n<br />

Mean (95% C.I.) NKCA levels at E:T = 50:1<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

p = 0 . 0 2 4<br />

T i m e 0 A f t e r 2 4 h o u r s<br />

Fi gu r e 50a: Ind i vi d u a l N K C (50:1) A l e v e l s Fi gu r e 50b: M e a n ( 9 5 % C . I . ) N K C (50:1) A l e v e l s<br />

(% k i l l ) i a t n Ti g m e 0 a n d a f t e r 2 4 h r s i n c (% u b a killin t i o g) n a t Ti m e 0 a n d a f t e r 2 4 h r s i n c u b a t i o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 34 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual NKCA (% killing at E:T ratio = 25:1)<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

Ti me c o u r s e o f NKCA 2 5 : 1<br />

T i me 0 2 4 h o ur s i n c uba t i o n<br />

Mean (95% C.I.) NKCA levels at E:T = 25:1<br />

40<br />

30<br />

20<br />

10<br />

0<br />

T i m e 0 A f t e r 2 4 h o u r s<br />

Fi gu r e 51a: Ind i vi d u a l N K C (25:1) A l e v e l s Fi gu r e 51b: M e a n ( 9 5 % C . I . ) N K C (25:1) A l e v e l s<br />

(% k i l l ) i a t n Ti g m e 0 a n d a f t e r 2 4 h r s i (% n c u killin b a t i g) o an t Ti m e 0 a n d a f t e r 2 4 h r s i n c u b a t i o n<br />

C o n c l u s i o n :<br />

T h e c o l o ri met ri c as s a y res u l ts c o n f i r m e d p r e v i o u s f l o w c yt o m e t r i c f i n d i n g s t h a t<br />

in cu b at i on <strong>of</strong> P BMC s for 2 4 h ou rs lead s to a s i g n i f i c a n t i n c r e a se in th e level s <strong>of</strong> N KC A.<br />

3 .3 .3. 2 R e p e a t a s s e -c e s l l s m p e r c n e n t a g n e d o e f x a m i N n a K t i o n o f N K s u b p o p u l a in t i o n s<br />

P B M C s af t e r 2 4 h o u r s i n c u b a t i o n<br />

Alth ou gh p re vi ou s res u l t s s h owed n o as s ociation b etween th e in creas e in N KC A a fter 2 4<br />

h o u r s i n c u b a t i o -c e n l l ( C o D f 3 P B M C s a n d N K<br />

- C D 5 6 + ) p e r c e n t a g e s , t h e a s s o c i a t i -o<br />

n w a s r e<br />

e x a m i n e d p r e a n d p o s t 2 4 h o u r s i n c u b a t i o n w i t h t h ed i s nu i mb n c r er e a <strong>of</strong> s s u b ject s . In ad d ition ,<br />

th e d is t ri b u t i on <strong>of</strong> NK cel l s acc ord in g t o t h e level <strong>of</strong> e xp res s ion o f C D5 6 an d C D16 was<br />

e x a m i n e d . T h e l e v e l o f e x p r e s s i o n m o a r f k e t rs h can e s e b e u s ed to d efi n e c yt oto xic an d<br />

r e g u l a -c t e l l o s . r H o y w e v e N r K , d u e t o t e c h n i c a l p rob lems with th e flow c yt omete r, on l y th e las t<br />

1 6 s u bj e c t s f r o m t h e were a b o v an e al 3 ys 1 ed .<br />

p < 0 . 0 0 1<br />

Fi gu re 52 (a), (b) an d (c) s h ow m e a n ( 9 5 % C . I . pe ) r c e n t a g e s o f N K -c e l l s (C D 3 - C D 5 6 + )<br />

w i t h s u b p o p u l a t i o n s o cf yt oto xi c N K -c e l l s (C D 3 - d i m<br />

C D 5 6 C D 1 6 + ) an d regu lat or y N K -c e l l (C D 3 -<br />

C D 5 6 b r i g h t C D 1 6 - ) in th e P BMC s at Ti m e 0 a n d a f t e r 2 4 i h n r c s u b a t i o n , r e s p . e Th c t ere i v we l ere y<br />

no s i g n i f i c a n t d i f f N e K r -c e n e c l l e ps r <strong>of</strong> i il es n b et ween Time 0 a n d rs 2 4 h a f t e r in cu b at ion .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 35 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Total CD56+ NK cell% in PBMCs<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

Time 0<br />

1 6<br />

I ncubated 24hr s<br />

Cytotoxic NK (CD56dim)% in PBMCs<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

Ti me 0<br />

1 6<br />

Inc ubat ed 24hr s<br />

1 6<br />

I ncubated 24hr s<br />

F i g u r e 52a: N K (%) i n P B M C s Fi gu r e 52b: C y t o t o x NK i c (%) Fi gur e 52c: R e g u l a t N o r K y (%)<br />

a t Ti m e 0 a n d a f t e r 2 4 h r s a t Ti m e 0 a n d a f t e r 2 4 h r s a t Ti m e 0 a n d a f t e r 2 4 h r s<br />

Fi gur e 52: P e r c e n t a -c g e l l e i n s t o t a l o a f n d e N a K c h s u b s e t a t T i m e 0 a n d a f t e r 2 4 h o u r s i n c u b a t i<br />

C o n c l u s i o n :<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 36 - I m p e r i a l o C n o d l o n l e g e L<br />

Regulatory NK (CD56bright) cells% in PB<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

Time 0<br />

Th e in creas e i n N K c yt ot oxi c activit y in P BMC s after 2 4 h ou rs in cu b ation was n ot<br />

a s s o c i a t e d w i t h i n e c a r s e s i n t h e p e r c e n t a g e o N f K -c e l l s or al terat i on in th e c y t o t o x i / c re gu lat or y<br />

N K -cell s u b p o p u l a t s . i o n<br />

3 .3 .3. 3 Ex p r e s s i o n o f N a l t C u r y a t o t o x i c R e c e p t o r s N ( k p 4 6 a n d N k p 3 0 ) b y c yt ot oxi c N K -c e l l s<br />

( C D 3 - d i m<br />

C D 5 6 C D 16 + ) p re an d p os t 2 4 h o u r s i n c u b a t i o n<br />

Ha vin g s h own t h at t h e i n creas e in N KC A in P BMC s after 2 4 h ou rs in cu b ation was n ot<br />

as s ociat ed wi t h i n creas es i n th e p ercen tag e <strong>of</strong> total N K -c e l l s or c yt oto xic an d re gu lator y N K -<br />

c e l l s , th is exp eri men t was p e r f o r m e t o d d etermi n e if th e in creas e in N KC A was as s ociated with<br />

a n i n c r e a s e i n t h e e x p r e s s i o n o f t h e N a t u r a l C y t o t o x i c 0 ) R on e c th e e p t o r s ( N k p 4 6 a n d<br />

c ytot oxi c N K -c e l l s . Th e e xp res s ion ( m e a n f l o r e s c e n t i n t e n s i t y : m . f <strong>of</strong> . i . th ) e N kp 4 6 (maj o r<br />

c y t o t o x i c r e c e p t o r ) o n c y t o t o x i c N C K D ( 3 - d i m<br />

C D 5 6 C D 1 6 + ) c e l l s w i t h e h s a i m e n P B M C s<br />

1 6 h e a l t h y s u b j e c -c t y t o s m e t r w y e p e r f o e r m e d a p n r i o a tr o l cu y lt us re e a n d aft er b 2y 4 f l o w<br />

h ou rs .<br />

Fi gu re 53 ( a ) a n d ( b ) s h ow th at th ere was a s ign ifican t in creas e ( +4 4 % ) in th e exp re s s ion<br />

<strong>of</strong> th e N kp 4 6 on c yt ot oxi c N K -c e l l s a f t e r 2 4 h r s i n v i t i r n o c u b a ep t eated i o meas n u( res R<br />

ANO V A: F = 3 8 .1 , p < 0 . 0 0 1 , n = 1 6 ; m e a n d i en f f e ce r = 2 7 .0 , s e = 4 .4 ). Fi gu re 5 4 ( a ) a n d ( b )<br />

s h o w t h a t t h e r e w a s a s i g n i f i c a n t d e c r e a -2 s e 2 % ( ) in th e exp res s ion <strong>of</strong> th e N kp 3 0 on c yt oto xic<br />

N K -c e l l s a f t e r 2 4 h r s i n v i in t cub r o at ion (F = 1 8 .0 , p = 0 .0 0 1 , n = 1 6 ; mean d iffe re n ce = 5 .4 , s e =<br />

1 .3 ).


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Nkp46 m.f.i. on Cytotoxic NK-cells<br />

Nkp30 m.f.i. on Cytotoxic NK-cells<br />

1 4 0<br />

1 2 0<br />

1 0 0<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Nk p 4 6 m.f .i. o n Cy to to x ic NK cells<br />

Ti me 0 2 4 h r s<br />

N k p 4 6 m .f.i. o n C y to to x ic N K cells<br />

Fi gu r e 53a: Individua l Nkp46 (m.f.i.) Fi gu r e 53b: M ea n ( 95% C. I.) N k p 4 6 ( m . f . i . )<br />

a t Ti m e 0 a n d a f t e r 2 4 incubation h r s<br />

a t Ti m e 0 a n d a f t e r 2 4 incubation h r s<br />

1 4 0<br />

1 2 0<br />

1 0 0<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

C o n c l u s i o n :<br />

Nk p 3 0 m.f .i. o n Cy to to x ic NK cells<br />

T i me 0 2 4 h r s<br />

N kp 30 m .f.i. on C y to tox ic N K cells<br />

1 25<br />

1 00<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 37 - I m p e r i a l o C n o d l o n l e g e L<br />

75<br />

50<br />

25<br />

0<br />

125<br />

100<br />

75<br />

50<br />

25<br />

0<br />

N =<br />

N =<br />

1 6<br />

1 6<br />

Time 0<br />

Ti me 0<br />

Fi gu r e 54a: Individua l N k p 30 ( m . f . i . ) Fi gur e 54b: M ea n ( 95% C. I. ) N k p 30 ( m . f . i . )<br />

a t Ti m e 0 a n d a f t e r 2 4 incubation h r s<br />

a t Ti m e 0 a n d a f t e r 2 4 incubation h r s<br />

T h e s e r e th s at u th l e it n creas s e is n NKC h o w A in P BMC s aft er 2 4 h ou rs in cu b ation was<br />

a s s o c i a t e d w i t h a n i n c r e a s e i n th e exp res s ion <strong>of</strong> Nkp 4 6 on c yt oto xic N K -cell s , an d it w a s a l s o<br />

as s ociat ed wi th a d e c r e a s e i n t h e e x p r e s s i o n alth o f ou N gh k p t3 h0 e amp li tu d e <strong>of</strong> th is d ecreas e<br />

w a s s m a l l.<br />

p < 0 . 0 0 1<br />

1 6<br />

24hr s<br />

p = 0 . 0 0 1<br />

1 6<br />

24hrs


Individual NKCA (% killing at E:T ratio = 50:1)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .3 .3. 4 N KC A, a s s e s s e d b y c o l o r i m e tri c m e t , h o d a f t e r 2 4 h o u ation r s i <strong>of</strong> n Pc BMC u b s wi t h<br />

250n M c o r t i s o l<br />

T h i s e x p e r i m e n t a i m t e h pe d revi ou t s exp o eri mc en o t 3 n . f 3 . i 2 b. y r 3 m t h e r e<br />

u s in g a col o ri met ri c m et h od with a lar ger n u mb er <strong>of</strong> s u b j ects , i.e. to d ete rmin e if 2 4 h rs<br />

in cu b at i on <strong>of</strong> P BMC s wi t h 2 5 0n M cortis ol in h ib its an in creas e in th e level s <strong>of</strong> th e NKC A.<br />

P BMC s fro m 3 1 h eal t h y s u b jects were in cu b ated for 2 4 h ou rs with or with ou t 2 5 0 n M<br />

c o r t i s o l p r i o r t o a s s e NKC s s i n A g bt y h t e h e col ori met ri c meth od a t ef fecto r : tar get ratios o f b oth<br />

5 0 : 1 a n d 2 . 5 : 1<br />

I n d i v i d u a l ( a m ) e a n a n ( d b ) N K C A l ls e after v e exp os u re <strong>of</strong> P B MC s to c ortis ol are s h own<br />

in Figu re 5 5 ( a ) , ( b ) an d 56 ( a ) , ( b ) . A s p f r o e u v n , i d th o ere u s l was y a s ign ifi can t re d u ction<br />

f o l l o w i n g e x p o s u r e o f P B M C s t o 2 5 0 n M o f c o r t i s o l in th e mean N KC A l evels at ef fector : tar get<br />

r a t i o = 5 0 (m : 1 e a n di f f e r e n c e = , SD 6 . = 6 6 9 .9 , p < 0 .0 0 1 , t = 5 . 4 1 , d ) f a n = d 3 2 0 5 : (mean 1<br />

di f f e r e n c e = , SD 9 . = 7 8 3 .1 , p < 0 .0 0 1 , t = 6 . 6 6 , d f = 3 0 , re ) s p e c t i v e [F l i y g u r e 5b 5 an d Fi gu re<br />

56b] .<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

NKCC % ( LDH a s s a y) 50:1<br />

0 n M 250nM cortisol<br />

Wi t hout dr ugC o r t i s o l 2 5 0 n M<br />

NKCA levels (95% C.I.) 50:1 ratio<br />

40<br />

30<br />

20<br />

10<br />

Fi gu r e 55a: In d i v i d u a (50:1) l lev N e K l C s A Fi gur e 55b: M e a n ( 9 5 % (50:1) C . I l . e v ) e l s N K C A<br />

(% killin g) <strong>of</strong> P BM Cs in c uba te d (% killin g) o f P B M C s i n c u b a t e d<br />

w i t h o r wi t h o u t c or t i s o l w i t h o r w i t h o u t l c o r t i s o<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 38 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =<br />

3 1<br />

p < 0 . 0 0 1<br />

3 1


Individual NKCA (% killing at E:T ratio = 25:1)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

NKCC % ( LDH a s s a y) 25: 1<br />

0 n M 250nM cortisol<br />

Wi t ho ut d r u gC o r t i s o l 2 5 0 n M<br />

NKCA levels (95% C.I.) 25:1 ratio<br />

Fi gu r e 56a: In d i v i d u a (25:1) l l e N ve K ls C A Fi gur e 56b: M ea n ( 95% C. I. ) NKCA (25:1) l e v e l s<br />

(% killin g) o f P B M C s i n c u b a t e d<br />

(% killin g) o f P B M C s i n c u b a t e d<br />

w i t h o r wi t h o u t c or t i s o l w i t h o r w i t h o u t l c o r t i s o<br />

C o n c l u s i o n :<br />

40<br />

30<br />

20<br />

10<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 39 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =<br />

I n c u b a t i o n o f P B M C s f o r 2 4 h o u r s w i t h c o r t i s o l ( 2 5 0 n f M N) KC c A. a u s e s a n i n h i b i<br />

3 .3 .3.5 NKC A l e v e l s b e t p w r e e a n d p o s t 2 4 h o u r in s cu b at ion wi th o r w i t h o u t 2 5 0 n M c o r t i s o l<br />

H a v i n g s h o w n t h a t t h e r e w a s a n i n c r e a s e i n t h e l e v e l s o f N p K < C A 0 .0 ( 0 1 , n = 3 1 )<br />

follo wi n g i n v i cu t r ltu o re <strong>of</strong> P B MC s fo r 2 4 h ou rs ; an d th at th e add ition <strong>of</strong> 2 5 0 cortis n M ol t o th e<br />

c u l t u r e m e d i u m i n h i b i t e d (p t h i < s 0 . r i 0 0 s 1 e , n = 3 1 as ) s, ociat t h ie on b et ween th es e d egree <strong>of</strong><br />

the i n c r e a s e s a n d t h e i n h i b i t i no alys n w ed e . r e a<br />

Th e in d ep end en t t-t es t s s h owed th at th e NKC A l evels <strong>of</strong> th e P BMC s b ef ore 2 4 h o u rs<br />

i n c u bat i on were n ot d i fferen t f ro m th e le vels o f P BMC s afte r 2 4 h ou rs <strong>of</strong> in cu b ation with<br />

2 5 0n M cort i s ol [F i g u r e 5 7].<br />

3 1<br />

p < 0 . 0 0 1<br />

3 1


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n<br />

NKCA 25:1 ratio (95% C. I.)<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

3 1<br />

Ti me 0<br />

3 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 40 - I m p e r i a l o C n o d l o n l e g e L<br />

3 1<br />

24hr s No dr 24hrs ug Cortisol<br />

Fi gu r e 57: M ea n (95% C. I .) <strong>of</strong> th e NKCA a t T ime 0 a nd aft e r 24 hr s in cu bat io n <strong>of</strong> P BM Cs<br />

w i t h / o u t 2 5 0 n M c o t r i s o l i n t h e t a r g e t : e f f e c t o r r a t i o o f 2 5 : 1<br />

Th e d egrees <strong>of</strong> an i n creas e i n N KC A le ve l after 2 4 h ou rs o f in cu b ation an d an in h ib ition<br />

<strong>of</strong> th is i n creas e i n N KC A <strong>of</strong> th e P BMC s in cu b ated with 2 50 n M cortis ol a re s tati s ticall y th e<br />

s ame.<br />

Th is fin d in g w a s a l s o e d b c y o c n o r f r e i l a r t n a i l m o y n s s, e in wh ich th e as s oci at ion b etween<br />

time c h a n g e s ( a f t ho e u r s 2 i n 4 c u b a t i o n w i t h o u t c o r t i s o l - T i m e 0 ) an d d i f f e r e n c e s (afte r 2 4<br />

h ou rs i n c u b a t i w o i n t h o u t cort is ol – with c o r t i s o l) b o th a t t h e r a t i o o f 5 0 : p 1 = ( 0 .0 4 2 , r = 0 .3 7 , n<br />

= 3 1 ) a n d 2 5 : 1 p ( < 0 . 0 0 1 , r = 0 . ) 7 [Fi 2 , gu re n 5 = 8 ]. 3 1<br />

Increase in NKCA 25:1 (24h - Time 0)<br />

40<br />

30<br />

20<br />

10<br />

0<br />

p < 0.001<br />

N o t s i g n i f i c a n t<br />

p < 0.001<br />

p < 0 .0 0 1<br />

n = 3 1<br />

r = 0 . 7 2<br />

- 10 Rsq = 0.5220<br />

- 30 - 20 - 10 0 10 20 30<br />

Reduction <strong>of</strong> NKCA 25:1 (No-drug - Cortisol)<br />

Fi gur e 58: C o r r e l a t i o n s b e t w e e n t h e c h a n g e s a n d d i f f e r e n c e s o f t h e N K % C A killin ( g: be t we e n a t<br />

T ime 0 a nd aft e r 24hr s incubat io n <strong>of</strong> P BM Cs wit h / out 2 5 0 n M c o r t i s o l i n t h e ) r a t i o o f 2 5 : 1


NK-cells (%) in PBMCs<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o n c l u s i o n :<br />

Th e d egree <strong>of</strong> in h ib it ion in th e NKC A b y th e i n v i t e r x o p os u re to th e 2 5 0 n M cort is ol was<br />

a l m o s t t h e s da eg m e ree <strong>of</strong> in creas e in th e levels o f N KC A a fter 2 4 h ou rs i n v i incu t r o b at ion <strong>of</strong><br />

P BMC s .<br />

3 .3 .3.6 C D 5 6 K-c N e l l s u b s e t p r o f i l e s i n P B M C s a f t e r 2 4 h o u r s i n c u b a t i o n w i t h 2 5 0 n M c o r t i s o l<br />

Ha v i n g c o n f i r m e d i n t h e l a r g e r c o h o r t o f s u b j e c ts t h a t 2 4 h o u r s i n with c u b a cor t i ti so ol n<br />

in h ib ited NKC A, th e e xp eri men t t o d eter min e if th is was d u e to a ch an ge in N K -c e l l p e t r a c g e n<br />

was rep eat ed . In ad d i t i on , N K -c e l l s u b s e t p r o f i l e s (p e r c e n t a g e s <strong>of</strong> c yt oto xic an d re gu lator y N K -<br />

c e l l s w i t h ) i w n e r e t h e x e a m . i Du P n B e M d to C tech n ical p rob lems in fl ow c yt om eter, on l y th e<br />

las t 1 6 s ub j ect s from t h e ab ove 3 1 s u b jects were an al ys ed .<br />

F i gu re 5 9 ( ), a (b) a n (c) d s h o (a) w mean ( 9 5 % C .I.) p e r c e n t a g e s o f N -c K e l l ( C D 3 - C D 5 6 + ),<br />

(b) c yt ot o xi c N K -c e l l ( C D 3<br />

- d i m<br />

C D 5 6 C D 16 + ) an d (c) re gu lat or y N K -c e l l ( C D 3<br />

- C D 5 6 b r i g h t C D 16 - )<br />

in th e P BMC s aft er 2 4 h o u r s i n c u b a tion w i t h a n d w i t h o u t 2 5 0 n M c o r t i s o l y. , As r e s fou p e nc d t i v e<br />

p r e v i o u s l y, th e r e w e r o e s i gn n ifi can t d iff eren ces i n -c e N l K l p e r c e n t a g e s a n d s u b p o p u l a t in i o n s<br />

P B M C s a f t e r 2 4 h r s i n c u b a tion w i t h a n d w t i 2 5t 0n h o M u cort is ol .<br />

Total NK (CD56) cell% in PBM Cs<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

No dr u g<br />

1 6<br />

Cortisol<br />

Cytotoxic NK (CD56dim ) cell% in PBM Cs<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

No dr ug<br />

1 6<br />

Cortisol<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 41 - I m p e r i a l o C n o d l o n l e g e L<br />

Regulatory N K (CD 56bright) cell% in PBM<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

No dr ug<br />

F i g u r e 59a: N K (%) i n t h e P B M C s Fi gu r e 59b: C y t o t o x NK i c (%) Fi gur e 59c: Re gula t or y N K (%)<br />

a f t e r 2 4 h r wi s t h / o ut co r t i s o l a f t e r 2 4 hr s wi t h / o ut co r t i s o l a f t e r 2 4 hr s wi t h / o ut co r t i s o l<br />

Fi gur e 59: P e r c e n t a -c g e ll e in s t ota l o a nd f e a ch N K s ubs et in th e P BM Cs a ft er 24 ho urs in cu ba t io n wit h<br />

a n d wi t h o u t 2 5 0 nM c or t i s o l<br />

C o n c l u s i o n :<br />

Th e c o r t i s o l a s s o c s i u a t p e p d r e s s i in P o B n M C s o a f t e N r K C 2 4 A h o u r s i was n c u b a t i o n<br />

n ot as s oci at ed wi th a c h a n g e N i K n -c e l l r o f p i l es.<br />

1 6<br />

Cortisol


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .3 .3.7 E x p r e s s i o n y o t f o t N a o t x u i r c a l R e C c e p t o r s ( N k p -c 4 ells 6 a n d N k p 3<br />

( C D 3 - C D 5 6 d i m C D 1 6 + ) a f t e r 2 4 h o u r s i n cu b a t i o n w i t h o r w i t h o u t 2 5 0 n M c o r t i s o l<br />

Ha vin g s h own t h at t h e i n h i b ition <strong>of</strong> an in creas e in N KC A in P BMC s afte r 2 4 h ou rs<br />

i n c u b a t i o n w i t h 2 5 0 n M c o r t i s o l w a s o c n o i t a t a s e s d w i c h t a h n g e s th i e n p ercen tage d is tri b u ti on s<br />

<strong>of</strong> t otal or c yt ot oxi c N K -c e l l s , th is exp eri men t was p erf or med t o d e t e r m i n e i cf ortis t h ol e<br />

i n d u c e d in h ib iti on wa s a s s o c i a t e d w i t h t h e e x e p r m e s a s j i o r o n c o y f t o t h o x i c r e c e p t o r o n<br />

c ytot oxi c N K -c e l l s. In e x p e r i m e n t 3 . 3 . 4 . 3 , was t h i s h own to b e in creas ed aft er 2 4 h ou rs<br />

in cu b at i on .<br />

Th e exp res s ion ( m e a n f l o r e s c e n t i n t e n s i t y : m . f <strong>of</strong> . i . th ) e Nkp 4 6 an d th e Nkp 3 0 on<br />

c y t o t o x i c N K C ( D 3 - d i m<br />

C D 5 6 C D 1 6 + ) cel ls wi th in P BMC s from 1 6 h ealth y s u b jects were<br />

a n a l y s e d b y w-c f yt l o om et r y p e rf or med af ter 2 4 h ou rs in cu b ation with or with ou t 2 5 0 n M<br />

cortis ol .<br />

Fi gu re 60 ( a ) a n d ( b ) s h ow th at th ere was a s ign ifican t in h ib ition <strong>of</strong> an in creas e in t h e<br />

exp res s ion <strong>of</strong> th e Nkp 4 6 on c yt oto xic N K -c e l l s a f t e r 2 4 h r s i n v i t i r n o c u b a e p t e a i t ed o n ( R<br />

meas u res ANOV A: F = 5 8 .4 , p < 0 .0 0 1 , n = 1 6 ; mean d ifferen ce = 1 3 .3 , s e = 1 .7 ). Fi gu re 61 (a)<br />

a n d ( b ) s h ows t h at t h ere was a s ign ifican t , b u t s ligh t d ecreas e in th e exp res s ion o f t h e Nkp 3 0 on<br />

c ytot oxi c N K -c e l l s a f t e r 2 4 h r s i n v i incu t r bo at ion (F = 1 3 .2 , p = 0 .0 0 2 , n = 1 6 ; me an d ifferen ce<br />

= 2 . , s3 e = 0 .6 ).<br />

1 4 0<br />

1 2 0<br />

1 0 0<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Nk p 4 6 m.f .i. o n Cy to to x ic NK cells<br />

N o d r u g Co rtiso l<br />

N k p 4 6 m .f.i. o n C y to to x ic N K cells<br />

1 25<br />

1 00<br />

75<br />

50<br />

25<br />

0<br />

N =<br />

p < 0 . 0 0 1<br />

1 6<br />

No d r u g<br />

Fi gur e 60a: M e a n ( 9 5 % C . I . ) N k p 4 6 ( m . f . i . ) Fi gur e 60b: Individual Nkp46 (m.f.i.) a f t e r<br />

a f t e r 2 4 hr s i n c ub at i o n o f P B M Cs wi t h / o u t c or t i s o l 24 hrs in c uba t io n <strong>of</strong> P BM Cs wi t h / ou t c o r t i s o l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 42 - I m p e r i a l o C n o d l o n l e g e L<br />

1 6<br />

cortisol


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 4 0<br />

1 2 0<br />

1 0 0<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Nk p 3 0 m.f .i. o n Cy to to x ic NK cells<br />

N o d r u g Cortisol<br />

N k p 3 0 m .f.i. o n C y to to x ic N K c e lls<br />

Fi gur e 61a: M e a n ( 9 5 % C . I . ) N k p 3 0 ( m . f . i . ) Fi gu r e 61b: T h e i n d i v i d u a l N k p 3 0 ( m . f . a i f . t e ) r<br />

a f t e r 2 4 hr s i n c ub at i o n o f P B M Cs wi t h / o u t c or t i s o l 2 4 h r s i n c u ba t i o n o f P BM C s wi t h / ou t c o r t i s o l<br />

C o n c l u s i : o n<br />

T h e s e r e s u l t s u gges t th at th e in h ib it ion <strong>of</strong> an in creas e in N KC A in P BMC s afte r 2 4 h ou rs<br />

in cu b at i on wi t h cort i s ol was as s ociated w ith an in h ib ition <strong>of</strong> an in creas e in th e e xp res s ion <strong>of</strong><br />

Nkp 4 6 on c yt ot oxi c N K -c e l l s .<br />

3 .3 .3. 8 Nkp 4 6 exp res s ion on c yt oto xic NK-c e l l s p r e a n d p o s t 2 4 h o u r in s cub at ion wi th o r<br />

w i t h o u t 2 5 0 n M c o r t i s o l<br />

12 5<br />

10 0<br />

7 5<br />

5 0<br />

2 5<br />

0<br />

N =<br />

p = 0 . 0 0 2<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 43 - I m p e r i a l o C n o d l o n l e g e L<br />

1 6<br />

No dr u g<br />

Ha vin g s h own t h at t h ere w as an in creas e in th e exp res s ion s <strong>of</strong> N kp 4 6 (m.f .i.) on th e<br />

c ytot oxi c N K -c e l l s (p < 0 . 0 , 0 1 n = ) f ol 1 6 lowi n g i n v i cu t r ltu o re <strong>of</strong> P BMC s fo r 2 4 h ou rs ; an d<br />

that the ad d it ive <strong>of</strong> 2 5 0 cortis n M ol t o th e cu lt u re med iu m in h ib ited th is in creas e, th e d egree <strong>of</strong><br />

th es e in creas es an d t h e i n hi b ition were an al ys ed . Th e in d ep en d en t t-tes t s s h owed th at th e<br />

e x p r e s s i o n o f N k p 4 6 -c e l ( l s m . b e f o . r e i 2 . 4 ) h o u r o s n wer i n e c u lowe b y a t r i to ho an t o x i c N K<br />

t h a t o n -cells c y t aft o e r t 2 4 o h ou x i rs <strong>of</strong> c in cu N bK ation with 2 5 0n M cortis ol [F i g u r e 62].<br />

1 6<br />

cortisol


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Nkp46 m.f.i. on Cytotoxic NK cells<br />

125<br />

100<br />

75<br />

50<br />

25<br />

0<br />

N =<br />

1 6<br />

Time 0<br />

1 6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 44 - I m p e r i a l o C n o d l o n l e g e L<br />

1 6<br />

24hr s No dr 24hrs ug cortisol<br />

Fi gur e 62: M e a n ( 9 5 % C . I . and ) individual expression <strong>of</strong> N k p 4 6 ( m . f . i . -c ) e lls o n t h e c y t<br />

( C D 5 6 dim CD16 + ) a t T i m e 0 a n d a f t er 2 4 hr s i nc u b at i o n <strong>of</strong> P B M Cs wi t h / o ut 2 5 0n M c o r t i s o l<br />

C o n c l u s i o n :<br />

Alth ou gh t h ere was an i n creas e in th e e xp res s ion s <strong>of</strong> N kp 4 6 (m.f .i .) on th e c ytot oxi c N K -<br />

c e l l s f o l l o w i n g 2 4 h o u r s i , th n c e u ad b a dt it i on o n <strong>of</strong> 2 5 0 cortis n M ol in h ib it ed t h i s r . i Th s e is<br />

in h ib iti on d i d n ot reach comp lete s u p p res s ion .<br />

3 .3 .3.9 NKC A an d Nkp 4 6 exp res s ion on c yt oto x ic N K -c e l l s p r e a n d p o s t 2 4 h o u r in s cub ati on<br />

with o r w i t h o u t 2 5 0 n M c o r t i s o l<br />

Ha v i n g t h e d i s c r e p a n c y b e t w e e n t h e c h a n g e s i n N KC A l e v e l s a n d c h a n g e s n i th e Nkp 4 6<br />

e x p r e s s i o n p - r a e n d p o s t- 2 4 h ou rs in cu b at ion with or with ou t 2 5 0 n M corti s ol , th e s ame 1 6<br />

volu n teers wh os e N kp 4 6 were ex amin ed ou t <strong>of</strong> th e 3 1 s u b j e c t s w e r -an e r al e ys ed ac cord in g to their level s <strong>of</strong> N KC A. A t ren d <strong>of</strong> ch an ges th at were s imil ar t o e t res h u lt s in Nkp 4 6 an al ys es w as<br />

ob tain ed i n t h i s an al ys i s <strong>of</strong> N KC A levels . Alth ou gh th ere was an in creas e in th e le vel s o f<br />

N K C A (p < 0 . 0 0 1 ) foll owi n g i n v i cu t r ltu o re <strong>of</strong> P B MC s fo r 2 4 h ou rs , an d th e ad d ition <strong>of</strong><br />

2 5 0 cortis n M ol t o th e cu lt u re med iu m in h ib ited th is ris e, th is inh ib ition d id n ot reac h comp lete<br />

s u pp res s ion [F i g u r e 3]. 6<br />

p < 0.001<br />

p < 0.001<br />

p < 0.001


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Means (95% C.I.) <strong>of</strong> NKCA in 25:1 ratio<br />

40<br />

30<br />

20<br />

10<br />

0<br />

N =<br />

1 6<br />

Ti me 0<br />

1 6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 45 - I m p e r i a l o C n o d l o n l e g e L<br />

1 6<br />

24hr s No dr 24hrs ug cortisol<br />

Fi gur e 63: M ea n (95% C.I .) and in divid ua l le ve l <strong>of</strong> NKCA a t T ime 0 an d af te r 24 hr s in c uba t io n <strong>of</strong><br />

P BM Cs wit h / out 250nM c or t iso l a t t a r g e t f : f e c t o r r a t i o o f 2 5 : 1<br />

C o n c l u s i o n :<br />

Th e in h ib it ion <strong>of</strong> an in creas e in N KC A le vels afte r 2 4 h rs i n v i in t cub r o at ion wi th 25 0 n M<br />

c o r t i s o l h a s a s s o c i a t i o n w i t h t h -cells e i aft en r h i b i t i o n<br />

th e 2 4 h rs i n cu b at i on .<br />

3 . 3 . 4 E n d o g e n o u s s t r e s s h o r m o l n e v e ls a n d N K C A ( c o l o r i m e t r i c m e t h o d )<br />

Ha vin g s h o w n t h a t e x p u o r s e o f P BMC s t o ex o gen ou s cortis ol f or 2 4 h ou rs ap p ear ed to<br />

b lock t h e cu l t u re as s oci at ed ris e in th e lev els <strong>of</strong> N KC A, t h e le vels o f en d ogen ou s c ortis ol in th e<br />

p l a s m a o f s u b ject s was meas u red to d eter min e if p rio r in vivo exp os u re af fected N KC A le vel s .<br />

I n a d d i t i o n , t h -S e a n p d l m a e l s a m t o a n i n l w e r v e a l s in o ord m o e er f a s to u r D e d H E A<br />

examin e th e h yp ot h es is th at p rior in vivo ex p o s u r e t o e i t h e r o f A t h e m i s a s<br />

l e v e l h e s . p l a s T m s a f r o m t h s e p a r a t P B e d M C s wer e an al ys ed to meas u re en d oge n ou s levels <strong>of</strong><br />

c o r t i s -S o l a n , d m D e l H a E t A bo y n i E LIS n A as s a ys . C o rrel at i on an al ys es b etween e n d ogen ou s<br />

l e v e l s o f s t r -a e s s s o c i a t e d h o r m -S o n e a s n d ( c m e o l r t a KC t i A o s level n o i l s n we , ) re D a H E n A d N<br />

u s ed to t es t t h e h yp ot h es i s .<br />

p < 0.001 p = 0.001<br />

p = 0.012


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .3 .4.1 En d o g e n o u s h o r m o n e a t T i l m e e 0 v p o e i n l t s a n d N K C A<br />

A t T i m e 0 p o i n t , t o h se ign r e ifi can w a t s correl n at ion b et ween e n d o g e n o u s c o r t i s o l l evels<br />

an d NKC A le vel s at b ot h an al ys es ratios <strong>of</strong> 5 0 : 1 ( r = , n . = 0 39 1 , n s ) a n d 2 5 : 1 (r = - . 0 , 1 n = 3 1<br />

n s ). D H E -S A l e v e l s , o n t h e o t h e r h a n d , h a d a s i g n i f i c a n t p o s i t i v e c o r r e l a t i o n w i t h N K C A l e v e l<br />

b u t o n l y a t t h e r a t i o o f , n 2 = 5 3: 1 , p ( = r 0 . = 0 ), 3 . a n 3 d 8 n ot wi th th e level s at th e ratio <strong>of</strong> 5 0 :1<br />

( r = , . n 1 = 9 3 1 , n s). o s ign N ifi can t c or rel at ion b et ween e n d o g e n o u s m e l a t lev o n i els n an d<br />

NKC A l evel s at th e rat io o f 5 0 : 1 ( r = - . 0 , n 9 = 3 1 , n s) a n d 2 5 : 1 (r = - . 0 , n 3 = 3 1 , n s) was fou n d<br />

a t T i m e 0 p o i n t.<br />

C o n c l u s i o n :<br />

Th es e res u l t s s u gges t t h at p rior in vi vo ex p o s u r e t o c o r tis ol or melat on in d id n ot aff ect<br />

NKC A l evel s at th e Ti me 0 p oin t, alth ou gh t h e r e i still s a p os s ib il it y th at p ri o r in v ivo exp os u res<br />

t o D -S H E ma A y b e p o s i t i v e l y a s s o d c i with a t e NKC A le vel s at Ti me 0 p oin t.<br />

3 .3 .4.2 En d ogen ou s h o r m o n e s levels an d t h e i n c as r e ed level s o f N K C A a f t e r ho u 2 r 4 s i n v i t r o<br />

i n c ub a t ion o f P B M C s w i t h o u t e x o g e n o u s c o r t i s o l<br />

T h e res u l t s fro m p re vi ou s e x p e r i m e n t [ 3 . 3 . 4 ] s h owed th at th ere were in d ivid u al<br />

d i f f e r e n c e s<br />

i n t h e l afte e v r 2 e 4 l h o s u r s o i f n c u b N a w t K i t i C h o A u n t e x o g e n o u s c o r t i s o l, i. e.<br />

s o m e o h f a d h i g t h h l e v e <strong>of</strong> l m s N KC A a n d th e ot h ers h a d l o w l e v e . l In s d ivi d u al s were d ivi d ed<br />

in to th ree g rou p s (h igh , mi d d le an d low NKC A l evels ) acco rd in g to a v e r a g e d l e v e l N at s K C A<br />

th e rati o <strong>of</strong> 5 0 :1 an d 2 5 :1 a f t e r 2 4 h o u r s i n w c u i t b h a o t u t i c o n r t is o l [Fi gu re 64].<br />

NKCA a f t e r 24h r s i n c u b a t i o n<br />

45<br />

30<br />

15<br />

0<br />

G r o u p o f i n d i v i d u a l s w i t h h i g h l<br />

(H i g h N : K me C aA n = 3 4 .2, SD = 6.8, n = 11)<br />

G r o u p o f i n d i v i d u a l s w i t h m i d d l<br />

(M i d N K : me C A an = 20.6, SD = 3.3, n = 9)<br />

Gr oup <strong>of</strong> i ndi vi dual s wi t h l ow l e v e l s o f t h e N K C A<br />

(L o w N K : C me A an = 7.1, SD = 4.8, n = 11)<br />

Fi gur e 64: G r o u p s d e f i n e d b y t e r t i a r y s p l i t o f t h e N K C A l e v e l s a f t e r 2 4 h o u r s i<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 46 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e g r o u p ith o f h i g h p l e o v e p l l s e o f t w h e t h N e t K e r C t A i a r y i s n p l i t High s ( N KC A:<br />

m e a n = 4.2, 3 SD = 6.8, n = 1) 1 1 an / 3 d t h e g r o u p o f p l e p w e o h o h a v e l o w l e v e l Low s ( N KC A:<br />

m e a n = 7 . 1, SD = 4 .8, n = 1) 1 1 were / 3 co mp ared wi th reg ard to th e levels <strong>of</strong> th eir en d ogen ou s<br />

h orm on es b y i n d e p e n d e t n t-tests. In ad d it ion , co rrel at i on an al ys es wer e p erf or med to ex amin e<br />

th e a s s o c i a t s i b o e t n w e e n e n d o g e n o u s h or mon es lev els an d th e in creas ed levels o f NKC A after<br />

2 4 h ou rs i n cub at i on .<br />

C o r t i s o l l e v e l s<br />

E n d o g e n o u s p l a s m a l e v e l s o f c o r d t i n s o s o i l g n i h f i a c a n t c orrel at i on with th e levels <strong>of</strong> th e<br />

N K C A b o t h a t t h e r a t i o o f , n 5 0 = : 1 3 1 ( , ) r n s a = n d . 2 0 5 9 : 1 ( , r n = . 3 1 0 , 2 ) n , s a n o d n<br />

statisticall y s ign ifi can t d iffer en ce i n m e a n s b e t w e e n t h e H i g h N K C d A the g Low r o u Np KC a n A<br />

grou p was f ou n d [ Fi gu re 6 5 ].<br />

Mean (95% C.I.) plasma cortisol levels (nM)<br />

2 0 0<br />

1 5 0<br />

1 0 0<br />

5 0<br />

0<br />

Lo w N KCA<br />

i n d i v i d u a l s<br />

M id NK CA<br />

i n d i v i d u a l s<br />

Hi gh NK CA<br />

i n d i v i d u a l s<br />

Fi gur e 65: M ea n (95% C.I .) pla s ma le ve ls <strong>of</strong> c ort is ol in t he High , int e r me diat e ( M id) a n d Lo w NKC A<br />

l e v e l g r o u p a s f t e r 2 4 h o u r s i n c u b a t i o n<br />

D H E A -S l e v e l s<br />

N o t s nificant<br />

i g<br />

En d ogen ou s p l as ma l evel s <strong>of</strong> D H E A -S a p p eared to b e p os itivel y as s ociated with N K C A<br />

l e v e l s b o t h a t t h e r (r a t i = o , . n o 3 f = 8 35 1 0 , : p 1 = 0 . 0 ) 3 an 7 d 2 5 :1 (r = , . n 3 = 7 3 1 , p = 0 . 0 ), 3 8<br />

an d th e Hi gh N KC A gr ou p h ad s i gn ifican tl y h i g h e r l e -S v co e mp l s ared wo it f h th e D level H E s A<br />

<strong>of</strong> th e Lo w N KC A g rou p [F i g u r e 6] (me an d ifferen ce = 1.6, t = 2.1, d f = 2 0 , p = 0 45) . 0 .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 47 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) plasma DHEA-S levels (mg/dl)<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

L ow N KC A<br />

i n d i v i d u a l s<br />

M i d N KC A<br />

i n d i v i d u a l s<br />

Hi g h NK CA<br />

i n d i v i d u a l s<br />

Fi gur e 66: M ea n (95% C.I .) pla s ma le ve ls <strong>of</strong> D H E A -S in t he High , in t e r me diat e ( M id) a n d Lo w NKC A<br />

l e v e l roups g a f t e r 2 4 h o u r s i n c u b a t i o n<br />

M e l a t o n i n l e v e l s<br />

En d ogen ou s p las ma level s <strong>of</strong> m e l a t o n ap i n p eared to b e p o s i t i v e l y a s s o c iated with N K C A<br />

l e v e l s b o t h a t t h e r (r a t = i .4 o 2 , n o f = 35 1 0 , : p 1 = 0 2 . 0 0 ) an d 2 5 :1 (r = , . n 3 = 8 3 1 , p = 0 . 0 ). 3 8<br />

M o r e o v e r , th e Hi gh N K C A g r o u p h a s d i g n i f i c ha igh n t el r y lev el s <strong>of</strong> mel at on in co m p ared with<br />

t h e l e v e l os w No KC f A gr t ou h p e [F i L g u r e 6 7] ( m e a n d i f f e r e 5.2, n c e t = 3 .2 1 , d f = 2 0 , p =<br />

0 . 01 0 ).<br />

p = 0 . 0 4 5<br />

I n a d d i t i o n , e n d s o pg las e n ma o u level s <strong>of</strong> mel at on in s h o w ed s i g n i f i c a ith n t c o r r e l<br />

t h e i n c r e a d s levels e o f th e N KC A a ft er 2 4 h ou rs fro m T i m e 0 t i m e p o i n t a t t h e r a t i 0 : o 1 (r o f 5<br />

= . 4 , n 7 = 3 1 , p = 0 . 0 ) 0 8 a n d 5 : 2 1 ( r , = n = . 34 1 2 , p = 0 . 0 ). 1 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 48 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) plasma melatonin levels (pg/mL)<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

L ow N KC A<br />

i n d i v i d u a l s<br />

M id N KCA<br />

i n d i v i d u a l s<br />

High N KC A<br />

i n d i v i d u a l s<br />

Fi gur e 67: M ea n (95% C.I .) pla s ma le ve ls o f me la t o n in in th e High , in t e r me d ia te (M id ) a n d Lo w N KC A<br />

le ve l gr o u p s a f t e r 2 4 h o u r s i n c u b a t i o n<br />

C o n c l u s i o n :<br />

Th es e res u lt s s u gges t th at p rior i n v i ex v o p os u re to c ort is ol d id n ot a f f e c t N K C A l e v , e l s<br />

b u t t h a t p r i o r i n v i v e o x p o s u r e -S s a n d t m o e l a D t w H o n e E r i A e n as s oci at ed wi th th e in creas ed<br />

l e v e l s o f NK C A a ft er 2 4 h ou rs i n v i t i r n o c u b a t . i o n<br />

S u m m a r y :<br />

T h e s e r e , s b y u th e l f t l -c s o y t w o m c e t o r n y f a n d i c r o l m o r i m meth e t r od i c s that th e lev el s <strong>of</strong><br />

t h e N af K t e C r A in c u b a t i o n o f P B M C s f o r 2 4 h o i u r n s c r e a . s e h d e T r e w e r e ch n an o ges in N K -<br />

c e l l an d c y t o t o -c x e l l i p c er c e n t N a g K e s a f t e r t h e 2 4 h o u r s i n c u b a t i o n o f P B M C s , b u t ht e<br />

e x p r e s s i o n o f Nkp t h e 4 6 recep tor was s h own to in cre as e wh ile th e exp res s ion <strong>of</strong> t h e Nkp 3 0 was<br />

n o t a f f e c t s i e d g n i f i c . a Th n t e l in y creas e <strong>of</strong> N KC A levels after 2 4 h ou rs in cu b ation was s h own to<br />

b e a s s o c i ted a wit h th e in creas e in Nkp 4 6 exp res s ion .<br />

p = 0 . 0 3 7<br />

U p p e r p h y s l i o g i c a l l e v e l s o f c no M), r t i in s vi o l tr o ( s t 2 r 5 e 0 s s mod el , we re s h own t o<br />

inhibit t h e in creas e <strong>of</strong> N KC A s een a f t e r 2 4 h r s i n c . u Th b a e t di egree o n <strong>of</strong> in h ib it ion in th e NKC A<br />

b y t h e 2 5 0 n M c o r t i s o l w a s a l m o s t t o th e s ame d eg ree <strong>of</strong> i n cre as e in th e levels <strong>of</strong> N KC A a fter 2 4<br />

h o u r s i n cu b at i on <strong>of</strong> P BMC s . T h is in h ib ition in th e NKC A level w a s not as s o ciated with a<br />

n u m e r i c a l c h a n g -c e e l i l n s t h a e n d l -c t e v h l e l l -p s u s o c b p u y l t a o t o f i , t o bn uo t N th x K e i c N K<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 49 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

i n h i b i t i o n s w s a h o w n t o b e a s s o c i a t e d w i t h i n h i b i t i o n ( m o . f . i N . on ) k p c4 yt 6 ot e ox xi p c r e s s i o n<br />

N K -c e l l s u b s e . t Howe s ver, th e d egree o f inhibition o f N k p 4 6 e x p r e ds id s i no ot n f u l l y m a the t c h<br />

s u p p r e s s i o n f t h e i n c r e a s e a f t e r 2 4 h . o u T r h i s s i f n c i u n b d a i t n i g o n i at m p th l ere i e are s ot t h er<br />

con trib u t i n g fact ors ap art f ro m th e N kp 4 6 exp res s ion .<br />

T h e a n a l y s e s i n a s s o c i a t i o n s b e t w e e n e n d o g e n o u s l e v e l s -h o or f ms t on r e es s s (co rt is ol ,<br />

de h y d r o e p i a n d r o s t e r o n e s u l p h a ( t e D H -S E ) A an d mel at on in ) an d NKC A le vels at T ime 0 , i.e .<br />

b e f o r e e t in h cu b at ion <strong>of</strong> P BMC s , d e m o n s t r a t e d t h a t t h e r e n o w e s r i e g n i f i c a n t r e s. l a t i o n s h i p<br />

H o w e v e r , t h e r e a p p e a r e d een t en do ogen b ou e s level p s o <strong>of</strong> s D i H E t A -S i an v d e c o r r e l<br />

m e l a t o n , i b un t n ot co rt is ol , a n d t h e N K C A l e v e l s ho u a r f s t o e f ir n vi 2 t4 r o i n c u b at i o , n i.e. aft er<br />

i n c u b a t i o n w i t h o u t t h pe res en ce <strong>of</strong> e n d o g e n o u s h o r m o n e s. Th es e res u lts s u gges t th at th e level s<br />

<strong>of</strong> p r i o r i n v i v e o x p o s u r -S e a n t d o m e l D a H t , E o bn uA i t n ot co rt is ol , ma y h ave b een p os itivel y<br />

as s ociat ed wi th th e in creas ed levels o f N KC A a fter 2 4 h o u r s in vit r o i n c u b a t i . Toget o n h er wi th th e fin d i n gs t h at t h e i n creas ed levels <strong>of</strong> N KC A w ere in h ib ited b y th e p res en ce <strong>of</strong> u p p er<br />

p h ys i o l o g i c a l l e v e l s o f c o r t i s o l [ 3 . 3 . 1 . 3 a n d 3 . 3 . 3 .4 ] a n d i n t h e t l e i r a t u r e [1 .2 .2 .3 an d 1 .2 .4 .2 ], it<br />

w a s s u g g e s t e d A-S t h a t n d D H m E e l a t o n i n m -c a ells y in vi h vo a as v a e cou na ter f f e c t e d t<br />

regu lat o r y h o rm on e a gai n s t cortis ol in N KC A le vels .<br />

Th es e fi n d i n gs s u pp ort t h e h yp oth es es th at p h ys iol ogi cal le vel s o f c orti s ol can s u pp res s<br />

N K c y t o t o x i c a c t i v i ; t y a d n i d r e c t h l A-S a y t a D n d H E m e l a t o n i n h a m v e a c y o u n t e r a c ting e f f e c ts<br />

again s t cort is ol u p on th e N K c y t o t o x i c a . c Th t i is v con i t cl y u s ion s u p p ort s th e p remis e th at th ere<br />

is a d i r e c t h o r m -i o n m e m u n i t l y i n k a g e a s a n e -im n d o mu c r ni e n arm o <strong>of</strong> th e p rop os e d in tegrated<br />

p s y c h o-n e u r o-e n d o c r ino-i m m u n e n e t w o rk; an d p artiall y s u p p orts th e h yp oth es i s th at s t res s ma y<br />

h a v e a d e t r i m e n t a l e f f e c . t Th u is p lo ead n s h e o n a tl o t th h e n ext i n v i exp t r o eri men ts exami n in g<br />

t h e e f f e c t o f -l c y m o p r h t o c i y t s e s o l a s a u n p i o n v e s T t i g a t i o n o f a n o t h e r d -i<br />

r e c t h o r m o n e<br />

i m m u n i t y l i n k a g e , i . e . l i n k a g e b e t w t e e h n e c o r t a i d s o a l p a t n d .<br />

i v e i m m u n e s y<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 50 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 4 In v it ro i n v e s t i g a t i o n i n t o t h e e f x f p e o c s t u r o e f t str e o e ss hor mo ne u p o n T-<br />

l y m p h o c y t e s<br />

B a c k g r o u n d<br />

T-l y m p h o c y t e s a r e i m p o r t a n t c e l l u l a r c o m p o n e n t s o f t h e a s d ys a tem p t i , v an e d i m m u n e<br />

on e <strong>of</strong> t h e i r m a j o r f s, u pn rolif c t i erat o n i on (an in creas e <strong>of</strong> th e s p ecific c ell t yp es a ga in s t s p ecific<br />

a n t i g e n s ) [s ee al s o 1 . 2 . 1 ] . is 1 kn own to b e affect ed b y th e s tres s h or mon e, cortis ol.<br />

Ph armacol ogi c al le vel s o f e x o g e n o u s g l u c o c o r t i c o i d are s k n o w n t o s u -l p ymp p r he oc s yt s e T<br />

p roliferat i ve act i vi t y i n v i . t In r t o h i s p r o j e c t , th e e f f e c t s o f p h y s i o l o g i c a l l e v e l s co ortis f ol u p on<br />

T-l ymp h oc yt es we re i n ves t i gated b y as s e s s in g p roliferati ve r es p on s es again s t an tig en s an d a<br />

mito gen . T h e p r o l i f e r a t e i was o n a s s e s s e b d y u s i n g [<br />

3 H ] -t h y m i d i n e i n c o r p o r a t i o , n an d m e t h o d<br />

later t h e e x p r e s s i o n o f v a r i o u s c e l l s u r f a c e r e c b e p y t o r u s s w -c i a yto s n met e g x ra y m tf o i n l e d o w<br />

e x p l o r e t h e -l p r y m o p f h o i c l y t e s -p s u op o b uf lat ion T s .<br />

A i m s<br />

T o c o n f i r m th e s u p p res s i ve e f f e c t o f a ma jor s tres s h o rm on e, c o r t i s o l , u p on T-<br />

l y m p h o c y t e p r o l i f e r a t i v e r e s p , o n s e s a n d t o e x p ech l an o is ms r e at t h e t h e u n d e r<br />

c e l l u l a r l e v e l<br />

W o r k i n g h y p o t h e s i s<br />

“A n in vi tr o m od el <strong>of</strong> s u s t a i n e s t d r e s s i m p a i rs T-l ymp h o c yt e p r ol ife rative a c t i v .” i t y<br />

In vitr o mod el o f s u s t a i n se tres d s is d efi ned as “mo re th an 2 4 h ou rs <strong>of</strong> e xp os u re t o u p p er<br />

p h ys i o l o g i c a l l e v e l s o f c o r t i s o l”.<br />

3 . 4 . 1<br />

T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o n s e s a g a i n s t c o m m o n a n t i g e n s<br />

T h i s s e r i e s o f e x p e r i m e n ts was d es ign ed to c o n f th e i s ur p p res m s ive e f f ect <strong>of</strong> c ortis ol u p on<br />

T-l ym p h o c yt e p r o l i f e r a t io n , a n d t o e x p l o r e t h e e f f e c t o f c o r t i s o l a t u p p e r p h y s i o . l o g i c a l l e v e l s<br />

Wh en p e r i p h e r a l b l o o d m o n o n u c l e a r c e l l P s B ( M C s ) a r e i n c u b a t e d p reviou w i t sh l y<br />

en cou n tered an ti gen s , mem or y T-l y m p h o c y t es a r e s t i m u l da ivid t e d le t ad o in g to i n creas ed<br />

3<br />

i n c o r p o r a t i o n o f [ H ] -th ym id in e. Un d er th e cu ltu re con d ition s u s ed , s u ch cu ltu res s h ou ld give<br />

rad ioact i ve cou n t s i n exces s <strong>of</strong> 3,0 0 0 cou n ts p er min u te (cp m).<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 51 - I m p e r i a l o C n o d l o n l e g e L


Individual 3 H-thymidine incorporation per PBMCs culture well (cpm)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

40 00<br />

30 00<br />

20 00<br />

10 00<br />

0<br />

P BMC s fro m ten h e a l t h y s u b j e c t s w e r e i n c u b a t e d w i t h o r n w s i (p t uh ri o fi u ed t a n t i g e<br />

p r o t e i n d e r i v a t i v e ( P P D ) o r H e r p e s z o s t e r a n t i g in e n va ) ri ou s con cen trat i on s <strong>of</strong> cort is ol (0 , 2 5 ,<br />

2 5 0 and 2 50 0n M). Al l d at a wer e coll ecte d on th e 6 t h d a y o f i n c u b , a an t i d o pn rol ife rat ive res p on s es were me as u red b y th e [ 3 H ] -t h y m i d i n e i n c o r p o r a t io n m e t h . o d<br />

3 . 4 . 1 T-l ym p h o c yt e p r o l i f e r a t i o n a f t e r i n c u b a tion <strong>of</strong> P BMC s fo r s ix d a ys with a n d with ou t<br />

e x o g e n o u s c o r t i s o l<br />

As e xp ect ed , i n vi t r o i n cu b at ion <strong>of</strong> p erip h eral b lood mon on u clear cell s (P BMC s ) in ti s s u e<br />

c u l t u r e m e d i u m ( T C M ) a l o n e f o r s i x d a did y s n ot cau s e l ym p h o c yt e p r o l i f e r a t ive re s p on s es<br />

[Fi gu re 6 8 a , ]. b N ot s u r p r i s i n g l y, th e a d d i t i o n o f v a r i o u s a m o u n t s o f c o r t i s o l (u p p er<br />

p h y s i o l o g i c a l l e v e l s : 2 5 0 n M , 2 5 n M a n d 2 5 0 0 n M h a ) d n o e f f e c t h i s u p r e o s n u l t.<br />

6 d a y c u l t u r e wi t h o u t a n t i g e n<br />

Mean <strong>of</strong> 3 H-thymidine incorporation per PBMCs culture well (cpm)<br />

0 n M 2 5 n M 2 5 0 n M2 5 0 0 n M<br />

5000<br />

4000<br />

3000<br />

2000<br />

1000<br />

0<br />

N =<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 52 - I m p e r i a l o C n o d l o n l e g e L<br />

1 0<br />

1 0<br />

�� ����� ��� � � � � � ������ �<br />

1 0<br />

0 n M 2 5 n 2 M 5 0 2 n 5 M 0 0 n M<br />

Fi gur e 68a : i n d i v i d u a l b a c k g r o u n d p s r <strong>of</strong> o l i f e Fi r gu a t r e i 68b: o n me a n ba c kgr ou nd pr olif er at io n<br />

P B M C s c u l t u r e d w i t h o u t a n t i g e n o f P B M C s c u l t u r e d w i t h o u t a n t i g e n<br />

1 0


Individual 3 H-thymidine incorporation per PBMCs culture well (cpm)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 4 . 1 2 T-l ymp h oc yt e p r ol ife rat ive res p on s e ag ain s t p u r i f i e d p r o t e i n d e r i v a t i v PPD) e ( a f t r e<br />

3 00 00<br />

2 50 00<br />

2 00 00<br />

1 50 00<br />

1 00 00<br />

50 00<br />

0<br />

i n c u b a t i o n o f P B M C s f o r s i x d a ys w i t h o r w i t h o u t e x o g e n o u s c o r t i s o l<br />

P BMC s fro m n i n e v o l u n t e e r s o u t o f r e t s p e o n d e d s a t i s f a c t o ily r to in vi tr o s ti mu lat ion with m yc ob act eri u m an t i g en (p u rified p rotein d erivati ve : P P D). Figu r e 6 9 a s h ows th e in d ivid u al<br />

r es p o n s e s f ro m n i n e vol u n teers wh os e P BMC s r e s p o n d e d s a t i s f a c t o ily r t o in vi tr o s ti mu lat ion with t h e a P n t P i D g an e n d th at al l res p on s es b u t on e were red u ced b y th e ad d ition o f 2 5 0 n M<br />

c o r t i s o l a n d a l l r e s p o n s e s w e r e s u p p r e s s e d b y t h e a l. d d Th i e t ad i o dn it ion o f <strong>of</strong> 2 5 0 0 n M c o r t i s o<br />

c o r t i s o l i n d u c e d a -d e d p o e s n e d e n t d e c r e a s t h e e i a m n o u n t o f [ 3 H ] -t h i d y i n m e i n c o r p o r a te d (F =<br />

3 4 .95 , p < 0 . 0 0 1 ) [Fi gu re 6 9 b ] . Pai red t-t es ts s h owed s ign ifican t r e d u c t i s o f n r 0o n M m to 2 5 0 n M<br />

(t = 8 6 0 4 , p = 0 .0 0 1 ), an d f r 0o n M m to 2 5 0 0 n M (t = 1 2 0 1 7 , p = 0 . 0 0 1 )<br />

I n d i v i d u a l p r o l i f e r a t i o n r e s p o n 20000 s e t o P D<br />

0 n M 2 5 n M 2 5 0 n M 2 5 0 0 n M<br />

Lymphocyte proliferative responses to PPD<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 53 - I m p e r i a l o C n o d l o n l e g e L<br />

15000<br />

10000<br />

5000<br />

0<br />

- 5000<br />

N =<br />

9<br />

No dr ug<br />

9<br />

2 5 n M<br />

9<br />

9<br />

2 5 0 n M<br />

2500nM cortisol<br />

Fi gu r e 69a : individua l pr olif e r at io n re s po nse Fi gu r e 69b: Me a n ( 9 5 % C . I . pr ) olif er at io n<br />

<strong>of</strong> P BM Cs t o the PP D a nt ige n r e s p o n s es o f P B M C s t o t h e P P D a n t i g e n<br />

C o n c l u s i o n :<br />

Ex o g e n o u s c o r t is ol s u p p r e s se s -d P ep P en D d en t T-l ymp h o c yt e p r olife rative res p on s es , an d<br />

th is can b e s een at t h e u pp er p h ys iol ogica l levels <strong>of</strong> c ortis ol , 2 5 0 n M as well as 1 0 times h igh er<br />

(2 5 0 0n M).<br />

p = 0 . 0 0 1<br />

p = 0 . 0 0 1


Mean 3 H-thymidine incorporation per PBMCs culture well (cpm)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 4 . 1 3 T-l ymp h oc yt e p r ol ife rat ive res p on s e ag ain s t Herp es an tigen a f t e r b i a n t ion c u <strong>of</strong> P BMC s<br />

for s ix d a ys wi t h a n d w i t h o u t e x o g e n o u s c o r t i s o l<br />

S i m i l a r f i n d i n g t s o t h o s w e r e w o i b t a wh i h n en e d P a Herp P D es z os ter an ti gen w as u s ed .<br />

P BMC s fro m ten v o l u n t e e r s e s p o n d e d s a t i s f a c t o ily r to in vi tr o s t i m u l a t i o n H w e i r p t e h s a n t . i g e n<br />

Fi gu re 7 0 a s h ows i n d i v i d u a l r e s p o n s from e s ten v o l u n t e e . r s All res p on s es b u t on e were red u ced<br />

b y t h e a d d i t i o n o f c o r t i s o l. Th e a d d i t i o n o f c o r t i s o l i n d u -d c e ep d en a d en d o t s de ecreas e in p roliferat i ve res p on s es meas u red b y [ 3 H ] -th ymid in e in corp orati on ( F = 1 5 .9 6 , p = 0 . 0 0 2 )<br />

[Fi gu re 7 0 b ] . P os t h oc p ai red t-tes t s h ow ed s ign ifican t r e d u c t i s o f n r 0o n M m to 2 5 0 n M (t = 9 5 7 8 ,<br />

p = 0 .0 0 4 ), an d f r 0o n M m t o 2 5 0 0 n M (t = 1 5 3 86 , p = 0 .0 0 1 ).<br />

800 00<br />

700 00<br />

600 00<br />

500 00<br />

400 00<br />

300 00<br />

200 00<br />

100 00<br />

0<br />

I ndi vi dual prol ife rat io n re s pons e to He rpe s<br />

Lymp hocyte proliferative resp on ses to Herp es<br />

0 n M 2 5 n M 2 5 0 n M2 5 0 0 n M<br />

60 000<br />

50 000<br />

40 000<br />

30 000<br />

20 000<br />

10 000<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 54 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =<br />

1 0<br />

No dr ug<br />

1 0<br />

2 5 n M<br />

1 0<br />

1 0<br />

2 5 0 n M<br />

2500nM cortisol<br />

Fi gu r e 70a : i n d i v i d u a l p r o l i f e r a t i p o n s e r e o s f Fi gur e 70b: M e a n ( 9 5 % C . I . pr ) olif er at io n<br />

P BM Cs t o Her pes a nt ige n r e s p o n s es o f P B M C s t o H e r p e s a n t i g e n<br />

C o n c l u s i o n :<br />

Exo gen ou s co rt i s ol s u p p r e s se s T-l ymp h o c yte p roli ferati ve res p on s es to m em or y a n tigen s ,<br />

a n d t h i s c a n b e s e e n a t t h l e o g i u c p a p l e l e r v e l p s h o y f s c i o o r t i s o l, 2 5 0 n M as well as 1 0 times<br />

h i g h e r (2 5 0 0n M).<br />

p = 0 . 0 0 4<br />

p = 0 . 0 0 1


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3.4 . 2 T-l y m ph ocy te prol if era tive res pons es a g a ins t s u p e r-a n t i g e n m a n i d t o g e n<br />

Ha vin g s h own t h at t h e ad d i t ion <strong>of</strong> c o r t i s o l in d u ced a d os e d ep end en t d ecreas e in i n v i t r o<br />

a n t i g e n s p e c i f ic -l T y m p h o c y t e p r o l i f e r a t i v e r e s p o n s e s s, eries t h i <strong>of</strong> s e x p e r i m e n t s was d es ign ed<br />

to d etermi n e i f c on cu rren t exp os u re t o c o rtis ol (2 5 0 n M) h a d s i m i l a r e f f e c t s in vitr f o l o l o w i n g<br />

s t i m u l a t i o n p o w i e r t f u h l p a n -c e T l l s t i m nt u s l , a i . e . s u p -an e r tigen - s t a p h y l o c o cal c en terot o xi n<br />

B ( S E B ) an d mi t ogen - p h y t o h a e m a g g l u t i n A i ( P n H A ).<br />

Th e n u mb er <strong>of</strong> c el l s p art i cu l arl y in th e p r oliferati ve res p on s e to th es e SE B an d P HA i s<br />

g r e a t e r a n d t h e m a x i m u m r e s p o n s e o c c u r s e a r l i e r t h a n f o r m e m o r y r e . c T a l h l e s e a n t i g e n s<br />

res p on s es s h o ul d gi ve rad ioacti ve c ou n ts in exces s <strong>of</strong> 1 0 , 0 0 0 c o u n t s p e r m i n u t e ( c p m on ) Da y 3<br />

o f c u l t u . r With e th es e m ore p owerfu l s ti mu li, th e as s a y was m od ified to u s e a wh ole b lo od<br />

meth od rat h er t h an P BMC s wh ich are ti m e con s u min g to p rep are.<br />

Blo od fr om t w e l v e h e a l th y s u b j e c t s w e r e , o d n i e l i u n t f e o d u , r w i th TC M an d in cu bat ed<br />

for t h r e e d a y s with a n d wi t h ou t SEB a n d P H A, in th e p res en ce or ab s en ce <strong>of</strong> 2 5 0 n M co rti s ol .<br />

All d at a were col l ect ed on t h e third d a y o f in cu b ation .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 55 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .4 .2 . 1 T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o aga n s e in s s t s tap h yl ococ cal en ter oto xin B (SE B) after<br />

i n c u b a t i o n o f d i l u t e d w h o l e b l o o d f o r t h r e e d a ys w i t h o r w i t h o u t e x o g e n o u s c o r t i s o l<br />

Lym p h oc yt es in th e d il u ted wh ole b lood s amp les fro m t w e l v e v o l u n t e e r rs es p on d ed<br />

s a t i s f a c t o rily to in vi tr o s t i m u l a t i o n w i th s t a p h y l o c o c c a (S l E B) e [Fi n g ut re e 71a]. r o t Th o e x i n B<br />

ad d ition <strong>of</strong> 2 5 0 cortis n M ol in d u ced a d e c r e a s ed res p on s e (mean d if feren ce = 1 8 2 35 , SD = 8 6 7 2 ,<br />

t = 7 .3, d f = 1 1 , p < 0 . 0 ) 0 [F 1 i g u r e 1b]. 7<br />

Individual proliferative responses to SEB (cpm)<br />

Lympho cyt e s prol i f e ra t i ve re s pon s e s<br />

1 2 0 0 0 0<br />

t o S EB<br />

1 0 0 0 0 0<br />

8 0 0 0 0<br />

6 0 0 0 0<br />

4 0 0 0 0<br />

2 0 0 0 0<br />

0<br />

No dr ug Cort isol<br />

P ro liferativ e resp o n ses to S E B (9 5 % C . I.)<br />

10 0000<br />

7 5000<br />

5 0000<br />

2 5000<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 56 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =<br />

1 2<br />

No dr u g<br />

Fi gu r e 71a : I nd i vi d u a l p r o l i f e r a t i v e Fi gur e 71b: M e a n ( 9 5 % C . I . ) p r o l i f e r a t i v e<br />

r e s p o n s e s <strong>of</strong> P BM Cs t o t h e S E B r e s p o n s e s o f P B M C s to th e SEB<br />

w i t h / o ut co r t i s o l a t Da y 3 w i t h / o ut co r t i s o l a t Da y 3<br />

C o n c l u s i o n :<br />

U p p e r p h y s i o l o g i c a l l e v e 2 l ( 5 0 ) o n f c o M r t i s o l c a n d e c r e a s e p r o l i f e r a ti v e r e s p o -n<br />

s e s o f T<br />

l y m p h o c y t e s a g a i n s t a s u p -an e r tigen , S E B.<br />

Mean (95% C.I.) proliferative responses to SEB (cpm)<br />

p < 0 . 0 0 1<br />

1 2<br />

Cortisol


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 .4 .2 . 2 T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o n s e s a g a i n s t p h A (P y t HA) o h a e aft m ea r g g l u t i n i n<br />

i n c u b a t i o n o f d i l u t e d w h o l e b l o o d f o r t h r e e d a ys w i t h o r w i t h o u t e x o g e n o u s c o r t i s o l<br />

L y m p h o c y t e s i n ilu t ted h e wh d ol e b lood s amp les fro m t w e l v e v o l u n t e e r rs es p on d ed<br />

s a t i s f a c t o rily to in vi tr o s t i m u l a t i o n p h w y t i o h t a h e m a g g l u t i n i n A ( P H A [Fi ) gu re 72a a n d b ]. Th e<br />

ad d ition <strong>of</strong> 2 5 0 cortis n M ol in d u ced a d e c r e a s ed r e s p o n s (mean e d if feren ce = 7 4 5 14 , SD =<br />

2 2 85 6 , t = 1 .3 1 , d f = 1 1 , p < 0 .0 0 1 ).<br />

Individual proliferative responses to PHA (cpm)<br />

Ly mph o cy t e s prol i f e ra t i ve re s po n s e s<br />

2 5 0 0 0 0<br />

t o P H A<br />

2 0 0 0 0 0<br />

1 5 0 0 0 0<br />

1 0 0 0 0 0<br />

5 0 0 0 0<br />

0<br />

No dr ug Cort isol<br />

P roliferative responses to P H A (95% C . I.)<br />

200000<br />

150000<br />

100000<br />

50000<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 57 - I m p e r i a l o C n o d l o n l e g e L<br />

0<br />

N =<br />

1 2<br />

No dr ug<br />

Fi gur e 72a : I nd i vi d u a l p r o l i f e r a t i v e<br />

Fi gur e 72b: M e a n ( 9 5 % C . I . ) p r o l i f e r a t i v e<br />

r e s p o n s e s <strong>of</strong> P BM Cs t o t he P H A r e s p o n s e s o f P B M C s to the P H A<br />

w i t h / o ut co r t i s o l a t Da y 3 w i t h / o ut co r t i s o l a t D y a 3<br />

C o n c l u s i o n :<br />

1 2<br />

Cortisol<br />

T-l ymp h oc yt e p r ol i fe rat i ve res p on s es to i n vitr o s timu lati on with a s u p e r -an tigen a n d a<br />

m i t o g e w n e r e s u p p r e s s e d b y t h e a d d i t i o n co ortis f ol ( 2 5 0 n M ) .<br />

p < 0 . 0 0 1


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3.4 . 3 C e l l s u r f a c e m a r n k p e r o s l i f e o r a t ing T-l y m p h o c y t es foll ow ing s timula tion w ith<br />

P HA<br />

H a v i n g s h o w n t h a t 2 5 0 n M c o r t i s o -l l y m d p h e o c y r t e a p s r o e l d i f e T r a t i v e r s e s p o n s e<br />

again s t a mi t ogen , a s e r i o u s o f i n v e s w t a i s g a p t e i r o f n o r m t o e id d en ti f y th e u n d erl yi n g<br />

m e c h a n i s m s f o r t h i s s u p p r e s s i v e e f f e c t o f oc yte c o p r rt ol i iferat s o l i on u . p o n l y m p h<br />

3 .4 .3 . 1 E x p r e s s i o n o f a n a p o p t o s i s ( C D 9 5 : -l ymp F a h oc s yt ) es i c n e l v i l t r s o u r f a c e m<br />

d u rin g P H A-i n d u c e d p r o l i f e with r a t a i n o d n w i t h o u t e x o g e n o u s c o r t i s o l<br />

T h i s e x p e r i m e n t e x a d m th i n e e exp res s i on <strong>of</strong> C D9 5 / Fas wh ich is a ma rke r o f ap op t os is on<br />

T-l y m p h o c ytes d u ri n g P H A-in d u ced p roliferativ e res p on s es . Dilu ted wh ole b lo od fro m s ev en<br />

h e a l t h y s u b j e c t s w e r a n a l y s e b d y f l o w c y t o m at e t r i m y e p o i n o t f s 0 , 2 4 , an d 4 8 hou rs <strong>of</strong><br />

i n c u b a t i o n a f t e r s t i . m Tu h e l e x a p r t e s s i o n o o n f C D 9 w 5 i -FI t T C h f l u o P r e H s c A e n t c o n j u g a ted<br />

a n t i b o y d o n e a c l h y m p h o c y t e s u -p b op u lat ion s u rface was meas u red b y fl ow c yt om etr y.<br />

I n u -s n timu lat ed b lood cu lt u res , th e exp re s s ion <strong>of</strong> C D9 5 / Fas , ap o p t o s i s m a r k e r, b y C D4<br />

a n d C D -cells 8 T was u n al tered ove r th e 4 8 h ou rs p eriod [Figu re 73a / b a n d F i g 4a/b]. u r e 7<br />

Individual percentages <strong>of</strong> CD8 T-cells<br />

expressing CD95 (%)<br />

80<br />

60<br />

40<br />

20<br />

0<br />

Mean (95% C.I.) CD95 expression (%) on CD8 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

T i m e 0 b a c k g 2 r 4 o h u r n d s b a c k g r o 4 u 8 n h d r s b a c k g r o u n d<br />

0h 24h 48h<br />

Fi gur e 73a : I ndividua l ba c kgr ou nd p e r c e nt a g e s Fi gu r e 73b: M e a n ( 9 5 % C . a I c . kground ) b<br />

o f C D -c 8 e l T l s e x p r e s s i n g C D 9 5 p e r c e n t a g e s o f C D 8 -c e T l l s e x p r e s s i n g C D 9 5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 58 - I m p e r i a l o C n o d l o n l e g e L


Individual percentages <strong>of</strong> CD8 T-cells<br />

expressing CD95 (%)<br />

P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual percentages <strong>of</strong> CD4 T-cells<br />

expressing CD95 (%)<br />

80<br />

60<br />

40<br />

20<br />

0<br />

Mean (95% C.I.) CD95 expression on CD4 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0h 24h 48h T i m e 0 2 4 h r s 4 8 h r s<br />

Fi gur e 74a : I ndividua l ba c kgr ou nd p e r c e nt a g e s Fi gu r e 74b: M e a n ( 9 5 % C . a I c . kground ) b<br />

o f C D -c 4 e l T l s e x p r e s s i n g C D 9 5 p e r c e n t a g e s o f CD4 T-c e l l s e x p r e s s i n g C D 9 5<br />

Wh en b lo od was s ti mu lat ed with P HA, i n c r e a si n g p e r c e n t a g e s o f -cells C D 4 a n d C D 8 T<br />

e x p r e s se d t h Ce D9 5 marker at 2 4 a n d 4 8 h ou rs i n c u b a t i [Figu o n re 75a a n d F i g u 6a r e ] . 7 T e h<br />

in creas es at 4 8 h ou rs were s tatis ticall y s i gn ifican t [ F i g u r e 7 5 b a n d F i b g ] u . r e 7 6<br />

80<br />

60<br />

40<br />

20<br />

0<br />

0h 24h 48h<br />

Mean (95% C.I.) CD95 expression (%) on CD8 T-cells<br />

8 0<br />

7 0<br />

6 0<br />

5 0<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

N o t s i g n i f i c a n t<br />

T im e 0 wi th PH A<br />

n o c o r t is o l<br />

p < 0 . 0 0 1<br />

p = 0 . 0 0 3<br />

2 4h rs wi t h P HA n o 4 8h rs wi th PHA n o<br />

c o r t i s o l c o r t is o l<br />

Fi gur e 75a : I n d i v i d u a l p e r c e n t a g e s o f C D Fi 8 gu r e 75b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 8<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 9 5 T-c i e l n l s P e H x A p r e s s i n H g A C s D t 9 i 5 m u i l a n t e P d<br />

whole blood culture in t h e ab s en c e o f c o r t i s o l whole blood culture in t h e ab s en c e o f c o r t i s o l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 59 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual percentages <strong>of</strong> CD4 T-cells<br />

expressing CD95 (%)<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h Ti me 0 wit h PHA<br />

n o c o r ti so l<br />

Mean (95% C.I.) expression <strong>of</strong> CD95 (%) on CD4 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

2 4 h r s wi th PH A n o 4 8 h r s wit h PHA n o<br />

co r ti so l c o r ti s o l<br />

Fi gur e 76a : I n d i v i d u a l p e r c e n t a g e s o f C D Fi 4 gu r e 76b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 4<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 9 5 T-cel i n l P s H A e x p r e s s t i n m g u l a t C e D d 9 5 i n P H<br />

whole blood culture in t h e ab s en c e o f c o r t i s o l whole blood culture in t h e ab s en c e o f c o r t i s o l<br />

C o n c l u s i o n :<br />

Th e s ti mu lat ion b y P HA l e a d s t o p r o g r e s s i v e l y C D9 i n 5 c r exp e a res s i sn ion g on b ot h C D4<br />

a n d C D -c 8 e l l T s t 2a 4 h ou rs an d 4 8 h ou rs in cu b ation .<br />

N o t s i g n i f i c a n t<br />

p < 0 . 0 0 1<br />

p = 0 . 0 0 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 60 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Ad d ition <strong>of</strong> co rt i s ol i n t h e cu ltu re with P HA h ad little or n o ef fect u p on th e p ercen tage <strong>of</strong><br />

b oth C D4 an d C D8 T-cel l s exp res s in g C D9 5 [ Figu re 7 7 an d Figu re 78].<br />

Individual percentages <strong>of</strong> CD8 T-cells<br />

expressing CD95 (%)<br />

Individual percentages <strong>of</strong> CD4 T-cells<br />

expressing CD95 (%)<br />

80<br />

60<br />

40<br />

20<br />

0<br />

0h 24h 48h T ime 0 wit h P HA ,<br />

c o r t i s o l<br />

Mean (95% C.I.) CD95 expression (%) on CD8 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

2 4h rs w ith PH A ,<br />

c o r t i s o l<br />

48 hrs wit h P HA ,<br />

c o r t i s o l<br />

Fi gur e 77a : I n d i v i d u a l p e r c e n t a g e s o f C D Fi 8 gu r e 77b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 8<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 9 5 T-c i e n l l P s H A e x p r e s t i m n u l g a t e C d D 9 5 i n P<br />

whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol<br />

80<br />

60<br />

40<br />

20<br />

0<br />

0h 24h 48h Time 0 with PHA,<br />

cortisol<br />

Mean (95% C.I.) CD95 expression (%) on CD4 T-cells<br />

80<br />

60<br />

40<br />

20<br />

0<br />

p = 0 . 0 5 3<br />

N o t s i g n i f i c a n t<br />

24hrs with PHA,<br />

cortisol<br />

p = 0 . 0 0 1<br />

p = 0 . 0 0 3<br />

p < 0 . 0 0 1<br />

p = 0 . 0 0 1<br />

48hrs with PHA,<br />

cortisol<br />

Fi gur e 78a : I n d i v i d u a l p e rc e n t a g e s o f C D 4 Fi gu r e 78b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 4<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 9 5 T-c i e n l l P s H A e x p r e s t i m n u l g a t e C d D 9 5 i n P<br />

whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol<br />

C o l l e c t i vel y, t h es e res u l t s s h owed th at th e ad d ition <strong>of</strong> c ort is ol d id n ot alter th e<br />

p e r c e n t a g es o f t h e c e l e l x s p r e s s in g C 95 D s u r f a c e m a r k Ce r D8 s T-lymp o n h o c yt e [ F i g u r e ] 7 9<br />

a n d C D -l 4 y m T p h o c y t e s [F i g u r e ] 8 at 0 2 4 ( a ) o r 4 ( b 8 ) h o u r s o f i n c u . b a t i o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 61 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mean (95% C.I.) CD95 expression (%) on CD8 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

2 4 h r s w it h P H A n o C o r t is o l 2 4 h r s w it h P H A + C o r t i so l<br />

Mean (95% C.I.) CD95 expression (%) on CD8 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

4 8 h r s wi t h PH A no C o r t i s o l 4 8 h r s w i t h PH A + C o r t i s o l<br />

Fi gur e 79a: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f Fi gu r e 79b: M ea n ( 95% C. I. ) pe rc e nt a ge s <strong>of</strong><br />

P H A s t i m u l a t -c e d l l s C D e 8 x p r T e s s i n g C D 9 P5 HA s t imula t ed C D 8 T-c e l l s e xp r es s in g CD9 5<br />

a f t e r 2 4 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l a f t e r 4 8 h ou r s o f i nc u b at i o n wi t h / o ut co r t isol<br />

Mean (95% C.I.) CD95 expression on CD4 T-cells<br />

80<br />

60<br />

40<br />

20<br />

0<br />

2 4 hr s w i t h PH A n o C o r t i s o l 2 4 hr s w i t h P H A + C o r t i s o l<br />

Mean (95% C.I.) CD95 expression (%) on CD4 T-cells<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

4 8 h r s w i t h P H A n o C o r t i s o l 4 8 h r s w i t h P H A + Co r t i s o l<br />

Fi gur e 80a : M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f Fi gu r e 80b: M ea n ( 95% C. I. ) pe rc e nt a ge s <strong>of</strong><br />

P H A s t i m u l a t -c e d l l s C D e 4 x p r T e s s i n g C D 9 P5 HA s t imula t ed C D 4 T-c e l l s e x p r e s s i n g C D 9 5<br />

a f t e r 2 4 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l a f t e r 4 8 h o u r s b at o f i o n i wi n c t h u / o ut co r t i s o l<br />

C o n c l u s i o n :<br />

C o r t i s o l (-)<br />

C o r t i s o l (-)<br />

C o r t i s o ) l ( +<br />

C o r t i s o l ( + )<br />

C o r t i s o l (-)<br />

C o r t i s o l (-)<br />

C o r t i s o l ( + )<br />

C o r t i s o l ( + )<br />

Up p er p h ys i ol o gi cal l evel s <strong>of</strong> cortis ol d id n ot alter th e e xp res s ion <strong>of</strong> the C D9 5 , th e<br />

ap op tos is s u r f a c e m a r k e r, on P HA s timu l ated p roliferatin g T-l ym p h o c y t e s -p u o b p u l a t n i s . o<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 62 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 4 . 3 . E 2 x p r e s s i o n o f c e l l-s u r f a c e An n e x i n-V an d c y t o p l a s m i P c r o p i d i u m i o d i n e ( P in I ) T-<br />

l ym p h o c yt e s a f t e r i n c u b a t i o n w i t h P HA f o r t h r e e d a ys w i t h o r w i t h o u t c o r t i s o l<br />

H a v i n g s h o w n t h a t c o r t i s o l d i d n o t a f f e c t t h e p e r c e n t a g e s o f c e l l s e x p r e<br />

ap op tos is m a r k e r , t h exp i s eri m en t was p e r f o r m e d t o in ves tigat e actu al ap op totic ch an ges o f<br />

P HA s ti mu lat ed p r o l i f e r a t i n g T-l y m p h o c y t s. e P e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s ( P B M C s )<br />

fro m ten s u b j e c t s w e a r n e a l y s e at d 4 8 h o u rs <strong>of</strong> in cu b at ion b y f l o w c y t o m ue st in r g y A n n e x i n-V-<br />

FITC f l u o r e s c e n t c o n j u g t i a b t o d e y d a n a d n p r o p i d i u m i o d i n e ( P I) to g a t e a n d m e t a o s u r e t h e<br />

ap op tot ic ch an ges on C D 8 a n d C -l D y 4 m p h T o c y t e s u -p b o p u l a t i s. o Ap n op tot i c cel ls were<br />

d e f i n e d a s c e l l s w i -V-FITC t h A n n pe ox s i it n ive (i .e . cel l s u rf ace h as ch an ged ) an d P I n egativ e<br />

( i . e . c e l l h a s n o t b een col lap s ed or n ecros i s ) s t a i n i in n g flow c yt o met r y.<br />

Th ere was n o s i gn ifi can t d ifferen ce in th e p e r c e n t a g e s o f a p o p t c o e t l l i s c (A n n e x i n-V<br />

p os itive an d P I n egat i ve) b etween P HA s t imu lated P BMC s in cu b ated with an d with ou t 2 5 0n M<br />

cortis ol b ot h on C D 3 + C D 8 + cells [C D 8 -l T ym p h o c yt e : Fi gu re 81a] a n d C D 3 + C D 8 - cells (C D 4 -T<br />

l y p h m o c y t e) [ Fi gu re 81b] .<br />

C o n c l u s i o n :<br />

An n e x i n V ( + ) % i n<br />

CD3CD8 ce l l s<br />

1 0 8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

No d r u gCortisol<br />

An n e x i n V( + ) % i n<br />

CD3+CD8- cel l<br />

1 0 0<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 63 - I m p e r i a l o C n o d l o n l e g e L<br />

8 0<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

No dr ugCort isol<br />

Fi gu r e 81a : I n d i v i d u a l p e r c e n t a g e s o f Fi gur e 81b: I ndivid ua l pe rc e nt a ge s <strong>of</strong><br />

a p o p t o t i c C D 8 -c T e l l s incubated 3 days a po pt ot ic C D 4 T-c e l l s i n c u b a t e d 3 d a y s<br />

w i t h a n d wi t h o ut c or t i s o l w i t h a n d wi t h o ut c or t i s o l<br />

Up p er p h ys i ol o gi cal l evel s <strong>of</strong> cortis ol d id n ot alter th e rate <strong>of</strong> ap op tos is o f P HA<br />

s timu lat ed T-l ym p h o c y t e s.


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . 4 . 3 . E 3 x p r e s s i o n o f a n a c t -2 i r v e c a e p t i o r o ) n c e l ( l C D s 2 u r 5 f : a c r e I m b L a -r<br />

y k e T<br />

l y m p h o c y t e s d u r i n g PH A -i n d u ced p rol iferat ion with a n d w i t h o u t e x o g e n o u s c o r t i s o l<br />

T h is e x p e r i m e n t e x a m d i th n e e x p r e s s i o n o f t h -cell e a T c t i v a t i o n s u r f a c e m a r k e , r C D2 5 :<br />

I L-2 rec ep tor, o n -l T y m p h o c y t s e f o l l o w i n g s t i m u l a t i o n o f w h o l e b l o o d d w the i t effect h P H A ; a n<br />

<strong>of</strong> 2 5 0 n M c o r t i s n o l t h i o s e x p r . e s s i o n<br />

Di l u t e d w h o l e d b l f o o r o m s e v e n a h s e s a t i l m t u l h a t y e d s w i u t b h j P e H A c t a n s d a n w a l y s e d<br />

b y f l o w c y t o m at e tim t r e y p oi n ts <strong>of</strong> 0 , 2 4 , an d 4 8 h o u r s o f i n c u . b Th a t e i e x o p n r e s s i o n o f C D 25-<br />

F I T C f l u o r e s c e n t c o n t j e u d g a a n t i y b o b d y e a c h l y m p h o c y t e s u -p b op u lat ion was me as u red at<br />

e a c h t i m e p o i n t.<br />

I n u -s n t i m u l a t e d b l o o d c u l t u r e s , -2 recep t h e to r, e b x y p C D4 r e an s d s Ci D8 o n o f C D 2 5 ,<br />

T-c e l l s w a s u n a lt e r e d o v e r t h e 4 8 h o u r s p e r i o d 2 [ a F n i d g u F r i e g u 8 3]. r e 8<br />

Individual percentages <strong>of</strong><br />

CD8 T-cells expressing CD25 (%)<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Mean (95% C.I.) CD25 expression (%) on CD8 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h T i m e 0 b a c k g 2 r 4 o h u r n d s b a c k g r o 4 u 8 n h d r s b a c k g r o u n d<br />

Fi gur e 82a : I ndividua l ba c kgr ou nd p e r c e nt a g e s Fi gu r e 82b: M e a n ( 9 5 % C . a I c . kground ) b<br />

Of C D 8 -c e l T l s e x p r e s s i n g C D 2 5 p e r c e n t a g e s o f C D 8 -c e T l l s e x p r e s s i n g C D 2 5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 64 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Individual percentages <strong>of</strong><br />

CD4 T-cells expressing CD25 (%)<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h<br />

Mean (95% C.I.) expression <strong>of</strong> CD25 (%) on CD4 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

T i m e 0 2 4 h r s 4 8 h r s<br />

Fi gur e 83a : I ndividua l ba c kgr ou nd p e r c e nt a g e s Fi gu r e 83b: M e a n ( 9 5 % C . a I c . kground ) b<br />

o f C D -cel 4 T l s e x p r e s s i n g C D 2 5 p e r c e n t a g e s o f CD4 T-c e l l s e x p r e s s i n g C D 2 5<br />

Wh en b lo od was s ti mu lat ed with P HA, i n c r e a si n g p e r c e n t a g e s o f -cells C D 4 a n d C D 8 T<br />

e x p r e s se d t h Ce D9 5 marker at 2 4 a n d 4 8 h ou rs i n c u b a t i [Figu o n re 84a a n d F i g u 5a]. r e Th 8 e<br />

i n c r e a s e s a t u rs 4 8 were h o s tat is ti cal l y s i gn ifi can t [ F i g u r e 4b 8 an d Fi gu re 8 5 b ] .<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h<br />

Mean (95% C.I.) CD25 expression (%) on CD8 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

p = 0 . 0 0 3<br />

T ime 0 with PH A<br />

n o c o r t i s o l<br />

p = 0 . 0 0 1<br />

p < 0 . 0 0 1<br />

2 4hrs w ith PHA no 4 8hrs w ith PHA no<br />

c o r t i s o l c o r t i s o l<br />

Fi gur e 84a : I n d i v i d u a l p e r c e n t a g e s o f C D Fi 8 gu r e 84b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 8<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 2 5 T-c i e n l l P s H A e x p r e s t i m n u l g a t e C d D 2 5 i n P<br />

whole blood culture in t h e ab s en c e o f c o r t i s o l whole blood culture in t h e ab s en c e o f c o r t i s o l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 65 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h<br />

Mean (95% C.I.) CD25 expression (%) on CD4 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Ti me 0 w ith PH A<br />

n o c or t i s ol<br />

24 hr s w ith PHA no 4 8hr s w ith PH A no<br />

c or t i s ol c or t i s ol<br />

Fi gur e 85a : I n d i v i d u a l p e r c e n t a g e s o f C D Fi 4 gu r e 85b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 4<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 2 5 T-c i e l n l s P e x H p A r e s s i 5 n g C i D 2 n s t i P m H u A l a t e d<br />

whole blood culture in t h e ab s en c e o f c o r t i s o l whole blood culture in t h e ab s en c e o f c o r t i s o l<br />

C o n c l u s i o n :<br />

P H A stimulation l e a d s t o p r o g r e s s i v e l y C D2 i n 5 c r exp e a res s i sn ion g on b ot h C D4 a n d<br />

C D 8 -c T ells aft e r 2 4 h ou rs an d 4 8 h o u r s i ation n c u b .<br />

p = 0 . 3<br />

0 0<br />

p = 0 . 0 0 1<br />

p < 0 . 0 0 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 66 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

A d d i t i o n o f c o r th t e i cu s o ll tu re t wi o th P HA h ad li ttle or n o ef fect u p on th e p ercen tage <strong>of</strong><br />

b oth C D4 an d C D8 T-cel ls exp res s in g C D2 5 [F i g u r e 6 an 8 d Fi gu re 8 7 ].<br />

Individual percentages <strong>of</strong> CD8 T-cells<br />

expressing CD25 (%)<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h<br />

Mean (95% C.I.) CD25 expression (%) on CD8 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

Ti me 0 wi th P H A,<br />

c or t is ol<br />

24 h rs wi th P HA,<br />

c o r t i s o l<br />

4 8 hr s wi th P H A,<br />

c or t is ol<br />

Fi gur e 86a : I n d i v i d u a l p e r c e n t a g e s o f C Fi D gu 8 r e 86b: M e a n ( 9 5 % C . I . ) t a p g e r s c e o n f C D 8<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 2 5 T-c e i l n l P s H A e x p r e s t i m n u l g a t e C d D 2 5 i n P<br />

whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol<br />

p < 0 . 0 0 1<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

0 h 2 4 h 4 8 h<br />

Mean (95% C.I.) CD25 expression (%) on CD4 T-cells<br />

4 0<br />

3 0<br />

2 0<br />

1 0<br />

0<br />

T ime 0 w i th P HA ,<br />

c o r t is o l<br />

p = 0 . 0 0 5<br />

p = 0 . 0 0 3<br />

p = 0 . 0 0 2<br />

p = 0 . 0 0 1<br />

24hrs w it h PH A ,<br />

c o r t i s o l<br />

p = 0 . 0 0 1<br />

4 8hrs wi t h P H A,<br />

c o r t is o l<br />

Fi gu r e 87a : I n d i v i d u a l p e r c e n t a g e s o f C F D i 4 g ur e 87b: M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f C D 4<br />

T-c e l l s e x p r e s t i m n u l g a t e C d D 2 5 T-c e i l n l P s H A e x p r e s t i m n u l g a t e C d D 2 5 i n P<br />

whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol whole blood culture in t h e pr e se n ce <strong>of</strong> c or t i sol<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 67 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C ollecti vel y, t h es e res u l t s s h owed th at th e ad d ition <strong>of</strong> c ort is ol d id n ot alter th e<br />

p e r c e n t a g es o f C D [ 8 Figu re 8 8 ] a n d C D [ Figu 4 re 89] T-cells e x p r e s s in g C 25 D s u r f a c e m a r k e r s<br />

at 2 4 ( a ) o r 4 ( b 8 ) h o u r s o f i n c u . b a t i o n<br />

Mean (95% C.I.) CD25 expression (%) on CD8 T-cells<br />

Mean (95% C.I.) CD25 expression (%) on CD4 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

6 0<br />

4 0<br />

2 0<br />

2 4 h r s w i t h P H A n o C o r t i s o l 2 4 h r s w i t h P HA + C o r t i s o l<br />

Mean (95% C.I.) CD25 expression (%) on CD8 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

4 8 h r s w i t h P H A n o C o rt i s o l 4 8 h r s w i th P H A + C o rt i s o l<br />

Fi gur e 88a : M e a n ( 9 5 % C . I . ) p e r c e n t a g e s o f Fi gu r e 88b: M e a n (95% C. I. ) pe rc e nt a ge s <strong>of</strong><br />

P H A s t i m u l a t -c e d l l s C D e 8 x p r T e s s i n g C D 2 P5 HA s t imula t ed C D 8 T-c e l l s e xp r es s in g CD2 5<br />

a f t e r 2 4 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l a f t e r 4 8 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l<br />

0<br />

2 4 hr s w i th PH A no C o r ti s ol 24 hr s w i th PH A + C o r ti s ol<br />

Mean (95% C.I.) CD25 expression (%) on CD4 T-cells<br />

6 0<br />

4 0<br />

2 0<br />

0<br />

4 8 hr s w i th PH A no C o r ti s ol 48 hr s w i th PH A + C o r ti s ol<br />

Fi gur e 89a : M e a n ( 9 5 % C . I . ) p e r c s e n o t f a g e Fi gur e 89b: M ea n ( 95% C. I. ) pe rc e nt a ge s <strong>of</strong><br />

P H A s t i m u l a t -c e d l l s C D e 4 x p r T e s s i n g C D 2 P5 HA s t imula t ed C D 4 T-c e l l s e x p r e s s i n g C D 2 5<br />

a f t e r 2 4 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l a f t e r 4 8 h ou r s o f i nc u b at i o n wi t h / o ut co r t i s o l<br />

C o n c l u s i o n :<br />

C o r t i s o l (-)<br />

C o r t i s o l (-)<br />

C o r t i s o l ( + )<br />

C o r t i s o l ( + )<br />

C o r t i s o l (-)<br />

C o r t i s o l (-)<br />

C o r t i s o l ( + )<br />

Up p e r p h y si ol o gi cal l evel s <strong>of</strong> cortis ol d id n ot alter th e e xp res s ion <strong>of</strong> C D2 5 , an acti vation<br />

s u r f a c e m a r k e r, on P HA s ti mu lated p r o l i f e r g a t -l T i y n m p h o c y t e s s u -p b o p u l a t i o n . s<br />

C o r t i s o l ( + )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 68 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S u m m a r y :<br />

T-l ymp h oc yt e p r ol i fe rat i ve res p on s es to i n vitr o s t i m u l a t i o n w i t h m e m o r y r e c a l l a n t igen s<br />

( P P D a n d H e r p e s ) a s w e l l a s a s u -an p e r tigen (S E B) an d a mi to gen (P HA) we re s u p p res s ed b y<br />

th e ad d i t i on <strong>of</strong> t h e u p p er p h ys iolo gical l e vel (2 5 0 n M) <strong>of</strong> co rti s ol.<br />

Sti m u l a t i o n b y P H s A to pl ro e a gres d s iv el y in creas in g s u r f a c e x p r e s s i o n s <strong>of</strong> b oth C D 9 5<br />

( F a s-L : a p o p t o s i s m a r k e r ) a n d C D 2 5 ( -2 I L r e c e p t o r : a c t i v a t i o n m a r k e o r n ) C D 4 a n d -C<br />

D 8 T<br />

c e l l s 4 a t h o u 2 r s a n d 4 8 h o u r s i ; n an c u d b th a t e i ad o dn it ion <strong>of</strong> th e upp e r p h ys i o l o g i c a l l e v e l<br />

( 2 5 0 n M ) <strong>of</strong> co rt is ol d id n ot alter th es e ex p res s ion s . U p p e r p h ys i o l o g i c a l l e v e l ( 2 5 n 0 M ) <strong>of</strong><br />

cortis ol was a l s o s h o w n t n to o a l t e r p e r c e n t a g e s o f a p t o h p e t ot i c s u r f a c e c h a n g e o s f th e cel l<br />

m e m b r a n e ( m e a s u r e d b y A n n e x i n V a P n H d A P I s ) t o i n m -l u ymp l a ht oc e yt d es . T<br />

A l t h o u g h t h ue n d erl yi n g mech an is ms are s till to b e e l u c i d ted a , t h e s e r e s u l w t s th at s t h ho e<br />

u p p e r p h y s i o l o g i c e a l l ( 2 5 0 l n e M v ) o f c o r t i s o l t o s u p p r e s s T-l ymp h oc yt e p r ol ife r at ive res p on s es .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 69 - I m p e r i a l o C n o d l o n l e g e L


Chapter IV<br />

Discussion<br />

- 1 70 -


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C O N T E N T O F C H A P T E R 4<br />

D i s c u s s i o n<br />

4 . 1 T h e i n f l u e n c e o f p s y c h o l o g i c a l i n t e r v e n t i o n u p o n s u s t a i n e d s t r e -s<br />

s a n d s t r e s s<br />

a ssoc ia t ed ch an ges i n un i versi t y stu d en t s fa ci n g exa ms a nd in p at i ent s wi t h<br />

H I V-i n f e c t i o n<br />

4.1 . 1 T h e i n f l u e n c e o f p s y c h o l o g i c a l u i p o n n t s te res r v s e pn ercep t i o tn ion in<br />

4 . 1 . 2<br />

u n i v e r s i t y -i s n f t e c u t e d e a d n u l t s s a n d H I V<br />

4 . 1 . 1 . An 1 tici p at ion o f s tres s - a c a ic d exa e mi m n at ion s b y u n ivers it y s tu d en ts<br />

a n d a w a r e n e s s o f r c r a y i n -i g n f e c H t I i V o n t reatm b y en t n a ï ve patients 174<br />

4 . 1 . 1 . T 2 h e i n f l u e n c e o f o l p o s g i y c h a l i n t e r uv pe on n t pi so ych n ol o gi cal<br />

w e l l -b e i n g 176<br />

T h e i n f l u e n c e o f h p o s l y o c g i c a l i n t e r v e n t immu i o n nu e p po aramet n e rs in u n i v e r s i t y s t u d e n t s f a c i n g a c a d e m i c e x a m s<br />

4 . 1 . 2 1 St r e s s-a s s o c i a t c e h d a n g e s an d d ifferen ces in immu n e p aramete rs in<br />

u n i v e r s i t y s t u d e n t s<br />

4 . 1 . 2 Th e in fl u en ce <strong>of</strong> p s ych ol ogical in terven ti on u p on immu n e<br />

p a r a m e t e r s in u n i v e r s it y s t u d e n t s<br />

4 . 1 . 3 Th e in fl u en ce <strong>of</strong> p s ych ol ogical in terven ti on u p on d is eas e p rogres s ion m ark er<br />

( C D 4 T c e l l c o u n t a ) n d s t r e s -r s e l a t e d p e -i r n f c e c e t e p d t i n i d i v o i n d u a l s 186 i n H I V<br />

4 .1 .3. 1 D i s e a s e p r o g r e s s i o n m a r k e r a n d s -r t r e l s s a t e d p e r c e in p t H i I o V- n<br />

inf e c t e d i n d i v i d u a l s<br />

4 .1. 3. 2 T h e i n f l u e n c e o f p s y c h o l o g i c a l i n t e C r D v 4 e n -cells t T i o as n a u p o n<br />

d i s e a s e p r e o s g s i o n m a r k e r -i i n f e n c t e d t i n h d e i v i d u H a I l s V<br />

4.2 S t r e s s h o r m o n e a s s o c i a t e d c h a n g i e s n v i in t immun r o e c ells a s an exemp la r <strong>of</strong><br />

t h e p s y c -n h e o u r o-e n d o c r i -i n o m m u n e n e t w o r k i n t e r a c t i o n<br />

4.2. 1 Ch an ges in N K -cells a f t e r i n v i i t n r c o u b a t i o n<br />

4 .2. 1 . 1 N K c y t o t o x i c a c t ( i v N i K t C y A ) -c a ell n pd r<strong>of</strong>i les N K a ft er in cu b at ion o f P B M C s f or 2 4 ho u rs i n v i t r o<br />

4 .2. 1 . 2 C o r t i s o l -i n d u c e d c h a n g e s i n N K C A l s e v e a -c n e l d l p r N o K f i l e s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 71 - I m p e r i a l o C n o d l o n l e g e L<br />

181<br />

184<br />

187<br />

188<br />

192<br />

193<br />

173<br />

181<br />

191


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4 .2. 1 . 3 E n d o g e n o u s l e v e l s o f s t r e s s h o r m o n ( e s c o r t i s -S) o l a n d a n d D H E A<br />

N K C A 194<br />

4 .2 .2 Ch a n g e s -cells i n aft er T i n v i inc t r u o b a t i o n<br />

4 .2.2 .1 E x p r e s s i o n o f d C u D r i 2 n 5 g p r o l i f e r a t iv e r e s p o n s e<br />

4 .2.2 .2 Exp res s ion o f C D9 5 a n d A n n d e u r x i n g i p r n o l i f e V r a t iv e r e s p o n s e<br />

4.3 Co n c l u s i o n s 198<br />

4.4 Fu t u re d i r e c t i o n s<br />

4 . 4 . 1<br />

P s y c h o l o g i c a l i n t e s r v e n t i o n<br />

199<br />

4 . 4 . 2 M e a s u r e m e n t s 199<br />

4 . 4 . 2 1 P s y c h o l o g i c a l m e a s u r e<br />

199<br />

4 .4 .2 .2 Immu n ol ogi cal meas u res i n v i v o<br />

4 .4 .2 . 3 In vi tr o inve s t i g a t -cells i o n o n N K<br />

200<br />

4 .4 .2 . 4 In vi tr o i n v e s t i g a -l t y i m o p h n o c y o t e n s T<br />

200<br />

4 .4 .3 P rop os al for fu tu re i n v i v s o t u d y<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 72 - I m p e r i a l o C n o d l o n l e g e L<br />

195<br />

196<br />

199<br />

195<br />

200


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4 . 1 T he i nfl ue nc e <strong>of</strong> psy c ho log ic al i nte rve nti o n upo n susta i ne d str e ss a nd s t r e s s-<br />

a ssoc ia te d c ha nge s i n u n i v e r s i t y s t u g d e xa n ms t s a nd f a i n c pa i n ti e nts w i th<br />

H I V-i n f e c t i o n<br />

Th is p roj ect ex ami n ed t h e h yp oth es is th at th e effects <strong>of</strong> s t res s u p o n p s yc h o l o g i c a l w e l l-<br />

b e i n g a n d g e n e r a l h e a l t h c a n b e a l l e v i a t e d b y p s y r c h v o e l n t o g n, i o c actin a l g i tn ht rou e gh th e<br />

in tegrat ed p s y c h o-n e u r o-e n d o c r i n o -i m m u n e n e t w . o r k<br />

T w o g r o u p s o f i n d i v i d u a l s w i t h d i e f n f e t r l i -e f v e n t a s s o c i a t e d s t r e s s were e s s el ect e d to t e s t t h e h yp o t h e s i s :<br />

1 . U n i v e r s i t y s t u d e n t a s c f a c d i n e g m inations i c were e x ua s ed m as an exa mp le o f<br />

in d ivid u al s wi th s u s tain ed , b u t a time-li m ited , s t r e s s f u l s , an i t d u th a e t pi ri o mar n y<br />

o u t c o m e s -c e l w l e p r e r e c e n t a N g e K s a n d N K C A l ; e v an e l d s<br />

2 . H I V-i n fect ed p at i en t s l i vin g with th e on g oin g s tres s <strong>of</strong> in fecti on were u s ed as an<br />

examp le <strong>of</strong> s u b ject s wi th s u s t a i n e d l -l i o f n e g s t r e , s s an d th e p ri mar y ou tc ome was<br />

C D 4 -c T e l l c o u n . t s<br />

4 . 1 . T1 he in fl uen ce <strong>of</strong> ps y ch ol og ica l interven tion u pon s tres s perc e ption in univ ers it y<br />

s t u d e n t s -i n f a e c n t e d a d H u l I t s V<br />

T h e f i r s t p a r t s o f is t h s e c t i d o i n s c u s s t h e e f f e c t s o f s (either t r e s s an ti ci p at ion o f e x ams f or<br />

u n i v e r s i t y e n s t s u d o r a w a r e n e s s o f -g c a o r i r n g y i l n i -th g f reaten e o n in g d is eas e f or p at ien ts with<br />

H I V-i n f e c t i o n ) on p s yc h o l o g i c a l w e l l-b e i n g [ 4 . 1 . 1 . 1 . ]<br />

Th ereaft er , th e f ol lowi n g p arts o f th is s ec tion d is cu s s th e i n f l u e n c <strong>of</strong> e p s ych ol o gi ca l<br />

in terven ti on u p on s tres s p e r c e p t i o n a n o d f f o l l o w t i h e n g c a t e g o ri s a t i o n o f t h e a p p r a i s a l o f t h e<br />

s t r e s s f u l l if e e v e n t [ 1 . 2 . 3 . 2 ] a s:<br />

1 . P r i m a r y a p p r ercep a i s ti a on l as : a P n e u t r a l o r b e n i g n s t i m u l u s o r a t h r e a t; a n d<br />

2 . S e c o n d a r y a p p r a i s a l : J u d g e m e n t ’s o cap f o ab n e il it y <strong>of</strong> c op in g w i t h t h e s tres s or<br />

s u b s eq u en t t o t h e p r i m a r y a p p r a i s a l.<br />

F i n a l l y t h e r e s u as l t th s e y rel at e to p e r c e i v e d q u a -o l f -life, i t y i .e. p ercep ti on o f c on trol<br />

( i n n e r o r o u t e r l o c u s o f c o n t r , o pl s) ych ol o gi cal fu n ct ion in g, an d s l e e p q u a , l a i r e t y d i s c u s s e d<br />

[ 4 . 1 . 1 . 2 .<br />

]<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 73 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4 . 1 . 1 . Antici 1 p at ion o f s tres s - a c a d e m i c e x a m i n s a t b y i o u n i v e r s i t y s t u d e an n t d s awaren es s <strong>of</strong><br />

c a r r y i -in n fecti g on H b y I treat V men t n a ï ve p a t i e n t s<br />

An ticip at ion o f acad emi c e x a m i n a t ns i o f o r u n i v e a r s s e x i a m t i n y e in d th s e t u d e n t s w<br />

cu rren t s tu d y to d et ermi n e i f it cau s es in c reas es in s t r e s s l e v e . l Th s e me an P SS level <strong>of</strong> th e<br />

u n i v e r s i t y s t u d e n t s b o t d h e m a i t c a e c x a a m i n a t i o n a n d w h e n t re h e fy ree w fr e om e xami n at ion were s imi la r to th e p u b li s h ed mean levels f o r u n i v e r s i t y s t u d e n ts [ C o h e n e t a l . , 1 9 8 . 3 In ] lin e<br />

with p revi ou s fi n d in gs [ M a e s , V a n B o c k s t a e l e e t a l . , 1 9 9 9 ; W h i t e h o u s e e t a l . , u1 n9 ivers 9 6 ] it y<br />

stu d en ts i n t h e cu rren t s t ud y rep orted mo r e an xiet y an d s tres s w h e n t h e y f a c e d a c a d e m i c<br />

e x i a n a m t i o n c s o m p a r e d t o w n h th e e y we r e free fr om acad emic exa min ation s [3 . 1 . 1 ]. . Th 1 is<br />

f i n d i n s u g p p o r t s th e v a l i d i t y o u f s i n g a c a d e m i c e x a m i n a t i as o n s a t i m -li e mited s tre s s fu l<br />

s itu ation .<br />

On e p os s ib le cri ti ci s m f or u s in g a c a d e m i c e x a m i n s a as t i a o sn tres s o r is th e v ari ab i li t y in<br />

s t u den t res p ons es to a c a d e m i c e i x n a t i m o n . s Som e s tu d en ts exp eri en ce mo re s tres s th an oth ers<br />

in res p on s e t o t h i s s i t u at i on , an d s ome c o n fid en t s tud en ts ma y e xp erien ce ver y littl e s tres s , if<br />

a n y . M o r e o v e r lth , ou a gh exp res s ed an xi e t y at ac ad emic e xamin ati on s is u s u all y th ou gh t <strong>of</strong> as a<br />

n e g a t i v e e x p e r i e n [ Dein c e zer & Sch u ll er, 1 9 98 ; Glas er et al., 1 9 8 5 ; Gru zelier, Lev y et al ., 2 0 0 1 ;<br />

Gr u z e l i e r , S m i t h e t a l . , 2 0 0 1 ; Ki e c o l t-G l a s e r e t a l . , 1 9 8 6 ; Ki e c o l t-G l a s e r e t a l . , 2 0 0 , 1 so ] m e<br />

s tu d en ts mi gh t feel ac ad emi c e x i a n a m t i o n a s r e a n o p p o r t u n i t y t o t e s t h i , s s/ o h th e at r c a p a b i l i t y<br />

th e acad emi c e x i a n a m t i o n fs or th e m can b e p ercei ved as an e x c i t ing e xp erien ce, or in oth er<br />

word s , a n i m p e t u in s p r i m a r y a p p r a i s a l [1 . 2 . 3 ]. . 2 F o r t h o s s t e u d e n t wh s o p ercei ve a cad emi c<br />

e x i a n a m t i o n as s an op p ort u n it y to s h ow t h eir cap ab ilit y, th e e x a i n a m t i o n ma s y b e p e r c e i v e d a s<br />

n ot a fea r b u t a p os i t i ve an xi ou s an ticip ation wh ich can als o c a u s e a r es p on s e towar d s figh tin g<br />

o r t a c k l i n g f o ach r ieve men t in th e ‘f i g h t o r f l i g h t’ r e s p o n s e s i n t h e p s y c h -n o e u r o-e n d o c r i n - o<br />

i m m u n e n e t w as o r can k b e s een in a c u t e s t r e s res s p on s es .<br />

Nevert h el es s , th e p e r c e i v e d s t r e s s e d s ( c P a S l S e ) c a n b e u s e d t o d i s th t os i e n g wh u i o s h<br />

p e r c e i v e t h e l i f e e v e cite n t s men a t s f rom a n th e os x e wh o p er ceive it as a s t r e s sfu l even t s in ce<br />

th e P SS were d es ign ed to a s s e s s t h e d e g r e e t o w h i c h s i t u a t i ’s o life n s are i n ap o n pe rai s ed as<br />

s tres s fu l [ C o h e n e t a l . , 1 9 8 . 3 Th ] is a p r i o r i e x p o s i n t oi f o th e P SS was tes ted as d is cu s s ed in th e<br />

follo wi n g s ect i on .<br />

Not s u rp ri s in gl y, aw a r e n e s s o f c a r l r i y -t f i h e r n e g a t e n i n g o n g o i n g d i s e a s e, -in H I fe cti V on ,<br />

f o r p a t i e n was t s f o u n d t o m b e o r e s t r e s s f u l th an an ti ci p at ion <strong>of</strong> a c a d e m inations i c for e x a m<br />

u n ivers it y s tu d en ts [ 3 . 2 . ]. 1 . On 1 th e ot h er h an d , an d p erh ap s con trar y t o in tu ition , t h e an x i e t y<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 74 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

levels exp res s ed b y i n d i v i d u a l s in th es e two d iffe ren t s tres s fu l s itu ation s were s h o wn to b e th e<br />

s ame [3 . 2 . 1 ]. . He 1 n c e , i a t n c b e i m p l i e d t h a t t h e m e a s u r e d n x l i e v e t l by s y th o f e Sa tat e an xi et y<br />

s c o r e ma y c h a r a c t e r i se m ore a n a c u t e r e s p o n <strong>of</strong> s e ‘f i g h t o r f l i g h t’ in th e p rimar y a p p rais al<br />

[ 1. 2 . 3 . 2 ] w h e r e a s t h meas e u red lev el s <strong>of</strong> s tres s b y th e P SS ma y in d icate th e accu m u lated l e v e l s<br />

<strong>of</strong> s tres s o v e r t h e t i p eriod m e .<br />

N o t a b l y , a n x i e t y l e i v e l n s t -in h fect e ed H iI n d iV vi d u al s d id n ot ch an ge over th e s tu d y<br />

p eriod , al t h ou gh t h os e rep ort in g h igh l e v e l s <strong>of</strong> s tr es s con s i s ten tl y rep ort ed mo re a n xiet y th an<br />

i n d i v i d u a l wh s o rep ort ed low le vel s o f s tr es s [3 . 2 . 1 ]. . 1 T h i s t r e n d b t e h t two e w e e t yp n es <strong>of</strong><br />

i n d i v i d u a l s lab ( elled as th e S t r e s s and e d N o t -s t r e s s de efin d ed b y a mi d li n e s p li t <strong>of</strong> th e P SS<br />

s c o r e s) w a s a l o s w o n s i h n t Imp h e act E ve n t Scal e ( IES ) m e a s u r e m e n t o f p r i m a r y a p p r a i s a l i n<br />

e v e n t -s p e c i f i c s t r e s s p e r c e p t i o n . T h e -p<br />

r i m a r y a p<br />

in fection d ecreas ed o ver t h e s tu d y p eri od , b u t the levels <strong>of</strong> th es e d ecreas es were al mos t<br />

p a r a l lel ed in th e S t r e s s an e d N o t -s tr es s ed s u b grou p s s o th at S t r e s s e d H I -in V fecte d in d ivi d u als<br />

a l s o r e p o r ted h igh er I E S s o r e s th an th e N o t -s t r e s s e i n d d i v i d u a l [ s 3 . 2 . ]. 1 . 1<br />

Th e fin d i n g t h at t h e s t at e an xiet y d id n ot ch an ge, b u t that t h e p r i m a r y a p p r a i s a l l e v e l d id<br />

d ecreas e o ver t h e s t u d y p eri od s u gges ts t h e p os s ib ilit y th at th e s tres s fu l imp act <strong>of</strong> b ein g<br />

d iagn os ed as c a r r ing y a l -t i f e h r e a t e n i n -in g fe cti d on i , can s e d ecre a s as e o , v e r t ime, H I (in V th is<br />

c a s e a f o u r m o n t h p with e r i o a d c c e s s p s t yc o h o l o g i c a l c a r e w n h e n e e de d ) , b u t th at th e an xi et y<br />

as s ociat ed wi t h b ei n g aware <strong>of</strong> car r yin g t h is d is eas e is les s amen d ab le to in terven tion , p o s s i b l y<br />

t h r o u g an h ticip at in g fu tu re s tres s fu l life e ven ts related to th e d is eas e. Th is ma y in d icate th at<br />

a n x i e t y c a n b e d r i v e n ked o r n ot p on r o ly v o f ro m t h e p r i m a r y a p p r a i s a l o f t h e s t r e s , s wh o r ich h as<br />

o c c u r r e d i n t h e p a s t o r t h e p r e s e n t, b u t als o f r o m t h o u g h t s a b o u t an d an ticip ation <strong>of</strong> p os s ib le<br />

fu tu re n egat ive even ts a s s o c i a t e d w i t h t h e . d i s e a s e<br />

In c on tras t , th ere was little c h a n g e o v e r t h e f o u r m o n t h s p p e r i c o e d i v i e n d q u -o a f l -life i t y<br />

levels , i .e . s en s e o f taki n g con tr ol o f o n ’s e own li fe m e a s u r e d b y t h e L o c u s o f C o n t r o l ( L o C )<br />

s c a l e; level s <strong>of</strong> p s y c h o l o g i c a l f u n c t i o n i n g m a s e a s u r e d b y t h e M e n t a u l m m C a r o y m o f p o n e n t S<br />

t h e -3 S 6 F ( M C S ); a nd level s o f s leep q u alit y a s m e a s u r e d th e b sy cal e <strong>of</strong> P i t t s b u r Sleep g h<br />

Qu alit y In d ex (P S Q I). T hese f i n d i n g s s u g g e st th at th es e p s ych olo gical d o main s ma y b e m ore<br />

s t a b l over e time (i .e . m ore th an th e f o u r m o n t h s u s e d i n t h i s s t u d oy r ) a m ore p ow erfu l<br />

i n t e r v ntion e ma y b e n e e ded t o d e t e c t c h a n g . e Altern s at ivel y, th er e is a p os s ib ilit y t h at oth er<br />

m e a s u r e m e n t s o f q u a l i t y o f l i f e d o m ma a i y n s b e mo re s en s it ive for d e t e c ting th e c h an ge th an<br />

th e ab ove q u es t i on n ai res . How eve r, as w as th e cas e with t h e meas u res <strong>of</strong> a n x i et y a n d p rimar y<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 75 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

a p p r a i s a l , th e N o n -s t r e s s e d H I -in V fect ed in d ivi d u al s were s h own to con s tan tl y rep ort a gr eater<br />

s e n s e o f t a k i c n o g n t r o l o f o ’s n e o w n l , i bf etter e p s ych ol o gi cal fu n ct ion in g, an d b etter s leep<br />

q u alit y th an th e S t r e s s ind e d ivid u al s [3 . 2 . 1 ]. . H 1 e n c e , i t c a n c o b n e c l u d e d t h a t meth t h e od to comp are two S t r e s se d an d N o t -s tr es s ed s u b grou p s b as ed on th e mid lin e s p lit <strong>of</strong> th e P SS level s<br />

m a y b e a u s e f u l a n d p r a c t i c a l w a y to i d e n t i t f h y e s t r e -related s s a n d t h e q u a -o l f -l i t i y f -related e<br />

d i f f e r e n c e s i n th e m e as u rem en ts in th e p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w . o r k<br />

4 . 1 . 1 . T 2 h e in f l u e n c e o f p s y c h o l o g i c a l i n t e r p s v y e c n h t o i l o g n i c l u a w p o e n l l-b e i n g<br />

As d es cri b ed i n t h e In t rod u ct ion [1 .2 .3 ], t h e s t r e s s p ercep t ion to b e e xamin ed in th e<br />

p r o j e c t w a s t h e p a r t i c i ’ p a ap n p t r s a i s a l o f s t r e s s f u l l i f e e v e n ts. Th e res u lts fr om b ot h s tu d y<br />

p op u lat i on s i nd i cat ed t h at t h e p s ych olo gi cal in terven tion s h ad n o clear b en efit u p on s t res s<br />

p e r c e p t i o n a p n e d r c e i v e d q u -o a f l -life. i t y T h e r are e a n u mb er o f f act o rs th at c o u l d exp lain th e<br />

g e n e r al l y n e g a t i v e r e s u l t s :<br />

1 . P s ych ol o gi cal in ter ven tion s ma y n ot i mp act u p o n t h s e t r e s s p ercep ti on meas u red in<br />

t h e c u r r e n t s t u d ; i e s<br />

2 . Th e s h ort p eri od <strong>of</strong> ti me in train in g an d p ractice <strong>of</strong> th e p s ych ol ogic al i n t e r v e n t s i o n<br />

f o r a c h i e v i n g t o s h o w c l e a r e ; f a f n e c d t / o s r<br />

3 . T h e rel at i vel y s mal l s amp le s izes .<br />

D e s p i t e t s e h e n e g a t i v e r e s u l t s , d a ta f r o m s o m e o f p st ych h e ol o gi cal m e a s u r e s, i .e .<br />

p e r c e i v e d q u a -o l f -life i t y (s p eci fi cal l y, t h e L o C , M C S a n d P S Q ), I in d icat e s o m e b e n e f i t fr o th m e<br />

J o h r e i i n t e r v e n t i o n o n t h e s e n s e o o n f t r t o l a k i o n f g ’s o c n e o w n l , i pf se ych ol o gi cal f u n ct ion in g,<br />

a n d s l e e p q u . a Sleep l i t qy u al it y ma y al s o in d icate s en s e <strong>of</strong> con tr ol in th eir life , p art icu rl y in th e<br />

s e n s e o f c o n t r o l i n r e l a x a t i o n a t n i g h t-tim e b oth co gn itivel y an d p h ys icall y, s o ch a n ge levels in<br />

s l e ep q u al i t y ma y al s o rep res en t ch an ges in th e s en s e <strong>of</strong> con t r ol . T h e s e b e n e f i ts m a y h a ve b een<br />

c l e a re r h ad t h e s t u d y i n v o l v e d a g r e a t e r n u m b e r o f (e.g. s u b j e mc ore t s th an 1 2 1 for th e LoC an d<br />

P S Q I o r 1 3 3 f o r t h e M C . S )<br />

T h i s s e c t i o n d i s c u s s e s t h e olo e f gical f e c t in ter o f ven p ti s on y c uh p on th es e s tres s<br />

p e r c e p t i o n ( p r i m a r y a n d s e c o n d a r y a p p r a i s a l s ) -o a f n -life d p e a r s c f e o i l l v o e w . d s q u a l i t y<br />

P r i m a r y a ppr a i s a l<br />

A m a j <strong>of</strong> o r s tres s man a i age m men t in terv en tion is to alter th e p rimar y a p p r a i s a l o f t h e<br />

s t r e s s f u l l i f e e v e n t ro f m a t h r e a t t a o n eu tral (o r e v e n a b e n i g n s t i m u ) l [1 u s .2 .3 .2 : T ext b o x 2 ] s o<br />

t h a t t h e e v e n lon t gi er s p ercei n o ved as s t res s fu l . Th is was aimed t o ach iev e b y p r o vid in g<br />

altern at i ve p ers p ect i ves [1 .2 .3 .3 : Te xt b o x 4 ].<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 76 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t h p e r o j e c t , t h e u n i v e r s i t ts y in s th t e u Rd el e axat n ion c on trol gr ou p exh ib ited in creas ed<br />

l e v e l s o f t h e S t a t e a n x i e t y s c o r e s w h e n t h e y w e r e f a , c a i n d g th e x a m ps yc s h o l o g i c a l<br />

i n t e r v e n t i o n s d i d n o t s h o w a n y e e c f t f s o n t h i e n c r e a s e i n S t h a e t e a n x i e t y s c o r ]. e s Th is [ 3 . 1 . 3 . 1<br />

f i n d i n m g a y b e in terp ret ed as th ei r p ercep tion <strong>of</strong> th e exa ms was n ot ‘n e u t r a l ’ in th e p rimar y<br />

ap p rais al cat ego r y. A s d i s c u s s e d b e f o r . e 1], th [ 4 e . S1 tat . e 1 an xi et y s c ores migh t re p res en t th e<br />

s u mmed level s <strong>of</strong> an ti ci p at ion <strong>of</strong> b oth th r eat an d imp etu s , s o th ere re main s a p o s s ility i b that<br />

s ome <strong>of</strong> t h e p art i ci p an t s mi gh t h ave b een ch an gin g th e wa y th e y view th e exa m as a wa y t o c op e<br />

w i t h t h i s s t r e s s , o r o r e v e n a w a -l y i t o f u o t p r a l e t o t tac h kl e th e em xams . Hen ce, f u tu re s tu d ies<br />

u s i n g u n i v e r s i t y s t u d e n t s s h o u l d i p n o v t e h e s t i s i b g y a t m e a s t u h r i n s g t h e y l e v e l s o f<br />

e x c i t e m e n t a s w e l l a . s a n x i e t y<br />

Similarl y, th ere w as n o ch an ge in th e S t a t e a n x i e t y s oc ver o r e th e fou r m on th s p eri od in<br />

t h e -in H fected I V in d ivi d u al s in ei th er th e w a i t -listed con tr ol g rou p o r th e in terven t ion gr ou p s .<br />

O n t h e o t h e r h a n d , th e IE S s c o r e s d i d d e c r e a s e i g n i f i c a n t l y a s d e s c r i b e d b e , f b o u r t e th ere was<br />

n o d i f f e c e r e i n n t h e d e c r b e e a s t e w e e n t h e p s y c h o l o g i c a l i n t e s r an v d e n th t e i w o a n i t -listed con trol g r o u ps. O n e p o le s s exp i b lan at ion f or th e i m p r o v e m e n t i n t i h e r S I s c E o r e s n o t e d o v e r t i in m th e e<br />

w a i t -listed c o n t r o l g r m o i u g p h t b e r e l a t e d t o th e t i m i n g i n m e a e s u q r u e i s n t g i o t n n h a i . r Du e e t o<br />

p r a c t i c a l d i f f i c u l t i e s i n a s k i n g t h e p a r t i c i p a n t s t o f i l l i t n h e t h e q u e s t i o n n<br />

w a i t -listed c o n t r o l u g p r co o mp let ed th e q u es ti on n aires s h ortl y b efo re (an d f or s om e <strong>of</strong><br />

p a r t i c i p a n , t ds u rin g) th e fi rs t week <strong>of</strong> ei th er o f th e p s ych olo gical t rain in g s es s ion . Hen ce, a<br />

p o s i t i v e a n t i c i p a t i t o n h fo e t rth o w com a r id n g p s y c h o l o g i c l a in ter ven ti on aft er a l on g waitin g<br />

p e r i o d mi gh t e xp lai n , at leas t in p art, th e o b s e r v e d i m p r o v e m e n t i n t h i s . d o m a i n<br />

Non eth el es s , t h e p s ych ol ogi c al in terven ti on s s h owed n o gr eater i mp ro vem en t or<br />

a l l e v i a t i o n i n t h e S t a t e a n s x c i o r e t s, r y el at is ve c o to r th e s w a o i t r -listed t h c e o n t I r E o S l g r o u p<br />

i n -p H atien I V ts .<br />

Se c o n da r y a p pr a i s a l<br />

Th e P S S s cores s h owed n o d iffer en ce b etween th e in terven tion g rou p s an d th e R elaxation<br />

con trol gr ou p at acad emi c exa min ation s , s o it was c on clu d ed th at th e p s ych ol ogi ca l in terven tion<br />

d id n ot affect th e p e r c e i v e d s t r s e s levels in u n ivers it y s tu d en ts facin g acad e mic e xa min ation s<br />

mor e th an t h e rel axat i on mi gh t h ave d on e .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 77 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Th e s c o r e s o f t h e P -i S n f S e c t e i d n i n d i t v i h d u e a l s H a I t V r e c r u re i t mu m e ch n t h igh w e er<br />

t h a n t h e l e v t e h l e s u n i v i e n r s i t y s t u d e n t s fa c i n g e x a m s , a n d t h e levels s ta yed at th e s ame h igh<br />

levels a f t e r f o u r m o n t h s p e r i o w d a i t -listed n t h e c o n t r o l g p r a o r t u i p c i p a n . t More s o ver, th e fou r<br />

mon th s <strong>of</strong> t rai n in g an d p ract ice in th e p s ych ologic al in terven tion s d id n ot c h a n g e t h se e h igh<br />

P S S s c o r s. e T h i s f i n d i n g s u g g e s t s th a t p e r c e i v e d s t r e s s l e v e l i n -in fected H I V in d ivi d u al s was<br />

n o t a f f e c t e t d h e b y p s y c h o l o g i c a l i n s. t e I r t v e n i t s i o p n o s s i b l e t sh tres a t s level t h e s h i g h<br />

a s s o c i a t e d -p o w s i t i v ma h e y nb ot e b e i amen n g ab le H to I ch V an ge with th e b rief in terven tion s<br />

u s e d i n t h is s t u d y . I t i s a l s o p o s s i b l e t h a t t h e r e l a t i v e l a y n d s m s a h l o l r t s a m t p i l m e e s i p z e r i o d<br />

limited t h e p ower t o d et ect s i gn ifican t eff ects th at migh t h ave b een s h own h ad th ere b een mor e<br />

p a r t i c i p a n t s a n d a l o n g e r i n t e r v e n t i o . n t i m e p e r i o d<br />

N o v e r t h e l e s , s it is c o n c l u d e d t h a t t h e p s yc h o l o g i c a l i n t e r v e n t i o n s s h o w e d n o s i g n i f i c a n t<br />

i m p r o v e m e n t o r a l l e v i a t i o n i n t h e P e r c e i v e d S t r e s s S c r a l e l a s c t o i r th e v s e rel t ax o at ion in u n i v e r s i t y s t u d e n t s f a c i n g th e w x a m i t -listed s o r c o t n o t r o l s i n -p atien H I ts V .<br />

Quality-o f -life<br />

T h e eas u res m o f p ercei ved c o n t r o l ( l o c u s o f c o n t r o , l p) s ych ol o gi cal fu n ct ion in g, a n d s leep<br />

q u alit y d id n ot ch an ge in th e w a i t -listed c on trol gr ou p i n t -in h fected e H iI n d iV vi d ual s ove r th e<br />

f o u r m o n t h s p . e Mr ore i o ove d r, n e i t h e r o f t h e p s yc h o l o g i c a l i n terven tion gr ou p s s h owed an y<br />

s tatis tical d i fferen ces i n t h es e levels a fter fou r mon th s <strong>of</strong> t h e in ter ven tion p eriod . Howeve r,<br />

alth ou gh a larger s a mp le s ize w o u l d b e n e e d e d c t o , n th f ere i was r a m t r e n , d i n t h e J o h r e , i g r o u p<br />

for imp ro ved s co res ac ros s all th e t h r e e o u t c o m e d o m a i . n Hen s ce, th ere re mai n s a p os s ib ilit y<br />

t h a t t h e t r a i n i n g a n d p r a c t i c e o f J o h r e i h a s i -o m f -l p r i f o e v e l d e v e p , l e wh s r c ich e i can v e d q u a l i t y<br />

b e a s s o c i a t e d w i t h i m p r o v e m e n t -focu i n st ed h e cop m in e g a sn ki i ln ls g [1 .2 .3 .2 : Te xt b ox 3 ].<br />

T o g e t h e r wi th th e cl ear d i f f e r e n t t r e n d s i n t h e e f f e c t u p o n t h e i m m (d u is n cu e sc se ed l l s<br />

b elow [4 .1 .2.2 an d 4 .1 .3. 2 ] ), a n d t h e f a c t t h a t t h e e f f e c t s e e m e d f a v o u r a b l e t o J o h r e for i<br />

u n i v e r s i s t u d y e n ts [ 3 . 1 . ] 3 an . 2 d H I -i n V f e c t e d i n d i v i d u a [3 l . s 2.2.2 a n d 3 . 2 ], . it 3 . is 2 s u gges ted that u n i qu e p s ych ol o gi cal f eatu res in th e J oh rei train in g an d p ractice ma y b e worth wh ile to<br />

exp lore fu rt h er.<br />

T h e t r a i n i n g a n d p r a c t i c e o f t h e -a s e d l m f i n i s t e pr s e ych d ol o gi cal in ter ven ti on u s ed in th e<br />

p r o j e c t a i m e d t o a c h i e v e t w o o b j f e o c r t i t h v e s p a r t i c i p a n t s :<br />

1 . B e h a v i o u r a l d o m a i n : s p e n d i n g t i m e a n d e f f o r t o n ’s o n e o s w e l n f b f e o n r e f o i n t e ; a n d<br />

2 . C ogn i t i ve d o mai n : acq u i rin g ad d ition al c on cep ts an d p ers p ectives for s tres s fu l e ve n t s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 78 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t h e b e h a v i o u r a l d o m a i n , o n e o f t h e u n i q u e f e a t u r e s o e f i J p o r h a r c t i c e i s t h a t ei qt ur ires<br />

a p artn er to p r a c t i s e w i t h w h i l e t h e S -h e l y f p n o s i s p r a c t i c e r e q u i r e s ’s o n own l y o ti n me e an d<br />

e f f o r t . Th i s i n vol ve men t o f oth ers as a p a rtn er / rec eive r f or th eir own J oh rei p racti ce co mes<br />

f r o m t w o o f i t s k e y c o n c e p t s a n d p r in cip les [ N a i t o , 2 0 0 3 : ]<br />

1 . “H e a l i n g o n e s e l f b y h e a l i n g o ”: t h e e r s a l i n g i s a m u t u a l oces p r s an d in teract ion , a n d<br />

i t b e n e f i t s e q u a l l y b o t h t h e J o h r e i g i v e r a n d r e c e i v e r s i n c e t h e p o hw ealin e r o g f w a s<br />

t a u g h t t h o se p iritu a al r h e i a l s i -l n e g igh t wh f ich r fl o ows m th rou gh giv er an d recei ver<br />

d u r i n g t h e J o h r e i p r a c t i c e ; a n d<br />

2 . ‘S p i r i t u a l ’: c o r w ere d h th e s p iri tu al h e a l i -li n g gh t an d love co mes an d tra vels b e yo n d<br />

t i m e a n d s p a c e , a n d t h i s S p i r i t u a l c o r d b o n d s a J o h r e i g i v e r w i t h a l <strong>of</strong> l th e p e op le wh om t h e gi ver cares ab ou t an d als o with s ometh in g greate r in th e s p iritu al realm , i.e.<br />

th e s ou rce o f th e s p i r i t l u light a itself.<br />

C o n t i n u e d p r a c t , i w c e h i c h i s a c o m m o n f e a t u r e i n b o t h J o h r e i a n d -h yp S e nl f os is , c an al s o<br />

en h an ce a t rai n ee’s s en s e <strong>of</strong> c on fid en ce in h is or h er o wn skills, th e m an ageab ilit y in cop in g<br />

s t r a t e g i e s [ 1 . 2 . 3 . , 2 wh ] ich can b e rep h ras ed as ‘S e lf-e m p o w e r m e n t .’ T h e a b o v e t w con o cep ts fou n d in th e J oh rei p ract ice, th eref or e, ca n b e s tren gth en ed s y n e r g i s t i with c a l l an y in creas e in th eir ‘Self-e m p o w e r m e n t ’, as th e y are rep eated in p ractice.<br />

I n t h e c o g n i t i v e d e o s m e a t i a n , g i b t l e h c o n c e p t s m a y o ha ave l s p r ovi d ed a J oh rei gi ver<br />

with b ot h a s en s e <strong>of</strong> s u p p o - r an t d a s e f n s r e o f m c o n n e c t e d - n e a s r s e c e t i v o e r, an d even<br />

s o m e t h i n g g r e a t , i . e . t r h e s o u i r c e n o f t h t e l i h g h . e t Th is s ma p y hi a ve r b ui ffered t u a l r e a l m<br />

a g a i n s t f a e n e y l i n g s o f l o n e l i n e s s o r h e lp l e s s n e s s, a n d c o n t r i b u t ed t o a n o v e r a l l s e n s e o f w e l -l<br />

b e i n g [ F r o m m , 1 9 5 6 ], c o n s i s t e n t w ith th e fin d in gs fro m the W h i t e h a l l S t u d y I I w h i c s h owed<br />

t h a t s o c i a l s u p p o r t a n d self-c o n f i d e n c e a b o u t ’s o n own e s ki ll s are i m p o r t a n t f a c t o s r f o r th e<br />

p r e v e n t i o n o f p oo r men tal h e a l t [ S h t a f f o r d & M a r m o t , 2 0 0 3 ; S t a n s f e l d e t a l . , . 1 9 9 7 ]<br />

F u r t h e r m o r , a e b e l i e f a n d e n c o e n f i n d o n s e l f / a o n r d s o m e t h i n g g r e a t e r m i g in h creas t h a ed v e<br />

t h e m e a n i n g f u l n e as s s Fr om m [1 9 5 6 ], Fr an kl [1 9 7 0 ] an d S t r a n g e t a l . [ 2 0 0 1 s u] gg es ted .<br />

A c c o r d i n g l y , J o h r e i m i g h e t n h a h n a c v e d t h e i r a b i l i t i e s i n -f ocu t h se ed m co e pa i n i g n g<br />

a p p r o a c h a s w e l l a s th e e m o t i - o n o r - p f o r c u o s e d b a l p p r e o a c m h e s [ 1 . 2 . 3 . 2 : T e x t b o x . 3 ]<br />

I n a d d i t i o n , t h e tw a b o cv on e cep ts , gi v e n rep eat ed l y in th e J oh rei p ractice, h ave p rovid ed<br />

th e p art i ci p an t s wi t h a ch an ce to recall or to gi ve in s igh t ab ou t th ei r own p ers p ectiv es related to<br />

‘Spirituality’. Th e word ‘Spirituality’ or ‘S p i r i tu a l ’ ma y s u gg es t va riou s con cep t s a ccord in g t o<br />

each in d ivi d u al and each occas ion or s itu ation [ R i c h a r d s & B e r g i n , 1 9 9 . 7 In ] th e J oh rei trai n in g<br />

s es s ion , t h i s vari et y <strong>of</strong> ‘Spi r i t u a l ’ th ou gh ts an d con cep ts are allowed an d s h ared in a gr ou p , an d<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 79 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

c o u l d b e l e f t i n a m b i g u i t y i f t o t a l a g r e e m e n t c o u l d n o t b e a c h i e e v e to d , feel a s l o n g a s t h e y<br />

c o m f o r t a b l e t o p r a c t i s e J o h r -ii]. e i [ A p p e n d i x 2<br />

Th e J o h r e i p a r t i c i p a n t s a w l e s en r o e cou ra ged to ap p reci at e th eir own d ou b ts ab ou t th e<br />

efficac y <strong>of</strong> th e in ter ven ti on , o r th e e x i s t e n c e o f t h e -ligh h e t a if l di ou n g b ts ab ou t th es e aros e<br />

n a t u r a l l y . T h e e s d o u b t s als c a o n b e left in amb igu it y al th ou gh th e y wer e als o en cou raged to<br />

p ractis e even wi t h d ou b t s s o th at th e y can tes t or ch allen ge th e d ou b t s b y th e ms elve s [ Ap p en d ix<br />

2-ii] i n o r d e r t o m a i n t ’s a i n i n n o e n r e c o h e r e . n Th c e es e met h od s u s ed in th e J oh rei s es s ion are<br />

b as ed on th e con cep t th at a m b i g u i t y m a y p r o v i d e i m p o r t a n t i n s i g h t s i n t o -c s o e g l f n i t i o n o f ’s o n e<br />

own life [ E m p s o n , 1 9 3 0 ; T o y a m a , 1 9 7 , 3 s] o th at th e in d ivi d u al s left in a m b i g u i t y ma y b e ab le to<br />

( 1 ) e s t a b l i s h a n a l t e r n a t i v e p e r s p e c t i v e t o c o p e w i t h s t r e s s f ; u l ( 2 ) l ach i f e iev e v e e a n gt s rad u al<br />

i n c r e a s e o f th e i r i n n e r-p e r s o n a l c o h e r e n [ c A e n t o n o v s k y , 1 9 9 3 ]; an d (3 ) weigh val u es an d goals<br />

t o m o d i f y t h e m e a n i n g o sf s fu a l t s r t a r n e s a c t [ i F r o a n k l , 1 9 7 0 ; P a r k & F o l k m a n , 1 9 9 to 7 ]<br />

i n c r e a s e t h e s e n s e o f m e a n i n g f u l [1 n . e 2 s s . 3 . 2 . ]<br />

Th e p os s i b l e l i n k b e t w e en t h e ab ove b eh aviou ral an d c ogn itive d omain s i s f ou n d in a<br />

con cep t <strong>of</strong> ‘S e l f -c u l t ivation’ [ Y u a s a & K a s u l i s , 1 9 8 7 ; Y u a s a e t a l . , 1 . 9 Th 9 3 is ] ‘S e l f-cultivation’<br />

ma y n ot b e exp l i ci t l y rec o gn is ed in Wes t ern cu ltu re, b u t it h as b een emp h as is ed in Eas tern<br />

cu ltu re in cl u d in g vari ou s trad ition al J ap an es e p ractices [ Y u a s a e t a l . , 1 9 9 . 3 Th ] e mot t os o f th is s e l f-cu lt ivat ion in cl u d e “p r a c t i c e m a k e s p e r f e c t” an d “p r a c t i c e p r e c e d e s k n o w l .” e d Th g e es e<br />

m o t t o s m e a n t h a t p r a c t i c e d o e s n o t r e q u i r e a f u l l u n d e r s t a n d i n g o f k n o w l e d g e i n t h e s u b j e c t, b u t<br />

b en efit s can b e ob t ai n ed , an d s kills an d kn owled ge can b e d evel op ed th rou gh b as ic p ractice o f<br />

‘K a t a’ - a s t a n d a r d f i o r s m e d o r s e q u e n c e o f e x e r c i s [ e Y s u a s a & K a s u l i s , 1 9 8 . 7 <strong>The</strong> ] id ea is that<br />

p r actice can b e u s e d t o d e , v an e l d o al p s o to b ri n g t o t h e f <strong>of</strong> o r con e s ci ou s a w a r e n e ss , ‘Tacit<br />

k n o w l e d g e’, i .e. kn owl ed ge th at wou ld ot h erwis e r e m a i hn id d en [ N o n a k a & T a k e u c h i , 1 9 9 5 . ]<br />

C ollecti vel y, t h e d evel op men t <strong>of</strong> th e ab o ve d o main s s h ou l d res u lt in th e followin g gain s :<br />

1 . S o c i a l p p s o u r t a n d s e n s e o f s u p p o r t ;<br />

2 . S p i r i t u a l a w a r e n e s s ; a n d<br />

3 . I n n e r -p e r s o n a l c o h e r e n c e m e a n i d n g f u l n e . s s<br />

H e n c e , f u t u r e i n v e s <strong>of</strong> t i J oh g a rei t i so hn o u ld in cl ud e examin ation o f th e ef fects on<br />

p e r c e i v e d s u p p o r t h e a s n e d q u a l -o i t f -l y i f e d o m a i n s u s i n g p q u b e l s t i s o n h n e a d i r e th s at as s es s<br />

t h e s e c o n s t r u c t s , s u c h th e a s K e s s e l e r P e r c e i v e d S o c i a l S u p p o r t ( K P S [ S C ) o v e n t r y e t a l . , 2 0 0 , 4 ]<br />

th e S p i r i t u a l I n v o l v e m e n t a n d B e l i e f s S c a l e ( S I [H B S a ) t c h e t a l . , 1 9 9 8 a ] n d th e Sens e <strong>of</strong><br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 80 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o h e r e n c e ( S o C ) [ A n t o n o v s k y , 1 9 9 3 ], a s w e l l a s th e s c a l e s o f s t r e s s , u p s e r d ic n e tp ht e i o n<br />

p roject s u ch as th e P ercei ved Stres s Scale (P SS) [ C o h e n e t a l . , 1 9 8 , 3 ] a n d s l e e p q , u th a e l i t y<br />

P i t t s b u r g h S l e e p Q u a l (P i SQI) t y I [ B n u d y e s x s e e t a l . , 1 9 8 . 9 ]<br />

4 . 1 . T 2 h e i n f l u e n c e o f h p o s l y c o g i c a l i n t e r u v p e o n i mt mu i o n e pa ra me ters in un i ve rs ity<br />

s t u d e n t s f a c i n g a c a d e m i c e x a m s<br />

Th e ch an ges in p ercen tages o f -c N e K l l s -cells a n d at acad T emi c exa mi n at ion time were<br />

s m a l l , a n d s i m i l a r i n th e d eg ree <strong>of</strong> ch an ges fou n d els ewh ere in th e literatu re u s in g u n ivers it y<br />

s tu d en ts [ Gr u z e l i e r , 2 0 0 2 b ; Gr u z e l i e r , S m i t h e t a l . , 2 0 0 1 ; Ha l v o r s e n & V a s s e n d , 1 9 8 7 ; Ki e c o -l<br />

t<br />

G l a s e r e t a l . , 1 9 8 6 ; M a e s , V a n B 9 o 9 c ; k U s c t h a e k l i n e e t e a t l . , a l 2 0 . 0 I , 1 n ] g 1 e 9 n d e r<br />

d i f f e r -cells e n c h ave e , b een rep N K ort ed t o b e low er in fe males th an males u n d er the age <strong>of</strong> 5 0<br />

[ J e n t s -U c h l l r i c h e t a l . , 2 0 . 0 Th 5 ] i s s t u d s y h o w e d t h e s a m a s e n o t g e r n d e ias r n d b , b u t t<br />

with regard t o s t res s [3 .1 .2 .3 ]. Si milar flu ctu ation s were al s o rep ort ed in s tu d ies that u s ed<br />

s l i g h t l y d i f f e r e n t i m m u n o-p h e n o t y p i n g : C D 2 w a s t u o s e d g -c a t e e l l T s -cells & in s tead N K <strong>of</strong><br />

C D4 5 [ M a e s , V a n B o c k s t a t e l a e l . , e 1 9 9 , 9 an ] d C D1 6 w a s c o m b i n e d w C D5 i t 6 h t o d e t e c t N -K<br />

cells [ d e G u c h t e t a l . , a k 1 i n 9 9 e 9 t ; a l . U , c 2 h 0 0 .�H 1 ] e n c e , c h a n g e s a n d d i f f e s r he ere n c e ma y<br />

h ave n o ap p aren t cl in ical imp acts u p on h ealth , b u t th e r e s u l t s a r e d i s th c u e s ligh s e d t <strong>of</strong> i sn tres s<br />

res p on s es .<br />

4 . 1 . 2 1 S t r e s s-a s s o c i a t e d c h a n g e s a n d d i f f e r e n c e i n s i m m u n e p a r a m e t e r s i n u n i v e r s i ty s t u d e n t s<br />

T h e l e v e l s o f l y m p h o -p c y o t e p u s u l b a t -c i e o l n l s , ( C N D K 4 -cells a n d ) an C d D th 8 e NK T<br />

c ytot oxi c act i vi t y (N KC A) w ere an al ys ed b y co mp arin g th e S t r es s ed an d N o t -s t r e s s e d<br />

s u b g r o u p s i t n h un e ivers it y s tu d en ts . A l t h o u g h t h -c e l l r p e r s c e ges n u t l a f rom t s th is o f N K<br />

s t u d y d id n ot s u p p ort p revi ou s f i n d i n g s i n t h e l i in t e wh r a t ich u r se tres s ed s t u d e n t s h ad lo w e r<br />

n u m b e r s or p ercen t age o f N K -cells in th eir c i r c u l a t i o n c o m p a r e d w i t h n o t-s t r e s s e d s t u d e n ts , the<br />

res u lts s h owed th at th e S t r e s s e s t d u d e n t s e x h i b i t low N KC A le vels c omp ared with th e N o t -<br />

s t r e s s e tu d e n ts [3.1 .2 . 1] in li n e wi th pub lis h ed find in gs [d e Gu ch t et al., 1 9 9 9 ; Dein zer &<br />

Sch u ller, 1 9 98 ; Gl as er et al ., 1 9 8 5 ; Gru zelier, Smith et al., 2 0 0 1 ; Halvo rs en & Vas s en d , 1 98 7 ;<br />

Ki e c o l t -G l a s e r e t a l . , 1 9 8 . 6 ]<br />

T h i s f i n d i n g l e a d s t o t h e at ih ny dp ivi o t dh ue al s i w s i t h<br />

h i g h s t r e s s levels , f r o m<br />

s u s t a i n e d s t r e [1 s s .2 .3 .2 ], ma y h a v e l ow NKC A l evels r e g a r d l e s o f t h e s i . t Th u is a t i o n<br />

h y p o t h e s i s m a y b e s p e c i f i e d sm u ch o r e th at th e h igh p ercei ved s tres s le vel ma y b e a s s o c i a t d<br />

e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 81 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

with a l o w p e r-N K -c e l l c yt o t o x ic a c t i v level. i t y N K -c e l l p e r c e n t a g e s N K a c n y d t o t o x i c a c t i v i t y<br />

m e a s u r e d b y u s i n g P B M C are s <strong>of</strong>t en u s ed t o g e t h e r s o e p a r a t as e sl tres y s b en ch marks wi th ou t<br />

c a l c u l a t i t n h g e p e r-N K -cel l c yt ot o xi c a ct i vi t y [Dop p et al. , 2 0 0 0 ; Lev y et al ., 1 9 8 9 ; Sch ed lows ki<br />

e t a l . , 1 9 9 3 ; W h i t e h o u s e e t a l . , . 1 T 9 9 h 6 i ] s p e r-N K -cel l c yt ot o xi c acti vit y, calcu late d as a N K<br />

c e l l p e r c e n t a g e t o y t N o K t o c x i ac ctivit y r at io, is kn own to b e imp aired in certain p h ys ical<br />

c o n d i t i s, o sn u ch as in ci rrh os is [ La s o e t a l. , 1 9 9 7 ] an d end omet ri os is [ O o s t e r l y n c k e t a l . , 1 9 9 . 4 ]<br />

I n s t r e s s r e s e a r c h , o n -a e n a m l e y t s a i s p a r p c e a l c u l a t e d t h i s p -N e r K -cel l c yt ot o xi c ac ti vi t y<br />

i n a c u t e s t r e s s s e t t i n g s , a n d m e n c t u i t e o n s e t d r e s t s h d a i t d a n o t a l t e r -N p e K r -cel l c yt ot oxi c<br />

a c t i v i t y , i . e . -i s t r n e s s d u c e d c h a n e g r e s d u e i n t o N K C a A -c l ell w t pe ercen r a tages t i o n o f N K<br />

[ S e g e r s t r o m & M i l l e r , 2 0 0 . 4 ] h is T ma y o n l y occu r in acu te s tr es s situations , given th e fin d in g<br />

that acu te s tres s c a n i n c r e a s -cel e l pb ercen o t tage h an d N NK KC A le vels [ D o p p e t a l . , 2 0 0 . 0 ]<br />

T h e r e f o r e , i t i s s u g g e s t e d t h a t f -cells u t u r e s t u d i<br />

s h o u l d a n a l y s e t h e p -N e r K -cel l c yt ot oxi c act ivi t y.<br />

In th is cu rren t s t u d y, in th e S t r e s s se tud d en ts , t h e l e v e l s o f p e t r -N h e K -c e l l c yt ot oxi c<br />

a c t i v i t a y n d N e w K r C e f A o u n d t o b e l o w , e alth r ou gh N K -c e l l p e r c e n t a g e s w e r e n o t d e c r e a s e d<br />

[ 3 . 1 . ]. 2 . T 1 h i s i m p l i e s t h a t t h e r e m a y b e o t h e r f a c t o r ( s ) a f f e c t i n g N KC A t h a n a s i m p l e c h a n g e n i<br />

N K -cel l n u mb ers / p ercen t ag es . Th is was in ves tigated b y lo o kin g f or d ire ct ef fects <strong>of</strong> i n v i t r o<br />

e x p o s u r e o f b l o o d t o c o r t i s o l [ 3 . 3 ] a n d i t s h w i l l d i b e s c u s s e d l a .1]. t e r [ 4 . 2<br />

I n t h a e n a l ys i s o f C -cells D 4 T ( H e l -l p e y r m p T h o c y t e s a n d -c R e e l l g s ), u th l e a r t e s o u l r t s y T<br />

s h owed th at th ere was n o s ign ifican t d i f f e r e n c e i n t h -cells e l b e et wee v e l n ts h e o f C D 4 T<br />

S tr es s ed and N o t -s t r e s s e u d b g r o u p s. T h i s r e s u l t is in lin e with p reviou s r e p o r t s; s o me s tu d ies<br />

rep ort an in creas e , ot h ers a d e c r e a s e, a n d s t i l l o r t h e n r o s c h r a e n p [d g o e Gu ch t et al ., 1 9 9 9 ;<br />

M a e s , V a n B o c k s t a e l e e t a l . , 1 9 . 9 T 9 h ] e p o s s i b l e c h a n g e or s n o c h a n g e in th e C D 4 T-cell<br />

p e r ce n t a g e s m a y b e d u e : t o<br />

1 . A c h a n g e o f d is tri b u ti on in C D 4 -c T e l l s a n d / o r in s u b s e t s ( T h , . Th 1 .2 a n -r d e g ) T , i. e.<br />

a r e l e a s e o f c e l l s i n t o t h e or c i hr omi c u nl g a <strong>of</strong> t i cells o n i n t o t i s s u ; e s<br />

2 . A ch an ge in rat e <strong>of</strong> cel l p r o d u ction, i. e . e n e g r a t i o r n i o n h i b i t i o n o f n e w ; c o e r l l s<br />

3 . A ch an ge in c e l l st d e r u c t , i o n i . r e v . e n t p i n g o r p r o m o t i n g c e l l d eath (p ro gra mmed cell<br />

d eath in the c e l l c y c l e . )<br />

T h e s e s c e n a r i o s occu m a r y in a s p eci fi c t i m e c o u r , s tartin e g wi th a cel l d is tri b u tion ch an ge an d th en g e n e r a t in g n ew cells an d th e p r e v e n t i o n o f c e l l . Th d is e a con t h s ecu ti ve c o u r se<br />

ma y refl e ct a s h ift f ro m an ala rm reacti on t o a s t a g e o f r e s i s alon t a n g c e th e li n es <strong>of</strong> Sel ye’s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 82 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

c l a s s i f i c a t i o [1 n s . 2 . 4 ]. . T 1 h i s a l a r m r e a c t i o n m e a n s t h a t p e r c e i g v a i n s it u a t i o n a s s t r e s a s n f bu e l c<br />

res p on d ed to i n t h e i m m u n e a r m o f -n t e h u e r o-e p n s d y o c h r o i n -i o mmu n e n et wor k b y a r e l e a se<br />

o f C D 4 -c e T l l s i n t o t h e c i . r Th c u is l p a o t s i s i b o n l e mech an is m in th e immu n e s ys t e m was<br />

s ug g e s te d in a rep ort s tat in g that t h e i n c r e a s e i n b t l h o o d f t s h e t -c r C e l D e l 4 s a w m T a ds u e to<br />

an in creas e <strong>of</strong> on e s u b s e t o f 4 -cells T C D (C D 2 5 + C D 4 + T-c e l l s u b s e t ) in n u rs es u nderg oin g<br />

s u s t a i n e d s t r e , s s i . e . n u r s e s w h o d i w a e g r s n e o e d with ‘ b u r n o u t ’ s yn d r ome [d e Gu c h t et al.,<br />

1 9 9 9 ] . Th is C D 2 5 + C D 4 + T-c e l l s u se b t is a mai n c omp on en t o f th e R e g u l a t -c o r e y l l -re T s g) ( T<br />

wh ich p l a y a m a j o r r o l e i n n e a r gy, t ol era n ce or i s n w i t c h i n g o f f i m t m h e u n e r e s p o n s e to<br />

p ath ogen s [ A k b a r e t a l . , 2 0 0 , 3 ] s o t h i s c o u l n d imp b e ort a an t fact o r in th e s u p p res sive ef fect <strong>of</strong><br />

s u s t ain ed s t res s u p on t h e i mmu n e r e s p o n s e s.<br />

R e c e n t l y , t h e d i r e c t i o n o f -i s n t d r u e c s e s d c h a n g e s i n C D -c 4 e l T l p e r c e n t a g e s , w h e t h e r t o<br />

i n c r e a s e o r t o d e c r e a s e , dw emon a s s trat e d to d ep en d up on th e c o n d i t i s o <strong>of</strong> n th e s tu d y, i . e. t yp e<br />

o f s t r e s s o r a n d t i m i n g T-c w e h l e l n C p e D r 4 c e n t a g e s w e r e , as m se ha own s u r be el d o w<br />

[ S e g e r s t r o m & M i l l e r , 2 0 0 . 4 Th ] e cat eg or ies <strong>of</strong> d et ai led s ettin g <strong>of</strong> th e ti min g in th e reviews<br />

[ M i l l e r & C o h e n , 2 0 0 1 ; S e g e r s t r o m & M i l l e r , 2 are 0 0 4 wh ] et h er th ere is s h o r t l a s t i n g - t i m e<br />

l i m i t e d a c u t e s t r e s s o r o n e t o f h e f o l l o w i n g f o u r c a t e g o r i e s o f s u s t a i n e d s t r e s s :<br />

1 . Br i e f n a t u r a l i ( p s r t e d i c t a b l e s e -l l f i m i t e d l i f e e v e n t s , e . g . a c a d e m i c e x a m i n a , t i o n )<br />

2 . Ch r o n i c -g ( o n i n g o r p e r s i s t e n t l i f e e v e n t, e . g . d i ), s e a s e<br />

3 . Even t s eq u en ce (d is cret e s t r e s s f u l e v e n t s o c c u r r e p e a t e d l , y ) o r<br />

4 . Distant (p as t b u t t rau mat ic even ts ).<br />

T h e s u s t a i d n s e t r e s s i n th e c u r r e n t s t u d e n t s tu d y falls in to th e b rief n atu rali s tic s tres s , an d<br />

t h e y m e n t i o n e d -c e l t l s h s ee a med t C n ot D 4 to ch T an ge in n u mb ers , b u t fu n ction al s u pp res s ion<br />

o r a s h i f t t o w a r d s h u m o r a l i m m u n e a c t i v a t i o e n c a w te o gor u l y d <strong>of</strong> o sc uc s tu ai r n ed u n d e r t h<br />

s tres s .<br />

Fu r t h e r s t u d i e u s s i n g u n i v e r s i t y s t u d e a n c a t d s e m f i a c c e i n i x g n a t i m o n s h ou ld con s id er<br />

e x a m i n i n th g e T-re g s u b-p o p u l a t i an o n d th e s u pp res s ion or s h ift o f i mmu n e res p on s es in th e<br />

f u n c t i o n a l m e a s u r e s ( b y m e a s u r i n g T t h o . k i 1 n e a n p d r o d T u h c . t i 2 o n c ) y t o e x p l o r e t h -e<br />

s t r e s s<br />

i n d u c e d e f f e c t o f n a t u r a l i s t -cells. i c s u s t a i n e d s t r e s s u p o n C D 4<br />

Th ere was n o d if feren ce in C D 8 -c T e l l s ( C y -l t y m o t p h o c x y i t e s c ) p e r T c en t a g e s b e tween<br />

th e S t r e s s and e d N o t -s t r e s s e s u d b g r o u p s, a n d t h i s is agai n c o n s i s t e n t with th e literatu re fin d in gs<br />

s h owin g th at s t r e s s-i n d u c e d c h a n g e s i n t -cells h e is l in e con v e s il s ten s t [S o egers f tr C om D 8 & T<br />

M i l l e r , 2 0 0 4 . ] T h ese i n c o n s i s t e n t r e s u lts m a y b e d u e t h t e o f a c t th at th e C D 8 -cel T l p op u lat ion P h . D . a t U n i v e r s i t y o f L o n d o n - 1 83 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

is n ot a h om o gen eou s en ti t y. Th e C D 8 -cell T p op u lat ion con s is ts <strong>of</strong> th ou s an d s <strong>of</strong> s p ecific C D8<br />

T-c e l l s m a d e f o r a s p e c , i an f d i it c takes a n t mu i g ch e n lon ger p e riod to m a k e a s p ecific im mu n e<br />

r e s p o n s e than a n i n n at e i mmu n e res p on s e. Hen ce, in con s is ten t res u lts ma y b e b ecau s e th e en d<br />

r e s u l t s o f c o m b i n a t i o n s o f v iou a r s ch an ge s i n t h e h e t e r o g e n e o u s -cells e n t we i re t y o f t h e<br />

s h o w n a n d b e c a u s e t e h t i m e p e r i o d w a s s h o e e r d t e e d r t o t h s a h n o w n a n y c h s a n g i e n u mb ers .<br />

F u ture i n v e s t i g s a t o f i o s n t r e -i s s n d u c e d c h a n g e s -cell, i n i f an t y, h e s h ou C lD d 8 take T th is h e t e r o g e n e o u s f e a t u r e o f -c e l l t p o h p e u l a t i C o D n 8 i n t o T a c c o u n t, s o s h ou ld u s e a s p eci fi c<br />

a n t i g e n t o s t i m u l a -c t e e l l a s u b t s , y p refe e<br />

c rab i f l y i in c omb C D in 8 at ion T with fu n ction al<br />

examin at i on s (p r ol i fe rat i ve res p on s es or c yto kin e p rod u ct ion s ).<br />

4 . 1 . 2 T h e i n f l u e n c e o f p s yc h o l o g i c a l i n t e r v e n t i o n u p o n im m u n e p a r a m e t e r u s n ivers i n it y<br />

s t u d e n t s<br />

Alth ou gh th e su b ject n u mb ers d ecreas ed b y t h e t i m e o f n d t sh et e <strong>of</strong> s acad e c o emi c<br />

e x inations a m l e a v i n g a t o t s tu a l d en o ts f , f 3 o 5 r t u n a t e h e l y we y re d is tri b u ted al mos t even l y<br />

acros s th e t h r e e g r o u s p . T h e f i n d i n g s i n d ic a t e d t h a t th e R elaxation c on trol gr ou p s howed a<br />

s i m i l a r t r e n d t o t h e s t r e s s e d i n d i v id u a l s i n t h e r a t l u r i e t a e t e xa m ti m e, i .e . th e tren d to d ecreas e<br />

N K -c e l l p e r c e n t a g ; e s a n d t h is a t w a s t al h tered p a r t i c u l a r l y i n t h e J [ o h 3 r . e 1 i . : Figu 3 . g r 2 re o u p<br />

2 6 ]. B a s e l i n e N K c yt o t o x i c a c t i v i t y r e s u l ts e w r e mis s ed d u e to th e d evel op men t an d ad ju s tmen t<br />

<strong>of</strong> th e G o d o y -R a m i r e z ’ s a s s e s s m e n t s o m th e t at h an o d al ys es <strong>of</strong> th e e ffects <strong>of</strong> in terv en tion u p on<br />

th e NK c yt ot o xi c act i vi t y were n ot p os s ib le to as s es s . Hen ce th e foll owin g s ecti on s d is cu s s th e<br />

res u lts <strong>of</strong> th e N K -cel l an d l y m p h o c y t e d i s t r i b u t i o n s l y i n e a c h g . r o u p<br />

R e l a x a t i c o n n t r o l g r o u p<br />

<strong>The</strong> r e l a x a t c on i o trol n gr ou p at acad emi c e x a time m s h ow ed s imi lar d e c r e a s e s in N K -c e l l<br />

l e v e l s to p u b li s h ed rep ort s ab ou t h i g h s t r e in s s d ividu e d al s [ B o r e l l a e t a l . , 1 9 9 9 ; G r u z e l i e r , S m<br />

e t a l . , 2 0 0 1 ; -S I a n k o u r a e i e t a l . , 2 0 0 0 ; M a e s e t a l . , 1 9 9 2 ; S e g e r s t r o m & M i l l e . r Howe , 2 0 0 ver 4 ] ,<br />

in ord er t o ma ke t h e o b t a i n e d c h a n g s e s t a t i s t i c a l l y t, s th i e g sn ai mp f i le c sa in ze cal c u lat ion s h ows<br />

th at th e s u b ject nu mb er n eed s more th an 3 9 . T h e n u m b e r o f s u b ject s was on l y 11 , s o d efin itive<br />

c o n c l u s i o n s f r o m t h e s e f i n d i n g s c a n n o . t Th is b e fi nm da in d g e ma y b e d u e to th e f o l l o w g i n<br />

p o s s i b i l i t i e s :<br />

1 . E x a m st r e s s d i d n o t s i g n if i c a n t l y -c e l l c l e v h e l a s ; n g e N K<br />

2 . T h e s a m p l e s i z e sw mall a s t t o o do et ect t h e ch an ge; o r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 84 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . T h e r e l a x a t i o n , p r o v i d e d b y t h -f e e e m d o b c a k c k n e p u r o o c e d u r e a s p revi s h o ou w sn l y<br />

[ E g n e r e t a l . , 2 0 0 , 2 its ] elf on l y or wi th at ten ti on given t o th e s tu d en ts (i.e. p laceb o<br />

effect) m i g h t h a v e b u f f t h e e r e s d t r e -i s s n d u c -c e d l l creas d N e K e.<br />

In ord er t o d et er mi n e t h es e h yp oth es es , a s s tated p reviou s l y, fu tu re in ves tigati on s h ou ld<br />

h a v e a n i n t e r v -free e n t i c on o n trol g rou p a s wel l as th e R elaxati on con tr ol g rou p .<br />

Self-h y p n o s i s g r o u p<br />

In th e p r e v i o u s r e p o r ts i n t h e l i t , e r s e a l t f-h u r yp e n o s i s t rai n in g an d p ractice were s h own to<br />

- +<br />

b u f f e r t h e s t r -i e s n s d u c e d d e c l i n l e v e l in s e i t h e r N K -c e l l l e v e ls ( l a b e l l e d C a s D 5 6 C D or/ 3 an d<br />

C D 1 6 + ) [ B a k k e e t a l . , 2 0 0 2 o ] r C D8 T-c e l l c o u n ts [ G r u z e l i e r , L e v y e t a l . , 2 0 , 0 o 1 r ] in b ot h NK<br />

c e l l s a n -cells d C [ D G 8 r u z e T l i e r , S m i t h e t a l . , 2 0 0 w 1 he ] r e a s n -in o n ter ven ti on c on trol s s h owed<br />

a s i g n i f i c a n t d . e c Th l i e n e elf-h S yp n os is g rou p i n t h e c u r r e n t s h o s w t e u d y n o c h a n g es in th e<br />

N K -cel ls l e v e l s a t acad e mi c e x s a . Ho m w e v e r, it is a l s p o s s i b l e t h a t th e n u mb er <strong>of</strong> s u b jects was<br />

t o o s m a l l t o d e t e c t di f f e r e n s; c e o r t h a t s t r e s -i s n d u c e d c h a n g e s i n t h e N -cells K w ere can cel led as<br />

a r e s u l t o f a l t e r a t i p o r n i m o a f r y t a p h p e r a i s a l fro m s tres s fu l t o ‘n e u t r a l .’ In c o n tras t, C D 8 -cell T<br />

levels w e r e creas i n ed in t h e elf-h S y p n o s i s g r o as u p s h own p revi ou s l y [ Gru zelier, Le v y et al .,<br />

2 0 0 1 ] al th ou gh th e c h a n g e d l e v e l s o f -cells t we h e re n ot C D rel 8 at ed T to th e s tres s p ercep tion in<br />

t h i s s t [3 u .1 d y .2 .2].<br />

He n c e , i t w a s c o n c l u d e d t h a t t h i s s tu d y p a r t i a l l y s u p p o r s t t h e h y p o t h e s i s t h a t S -e<br />

l f<br />

h y p n o s i s m a y h a v e a c t e d a s s t -b r u e f s s f e r i f n o g r u n i v e r s i t y s t u d e n f t s a c i n g s a , c a d e m i c e<br />

t h e r e f o r e , it w o u l d b e w o r t h e x a m i n i n g i t f u r t h e r i n g a r e a s t e u r d y n u m u s b i e n r g o f a s u b j , e c t s<br />

a n d w i t h m e a s u r e m e n t s o f f u -c n c e t l i l o s n , a l i . a e c -cell . t i a ct c v i y vi t t y o y t o t a o x f i c C D T 8 T<br />

s p ecific an ti gen , u s in g a d is eas ed p op u lation in wh ich th e a n t i g ( e s n ) c a n b e s p e c as i f i e d<br />

p rop os ed ab ove.<br />

J o h r e i g r o u p<br />

I n t e r e s g l t y, i th n e r e s u l t f r o m t h e d c y u sr h owed r e n t th at s t th u e level s <strong>of</strong> N K -c e l l<br />

p ercen tage in th e J oh rei g r o u p w e r in e cre as ed at acad emi c e xams . Alth ou gh th e a mp litu d es <strong>of</strong><br />

t h i s i n c r e w a s e e r e r e l a t i v e l y s m a l l an d al l p ercen tages an d cou n ts were with in th e n o r m a l ra n g e<br />

[ H a n n e t e t a l . , 1 9 9 , 2 e ] i g h t o f e l e v e n J o h r e i p a r t i c i w p e a d n t r a s i s e d s h p o e r c e n ta g e s -cells o f N K<br />

i n t h e i r p e r i p h e . r Th a l is tren b l d o o was d s ign ifi can tl y d iffe ren t f r th o at m <strong>of</strong> th e R el axat ion co n t r l o an d the Self-h yp n os is g r o u p s; a n d t h e e x p e c t e d d i -cells<br />

r e c t i o n i<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 85 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

b a s e d o n t h e o b s e r v a t i o n o f s t r e s oth s e d in i th n e d cu i v rren i d t u sa tl u ds y an b d in th e literatu re<br />

was o p p o s i t e t o t h a t o t f h e J o h r e i g r o u p i n t h e c [ u r 3 . r e 1 . n ]. t 3 . 2 s t u d y<br />

A s d e s c r i b e d i n t h e i n t r o d u c t i o n [ 1 . 2 . 4 . 2 c u t a n e d s t 1 r . e s 2 s . i 4 s . 3 k ] n , o w a n i n t c o r e a s th e e<br />

l e v e l s o f N K -cel l p ercen tag es an d N K c y t to o xic act i vi t y [ D o p p e t a l . , 2 0 0 0 wh ] ile s u s tai n ed<br />

s tres s is kn own to d ec reas e th e le vels . Bo rella et al . [1 9 9 9 ] r e p o r t e d at s t h u d e n t s wh o are<br />

e m o t i o n a l l y s t a b l e i n p e r s o n a l i t y p r o f i s l e e d h N a K v e c i y n t c r o e t a o x i c a c t i g v th i eir t y d u r i n<br />

acad emi c e x s. a Fu m r t h e r , i n t h e o t h e r n o t-d is eas ed p op u lation , D e G u c h t e t a l . orted a l s o r e p<br />

[1 9 9 9 ] t h at su s t ai n ed s t res s i n creas ed N K -c ell cou n t in th e gr ou p with h igh p r<strong>of</strong>es s ion al s t r e s s�<br />

( m e a s u r e d b y t h e N u r s e S t r e s s I n d e x b) u t l o w p s y c h o p a t h o l (th o g os y e wh o h ave g ood ad ap tive c o p i n g a b i l i t i e s t o t h e i r s y m p t o . m Th s ) e s e f i n d i n g s a n d t h e u lts r e s from th e cu r ren t s tu d y<br />

s u gges t ed t h e p os s i b i l i t y t h at J oh rei ma y h ave i n c r e a s ed t h e em otion al s tab ilit y or d ecreas e<br />

p ath ologi cal i mp act o f s t r e s s . F u t u r e r e s e a r c h s o n J o h r<br />

s h o u l d e m p l o y a l a r g e r s a m p meas l e us res i z oe f p w e r i -N t K h -c e l l c y t o t o x i c lev a c els t i in v i t y<br />

ord er t o c on fi rm t h i s fi n d i n g.<br />

Des p ite th e limitations, it is, n e verth eles s , con clu d ed th at th e p s y c h o l o g i c a l i n t e s, r v e n t i o n<br />

p a r t i c u l a r l y oh J rei, ap p eared to h a v e p os s ib le b u fferin g or even c o u n t e r a c t in g e f f e c ts <strong>of</strong><br />

examin at ion s tr es s u p on the d i s t r i b u t -cells i o , n a n d/or o f C D 8 -cells t T h , e in th N e K u n ivers it y<br />

s t u d e ts. n<br />

4 . 1 . T 3 h e i n f l u e n c e o f p s y c h o l o g i c a l is i ea n t s e pr rog v e res n t s i ion o n ma u rp ker o n ( CD4 d T<br />

c e l l c o u n t ) a n d s t r e s s-rel a te d perce pti o n in H I V-i n f e c t e d i n d i v i d u a l s<br />

T h e h u m a n i m m d u e n f o i c i e n viru c y s ( HI V), a l e n t i v i r u s o f a s u b g r o u p -vir o f ur s es e t , r o<br />

p r o g r es s i vel y d es tr o ys th e i mmu n e cells, C D -cells 4 T i n p a r t i c u l , a r a n d t h i s to l th e a life- d<br />

t h r e a t e n i n g d i s e e, a s t h ac e q u i r e d i m m u n o d e f i c s yn i e dn ro c me y (A I D S), a n d d e a . Th t h e d ecl in e<br />

o f C D -cells 4 T is kn o wn to b e a s s o c i a t d e with a r i s k o f d e v e l ing o p op p ort u n is ti c infect ion s s u ch<br />

a s P n e u m o c y s t i s c a r in i i p n e u m o n i a o r o e s o p h a g e a l c a n d i d i a a s i s s w e l l a t s h r e i s k o f d e v e l o p i n g<br />

t u m o u r s, p a r t i c u l a r l y th o s e r e l a t e d t o i m m u n e s u p p r e s s i o n , s u t c h Ke ap a s o s i ’s sarco ma or<br />

N o n -H o d g k i n s l y m p h o m . a<br />

Hen ce, H I V i n f e c t i o n m a y b e c o n s i d e r e d t -lon o b g e b ia ol ol gi i cal f e an d p s ych ol og ical<br />

s t r e s s o r, a n d i t i s k n o w n t h a t s t r e s s l e v e l s c o n t r i b u te t d o e t r i m e n t a l e s a o s u s o t c i c a t o e d m w i t h<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 86 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

HIV d i s e a s e p r o g r e [C s s atalan i o n et al ., 1 9 9 5 ; C ol e et al., 2 0 0 3 ; C ole et al., 1 9 9 7 ; C ole et al. ,<br />

1 9 9 6 ] . Th e c u r r e n t p r o j e c t a i m e d t o d e l c r e a s v e e t l h e o f s -i t n f r e c e t s e d s i n ud als i v n i d t h e H I<br />

s o th at t h ei r d i s eas e p rog res s ion can b e d e l a ye d , all owin g th es e in d ivid u al s to mai n tain th ei r<br />

h e a l t h a n d w e l l-b e i n g an d d ela y th e req u iremen t to co mm en ce an ti ret r ovir al d ru g t h erap y an d it s<br />

i n h e r e n t c o m p l i c a t i . o n s<br />

4 .1 . 3. 1 Di s eas e p rog res s ion ma rke r a n d s t r e s -r s e l a t e d p e -i r n f c e c e t e p d t i n i d i v o i n d u a l s i n H I V<br />

C D 4 -c T e l l c o u n ts i n -i H n f I e c V t e d i n d i v i d u a l s , a m a j o r c l i n i c a l p a r a m fo e r t e mr on it ori n g<br />

d i s e a s e p r o g r e s s i o n , i d s e c l k i n o n w e n o v t e r o t h e c o u r s e o f -l t o h n i g s i l n i f e c [d t e i Wol o n f et<br />

a l . , 1 9 9 7 . ] A s t e a d y d e c l i n e i T-c n e l l C c D o 4 u n t s o f 7 ± 3 c pe er l l s l p er m o n t h o ver a 1 2<br />

m o n t hs p e r i p o r d i o r t o t h e i r e n r o l m e n t i n t o t h e s th t e u tot d y al w <strong>of</strong> a s 9 5 H o b I s e V- r v e d i n<br />

i n f e c t i e n d i v i d u a l s [3 .2 .3 .1 ]. Similarl y, H I V-in fected i n d i v i d u a l s wh o are n ot rec eivin g an y<br />

a n t i -r e t r o v i r a l t r e a t m e n ts in ou r w a i t -listed c o n t r o l g r o s u h p o w e d a d e c l i n e -cell i cn ou n tC s D 4 T<br />

o f 1 2 ± 1 7 c e pl er l s l p er m o n t h o ver a f i v -m e o n t h p e r i [ 3 o . d 2 . 2 . 2 . ] T h e s e w e r w e i t h i n t h e<br />

av e r a g e r a n g e o f p u b l i s h e d f i n d i (8 n g s to 1 6 c e l l ps er l p er m on th ) [ d e W l f o e t a l . , 1 9 9 . 7 In ]<br />

t h e c u r r e n t p r o j e c t , t h i s r a t e -cells o f was d a n e a c l y l sed i n e ord er i tn o t h e n u m b e r<br />

d e t e r m i n e i f s t r e s s p e r c e p t i o n h s a with s a tn hy is rat a s e s <strong>of</strong> o c di ecl a t in i e. o n<br />

Th e res u l t s in t h e H I V-i n fected i n d i v i d u a l s s h owed th at o b s e r v a t i o n a l s in gle time p oin t<br />

m e a s u r e m e n t s o f p e r c e i v e d s t r e -o s s f -life , q a u n a d l si leep t y q u al it y d id n ot c o r r e l a t with e th e rat e<br />

o f c h a n g e i n -c e l t l h c e o u n , C t i.e. s D 4 s cores T at on e s in gl e tim e p o i n t d id n ot p r e d i c t or<br />

i n d i c a t e h e r a t e o f c h a n g e i C n D t 4 h -c e e T l l c o u n . t s I n a d d i t i o n , t h e levels c h a n ove g e r th e<br />

s tu d y p eri od in th e P e r c e i v e d S t r e s s S c a l e ( P S S als ) o d i d n o t c o r r e l a t e wi th th e rate <strong>of</strong> d eclin e.<br />

Howev er, th e res u lt s d i d t h s a t h d e o c r w e a s es ove r a f o u r -m o n t h p e r i o d t h i s e n e n s e o f t a k i n g<br />

co n t rol o f o ’s n e o w n l i o r f e i n n e r-p e r s o n a l c o p i n g a ( LoC b i l ), i p t s y c h o l o g i c a l f u n c t i o n i n g<br />

( M C S ) a n d s l e e p q u a l i t y ( P S Q we I ) r e s t r o n g l y c o r r e l a t de e c d l i w n i e in t h t h e<br />

c o u n t s [ 3 . 2 . 1 . 2 . ]<br />

C D 4 -cell T<br />

T h e s e f i n gs d i m n a y i m p l y t h e p o s s i b i l i t y t h l a e t v e ls c h a f o n au g e ton o m y o r at ti tu d es <strong>of</strong><br />

a c t i v e l y b e i n g e n g a g e d i n t , h as e i op r p os l i ed f e to meas u res <strong>of</strong> p as s ivel y e xp erien c ed s tres s<br />

(s tres s p ercep ti on ), ma y b e a s s o c i a t d e w i t h t h e r a t e o f c h a -c n e g e l l i n c t o -h<br />

u e n t C D 4 i T n H I<br />

i n f e c t e d i n d i v i d u . a T l h s i s p o s s ib i l i t y is c o n s is ten t with th e s u gges tion in th e Wh iteh all Stu d y II<br />

[ B o s m a e t a l . , 1 9 9 8 th ] at ‘s e l f -e m p o w e r me n t ’ m ay h a ve b en eficial effe cts o n t a c k l di is n eas g e<br />

p h ys iol o gi cal l y. Fo r t h e p u rp os e <strong>of</strong> e xa mi n in g th is h yp oth es i s th at an in creas e <strong>of</strong> th e s en s e <strong>of</strong><br />

‘s e l f -e m p o w e r m e n t ’ imp rov es ( d e l a s) y d i s e a s e p r o g r in e s s i H o I -i n V n f e c t i o n o r m a i n t a ,<br />

i n s h e a l t h<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 87 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

th e S e n s e o f C o h c e r e (SoC) n [ A n t o n o v s k y , 1 9 8 7 ] ma y b e a go od d om ain to as s es s in f u t u r e<br />

s t u d i e s, b ecau s e t h e S o C i s d e s i g n e d t o m e a e s u a r p o s i t i v e i n n -p e r ers on al coh eren c e wh ich con s is ts <strong>of</strong> th e le vel s o f c omp reh en s ib ility, man ageab ilit y an d mean in gfu ln es s [ 1 . 2 . 3 . 2 . ]<br />

I n c o n t r a s t t o t h e -c a ell n a cou l ny ts s , ti h ere s was o f n o t ren h d e in th C e D level 4 T s <strong>of</strong> th e<br />

H I V v i r a l -c e l l o o u c n a t s d i o n -i r n f e H c I t N e d K V i n d i v i d u a l s ( n o t r e c e i v i n g a n t i-r e trovi ral<br />

t r e a t m e n t ) a cros s t h e five m o n t h s p e r i o d w i t h r e g a r d t o e i t h e r t h e C D 4 g r a d i e n t o r t h e evels l o f<br />

th e p ercei ved s tres s , q u a l -o i t f -li y fe o r s l e e q p u a l i [ 3 t . y 2 . 1 . 2 ]. T h e l e v e l s o f H I V a r v e i r a l l o a d<br />

clin ical l y u s ed to m on it or d i s e a s e p r o g r e s s i o n i n c o m b i n a t i -cell o n w i t h t h e<br />

c o u n t s , a t n d h e ay re u s e d to e x a m i n e t h e r e s p o n s e ti-ret t o ro vi a ral n t reat m en ts , s o t h e viral l oad<br />

levels mi gh t n ot b e a s u i t a b l e o u t c o m e m e a s u r e f o r s t u d su y b j e cts wh o are n ot rece ivin g a n t i -<br />

retro viral t r e a t m e n t . S i -c m i e l l s a r a r l e y k n , o w p l n a an y t l o imp t ort h an o t u rol g e h in N K<br />

d e f e n s i v e m e c h a n i i n f s e c m t s i o n p a r a o n g d r a e i s s n i [F o s a u t c i e t H a I l . , V 2 0 0 , 5 n] o con s is ten t<br />

tren d wa s f o u n d b e t w e e -c n e l l t s h a n e d d n i s u e m a s b e e p r o g H r I o e s f V-i s n i f o ect N n ed K i n<br />

i n d i v i d u a l s, s -c o e l l l e N v K e ls m i g h t a l s n o t b e a s u i t a b l e o u t c o m e m e a s u r e f o r u s t b u j d e y cts. s<br />

C o l l e c t i v e l y, it can b e c o n c l u d e d t h a t t h e r a t -cell e c ou o f n t (C d D4 e c l i n e i n C D 4<br />

g r a d i e n t ) in treat men t n a ï v e H I -in V fected p at ien ts is an imp ortan t an d u s efu l p ractical o u t c o m e<br />

meas u remen t f or th e in ves ti gati on <strong>of</strong> th e effect <strong>of</strong> p s y c h o l o g i c l a in ter ven ti on u p on d i s eas e<br />

p rogres s i on . N o t a b l y, it i s a l s o d e m o n s t r a te d t h a t t h e c h a n g e l e v e l s p o e f r c e i v e d q u a -o l f -life, i t y<br />

w h i c h can b e i n t e r p r e t e d a s t h e attitude c h a n <strong>of</strong> g e act i vel n y b e i n g e n g a g e d i n t h e i life r an d / or<br />

t h e c h a n g e i n s t e h n e s e o f m e a n i n g f u l n , e s m s a y h a v e d i re ct as s oci at i on s with this c h a n g e th i e n<br />

C D4 T-c e l l c o -p u a t n i e t n t . s A c i cor n d in gl H y, I i V m p r o v e m e n t o f t h e -f m ocu e a sn ed i n cop g in g<br />

skills [ 1 . 2 . 3 . 2 ] m a y h a v e b e n e f i c i a l e f f e c t a s n d u w p e o l n l-b e h i e a n g, l an t d h th erefo re it can b e<br />

o f g r e a t i n t e r e s t f o r t h e ect e f f <strong>of</strong> p s ych ol o gi cal in ter ven tion .<br />

4 .1. 3. 2 Th e i n f l u e n e c <strong>of</strong> p s ych ol ogi cal in terven ti on u p on C D 4 -c T e l l s a s di a s e a s e p r e o s g s i o n<br />

m a r k e r i -i n f e c t t e d h i n e d i v i H d I u a l V s<br />

T h e r e s u l t s s h o w e d t h a t, in all th ree g rou p s , t h e r e w a s a s t e a d y d -cell e c l i n e i n t h<br />

c o u n t s b e f o r e t h e s t u d y c o a m n m d e n c t e d h e a b s -c o e l l u c t o u e n t s C w D e 4 r e s i T m i l a r [ 3 . 2 . 3 . 2 ]<br />

Aft er c om men cemen t , th is d e c l i n e o -cells f C c D o n 4 t i T n u e in d c o n t r o l s (t h e w a i t -l i s t con e d trol s<br />

in th e fi ve mon th s s tu d y [3 .2 .2 .2: F i g u r ] e an 4 d 0 th e Dat ab as e con trol s in th e 2 4 mon th s s tu d y<br />

[ 3 . 2 . : 3 . 2 F i g u r ]) e . T 4 h 4 e o n-t r e a t m e n t a n a l y s i h s o w e d t h a t this d e c l i n e r a t e o -cells f C D 4 T<br />

was s top p ed , an d even reve rs ed , in th e H I V-i n f e c t i e n d i v i d u a l s fo l l o w i n g J o h r e i an t r d a i n i n g<br />

p r a c t i c e o v e r t h e f i v e m wh o n ile t h t s h e p r e r i w o a s d n h o a n c g e in t h e elf-h S y p n o s i s g r o u . p Th is<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 88 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

i n t e r e s t i n g d i f f e r s e h n o t w n t r b y e n d t h -t e r e a o t n m e n t a n a l y s i s n t h e f i v e m o n , t hh owe s ver s t , u d y<br />

w a s n o t c o n f i r m e d b y t h -t e o-t I r n e t a t e n a t n i a l o y n s i u s g g e s t i n g t h a t uf tu re s t u ies d exami n in g<br />

this e f f e c t o f J o h r e i will r e q u i r e a l a r g e r s a m p l e s i z e ( m o r e t h a n 8 4 s u b j e c t s p e r e a c h g r o u p )<br />

[ 3 . 2 . : 2 . 2 T a b l e ]. 3 9<br />

Th e red u ct i on i n t h e d ecl i n e <strong>of</strong> th e C D4 T-cells in th e in d i vid u al s in th e J oh rei gro u p m a y<br />

h a v e c o n t r i b u t be oth d pt so ych ol o gi cal a n d p h y s i o ical l o g s tr es s red u ct ion . In ad d it ion to<br />

imp ro vi n g i n d i v i d u a l ’s w e l l -b e i n g, th ere i s b oth an in d ivid u al and econ omic b en efi t in th at an y<br />

red u cti on i n t h e s p eed <strong>of</strong> d eclin e <strong>of</strong> C D4 T-cell c ou n ts will effecti vel y d el a y th e ti me wh en an<br />

i n d i v i d u a l p a t i en t w il l m e n c e o e m x p e n s i v a e n t i-r e t r o v i r a l tr e a t m e n t s. Th is will on l y b e d ela yed<br />

r a t h e r t h a n a , v o i b d u e t d m a y h e l p t o k f e r e o p m a a w a v y i c i o u s o c i f r s c t l r e -in s s d u ced<br />

d etrimen tal ch an ges towa rd s a c c e l e r a t i o n o f t h e d i s c e a s s e towa p r rd o s AIDS an d wi ll d ela y<br />

e x p o s u r e t o t h e t o x i c s i d e e f f e c t s o f a n t i-r e t r o v i r a l d r u . g s<br />

Li mitat ion s h ou ld al s o b e men tion ed . R e c r u i t ing a n d m o t i v a t in g p a r t i c i p a n for t s a<br />

r a n d o m i s e d c o n t r o l l e d t r i a l ( R C is T ) kn o wn to b e ch al len gi n g. W a l k e r s u g g e s t e d i n h<br />

t h a t p erfor mi n g e x p l a n a t o ry an d p ragmati c R C Ts can min imis e th es e p rob lems [ W alker &<br />

A n d e r s o n , 1 9 9 9 ]. I n f a c t , t h e u n i v e r s i t y s t u d e n t s t u d y -ou d i t d rat e n o ut p u nh ta il v e a h i g h d r o p<br />

th e time t h e t rai n i n g s es s i on s were co mp leted . Th is ma y b e d u e to th e fact th at th e cu rren t s tu d y<br />

u s i n g u n i v e r s i t y u s d e n t s e m p l o y e d t h e m o -fe c k ed bn ack e u r so es s ion s as a c on trol con d ition ,<br />

wh ich i s s i mi l ar t o exp l an at or y an d p rag matic trial s in ce th e s ame a mou n t o f ca re an d atten tion<br />

w a s g i v e n t o t h e c o n t r o l i n d i v i d u a l s . in th O e n HIV t h se tu do y, t h th e r c on h a tr n ol d g rou p<br />

s u b j e c t s w e r e r a n d o m l y a s s i g n e d a n d h a d t o w a i t f o r f o u r -ou m t o rn at t e h s , a n d h a d h i g<br />

c o m p a r e d w i t h t h e S e -h l f yp n os is an d J oh rei g rou p s .<br />

F u r t h e r , lth ou a gh th e s tu d y s u b ject s were ran d oml y as s ign ed to th e th ree gr ou p s , actu al<br />

n u m b e r s f o r an t h al e ys es were d if feren t a n d th e nu mb er in th e J oh rei gr ou p was th e s malles t in<br />

t h e -p atien H I t V s tu d y. Th is was n ot a s s o c i a t e d w t i h t e h d -ou r o t p rat e b u t b ecau s e th e n u mb er <strong>of</strong><br />

s u b j e c t s w h o w e r e a s s i g n e d t o t h e g r o u p b u t d id n o t t u r n a r o u n d t h e f i r s t t r a i n ni g s es s ion was<br />

th e larges t i n t h e J oh rei gr ou p . It ma y h a v e reflect ed s ome p s ych olo gical d iffi cu lties in t r yin g a<br />

n o v e l ( o r e v e n s t r a n g e l y s o u n d i n g ) p r o c e d u r e l i k e J o h r e i . T h i s m a y h a v e r e s u l t e d -i<br />

n a s e l f<br />

s e l e c t i w o n i t h i n t h e J o h r e t i o w g a r o d u s p a p lar a r pt ers i on c u al it y t yp e, e.g . op en m in d edn es s or<br />

n ovelt y s e eki n g in th e T e m p e r a m e n t a n d C h a r a c t e r (TC I n v I) e n [ C t l o r n y i n g e r e t a l . , 1 9 9 . 3 ]<br />

Th is p ers on al i t y fact or s h ou ld b e exa min ed in fu tu re in ves tigation .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 89 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Co m p l i a n c e o f u s i n g p r o c e d u r e a f t fo e r th e t sh te u d y t pr eri a i od n i was n g s imila r b etween<br />

J o h r e i a n d S e l -h f yp n os is , b u t wi th regard to coll ection <strong>of</strong> t h e d a t i a n t h -p e a t i e H n I t I s , V t u d y<br />

p a r t i c i p a n t s i n t h e S -h e l yp f n os is gr ou p at ten d ed more s amp le c ollecti on time p oin ts . Th e<br />

a p p o i n t m e n t s f o r t h -c e o l d l a e t c a t i o n s e s s i o n s i n b o t h S -h e l yp f n os is an d J oh rei gr ou p s were<br />

m a d e b y t h e s a m e r e s e a r c h a s s i s t a n t (Mr. B . B e n n e t t wh ) o h ad at ten d ed b ot h in terv en tion<br />

s e s s i o n s . He n c e , th i s m a y i n d i c a t e t h a t i n d i v i d u a l s i n t h -h e yp S e nl f os is gr ou p were mo re<br />

c o m m i t t e d t o t h or e b e s n t e u f d i y t d e m o r e f r o m c o n t a c ts wi th the s t u d y r p s e o n e l (Dr. T .<br />

L a i d et l al. a ) w t h a n t h e J o h r e i p art icip an ts , reme mb erin g th at J oh rei , f or th e m os t p art , was<br />

p erfor med wi th a p art n er. N o n e t h e l e s s , a n e cau x t r ti a on s h ou ld b e gi ven wh en th e p s ych ol ogical<br />

effect fr om t h e res u l t was d i s cu s s ed . On e p roced u re to ov erc ome th i s b ias i s to u s e th e meth od<br />

<strong>of</strong> t h e I n t e n -t t o-treat i o n an al ys is as ap p li ed in th e cu rren t s tu d y.<br />

Al t h o u g h t h e r e r limitations, e m a i n t h e s e i n v i v s o t u d i e s d e m o n s t t h a r t : a t e d<br />

A c a d e m i c e x a m i n s a t i c a o i n<br />

n d u c e s t r e s s i n u n i v e r s i t y s t u d e n ts [ 3 . 1 . 1 . 1 ; ]<br />

N K -c e l l f u n c t i o n a p p e a r e d t o b te e d a wit s s o h c si ta res s p ercep ti on in u n ivers it y<br />

s t u d e n t s [ 3 . 1 . 2 . 1 ; ]<br />

P s y c h o l o g i c a l i n t e r v e n t i -s t o r e n s s-i n d um ced a y c o u n t e r<br />

l o s s -c e o l l f p e r c N e n K t a g e i n u n i v e r s i t y s t [ u 3 d . e 1 n . t 3 s . 1 : F i g u r e 2 ; 6 ]<br />

P s yc h o l o g i c a l i n t e r v e n t i o n , p a r t i c u l a r ly J oh rei, ma y s l ow th e d is eas e p ro gres s ion i n<br />

H I V-i n f e c t e d p a t i e n [ t 3 s . 2 . 3 . 2 : F i g u r e 4 ; 3 a ] n d<br />

I m p r o v e d p e r c e i v e q d u a l -o i t f -life y s c o r e s a r e n e g a t i v e l y a s s do is c i eas a t e e d w i t h<br />

p r o g r e s s -i i n f o e c n t e d p i a t n i e n [ t 3 H s . 2 I . 1 V . 2 : T a b l e 3 , 0 an ] d J oh rei ap p eared to i m p r o v e p e r c e i v e d -o q f u -l a l i f i e t s y c o r e s [ 3 . 2 . 2 . 1 : T a -3 b 7 l ] . e s 3 5<br />

Th e s e f i n d i n g s u pp ort th e h yp ot h es is th a t p s ych ol ogi cal in terv en tion m a y alle viat e th e<br />

d etrimen tal effe ct s <strong>of</strong> s tres s u p o n w e l l -b e i n g; a n w d a r r a n t t h e n e e d o f f u r t h in e r ves ti gat ion on<br />

the ps y c h o-n e u r o-e n d o c r i n -i o m mu n e n et wor k, p a r t i c u l th a r e l in y fl u en ce <strong>of</strong> J oh rei u p on th e<br />

n e t w o r .<br />

k<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 90 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4 .2 S t r e s s h o r m o n e a s s o c i a te d c ha ng e s i n v i t i r i mmune o n c e ll s a s a n e x e m p l a r o f<br />

the p s y c h o-n e u r o-e n d o c r i n -i o m m u n e n e t w i o n r t k e r a c t i o n<br />

Th e s t u d i e s u s u i n i n v g e r si t y s t u d -i e n f e t c t d s e p a t i e a n t s n d e m o n H s t I r a t V e d t h a t<br />

p s y c h o l o g i c a l s t s r e as ffect ed in vi vo d i s t r i b u t i o n o f<br />

i m m u n e c e l l -c s e l l i s n -cells. c a l n d u d T i n g N K<br />

Th e r e h a s b e e n g r a o w i n g b o d y o f e v i d e n c e w h i c h s u g g e s t s t h a t c o r t p i s a o r t l i c ( u l a rly i n t e ract i on<br />

with t h e g l u c o c o r t i c o i d t y p e r I I e c e p t o r ) m a y p n l i a m y p o a r t a n t r ol e in s t r e s -in s d u ced ch an ges<br />

[ B a u e r e t a l . , 2 0 0 3 in ] b oth l ymp h oc yt e d is tri b u tion [ D h a b h a r e t a l . , 1 9 9 6 a ] n d i m p a i r e d c e l l-<br />

med iat ed res p on s e [ B a u e r e t a l . , 2 0 0 . 1 ]<br />

H e n c e , th e e f f e c t s o f s t r e s s h o r m o n o e s r t ( i c s o l i n p a r t i c u l a r ) im u mu p o n e t cel h e l s were<br />

in ves ti gat ed i n v i t i r n o o r d e r t o e x a m i n e i f an t y h de r irect e a ir ne teract ion s b et wee n th e s t r e s s<br />

h o r m o n e s a n d h ich i m c o m u l u d n f e u n c t c i o e n a l l y s d e m o w n a s t p r a a r t e o the f p s y c h -n o e u r o-<br />

e n d o c r i n -im o mu n e n et work .<br />

T h i s a p p r o a c h c o n s i s te d o f t w o s e r i e s o f e x p e r i m e n t s : ( 1 ) a n i n v e s t i o g a f t i o -c n N ells K an d<br />

(2 ) a n a n a l y -cells s i s . Th o e f fu n ct T ion al p arameters in c e l l u l a r i ity m m [ R u o n s e , 2 0 0 2 ], wh ich w e r e r e p o r to t e d e c r e a se u n d e r s u s t a i n e d s t r , e s i s n c l u : d e<br />

1 . Cy t o t o x i c a c t i o v i f t -c y e N l K l s a n d / o r -cells c y a gai t o n s t to arget x i c cel ls T (t u m ou r<br />

cells an d vi ral l y i n f ect ed cel ls ) [ B orella e t al., 1 9 9 9 ; Gru zelier , Smith et al., 2 0 0 1 ;<br />

I n o u e-S a k u r a i e t a l . , 2 0 0 0 ; M a e s e t a l . , 1 9 9 2 ; P i k e e t a l ; . an , d 1 9 9 7 ]<br />

2. T-l y m p h o c y t e p r o l i f e r a t i v e r e s p o g n e s n , e s a s t u p o e r-an a ti gen m i t or o s p eci fic<br />

an tigen s [ S i l b e r m a n e t a l . , 2 0 0 . 2 ]<br />

Hen ce, in th is p roj ect , th e e ffect <strong>of</strong> i n v i t e x r p o s u r e t o t h e s t r e s s h o r m o n e ( c o r t i , s o in l )<br />

t h e u p p e r p h y s i o l o g i vc els a l an l d e for m o re th an 2 4 h ou rs , u p on th e NK c yt ot oxic activit y a n d<br />

t h e -l y T m p h o c y t e p r o l i f e r a t i v e r s e were s p o n is ne ves ti g at ed .<br />

4 . 2 . Cha 1 ng es in NK-cells a fter in vitro i n c u b a t i o n<br />

U s i n g p e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s ( P B M C s ) , (N N K K C A c ) y lev t o el t o x i c a c t i v i t<br />

was i n v e s t i g a t e d b y u s i n g t h e -R G a o m d i o y r e z ’ s f l o w c y t o m e t [G r y o d m o e y-R t ami h o d rez et al .,<br />

2 0 0 0 ] t o o b t a i n a p i l o t r e s u l t , a n d t h e n e x a m i n e d b y u s n i g t h e C y t o T ® o x 9 wh 6 ich meas u res an<br />

amou n t <strong>of</strong> r e l e a s ed L a c t a t e d e h y d r o g e n a s e ( L D H ) f ro m th e d ead cel ls . T hese tw o d ifferen t s ets<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 91 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

<strong>of</strong> res u lt s fro m th e tw o a l t e r n a t i v e t h m o e d s <strong>of</strong> me as u ri n g N K C A l e v e l pr s o v i d ed a mo re<br />

c o m p r e h e n s i v e a c c o u n t.<br />

4 . 2 . 1 . N 1 K c y t o t i o x c a c t i v i t y ( -c N e l K l C p A r ) o f i l ae l fter s e in v cu e b at l ion s o f Pa B MC n d s N K<br />

for 2 4 ho u rs i n v i t r o<br />

NKC A l evel s we re s h own t o i n c r e a s e a f t e r i n c u b a t i o n o f P B M C s f o r 2 4 h o u r s a n d t h i s<br />

i n c r e a s e d l e v e l w a s s o c i a t e d w i t n c h r e a s n e d l e v e l s o f t h e p -N e r K -c e l l c yto t o x i c a c t bi uv t i t y<br />

n o t t o a n i n c r e a -c s e l l e s u b si et [ n C o o p c e r y , F t e h o n i t g e r o & x i C a l c i g i u r N i , K 2 0 0 1 n ] um b e r s.<br />

T o m i n i m i s e t h e p o s s i b i l i t y acti o f vat ion cau s ed b y an in teracti on b etween an tigen<br />

p r e s e n t a t i o n -cells c e dl u ri l n g s th e 2( 4 hA ou P rs C i ) n v a i t n i r d n o c u b N a t K , i mon o n oc yt es w ere<br />

r e m o v e d f r o m P B M C s b y c u l t u r i n g f o r 1 h o u . r P r i e n v i sa o l y, u p Nl KC a s t A i level c f wl as a s k<br />

r e p o r t e d t o -c b e l l h s i u b s g e h t e a r d h e r i e d n t o t p l h a e s t i N c K f l -ad a s hk eren s t h a n i n t h e n o n<br />

N K -c e l l s u b s e t w h e n -2 i , n c a u n b d a t h e s d e w t i w o t -s h ets N K exp I s L res u b s d iffe ren t<br />

ch emoki n e recep tor p ro fi les [ I n n g j e r d i n g e n e t a l . , 2 0 0 . 1 ] T h e P B M C ps rep ared wi t h th is m o n o c y t e d e p l e t i o n p r o c e d u r h e a v s e h r o em u o l v d e d t h -c e l l N K s u b s e t a d h e r e d t o flas p l ks a s t i c<br />

a s w e l l a s m o n o c yt e s , b u t p e r -N K -cell c ytoto xic acti vit y was in creas ed in th e cu rre n t s tu d y, s o<br />

th is s u gges ts th at th ere were oth er f a c t o r s w h i c h c o n t r i b u t e t o t . h e i n c r e a s e<br />

N K -cel ls are ri ch in t h e i r s u rf a c e r e c e p t o r w s h i c h c o n v e y in h ib it ion o r a c t i v a t i o n s i g n a ls<br />

[ M i d d l e t o n e t a l . , 2 0 . 0 Th 2 ] e Nkp 4 6 i s n as k a n m o a i w n a c t i v a t i o n s i g n a l f or th e c ytoto xic<br />

l y s i n g a c -cells, t i n v a m i e l t y t y h e N o a t f u r a l C N y K t o t o x i c R e c e p t o r ( N [Sp C R a) ggi ari et al . ,<br />

2 0 0 1 ] , an d t h e exp res s i on <strong>of</strong> th is rec ep tor was s h own to in creas e afte r th e in cu b ation alth ou gh<br />

t h e e x p r e s s i o n o f t h e o t h e r N C R , t h e N k p . 3 Hen 0 , ce, w a th s e in n creas o t ea d f lf evel e c t s e o f d th e<br />

p e r -N K -cel l c yt ot o xi c a c t i v i t y a f t e r t h e i n c u b a t i o n c o u l d b e o n a c c o u n t o f :<br />

1 . In cre as i n g t h i s Nkp 4 6 activation s ign als ; an d /or<br />

2. De c r e a s i n g e f f e c t s o f i n h i b i t o r y p r o c e s bs y e oth s er o f u nt id h en e ti fi a ed c t i v a t i o n<br />

f a c t o r s.<br />

On e p o s s i b l e d e c r e a s i n g i n h i b i t o r y e f f e c t i s o val t <strong>of</strong> h en e d ogen r ou e s m h u moral<br />

s u b s t a n c es ( s u c h a s s t r e s s h o r m o n e s p) rep i arat n t ion h e fo r i n v i in t cu r o b at ion . Th e p las ma<br />

s ep arat ed fro m t h e P BMC s was r ep laced b y a cu ltu re med iu m with a o n e -tenth, lo w<br />

c o n c e n t r a t i oetal o n Co al f S eru F m wh ic h con tain s little o r n l o e v e l s o f e n d o g e n ous cort is ol.<br />

Th e h yp ot h es i s t h at t h i s rem ov al o f en d o gen ou s cortis ol cau s es th e activati on in th e levels <strong>of</strong><br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 92 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

p e r -N K -cel l c yt ot o xi c act i vi t y an d th e ex p res s ion <strong>of</strong> th e N kp 4 6 (an d Nkp 3 0 ) was in ves tigated in<br />

th e foll owi n g exp eri men t s .<br />

4. 2 . 1 . C 2 o r t i s o l -i n d u c e d c h a n g e s i -c n e l l p N r K o f C i A l e s l e v e l s a n d N K<br />

C o r t i s o l w a s s h i o w n h n i b t i o t t h e i n c r e a s p e e r-N o f K t -c h e l l c y t o t o x i c aa ft c er t 2i 4v hi rs t y<br />

i n c u b a t i o n o f P B M C s a n d this inh ib ition <strong>of</strong> th e i n c r e a s e was s h own to b e a s s o c i a t ed with an<br />

i n h i b iti on <strong>of</strong> t h e e x p r e s s i o n o f th e N k p 4 6 ( a n d a l s o w i t h t h e o f i t n h h e i N b k i p t 3 0 i on ) o n th e<br />

c y t o t o -cell x i s uc b s et s . N H K o w e v e r , t h e s e i n h i b i t i o n s o f t h e i n c r e a s e i n t h -N e K p -cell e r<br />

c y t o t o x i c a c t i v i t y w e r e n o t f u l l y a c h i e v e d ir i n a t m e r p m l s i o f t u h e d an e d Nkp o 4f 6 N K C A<br />

e x p r e s s i o n . T h i s a g a i imp n lies th at th ere m a y b e o t h e r c on trib u tin g facto rs .<br />

R ecen tl y, i n v i s v t o u d i e s u s i n g m i c e ( c . f . g l u c o c o r q t u i c v o a i l e d n t i h or s mon t h e ie n mi ce<br />

to co rti s ol in h u man ) h ave s h own th at glu coco rticoid r e s i s t a n c e c a n u c b e d i b sn y ocial d<br />

d is ru p ti on s t res s (i .e. rep et i t ive d is ru p tion s b y in s ertin g in tru d ers in to a ca ge to s tre s s mice)<br />

[ A v i t s u r e t a l . , 2 0 0 1 ; Q u a n e t a l . , . 2 0 0 T 1 h ] i s g l u c o c o r t i c o i d r e s i s t a n c e b e w a s r e p o r t e d t o<br />

a s s o c i a t d e w i t h t h e e r d u c e d f u n c t in i o the n gl u coc ort ic oi d recep to r in th e C D 1 1 b pos itive<br />

m a c r o p h a g e s ( i . e . o n e o f m a j o r a n t i g e n p r e s e n t a t ; i C o D n 1 c 1 e b l l i s p a r t o f t h e ’ c e l l s<br />

i n t r a c e l l u l a r a d h e s i o n m o l e c u l e s w h i c h a r e e x p ) r in e as s s oci e d at u io p n o n wi ta h c t h ei i r v a t i o n<br />

i m p a i r e d n u c l e a r an t r s locat i on <strong>of</strong> gl u coc o rt icoi d recep t or an d th e lack o f tran s crip ti on al<br />

s u p p r e s s i o n -k B o f b y g N l F u c o c o r t i c w o h i e d n -cells N K in ter act wi th th e ma crop h ages [Qu an et<br />

a l . , 2 0 0 3 . ] It is th eref ore s u g ges ted th at m o n o c y t e d ep letion cau s e a re mo val <strong>of</strong> th e C D1 1 b<br />

p os itive ma crop h ages res u lt in g in a d ecre as e in th e i n h i b i t o r y p r o c e s s e s o f t . h e a c t i v a t i o n<br />

It i s w e l l-k n o w n t h a h t a r m p a c o l o g i c a l le v el s <strong>of</strong> c ortis ol af fect gen omi c man ifes tati on s in<br />

N K -c e l l s , f o r e x a m p l e , t h e ol f e th v e l G s r a n z y (a m maj e or A c yt ot o xi c mol ecu le c on tain ed in<br />

t h e cy t o p o l f a N -c K s e l l m s) h a v e b e e n re p o r t e d t o b e -cells r were e d exp u c os ed e d to w h e n N K<br />

t h r e e M <strong>of</strong> c ort is ol [ Z h o u e t a l . , 1 9 9 . 7 ] H o w e v e r , t h e r e a i l s s a o g r o w i n g b o d y id o f en ce e v<br />

wh ich h as d e m o n s t r te a d t h a t t h e r e a l r s e o n -g n e n o m i c c o r t i s o l e f f e c s t u s c h a s i t r h e c t d -n<br />

o n<br />

s p e c i f i c n o n-g e n o m i c s t e r o i d th a rc ou t gh i o h n i g h-a f f i n i m t e y m b r a n e-b i n d i n g s i t , e i.e. s c ort is ol<br />

c a n a f f e c t t h e a -k c B t via i v s i t e y r o -m i o d e f m b r N a F n e i n r t a c e t i o n s w i t h o u t i n v o l v e m e n t <strong>of</strong> th e<br />

gen omi c co rt is ol r e c e p t o r in th e n u cleu s [ F a l k e n s t e i n e t a l . , 2 0 . 0 Alth 0 ] ou gh th es e were b as ed<br />

on th e ob s ervat i on s wh en cortis ol was gi ven in p h armacol ogical d os e, th ere re mai n s a<br />

p o s s i b i l i t y t h a t t h e s e g e -g n o e m n o i m c i c a n m d e c n h o a n i s m s o f c o r t i s o ls l o bm e a iy n vol a ved in th e effect cau s ed b y t h e u p p er levels <strong>of</strong> p h ys iol ogi cal d o s a g e o f c orti s ol s h own in th e cu rren t<br />

s tu d y.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 93 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e s e p os s ib le con tri b u ti n g factors remai n to b e e l u c i d a t e d i n t h e f u t u r e i n , v b e u s t t i g a t i o n<br />

th is s eri es o f e x p e r i m e n t s c o n c l u d e d t h a t u p p e r p h ys iol ogi cal le vel o f c ortis ol can s u p p r e s s p e r -<br />

N K -c e l l c y t o t o x i c a c n t d i N v i k p t 4 y 6 e x p r e . s s i o n<br />

4 . 2 . 1 . E 3 n d o g e n o u s l e v e l s o f s t -S) r e an s d N s K C A h o r m o n e s ( c o r t<br />

T h e o t h e r p r o p o s e d s t r -as e s s oci at ed h or mon es , i .e . D H E A -S a n d m e l a t , o are n i k n own to b e an tagon i s t i c agai n s t t h e s u p p res s ive ef fects o f co rtis ol u p on l ymp h oc ytes as d es crib ed in th e<br />

i n t r o d u c t i o n [ 1 . 2 . 2 . 3 a n d 1 .2 . 4 . 2 ] , b u t ht e res u lt s d e m o n s t r a t ed th at th ere was n o s i g n ifican t<br />

r e l a t i o n s h i p b e t w e e n e n d o g e n o u s l e v e l s o f -a s s t o r c e i s a s t e d h o r m o n e an s d th e NKC A le vel s<br />

b e f o r e t h e i n c u b a t i o n o f P B M C s . H o w e , v th e r ere ap p eared to b e p o s i t i v e r r e c l o a t i o n bs etween<br />

e n d o g e n o u s l e v e l s o f s t -a r e s s s o c i a t e d h -S o an r d mel m o at n on e in s ) an d ( th D e NH KC E A<br />

l e v e l s a f t e r 2 4 h r s i f n r c e u e b a t f i r d o o m n g e n e o n u s h o r m o n e s.<br />

This fin d in g was h yp ot h es is ed to b e a s s o c i a t e d w i t h t h -S e l o n g t<br />

a n d m e l a t o -cells n i n b al an u ce p o wi n th a sN u pK p res s ive effect <strong>of</strong> c ortis ol . In ot h er word s ,<br />

t h e d i f f e r e n c e b e t w e e n t h e s e N K C A l e v e l s m iated a y wi b e th a ts hs e o sc tage <strong>of</strong> al ar m to<br />

r e s i s t a n c e a n d th e s tage <strong>of</strong> exh au s tion in S e l y e’s clas s ificati on [1 . 2 . 4 ]: . 1<br />

N K -cel l s wi t h h i gh N KC A le vel a fter 2 4 h ou rs in cu b ation (with h igh levels <strong>of</strong><br />

D H E A -S an d mel at on in ) ma y b e mixtu re <strong>of</strong> N K -cells in a s ta ge <strong>of</strong> a l a re a r c t m i o n<br />

an d res is tan ce w h e r e c e l l s a r e a b l e with t o b ot r e h s act p o in vat d ion an d in h ib ition<br />

fro m th e vari ou s fact o rs i n cl u d in g h ormo n es , s o th e y can b e acti vated wh en va riou s<br />

inhibi t o r y f a c t o r s ( i n c l u d i n g e n d o g e n o u s c o r t i s o l ) w e r e r e m o v e d ; a n d<br />

N K -c e l l s w low i t Nh KC A le vel a ft er 2 4 h ou rs in cu b ation (with low le vels o f<br />

D H E A -S an d mel at on i n ) ma y b e N K -cell s in an exh au s ted s tage, s o th e y can n ot<br />

res p on d .<br />

Th is h yp ot h es is can b e s u mmaris ed an d p arap h ras ed b y s t a t i h a n t g th e s u p p res s ive effects o f c o r t i s o l u p o n K-c e N l l s i s c o u n t e r : a c t e d b y<br />

D H E A -S: a n o t h e r m a j o r a d r e n o a x c i s; o r a n t d i c a l h o r m o n e<br />

Me l a t o n : i a n m a j o r h o r m o n e as s oci at ed wi th s leep in th e c i r c a d i a n rh y t . h m<br />

In o r d e r t o t e s t t h i s h yp o t h e s i s , t h e d i u r n a l p a t t e r n i n t h e l e v e l s o f t h e s e h o r m o n e s ogeth t er<br />

with cort i s ol an d d i u rn al ch an ges in th e levels o f N KC A b oth at Tim e 0 an d 2 4 h ours after in<br />

vitro in cub at ion w o u l d n e e d t o b e e x a m , an i n d e t d h e n t h e a s s o c i a t i o n th ese<br />

b e t w e e n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 94 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

comb in at ion s w o u l d n e e to d b e an al ys ed in fu tu re in vitr o s t u d i e s i n v e s tigatin g th e effect <strong>of</strong><br />

s t r e s s-a s s o c i a t e d h -cell o r s . m o n e s u p o n N K<br />

N o n e t h e l e s s , t h e r e s u l t s s u p p o r t t - h e d i r e c<br />

c e l l s a s a p a r t o f -n e t u r h e o-e n p d s o y c r h i o -i n o mmu n e n et wo rk.<br />

4 . 2 . Ch 2 a n g e s -cells i n a f t T e in r vitro i n c u b a t i o n<br />

O n e o f m a j o r f u n s c t o i f o -c n e l l T s in s e l f-d e f e n c e i s t h e a p b r i o l i f i e r t a te y an t d o ge n erat e<br />

a p p r o p r i a t e c e l l p h e n o t y p e s w h i c h h a v e s a p e f c f i f i n i c a g t a y i n s t a s p e c i f i c a n t i g e n . O n e m e t h o d<br />

u s e d t o m e a s u r e t h i s a b i l th i e t [ y h a s b e e n<br />

3 H ] -t h ym i d i n e i n c o r p o r a , t roli i p o n ferat i v e T-c e l l<br />

res p on s e as s a y [ W e y t s e t a l . , 1 9 9 b7 as ] ed on th e fi n d in gs th at in vitr o stimulation with a<br />

m i t o g e n , s u p e -a r n t i g e n o r s p e c i f i c -c e a l n l t s i r g e s u n l s t i a n g c t i i n v [ p a An r t o tia l e i et s f e r T a t i o n<br />

a l . , 2 0 0 3 ; K a e c h & A h m e d , 2 0 0 3 ; S e d e r & A h m e d , . 2 0 0 3 ]<br />

It i s w e l l-kn own t h at p h armac olo gical le v els <strong>of</strong> c ortis ol ( or glu coc ortic oid s ) can s u p p res s<br />

th e p rol iferat i ve res p on s es <strong>of</strong> h u man cells [ H e t t m a n n s p e r g e r e t a l . , 1 9 9 . 3 In ] th e cu rren t s tu d y,<br />

t h e p pu er ph ys iol ogi c al lev el o f c ortis ol ( 2 5 0n M) was als o s h own t o s u p p r e s s T-cells’<br />

p roliferat i ve res p on s es a g a i n s t m ito gen , s u p er an tigen an d recall a n t i g e n s, a n d e x p r e s <strong>of</strong> s i o n<br />

t h e i r c e l l-s u r f a c e m a r k e r s w e r e con m e cu a s rren u r e tl d y in o rd er t o in ves tigat e th e p os s ib le s ites<br />

<strong>of</strong> th e s u p p res s i ve effe ct s <strong>of</strong> co rtis ol.<br />

4 . 2 . 2 . E 1 x p r e s s i o n o f C D 2 5 d u r i n g p r o l i f e r a t iv e r e s p o n s es<br />

Th e p rol ifer at ive res p on s e i n -l ymp T h oc yt es con s is ts <strong>of</strong> f ou r p r oces s es : (1 ) r eco gn ition <strong>of</strong><br />

a s timu l u s ; (2 ) act i vat i n g cel l c ycle p r ogr es s ion ; (3 ) p roces s <strong>of</strong> actu al c ell d ivi s ion ; an d (4 )<br />

ap op tos i s <strong>of</strong> e xces s i ve cel l s . W i t h i n t h i s p r o c e s s , t h e f o l lowin g tw o p os s ib ilities for s u p p res s ive<br />

e f f e c t o f c o r t i s o l o n t h e p r o l i f e r a t i v e r e s p o n s e s w e r e : i n v e s t i g a t e d i n t h e<br />

1 . D e c r e a s i n g a c t i v a t i o n , a n d<br />

2 . In cre as i n g ap op t os i s .<br />

Fl o w c y t o m e t r y t e c h n i q u e h a s b e e n i n t r o d u c e d t o i s e m x s a <strong>of</strong> m i n e t h e m e c h a n<br />

p r o l i f e r a t i v e r e s p o n u s s e s i n g s o m e maj o r cel l s u rface acti vation mar kers , i.e. C D 6 9 , C D 7 an 1 d<br />

H L A -D R , b u t i t w a s s h o w n t h a t o t f h t e h e s e x p m r a e r k s e s r can i o n ot b e al t ern at ives to P h . D . a t U n i v e r s i t y o f L o n d o n - 1 95 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

reflect th e le vel s <strong>of</strong> p r ol ifer ation in c o m p a r i s o n w i t h e h m e t h o d u s in g th e [ 3 H ] -t h ymid in e<br />

i n c o r p o r a t [ i C o a r n u s o e t a l . , 1 9 9 7 ; H u t c h i n s o n e t a l . , 1 9 9 9 ; R u t e l l a e t a . l . , 1 9 9 9 ]<br />

I n t e r l e u -2 k i ( n I L 2 ) i s k a n s o w a n m a j o r c y t o k t i o n e i n -cell d u c p rol e if erat T ion b y b in d in g<br />

w i t h t -2 h e r e c I e p L t o r , i . e . C D 2 5 , -C D2 a n d 5 in t teract h i s ion I L is 2 al s o kn own to b e es s en tial<br />

f o r -cells T t o p r o l i f e r a t e w i t h o t h e r stimuli c y t o k i [ M n e a l e k e t a l . , 2 0 0 . 1 He ] n c e , o n e o f th e<br />

a b o v e h y p o t h es es o f s u p p r e s s i v e e f f e c t s o f c o r t i s o l u p o n p r o l i f e r a t i v , e th r at e s cort p o n i s se ol s<br />

d e c r e a s e s a ati c t on i pv roces s o f -l y T m p h o c y t e s, w a s t e s y t e x d a m b i n i n g t h e l e v e l s o Cf D2 5<br />

e x p r e s s i o n t h e c e l l s u . r f a c e<br />

T h e e x p r e s s i o n o f C D 2 5 i n t h e c u r r e n t s t u d y s h o w e d a d r a m a t i c i n c r e a s e 4 8 a f ht ou e r rs <strong>of</strong><br />

i n c u b a t i o n w P HA i t h o r P P D , b u t this i n c r e a s ed r a t e w a s a g a i n n o t d ec reas ed b y th e<br />

p h ys iol o gi cal level <strong>of</strong> co rt is ol. He n c e , a l t h o u g h th e p o s s i b i l i t y o f i m p a i r m e n t i n o t h e r a c t i v a t i o n<br />

m a r k e r s o n t h e c e l l s , u r f a c s e u c h -DR , a is s ti ll tH o L b e A e x a m i ne d i n f u ture e x p e r i m e n t , s it<br />

a p p e a r s that th ere ma y b e an oth er u n id en tified m e c h a t h n a t i h as s a m g r e a t e r i m p a c t on th e<br />

s u pp res s i ve effect o f c ort i s ol in p r olifer at ive res p on s es .<br />

4 . 2 . 2 . Exp 2 res s ion o f C D 9 5 an d An n exin V d u r i n g p r o l i f e r a t iv e r e s p o n s e<br />

P r e v i o u s l y i n t h e l i t e r a t u r e , t h a i t a l w t a e s r i r n g e p t o r h e t e ol d rtis e v e ol l in o f ca rp c<br />

l ymp h oc yt es wa s as s oci at ed w i t h in a n cre as e in ap op tos is d u ri n g th e p roliferati on r es p on s e to a<br />

mito gen (P HA) an d a s u p e r -a n t i g e n s u c h a s l i p o p o l y s a c c h a r i d e ( L P [W S ) e y t s e t a l . , 1 9 9 . 7 In ]<br />

t h e i r s t u d y , t h e r a t e o f a p w o p a t s o s m i s e a s u r e d t b h y e m e t h o d u s i n g T t d -med h T e i at ed d UTP<br />

n i c k e n d l a b e l l i n g ( T U N E L as ) s a y, s o th e act u al ap op tot ic p r oces s in a n u cleu s was d etected an d<br />

t h e a m o u n t o f a p o p t h o a t n i g c e s c w a s m e a s . u r e d<br />

Ap op tos is i s k n o w n t s o t a e r i t h t e r th e c f e l l -s r u o r f m a c e m e c h (e.g a n . a i c as s cad m e<br />

in d u ced b y C D 9 5 / F a s an d C D 9 5 L/ F a s-l i g a n c d o n t a c t s) o r th e c yt op las mi c m ech an is m (e. g.<br />

m i t o c h o n d r i a re l e a se s th e c y t o c h r ; o a m e g e n o C m i c c a s c [ a B d e d n e r e t a l . , 1 9 9 9 med ] iat ed b y<br />

B a x c o m p l e x e s w i t h i n n a u c l e u s). F o r t h e p u r p o s e o f d ap e op t e tot c t ic i ch n g an ge on th e cel l<br />

s u rface, a met h od u s in g An n exin V wh ich can b i n d t h e p h o s p h a t i d y l s e r hi as n e b een d e v e l o p ed<br />

[ v a n E n g e l a n d e t a l . , 1 9 9 . 8 P ] h o s p h a t i d y l s e r i n e i s o n e c o m p o n e n t t o h f e c e l l-m e m b r an e an d it is<br />

l o c a t ed i n s i d e t h e memb ran e in live cells ; an d it comes ou t s id e <strong>of</strong> th e memb ran e w h en th e cell<br />

d i e s a n d l o o s e s t h i s t i g h t c o n t r o l.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 96 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t h e c u r r e n t s t u d y , s h a r p i n c r e a s e s i n t h e l e v e l s on o f th e t h e C D 9 5 ( F a s ) e<br />

s u r f a c e o f C D 4 a n d 8 T-c C D e l l s were ob s erved aft e r 2 4 a n d 4 8 h ou rs i n v i in t cub r o at ion wi th P H A o r P P D , b u t t h e p h y s i o l o g i c a l l e v e cl ortis o f ol d id n ot in fl u en ce t h e s e in creas es . Fu rth er ,<br />

t h e p h y s i o l o g i c a l l e v e l o f c o r t i s o l d i d n o t a f f e c t t h e l e v e l s o f A n n e x i n V o n t h ace e c afte e l l r s u r f<br />

4 8 h o u r s i n c u b . a Hen t i o ce, n it was c on cl u d ed th at cortis ol d id n ot alter ap op totic c ell s u rface<br />

c h a n g e s o n p r o -l l ymp i f h oe c yt r es a . t In i ord n g er t o T c on fir m th e ap op totic ch an ge b y th e<br />

p h ys iol o gi cal level <strong>of</strong> c o r t i s o l f u r t h e r , t h e T U N E L a s s a y n e e t d s o b ed e . p e r f o r m<br />

O n t h e o t h e r h a n d , i n t h e ortis n u c l ol e u h s a s , b c e e n s h own to inhibit th e N F - B acti vation<br />

[ B a r n e s , 1 9 9 7 ] an d to in du ce a n e a r l y G1 p h a s e b l o c k i n c e l l-c y c l e ( G 1-S-G 2 -M ) p r o g r e s s in i o n<br />

a tu mou r cel l li n e [ S a n c h ez e t a l . , 1 9 9 3 res ] u lti n g in d el a y <strong>of</strong> th e c e l l d i v . i T s h i e o p n r o c e s <strong>of</strong><br />

a c t u a l c e l l d can i v i b e s m i e o a n s u r ed b y th e met h od u s in g carb o x yf lu ores cein s u cci n imid yl es ter<br />

( C F S E ) [ L y o n s , 2 0 0 0 ], i n w h i c h l e t v h e e l o f in ten s it y <strong>of</strong> th e C FS E can b e meas u re d in th e<br />

s t a i n e d c e l o l f s t h c e y t o an p d l this a ls ev el m h al ves wi th each cell d ivis i on . Hen ce, fu tu re<br />

i n v e st i g a t i o n o n e f t f e h c e t o f c o r t i s o l u p o n T-l y m p h o c y t e s s h o u l in d clu d e t h i s c e l l-c ycl e<br />

p r o g r e s s i o n a n a l y s i s i n a d d i t i o n t o t h e f u r t h e r a n a l y s e s o f a p o p . t o t i c c h a n g e s<br />

N e v e r t h e l e s s , th e p h ys i ol ogi cal level <strong>of</strong> c ortis ol was s h own to s u p p res s h u man T-c ell s<br />

p r o l i f e r a t i v e r e s p o s. n T s h e i s m a y o r m a y n o t i n c r e a s e a p o p t o s i s , b u t i t n h c i r s e a p o s e s d i b l e<br />

ap op tot i c ch an ge b y c ort i s ol was n ot d etected th rou gh th e ch an ge on th e cell s u rf ac e.<br />

Th e s e i n v i e x t p r e o r i m e n ts d emon s trat e t h e feas ib ilit y <strong>of</strong> th e en d o c r i n -i o m m u n e etwor n k.<br />

Th e in v i t m r o d e l o f s t r e s s w a s s h o w n t o s u : p p r e s s<br />

N K -cell f u n c t i , o i n . e . p -N e r K -c e l l y t c o t o x i c a c t i v i t y t o t u m o ; r a c n e d l l s<br />

T-c e l l f u n c t , i .e. o n p r ol ifer at ive res p on s e to s u b s tan ces related to in fecti on .<br />

In ad d it ion , D H E A -S ( i n a oco d r e rtical n h o rm on es ) an d melat on in (in h orm on es<br />

as s ociat ed wi th ci rcad ian regu lati on ) ma y h ave a n t a g o n i s t i c a s s o c i a t i ao gain n s s t co rt is ol as<br />

s h o w n b thei y r e f f e c t s N -c K o e l n l f u n c t . i o n<br />

T h e s e supp ort that t h e r e i s a d i e e r n e h o c r m t o n e s r ( e c o l r t a i s t o l rt i , icu o i lar, n s p a h i p b e t<br />

a n d D -S H E A a n d m e l a t o n i n ) -c e a l n l d s -l ymp i a n m d hm oc u yt T n es e ) an d c d emon e l sl trate s ( N K<br />

p os s ib le in teract ion wi th in the p s y c h -n o e u r o-e n d o c r i n -i o mmu n e n et wo rk.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 97 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4.3 C o n c l u s i o n s<br />

Th e i n v i s v t o u d y u s i n g u n i v e r s i t y s t u d e c n o t n s f i r m e d t h a t e x a pm arati p r on e s p rov o ke<br />

a n x i e t y a n d i n c r e s a t s r e s s in s t u d e n t . s T h e s t u d y s h o w e d t h a t s t r e s s p e r c e p t wi as o n as s oci at ed<br />

with N K c y t o t o x i c a c t i v i t y ; l e a v n e d l i s t d e m o n s trat ed th at p s ych ol o gical in ter ven tion ma y<br />

b u f f er a n d / o r r e v e dr etrimen s e tal e f f e c t s o f s t r e s s u p o n t h e i m m c u e n lls, e p art icu larl y th e e ffect s<br />

o n -cells N K . Th e i n v i sv tu o d y u s i n g -in fect H ed I iV n d ivi d u al s con fi rmed th at th ere is a s tead y<br />

d e c l i n e i n -cell C D c4 ou nT ts in th e p a t i e n t s w h o a r e n o t r e c e i v i n g a n t i-r e t r o v i r a l t r e a t m e n t; an d<br />

it d e m o n s t r a t d e th at p s ych ol o gi cal in ter v en tion m a y d e c r e a s thi e s d e c l i . T n e h e s e e ffect s we re<br />

p articu l arl y as s oci at ed wi t h th e t r a i n i n g a n d p r a c t i c e o f J o h r e i.<br />

In ad d it ion , the d ecl in e i n C D -c 4 e T l l c o -in u n fect t ed s p at ien i ts n w a s H I f o V u n d e t o b<br />

p o s i t i v e l y a s s with o c i a d t e c e l d i n s e in th e p ercei ved q u a l i -o t f y -l i f e c s o r es. Al th ou g h a large r<br />

s a m p l e o u l s d i b e z n e e d e d w f o r s t a t i s t i c a l , s Ji oh g n rei i f ap i c pa eared n c e to i mp ro ve th es e<br />

q u a l i -o t f y -li fe s co res . T h e se r a i s a e p o s s i b i l t i h a t y i m p r o v e m e n t o f t -f h o e c u s m e d a o n c p i n g<br />

skills m a y h a v e b e n e f i c i a l e f f e c t s u p o n d i s e a s e p r o g r e s s i - o an n d m /or o r e t h a n t h e e m o t i<br />

p r o b -f o l c us e d m c o p i n g s t r a t e g . i e s<br />

In vitr o e x p o s u r e t o t s th res e s h orm on e, c o r t i s o l , s u p p res s ed N K -c e l l a n d -l y m T p h o c y t e<br />

fu n ction s . Ot h e r s t r e -a s s s s o c i a t e r d m h o o n es ( D H -S E an A d m el at on in ) ap p eared to b e<br />

an tagon is ti c a g a i n s t t h e e f f e c t n o f c N -c o K r e t l i l s o f l u n c . o t i T e o s h n e s h owed d irec t in teract ion s<br />

o f s t r e s s h o r m o n e s , an d o d emon n sc trat e a l mech l s an is m o wh f ereb y t h e i m m u n e<br />

s t r e s s c o u l d a c t h e s u p y p o c n h o-n e u r o-e n d o c r i o-im n mu n e n et wor k t o r e g u l a t e i m m u n e f u n . c t i o n<br />

T h e s e f i n d i n g s u pp ort th e h yp ot h es is th a t p s ych ol ogi cal in terv en tion m a y c ou n teract th e<br />

d etrimen tal effe ct s <strong>of</strong> s tres s u p o n p s yc h o l o g i c a l w e l l-b e i n g a n d g e n e r a l actin h e a g l tt h rou h gh a n<br />

inte g r a t e d p s y -n c e h u o r o-e n d o c r i n -i o m m u n e n e t w ; o r a n k d c l e a r l y w a r r a n t t h e n e e or d fu f rth er<br />

i n v e s t i g a t i o n o i f n t e r a c t i o th n s e n e i t n w o r , k p a r t i c u th l e a in r fl l uy en ce <strong>of</strong> J oh rei u p o n th e<br />

n e t w o r .<br />

k<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 98 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4.4 F u t u r e d i r e c t i o n s<br />

In ord er t o i n v e s t i g a t e t h e -n e p u s r y o-en c h o d o c r i n -im o mu n e n et work in teract ion s fu rth er,<br />

s everal s u g ges ti on s were rai s ed in th e p r e c e d i n g r e p o r t. Th is s ection lists thos e s u g g e s t i o n an s d<br />

p r o p o se s fu t u re wo rk .<br />

4 . 4 . P 1 s y c h o l o g i c a l i n t e r v e n t i o n s<br />

I n t e r v e n t -f i ree o n c on trol s as wel l as r el ax ation c o n t r ol g r o u p f o r s t u d e n t s s t u d y<br />

A la rg er s a mp le s ize (e. g. m ore th an 8 4 s u b jects p er g r o u p -p f a t o i e r n t s s t H u I d y ) V<br />

4 . 4. 2 Me a s u r em e n t s<br />

4 . 4 . 2 . P 1 s y c h o l o g i c a l m e a s u r e s<br />

C o m p a r i s o n a n a l y s i s b e t w e e n t w o s u b g r b o a u s p e s d o : n<br />

1 . T h e m i d l i n e s p l i t o f t h e e s p t i r o e n s s s c p a e l r e f c s o r t h e s t r -r e s e s l a t e d d i f f e r e n c e s :<br />

Th e P ercei ved S t res s S cal e (P SS) [ C o h e n e t a l . , 1 9 8 3 ]<br />

T h e K e s s e l e r P e r c e i v e d S o c i a l S u p p o r t ( K P S [ S C ) o v e n t r y e t a l . , 2 0 0 4 ]<br />

2 . Th e c r i t e r i w o h n e t h e r t h e -o q u f -life a l i sc t y o r e s i m p r o v i n g o r w fo or r s th e n i n g<br />

c h a n g e i n d i s e a s e p r o g r e s s i o n o r m a i n t e n a n c e o f h e a l t h :<br />

Th e S e n s e o f C o h e r e n c e (S o C) [ A n t o n o v s k y , 1 9 8 7 ]<br />

Th e S p i r i t u a l I n v o l v e m e n t a n d B e l i e f s S c a l e ( S I [ B H S a ) t c h e t a l . , 1 9 9 8 ]<br />

Th e P i t t s b u r g h S l e e p Q u a l (P i SQI) t y I [ B n u d y e s x s e e t a l . , 1 9 8 9 ]<br />

3 . A co v a r i a t e f a c t o r : p e r s o n a l i t y t r a i t<br />

Th e T e m p e r a m e n t a n d C h a r a c t e r (TC I n v I) e n [ C t l o r n y i n g e r e t a l . , 1 9 9 3 ]<br />

4 .4 .2 . 2 I m m u n o l o g i c a l m e a s u r e i s n v i v o<br />

N K -cel ls : Pe r -N K -c e l l c y t o t -ce o x l l i s u c b s e t a c c o u t n t s i a v n d i p t e r c y e n , t for a g e s N K<br />

i n d i v i d u a l s w i t h a c u t e o r s u s t a i n e d , b u t l i m i t e d , s t r e s s<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 1 99 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C D 4 -c T ells : Su b s e t (Re g u l a t -c o e r l l y i n p T a r t i c u l a r c) ou n ts an d p ercen tages , fu n ction al<br />

m e a s u r e s e . g . T h . 1 a n d T h . 2 c y t o k i n e p r o d for u c t bi ot o h n s h eal th y<br />

indivi d u a l s a n d p a t i e n t s w i t h s u s t a i n e d s t r e s s<br />

4 .4 .2 . 3 In v i t r i o n v e s t i g a t o i n o n -cells N K<br />

C D1 1 b p os it ive mac rop h ages a n a l y s i s c o n c u r r e n t l y w i t h p -N e r K -cel l c yt ot o xi c<br />

a c t i v i t y<br />

N F -k B a n a l y s i s w i t h c o r t i s o l r e c e p t o r ( G C R ) a n a l y s i s<br />

Di u r al n p attern in th e e n d o g e n o us s t r e s s h o r m o n e l e v e l c s o n c u r r e n t l y th w e i Nt KC h A<br />

levels b ot h at Ti me 0 an d 2 4 h ou rs after i n v i t i r n o c u b a t i o n<br />

4 . 4 . 2 . I 4 n v i t r i o n v e s t i g -l a t y m i p h o n c y t e o s n T<br />

Cell-c y c l e p r o g r e s s i o n a n a l y s ( e i . s g . C F S E a n a l y s i s )<br />

T U N E L a s s a y f o r p r o l -l i y f m e p h r o c a y t s e i v e T<br />

4 .4 .3 P r o p o s a l f o r f u t in u r vivo e s t u d y<br />

Eth ical ap p roval an d fu n d i n g h ave b een g ran ted for a fu rth er s tu d y in to th e e ffects <strong>of</strong><br />

J o h r e i i n H I V p a t i . e T n h t e s p r o p o s a l a i m s t o i n v e s t i g a t e t h e -n e i u r n t o-e e n g d r o c a r t ino- e d p s y c h o<br />

i m m u n e n e t w o r k i n t e r a c t i o n s ; an d to con f irm an d exp lo re th e majo r r e s u l t s fr om th e P h .D.<br />

p roject th at J oh rei ma y h ave b en eficial ef fect u p on d i s e a s e p r o g r e , s (m s e i a o s n u r e d C i D n 4 -T<br />

c e l l c o u n t s), i n -i H n f I e c V t e d i n d i v i d u a l s n o t r e c e i v i n g a n t i-r e t r o v i r a l t r e a t m e n t [ A p p e n d i x 7 ].<br />

R e f e r en c e s<br />

Ade r , R. , & Co he n, N. ( 1993) . P s yc hon e ur oimmu no lo gy : c on dit io nin g a nd s tr es s . A n n u R e v P s y c h o l , , 4 4<br />

53-85.<br />

Afari, N., Eisenberg, D. M., Herrell, R., Goldberg, J., Kleyman, E., Ashton, S., & Buchwald, D. (1999).<br />

U s e o f a l t er n at i ve tre at me nt s by c hr on ic f at ig ue s yn dr ome dis c or da nt t win s . I nt e gr ati ve<br />

M e d i c i n e ( , 2 / 2 3 ) , -103. 9 7<br />

Ajetunmobi, O. (2002). M a ki n g s en s e o f c ri t i c a l ap p ra i sa l. London: Arnold.<br />

A k b a r , A . N . , T a a m s , L . S . , S a l m o n , M -St . , e j ic & , M V . u ( k 2m 0a 03) n o . v <strong>The</strong> i c pe r iphe r a l ge ne r at io n <strong>of</strong> CD4+ CD2 5+ re gula t or y T ce lls . Immunology, 109(3), 319-325.<br />

Ale nz i, F. Q. , & Wa rr e ns , A. N. ( 20 03) . Ce llula r a nd mo lec ula r t he me s in a po pt os is . Wi e n Kl i n<br />

Wochenschr, 115(15-16), 563-574.<br />

A n s t e a d , M . I . , H u n t , . K. T ( 19 . 98) . A Var . ia , bilit y C <strong>of</strong> a pe r ip l he s ra o l bn lo o, d S . L . , & B u<br />

l y m p h o c y t e b e -2-a t a dr e ne r gic r ec e pt or de ns ity in hu ma ns . A m J R e s p i r C r i t C a r ( e 3 Pt M e d , 1 5 7<br />

1), 990-992.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 00 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Ant ia , R. , Be r gs tr om, C. T ., P ilyu gin , S. S. , K a e c h , S. M. , & Ahme d , R. ( 20 03 ). Mo de ls <strong>of</strong> CD8 +<br />

r e s po n se s : 1 . W h a t i s t -inde h e a pe n t nd i eg nt e n pr olif er a t ion progr a m. J T h e o r B i o l (4), , 585- 2 2 1<br />

598.<br />

Ant oni, M . H. , Crue ss , D. G., Klima s , N. , M ah e r , K. , Cr ue s s , S., Kuma r , M . , Lut ge nd or f , S. , I ro ns on , G. ,<br />

Sc h n e i d e r m a n , N ., & Fl e t c h er , M. A. ( 2 0 0 2) . St r e s s ma n a ge m e nt a nd immu ne s ys te m<br />

r e c o n s t i t u t i o n -inf e ct i ed n ga y s me y n m ove p r t ime o m : ea ff ec t ts i on c t ra ns H it I io na V l na ive T<br />

c e lls ( CD4 (+) CD45RA( + ) CD29 (+ )) . A m J P s y c h i a t r (1), y , 143-145. 1 5 9<br />

Antoni, M. H., Cruess, S., Cruess, D. G., Kumar, M., Lutgendorf, S., Ironson, G. , De tt me r, E. , Will ia ms ,<br />

J . , K l i m a s , N . , F l e t c h e r , M . A . , & S c h n e i d e r m a n , -be N ha . vio ( r2 a0 l 0 s0 t re ) . ss C o g n i t i v e<br />

m a n a g e m e n t r e d u c e s d i s t r -h e s s o u a r n d 2 4 u r i n a r y f r e e c o r t -i<br />

s o l o u t p<br />

inf e ct e d ga y me n. Ann Behav Med, 22( 1 ) , -37. 2 9<br />

A n toni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., Yount, S. E.,<br />

M c G r e g o r , B . A . , A r e n a , P . L . , H a r r i s , S . D . , P r i c e , A . A . , & - C a r v e r , C . S . ( 2 0<br />

b e h a v i o r a l s t r e s s m a n a g e m e n t i n t e r v e n t i o n d e c r e a s e s t h e va p le r nc e <strong>of</strong> de pr e ss ion and e nhan c e s<br />

b e n e f i t f i n d i n g a m o n g w o m e n u n d e r t r e -s a tt a ge m e bn re t a st f ca o nce r r e . a He r l alt y h Ps y ch ol ,<br />

20(1), 20-32.<br />

Antonovsky, A. (1987). U n ra v el i n g t h e m ys t er y <strong>of</strong> h ea l t h : h o w p e o p l e m an a g e s t r es s a nd st a y we l (1s l t<br />

ed.). San Fran c i s c o : J o -Ba s s se s y .<br />

Ant ono vs ky, A. ( 1993) . T he st r uc t ur e a nd pr op e rt ie s <strong>of</strong> th e s e nse <strong>of</strong> c oh e re nce sc a le . S o c S c i M e d ( , 6) , 3 6<br />

725-733.<br />

Avit s ur , R. , St a r k, J . L., & She r id a n , J . F. ( 200 1 ) . So c ia l St r e ss In du ce s Glu c oc or t ic oid Resis t a nce in<br />

S u b o r d i n a t e A n i ls m . Hormones a and Behavior, 39(4), 247-257.<br />

B a i d e r , L . , A n d r i t s c h , E . , U z i e l y , B . , G o l d z w e i g , -Hadani, G . , E v e P., r H<strong>of</strong>man, G., Krenn, G., &<br />

Sa moni gg, H. ( 2003) . Ef fe ct s <strong>of</strong> a ge on c op ing a nd ps yc ho lo gic a l dis t r es s in wome n dia gn os e d<br />

w i t h b r e a s t c a n c e r : w <strong>of</strong> r e lit v i e r at ur e and ana lys is <strong>of</strong> t wo dif f er e nt ge ogr a ph ica l s et t in gs . Cr i t<br />

R e v O n c o l H e m a t ( o l 1 ) , -16. 4 6 5<br />

Ba ide r , L. , P er e tz , T ., Ha da ni, P . E. , & Ko ch , U. ( 20 01 ) . Ps yc ho lo gic a l in t e r ve nt io n in c a nce r pa t ie nt s : a<br />

r a ndomiz e d st udy. G e ne r al H o sp i t al Ps y c hi a try, 23, 272-277.<br />

B a k k e , A . C . , P u r t z e r , M . Z . , & N e w t o n , P . ( 2 0 0 2 ) . -guide T h e d e ima f f e ge c t r y o on f h y p n o t i c<br />

p s yc h o l o gi c a l we l l-be ing a nd immu ne f un ct ion in pa t ien t s wit h pr ior br ea s t c a nc er . J Ps yc ho s om Res, 53(6), 1131-1137.<br />

Bakker, A. B., Wu, J., Phillips , J . H. , & La nier , L. L. ( 20 00 ) . NK c e ll a ct iva t io n : dis t in c t s t imu la t or y<br />

pa t hwa ys c ou nt er ba la nc ing inhib it or y s ign a ls . Hum Immunol, 61(1), 18-27.<br />

B a r n e s , P . J . ( 1 9 9 7 ) . N u c l e a r f a -kappa c t o r B. I n t J B i o c h e m C e l l (6), B 867-870. i o l , 2 9<br />

B a t e y , D . M . , K nn, a u P. f m G., a Raczynski, J. M., Hollins, J. F., Murphy, J. F., Rosner, B., Corrigan, S.<br />

A., Rappaport, N. B., Danielson, E. M., Lasser, N. L., & Kuhn, C. M. (2000). Stress<br />

m a n a g e m e n t i n t e r v e n t i o n f o r p r i m a r y p r e v e n t i o n o f has h y e p I e r t e n t i o n : d e<br />

o f T r i a l s O f H y p e r t e n s i o n -I ) . P A r n e n v u a e l n s t i o f n e ( p i T d O e H m P i o , l 45-58. o g y , 1 0<br />

Bauer, J., Hohagen, F., Gimmel, E., Bruns, F., Lis, S., Krieger, S., Ambach, W., Guthmann, A., Grunze,<br />

H . , F r i -M t o s n c t h e r o , R . , & e t a l . ( 1 9 9 5 ) . I n d u c t si ynt o n he o sf is ac ny d t fo ek ve i r n e suppr e sse s<br />

REM s le ep a nd impr ove s mood in pat ie nts wi t h maj or de pr e ss io n . B i o l P s y c h i a t (9), r y , 611- 3 8<br />

621.<br />

Ba ue r , M . E. , P apa dopoulos , A., P oo n, L. , Per ks , P. , Ligh t ma n , S. L. , Ch e c kle y, S. , & Sh a nks , N. ( 20 03) .<br />

Alt e r e d glu c oc ort ic oid immunore gu la t io n in tr e at me nt re s ist a nt depr es s io n .<br />

P s y c h o n e u r o e n d o c r i n o l o g (1), y , 49-65. 2 8<br />

Ba ue r , M . E. , P er ks , P ., Light ma n , S. L. , & Sh a nks , N. ( 20 01) . Res tr a in t s tr es s is a s so c ia ted wit h c ha nge s<br />

in gluc oc or t ic oid immunor e gula t io n . P h y s i o l B e h a v (4) , 525-532. 7 3<br />

B e c h e r , B . , P r a t , A . , & A n t e l -i , m m J . u n e P . c o n ( n 2 e 0 c 0 t 0 ) i . o n : B r i -r a i m e gula n m u n t or o y pr ope rt ie s <strong>of</strong><br />

C N S -r e s id e nt c e lls . G l i a , (4), 2 9 293-304.<br />

B e d n e r , E . , L i , X . , G o r c z y c a , W . , M e l a m e d , M . R . , & D a r z y n k i e w i c z , Z . ( 1 9 9 9 ) .<br />

la s e r s c an nin g c yt ome t r y. C y t o m e t r y , (3), 3 181-195. 5<br />

Be la n<strong>of</strong>f , J . K. , Roths child, A. J . , Ca s s id y, F. , De Ba tt is ta , C. , Bau lie u , E. E. , Sc hold , C. , & Sc ha t z be r g, A.<br />

F. (2002). An open label trial <strong>of</strong> C-1 07 3 ( mife pr ist on e) f or ps yc hot ic ma jo r de pre ss io n . B i o l<br />

P s y c h i a t r y (5), , 386-392. 5 2<br />

B e s e d o v s k y , H . , & S o r k i n , E . ( 1 9 7 7 ) . N e t w -ne o r ur k oe o f nd oc i m r in m e u int n e er a ct ions . Cl in Ex p<br />

Immunol, 27(1), 1-12.<br />

B e s e d o v s k y , H . O . , & d e l R e y , A . ( 2 0 0 0 ) -H . P A T h e a x c i y t s o k -ba f i e n ce e k d c ir c uit . Z Rheumat ol , 59<br />

Suppl 2, I I -30.<br />

/ 2 6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 01 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

B e s e d o v s k y , H . O . , & d e l R e y , A . ( 2 0 0 1 ) . C y t o k i n e s a s m e d i a t o r s o f c e n t -r<br />

a l a n d p e r i p h e r a l I<br />

Ne ur oe nd oc r in e int er a ct ions . I n Ad e r , R. , Fe lt e n , D. L. & Coh e n , N. ( Eds . ) ,<br />

P s y c h o n e u r o i m m u n o l o g y 3 r d (pp. e d i t 1-1 i 7 o ) n . Sa n Die go: Ac a de mic P re s s .<br />

B i a s son i, R. , Cant oni, C., P e nde , D. , Sivo r i, S. , Pa ro lin i, S. , Vit a le , M . , Bott in o , C. , & M or et t a, A. ( 20 01) .<br />

H u m a n n a t u r a l k i l l e r c e l l r -re e ce c e pt p or t o s . r I s m m a u n d n o l c o R e v , 203-214. 1 8 1<br />

B i o n d i , M . ( 2 0 0 1 ) . E f f e c t s . o In f Ader, s R., t Felten, r e s D. s L. & o n i m m u n e f u<br />

Cohen, N. (Eds.), P s y c h o n e u r o i m m u n o l o g y 3 r d (pp. e d i t 189-226). i o n San Diego, U. S. A.:<br />

Ac a de mic Pr e ss .<br />

B l a n k , T . , N i j h o l t , I . , E c k a r t , K . , & S p i e -T s es r, m PJ ot . en t( iat 2 ion 0 0 2 in ) . mous P r e i m i n g o f L o n g<br />

h i p p o c a m p u s b y c o r o t i r c o p -r i n e l e a s i n g f a c t o r a n d a c u t e s t r e s s : i m p l i c a t i o n s f o r h -i<br />

p p o c a m p u s<br />

de pe nde nt le ar ning. T h e J o u r n a l o f N e u r o s c i , 3788-3794. e n c e , 2 2<br />

Boe r ee , C. G. ( 2002) . <strong>The</strong> Emot io nal Ner v ous Sy st e m: Th e l i mbi c s ys te m an d t he aut on omic ne rv ous s y s , t f r om e m h t t p : / / w w w. s h i p . e d u / ~c gb o e r ee / l i m b i c s ys t e m . h t m l<br />

B o n n e a u , R . H . , Z i m m e r m a n , K . M . , I k e d a , S . C . , & J o n e s , B . C . ( 1 9 9 8 ) . D i f f -e<br />

r e n t i a l e f f e c t s o f s t<br />

i n d u c e d a d r e n a l f u n c t i o n o n c o m p o n e n t s o f t h e s i h m e r p l e s x v i r -s u pec s if ic me mo r y c yt otoxic<br />

T-lymp ho c yt e r es pons e . J N e u r o i m m u n o l (2), , 191-199. 8 2<br />

Bor e lla , P . , Bar ge llini, A., Rove s t i, S. , P in e lli , M . , Vivo li, R. , Solf r ini, V. , & Vivol i, G. ( 199 9) . Emot io na l<br />

s t abilit y, a nx ie t y, a nd nat ur a l kille r a c t ivit y u nd e r e xa min at io n st re ss .<br />

P s y c h o n e u r o e n d o c r i n o l o g (6), y , 613-627. 2 4<br />

Bor n, J ., Ha ns e n, K., Ma rs ha ll, L. , M olle , M . , & Fe hm, H. L. ( 19 99 ) . T imin g t he en d <strong>of</strong> noc t ur na l s lee p .<br />

Nature, 397(6714), 29-30.<br />

Bor n, J ., La nge , T ., Ha ns e n, K., M olle , M . , & Fe hm, H. L. ( 19 97) . Ef fe ct s <strong>of</strong> s lee p an d c irca dia n rh yt hm on huma n c ir c ulat ing immune c e lls . J I m m u n o l , (9), 1 5 4454-4464. 8<br />

Bos ma , H. , Pe te r , R., Sie gr is t , J . , & Ma r mot , M . (1 99 8) . T wo a lt er nat ive j ob s tr e ss mo de ls a nd th e r is k <strong>of</strong><br />

c or ona r y hea rt dis ea s e. A m J P u b l i c a l H t e h , (1), 8 8 68-74.<br />

Boyum, A. ( 19 74) . Se pa ra t ion <strong>of</strong> blo od le ucoc yt e s , gr a nu lo c yt e s a nd lymp ho c yt e s. T i s s u e A n t i g ( e 4) n s , , 4<br />

269-274.<br />

Buc kingh a m, J . C., Loxle y, H. D. , Ch r is t ia n , H. C. , & Ph ilip , J . G. ( 199 6). Ac t iva t io n <strong>of</strong> t he HP A a xis by i m m u n e i n s u l les t s a: nd r in o t er ac t ions <strong>of</strong> c yt okine s , e ic os a no id s , glu c oc or t ic oids . Ph ar ma col<br />

B i o c h e m B e h a v , ( 1 ) 5 , 4 -298. 2 8 5<br />

Buys s e , D. J . , Re ynolds , C. F., 3rd , Mo nk, T . H. , Be r ma n, S. R., & Ku pf er , D. J . (1 98 9) . T he P it ts bur gh<br />

S l e e p Q u a l i t y I n d e x : a n e w i n s t r u m hia e n t r ic f pr o r a ct p ic s e y c a nd r e se ar c h. Ps y ch i at ry Res ,<br />

28( 2 ) , -213. 1 9 3<br />

Ca nnon, W. B. ( 1914) . Re ce nt St ud ie s <strong>of</strong> Bo dil y Ef f e ct s <strong>of</strong> Fe a r, Ra ge , a nd P a in . <strong>The</strong> Jo ur na l <strong>of</strong><br />

P h i l o s o p h y , P s y c h o l o g y a n d S c i e n t i f (6), i c 162-165. M e t h o d s , 1 1<br />

Cannon, W. B. (1932). <strong>The</strong> wisdom <strong>of</strong> the body. Ne w Yo r k: W. W. No r t on & Co mp a ny in c.<br />

Ca nnon, W. B. ( 1934) . T he Sign if ic a nc e <strong>of</strong> t he Emo t io na l Le ve l. T h e S c i e n t i f i c M o (2), n t h 101-110. l y , 3 8<br />

C a r b o n e , J . , G i l , J . , B e n i t o , J . M . , -F N e r a n v a n r d r e o z , J A . , M B u a n r o t z o l o m e , J . , Z a b a y , J . M . , L o p e z<br />

F . , & F e r n a n -Cr d e uz z , E. ( 20 00) . I ncr e as e d le ve ls <strong>of</strong> a ct iva t e d s ub se ts <strong>of</strong> CD4 T ce lls a dd to t he p r o g n o s t i c v a l u e o f l o w -inf C D e 4 ct e d dT r ug use c e rs . l A i l d s , c (18), 1 o 4 u n t s i n a<br />

2823-2829.<br />

C a r t e r , R . N . , P i n n o c k , S . B . , ) . Doe & s H te he r ab mygda e r t , la J modula . ( 2 t0 e 0 a4 da pt at io n t o r e pea te d<br />

s t re ss ? N e u r o s c i e n c e , ( 1 ) 2 , 6 -19. 9<br />

Ca r uso, A. , Lic e nz ia t i, S., Cor ulli, M . , Ca nar is , A. D. , De Fr a nc es c o , M . A. , Fio r e nt in i, S. , P er oni, L. ,<br />

Fa l l a c a r a , F. , D i m a , F. , B a l s a r i , A. , & T u r a n o, A. ( 1 9 9 7 ) . ow Fl c yt ome t r ic ana lys is <strong>of</strong> ac t iva t io n<br />

ma r ke r s on st imula t e d T c e lls an d th e ir c orr e la t io n wit h c e ll pr olif er at io n . C y t o m e t r y , (1), 2 71- 7<br />

76.<br />

Ca s e y, F. B. , Eis e nber g, J ., P et er s on , D. , & P ie pe r, D. ( 19 74) . Alt e r e d a nt ige n up t a ke an d dis t r ib ut io n due to exposur e t o e xt r e me e nvir on me nt a l te mp era t ur e s or s le e p de pr iva t io n . J Reti c ul oen dot hel So c,<br />

15(2), 87-95.<br />

Ca s te ln a u , P . A., Ga r r et t, R. S., Pa lin s ki, W. , Wit z t um, J . L. , Ca mp be ll, I . L. , & Po we ll, H. C. ( 19 98 ) .<br />

A b n o r m a l i r o n d e p o s i t i o n a s s o c i a t e d w i t h l i p i oxidat d p e r io n in tr a ns ge nic mic e e xpr es s in g<br />

i n t e r l e -6 u k in i n the brain. J N e u r o p a t h o l E x p N e u ( r 3 o ) l , -282. 2 5 6 7 8<br />

Ca t a la n, J . , Bur ge s s , A., & Klime s , I . ( 19 95 ) . P s y c h o l o g i c a l M e d i c i n e o f H . I Oxf V or I d n : f Oxf e c t ord i o n<br />

M e dic a l P ub lic a t ions.<br />

Cha ng, S. O. ( 2003) . T he nat ur e <strong>of</strong> t ou c h t he ra py r e lat e d t o Ki: pr a ct it io ne r s ' per s pe ct ive . Nur s He alt h Sci ,<br />

5(2), 103-114.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 02 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Cha r ne y, D. S. ( 2004). P s yc hobio lo gic a l me ch a nis ms <strong>of</strong> re s ilie nc e a nd vu ln e ra bilit y: i mpli c a t io ns fo r<br />

s uc ce s sf ul a da pt a t ion t o e xt r e me st re s s . A m J Ps y c h iatry, 161( 2 ) , -216. 1 9 5<br />

C h r o u s o s , G . P . ( 1 9 9 5 ) . T h e h y p -p o i t t h a u l i a t m -a a i d r c r y e n a l a x i s a n d i m -me m u dia n e te d in f la mma t ion. N<br />

Engl J Med, 332(20), 1351-1362.<br />

C h r o u s o s , G . P . , & G o l d , P . W . ( 1 9 9 2 ) . T h e c o n c e p t s o f s t r e s s a n f d s t r e s s s y s t e m<br />

phys ic a l a nd beha vior a l home os ta s is . Jama, 267(9), 1244-1252.<br />

Cla r ke , P . B. ( 2000) . J a p a n e s e n e w r e l i g i o n s : i n g l o b a l . p Ric e r s hmo p e c nd t i , v Su e r r e y: Cur z on.<br />

Cle a r e , A. J . ( 2003) . T he neur oe nd oc r in olo gy <strong>of</strong> ch r on ic f at igue s yn dr ome . E n d o c r R e v , (2), 2 4 236-252.<br />

Cle r ic i, M . , Tr a ba tt oni, D., P ic on i, S. , Fu s i, M . L. , Ru z z an te , S., Cle r ic i, C. , & Villa , M . L. ( 19 97) . A<br />

pos s ible r ole fo r t he c ort is ol/a nt ico rt is ols imba la nc e in t he pr ogr es s io n <strong>of</strong> hu ma n<br />

immuno de f ic ie nc y vir us . P s y c h o n e u r o e n d o c r i n o l o g y , 2 2 , S27-31. S u p p l 1<br />

Cloninge r , C. R., Svr a kic , D. M . , & Pr z yb e c k, T . R. ( 19 93) . A ps yc ho biolo gic a l mo de l <strong>of</strong> te mp e ra me nt<br />

a nd c ha ra ct e r. A r c h G e n P s y c h i a t (12), r y , 975-990. 5 0<br />

C l o w , A . , P a t e l , S . , N a j a f i , M . , E v a n s , P . D . , & H u c k l e b r i d g e , F . ( 1 9 9 e 7 ) t o . T h e c o r t i s o l r e s p o n s<br />

ps yc holo gic a l c ha lle nge is pr e ce ded by a tr a ns ie nt r is e in en do ge no us in hibit or <strong>of</strong> mon oa min e<br />

oxida s e . L i f e S c i (5), , 567-575. 6 1<br />

Clow, A. , Ve l luc c i, S. V., P ar r ott , R. F. , Hu c kle br id ge , F. , Se n , S. , & Eva ns , P . ( 20 00) . En do ge no us monoamine oxidase inhibit or y a ct ivit y a nd HP A a c t iva t io n in t he pig. L i f e S c i (1), , 35-41. 6 6<br />

Cohe n, L. , Lit t le f ie ld, C., Ke lly, P . , M a ur er , J. , & Ab be y, S. ( 19 98) . P re dict ors <strong>of</strong> qu a lit y <strong>of</strong> lif e a nd a dj us t men t a ft er lung t ra ns pla nt at io n . C h e s t , ( 1 3 1 ) 3 , -644. 6 3 3<br />

Cohen, S., & Herbe rt , T . B. ( 19 96) . He a lth psyc ho lo gy: ps yc ho lo gic a l f a c to r s a nd ph ys ic a l dis e a se fr om t he pe rs pec t ive <strong>of</strong> huma n ps yc ho neu r oimmu no lo gy. A n n u R e v P s y c h o l , 113-142. , 4 7<br />

Cohe n, S. , Ka mar c k, T., & Me r me lst e in , R. (1 98 3 ). A glo ba l me a s ur e <strong>of</strong> per ce ive d s tr e ss . J He alt h So c<br />

Behav, 24(4), 385-396.<br />

Cole , R. L. , & Sa wc he nko, P . E. ( 20 02) . Ne uro t ra ns mitt er re gu la t io n <strong>of</strong> c e llu la r ac t iva t io n an d<br />

ne urope pt id e ge ne e xpr e ss ion in th e pa ra ve nt ric ula r nu c leu s <strong>of</strong> t he hyp ot ha la mus . J Ne ur osc i ,<br />

22( 3 ) , -969. 9 5 9<br />

Cole, S. W., Kemeny, M . E., Fa he y, J . L. , Zac k, J . A. , & Na lib <strong>of</strong> f , B. D. (2 00 3) . Ps yc ho lo gic a l r is k<br />

f a ct ors fo r HI V pat hoge nes is : me dia t io n by t he a ut on omic ne r vo us s ys t e m. Bi ol ogi c al<br />

P s y c h i a t r y (12), , 5 1444-1456. 4<br />

C o l e , S. W. , K e m e n y, M . E . , & T a yl o r , S. E . ( 1 9 9 7) . So c i de a l nt i it y a nd ph ys ic a l hea lt h: a cc e le r at ed HI V<br />

p r o g r e s s i o n i n r -s e ej ns e it c ive t i ga o n y me n. J P e r s S o c P s y c h (2), o l 320-335. , 7 2<br />

Cole , S. W. , Ke me ny, M . E., T a ylo r , S. E. , Vis s c he r , B. R. , & Fa he y, J . L. ( 19 96 ) . Ac c e ler at e d c our s e <strong>of</strong><br />

h u m a n i m m u n o d e f i c i e n c y v us i r inf ec t io n in ga y me n who c on c e a l t he ir ho mo se xu a l id en t ity.<br />

P s y c h o s o m M e d , (3), 5 219-231. 8<br />

C o o p e r , M . A . , F e h n i g e r , T . A . , & C a l i g i u r i , M . A . ( 2 0 0 1 ) . T h e b i o l o g y o f h u m a n -c n a et ll u r a l k i l l e r<br />

s ubse ts . T r e n d s I m m u n o l (11), , 2 633-640. 2<br />

Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., &<br />

Ca ligiur i, M . A. ( 2001) . Huma n nat ura l kil le r c e lls : a un iq ue in na te immu nor e gu la tor y r ole f or<br />

t he CD56 ( br igh t ) subse t . Blood, 97(10), 3146-3151.<br />

C o ve n t r y, W. L. , G i l l e s p ie , N. A. , He a t h , A. C. , & M ar t in , N. G. ( 200 4) . P er c e ive d s oc ia l s up por t in a<br />

l a r g e c o m m u n i t y s a - m - ap ge l e a nd se x diff er enc e s . S o c P s y c h i a t r y P s y c h i a t r E p (8), i d e m i o l , 3 9<br />

625-636.<br />

C r u e s s , D . G . , A n t o n i , M . H . , G o n z a l e z , J . , F l e t c h e r , n, M R., . Ironson, A . , K G., l i & m a s , N . , D u r a<br />

Sc hne id e r ma n , N. ( 2003) . Sle e p dis t ur ban c e me dia t es t he as s oc ia t io n be t we e n ps yc holo gic a l<br />

d i s t r e s s a n d i m -pos m u it n ive e me n s at nd a wome t u n s on c oa mb m in o at n io g n a nt ir H et I rovir V a l<br />

t her a py. J P s y c h o s o m R e (3), s , 185-189. 5 4<br />

C r u e s s ., Ant , on D i, . M . H. G , Kuma r , M ., I ron s on , G. , M c Ca be , P . , Fe r na nd ez , J . B. , Fle t ch e r , M . , &<br />

S c h n e i d e r m a n , N . ( 1 9 9 9 ) . C -be o g n ha i t vio i v r ae l s t re ss ma na ge me nt buf fe rs dec re a se s in<br />

d e h y d r o e p i a n d r o s -S t ) e r o a n e d s i u n l c f r a e t a s e e -S s ( r aD t io H i E a nd n A t h e c o r t i s<br />

r e d u c e s m o o d d i s t u r b a n c e -s e ropos a n it d ive me p n. e r c e i v e d s t r e s s<br />

P s y c h o n e u r o e n d o c r i n o l o g (5), y , 537-549. 2 4<br />

Cruess, S., Antoni, M., Cruess, D., Fletcher, M. A., Ironson, G., Kumar, M., Lutgendorf, S., Hayes, A.,<br />

K l i m a s , N . , & S c h n e i d e r m a n , 2000). N . ( Re du c t ions in her pes s imp le x vir us t yp e 2 a nt ib ody t it er s af te r c ogn it ive be ha vior a l s tr es s man a ge me nt an d re la t io ns hips wit h ne ur oen do cr in e<br />

f u n c t i o n , r e l a x a t i o n -pos s it ive k i me l n . l P s y c , h o s o a m n M d e d , ( s 6 ) 6 o 2 , c -8<br />

i 2 8 a l s u p p o<br />

837.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 03 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Cunningha m , E . T . J . , & D e S o u z a , E . B -1 . r ec ( e1 pt 9 9 o3 rs ) in . the I n br t ae in r l and e u k end i n ocr in e<br />

t is s ues . Immunology Today, 14, 171-176.<br />

Cut olo, M . , Giust i, M ., Foppia ni, L. , Se r io lo , B. , Br ia ta , M. , Bis s o , A. , Fa e lli, F. , Fe l li, L. , Pr et e , C. ,<br />

P i z z o r n i , u C l l . i , A & . S ( 2 0 0 0 ) . T h e h y p -p o t i h t a u l i a m t -a i a dr c r eno y c or t ica l a nd gona da l a xis<br />

f unct ion in rh e umat oid ar thr it is . Z Rheumatol, 59 Suppl 2, II/65-69.<br />

D a n t z e r , R . ( 2 0 0 4 ) . C -induc y t o k i e d n e s ic kn e ss be ha viour : a ne ur oimmu ne r e sp on se to a ct iva t io n <strong>of</strong> in nat e<br />

i m m u n i t y. E u r J P h a r m a c o l ( , 1-3), 5 0 399-411. 0<br />

de Guc ht , V. , Fis c hle r, B., & De ma ne t , C. (1 99 9 ) . I mmu ne dysf un ct io n as s oc ia te d wit h c hro nic pr <strong>of</strong>e ss io na l st r es s in nurs e s . P s y c h i a t r y R e ( s 1 , ) , 8 5 -111. 1 0 5<br />

de Kloe t , E. R. (2000) . St re s s in t he bra in . Eur J Ph ar ma co l , 405( 1-3), 187-198.<br />

de Kloe t , E. R. (2003) . Hor mon es , br a in a nd st r es s . Endocr Regul, 37(2), 51-68.<br />

de Kloe t , E. R. , Oit z l, M . S., & J oe ls , M . ( 1999 ) . St r es s a nd c ogn it io n: a r e c or t ic os te r oid s go od or ba d<br />

guys ? T r e n d s N e u r o s c i (10), , 422-426. 2 2<br />

d e K l o . e R., t Vre , ugd E e nhil, E., Oit z l, M . S. , & Jo e ls , M . (1 99 8) . Br a in c or t ico st e ro id r ec ep t or ba la nc e in<br />

he a lt h a nd dis e as e . E n d o c r R e v , (3), 1 9 269-301.<br />

de Wolf , F. , Sp ij ke r ma n, I ., Sc he lle ke ns , P . T. , La nge nd a m, M . , Ku ike n , C. , Ba kke r , M . , Ro os , M . ,<br />

Coutinho, R., M i e d e m a , F . , & G o u d s m i t , -1 J RNA, . ( 1 9 9 7 ) . A I D<br />

C D 4 + -c T e ll c ou nt an d funct ion: ma r ke rs wit h r ec ip r oca l pre dic t ive va lu e ove r t ime aft e r<br />

s e r oc on ve rs io n . A i d s , (15), 1 1 1799-1806.<br />

D e i n z e r , R . , & S c h u l l e r , N . ( 1 9 9 8 ) . D y n a m s-r i c es la o te f d s de t r ce re s as e <strong>of</strong> sa liva r y i mmu no glo bu lin A<br />

( s I gA) : r e la t io nship t o s ympt oms <strong>of</strong> t he c ommo n c old a nd st udyin g be ha vio r . B e h a v M e d , ( 4) 2 , 3<br />

161-169.<br />

D h a b h ar , F. S. , & Mc E we n , B . S. ( 1 9 9 7) . Ac u t e s t r e ss en h a nc e s wh i l e c h r on i c st r e s s s u p pr e s s es ce - l l<br />

m e d i a t ed immunit y in vivo : a po t en t ia l r ole fo r le uko c yt e t r af f ic kin g. B r a i n B e h a v I m m u ( n 4) , 1 1<br />

286-306.<br />

Dhabhar, F. S., Miller, A. H., McEwen, B. S., & Spencer, R. L. (1996). Stress-induced changes in blood<br />

l e u k o c y t e d i s t r i b u t i o n . R o l e o f a d r e s n . a J l I s m t m e u r n o i l d , (4), h 1 o 5 r 1638-1644. 7 m o n<br />

D o p p , J . M . , M i l l e r , G . E . , M y e r s , H . F . , & F a h e y , J . L . ( 2 0 0 0 ) . I n c r e a s e d -c n ea lt l u mo r a l biliz k i l al e t ion r<br />

a nd c yt ot ox ic it y dur ing ma r it a l c onf lic t . B r a i n B e h a v I m m u (1), n , 10-26. 1 4<br />

Downing, J. E., & Miyan, J. A. (2000). Ne ural immu no r e gu la t io n: e me r gin g r ole s f or ner ve s in immu ne home ost a s is a nd dis e as e . I m m u n o l T o d a y , (6), 2 281-289. 1<br />

E d e l l -Gu s t a ff s on, U. M. ( 2002) . In s uf f ic ie nt sle e p , c ogn it ive a nxie t y a nd hea lt h t r an s it io n in me n wit h<br />

c o r o n a r y a r t e r y d i s e a s e : a s e -r l f e port a nd po lys omnogr a phic s tu dy. J Adv Nurs, 37(5), 414-422.<br />

E d e l l -Gu s t a ff s on, U. M., & Het t a, J . E. ( 20 01) . Fr a gme nt e d s le e p a nd t ir ed nes s in ma le s a nd f e ma les one ye a r a ft er per cu t ane ous t r ans lu min a l c or on ar y a ngio pla s t y (PT CA) . J Adv Nurs, 34(2), 203-211.<br />

Egne r , T . , St ra ws on, E., & Gr uz e lie r , J . H. ( 20 02 ) . EEG Si gn a t ure a nd P hen ome lo gy <strong>of</strong> Al ph a /t he t a<br />

Ne ur <strong>of</strong> e ed bac k T ra ining Ve r s us M oc k Fe e db a c k. Ap pli e d Ps yc ho ph y si ol og y an d Bi <strong>of</strong> e ed ba c k ,<br />

27( 4 ) , -270. 2 6 1<br />

Ehle r s , C. L. , Kupf er , D. J ., Buys s e , D. J . , Clu s s , P . A., Miewald, J. M., Bisson, E. F., & Grochocinski, V.<br />

J . ( 1998) . T he P it ts bur gh s t udy <strong>of</strong> nor ma l s le ep in yo un g a du lt s : f oc us on th e r e la t io ns hip be t we e n wa kin g a nd s le e ping EEG s pe ct r a l pa t te rn s . El e ct ro e nc e phal og r Cl i n Ne uro ph ys iol ,<br />

106( 3 ) , -205. 1 9 9<br />

E l e nko v, I . J . , & Ch r ou s os , G . P . ( 1 9 99 ) . St r es s H o r mo n e s, T h 1/ T h 2 p at t er ns , P r o / An -inf t i la mma t or y<br />

Cyt okin e s a nd Sus c e pt ibilit y t o Dis e a se . T r e n d s E n d o c r i n o l M e ( t 9 a ) b , -368. 3 1 5 0 9<br />

E l e n k o v , I . J . , W i l d e r , R . L . , C h r o u s o s , G . P . , & V i z t i h , e t i E c . n S e - . r - av n e ( int 2 0 e0 gr 0 ) at . ive T h e s y m p a<br />

int e rf a ce bet we e n t wo s upe rs ys t e ms : t he br a in a nd t he immu ne s ys t e m. P h a r m a c o l R e v (4), , 5 2<br />

595-638.<br />

Empson, W. (1930). S e v e n t y p e s o f a m b i . g London,: u i t y Chatto and Windus.<br />

Eva ns , P . , Hu c ke le br idge , F., & Clo w, A. ( 20 00 ) . Mind, I mmu nit y an d He alt h: Th e Sci e nc e <strong>of</strong> P s y c h o n e u r o i m m u n o l o g . y Londo n , U. K. : Fr ee As s oc ia t io n Boo ks .<br />

Fa l ke ns t e in , E. , T illma nn, H. C., Ch r ist , M . , Fe ur in g, M . , & We hlin g, M . (2 00 0) . M ult ip le ac t io ns <strong>of</strong> s t e r o i d h o r m o n - e - s a f ocu s on ra pid, nonge nomic e f fe c ts . P h a r m a c o l R e v ( , 4 ) 5 , 2 -556. 5 1 3<br />

Fa uc i, A. S. , M a vil io, D., & Kot t ilil, S. ( 20 05 ) . NK c e lls in HI V inf e ct io n: par a digm f or prot e ct io n or<br />

t a r get s f or a mb ush. N a t R e v I m m u n (11), o l , 835-843. 5<br />

Fa ymon vi lle , M . E., La ur e ys , S. , De gu e ld r e , C. , De lFio r e , G. , Lu xe n , A., Franck, G., Lamy, M., &<br />

M a que t , P . (2 000) . Ne ur a l me ch a nis ms <strong>of</strong> a ntin oc ic e pt ive ef f ec ts <strong>of</strong> hyp nos is . An e st hes iol og y ,<br />

92(5), 1257-1267.<br />

Fe l t e n , S. Y . , & Fe l t e n , D . L. ( 19 9 4) . N e ur -immun a l e in t er a ct ions . P r o g B r a i n R e s , , 157-162.<br />

1 0 0<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 04 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Field, A. (2003). Di s c o v e r i n g S t a t i s t i c s u s i n g S P S S f o r W . London, i n d o w s U.K.: SAGE Publications.<br />

Fior ina , P . , La tt uada , G., Silve s t r in i, C. , P on ar i, O. , & Da ll'Ag lio , P . (1 99 9) . Dis ru pt io n <strong>of</strong> no c tur na l<br />

m e l a t o n i n r h y t h m a n d i m m u n o l o g i c a l i n v o l v e m e n t i n i s c h a nts. e m i Scand c s t r J o k e p a t i e<br />

Immunol, 50(2), 228-231.<br />

F l i e r , J . S . , & U n d e r h i l l , L . H . ( 1 9 9 5 ) -p . i t T u h i e t -a h a y d r p r o y e t n a h l a l a m x i s c a n d i m -me m u dia n e t e d<br />

inf la mma t io n . S e m i n a r s i n m e d i c i n e o f t h e B e t h I s , 1351-1362. r a e l H o s p i t a l , 3 3 2<br />

F o l k a r d , S . ( a1 nc 9 e r9 hyt 0 hms ) : . s ome C pra i ct ic r a l c a na d td he oi re ta ica n l imp lic p ae t io r ns . f Ph o il or s m<br />

T r a n s R S o c L o n d B B i o l (1241), S c i , 543-553. 3 2 7<br />

Fol kma n , S. , & M os kowit z , J . T . ( 20 04 ) . Co pin g: p it f a lls a nd pr omis e. A n n u R e v P s y c h o l , 745-774. , 5 5<br />

Fos t e r , R., & Kr e itz ma n, L. ( 20 04) . R h yt h m s o f L . i Londo f e n : P r <strong>of</strong> ile Books Lt d.<br />

Frankl, V. E. (1970). M a n ' s s e a r c h f o r m e a n i n g : a n i n t r o d u c t i o n t ( A o ne l wly o g o t r eh v. e r a nd p y e nl.<br />

ed.). Boston: Simon and Schuster.<br />

F r e e d m a n , A . , K a u f e r , D . , S h e m e r , J . , H e n d l e r , I . , S o r e q , H -K . , a s & p a , T u I . r 1996) ( . P yr ido s t igmine<br />

br a in pe net ra t ion under st re s s e nha nce s ne uron a l e xvit a bilit y a nd in du c es e ar ly imme ndia t e<br />

t r ans cr ip t io na l r es pons e . N a t u r e M e d i c i , n 1382-1385. e , 2<br />

Fromm, E. (1956). T h e a r t o f . l Ne o v w i Yo n g r k, : Ha r pe r .<br />

F u r n h a m , A . , & S t e e l 3) e . , M ea H s. ur in ( g 1 loc 9 9 us <strong>of</strong> c ontr ol: a c r it iq ue <strong>of</strong> ge ner a l, c hild r en 's , he a lt h a nd w o r k-r e la t e d lo cus <strong>of</strong> contr ol que st io nn a ire s . B r i t i s h J o u r n a l o f P s y ( c 4 h ) o l , o g -480. 4 y 4 , 3 8 4<br />

Ga a b, J. , Hu st er , D., Pe is e n, R., En ge rt , V. , He it z , V. , Sc had , T ., Sc hur me ye r , T . H., & Eh le r t, U. ( 20 02) .<br />

Endocr in e st re s s r es pons es in c hr on ic f at igu e s yn dr ome . I n t e r n a t i o n a l C o n g r e s s S e , r i e s , 1 2 4 1<br />

41-46.<br />

G a a b , J . , R o h l e d e r , N . , H e i t z , V . , E n g e r t , V . , S c h a d , T . , S c h u r m e y e r , T . H . , & - E h l e r t , U . ( 2 0 0 5 ) .<br />

i n d u c e d c h a n g e s -induced i n L pro-in P S f la mma t or y c yt okin e pro du ct io n in ch r on ic f at igu e<br />

s yndr ome . P s y c h o n e u r o e n d o c r i n o l o g (2), y , 188-198. 3 0<br />

G a r c i a-M a u r i n o , S . , P o z o , D -V . ic , o, A. C a , r Ca r li vo, l l J . o R., & Guer r er o , J . M . (1 99 9) . Me la t on in<br />

a c t i v a t e s T h 1 l y m p h o c y -12 t e production. s b y i L i n f c e r e S c a i (20), s , i n 6 2143-2150. 5 g I L<br />

Ga r ss e n , B. ( 2004). P s yc hologic a l f a ct or s an d c a nce r de ve lo pme nt : e vid e nce af te r 30 ye a rs <strong>of</strong> re s ea rc h .<br />

C l i n P s y c h o l R (3), e v , 315-338. 2 4<br />

Ge ye r , S. ( 19 97) . Some c onc e pt ua l co ns id er atio ns on t he s e ns e <strong>of</strong> co her e nc e . S o c ial Sci e nce & M e dic i ne ,<br />

44(12), 1771-1779.<br />

Gigna c , M . A. , & Gott lie b, B. H. ( 19 96 ) . Ca re gi ve r s ' a pp r a isa ls <strong>of</strong> e ff ic ac y in c opin g wit h de me nt ia .<br />

<strong>Psycho</strong>l Aging, 11(2), 214-225.<br />

G i l l a n i , N . B . , & Sm i t h , J . C . ( 2 00 1 ) . Z e n M ed i t a t i o n a n d AB C R e l a x at i o n T h eo r An y: Exploration <strong>of</strong><br />

r e la xat io n st at es , be lie fs , dis pos it io ns , a nd mot iva t io ns . J o u r n a l o f C l i n i c a l P s y , c 839- h o l o g y , 5 7<br />

846.<br />

G l a s e r , R . , K i e c o l t-G l a s e r , J . K . , S t o u t , J . C . , T a r r , K . L . , S p e i c h e r , C . E . , & H o l l -i<br />

d a y , J . E . ( 1 9 8 5 )<br />

r e l a t e d i m p a i r m e nt s in c e llula r immu nit y. P s y c h i a t r y R e (3), s , 233-239. 1 6<br />

G l a s e r , R . , Ma c C a l l u m , R . C . , La s ko ws k i , B . F. , M a l a r ke y, W. B . , Sh e r i d a n , J . F. , & K i e -Gla c ol t s e r , J . K.<br />

( 2 0 0 1 ) . E v i d e n c e f o r a s h -1 i f t o i -2 T n h c y t h o e k i n T e h r e s p o n s e a s s o c i a t e d w i t h c h r o n i c s t r e s s<br />

and aging. J G e r o n t o l A B i o l S c i (8), M e M477-482. d S c i , 5 6<br />

Godoy-Ra mir e z , K., Fr a nc k, K., & Ga in e s, H. ( 20 00 ) . A no ve l me t ho d f or th e s imult a ne ous a ss e ss me nt <strong>of</strong> n a t u r a l k i l l e r c e l l c o n j u g a t e f o r m a t i o n a n d c y t o t o -c x i e l c l i l e t ve y l a b t y m t u h l e t i-para s i n me g l e t er<br />

f low c yt ome t r y. J I m m u n o l M e t h o d ( s 1-2), , 2 35-44. 3 9<br />

Gold, P . W. , & Chr ous os, G. P . ( 19 99) . Th e en do cr in olo gy <strong>of</strong> me la nc holic a nd a t yp ic a l de pr e ss io n:<br />

r e la t ion t o ne ur oc irc uitr y a nd s oma t ic co nse qu e nc es . P r o c A s s o c A m P h y s i c i ( a 1 n ) s , -34. 2 1 2 1 1<br />

Gold, P . W. , Dr e ve ts , W. C., & Ch ar ne y, D. S. ( 20 02 ) . Ne w in s igh t s int o t he role <strong>of</strong> c ort is ol a nd t he gluc oc or t ic oid r e ce pt or in s e ve re de pr es s io n . B i o l P s y c h i a t ( r 5 y ) , 5 -385. 3 2 8 1<br />

Goldsby, R. A., Kindt, T. J., & Osborne, B. A. (2002). Cell-m e d i a t e d e f f e c t ons o r e s . r Ie n s KUBY p<br />

i m m u n o l o g y (pp. 360-3 62 ) . Ne w Yor k: W. H. Fr e e ma n a nd Co mp an y.<br />

G o l i go r s ky, M . S. ( 2 0 0 1 ) . T h e c o n ce pt o f c e l l u l a r "f i gh -or-f t ligh t " r e ac t ion t o s tr e ss . Am J Ph y s i ol Re nal P h y s i o l , (4), 2 8 F551-561. 0<br />

G o u l d i n g , N . J . ( 2 0 0 4 ) . T h e m o l e c xit u l y a <strong>of</strong> r glu c o m c op cl or e t ic oid a c t ions in in f la mmat io n - a four-r in g<br />

c ir c us . C u r r O p i n P h a r m a c (6), o l 629-636. , 4<br />

Gr uz e lie r , J . H. ( 1998) . A wor kin g mo de l <strong>of</strong> th e ne ur oph ys io log y <strong>of</strong> hyp no s is : A r e vie w <strong>of</strong> e vid e nc e .<br />

C o n t e m p o r a r y H y p n o s i , 5-23. s , 1 5<br />

G r u z e l i e r , J 002a . ). H A . r e( vie 2 w <strong>of</strong> t he impa c t <strong>of</strong> hyp nos is , re la xat io n , gu id e d ima ge r y a nd in divid ua l<br />

dif f er e nc e s on as pec ts <strong>of</strong> immun it y a nd he a lth . S t r e s s (2), , 147-163.<br />

5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 05 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Gr uz e lie r , J . H. ( 2002b) . T he r ole <strong>of</strong> ps yc ho lo gic a l in t e r ve nt io n in mo du lat in g a s pec t s <strong>of</strong> immu ne funct i o n i n r e l a t i o n t o h e a l t h a n d we l l-being. I n t R e v N e u r o b i , 383-417. o l , 5 2<br />

G r u z e l i e r , J . H . , C l o w , A . , E v a n s , P . , L a z a r , -body I . in , f lu & e nc W e s a on l k immunit e r , L y: . ( 1 9 9 8 ) . M i n d<br />

l a t e r a l i z e d c o n t r o l , s t r e s s , i n d i v i d u a l d i f f e r e n c e s p r e xis. d i c Ann t o r s N , Y Acad a n d p Sci, r o p h y l a<br />

851, 487-494.<br />

G r u z e l i e r , J . H . , L e v y , J . , W i l l i a m s , J . , & H e n d e r s o n , D . ( 2 -hypnos 0 0 1 ) . S is e l an f d e xa m st re s s :<br />

c o m p a r i n g i m m u n e a n d r e -re l la a x te a d t ima i o n ge r y f or inf lue nc es on immu nit y, he a lt h an d mo od .<br />

C o n t e m p o r a r y H y p n o s i , 73-86. s , 1 8<br />

Gr uz e lie r , J . H. , Smit h, F., Na gy, A. , & He nde r s on , D. C. ( 20 01 ) . Ce llu la r a nd humora l immu nit y, mo od a n d e x a m s t r e s s : t h e i n f l u e n c e s o f -hypnos s e l f is a nd pe rs ona lit y pr e dic to rs . In t J Ps y c ho phy s io l ,<br />

42(1), 55-71.<br />

H a a s , H . S . , & S c h a u e n s t ) e . i I mmu n , nK it . y, h( or 2 mone 0 0 1 s , a nd t he br a in . A l l e r g y , (6), 5 470-477. 6<br />

Ha lvor s e n , R. , & Vas s end, O. ( 19 87 ) . Ef fe ct s <strong>of</strong> e xa min a t io n s tr es s on s ome c e llula r immu nit y f un ct io ns .<br />

J P s y c h o s o m R e (6), s , 693-701. 3 1<br />

H a n , K . S . ( 2 0 0 2 ) . T h e e f f e c t o f a n i n t e na g r ge a t me e d nt s pr t or gr e s as m on m a t he ps yc ho lo gic a nd phys iolo gic s t re s s r ea ct ions <strong>of</strong> pe pt ic ulc e r in Ko r e a . I n t J N u r s S ( t 5 u ) d , -548. 3 5 9 3 9<br />

H a n n e t , I . , E r k e l l -Yuks e r e l, F. , Lyd ya r d, P ., De ne ys , V. , & De Bru ye r e , M . ( 19 92 ) . De ve lo pme nta l a nd m a t u r a t i o n a l c h a n g e s i n blood h u m a lymphocyte subpopulations. I m m u n o l T o d a y , (6), 1 215, 3<br />

218.<br />

Ha ns e n, M . K., T a is hi, P ., Che n , Z. , & Kr ue ge r , J. M . ( 199 8 ). Va got omy blo c ks t he in du ct io n <strong>of</strong><br />

i n t e r l e -1 u k b i e n t a -1 b ( e I t L a ) m R N A i n t h e b r a i n o f r -1beta. a t s J i n r e s p o n s e t<br />

N e u r o s c i , (6), 1 8 2247-2253.<br />

Ha r dac r e, H. (1988) . K u r o z u m i k y o a n d t h e n e w r e l i g i . o Pr n s inc et o f on , J N.J a p .: a n P r ince ton Unive r s it y<br />

Pr e ss .<br />

Ha t c h, R. L. , Bur g, M . A., Na ber ha us , D. S. , & He llmic h , L. K. ( 19 98) . T he Spir it ua l I nvolve me nt a nd B e l i e f s Sc a l e . D e ve lopme nt a nd t es t in g <strong>of</strong> a ne w in s t r ume nt . J F a m P r a c t (6), , 476-486. 4 6<br />

He im, C. , Eh le r t, U., & He llha mme r , D. H. ( 20 00 ) . Th e po te nt ia l ro le <strong>of</strong> hyp oc ort is olis m in t he p a t h o p h y s i o l o g y o f s t -re r e s la s t ed bo dily dis orde r s. P s y c h o n e u r o e n d o c r i n o l o g ( y 1 , ) , -35. 2 5 1<br />

He nnig, J . , Ne tt er , P ., & Voigt , K. ( 20 00) . M ec ha nis ms <strong>of</strong> c ha nge s in lymp ho c yt e nu mb er s a f te r<br />

ps yc holo gic a l s t r es s . Z Rheumatol, 59 Suppl 2, II/43-48.<br />

H e r m a n , J . P . , C u l l i n a n , W . E . , Z i e g l e r , D . R . , & T a s k e r , J . G s . ( 2 0 0 2 ) . R o l e<br />

mic r oe nvir onme nt in st re s s int e gr at io n . E u r J N e u r o s c (3), i , 381-385. 1 6<br />

He t t ma nn sp e r ge r, U., T enor io, S. , Orf a nos , C. E. , & De t mar , M . ( 19 93) . Cor t icost e roids ind uc e<br />

p r o l i f e r a t i o n b u t d o - n or o t IL-1 i beta-i n f l u e n c d e u T N c F -1 e xpr d e ss io I n <strong>of</strong> C human A M<br />

de r ma l mic r ova sc ula r e ndot he lia l c e lls in vit r o . A r c h D e r m a t o l R e ( s 6 , ) , 2 8 -351. 3 5 4 7<br />

He us er , I. , & La mme r s , C. H. ( 200 3 ) . St r e ss an d t he br a in . N e u r o b i o l A g i n g , 2 4 , S69-76; S u p p l 1<br />

d i s c u s s i o n -62. S 8 1<br />

Hingor a ni, R. , Bi, B., Da o, T ., Ba e , Y. , M at suz a wa , A. , & Cr is pe , I . N. ( 200 0) . CD9 5/ Fa s Sign a lin g in T<br />

L y m p h o c y t e s I n d u c e s t h e C e l l C y c l e C o n t r -1 o l / W P A r F-1 o t , Wh e i n ic h p P2 r1 omot c i p e s<br />

Apoptosis. J I m m u n o l , (8), 1 6 4032-4036. 4<br />

Hlatky, M. A., Boothroyd, D. B., Melsop, K. A., Brooks, M. M., Mark, D. B., Pitt, B., Reeder, G. S.,<br />

Roge r s , W. J . , Rya n, T. J ., Whit lo w, P . L. , & Wie ns , R. D. ( 20 04) . Me dic a l c os ts a nd qua lit y <strong>of</strong> lif e 10 t o 12 ye ar s af te r r andomiz at io n to a ngio pla s t y or byp a s s s ur ge r y f or mult ive s se l c oro na r y<br />

a r te r y dis e as e . C i r c u l a t i o n (14), , 1 1 1960-1966. 0<br />

Hols boe r , F. ( 2001) . St re s s , hyp e r co rt is olis m a nd c ort ic ost e ro id r ec e pt or s in de pre ss io n : imp lic a t io ns f or t her a py. J A f f e c t D i s ( o 1-2), r d , 77-91. 6 2<br />

Hor owit z , M . , Wilne r , N., & Al va r e z , W. ( 197 9 ) . I mp a ct <strong>of</strong> Eve nt Sc a le : a mea s ur e <strong>of</strong> s ubje c t ive s tr es s .<br />

Ps y c h o s o m M e d , (3), 4 209-218. 1<br />

Huc kle br id ge , F., Se n, S., Eva ns , P . D. , & Clo w, A. ( 19 98 ) . T he r e lat io ns hip be t we e n c ir c ad ia n pat te r ns<br />

<strong>of</strong> sa liva r y c or t is ol a nd e ndoge no us in hib it or <strong>of</strong> mo noa min e ox id as e A. L i f e S c i (25), , 6 2321- 2<br />

2328.<br />

H u e t h e r , G . ( 1 9 9 6 ) c. e nt T ra h l e a da pt at ion s yndr ome : ps yc ho s oc ia l s tr e ss as a t r igge r f or ad a pt ive<br />

modif ic a t io ns <strong>of</strong> bra in s tr uc t ur e a nd br a in f unc t io n . P r o g N e u r o b i o l ( , 6 ) , 4 8 -612. 5 6 9<br />

H u l l , J . T . , W r i g h t , K . P . , J r . , & C z e i s l e r , C . A . ( 2 0 0 3 ) . T h e i n f l u e n s c ae nd o f s u b j e c t i v e a l e r t n e s<br />

mot iva t io n on huma n perf or man c e in de pen den t <strong>of</strong> c irc a dia n a nd home ost at ic re gu la t io n . J Bi ol Rhythms, 18( 4 ) , -338.<br />

3 2 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 06 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

H u t c h i n s o n , P . , D i v o l a , L . A . , & H o l d s w o r t -induced h , S . T-ce R . ll CD69 ( 1 9 9 9 e) xpre . sM s io i n t is o g a e n<br />

l e s s s e n s i t i v -c e l l m f u e n a c t s i o u n r t h e a n [ o ( 3 f ) H -t hymidin ] T e upt a ke . C y t o m e t r y , ( 5 ) 3 , 8 -2<br />

4 4<br />

249.<br />

I nngj er din ge n , M ., Da maj , B., & M a gh a z ac hi, A. A. ( 20 01 ) . Expr e ss io n a nd re gula t io n <strong>of</strong> ch e mo kin e<br />

r e ce ptor s in huma n nat ura l kil le r c e lls . Blood, 97( 2 ) , -375. 3 6 7<br />

Inoue-S a k u r a i , a , S., C & . Mo , r imoto, M a K. r ( 2000). u y a P om stt r au ma t ic s tr es s an d lif e st yle s ar e<br />

a s s o c i a t e d w i t h n a t u r a l k i l l e r c e l l a c t i v i -Awa t y i j i n e a rv ti hqu c t a ke i m in s J apa o f n. t h e H a n s h i n<br />

P r e v M e d , (5), 3 1 467-473.<br />

I n s er r a , P . , Z h a n g, Z . , Ar d es t an i , S. K . , Ar a gh -Niknam, i M., Liang, B., Jiang, S., Shaw, D., Molitor, M.,<br />

Elliot t , K. , & Wat son, R. R. ( 199 8 ) . M od ula t io n <strong>of</strong> c yt okin e pr odu ct io n by de hydr oep ia nd rost e rone ( DHEA) plu s me la ton in ( M LT) su pp le me nt at io n <strong>of</strong> old mic e . Proc Soc<br />

E x p B i o l M e d (1), , 2 76-82. 1 8<br />

J a c obs , R. , Hint z en, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K. W., & Schmidt, R. E.<br />

( 2001) . CD5 6b r ight ce lls dif f er in th e ir KI R re pe rt oire a nd c yt ot ox ic f e at ur e s f rom CD5 6d im NK<br />

c e lls . E u r J I m m u n o l (10), , 3 3121-3127. 1<br />

J a ne wa y, C. A. , T r a ve rs , P ., Wa lp or t, M., & Shlomchik, M. (2001). I m m u n o b i o l o g . y Ne w Yo r k:<br />

Chur c hill Li vin gs t one .<br />

J e n t s -Ullr c h ic h, K. , Koe nigs ma nn, M ., Mo hre n , M. , & Fr a nke , A. ( 20 05) . Lymp ho c yt e s ub s et s ' r e fe re nc e<br />

r a n g e s i n a n - a and g e gender-b a l a n c e d p o p u l a t i o n o f 1 0 0 h e a l t h y - - a d monoc u l t s e nt r ic Germa n<br />

study. C l i n I m m u n o l ( , 2 ) 1 , 1 6 -197. 1 9 2<br />

J o h n , C . D . , & B u c k i n g h a m , J . C . ( 2 0 0 3 ) . C y t o k i n e s : r -p e i g t u l u i a t - i a r o n y o f t h e h y p o t h a l a m o<br />

a dr enoc ort ic a l a xis . C u r r O p i n P h a r m a c (1), o l 78-84. , 3<br />

J o n u l e i t , H . , & Sc h m i t t , E . ( 2 0 03 ) . T h e R e gu l a t or y T C l e Fa l mil y: D is t inc t Subse t s a nd t he ir<br />

I nte rr e la t io ns . J I m m u n o l , (12), 1 7 1 6323-6327.<br />

J os eph, S. ( 200 0) . Ps yc homet r ic e va lu a t io n <strong>of</strong> Ho r owit z 's I mp a ct <strong>of</strong> Eve nt Sc a le : a re vie w. J Trauma<br />

S t r e s s , (1), 1 101-113. 3<br />

Kaech, S. M., & Ahmed, R. (2003). Immunology. CD8 T c e lls r e me mb e r wit h a lit t le he lp . Sc i en c e,<br />

300(5617), 263-265.<br />

Karin, M., & Lin, A. (2002). NF-ka pp a B a t the c ro s sr oad s <strong>of</strong> lif e an d de a th . N a t I m m u n o (3), l , 221-227. 3<br />

K e e f e r , L . , & B l a n c h a r d -u p , o f E r . e l a x a B t . i o n r ( e s 2 p o 0 dit n s 0 ation e 2 m ) e a s . a A o n e y e a r<br />

t r ea t men t f or ir r ita ble bowe l s yn dr ome . B e h a v i o u r R e s e a r c h a n d T h e r , 541-546. a p y , 4 0<br />

Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., & Broussard, S. R.<br />

( 2 0 0 3 ) . C y t o k -induc i n e e d s ic kn e s s be ha vior . B r a i n B av e h Immun, 17 Suppl 1, S112-118.<br />

Kidd, P . ( 200 3 ) . T h1/T h2 ba la nce : t he hyp ot he s is , it s limit a t io ns , an d implic a t io ns f or hea lth a nd dise as e .<br />

A l t e r n M e d R (3), e v , 223-246. 8<br />

K i e c o l t -Gla s e r , J . K., & Gla se r , R. ( 199 2 ) . P syc ho ne uro immu nolo gy: c a n ps yc ho lo gic a l in t e r ve nt io ns<br />

modula t e immunit y? J C o n s u l t C l i n P s ( y 4 c ) h o , l , -575. 5 6 9 6 0<br />

K i e c o l t -Gla s e r , J . K., & Gla se r , R. ( 199 9 ) . P syc ho ne uro immu nolo gy a nd c a nc er : f ac t or f ict io n ? Eu r J<br />

Cancer, 35(11), 1603-1607.<br />

K i e c o l t -G l a s e r , J . K . , G l a se r , R ., St r a i n , E . C., St o , u J. t C., Tarr, K. L., Holliday, J. E., & Speicher, C. E.<br />

( 1986) . M od ulat ion <strong>of</strong> ce llula r immu nit y in m e dic a l s tu de nt s. J B e h a v M e d (1), , 5-21. 9<br />

K i e c o l t -Gla s e r , J . K., M ar uc ha , P . T ., At kin s on , C. , & Gla s er , R. ( 20 01) . Hyp nos is a s a mod ula t or <strong>of</strong><br />

c e l l u une l dys a r e gu la ti ion m dur m ing a c ut e s tr e ss . J C o n s u l t C l i n P s (4), y c h 674-682. o l , 6 9<br />

Kir s c hb aum, C. , Pr uss ner , J . C., St on e , A. A. , Fe de r e nko , I. , Ga ab , J . , Lint z , D., Sc homme r, N. , &<br />

H e l l h a m m e r , D . H . ( 1 9 9 5 ) . P e r s i s t e n t h i g h c o r t i s o ologic l r e as l p so t rn es s e in s t o r e p e a t e d p s<br />

a s ubpo pu lat io n <strong>of</strong> hea lt hy me n. P s y c h o s o m M e d , (5), 5 468-474. 7<br />

Koh, K. B. (1998). Emotion and immunity. J P s y c h o s o m R e ( s , 2 ) , 4 5 -115. 1 0 7<br />

Kosslyn, S. M., Thompson, W. L., Costantini-Fe r r a nd o , M . F. , Alp e r t , N. M . , & Spie ge l, D . ( 20 00 ) .<br />

H y pnot ic vis ua l illus ion a lt e r s c olo r pro c es s in g in t he br a in . A m J P s y c h i a t r ( y 8 , ) , 1 5 7 1 -1284. 2 7 9<br />

Kr onfol, Z. , & Re mic k, D. G. ( 200 0 ) . Cyt okin e s an d t he br a in : imp lic a t io ns f or c linic a l psyc hia t r y. Am J<br />

P s y c h i a t r y , ( 5 ) 1 5 , 7 -694. 6 8 3<br />

Kr ue ge r , J . M. , & Ma j de , J. A. ( 19 94) . M ic r ob ia l pr od uc ts a nd c yt okin e s in s le ep a nd f e ver r e gu la t io n .<br />

C r i t R e v I m m u n ( o 3-4), l , 355-379. 1 4<br />

Kr ue ge r , J . M. , & Ma j de , J. A. ( 20 03) . Hu mor a l lin ks be t we e n s le ep a nd t he immu ne s ys tem: r e s e ar c h<br />

is s ue s . Ann N Y Acad Sci, 992, 9-20.<br />

K r u e g er , J . M. , Ma jde , J . A., & Ob a l, F. ( 2003 ) . Sle e p in ho st de fe ns e. Brain Behav Immun, 17 Suppl 1,<br />

S41-47.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 07 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

La idla w, T . M . ( 1994) . Hypnos is a nd bre at hin g t r a in in g in t he t r ea t me nt <strong>of</strong> a nx iet y: T hre e c a s es .<br />

A u s t r a l i a n J o u r n a l o f C l i n i c a l a n d E x p e r i m e n t a is., l H 22( y p n 2 o ) s , -145. 1 3 7<br />

La idla w, T . M . ( 1999) . T he int e rr upt dist ra ct io n pro c e du re : a br ief hyp not ic in t er ve nt io n f or be lie f c ha nge a nd dimin is hin g dis t r es s . A m e r i c a n J o u r n a l o f C l i n i c a l , 22-34. H y p n o s i s , 4 2<br />

Laso, F. J., Madruga, J. I., Giron, J. A., Lopez, A., Ciudad, J., San Miguel, J. F., Alvarez-Mon, M., &<br />

Or f a o, A. ( 19 97) . Dec r ea s ed nat ur a l kille r c yt ot ox ic a ct ivit y in c hr on ic a lc oh olis m is a ss oc ia t e d<br />

wit h a lc oh ol live r dis e as e but no t a ct ive e t hano l c on s umpt io n . H e p a t o l o g y , (5), 2 5 1096-1100.<br />

L a v i e , P 0 . 0 1 ) ( . 2 S l -wa e e ke p a s a bio logic a l r hyt hm. A n n u R e v P s y c h o l , 277-303. , 5 2<br />

La wr e nc e , D. A., & Kim, D. ( 20 00 ) . Ce ntr a l/p e r ip her a l ne r vo us s ys t e m an d immu ne r e s pon s e s .<br />

Toxicology, 142(3), 189-201.<br />

La yc oc k, J . , & Wis e , P . ( 2003) . E s s e n t i a l E n d o c r i n o . l O o x g f y or d : Ox fo r d unive r s it y pre s s .<br />

Lazarus, R. S. (1999). S t r e s s a n d e m o t i o n : a n e w s y n t . h Londo e s i s n : Sp r inge r P ublis hing Co mp a ny, I nc .<br />

Lazarus, R. S., & Folkman, S. (1984). S t r e s s , A p p r a i s a l a n . d Ne C w o Yo p i rn k: g Sp r inge r Publis hin g<br />

Compa ny. LeDoux, J. (1998). T h e e m o t i o n a l . b London, r a i n U. K.: Phoenix.<br />

Lehmann, E. H. (2001). S t u d y S i z e D e t e r m i n a t i o n ( S D D ) p , r 2005, o g r a m from m e<br />

h t t p : / / w w w . u i b . n o / i s f / p e o p l e / d o c / s s d . h t m<br />

Le ppa ma ki, S. , P ar tone n, T ., Va kku r i, O. , Lo nn qvis t , J . , Pa rt in e n , M . , & La ud on , M . ( 20 03) . Eff e ct <strong>of</strong><br />

c o n t r o l -r l e le d as e me lat onin on s le ep qua lit y, mo od , a nd qua lit y <strong>of</strong> lif e in s ubj ec t s wit h s e as on a l<br />

o r w e a t h e r-a ss oc iat e d c hange s in mo od an d be ha vio ur . Eur op ea n Ne ur ops y ch op har ma co l og y ,<br />

13( 3) , 137-145.<br />

Le vy, S. M . , He r be r man, R. B., Simo ns , A. , Wh it e s id e , T . , Le e , J . , M c Do na ld , R. , & Bea dle , M . (1 98 9) .<br />

P er s ist e nt ly low na t ur a l kille r c e ll a c t ivit y in no r ma l a du lt s : immu no lo gic a l, ho r mo na l a nd mo od c orr e la te s . N a t I m m u n C e l l G r o w t h (3), R 173-186. e g u l , 8<br />

L o r i a , R . M . ( 2 0 0 2 ) . -r eI gula m m t io u n e an u d p t umor apopt os is by a nd r os te ne s te r oids . S t e r o i d s , (12), 6 7<br />

953-966.<br />

Lundbe r g, U. ( 2005) . St r e ss hor mo nes in hea lt h a nd illn e s s : t he role s <strong>of</strong> wo r k a nd ge nd er .<br />

P s y c h o n e u r o e n d o c r i n o l o g (10), y , 1017-1021. 3 0<br />

Lyons , A. B. ( 2000) . Ana lys in g c e ll div is io n i n vi vo a nd in vit r o us in g f lo w c yt ome t r ic me as ur e me nt <strong>of</strong> CFSE dye dilu t ion. J Immunol Methods, 243( 1-2), 147-154.<br />

M a dde n , K. S. ( 2001) . Cat e chola min e s , s ymp a t het ic ne r ve s , a nd immu nit y. I n Ad e r , R. , Fe lt e n , D. L. &<br />

Cohen, N. (Eds.), P s y c h o n e u r o i m m u n o l o g y 3 r d (pp. e d i t 197-2 i o n 16 ) . Sa n Die go: Ac a de mic<br />

Pr e ss .<br />

M a es , M . , Lin , A. H., De lme ir e , L. , Va n Ga s te l, A. , Ke nis , G. , De J on gh , R. , & Bos ma ns , E. ( 19 99) .<br />

E l e v a t e d s e r u m i n t -6 e (IL-6) r l e u k and i n IL-6 r e c e p t o r ce ntr c o at n io ns in post tr a umat ic str e ss<br />

d i s o r d e r f o l l o w i n g a c c i -ma d e de n t tr a l auma m ta ic n e ve nts . B i o l P s y c h i a t ( r 7 y ) , 4 -839. 8 5 3 3<br />

M a es , M . , St e ve ns , W., Pe et e rs , D. , De Cler c k, L. , Sc ha r pe , S. , Br idts , C. , Sc hot te , C. , & Cos yn s , P .<br />

(1992). A study on the blunted na tu r a l kille r c e ll a c t ivit y in s e ve r e ly de pr e s se d pa t ie nt s. Life Sci ,<br />

50( 7 ) , -513. 5 0 5<br />

M a es , M . , Va n Boc ks t ae le , D. R. , Ga st e l, A. , So ng, C. , Sc ho t te , C. , Nee ls , H. , DeM ee st er , I. , Sc ha r pe, S. ,<br />

& Ja n ca , A. ( 1 9 9 9) . T he ef f ec t s <strong>of</strong> p s yc h o l o gi c a l s t r es s on e ukoc l yt e s ub s et dist r ibut ion in<br />

huma ns : e vid e nce <strong>of</strong> immune a ct iva t io n . N e u r o p s y c h o b i o l o g y ( , 1 ) 3 , -9. 9 1<br />

Maier, S. F. (2003). Bi-d i r e c t i o n a l i m -bra m u n in e c ommu nic at ion: I mplic a t io ns fo r un der st an din g s t r es s ,<br />

pain, and cognition. B r a i n B e h a v I m m u (2), n , 69-85. 1 7<br />

M a i e r , S . F . , & W a t k i n s , L . R . ( 1 9 9 8 ) . C y t o k i n e s f o r p s y c h o l o g i s t s : i m p l i -c<br />

a t i o n s o f b i d i r<br />

t o-br a in c ommunic at ion for und er st a nd in g beh a vio ur , mo od , a nd c ognit io n . Ps y c hol ogi c al<br />

R e v i e w , , 1 83-107. 0 5<br />

Malek, T. R., Yu, A., Scibelli, P., Lich t e n h e l d , M . G . , & C o d i a s , E . K . - ( 2 0 0 1 ) . B r<br />

2 r ec e pt or s ign a ling f or e xte nde d gr owt h t o mu lt ip le c yt okin e s a nd f unc t io na l ma t ur at io n <strong>of</strong> a n t i g -a e n c t iva t ed T ce lls . J I m m u n o l , (3), 1 6 1675-1683. 6<br />

M a n d e l b o i m , O . , & P o r g a d o r , A 46. . I ( n 2 t 0 0 1 J ) . B i N o c K h p e m C e l l (12), B i 1147-1150. o l , 3 3<br />

M a r mot , M . ( 2004) . W h i t e h a l l I I , S 2004, t u d y from ht t p : / / w w w. u c l . a c . u k/ wh i t e h a l l I I /<br />

M a r s h a l l , L . , & B o r n , J -immun . ( 2 0 e 0 in 2 ) t er . a ct B ions r a i in n s le e p. I nt R e v N e u r o b i o l , , 93-131. 5 2<br />

M a r z , P . , H e e s e , K . , D i m -S i t c r h i m a u d e t s z , B . , -J R o s h n e , S . , & O t t e n , U . ( 1 9 9 9 ) . -6 R o l e o f i n t e r l e u<br />

and soluble IL-6 r e c e p t o r i n -s pe r e cg if i ic o in n du ct ion <strong>of</strong> a st roc yt ic diff e re nt ia t io n a nd neurotrophin expression. G l i a , (3) 2 , 6 191-200.<br />

M a sc hke , C. , & He cht , K. ( 2004) . St r es s ho rmo ne s an d s lee p dist urb a nc e s - e lec tr op hys iolo gic a l a nd hor mona l a s pe c ts . N o i s e H e a l (22), t h , 49-54.<br />

6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 08 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

McEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R.<br />

H., Kit s on , R. P., M ille r , A. H., Sp e nc e r , R. L. , & We is s, J . M . ( 19 97) . Th e r ole <strong>of</strong><br />

a dr enoc ort ic oids as modulat ors <strong>of</strong> immu ne fun c t io n in he a lt h a nd dis e as e : neur a l, e nd oc r ine a nd immune in t e ra ct ions . B r a i n R e s B r a i n R e s ( 1-2), R e v 79-133. , 2 3<br />

M c G a u g h , . J L., & Ro oz e nda a l, B. ( 2002) . Ro le <strong>of</strong> ad re na l st re s s ho r mon e s in f or min g la s t in g me mo r ie s<br />

in t he br a in . C u r r O p i n N e u r o b i ( o 2 l ) , 1 -210. 2 0 5<br />

M c Glon e , J . J. , Lumpkin, E. A., & No r ma n , R. L. ( 19 91 ) . Ad r e no co rt ic otr opin s t imula te s na t ur a l kille r<br />

c e l l a c t i vi ty. Endocrinology, 129(3), 1653-1658.<br />

M c Hugh , R. S. , & She va c h, E. M . ( 200 2 ) . T he r ole <strong>of</strong> su ppr e ss or T c e lls in re gula t io n <strong>of</strong> immu ne r e s ponse s . J A l l e r g y C l i n I m m (5), u n o 693-702. l , 1 1 0<br />

M e eha n , T. C. (1998) . T he r ape ut ic to uc h a s a nu r s in g in t er ve nt io n . J A d v Nurs, 28(1), 117-125.<br />

M iddle t on , D. , Cur ra n, M ., & Ma xwe ll, L. ( 20 02 ) . Na t ur a l kille r c e lls a nd t he ir r ec e pt ors . Tr ansp l ant<br />

I m m u n o l o g y , ( 2-3), 1 0 147-164.<br />

M i l l e r , A . H . , S p e n c e r , R . L . , h a s s St e in, t t , J . ,<br />

M . (199 4) . Ef f ec ts <strong>of</strong> s e lec t ive t yp e I a nd I I ad r e na l s te r oid a go nis t s on immu ne ce ll dis t r ibu t io n .<br />

E n d o c r i n o l o g y , (5), 1 3 1934-1944. 5<br />

M i l l e r , G . E . , & C o h e n , S . ( 2 0 0 1 ) . P s y c h o l o g i c a l i n t e r v e n t i o n s a n d -a t na h e lyt i ic m m u n e s y s t e m : a m<br />

r e v i e w a n d r it c ique . H e a l t h P s y c h o (1), l , 47-63. 2 0<br />

M ilr os s , M . A. , P ipe r , A. J ., Nor ma n , M . , Dob bin , C. J . , Gr uns te in , R. R. , Su lli va n , C. E. , & Bye , P . T .<br />

( 2002) . Su bje ct ive s le e p qua lit y in c ys t ic f ib ro s is . S l e e p M e d ( , 3 ) 3 , -212. 2 0 5<br />

Mold<strong>of</strong>sky, H. (1995). Sleep and th e immu ne s ys t e m. I n t J I m m u n o p h a r m a c (8), o l , 649-654. 1 7<br />

M o n t g o m e r y , G . H . , D u H a m e l , K . N . , & R e d d , W . -a na H lys . is ( 2 o0 f 0 h0 ypnot ) . A ica m lly e t induc a e d<br />

a na lge s ia : how e f f ec t ive is hypn os is ? Int J Clin Exp Hypn, 48( 2 ) , -153. 1 3 8<br />

M o r e t t a , L . , B eo nde t t , D. i , n Mo in , ga rC i, . M , . C., P Bia ss on i, R. , & M or e tt a , A. ( 20 02) . Hu ma n nat ur a l<br />

ki lle r c e lls : t he ir or igin, r e c e pt or s a nd f un ct ion . E u r J I m m u n o l (5), , 1205-1211. 3 2<br />

M o y n i h a n , J . A . , & S t e v e n s , S . Y . ( 2 0 0 1 ) . M e c h a n i -i s n m d s u c o e f d m s t o r d e u s s l at i o n o f I mm u n i t y in<br />

a nima ls . I n Ad e r , R., Fe lt e n, D. L. & Co he n, N. ( Ed s .) , P s y c h o n e u r o i m m u n o l o g y 3 r d (pp. e d i t i o n<br />

227-250 ) . Sa n Die go, U. S. A.: Ac a de mic Pr es s .<br />

M u l l a , A . , & B u c k i n g h a m , J . C . ( 1 9 9 9 ) . R e g u l -p a t i i t o u n i t -a o a f dr r ey na t h l e ax is h y bp y o t h a l a m o<br />

c yt okine s . B a i l l i e r e s B e s t P r a c t R e s C l i n E n d o c r ( i 4 ) n o , l -521. 5 M 0 3 e t a b , 1 3<br />

M unc k, A. , Gu yr e , P . M., & Holb r oo k, N. J . (1 98 4 ). P hys io lo gic a l f un c t io ns <strong>of</strong> glu c oc ort ico id s in s tr es s<br />

a nd the ir r e lat ion t o phar ma colo gic a l a c t io ns . E n d o c r R e v (1), , 5 25-44.<br />

M y e r s , B . L . , & , P. B (199 a d i a 5) . Ch ange s in c ir c a dia n r hyt hms a nd s le e p qu a lit y wit h a gin g:<br />

me c ha nis ms a nd int er ve nt ions. N e u r o s c i B i o b e h a v R ( e 4 v ) , 1 -571. 5 9 5 3<br />

Naito, A. (2003). D a i l y J o h r e i T e c h n i q u e H a n . d London: b o o k Imperial College London.<br />

N a i t o , A . , L a i d l a w , ett, T . B. M., M . Gruzelier, , B e n n J. H., Burton, S. E., & Henderson, D. C. (2005, 22-<br />

26 August). Th e i nfl ue nc e <strong>of</strong> ps y ch olo gic al i nt e rv e nt io ns up on s tr e ss re l at ed c han ges : 2. I n<br />

d i s e a s e a s s o c i a t -i e nf d ec te s d t patie r e ns ts . s P a i p e n r H p r I e V s e n t e d a t t h e 1 8 t rh e ss W o r l d C o n g<br />

on P s yc ho soma t ic M edic ine , Ko be , Ja pa n .<br />

Nona ka , I . o. , & T a ke uc hi, H. ( 199 5 ) . T h e k n o w l e d g -c e r e a t i n g c o m p a . n Ne y w Yo r k: Oxf or d Unive r s it y<br />

Pr e ss .<br />

O'M a t hu na, D. P ., Pr yj ma c huk, S. , Sp e nc e r , W. , St a nwic k, M . , & M at th ie s e n, S. ( 20 02) . A c r it ic a l<br />

e v a l u a t n i <strong>of</strong> o t he th e or y a nd pr a ct ic e <strong>of</strong> t her ap e ut ic t ouc h . N u r s P h i l o s o p (2), h y , 163-176. 3<br />

Oos t er lyn c k, D. J ., Me ule ma n, C. , La c qu et , F. A. , Wa e r , M . , & Kon in c kx , P . R. (1 99 4) . Flo w c yt ome t r y<br />

a na lys is <strong>of</strong> lymphoc yt e s ubpopu la t io ns in per it on ea l f lu id <strong>of</strong> wome n wit h e nd ome tr ios is . Am J<br />

R e p r o d I m m u n o l (1), , 3 25-31. 1<br />

Opf e r ma n , J. T . , & Kor s me ye r , S. J . ( 200 3 ) . Ap op t os is in th e de ve lo pme nt a nd ma int e na nc e <strong>of</strong> t he<br />

immune s ys t e m. N a t I m m u n o (5), l , 410-415. 4<br />

P ac a k, K. , & P a lkovit s , M . ( 200 1) . St re s so r sp e c if ic it y <strong>of</strong> c e nt ra l ne ur oe nd ocr in e re s po nses : imp lic a t io ns<br />

f o r s t r e -r s s e lat e d dis ord e rs . E n d o c r R e v , (4), 2 2 502-548.<br />

P ar ia nt e , C. M . , & M ille r , A. H. ( 20 01) . Glu co c ort ic oid re c ep t or s in ma j or de pre s s io n : r e leva nc e t o<br />

pa t hoph ys io lo gy a nd t r e at me nt . B i o l o g i c a l P s y c h i ( a 5 t ) , r 391-404. y , 4 9<br />

P ar k, C. L. , & Folkma n, S. ( 199 7 ) . St a bilit y a nd c han ge in ps yc hoso c ia l r es our c es dur in g c a r e givin g a nd be r ea ve me nt in pa rt ne r s <strong>of</strong> men wit h AI DS. J P e r s , (2), 6 421-447. 5<br />

P att e rs on , D. R. , & Je ns en, M . P . ( 20 03 ) . Hypn os is a nd c lin ic a l pa in . P s y c hol Bull, 129( 4 ) , -521. 4 9 5<br />

P att e rs on , E. F. ( 1998) . <strong>The</strong> philo s op hy a nd ph ys ic s <strong>of</strong> ho lis t ic hea lt h ca re : s pir it ua l he a lin g a s a wo r ka ble<br />

int e r pr et at io n . J A d v N u r s (2), , 287-293.<br />

2 7<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 09 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P e r l s t e i n , R . S . , W h t m a l l , M . H . , A b r a m s , J . 993). S . , Syn M eo ru gg is e t ic y , r oles E . <strong>of</strong> H . , & N e t a , R .<br />

I n t e r l e -6 u k , i n I n t e r l -1, e u ak nd i n T umo r Ne c ros is Fa c t or in th e ad r en oc ort ic otr op in r e sp on se t o<br />

ba c te r ia l lip op olys a c c ha r ide in vi vo . Endocrinology, 132, 946-952.<br />

P i k e , J . L . , S m i t h , T . L . , H a u g e r , R . n, L . T , . L., N Mi c Clint a s s i ic o k, , J ., P Cos . t low, M . , C. , P & a t t e r s o<br />

I r win, M . R. (1 997) . Chr onic lif e s tr e ss a lte rs s ymp a t het ic , neu r oe nd oc r in e , a nd immu ne r e s pons ivit y t o a n a c ut e ps yc holo gic a l s t r es s or in hu ma ns . P s y c h o s o m M e d , (4), 5 447-457. 9<br />

P r o m e g a . ( 2 0 0 4 ) . C y t o T o x -r 9 6 a : d i ao ct N ive o n Cyt ot ox ic it y As s a y. U.S. A.<br />

Quan, N., Avitsur, R., Stark, J. L., He, L., Lai, W., Dhabhar, F., & Sheridan, J. F. (2003). Molecular<br />

me c ha nis ms <strong>of</strong> gluc ocort ic oid r es is ta nce in s ple no c yt e s <strong>of</strong> s oc ia lly s t r es s ed ma le mic e . J<br />

N e u r o i m m u n o l , ( 1-2), 1 3 7 51-58.<br />

Qua n, N. , Avit s ur , R., St ar k, J . L. , He , L. , Sh a h , M. , Ca ligiu r i, M . , P a dge tt , D. A. , M ar ucha , P . T . , &<br />

She r ida n , J . F. ( 2001) . Soc ia l s tr e ss in c re as e s t he s usc e pt ib ilit y t o e nd ot ox ic sh oc k. J ou r nal <strong>of</strong> N e u r o i m m u n o l o g y , ( 1-2), 1 1 5 36-45.<br />

Raymond, J., Varney, C., P ar kin s on , L. A. , & Gr uz e lie r, J . H. ( 200 5 ) . Th e e ff e ct s <strong>of</strong> a lp ha /th e t a<br />

ne ur<strong>of</strong> ee dba c k on per s ona lit y a nd mo od. B r a i n R e s C o g n B r a i n ( 2-3), R e s 287-292. , 2 3<br />

Reichlin, S. (1993). <strong>Neuro</strong>endocrine-I mmu ne in t e ra ct io ns . N e w E n g l a n d J o u r n a l o f M e d i , 1246- c i n e , 3 2 9<br />

1253.<br />

Ric ha r ds , P . S. , & Be r gin, A. E. ( 19 97) . A s p i r i t u a l s t r a t e g y f o r c o u n s e l i n g a n d p (1st s y c eh d.) o t . h e r a p y<br />

Wa s hin gt on , DC: Ame r ic a n P s yc ho lo gic a l As s oc ia t io n.<br />

Rohle de r, N. , Kudie lka , B. M ., He llh a mme r , D. H. , Wo lf , J . M ., & Kir sc hb au m, C. (2 00 2) . Age and sex<br />

s t e r o -r i e d l a t e d c h a n g e s i n g l u c o c o r t i c o i d -inf s e la n s mma i t i to v ri y t c yt y okine o f pr p r oduct o io n<br />

a f te r ps yc ho so c ia l st r es s . J o u r n a l o f N e u r o i m m u n o l ( o g 1-2), y , 69-77. 1 2 6<br />

Rohle de r, N. , Sc homme r , N. C., He llh a mme r , D. H. , En ge l, R. , & Kirs c hba um, C. ( 20 01 ) . Se x dif f e re nce s<br />

in gluc oc or t ic oid s e ns it ivit y <strong>of</strong> pr oin f la mma to r y c yt okin e pr od uc t io n a ft er ps yc hos oc ia l st re s s .<br />

P s y c h o s o m M e d , (6), 6 966-972. 3<br />

Rooz e nd a a l, B. ( 2000) . 1999 Cu rt P . Ric ht er a wa r d . Glu c oc or t icoids a nd th e r e gula t io n <strong>of</strong> me mor y<br />

c o n s o l ation. i d P s y c h o n e u r o e n d o c r i n o l o g (3), y , 213-238. 2 5<br />

Ros e , N. R. ( Ed .) . ( 2002) . M a n u a l o f c l i n i c a l l a b o r a t o r y i : m Ame m u n ro ic l ao n g y So c ie t y f or<br />

M ic r obio lo gy.<br />

Roth, A., & Fonagy, P. (1996). Wha t wo r k s fo r wh om? a c r it i cal r e vi e w <strong>of</strong> ps yc hot her ap y r e s ear ch . Ne w<br />

Y o r k, U. S. A. : T he Guilf ord P re s s.<br />

Rot te r , J . (1 96 7) . A Ne w Sc a le f or t he Me a sur e me nt <strong>of</strong> I nt er per so na l T ru st . J o u r n a l o f P e r s o n a (4), l i t y , 3 5<br />

651-665.<br />

Rutella, S., Rumi, C., Lucia, M. B., Barberi, T., Puggioni, P. L., Lai, M., Romano, A., Cauda, R., &<br />

Le one , G. ( 19 99). I nduct ion <strong>of</strong> CD6 9 a nt ige n on nor ma l CD4 + a nd CD8+ lymp ho c yt e s ubse t s<br />

a n d i t s r e l a t i o n s h i p w i t h -c t eh lls e . C y p t h o e m n e t o r t y , (3), p e 3 95-101. 8 o f r e s p o n d i n g T<br />

S a k a m i , S . , I s h i k a w a , T . , K a w a k a m i , N . , H a r a t a n i , T . , F u k u i , O., A Araki, . , K o S., b a & y a s h i , F . , F u j i t a<br />

Ka wa mu r a , N. ( 2002) . Coe mer ge nc e <strong>of</strong> ins omn ia a nd a s hift in t he T h1/T h2 ba la nc e t owa r d T h2 domina nc e . N e u r o i m m u n o m o d u l a t i o ( n , 6 ) , 1 0 -343. 3 3 7<br />

S a n c h e z , I . , G o y a , L . , V a l l e r g a , A . K . , & F i r e s t o n e , G . L . ( 1 9 9 3 ) . G l u c o c o r t i c o i d s r er e st v e r at r s i b l y a r<br />

he pat oma c e ll gr owt h by induc in g a n e a r ly G1 blo c k in c e ll c yc le pr ogr e ss io n . Cel l Gr owt h<br />

D i f f e ( r 3 , ) , 4 -225. 2 1 5<br />

Sa pols ky, R. M . ( 2000). T he po ss ib ilit y <strong>of</strong> ne ur ot ox ic it y in t he hip po ca mp us in maj or dep re s s io n : a<br />

pr ime r on ne ur on de at h. Bi ol Ps y c hia t r y , (8), 4 8 755-765.<br />

Sa pols ky, R. M ., Rome ro, L. M . , & M un c k, A. U. ( 20 00 ) . Ho w do glu c oc or t ic oids in f lu e nc e st re s s<br />

r e s ponse s ? I nt e gr at ing pe r mis s ive , s up pr e ss ive , s t imu la to r y, a nd pr ep a ra t ive a ct io ns . En doc r Re v,<br />

21(1), 55-89.<br />

Sa ur o, M . D., J or ge ns en, R. S . , & P e d l o w , C . T . ( 2 0 0 3 ) . S t r e s s , g l u c o c o r t i c o i d s -,<br />

a n d m e m o r y : a m e<br />

a na lyt ic r e vie w. S t r e s s (4), , 235-245. 6<br />

Sc ha t z be r g, A. F., Rot hs c hild, A. J . , La ngla is , P . J . , Bir d, E. D. , & Co le , J . O. ( 19 85 ) . A<br />

c o r t i c o s t e r o i d / d o p a m i n e h y p o t h e s i s f o r pr p s es y c sh ion o t ai nc d rd e lat e d s ta te s . J Ps y c hi atr Re s ,<br />

19(1), 57-64.<br />

Sc he dlows ki, M ., J a cobs , R., St r at ma nn, G. , Ric ht er , S. , Ha dic ke , A. , T e we s , U. , Wa gn e r , T . O. , &<br />

Sc hmidt , R. E. ( 1993). Cha nge s <strong>of</strong> na tu ra l kil l e r ce lls du r in g a c ut e ps yc holo gic a l s t re s s. J Cl i n<br />

Immunol, 13(2), 119-126.<br />

Sc hmit z , N. , Ne uma nn, W., & Op per ma nn , R. ( 20 00 ) . Str e ss , bur nout a nd lo c us <strong>of</strong> c on tr ol in Ge r ma n<br />

nur se s . I n t J N u r s S (2), t u d 95-99.<br />

, 3 7<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 10 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Sc homme r , N. C., He llha mme r , D. H. , & Kir sc hb a um, C. ( 20 03). Dis s oc iat io n be t we e n r e ac t ivit y <strong>of</strong> t he h y p o t h a l a m u s-p i t u i t -a a d r y e n a l a x i s a n d t h e s y m p -a a t dr h e na t i l -me c du lla r y s ys t e m t o r e pea t e d<br />

ps yc hos oc ia l s tr e ss . P s y c h o s o m M e d , (3), 6 450-460. 5<br />

Sc hulz , K.-H. ( 2001) . Re vie w: ps yc ho lo gic a l in t e r ve nt io ns ha ve a nar ro w a pplic a t io n in in flu e nc in g<br />

i m m u n e response. E v i d B a s e d M e n t H e (3), a l 83-. t h , 4<br />

Se a ma n, W. E. ( 2000). Na tur a l kille r c e lls a nd na tu ra l kil le r T c e lls . A r t h r i t i s R h e (6), u m , 1204-1217. 4 3<br />

S e a w a r d , B . L . ( 2 0 0 0 ) . S t r e s s a n d h u m a n s p i r i t u a l i -body-s t y : a pt ir it t he h ae ling. c r J o s s r o a d s o f m i n d<br />

M i ch D e n t A s s o (4), c , 28-32, 8 2 34.<br />

Se de r , R. A. , & Ahme d, R. (200 3) . Simila r it i e s a nd diff e re nce s in CD4+ a nd CD8+ ef f ec tor a nd me mo r y<br />

T c e ll ge ne r at ion. N a t I m m u n o ( l 9 , ) , 4 -842. 8 3 5<br />

S e g e r s t r o m , S . C . , & M i l l e r , G . E . ( 2 0 0 4 ) . P s y c h o i l m o m g u i n c e a l s y s t e m r e : s s a - m a n e t d a t h e h u m a n<br />

a na lyt ic s t ud y <strong>of</strong> 30 ye ar s <strong>of</strong> inq uir y. P s y c h o l B u l l (4), , 601-630. 1 3 0<br />

Se l ye , H. ( 19 36) . A s yndr ome pr odu c e d by dive r s e noc uo us a ge nt s . N a t u r e , , 1 32. 3 8<br />

Se l ye , H. ( 19 75a ) . Confus ion an d co ntr ove rs y in t he s tr e ss f ie ld. J Hu ma n Str e ss , 1(2), 37-44.<br />

Se l ye , H. ( 19 75b) . I mplic a t ions <strong>of</strong> st r es s c on ce pt . N Y S t a t e J M (12), e d , 2139-2145. 7 5<br />

Shapiro, S. L., Bootzin, R. R., Figueredo, A. J., Lopez, A. M., & Schwartz, G. E. (2003). <strong>The</strong> efficacy <strong>of</strong><br />

m i n d f u l n e s s-b a s e d s t r e s s r e d u c t i o n i n t h nt e <strong>of</strong> t sr le e a et p m dis e t ur banc e in wome n wit h br ea s t<br />

c a nce r : a n e xp lor a tor y st udy. J P s y c h o s o m R e (1), s , 85-91. 5 4<br />

Si lbe r ma n , D. M ., Wa ld, M ., & Ge na r o , A. M . ( 20 02 ) . Ef fe ct s <strong>of</strong> ch r on ic mild s t re s s on lymp ho c yt e<br />

p r o l i f e r a t i ve r es p on s e . P a r t i c i p at i o n o f s er u m t h yr o id hor mo nes a nd c or t ic os te r on e . I nt<br />

I m m u n o p h a r m a c o l ( , 4 ) 2 , -497. 4 8 7<br />

Spa ggia r i, G. M ., Ca r os io, R., Pe nd e , D. , Ma rc e nar o , S. , Rive r a , P . , Zo c c hi, M . R. , M or et ta, L. , & P oggi, A. (2001). NK cell-m e d i a t e d l y s i s o f a u t o l o -p g r o e u s e n t a i n g t i c e g l e l s n i s t r i g eg d e r by t he<br />

e n g a g e m e n t o f t h e p h o s p h a t i d -kin y l i an s e o s up i ot n o liga l t3 ion <strong>of</strong> t he nat ur a l c yt ot ox ic it y<br />

receptors NKp30 and NKp46. Eur J Immunol, 31(6), 1656-1665.<br />

S p a t h-Sc hwa lb e , E., Ha ns e n, K. , Sc hmid t , F. , Sc hr e z en me ie r , H. , Ma r sh a ll, L. , Bur ge r , K. , Fe hm, H. L.,<br />

& B o r n , J . ( 1 9 9 8 ) . A c u t e e f f e c t s o f r e c o m b -6 i n on a n t endocrine h u m a n and i n central t e r l e u k i n<br />

ne r vous s le e p f unc t ions in he a lt hy me n . J Clin Endocrinol Metab, 83(5), 1573-1579.<br />

S p a t h-Schwalbe, E., Scholler, T., Kern, W., Fehm, H. L., & Born, J. (1992) . No ct ur na l<br />

a dr enoc ort ic otr opin and cort is ol s ec r et io n de pe nd s on s lee p dur at io n a nd dec re a se s in as s ocia t io n<br />

wit h s po nt an e ous a wa ke ning in t he mo r nin g. Th e J ou r nal Of Cli ni c al En do c ri nol ogy An d<br />

M e t a b o l i s m (6), , 1431-1435. 7 5<br />

Spiegel, D., Bloom, J. R., Krae me r, H. C. , & Go t t he il, E. ( 198 9). Eff e ct <strong>of</strong> ps yc ho s oc ia l t rea t me nt on s ur viva l <strong>of</strong> pa t ie nt s wit h me ta st at ic bre a st ca nc e r . L a n c e t , (8668), 2 888-891.<br />

Spielberger, S. D., Gorsuch, R. L., & Lushene, R. E. (1970). ST A I M a nu a l. P a lo Alt o : Co ns ult in g<br />

P s yc ho l o gi s t Pr es s .<br />

St a f f or d , M . , & M ar mot , M . ( 20 03 ) . Ne igh bo ur ho od dep r iva t ion a nd hea lt h: doe s it a ff e ct us a ll e qu a lly?<br />

I n t J E p i d e m i (3), o l 357-366. , 3 2<br />

St a ns f e ld , S. A. , Fuhr e r , R., He a d , J . , Fe rr ie , J. , & Sh ip le y, M . ( 19 97). Wor k a nd ps yc hia tr ic dis ord e r in<br />

t he White ha ll I I St udy. J P s y c h o s o m R e (1), s , 73-81. 4 3<br />

St e wa r t , J . H. ( 2005) . Hypnos is in c ont e mpo ra r y me dic in e . M a y o C l i n P r o ( c 4 , ) , 8 0 -524. 5 1 1<br />

S t i c k g o l d , R . , H o b s o n , J . A . , F o s s e , R . , & F o s s e , M . ( 2 0 0 1 ) . S l e e p , l e a r n i n g , a n -line d d r e me a m mo s : ro y f f<br />

r e p r o c es s in g. S c i e n c e , (5544), 2 9 4 1052-1057.<br />

St ic kgold , R. , & Wa lke r , M . P . ( 200 5 ) . Me mo r y c on s olid at io n a nd re c ons olid a t io n : wh a t is t he r ole <strong>of</strong><br />

s le e p? T r e nd s N eu r os ci.<br />

S t r a n g , S . , & S t r a n g , P . ( 2 0 0 1 ) . S p i r i t u a l t h o u g h t s , c o p i n tg umour a n d ' s e n s e o f c o h e r e n c e<br />

pa t ie nt s a nd t he ir s pous es . P a l l i a t M e (2), d , 127-134. 1 5<br />

St r a ub, R. H. , Ma ye r , M., Kre utz , M . , Le e b , S. , Sc ho lme r ic h , J ., & Fa lk, W. ( 20 00) . Ne ur otr a ns mitt er s <strong>of</strong><br />

t he s ymp a t het ic ne r ve te r mina l ar e po we r f ul ch e mo at tr a ct a nt s f or mo noc yt e s . J L e u k io ol, c B<br />

67( 4 ) , -558. 5 5 3<br />

St r a ub, R. H. , Sc holme r ic h, J., & Zie tz , B. ( 20 00 ) . Re pla ce me nt t he ra py wit h DHE A plu s c ort ic ost er oid s<br />

i n p a t i e n t s w i t h c h r o n i c i n f l a m m a t o r y - - sd ubs i s e ta itu s e ts es <strong>of</strong> a dr e na l a nd s e x ho r mon e s . Z<br />

Rheumatol, 59 Suppl 2, I I / -118. 1 0 8<br />

Sudo, N . , Y u , X . N . , S o g a w a , H . , & K u b o , C . ( 1 9 9 7 ) . R e s t r -s a pe i n ct if ic s t c hr ae ns ge s s c in a u s e s t i s s u e<br />

t he immu ne c e ll dis tr ibut ion. N e u r o i m m u n o m o d u l a t i ( o n 3 , ) , 4 -119. 1 1 3<br />

Sundin, E. C. , & Hor owit z , M. J. ( 20 02 ) . I mpa c t <strong>of</strong> Eve nt Sc a le : ps yc home tr ic pr ope rt ie s . B r J Ps y c hi at r y ,<br />

180, 205-209.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 11 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Suz uki, S. , De nne r st e in, L., Gr ee nwo od , K. M . , Ar ms tr on g, S. M . , Sa no , T . , & Sa t ohis a , E. ( 19 93) .<br />

M e la ton in a nd hor mona l cha nge s in dist ur be d s le e p du r in g la t e pr e gn a nc y. J P i n e a l R e (4), s , 1 5<br />

191-198.<br />

T ab a ch n i c k, B . G . , & Fi d e l, l L. S. (1996). U s i n g M u l t i v a r i a t e S t a t . i Ne s t w i c Yo s r k: Ha r pe rCollins<br />

Colle ge P ub lis he rs .<br />

T ana ka , M. , Yos hida , M., Emoto , H. , & I s hii, H. ( 20 00 ) . Nor adr en a lin e s ys te ms in th e hypot ha la mus ,<br />

a m y g d a l a a n d l o c u s c o e r u l e u s a r e i n v o l v e d i n t h e p nxie r o v o t y: c a bt ai so ic n s to udie f a s . Eur J<br />

Pharmacol, 405( 1-3), 397-406.<br />

Thase, M. E., Kupfer, D. J., Buysse, D. J., Frank, E., Simons, A. D., McEachran, A. B., Rashid, K. F., &<br />

G r o c h o c i n s k i , V . J . ( 1 9 9 5 ) . E l e c t r o e n c e p h a l o g r a p h i c s l e e p -episode p r o f i and l e s i n s i n g l e<br />

r e cur re nt un ip olar f or ms <strong>of</strong> maj or de pr es s io n : I . Co mp ar is on dur in g a c ut e de pr e ss ive s t at es . Bi ol<br />

P s y c h i a t r y (8), , 506-515. 3 8<br />

Toyama, S. (1973). Nihongo no ronri. Tokyo: Chuo Koronsha.<br />

Tr a mbas , C. M . , & Gr iff it hs , G. M . (2 00 3) . De live r in g t he kis s <strong>of</strong> de at h . N a t I m m u n o (5), l , 399-403. 4<br />

T s i g o s , C . , & C h r o u s o s , G . P . ( 2 0 0 2 ) -p . i H t y u p i o t -a h a dr a r l ey a na m l i ac xis , ne uroe ndocr ine f a ct or s an d<br />

s t re ss . J P s y c h o s o m R e (4), s , 865-871. 5 3<br />

T u r n b u l l , A . V . , & R i v i e r , C . L . ( 1 9 9 9 ) . R e g u l a t i -p o n i t o u f i t -a h a d e r y e h y na l p ax o t is h a bl y a m i c<br />

c yt okine s : a c t ions a nd me c ha nis ms <strong>of</strong> ac t io n . P h y s i o l R e v ( , 1 ) , 7 -71. 9 1<br />

Uc ha kin , P . N. , T obin, B., Cubb a ge , M . , M ars ha ll, G. , J r. , & Sa ms , C. ( 20 01) . I mmu ne re sp ons ive ne ss<br />

f o l l o wi n g a c a d e m i c s t r es s i n f i r st-ye a r me dica l s t ude nt s . J I nt er f e r o n C y to k i n e R e s ( , 9 ) 2 , 1 -6<br />

8 7<br />

694.<br />

Uchino, B. N., Bernston, G. G., Holt-L u n s t a d , F . , & C a c i o p p o , J . T . ( 2 0 0 -induce 1 ) . S t d r e as us t on omic<br />

a nd immu no lo gic r e a ct ion. I n Ad e r , R. , Fe lt en , D. L. & Co he n , N. ( Ed s .) ,<br />

P s y c h o n e u r o i m m u n o l o g y 3 r d (Vol. e d i t 2, i o pp. n 317-334). Sa n Die go , U. S. A. : Ac a de mic<br />

Pr e ss .<br />

va n Enge la nd , M ., Nie la nd, L. J . , Ra mae ke r s , F. C. , Sc hu t t e , B., & Re ut e lin gs pe r ge r , C. P . ( 19 98) .<br />

Annexin V-a f f init y a s s a y: a r e vie w on a n a pop t os is det e ct io n s yst e m bas e d on phos pha t id yls e r ine e xpos ur e . C y t o m e t r y 1( , 1 ) 3 , -9. 1<br />

v a n R e e t h , O . , S t u r i s , J . , B y r n e , M . M . , B l a c k -Ba m a le n , r ia uJ x . , M D . , . Le , proult L ' H , e R., r m i Olin t e e r ,<br />

C., Re f et <strong>of</strong> f , S. , T ur e k, F. W., & va n Ca ut er , E. ( 19 94 ) . No c tu r na l e xer c ise ph as e de la ys<br />

c i r c a d i a n r h y t h m s o f m e l a t o n i n a n d t h y r o t r o p i n es t ion e c r in no r ma l me n. A m J P h y s i o l ( 6 , Pt 2 6 6<br />

1), E964-974.<br />

Ve r kuyl, J . M . , He mby, S. E., & J oe ls , M . ( 200 4 ) . Chr on ic s tr es s att e nua te s GABAe r gic in hibit io n a nd a lt e rs ge ne ex pre s s ion <strong>of</strong> par voc e llu la r ne ur on s in r at hyp ot ha la mus . Eu ro pe an J our nal <strong>of</strong><br />

N e u r os c i ence, 20(6), 1665-1673.<br />

V o l l e r , A . ( 1 9 7 8 ) . T h e -linke e n z d y m im e mu nos orbe nt as s a y ( ELI SA) ( t he or y, t e ch niq ue a nd a pp lic at io ns ).<br />

R i c C l i n L ( a 4 b ) , 8 -298. 2 8 9<br />

V o l l m e r-C o n n a , U . ( 2 0 0 1 ) . A c u t e -t o-br s a in i c ommunic k n e a ts ion? s b e h a v i o u r<br />

Ps y c h o l Med, 31(5), 761-767.<br />

Wa lds t e in , S. R., Ne uma nn, S. A. , Dr os s ma n , D. A. , & No va c k, D. H. ( 20 01) . Te a ch in g ps yc hos oma t ic<br />

( biops yc hos oc ia l) medic ine in Un it e d St a te s me dic a l s c hoo ls : s ur ve y f in din gs . Ps y c hos om M e d ,<br />

63( 3 ) , -343. 3 3 5<br />

Walker, L. G., & Anderson, J . ( 19 99) . Te st in g c omp le me nt ar y a nd a lte r na t ive t he ra pie s wit hin a r e se ar c h<br />

pr ot oc ol. E u r J C a n c e r (11), , 3 1614-1618. 5<br />

Wa lke r , L. G. , He ys , S. D., & Ere min , O. ( 199 9 ) . Su r vivin g c a nc e r : do ps yc hos oc ia l fa c to rs c oun t ? J<br />

P s y c h o s o m R e s ( , 6 ) 4 , 7 -503. 4 9 7<br />

W a l k er, M. P., Stickgold, R., Alsop, D., Gaab, N., & Schlaug, G. (2005). Sleep-d e pe nd e nt mo t or me mor y<br />

pla s t ic it y in t he huma n bra in. N e u r o s c i e n c e , ( 4 1 ) 3 , 3 -917. 9 1 1<br />

Wa l l s t o n , K . A. , Wa l l s t o n , B . S. , & D e Ve l l i s , R . ( 1 9 78 ) . De ve l o p m e n t o f t h e m u lt i d i m e n s i o n a l h th e a l<br />

loc us <strong>of</strong> c on tr ol (M HLC) s c a le s. H e a l t h E d u c a t i o n M o n o g r , a 161-170. p h s , 6<br />

W a n g , J . , & D u n n , A . J . ( 1 9 9 9 ) . T h -6 e i r n o l t e h e o f a c i t n i t v e a r t l i e o u n k i o n f t -p h e i t h u y i p o t -t<br />

a h r a y l a m o<br />

a d r e n o c o r t i c a l a x i s a n d b r a i n i n d o l e a m i n e s b y e n -1 d o be t o ta x . i Bra n ia n Re d s i , n t e r l e u k i n<br />

815( 2 ) , -348. 3 3 7<br />

Wa r e , J . E. J ., Kos ins ki, M ., & Ke lle r , S. D. (1 99 4 ). SF-3 6 Ph y si c al and Me nt al He alt h Summa r y Scale s :<br />

A U s e r 's M a n u al. Bos ton: Ne w En gla nd M e dic a l Ce nt er .<br />

W a t k i n s , L . R . , & M a i e r , S . F . ( 1 9 9 9 ) . I m p -t l i o-bra c a t in i o communic n s o f i am t ion m u n f or e s ic kn e s s an d<br />

pain. P r o c N a t l A c a d S c i (14), U S 7710-7713.<br />

A , 9 6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 12 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

We be r , B. , Le wic ka , S., De us c hle , M . , Co lla , M . , Vec s e i, P . , & He use r , I . ( 20 00) . I ncr e as e d diur na l<br />

pla s ma c on c e ntr a t ions <strong>of</strong> c or t iso ne in de pr e sse d pat ie nt s . J C l i n E n r d o i c n o l M e t a (3), b , 1133- 8 5<br />

1136.<br />

W e y t s , F . A . , -va V n e Ke r b me u r ng a de , B. M ., Fl ik, G., La mb e r t , J. G. , & We nde la a r Bo nga , S. E. ( 19 97) .<br />

Cons er va t io n <strong>of</strong> a poptos is as a n immu ne r e gula t or y me c ha nis m: e ff e ct s <strong>of</strong> c ort is ol a nd c or tis on e<br />

on c ar p lymp hoc yt e s . B r a i n e h a v B I m m u n , (2), 1 1 95-105.<br />

Whitehouse, W. G., Dinges, D. F., Orne, E. C., Keller, S. E., Bates, B. L., Bauer, N. K., Morahan, P.,<br />

Ha upt , B. A. , Ca r lin, M . M ., Blo om, P . B., Zau gg, L. , & Or ne , M . T . ( 199 6 ). P s yc hos oc ia l a nd i m m u n e e f f e c t s o f s e -hypnosis l f tr a in ing f or st r es s man a ge me nt t hr ou gh out t he f ir st se me ste r <strong>of</strong><br />

me dic a l s c hoo l. P s y c h o s o m M e d , ( 3 ) 5 8 , -263. 2 4 9<br />

Wilcox, R. R. (1997). I n t r o d u c t i n g t o R o b u s t E s t i m a t i o n a n d . H Sa y p n o Die t h e go s : i Ac s aT de e mic s t i n g<br />

Pr e ss .<br />

W o l f , O . T . , & K ci t ions r s <strong>of</strong> c de h hyd b roe a pia u m ndr , os te rC one . a nd ( it s 1 s9 ulf 9 at e 9 in ) t h. e c en A tr a l<br />

ne r vous s ys t e m: e ff ec ts on c ogn it io n a nd e mot io n in a nima ls an d humans . Br ai n Res Br ai n Re s<br />

Rev, 30( 3 ) , -288. 2 6 4<br />

Y a n g , E . V . , & G l a s e r , R . ( 2 0 0 -induced 2 ) . S t r e immunomodulation s s<br />

and the implic a t io ns f or he a lth . In t<br />

I m m u n o p h a r m a c o l ( , 2-3), 2 315-324.<br />

Yua s a , Y., & Ka s ulis , T . P. ( 198 7) . T h e b o d y : t o w a r d a n E a s -body t e r n theory. m i n d Alba ny: St a t e<br />

Unive r s it y <strong>of</strong> Ne w Yor k P re s s .<br />

Yua s a , Y., Na ga t omo, S., & Hull, M . S. ( 1993 ) . T he b o dy , se l f-c ul t i v at i on, and ki-e n e r g y. Alb a ny: St a t e<br />

Unive r s it y <strong>of</strong> Ne w Yor k P re s s .<br />

Zhou, J., Olsen, S., Moldovan, J., Fu, X., Sarkar, F. H., Moudgil, V. K., & Callewaert, D. M. (1997).<br />

G l u c o c o r t i c o i d r e g u l a t i o n o f n a t u r a l c y t o t o x i c i t y : e f f e c t s o f c o r t i s o l o n t h e<br />

f unct ion <strong>of</strong> a c lone d huma n na tu ra l kil le r c e ll lin e . C e l l I m m u n o l (2), , 108-116.<br />

1 7 8<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 13 - I m p e r i a l o C n o d l o n l e g e L


A p p e n d i x : 1 Ethi c s a p p r o v a l , i n f o r m a t i o n s h e e t a n d c o n s e n t<br />

R I V E R S I D E R E S E A R C H E T H I C S C O M M I T T E E<br />

A P P L I C A T I O N F O R M<br />

I f y o u r e q u i r e m o r e s p a c e t o a n s we r a<br />

q u e s t i o n t h e n p l e as e a d j us t t h e s i z i n g<br />

o f t h e a n s we r s p ac e ac c o r d i n g l y .<br />

- 2 14 -<br />

V e r s i o n 2 0 0 3 . 0 1<br />

N a m e o f L e a d I n v e s t i g a t o r: P r o f . J o h n H G r u z e l i e r<br />

D e p a r t m e nt : C o g n i t i v e N e u r o s c i e n c e a n d B e h a v i o u r<br />

A d d r e s s : Ch a rin g C ross C ampu s, Imp eri a l C olleg e Lon d on , St Dun stan 's R oa d,<br />

L o n d o n , W 6 8 R F<br />

[1] Please state project title.<br />

T h e E f f e c t s o f T w o P s y c h o l o g i c a l I n t e r v e n t i o n T e c h n i q u e s , -Hy S e l pn f os is a n d th e<br />

J o h r e i H e a l i n g M e t h o d, o n Q u a l i t y o f L i f e , P s y c h o l o g i c a l W e l -B l eing , E E G<br />

m e a s u r e s a n d V a r i o u s I m m u n o l o g i c a l M e a s u r e s i n c l u d i ounts n g C iD n 4 ea + rl c y<br />

HI V: A Ra nd o ml y Con tr oll e d P ilo t Stu dy .<br />

[2] What question is the project seeking to answer, and what will be the value <strong>of</strong><br />

obtaining this answer? This should also be clearly explained within the<br />

p a t i e n t i n f o r m a t i o n s h e e t .<br />

Whe n pat ie nts ar e ne wl y dia gno s e d wit h HI V, t her e is <strong>of</strong>t e n a s ub st a nt ia l pe r io d <strong>of</strong> t ime wh e n<br />

t he ir CD4+ c ount s a r e pre s er ve d , a nd a nt ir et ro vir a l t r e at me nt ( ART) is not r e qu ir e d . Pa t ie nt s ar e<br />

h e a l t h y i n a l l o t h e r r e s p e c t s , a n d j o b s a n d h o m e l i f e c a r r i e s ounts o n . f all O v ae nr d t i m e , C D 4 + c<br />

ult ima t e ly mo s t pa t ie nt s s ta rt to ta ke ART . Ou r pr ima r y q u e st io n is wh e t he r we c an p ro lo ng t h is<br />

s t at e .<br />

T h i s p r oj ec t s e e ks t o i n ve s t i ga t e t he p os s i b l e i m p a c t u p o n Qu a l i t y o f Li f e , p s yc h o l o gi c a l we -l<br />

l<br />

b e i n g , v a r i o u s i m m u n e p a r a m e t e r s l t h a n s d t a t h u e s a o f t w o i n t e r v e n t i o n s , -hypnos s e l f is a nd J ohre i<br />

( a J a p a n e s e h e a l i n g m e t h o d ) . A t h i r d g r o u p w i l l b e p u t o n a w a i t i n g l i s t a wa n d i t a -l c t i a s t ' ‘ e d<br />

c ontr ols f or t he f irs t 4 mont hs <strong>of</strong> t he s tu dy. Su bj e c ts wil l be r a nd omly a s s ign e d a ft er<br />

s t r a t i f i ca t i on on CD4+ le ve ls t o on e <strong>of</strong> t hes e th r e e gr ou ps .<br />

T h e p u r p o s e s o f J o h r e i a n d s e -hypnos l f is a re s imila r . Ea c h t e ch niq ue will be t a ugh t to par t ic ip a nts r a ndomly a s s igne d t o t he s pec if ic in t er ve nt ion wit h t he pur pos e s <strong>of</strong> a id in g in ps yc ho lo gic a l<br />

a dj us t men t t o t he ir c ondit ion, ma int a in in g t heir qu a lit y <strong>of</strong> lif e an d bo lst er in g t he ir immu no lo gic a l<br />

de f enc e s ys t e m t hr ough da ily pr a ct ic e . I n ad dit io n , c ogn it ive a s se s s me nts wil l be un der take n<br />

us ing e le c t ro phys iologic a l ( EEG) me a su re s .<br />

S h o u l d p a r t i c i p a n t s m is a si ta n t e a wh i n e r e t he h ir CD4+ c ount s r e ma in high a nd ph ar ma c olo gic a l<br />

t r ea t m en t i s s t i l l d e e m e d u n ne c es s ar y, o r t h at t h e i r q u a l i t y o f l i f e an d ps yc h o l o gi c a l we -be l l ing is<br />

s i g n i f i c a n t l y b e t t e r t h a n t h o s e w i t h o u t t h e i n t e r v e n t i o n ns s , c ould e i bt e h e r o f t h e s e t w o<br />

e a s ily a dd e d t o t r ea t ment pr ot oco ls in e ar ly HI V.<br />

T he s e t wo in t e r ve nt ions a re in a d d it io n t o b est c o n ve nt io n a l me d ica l c a re give n b y t h e Ch e ls e a &<br />

We s t min s te r He a lt hc ar e NHS Tr u st , a nd wil l b e a d min is te re d wit h t h e p ar t ic ip at io n <strong>of</strong> c lin ic ia n s<br />

invol ve d in t h e pat ie nt s ’ c ar e .


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

[3] Please provide an outline <strong>of</strong> the project, this should include procedures to be<br />

used, measur es to be made, justification <strong>of</strong> sample size & plans for statistical<br />

a n a l ys i s . [Paras2.1-2.8]<br />

T h e t w o i n t e r v e n t i o n s a r e s -hypnos e l f is a nd the J ohr e i he a ling me t ho d f r om J a pa n .<br />

H yp n o s i s i s a we l l-r e c ognis e d me dic a lly a c c ep t e d ps yc ho lo gic a l in t e r ve nt io n . It ha s be e n us e d in<br />

ma ny s t ud ie s wit h me dic a l c ond it io ns a nd our la bo r at or y ha s ca rr ie d out a s er ie s <strong>of</strong> in te r ve nt io nis t<br />

hypnosis st ud ie s ( Fox e t a l, 1999 , Gr uz e lie r e t a l, 20 01 , La id la w e t a l. , 20 03 ) . It ha s be e n us e d in<br />

s ympt om c ont r ol in va r ious me dic a l c on dit ion s , in c lu din g pa in c ont ro l, a nd in no r ma lis in g t he i m m u n e s y s t e m w h e n u n d e r s t r e s s ( G r u z e l i e r e t a l . , 2 0 0 1 ) . I t ovide h a s d p r a bu ff er in t he fac e <strong>of</strong><br />

s t re ss ( Gr uz e lie r e t a l, 2001, La id la w e t a l. , 20 03 ) . I n t he pre s en t s t ud y, hyp no s is wil l be t au gh t a s<br />

a s k i l l s o i t c a n b e p r a c t i s e d i n t h e f o r m -hypnos o f s e l f is in t he pr iva c y <strong>of</strong> t he pa rt ic ip a nt s ' own<br />

h o m e s . -going O n suppor t a n d s u p e r v i s i o n w i l l b e p r o v i d e d t h r o u g h o u t t h e s t u d y p e r i o -d<br />

. S e l f<br />

hypnos is wil l be t a ught by a n e xpe rt in me dica l hyp no s is .<br />

I n Ja pa n a nd ma ny ot her count r ie s, s ome 3 millio n pe op le pr ac t ise th e Jo hre i lif e s t yle a nd he a lin g<br />

m e t h o d . I t i s p r i m t a r i s l e d y i p r n a c t h e f a m i l y s e t t i n g a n d i n v o l v -s e s t yle a ah ne d a l t h y l i f e<br />

a ppre c ia t io n <strong>of</strong> be aut y. I n t he f irs t pu blis he d Jo hr e i st ud y, me dic a l s t ud e nt s illu s tr a te d t hat pr a ct is in g J oh re i pr ovide d he lp in c op in g wit h e xa m s tr e ss . An in t r odu ct io n to J oh r e i will be ta ught t o pa rt ic ipa nt s , a nd s uper vis ion f or part ic ip a nt a nd f a mily me mb e r or a not her su pp ort<br />

pe r son will be pr ovide d t hrough ou t t he st ud y pe r io d , a s in t he Hyp no s is c ond it io n . Jo hre i will be t a u g h t b y a m e d i c a l d o c t o r w h o h a s b e e n t r a i n e d i n t is ed J o h it r se in i ce a n ch d ildhood. p r a c<br />

T he f ou r a re a s <strong>of</strong> outc ome mea s ur e s a re immu no lo gic a l va r ia ble s , ps yc ho lo gic a l va r ia ble s ,<br />

c o g n i t i v e v a r i a b l e s a n d , f o r t h e t e r m o f t h e s t u d y , m a r k e r s o f p r o g r e s s i - o n o f d i s e a s e , a s s e<br />

i n t e r v e n t i o nd n at a t he f i n i s h o f t h e study. A t t h e b e g i n n i n g o f t h e s t u d y ipants , a l l wil p l a r t i c<br />

p r o v i d e d e s c r i p , t whic i v e h wi ll in c lude de mogr a phic det a ils a nd me dic a l hist or ies .<br />

S t u d y d e s i g n<br />

T his r a nd omis e d c ont r olle d t r ia l wil l in c lu de 15 0 pat ie nt s wh o ha ve bee n dia gn ose d wit h HI V but a r e n a ï v e-t o-tr ea t ment , mea nin g t hat t he ir CD4 + co unt s ar e s uf f ic ie nt ly high t ha t ART is not indic a t e d. Re a lis t ica lly, t his me a ns t hat t he CD4 + c ou nt is < 40 0 bu t a bo ve 200 ( irr e sp e ct ive <strong>of</strong> vir a l<br />

loa d) . T he st ud y dur a t ion f or ea c h pa rt ic ip a nt is a pp ro xima t e ly 5 mo nth s . Th e pla nn e d mon th ly<br />

int a ke is <strong>of</strong> 6 – 9 pa t ients t o e ac h <strong>of</strong> th e t hre e gr ou ps ( i. e. 18 - 27 ne w pe op le ea c h mon t h) .<br />

T he thr ee gr ou ps wil l be r e cr uite d th r ou gh Dr Simo n Ba r t on an d his c lin ic a l c olle a gu e s at Ch e ls e a<br />

& W e s t m i n s t e r H e a l t h c a r e N H S t . T r An u s in de pende nt st at is t ic ian wil l r a nd omly a s s ign<br />

pa rt ic ip a nts t o e ithe r one <strong>of</strong> t he t wo in t er ve nt io n gr ou ps or t he wa i t -l i s t ce ont d r ol gr ou p us ing a<br />

s t ra t if ied ra nd omis at ion on CD4 + c ou nt s.<br />

O u t c o m e m e a s u r e s w i l l i n c l u d e t h e p s y c h o l o g i c a l q u e s , t blood i o n n a an i r d e s ur ine sa mple s f or<br />

immune a s sa ys , a nd c ognit ive da t a de ta ile d be lo w a nd illu s t r a te d in t he dia gr a m f ollo win g.<br />

Ba s ic a lly, t he des ign invol ve s 8 s e ss io ns wit h t hre e maj or a ss es s me nt po int s ove r , at th e mo s t , s ix<br />

mont hs. T he f ir st f our s es s ions in t he f irs t mon t h ar e int er ve nt io n int e ns ive , fo llo we d by 4<br />

m o n t h l y -up sf e s so ion l s . l Ea o cw h tr a ining s e s s io n will t a ke a bo ut 2 ho ur s a nd is plan ne d t o be he ld a ft er wo r king hour s a t t he Ch ar in g Cr os s Ca mp us s it e . P ar t ic ip a nt s will be r e cr uit e d<br />

mont hly to be in training groups <strong>of</strong> 6 – 9. Th e t hr ee as s es s me nt po in t s inc lu de a ll t he<br />

immuno lo gic a l a nd ps yc hologic a l t es ts des c r ib e d be lo w a nd de s ign a t ed a s out c ome me a su re s .<br />

I N T E R V E N T I O N G R O U P S S C H E D U L E<br />

1 2 3 4 5 6 I 7 n t e r v e n t i o n s s i s o e n s ( f i r s t 4 a r e w e e k l y , l a s t 3 m o n t h l y )<br />

1 &2 3 M a i n a s s e s s m e n t p o i n t s<br />

E nd o f Mo nt h: 1 2 3 4 T i m e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 15 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

W A I T-L I S T E C D O N T R O L S C H E D U : L E<br />

0 1 2 3 4 5 6 I n t 7 e r v e n t s i e s o s n i o n s<br />

1 &2 3 4 M a i n a s s e s s m e n t p o i n t s<br />

E nd o f Mo nt h: 1 2 3 4 5 6 T i m e 7 8<br />

A s s e s s m e n t v a r i a b l e : s<br />

P s y c h o l o g i c a l v a r i a b l e s : ( S t e h r o i s e s n 1 o t n e r e p d e i t i n t g i o n )<br />

H y p n o t i s a b i l i t y a n d i m a g i n a t i v e a b i l i t Crea i e s : t ive I ma gina t ion Sc a le ( Wils on & Bar ber , 197 8 ) ,<br />

a n d S t a n f o r d H y p n o t -C) i ( We c is en hS <strong>of</strong>f u er s & c Hilga e p r d, t 19 i 62) b . i I t l is i t y S c a l e<br />

h y p o t h e s i s e d t h a t h y p n o t i s a b i l i t y o r a b i l wil i t l y inf t lu o e nv ci e s u the a l outc i s e ome va r ia bles ( L a i d l a w e t a l . , 1 9 9 6 )<br />

P e r s o n a l i : t Ty o st ud y per s ona lit y t ype s a nd co pin g s t yle s in r e la t io n t o pr ogn os is. ( Wat s on e t a l. ,<br />

1 9 8 4 ) . A s s e s s e d w i t h t h e -Cr M a own r l o w e e So c ia l De s ir a bilit y Sc a le ( Cr own e & M ar lo we , 19 60) and the Cou rt old: ( Bar ge r , Kir c he r & Cr oyle , 19 97 ). Tr a it an xie t y fr om Sp ie lb e r ge r 's STAI<br />

( Spie lbe r ge r , Gors uc h & Lus he ne , 197 0) , a nd Pe r so na lit y Syn dr ome Qu e s t io nn a ir e ( Gru z e lie r ,<br />

2000)<br />

Social Support: So c i a l s u p po r t h as b ee n l i n ke d t o m en t a l h e a l t h o f p at ie nts . I t c a n be ea s ily<br />

a s s e s s e d w i t h -min t h e Si gn 1 0 if ic a nt Ot he r s Sc a le (Po we r s , Ca mp io n & Ar is , 198 8 ) . Fur th e r t o<br />

t his is a s c a le t o a ss e ss s pir it ua lit y ( Ha tc h et al. , 19 98 ) .<br />

P s y c h o l o g i c a l v a r i a b : l S e s e r i e s ( d 2 e p e n d e n t v a r i a b l e s )<br />

D e p r es si o n an d a nx ie t y : B ec k D e p r es s i o n I n ve n t or y ( B D I , Be c k, 1 9 9 0) ar gu a b l y t h e m o st we -l<br />

l<br />

us e d instr ume nt to a ss es s de pre s s io n in c lin ic a l s t ud ies , as is th e St at e Tr a it An xie t y I nve nto r y<br />

( ST AI , Sp ie lb e r ge r , Gor suc h & Lus he ne , 19 70 ) fo r a nx ie t y.<br />

P T S - D l i k e s y m p t o : m s I m p t a <strong>of</strong> c Eve nt Sc a le ( IES, Hor owit z , Wiln e r , & Alva r e z , 19 79 ) us e d<br />

wit h HI V dia gnos is as ev e nt in No rd in , Be r gla nd , Glime liu s & Sj od en , 200 1 . Can id e nt if y<br />

i n t r u s i v e t h o u g h t s ( a s s o c i a t e d w i t h h i g h c o r t i s o l w h i c h c a n -h<br />

a v e n e g a t i v e e f f e c t<br />

r e gula t io n ) . P er ce ive d St r e s s Sc a le (P SS) .<br />

Q u a l i t y o f l i f e a n d a c t i v i : t WHOQO y l e v e l s L ( Wor ld He a lth Or ga nis at io n , 19 96 ) in t er nat ion a lly<br />

u s e d s cr e e n f or q ua l i t y o f l i f e c ha n ge s a nd t h e S F3 6 ( J e n ki n s o n e t a l . , 1 9 9 4) , a we -used l l<br />

ge ne r a lis e d in st rume nt f or qua lit y <strong>of</strong> lif e .<br />

Copi ng : Th e COP E, a mult idime ns io na l c op in g in ve nt or y ( Car ve r , Sc he ier & We in t ra ub , 19 89) inc lude s in fo r mat ion a bout t ur nin g t o s pir it ual s ou r ce s , de nia l a nd dis e nga ge me nt a mo ng oth e r<br />

sub-s c a l e s , w h i c h a r e o f i n t e r e s t i n t h i s s t u d y . L o c u s o f ol. C o n t r<br />

P s yc hol ogi ca l vari able s: Ser ie s 3 ( c o n t i n u o u s d a t a )<br />

D i a r y d : a t P ea rs ona lis e d Emot iona l I nde x (PEI , La id la w, 19 99 ) . Use d wit h pa t ients ( La idla w,<br />

2001). M oo d pa r a me te r s bot h pos it ive a nd nega t ive : an x i ou s , e ner get ic , t i re d , c onf i de nt , uns ur e ,<br />

e l at e d, d e p r e s s e d , a g r e e a b l e , h o s t i l e , -headed c l e a r and i n e f f e c t i r v e a t e d o n a L i k e r t -s<br />

c a l e a s a 5<br />

min da ily dia r y. Addit iona l que s t io ns in c lu de s le e p qu a lit y, ho me wo r k pr a ct ic e , he a lth st at us , a s<br />

m o d e r a t o r v a r i a b l e s t h a t c o u l d i n f l u e n c e o u t c o m e m e l a fa s u ct r ors e s . : s pa E cx e t e f or r n qualit a a t ive<br />

c omme nts af te r t he pr ompt : 'An yt hin g dif f e r en t hap pen t od a y?' r a t e d by r es e ar c he rs on a -3 to +3<br />

s c a le .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 16 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

C o g n i t i v e v a r i a b l e s<br />

Ne ur ops yc ho phys iologic a l s t udie s wo uld in c lu de e lec tr oe nc e ph a lo gr a ph ic ( EEG) , a nd e l e c t r o d e r m a l t i vi a t c y ( E D A) . T h e se st u d i es w i l l a d d r e s s t h e f o l l o wi n g i s s u e s :<br />

Lat er ali se d br a in funct ion and it s r el a ti o ns hip wi t h i mmun e st at u s , mo o d , c o pi n g s ty le , a nd<br />

r e s ponse t o i nt er v enti on i n pati e nt s: We h yp ot h es is e a r e lat io n s h ip a mo n g t h es e va r ia b les ba s e d<br />

on ear lie r wo r k wit h HI V inf ec t io n ( Gr uz e lie r e t a l. , 1 9 9 6) wh ic h s h o we d t ha t h e mis p he r ic<br />

a s ymme t r y me a s ur es pre dict e d immu n e c o mpe t e nc e a n d we r e c o rr e lat e d wit h mo o d s ta tu s (a ls o<br />

s e e Da vid s o n a nd Toma r ke n, 19 8 9; Ka n g et al. , 1 9 9 1 ; Whe e le r e t a l. , 1 9 9 3; La n e e t<br />

a l . , 1 9 9 7 ; . P a p o u s e k a n d S c h u l t e r , 2 0 0 1 ; G r u z e l i e r e t a l . , 2 0 0 1 )<br />

I m m u n o l o g i c a l m a r k e : r s<br />

- CD pr <strong>of</strong> ile inc luding numb er s an d pe r ce nt a ges <strong>of</strong> CD3, CD4 , CD4 5RA/ RO, CD8 , CD1 6 a nd<br />

CD56 ( Va n der P ompe e t a l. 19 97 ) . & CD4 ab s olu te c oun t , CD4 / CD8 r at io a nd HI V vir a l<br />

loa d a s a ma r ke r <strong>of</strong> dis e as e pr ogr es s io n .<br />

- N K c e l l a c t i vi t y a s m a r ke r s o f a n t i-in f e ct io n in in na te immu nit y ( Eva ns et a l. 200 0)<br />

- Cor t is ol ( ur ine) as a ma r ke r <strong>of</strong> ch r on ic st r es s a nd st imu la t or <strong>of</strong> T h2 ( Dh a bh ar et a l. 20 01 ,<br />

E v a n s e t a l . 2 0 0 0 , S c h e d l o 94) w s k i e t a l . 1 9<br />

- D H E A ( u r i n e ) a s a m a r k e r o f T h 1 / T h 2 b a l a n c e w i t h C o r t i s o l ( E v a n s e t a l . 2 0 0 0 )<br />

- M e la to nin (ur ine) c or re la t in g wit h s le e p qu a lit y a nd migh t be a immu ne s t imu lat in g ( T h1<br />

p r e d o m i n a n t l y ) h o r m o n e ( M a e s t r o n i 2 0 0 1 )<br />

- M A O -A I ( a s a m a r k e r o f c a t e c h o l a ) m , i n -g e I N a s F m e c m r a e , t -2, i o Soluble I n L IL-2 r e c e pt or<br />

( a s a T h 1 d o m i n a n -4, t IL-1 c y 0 t o ( k a i s n e a ) , T h I 2 L d o m i n a n t -6, c y CRP t o k i n e ) ( s e r u m )<br />

( a s a ma r ker <strong>of</strong> inf la mma t ion) .<br />

SAMP LE S IZE C A LC U LAT ION : T he bet we e n gr ou p co mp a r iso ns will t a ke pla c e us ing<br />

Johrei, hypnosis and contr ol gr ou p da ta fr om gr ou ps s ize s <strong>of</strong> 50 par t ic ip a nt ea c h . T he wit hin gr oup dat a ca n inc lude those par t ic ip an ts wh o ha ve be en in t he c on tr ol gr ou ps pr io r t o be ing<br />

r a n d o m l y a s s i g n e d t o e i t h e r J o h r e i o r -hypnosis. s e l f This will provide up to 75 part ic ip a nts in<br />

e a c h <strong>of</strong> t he t wo int e r ve nt ion gr ou ps . Th e se nu mb e rs c ome fr om a po we r a na lys is us in g<br />

ST AT I ST I CAL ANAL YS I S: St at i sti c s wi l l be c alc ula te d usi ng SPSS v 11 .<br />

M u l t i v a r i a t e a n a l y s e s w i l l b e u -g s r e d o u p i n c o m t p h a e r i b s e o t n s w , e e a n d r e p e a t se ure d s m ae nd a<br />

c o r r e l a t i o n a l a n a l y s e s f -gr o r oup t ch ha e nge w i s . t h i n<br />

[4] Please specify the source and type <strong>of</strong> subjects to be recruited and how this will<br />

be done. Also state the expected numbers to be recruited.<br />

1 5 0 p a t i e n t v o l u n t e e r s w i l l b e nt r inuous e c r u i ba t se is d f r om o n t he a c linic o s wh e r e t he y r ec e ive<br />

t he ir dia gn os is unde r t he s upe r vis io n <strong>of</strong> in ve st iga t or an d c lin ic ia n Dr Simo n Ba rt on .<br />

Re c r uit me nt wil l be via a Re s e ar c h Nur se or by on e <strong>of</strong> t he in ve s t iga t ors .<br />

I n c l u s i o n c r i t e r i a i n c l u de :<br />

1. H I V p o s i t i v e<br />

2. Age 18 – 70<br />

3. CD4 + c ou nts > 200.<br />

E x c l u s i o n cr i t er i a i n c l u d e :<br />

1. On ART .<br />

2. Abusing drugs or alcohol.<br />

3 . I n a no t he r t r ia l whic h would c o n f lic t .<br />

[5] What will be the duration <strong>of</strong> the project and where will it be undertaken?<br />

T he proje ct wil l t a ke pla c e at the Depa rt me nt o f Co gn it ive Ne u r o sc ie n ce & Be h a vio u r , 1 0 th f lo o r<br />

<strong>of</strong> the La b b lo c k, Char ing Cr os s Ca mp u s o f Imp e r ia l Co lle ge Lo n d o n . I t will c o mme n c e wh e n<br />

Et hic s a p pr o va l is ga ine d, a nd c o nt in u e u nt il 1 5 0 p at ie nt vo lu n t e er s h a ve c o mp let e d t he ir tra in in g.<br />

I t i s e st i m a t e d t ha t t his will t a ke a p p r o x imat e ly 1 8 mo n t h s .<br />

[6] Within this project, what treatment and procedures will be performed on subjects<br />

that are extra to normal patient care? <strong>The</strong>se details should be clearly<br />

s t a t e d i n t h e p a t i e n t i n f o r m a t i o n f o r m .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 17 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e r e a r e n o s if p ic e c tr ea t men t s tr at e gie s f or HI V po s it ive pat ie nts at t his st a ge <strong>of</strong> t he ir dise a s e.<br />

Nor ma l c ar e in c lude s t he monit or in g <strong>of</strong> t he ir CD4 + le ve ls . ART wil l c omme nc e wh e n<br />

a p p r o p r i a t e . I n a d d i t i o n t o t h i s m o n i t o r i n g , p a t i e n t s w i l l b ipat e o ing f f e in r e d a c h a n c e o f p a r t i<br />

t h i s p r o j e c t , w h i c h o f f e r s t r a i n i n g i n o n e o -hypnos f s e l f is , or Johre i a s de sc r ibe d a bo ve .<br />

[7] Please state the potential hazards to subjects, if any. What is the probability <strong>of</strong><br />

these occurring? What precautions will be taken to meet them? This<br />

i n f o r m a t i o n s h o u l d b e c l e a r l y s t a t e d i n t h e p a t i e n t i n f o r m a t i o n f o r m .<br />

No pote nt ia l ha z ar ds .<br />

[8] What procedures, if any, may cause discomfort or distress to subjects? What<br />

degree <strong>of</strong> discomfort or distress may this entail? What is the probability <strong>of</strong><br />

s u c h d i s c o m f o r t o r d i s t r e s s oc c u r r i n g? T h i s i n f o r m a t i o n s h o u l d b e c l e a r l y<br />

s t a t e d i n t h e p a t i e n t i n f o r m a t i o n f o r m .<br />

Ane c dot a lly, in it ia l s e s s ions <strong>of</strong> J oh re i oc ca s ion a lly ha ve be e n a ss oc iat e d wit h min or s ymp t oms o f h e a d a c h e o r c o n g e s t i o n . T h i s w a s n o t o ve b s d e r in e it her <strong>of</strong> t he pr e vious J ohr e i st ud ies do ne at<br />

I mpe r ia l Co lle ge .<br />

[9] Please state the personal experience <strong>of</strong> the investigator in the field concerned.<br />

Pr <strong>of</strong> Gr uze lie r has e xt ens ive r es e ar c h e xpe r ien c e in t he f ie ld <strong>of</strong> HI V ( Ba ld e we g, Ca t a la n et a l,<br />

1995, Ba lde we g, Ric c io e t a l, 19 95, Gru z e lie r et a l. , 19 96 , Ba ld e we g e t a l, 19 97) . He has publis he d ma ny pape rs about hyp nos is in c lu din g it s us e as a n int er ve nt io n a ge nt ( Gr uze lie r e t a l. ,<br />

2001; Fo x e t a l, 1999) , as has Dr La id la w ( La id la w & Wi lle t t , 20 02 ; La id la w, 19 99 ) . His<br />

r e se a rc h t e a m ha s c onduct e d t wo pr e vio us st ud ie s us in g s imila r de s ign s t o t he pr e se nt st ud y<br />

i n v o l v i n g b o t h J o h r e i a n d s -hypnos e l f is ( on e c omple t ed RR 28 83 , La id la w e t a l, 20 03 a nd on e<br />

ongoing, RR2959.).<br />

[10] Written consent should be standard practice, please enclose copies <strong>of</strong> the<br />

consent form and information sheet. If non-written consent is proposed then<br />

this must be justified to the Committee. [Paras 3.1-3.3]<br />

If a routine clinical procedure precedes or follows what is proposed to be done<br />

by way <strong>of</strong> this application, the Information and Consent Forms for those<br />

procedures should be also included with Patient Information and Consent<br />

forms for t h i application. s<br />

n/a<br />

[11a] Have the consultants responsible for the overall care <strong>of</strong> the patient been<br />

informed and their approval given?<br />

Dr Sim on Ba rt on is th e c on s u lt an t res p ons ib le an d is a cu rren t in ves tigator in th is<br />

a p p l i c a t . i o n<br />

[11b] Have you gone through the appropriate process within the Clinical Directorate<br />

in which you wish to undertake your research?<br />

Yes an d recei ved ap p ro val f ro m th e res ea rch com mittee, No ve mb er, 2 0 0 2 .<br />

[11c] Will the subjects' General Practitioner be informed <strong>of</strong> the recruitment <strong>of</strong> the<br />

subject before the study begins? Is the subjects consent to this information<br />

being passed as a condition <strong>of</strong> participation?<br />

[12] Please state any interest, i.e., <strong>of</strong> pr<strong>of</strong>it, personal or departmental, financial or<br />

otherwise, relating to the study. [Paras 7.1-7.2]<br />

Non e.<br />

[13] Does the study involve the administration or application <strong>of</strong> a medicinal product<br />

or substance? [Para 5.1-5.3]<br />

Yes N o<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 18 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

[15] Please list all staff involved with this project - all staff m u s t s i g n t h i s<br />

section:<br />

N a m e & T i t l e Signature Q u a l i f i c a t i o n ( s ) I n v o l v e m e n t<br />

P r<strong>of</strong> J H<br />

G r u z e l i e r<br />

Dr TM<br />

L a i d l a w<br />

D r A N a i t o<br />

Dr P<br />

D w i v e d i<br />

Dr D<br />

H e n d e r s o n<br />

Dr Sim on<br />

B a r t o n<br />

R es earch<br />

As s i s t a n t<br />

D a t e o f s u b m i s s i o n :<br />

1 F e b r u a r y 2 0 0 3<br />

N a m e :<br />

P r o f J H G r u z e l i e r<br />

P h D P r i n c i p l e i n v e s t i g a t o r<br />

P h D Overall s u p ervis i on <strong>of</strong> d ata<br />

collecti on an d p at i en t i n t eraction<br />

with th e s t u d y.<br />

MD an d P h D<br />

c a n d i d a t e<br />

T r a i n i n g i n s e -h l f y p n o s i s<br />

Train in g i n J oh rei an d<br />

immu n ol o gi cal l ab w or k.<br />

P h D EE G d ata c ollection an d an al ys is .<br />

P h D Su p ervis ion <strong>of</strong> i mmu n ol ogical lab<br />

w o r k<br />

M D C lin ician res p on s ib le for p atien t<br />

treatmen t .<br />

t o b e a p p o i n t e d<br />

Sign atu re <strong>of</strong> In v e s t i g a t o r :<br />

Ad d res s : Dep t <strong>of</strong> C o gn i t i ve<br />

Neu ros ci en ce & Beh a vi ou r, C h arin g<br />

C ros s C amp u s , Imp eri al C ol leg e<br />

Lon d on , S t Du n s t an 's R oad , Lo n d on ,<br />

W 6 8 R F<br />

Dat a i n p u t , recru i t men t, lab<br />

as s is tan ce.<br />

C on tact Tel & Bl eep<br />

N o :<br />

0 2 0 8 8 4 6 7 3 8 6<br />

C l i n i c a l T e a m i n w h i c h In v e s t i g a t o r w o r k s : n/a<br />

O t h e r C l i n i c a l T e a m s / D e p t i n v o l v e d i n r e s e a r c h : C h e l s e a & W e s t m i n s t e r H o s p i t a l<br />

N a m e a n d S i g n a t u r e o f C o n s u l t a n t , G P o r C o m m u n i t y P h y s i c i a n i n o v e r a l l c h a r g e . (<br />

You a re<br />

remin de d th a t by s i g n i n g this for m y ou ta ke res pons i bility f or the c ontents a n d<br />

a c c u r a c y o f t h i s E t h i c s C o m m i t t e e A p p l i c a t i o n . Y o u m u s t b e m e d i c a l l y q u a l i f i e d ) :<br />

D r S i m o n B a r t o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 19 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Study T i t l e<br />

P a r t i c i p a n t I n f o r m a t i o n S h e e t<br />

T h e E f f e c t s o f T w o P s y c h o l o g i c a l I n t e r v e n t i o n T e c h n i q u e s , -Hyp S e l f no si s<br />

a n d t h e J o h r e i H u a e l i t a y o l f L i f n e , g P sy c ho M e l o g t i c a h l o W d e l l-B , e i ng o , n Q<br />

E E G m easure s a nd Va ri o us Imm unol og ic al M ea sures i n HIV: A Ra ndoml y<br />

C o n t r o l l e d P i l o t S t u d y ( o r ‘ T h e -h S e y l p f n o s i s a n d J o h r e i S t u d y ’ )<br />

I n v i t a t i o n p a r a g r a p h<br />

Y o u a r e b e i n g i n v i t e d t o t a k e p a r t i n a r e f s o e r a e r c h y o u s t d u e d c y i , . it d e is B e i mp o rt an t for<br />

yo u to u n d ers tan d wh y th e res earch is b ei n g d on e an d wh at it will in vol ve. P leas e t ake ti me to<br />

read th e fol l owi n g in f or mat ion ca refu ll y an d d is cu s s it with frien d s , relatives an d yo u r GP if<br />

yo u wis h . As k u s if th ere is an yth in g th at is n ot clear or if you w ou ld like m or e in fo rmation .<br />

Take ti me t o d eci d e wh et h er o r n ot you w is h to take p art .<br />

C on s u mers for Et h ics in R es earch (C ER E S) p u b lis h a leaflet en titled ‘Med ical R es earch an d<br />

Y o u ’. Th is lea fl et gi ves mo re in fo rmati on ab ou t med ical res ea rch an d loo ks at s om e<br />

q u es tion s you ma y wan t to as k. A cop y m a y b e ob tain ed fr om C ER ES, P O B o x 1 3 6 5 ,<br />

Lon d on N1 6 0 B W.<br />

W h a t i s t h e p u r p o s e o f t h e s t u d y ?<br />

We w ou ld li ke t o in vi te you t o b e a p artic ip an t in a 5-m on th lon g s t u d y t h a t i ns d ed i n to t e<br />

f i n d o u t w h e t h e r t h e a d d i t i o n o f -h s e yp l f n os is or a h eal in g met h od called J oh rei t o t h e regu lar<br />

treatmen t you re cei ve at C h e l s e a a n d We s t m i n s t e r H o s p i t a l will h elp clin icall y or i n you r<br />

q u alit y <strong>of</strong> li f e.<br />

W h y h a v e I b e e n c h o s e n ?<br />

W e w o u l d l i k e amin t o e th e x ef fi cac y o f p s ych ol ogi cal in terv en tion s on th e q u ality o f life in<br />

HIV p at ien ts , s o you h ave b een i n v i t e d t o p a r t i c i p a t e i n t h e p r o j e c t. It is u p to you t o d ecid e<br />

w h e t h e r o r n o t t o t a k e p a r t . I f y o u d o d e c i d e t o t a k fo e rmati p a r on t y o u w i l l b e g i<br />

s h eet to keep an d b e as ked t o s ign a con s en t for m. If you d ecid e to take p art you ar e s till free<br />

to with d raw at an y ti me an d with ou t givi n g a reas on . R efu s al to p articip ate o r s u b seq u en t<br />

w i t h d r a w a l w i l l n o t a f f e c t t h e s t a n d a r d o f . c a r e y o u r e c e i v e<br />

W h a t w i l l h a p p e n t o m e i f I t a k e p a r t ?<br />

Th is res earch p roj ect i s d es ign ed as a ran d omis ed trial.<br />

D r T M L a i d l a w<br />

Depar t ment <strong>of</strong> Co gni t i v e<br />

Neur os ci en ce & Beha vi our<br />

Charing Cross Hospital<br />

S t D u n s t a n ’ s R o a d<br />

L O N D O N W 6 8 R P<br />

Someti mes b ecau s e we d o n ot kn ow wh ic h wa y o f tr eatin g p atien ts is b es t, we n eed to make<br />

comp ari s on s . I n a r a n d o m i s e d e o t p r l i e a w l i , l l p b e p u t i n t o g an r o d u th p s en comp ared . Th e<br />

grou p s are s el e ct ed b y a c omp u ter t h a t h a s n o in for mation ab ou t th e in d ivid u al – i.e. b y<br />

ch an ce. P at ien ts in each grou p th en h ave a d ifferen t tre atmen t an d th es e are c omp a red .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 20 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t h i s r e s e a r c h p r o j e c t , y o u w i l l b t o e o r n e a n o d f o t m h l r e y e g a r s o u s p i s : g n s -h e d l yp f n os is o r J o h r e i w h i c h -tou i s ch a h eal n o in n g m et h od fro m J ap an an d a waitin g lis t b efo r e you a re<br />

a s s i g n e d t o e i t h e r s e -h l f yp n os is or J oh rei . P leas e read th e d es crip tion s fo r all th re e gr ou p s .<br />

O n e -t h i r d o f t h e p th e o e p sl tu e d y i wi n ll b e p u t on to th e waitin g lis t to h a ve th eir t rain in g in 4<br />

mon th s ti me, d u ri n g wh ich , if you are in t h is grou p , you will b e as ked t o c omp lete s ome<br />

p s ych ol ogi cal tes ts . Th is d ela y fo r s o me p articip an ts p rovid es a co mp aris on f or th e effects <strong>of</strong><br />

train in g ov er th e 4 m on th s , a n eces s ar y re q u iremen t in a s cien tific s tu d y <strong>of</strong> th is t yp e. Th e<br />

r e m a i n d e r ( 2 / 3 r d s o f p e o p l e i n t h e s t u d y ) w i l l h a v e -o t r h -les e i s r im t mr a ed i in at i el n g y. m o r e<br />

Y o u m u s t f e e l a l l r i g h t a b o u t p a r t i c i p a t i n g r di ela n yed e i con t h e dr it ion t , h as e i m m e d i a t e o<br />

yo u c ou ld b e ran d oml y as s i gn ed to eith er.<br />

Meetin g s ch ed u le :<br />

Ses s i o n s 1 t o 4 a r e h e ( 2 l d h o u w r e s e k a l c h y ). S e s s i o n s 5 t o 1 4 a r e h e l d (1 o n c e a m o n t h<br />

h o u r e a c h ).<br />

I N T E R V E N T I O N G R O U P ’ S S C H E D U L E<br />

1 2 3 4 5 6 7 I n t e r v e n t i o n s e s s i o n s ( f i r s t 4 a r e w e e k l y , l a s t 3 m o n t h l y )<br />

1 & 2 3 M a i n a s s e s s m e n t p o i n t s<br />

End <strong>of</strong> Month: 1 2 3 4 T i m e<br />

W A I T-L I S T E C D O N T R O L S C H E D U : L E<br />

0 1 I n t e r 2 v e n t i o n 3 s e s s i o 4 n s 5<br />

1 & 2 3 4 M a i n a s s e s s m e n t p o i n t s<br />

End <strong>of</strong> M on t h : 1 2 3 4 5 6 7 8 T i m e<br />

If you are in th e w a i t -listed g r o u p , y o u w i l l h a v e y o u r f i r s t E E G a n d t e s t i n r g s e s s i o n , a n d<br />

4 mon th s you wi ll en ter in to th e s eq u en ce as d etailed ab ove.<br />

T h e m a i n c o l l e c t i o n s o f d a t a w i l l b e c o m p o s e d o f -a p a n p d e -p r en ci l tes t res u lt s ab ou t h ow you<br />

are feel in g an d cop in g, b lo od s amp les to mon itor you r s tres s le vels an d a b rain wa ve s tu d y.<br />

A l l p a rt ici p an ts wi ll b e as k ed to give b loo d s amp les (2 0 mls ) an d fill ou t q u es tion n aires b oth<br />

a t t h e b e g i n n i n g o f t h e -u p ( a p t r 6 m o j n t h e s ) c f o t r f , u r t h e a r t t h r e e m<br />

h o r m o n e a n d i m m u n e a n a l y s i s . T h e m e a s u r e m e n t s w i l l i n c EE l G u d e f o r s o m e o f y o<br />

(electr oen cep h al ograp h ) wh ich rec ord s th e electrical activit y <strong>of</strong> on e’s b rain . Th is is a<br />

c o m p l e t e l y -in n vas o n ive p roced u re, wh ich in volves th e attach m en t <strong>of</strong> va riou s elect rod es to<br />

y o u r h e a d u s i n g a c a p a n d s o m e g e l . P l e a s e n o t e t h a t t h e ced e l on e c t th r e o sd ue rface s a r e p l a<br />

<strong>of</strong> th e s ki n on l y an d th ere is n o d an ge r o f electric s h oc k.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 21 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Fo llowi n g at tach men t o f th e elect rod es , you will b e s eated in fr on t <strong>of</strong> a c omp u ter mon itor an d<br />

i n s t r u c t e d t o d o c e r t a i n t a s k s s u c h a s r e m e m b e r i n g s o m e on th w o e r d s a n d f a c e s p r<br />

comp u ter s cre en . Th ere wi ll b e th ree E E G rec ord in g s es s ion s s p read th rou gh ou t a wh ole<br />

p eriod <strong>of</strong> th e s t u d y ea ch las ti n g ab ou t two h ou rs . All d etails an d d ata res u ltin g fr om th e s tu d y<br />

will remai n s tri ct l y c on fi d en ti al.<br />

T h e t w o s e t s o f t r a i n i n g a r e in S e l f-H yp n o s i s a n d J o h r e i :<br />

Self-Hyp n os is : H yp n os is is an alte red s tate <strong>of</strong> con s ciou s n es s th at can feel like d eep relaxati on<br />

d u rin g wh ich a p ers on can u s e th eir imagi n ation in a p owerfu l wa y. Se veral res ea rch<br />

s t u d i e s h a v e s h o w n t h a t m a n y, a l t h o u g h n o t a l, l p e op le can con tr ol th ei r p ain an d af fect<br />

th eir emot i on s , an d even al ter th eir i mmu n e s ys te ms , d eter min ed b y h ow th e y u s e t h e<br />

h yp n oti c s tat e. On e recen t s tu d y b y D r M ich ael An ton i <strong>of</strong> th e Un iv ers it y <strong>of</strong> Mia mi<br />

s h owed th at p at ien ts wi th HIV h ad , on a v erage , a b etter q u alit y <strong>of</strong> life, an d in d eed , man y<br />

p o s i t i v e l y a f f e c t e d t h e i r i m m u n e s y s t e m w i t h a g r o u p p r o g r a m m e i n c l u d i -h n yp g s ne os l f is ,<br />

s imilar t o th e on e we p lan for th os e <strong>of</strong> yo u ran d oml y as s ign ed t o th is arm o f th e s tu d y.<br />

W e t h i n k t h a t s u c h a p r o g r a b e m pm rop e erl s h y o tu es l ted d h ere in Lon d on . If you a re<br />

as s ign ed to th e h yp n os is c on d ition , you w ill firs t e xp erien ce h yp n os is , th en learn h ow to<br />

u s e s e l f-h yp n os is . Va ri ou s p os s ib le goa ls will b e d is cu s s ed an d you will b e tau gh t h ow<br />

t o u s e s e l -h f y p n o s i s f o r a t l h s e y o g u o c h o o s e . Y o u w i l l b e a s k e d t o p r a c t i c e y o -u<br />

r s e l f<br />

h yp n os is d ai l y d u ri n g th e p roject .<br />

J oh rei : J oh rei is a J ap an es e h ealin g meth od . An yon e c an learn to d o J oh rei afte r<br />

u n d ers tand in g th e core p ri n cip les an d b asic tech n iq u es . Healin g m eth od s h ave m an y<br />

variati on s an d J oh rei is b as ed on th e con cep t <strong>of</strong> ‘h ealin g on es elf b y h ealin g oth ers ’ u s in g<br />

a n o n-t ou ch in g met h od . J oh rei h as ju s t b egu n to b e s cien tificall y t es ted with s ome<br />

e n c o u r a g i n g r e s u l t s . M i l l i o n s o f p e o p l e a r o u n d t h e w o eir r l d u s e J o h r e i t<br />

h ealth , in cl u d in g p eop le wi th HIV. Du rin g you r ti me in th e p roject , yo u will lea rn t h es e<br />

tech n iqu es . J oh rei is s ai d to reli eve s ymp t oms , even th ou gh s o me p e op le fo r a d a y or s o<br />

a s t h e y l e a r n t h e t e c h n i q u e s c a n e x p e r i e n c e b r i e f , m i n o r d i s c o m mild f o r t s u c h a s<br />

s ymp toms <strong>of</strong> h ead ach e, s weatin g or d iarr h oea, alth ou gh we h ave s een n on e <strong>of</strong> th is h ere in<br />

ou r p revi ou s s t u d i es . Du ri n g t h e p roject , you will b e as ked t o p ractis e J oh rei ev er y d a y<br />

with s omeon e (p art n er, d au gh ter, frien d e tc.).<br />

I f y o u a g r e e t o ate, p a you r t i wi c li l p b e on e <strong>of</strong> 1 5 0 p eop le like you rs elf with d iagn o s ed HIV<br />

wh o wi ll b e in vi ted to p art ici p at e in th e p roject. You , alon g with th e oth ers , will co mp lete<br />

v a r i o u s t e s t s , a n d w i l l h a v e -wa y o ves u r ) meas E E G u red ( b . r Ya ou i n wi ll h ave th es e tes ts at<br />

th e b egi n n in g, an d agai n at fou r - fi ve mo n th s for a r ep eat s et o f tes ts . Howe ver, yo u will<br />

meet re gu larl y in a grou p o f 6 - 9 o t h e r s t u d y s u b j e c t s i f y o u a r e a s s i g n e d t o l e a r -n<br />

s e l f<br />

h y p n o s i s o r J o h r e i . I n s -h e l y f p n o s i s , t h e g r -o o r u d p i n a c t o r w i l l b e D r T a n n is Lai d law, a<br />

p s ych ol ogi s t wi th e xt en s ive e xp eri en ce in clin ical h yp n os is . If you a re in th e J oh rei gr ou p ,<br />

yo u wil l b e t rai n ed b y Dr Akira Nai to , a d octor t rain ed in b oth wes tern med icin e a n d th e<br />

J oh rei h eal in g met h od . If you are in th e w aitin g lis t gr ou p , you will b e ran d oml y as s ign ed to<br />

e i t h e r J o h r e i o r s e -h l f y p n o s i s i mn on 3 th s ti me wh en you wi ll j oin with oth ers in th e train in g.<br />

All th e b rai n wa ve s tu d ies will b e with D r P rab u dd h Dwived i, wh o is a clin ical p s ych olo gis t<br />

w i t h s p e c i a l i s e d k n o w l e d g c e t i n g o f E E c G o n s d t u d i e s . T h e S -h e l yp f n os is , J oh r ei an d<br />

EE Gs wi ll b e p erf or med at th e C h arin g C ros s Hos p ital.<br />

Self-h yp n o s i s o r J o h r e i s c h e d u l e :<br />

I f y o u a r e i n e i t h e r o f t h e -h s e yp l f n os is or J oh rei g rou p s , you will meet t ogeth er wit h th e<br />

o t h e r p a r t i c i p a n t u r s a g r n d o u p y -o o c rd o in at or on e s es s ion a week f or fou r w eeks ( 1 to 4 on<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 22 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

t h e d i a g r a m a b o v e ) . Y o u w i l l l e a r n -h s e yp l f n os is or J oh rei in ord e r to b egin p ractic e at h om e.<br />

A s mall d ai l y d iar y wi ll b e creat ed s p ecifi call y f or you , to b e filled ou t at th e en d o f each d a y<br />

(takin g ab ou t 2 mi n u tes ) an d kep t fo r th e d u ration <strong>of</strong> th e p roj ect.<br />

Aft er th is m on th <strong>of</strong> w eekl y meetin gs , th e s h orter m eetin gs will b e s p aced at on e me etin g a<br />

mon th fo r th e d u rat ion o f th e p roj e ct, an d you a re welc om e to con tin u e p as t you r fi n al<br />

a s s e s s men t p oi n t . Al t oget h er , you will h a ve th ree tes tin g s es s ion s for EE G an d two fo r<br />

p s ych ol ogi cal tes ti n g, las ti n g ab ou t 2 h ou rs . Th e tes tin g is for th e p u rp os e <strong>of</strong> m on itorin g you r<br />

p r o g r e s s a n d y o u r r e s p o n s e t o s e -h l f y p n o s i s o r J o h r e i . W h e n y o u artmen a t t e n t d on o u r d e p<br />

t h<br />

t h e 1 0 floor <strong>of</strong> th e med ical s ch o ol f or yo u r EE G tes tin g you will h ave p len t y <strong>of</strong> ti me to fill<br />

ou t th e p s ych ol ogi cal tes ts . Th e y are n o t on erou s an d th ere are n o ri gh t o r wr on g an s wers ,<br />

alth ou gh you r op in ion wi ll b e s ou gh t ab o u t man y d iffe ren t as p ects <strong>of</strong> you r exp erie n ce.<br />

As s es s men t ti mes in vol vi n g p s ych ol ogica l tes ts an d EEG are in d icated b y th e a rro ws lab elled<br />

1 ,2 an d 3 .<br />

W h a t d o I h a v e t o d o ?<br />

T h e r e a r e n o l i f e s t y l s. e N r o e s ps et ci r al i ch c t an i ge o n is req u ired f or th is s p ecific s t u d y in you r<br />

l i f e s t y o l t e h e r t h a n i n c o r p o r a t i n g i n t o y o u r d a i l y s c h e d u l e s o m e t i m e t o p r a c t i c e -y<br />

o u r s e l f<br />

h yp n o s i s o r J o h r e i.<br />

W h a t i s t h e d r u g o r p r o c e d u r e t h a t i s b e i n g t e s t e d ?<br />

You wi l l n ot b e gi ven an y d ru gs in ad d ition to you r u s u al med icati on s .<br />

W h a t a r e t h e a n l a t e i r v e s f o r d i a g n o s i s o r t r e a t m e n t ?<br />

You s h ou l d feel fre e t o as k you r GP ab ou t you r d iagn os is an d an y altern ative treat men t fo r it.<br />

W h a t a r e t h e s i d e e f f e c t s o f t a k i n g p a r t ?<br />

W e e x p e c t n o s i d e e f f . e c t s<br />

W h a t a r e t h e p o s s i b l e b e n e f i t s o f t a k i n g p a r t ?<br />

W e hop e t h at b o t h i n t erv en t i on s will h elp you . Howe ver , th is can n ot b e gu aran teed . Th e<br />

in format i on we get fro m t h i s s tu d y ma y h elp u s to b etter treat fu tu re p atien ts with HIV.<br />

W h a t i f n e w i n f o r m a t i o n b e c o m e s a v a i l a b l e ?<br />

S o m e t i m e s d u r i n g t h e c o u r s e o f a r e s ce h a r p roj ect n ew in fo rmat i on b ecom es avail ab le ab ou t<br />

th e treat men t / d ru g th at is b ei n g s tu d ied . If th is h ap p ens , you r r es earch d oct or wil l tell you<br />

ab ou t it an d d is cu ss wi th you wh eth er yo u wan t to con tin u e in th e s tu d y. Y ou m a y d ecid e to<br />

w i t h d r a w b u t u di ecid f e y o to con ti n u e in th e s tu d y yo u will b e as ked to s i gn an u pd ated<br />

con s en t for m.<br />

Alte rn at ivel y, on recei vi n g n ew in fo rmati on you res earch d oct or mi gh t con s id er it t o b e in<br />

y o u r b e s t i n t e r e s t s t o w i t h d r a w y o u f r o m t h e s t u d y . H e / s h se o nw s i an l d l e x p l a i n t h e r e a<br />

arran ge fo r you r ca re t o c on tin u e.<br />

W h a t h a p p e n s w h e n t h e r e s e a r c h s t u d y s t o p s ?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 23 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e i n t e n s i o n i s t h a t y o u w i l l b e i n d e p e n d e n t i n y o -h u r yp s ne os l f is an d J oh rei s ki l ls an d will<br />

n o t n e e d f u r t h e r i n s t r u c t i o n . H o w e v e r , a l i s t o f q u a l i f i e d p r a c s t in i t i Lon o n e dr on can b e<br />

mad e avai lab le t o you on co mp letion o f t h e s tu d y.<br />

W h a t i f s o m e t h i n g g o e s w r o n g ?<br />

If ta kin g p art in th is res ear ch p roject h ar ms you , th ere a re n o s p ecial c o mp en s ation<br />

a r r a n g e m e n t s . I f y o u a r e h a r m e d d u e t o s o m e o n e ’ ma s y n he ag vl e i gr g ou e n nc de s , t h e n y o u<br />

for legal act ion b u t you ma y h ave t o p a y f or it. R egard les s o f th is , if you wis h to comp lain<br />

ab ou t an y as p ect <strong>of</strong> th e wa y you h ave b ee n ap p roach ed or treat ed d u rin g th e cou rs e <strong>of</strong> th is<br />

s t u d y , t h e n o r m a l N H S c o m p l a i n t s m e c h a n i s m ilab s m le a y t o b yo e u . a v a<br />

W i l l m y t a k i n g p a r t i n t h i s s t u d y b e k e p t c o n f i d e n t i a l ?<br />

All in f or mat i on t h at i s c ol l ected ab ou t yo u d u rin g th e cou rs e <strong>of</strong> th e res earch will b e kep t<br />

s trictl y c on fi d en t i al . Al l i n for mation ab ou t you will b e kep t s ecu rel y at Imp erial C ollege,<br />

C h arin g C ros s Hos p i t al , Lon d on , an d u n der p ers on al s u p ervis ion <strong>of</strong> th e r es earch ers wh en<br />

b ein g tran s p ort ed fro m C h el s ea & Wes tm in s ter Hos p ital to C h arin g C r os s Hos p ital .<br />

W h a t w i l l h a p p e n t o t h e r e s u l t s o f t h e r e s e a r c h s t u d y ?<br />

T h e r e s u l t s o f t h i s s t u d y a r e in ten d ed to p rovid e n ew in f or mation ab ou t th e tr eatme n t <strong>of</strong><br />

p eop le wi th n ewl y d iagn os ed HIV , an d will b e p u b lish ed as acad emic p ap ers in p r<strong>of</strong>es s ion al<br />

jou rn al s . It wi ll b e th e b as is <strong>of</strong> talks at c on feren ces ar ou n d th e world . No n ames or oth er<br />

i d e n t i f y i n ects g a <strong>of</strong> s p th e p art ici p an ts wi l l b e d is clos ed d u rin g an y <strong>of</strong> th es e c om mu n ication s .<br />

W h o i s o r g a n i s i n g a n d f u n d i n g t h e r e s e a r c h ?<br />

Th is res earch i s s p on s ored b y th e or gan is ation th at teach es J oh rei in J ap an . It is or gan is ed b y<br />

th e Dep t . <strong>of</strong> C ogn i t i ve Neu ros cien ce an d Beh avi ou r, Imp erial C ollege Lon d on .<br />

W h o h a s r e v i e w e d t h i s s t u d y ?<br />

Th e R i vers i d e R es earch Et h i cs C o mmitte e revi ewed th e s tu d y.<br />

C o n t a c t f o r f u r t h e r i n f o r m a t i o n<br />

Dr Tan n i s Lai d l aw can an s wer an y fu rth e r q u es tion s on 0 2 08 8 46 7 04 2 or email :<br />

t . l a i d l a w @ i c . a c . u k<br />

Th an k you fo r con s i d eri n g t a kin g p art in ou r res ea rch p roject. P leas e take th is in fo rmation<br />

s h eet h ome wi t h you .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 24 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T i t l e o f P r o j e c t :<br />

P A R T I C I P A N T C O N S E N T F O R M<br />

T h e E f f e c t s o f T w o P s y c h o l o g i c a l v e I n t i e o r n T e c h n i q u e s , S e -Hyp l f no si s<br />

a n d t h e J o h re i He a l i n g M e t ho d , o n Q u a l i t y o f L i f e , P sy c ho l o g i c a l W e -B l l e i ng ,<br />

E E G m easure s a nd Va ri o us Imm unol og ic al M ea sures i n HIV: A Ra ndoml y<br />

C o nt rol le d Pi lo t St udy .<br />

( T h e p a t i e n t / v o l u n t e e r s h o u l d c o m p l e t e t h e w h o l e t h o i f s s h e e t h i m / h e r s e l f )<br />

H a v e y o u r e a d t h e I n f o r m a t i o n S h e e t ?<br />

Y e s N o<br />

H a v e y o u h a d t h e o p p o r t u n i t y t o a s k q u e s t i o n s a n d d i s c u Y s e s t h N e o s t u d y ?<br />

H a v e y o u r e c e i v e d s a t i s f a c t o r y a n s w e r s t o a l l o f y o u r Y q u e s e s t i N o n s ?<br />

H a v e y o u r e c e i v e d e n o u g h i n f m o r a t i o n a b o u t t h e s t u d y ?<br />

Y e s N o<br />

W h o m h a v e y o u s p o k e n t o ? ( w r i t e n a m e ) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _<br />

Do you un d erst and t ha t you a re free t o wi t h d ra w from th e st ud y,<br />

a t a n y t i m e , w i t h o u t h a v i n g t o g i v e a r e a s o n , a n d w i t h o u t a f f e c t i n g<br />

t h e q u a l i t o y u r o f p r e y s e n t o r f u t u r e m e d i c a l c a r e ? Y e s N o<br />

D o y o u a g r e e t o t a k e p a r t i n t h i s s t u d y ?<br />

D r T M L a i d l a w<br />

D e p a r tme n t o f C o g n itiv e<br />

N e u r os c ien c e & Be h a v io ur<br />

Fa c u lty o f Me d ic in e<br />

Imperia l C o lle g e o f Sc ie n c e ,<br />

T e c h n o l o g y a n d M e d i c i n e<br />

S t D u n s t a n ’ s R o a d<br />

L O N D O N W 6 8 R P<br />

Y e s N o<br />

I u n d erst an d th at th e Loc a l Et hi c s C ommi tt ee ma y r evi e w t h i s form a s p a rt <strong>of</strong> a<br />

mon i t orin g p roc ess.<br />

N A M E I N B L O C K L E T T E R S :<br />

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _<br />

C o n t a c t s : A d d r e s s : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _<br />

T e l e p h o n e n u m b e r ( s ): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _<br />

E m a i l : ___ ___ ___ ___ ___ ___ ___ ____ ___ ___ ___ ___ ___ ___ ___ _<br />

S i g n a t u r e : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ t e: D a ___ _ / ___ __ / ____ ___<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 25 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Appe ndi x 2 : P s y c h o l o g i c a l t r a i n i n g i n t e r v e n t i o n p r o t o c o l s<br />

1. S e l f h y p n o s i s t r a i n i n g<br />

S e s s i o n p l a n s<br />

In s t r u c t o r ma n u a l ( w i t h c s r i p o f s e l -h f y p n o s i s f o r -r a u e d c i o r o d i ) n g 230<br />

2. Johr e i t r a i n i n g<br />

C o u r s e d e s c r i p t i o n<br />

O n e -h ou r In t r o d u c r t y o S e m i n a r P o w e r p o i n r t e s e P n t a t (wi i o tn h n ot es:<br />

a s a n e x a mp l e o f , e x t r a c t f r o m , t h e e x p l a n a t i o n i n t h e J o h r e ti ra in in g<br />

s e s s i s) o n<br />

256<br />

J o h r e i H a n d b o o k<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 26 - I m p e r i a l o C n o d l o n l e g e L<br />

227<br />

253<br />

272


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

D r . T a n n i s M. L a i d l a w<br />

I m p e r i a l C o l l e g e L o n d o n<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 27 - I m p e r i a l o C n o d l o n l e g e L


P s y c h ol o gi cal in ter ven ti on an d p s y c h o-n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S e l f-h y p n o s i s G r o u p<br />

S e s s i o n 1 : I n s t a n t R e l a x a t i o n<br />

1 . N a m e t a g s<br />

2 . In tr od u ct i on s <strong>of</strong> p eop l e i n clu d i n g me.<br />

3 . T o p i c o f t h e D a y : I n t r o d u c t i o n t o h y p n o s i s a n d P N I<br />

- S t o r y o f m y P h D<br />

- S t o r y o f u s i n g h y p n o s i s i n i n f e c t i o n s<br />

- Ima ger y t o b e u s ed<br />

4 . H yp n os i s S es s i on 1 : I n s t a n t R e l a x a t i o n<br />

H y p n o s i s S e s s i o n 1 : ‘ I n t r o d u c t i o n ’<br />

T h e H y p n o s i s P r o c e d u r e : ‘ T h e B e a k e r D i a g r a m ’<br />

S e s s i o n 2 : V i e wi n g t h i n g s d i f f e r e n t l y t o r e g a i n c o n t r o l<br />

5 . D e -B u g g i n g N e g a t i v e T h o u g h t s R e c o r d<br />

6 . H yp n os i s S es s i on 2 : ‘ S y m b o l ’<br />

S e s s i o n 3 : B r e a t h i n g y A w n x a i e t y a n d P a n i c<br />

7 . T h e F e e d b a c k L o o p o f N e g a t i v e T h o u g h t s<br />

P h y s i o l o g i c a l R e a c t i o n s t o S t r e s s<br />

M u s c l e s b e c o m i n g t e n s e o r w e a k<br />

S o m e C a t a s t r o p h i c T h o u g h t s<br />

T h e B r e a t h i n g T r i a n g l e<br />

8 . H yp n os i s S es s i on 3 : ‘ S h a r k s ’ n ’ B a t s ’<br />

S e s s i o n 4 : Ge t t i n g r i d o f p e s k y t h o u gh ts<br />

9 . Step-b y -s t e p I n s t r u c t i o n s f o r t h e I n t e r r u p t D i s t r a c t i o n P r o c e d u r e<br />

1 0 . H yp n os is S e s s i o n : ‘C 4 o a s t l i ’ n e<br />

P o s t -t r a i n i n g T r a c k s : T o p r o v i d<br />

1 1 . H y p n o s i s P o s t T r a i n i n g<br />

S e s s i o n s :<br />

5 : ‘ B l u e ’<br />

6 : ‘ B e a c h ’<br />

7 : ‘ T h r u g m u t t o n ’<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 28 - I m p e r i a l o C n o d l o n l e g e L


C o u r s e d e s c r i : p Dt a i l y o Jn o h r e i L ( a y i n g-o n -o f -h a n d s �l i k e he a l i n g m e t h o d ) C o u r s e<br />

L e n g t h o f c o u r s e : 4 w e e kl y t r a i n i n g + s 3 m o n t h f /u A c c o m m o d a t i : o n I m p e r i a l C o l l C e h g e a r i n g C r o s s C a m p u s<br />

Av a i l a b i l i t y :<br />

W e d n e s d a y s h 2 o u r s ( 1 8 : -2 3 0 : 3 0 ) E n try : T h o s e w h o a g r d e e with a c o n s e n t f o r m<br />

B o o k : H a n d o u t s T u t o r’s c e r t i f i c : a t Je oh rei in s tru ctor, Ad u lt teach in g, M.D .<br />

Progression:<br />

1 . S t r e s s m a n a g e m e n t t o o l s<br />

2 . P r a c t i s i e t h n o d g a s h a e d a i a l l y h i e a n l t g h m a m i n t e n a n c e t e c h n i q u e<br />

Study details:<br />

J oh rei is a h ealin g meth od wi th th e con ce p t <strong>of</strong> ‘h e a l o n e s e l f b y h e a l i n g o ’ t f h o e r s e l f-care o r m ain tain in g h eal th & h ap p in ess .<br />

S t u d y i n g t h e s u b j e c t p r o v b od i y in d de ail s y life. a w a y f o r y o u t o b a l a n c e y<br />

You will fin d s ome ap p licat ion s <strong>of</strong> J oh rei fo r you r d ai l y li fe in th is cou rs e.<br />

<strong>The</strong> study-subject can be divided into tw o parts:<br />

1 . Th e s tu d y <strong>of</strong> Dail y J oh rei , in cl u d in g tech n iqu es h ow to p erf orm th e h eal in g met h od in a co mp et en t man n er.<br />

2 . A s tu d y o f th e p h ilos op h y & p ri n ci p les o f J oh rei , l oo ki n g p art icu larl y at th e w a y th e h eal in g p roces s ta kes p lace an d th e s ign ifi can ce o f th es e<br />

mean in gs in real li f e.<br />

Tho s e t w e o l e m e n t s a r e s e e n a s -c i o n n t e r c t i n g . I t p r o v i d e s y o u w i t h a to n ao p ply p o r th t es u n e i tech t y n i qu es & ph il os o ph y in t o da il y li fe.<br />

A i m s a n d O b j e c t i v e s o f D a i l y J o h r e i c o u r s e<br />

Overall<br />

Aims: T o i n t r o d u c e t h e b a s i c c o n c e p t s o f J o h r e i p h i l o s o p h y , p r i n c i p l e s a n d p r a c t i c e<br />

T o p r o v i d e o p p o r t u n i t i e s , e n c o u r a g e m e n t a n e d p articip i n s p an i r ts a to t i ap o pn ly t J oh o rei t h Art <strong>of</strong> Li vi n g an d J oh rei p ract ice to d ai l y li fe.<br />

T o e n s u r e t h e p a r t i c i p a n t s a r e a b l e t o g i v e D a i l y J o h r e i c o m p e t e n t l y a n d i n s a f �i e m n a n a n e r -p n o r<strong>of</strong>es n s ion al cap aci t y.<br />

O u t c o m e s : At th e en d o f th e c ou rs e p art i ci p an ts wi ll b e a b l e t o : -<br />

1 . I d e n t i t f h e y b a s i c p r i n c i p l e s a n d c o r e c o n c e p t s o f J o h r e i<br />

2 . G i v e d a i l y J o h r e i c o m p e t e n -p t r l o y f e i s n s i a o n a n l o n c a p a c i t y<br />

3 . State t h e m a i n a s p e c t s c o n c e r n i n g t h e s a f e p r a c t i c e o f J o h r e i<br />

4 . B e a w a r e o f o p p o r t u n i t i e s i n t h e f u t u r e f o r r e i n f o r c i n g a n d f u r ht er u n d ers tan d in g <strong>of</strong> J oh rei p h il os op h y an d p racti ce.<br />

- 2 53 -


Session 1<br />

Ai ms : T o p r o v i d e a n o v e r v i e w a n d p r a c t i c a l i n t r o d u c t i o n t o J o h r e i<br />

O u t c o m e s: At t h e e n d o f t h e s e s s i o n p a r t i c i p a n t s w i l l b e a b l e t o - :<br />

1 . State t h e m a i n e l e m e n t s o a r f d s h J e a l o t h i r e r e l i �( f e 3 a s f o t s u y n l d e a t a i o n , h J o h r l e i i v i e s w t p o i n t c o f i l w l n a e s y s ) t o w<br />

2 . Id e n t i f y h o w J o h r e i m a y b e u s e d i n ( mean d a i l in y g ol f i ‘S f e p i r i t u a ’, l i T t u y n i -i n g , P r a c t i c a l J o h r e i )<br />

3 . D e m o n s t r a t e t h e e s s e n t i a l e l e m e n t s o f J o h r e i a s ( a D d a i l y y p J r o a h c r t n e i q c u e e t s ) e c h<br />

Session 2<br />

Aims: T o in trod u ce th e b as ic p ri n ci p les an d a core p h il os op h y s u p p ort in g J oh rei p ract ice an d it s ap p li cat ion for d ai l y li fe .<br />

O u t c o m e s: A t t h e e n d o f t h e s e s s i o n p a r t i c : i - p a n t s w i l l b e a b l e t o<br />

1 . I d e n t i f t y h e b a s i c p r i n c i p l e s s r u e p i p o p r t a i c t n i g ( s c p e J i r o i h t p r e c e d e s p h y s i c a l , t o x i n s a n d c l o u d s , p r o c e s s o f p u r i f i c a t i o n , I Z U N O M E )<br />

2 . B e a w a r e o f ‘M A K O T O ’ (l o v e , s i n c e r i t y a n ) d as i a n co t re e g cr on i t cep y t <strong>of</strong> J oh rei p h il os op h y an d p ract ice. 3 . S t a t e t h e f i v e f i n g e r r u l e s o f J o h r e i<br />

4 . R e c o g n i s e t h e b r i e f h i s t o r i c a l b a c k g r o u n d o f J o h r e i a n d a p p r e c i a t e t h e w o r k s o f M o k i c h i O k a d a<br />

5 . B e a w a r e o f t h e i m p o r t a n c e o f i n t e n t i o n s o t h a t t h e y c a n a p p l y v i s u a l i s a t i o n i n t o J o h r e i p r a c t i c e<br />

6 . D e m o n s t r a t e a b a s i c t e c h n i q u e s o f J o h r e i w i t h v i s u a l i s a t i o n<br />

Session 3<br />

Aims: T o p l o e r x e t h e w i d e r a s p e c t s o f J o h r e i p h i l o s o p h y e m b r a c i n g t h e v a l u e o f a r t a n d b e a u t y f o r b o t h i n s p i r a t i o n a n d w e -b l l e i n g<br />

T o e x p l o r e J o h r e i p h i l o s o p h y o f n u t r i t i o n a n d t h e v a l u e o f a l i f e s t y l e i n h a r m o n y w i t h N a t u r e<br />

To en cou r age s tu d en ts to b e aw ar e o f t h e im p o r t a n c e o f s p i r i t u a l c o n n e c t i o n w i t h o u r s e l v e s , o t h e r s a n d N a t u r e<br />

O u t c o m e s: A t t h e e n d o f s e s s i o n p a r t i c i p : a - n t s w i l l b e a b l e t o<br />

1 . R e v i e w s e q u e n c e o f D a i l y J o h r e i t e c h n i q u e<br />

2 . Be aw are <strong>of</strong> th e wid er as p ects <strong>of</strong> J oh rei p h il os op h y e mb raci n g th e val u e <strong>of</strong> a rt an d b e a u t y f o r b o t h i n s p i r a t i o n a n d w e l l b e i n g<br />

3 . Ou t l i n e t h e J o h r e i p h i l o s o p h , y ‘N o a n t u n r u e t r F i a t r i m ’ o i a n n g d t h e n a t u r e<br />

4 . B e a w a r e o f t h e v a l u e o f s p i r i t u a l c o n n e c t S i o p n i r ‘ i t u a l ’ with c o r ou d rs elv es , oth ers an d Nat u re<br />

Session 4<br />

Aims: T o r e i n f o r c e t h e b a s ic p r i n c i p l e s a n d c o r e c o n c e p t s o f J o h r e i, an d th e s afe p ract ice within a n -p o n r o f e s s i o n a l c a p a c i t y<br />

O u t c o m e s: A t t h e e n d o f s e s s i o n p a r t i c i p : a - n t s w i l l b e a b l e t o<br />

1 . P r a c t i c e D a i l y J o h r e i c o m p e t e n t l y w i t h i n t h e h o m e -p r a o n f d e s s w i o n t a h l o c t a ity p h a e c r s i n a n o n<br />

2 . R e v i e w t h e s e q u e n c e o f D a i l y J o h r e i t e c h n i q u e a n d k n o w t h e s e q u e n c e o f S p i r i t u a l J o h r e -J i o & h r e S i e l f<br />

3 . Be aw are <strong>of</strong> op p ortu n iti es in th e fu tu re fo r rei n f orci n g an d fu rt h er u n d ers tan d in g <strong>of</strong> J oh rei p h il os op h y an d p racti ce.<br />

- 2 54 -


S C H E M E O F W O : R D K a i l y J o h r e i cour s e<br />

C o u r s e : D a i l y J o h r e i h e a l i n g m e t h o d s w i t h b a c k g r o u n d p h i l o s o p L h e i c e s t u r e r : D r . A k i r a N a i t o<br />

U n i t N o / T i t l e 4 u n i t s<br />

Le vel : b e g i n n e r<br />

S e s s i o n T o p i c s ( A i m s ) &<br />

T e a c h i n g m e t h o d s L e a r n i n g As s e s s m e n t R e s o u r c e s K e y-c o n c e p t s<br />

No.<br />

C o n t e n t s ( O b j e c t i v e s )<br />

activities t e c h n i q u e s<br />

1 D a i l y J o h r e i<br />

Facilitating br a i n s t o r m i B n r g a i n s t o r m i O n b g s e r v a t i o n P o w e r -p o i n t J o h r e i<br />

F o u n d a t i o s n <strong>of</strong> J oh rei phi l o s o p h y P o w e r -p o i n t p r e s e n t a t P i a i o n r w o r k Q & A Wh ite b oard “S p irit p reced es<br />

D a i l y J o h r e i t e c h n i q u e s D e m o n s t r a t i o n P r a c t i c a l G r o u p w o r k<br />

“ R e a l i a ” C D p h y s i c a l ”<br />

Q & A<br />

Q & A<br />

“h eal on es elf b y<br />

G i v e n i n f o r m a t i o n G u i d e d r e ing a d<br />

H a n d o u t s h e a l i n g o t h e ” r s<br />

2 P r i n c i p l e s o f J o h r e i p r a c t i c Facilitatin e g d is cu s s ion D i s c u s s i o n Dis cu s s ion P o w e r -p o i n t “P roces s <strong>of</strong><br />

H i s t o r i c a l b a c k g r o u n d P o w e r -p o i n t p r e s e n t a t P i a i o n r w o r k O b s e r v a t i o n Wh ite b oard pur i f i c a t i o n ”<br />

Hi s t o r y o f J o h r e i D e m o n s t r a t i o n P r a c t i c a l G r o u p w o r k<br />

“ R e a l i a “ M ” A K C O T D O ”<br />

P r o c e s s o f P u r i f i c a t i o n<br />

G u i d e d r e ing a d<br />

In ten tion :<br />

Visualisation<br />

Q & A<br />

Q & A Q & S A P O C<br />

“You are wh at<br />

In t e n t i o n G i v e n i n f o r m a t i o n<br />

H a n d o u t s<br />

y o u t h i ” n k<br />

3 A r t a n d B e a u t y<br />

P o w e r -p o i n t p r e s e n t a t G i u i o n d e d r e a d i n O g b s e r v a t i o n P o w e r -p o i n t “P arad is e on<br />

A r t o f N a t u r e<br />

D e m o n s t r a t i o n P r a c t i c a l P a i r w o r k<br />

W h i t e b o a r d<br />

e a r t h ”<br />

“R ealia” C D A p p r e c i a t s i o n<br />

& g r a t i t u d e<br />

N a t u r e f a r m i Q n g & A<br />

Q & A Q & A<br />

Nutrition<br />

S p i r i t u a l C G o i r v d e n i n f o r m a t i o n<br />

H a n d o u t s “ S p i r i t u a l c o r d ”<br />

4 R e v i e w i n g J o h r e i s s e s s i o n P o w e r -p o i n t p r e s e n t a t P i a i o n r w o r k F e e d b a c k P o w e r -p o i n t “ I Z U N O M E ”<br />

S p i r i t u a l J o h r e i<br />

D e m o n s t r a n t P i r o a c t i c a l G u i d e d r e a d i n O g b s e r v a t i o n Wh ite b oard L o v e f o r o t h e r s<br />

S e l f-J o h r e i<br />

Quiz<br />

Quiz<br />

Quiz “ R e a l i a ” C D<br />

Q & A<br />

Q & A Q & A<br />

C e r t i f i c a t i o n f o r a t t e G n d i a v n e c n e i n f o r m a t i o n G r o u p w o r k<br />

H a n d b o o k<br />

- 2 55 -


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

D a i l y J o h r e i<br />

W e l c o m e ! A n d t h a n k y o ming. u f o r c o<br />

I a m ve r y ho no ur e d a nd ha ppy t o be a ble t o ha ve t his opp ort un it y to ta lk t o yo u a bo ut Jo hre i.<br />

Le t me in t r od uce my s e lf , I a m ……<br />

F i r s t t h i n g I w o u l d l i k e t o s t a r t w i t h i s -int a rodu s e l f ct io n se ss ion.<br />

C o u l d y o u s t a t e y o u r n a m e , w h e r e y o u c nd o m what e f r kind o m <strong>of</strong> a thought has brought you here, in<br />

ot her wo r ds , t he obj e ct ive or ex pec t at io n t o co me t o t oda y’s t a lk br ie f ly, ple a s e ?<br />

W h a t d o y o u w a n t t o t a k e a w a y f r o m T o d a y ’ s s e s s i o n ?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 56 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Wh a t do you co n si d e r ‘ Spi ri t’ o r<br />

‘ S p i r i t u a l i t y ’ i s ?<br />

&<br />

W h e n d o o u y t h i n k a b o u t i t ?<br />

B r a i n s t o r m i n g !<br />

Hi g h sp i ri t , lo w sp i r i t, mean sp i r i t , t eam sp i r it … . .<br />

F i r s t o f a l l , it h t his I br a in w o s tor u ming l d s e s sl ion. i k e t o s t a r t w<br />

I n Bra in s to r ming, t her e a r e no r igh t or wr on g a ns we r s .<br />

P le as e disc uss in the gr oup t ha t wh a t do yo u co ns id e r ‘s pir it ’ or ‘s pir it ua lit y’ t o be ?<br />

B y t h i s I m e a n , w h a t s o r t o f t h i n k i n g c o m e s t o y o u r m i n d w h e n y o u h e a r d t ‘s h pir e w it o ’ r or ‘s pir it ua lit y’.<br />

Do you ha ve a ny de f init ion a bo ut t hes e ?<br />

A n y d i f f e r e n c e b e t w e e n ‘ s p i r i t ’ a n d ‘ s p i r i t u a l i t y ’ ?<br />

T he n ne xt qu es t ion is whe n do yo u t hin k a bou t th e c on ce pts <strong>of</strong> ‘s pir it ’ or ‘s pir it ua lit y’, in ot her wo r ds ,<br />

w h a t s o r t o f s i t eu s a you t i o tn hin m k a t he k s e ?<br />

Ar e you a l wa ys t hinkin g <strong>of</strong> t hes e ? Or yo u have ne ve r t hou gh t <strong>of</strong> t he se ?<br />

Y o u s u r e l y k n o w t h e w o r d , s o a t l e a s t o n c e y o u h a v e , h a v e n ’ t y o u ?<br />

A n y i d e s a ple a se .<br />

An yt hin g yo u ma y t hink <strong>of</strong> wou ld be ve r y he lp f ul a nd use f ul for us .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 57 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h r e e w a y s i n w h i c h t o a t t a i n s p i r i t u a l a w a r e n e s s<br />

B e a u t y<br />

S p i r i t u a l P r a c t i c e<br />

Life Challenges<br />

This s lid e is a summa r y <strong>of</strong> wha t I ha ve he ar d f r om pr e vio us gr ou ps <strong>of</strong> t he s itu at io ns wh e n th e y ma y t hin k<br />

<strong>of</strong> the sp ir it or s pir it ua lit y. <strong>The</strong> se ar e t yp ic a l e x a m p l es <strong>of</strong> t h e wa ys t o be a wa r e <strong>of</strong> sp i r i t i n Jo h r e i as we l l.<br />

Li f e c h a l l e n ge s i n c lude whe n yo u a re s uf fe r ing s ome t hin g dif f ic ult l i k e a t t gding e n f un e ra ls or e mot iona lly<br />

d r a i ing n t ime . Sp ir it ua l pr ac t ice i n c l e u s d w o r s h i p , m e d i t a t i o n , a n d s . p i r i t u a l h e a l i n g<br />

I n J ohre i t his ‘B e a u t ’ y i s h i g h l y e m p h a s i z e d a n d i t i n c l u d e s a p m i a e s c t e e r o p f i e a c r e s t i n l i w k e h i you c h<br />

m a y find a s pir it <strong>of</strong> an ar t ist , a nd s o m e w h e r e w be i t aut h if ul sc e ne r y in which you m a y f e e l yo ur s pir it is<br />

uplif t e d.<br />

A s y o u h a v e r a i s e d a n d h e a r d f r o m ’ o t hough h e r s t s ab out ‘s p i r i t ’ and ‘s p i r i t u ’, a l t her i t e y ar e qu it e a lot <strong>of</strong><br />

me a nin gs or co nce pts you c ould t hin k wh e n yo u he ar t hes e wo r ds . T he pur pos e <strong>of</strong> ha vin g t his br a in<br />

s t or min g wa s t hat I would li ke yo u t o kn ow t ha t t he s pir it is not ve r y mu c h fa r f r om e ve r yd a y lif e nor f or c e rt a in sp e c ia l people only.<br />

I t i s , i n a w a ve y , r yone f o r <strong>of</strong> e us in e ve r yda y lif e . I t is in ‘a n y t i m e a n d a n y w h e r e f o r ’ a n y o n e<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 58 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Mokichi Okada<br />

1882-1955<br />

Healing and<br />

Spirituality<br />

f o r A L L<br />

T his is a p ict u re <strong>of</strong> M okic hi Oka d a , a f o u nd e r o f Jo h re i.<br />

T he me ss a ge h e ha d t r ie d t o c on ve y wa s t h at a s s p ir it u a lit y is f or a ll, h e a lin g o r a bilit y t o he a l o t he r<br />

pe ople is a lso f or a ll. J ohr e i is on e <strong>of</strong> a p ra c t ica l a n d ef fe ct ive a p plic a t io n <strong>of</strong> an d a t a n gib le e x a mp le <strong>of</strong><br />

r e a lis at io n o f wha t you ma y s e e t h e f ut u re in th is e mp o we r in g me s s a ge .<br />

I t is a lwa ys e mpha s is e d in Johre i ph ilo s op hy th a t “E V E R Y O N E F YOU O C AN AP P LY JOHREI t o<br />

AN Y T H I N G a t AN Y T I M E an d AN Y WH E R E yo u wa n t”.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 59 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Johrei<br />

P u r i f y i n g o u r s p i r i t a n d u p l i f t i n g o u r s o u l<br />

T h e w o r d ‘ J O H R E I ’ i s i n J a p a n e s e a n d c o n s i s t s o f t h w and o C Rei. h i n e s e c h a r a c t e r s , J o<br />

T h i s l i t e r a t e l y m e a n s p u r i f y i n g t h e s p i r i ur t s oul. a n d J ohr i em i p has l i a e lot s <strong>of</strong> u p fa l ci et f s t , si o n I g o<br />

would l ike t o in t r oduc e t he m on e by on e .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 60 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Maintaining health and happiness in a family<br />

Home practice<br />

D a i l y J o h r e i p r a c t i c e<br />

T he J oh r e i pr ac t ic e is a da ily e xe r c is e like me dit a t io n , j oggin g or wa l kin g.<br />

T he pur pos e <strong>of</strong> J ohre i pr ac t ic e, a ma in ob je c t ive in t he tr a in in g workshop i.e. learning why and how to<br />

pr a ct is e J ohr e i, is t o ma inta in hea lt h an d hap pin e s s in fa mily a nd f r ie nds , in ot her wo r ds , t o c r ea t e “a<br />

b e t t e r a n d b e a u t i ” f u f rl om w yo o r ur l ed nvir onme nt .<br />

B y t h i s I m e a n t h a t t o b e c o m e c o n f i d e n t a n d c o m c t f i o r s t e a b J l o e h r t e o i p r w a i t -pr h i <strong>of</strong> n e ss a io nn a l o n<br />

c a pac it y.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 61 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S u p p o r t i n g p e o p l e w h o s u f f e r<br />

I n a ddit io n , s inc e Johre i his t or ic a lly b e ga n a s a t he r ap e ut ic ac t , yo u ca n s u p p ort fr ie n d s a n d f a mily wit h<br />

J ohre i wh e n t h e y a re suff e r ing fr o m s o me t ough c o n d it io n s a s we ll.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 62 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

M u t u a l H e a l i n g<br />

‘ H e a l i n g o n e s e l f b y h e a l i n g o t h e r s ’<br />

T his is t he c en tr a l c onc e pt on wh ic h J o h re i p hilo s o p h y a n d p ra ct ic e is ba s ed .<br />

I t is not j us t givin g or r e ce iving h e a lin g. I t is a mu t ua l p r oc e ss .<br />

‘Y o u c a n h e a l y o u r s e l f b y h e a l i n g ’ o t h e r s<br />

H e n c e y o u c a n p l a y a r o l e t i n �‘a g c r e b a e t t e r a n d b e a u t i ’. f u l w o r l d<br />

A c ouple <strong>of</strong> people is t he s ma lle s t un it <strong>of</strong> th e s oc ie t y.<br />

Ha ppine ss a nd hea lt h ca n be re a lis e d an d sp r ea d fr om th is s ma lle st un it wit hin f a mily a nd fr ie nd s t o lar ge r<br />

unit s , s a y c ommunit y, s oc iet y a nd ult ima t e ly a ll t he wo r ld . T his pr oc es s is c a lle d by J ohr e i c r ea t in g<br />

‘P a r a d i s e o n ’: E a r be t tt h er an d be a ut if ul wor ld - - f ir s t pe rs on a lly a nd e ve nt ua lly a s a c ommu nit y.<br />

T h i s r ea l i s a t i o n ca n be ac h i e ve d t hr o u gh Jo h r e i p r a ct i c e it s e l f , a n d a l s o t h r o u gh t an gi b l e p r a c t i ce o f he o t r<br />

t e net s <strong>of</strong> J ohr e i philos ophy.<br />

I n or der to p ra ct is e Johre i e ff e ct ive ly a n d t o en j o y J o hr e i th o r ough ly, a p pr e c iat io n s a n d<br />

a c knowle d ge me nt s <strong>of</strong> t his Johre i p h ilo s o p h y is ve r y imp o r t a nt an d a ls o e nc o u ra gin g.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 63 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h r e e f o u n d a t i o n s o f J o h r e i � p h i l o<br />

- Ap p reci at i o n wi th g rat i t u d e in a d ai l y l i f e -<br />

A r t o f H e a l i n g<br />

A r t a n d B e a u t y<br />

A r t o f N a t u r e<br />

T h e J o h r e i p h i l ophy o s c ons is t s <strong>of</strong> t hr e e f ounda t io ns a s yo u ca n se e he re :<br />

Ar t <strong>of</strong> He a lin g whic h is J ohr e i pr a ct ic e its e lf , a nd e mph a s is in g t he imp or ta nce a nd a ppr ec iat io n <strong>of</strong> ‘Ar t<br />

a n d B e a u ’ t and y ‘A r t o f N a ’. t u r e<br />

I n J ohre i, it is e mpha s is e d t ha t t o be a wa r e <strong>of</strong> t hes e id e a l ult ima t e go a ls is ve r y imp or ta nt , bu t it a ls o is<br />

e qua lly imp or t a nt to ma ke one s te p t owa r ds th e go a ls . I n oth e r wo r ds , yo u ar e en c our a ge d t o part ic ip a te in<br />

t a n g i b l e a c t i v i t i e s o f t h e J o h r e i p h i l o s o p h y i n a l l a s p e c t s i n e v e r y d a y l i nt, f e f r o m y o u r o w n e n v<br />

whic h me a ns t o s ta rt cr e at ing “a b e t t e r a n d b e a u t i .” f u l w o r l d<br />

De t a ils <strong>of</strong> t he s e ta ngible a c t ivit ie s a re c ove red in t he tr a in in g wor ks ho p . I n th e t r a inin g wor ks ho p , f ir st<br />

A r t o f h e a l i n g i s t h e m a i n o b j e c t i v e t o l e a r n a n d t at o ions a p p will l y be b u touc t he t h d e o t h e r t w o f o u n d<br />

u p o n f o r f u r t h e r u n d e r s t a n d i n g o f f i r s t A r t o f h e a l i n g , s i n c e t h e s e t h r e e p h i l o s o p h i e s -c a onne r e i n ct t in e r g<br />

wit h e a ch ot her .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 64 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T his is a br ie f int r oduct ion a nd o ve r vie w o f J o h r e i.<br />

Do you have any questions a b o u t i t ?<br />

Now, if s ome one as ke d you “Wh a t i s J o h ”, r e i w ? h a t w o u l d y o u t e l l t h e m ?<br />

Suppos e I wa s t he per s on who as ke d yo u wh a t is J oh r e i.<br />

T e ll me a bo ut it .<br />

What would you say to me?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 65 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

H e r e a r e t h e s u m m a r i s e d k e y s door t o <strong>of</strong> yo o p ue r n Johre t h i e xper ie nce wh ic h yo u wi ll b e c ove r in t he t r a ining wo r ks hop.<br />

T hr e e f ou n d at ions <strong>of</strong> J ohr e i philo s o ph ie s , wh ic h I h a ve a lr ea d y gi ve n t h e t it le s .<br />

T hr e e r eq u ir e ments to st a rt pr ac t is in g o r t o get re a d y t o J o hr e i.<br />

F i v e p r i n c i p l e s i r n t o o pr r ac d e t is e J ohr e i pr ope r ly.<br />

K e y o b j e c t i v e s<br />

Three foundations<br />

Three requirements<br />

Five principles<br />

(Five fingers rule)<br />

Fi ve f in ge r r u le s for me mor is in g a n d re min d in g wh a t t he ke y t h o u ghts a re wh e n yo u pra ct is e J ohre i.<br />

P l e a s e s t a r t e x p l o r i n g t h e s e d e t a i l s i n t h e t r a i n i n g s e s s i o n , s h a l l w e ?<br />

T o d a y , I w o u l d l i k e t o s h o w y o u j u s t t h e t <strong>of</strong> i t hose l e n a am nd e s wa nt you to tr y t he f ir st ste p <strong>of</strong> J ohr e i<br />

e x p e r i e n c e , n a m e d a s -in. T u n i n g<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 66 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n or der to pra ct is e Johre i, t he re a re on ly t hr ee r eq uir e men t s.<br />

You are encouraged to hold your doubts if you have any, so you do not have t o BELI EVE th e s e t wo , bu t<br />

p l e a s e T R U ST t he s e a s yo u ca n t r us t s o m eo ne e ve n yo u c a n n ot t r u l y b e l i e ve t h e m -) ; .<br />

T he t wo a re 1 . Tr ust t he powe r o f t he LI GHT , a n d 2 . t he ABI LI T Y o f yo ur se lf .<br />

Y o u a r e q u i t e a l l r i g h t t o f e e l t h a t y o u c a n n eo lf t rt ight r u s nt ow, y o u but r s I a m s ure that yo u c a n t ru st th e<br />

ABI LI T Y <strong>of</strong> your s e lf if you ar e wis hin g t o be or ma kin g s ome ef f or ts to wa r ds yo ur id ea l se lf .<br />

Do not ign or e your ne gat ivit ie s bu t f oc us mo re in t o t he ot he r s id e r a th er t ha n co nce ntr at in g on ne ga t ive s .<br />

T h is is no t ign or ing, hiding f r om or e ve n de nyin g t ha t yo u ha ve do ubt s . I t is j us t wa it in g f or t he r ight t ime<br />

t o dea l wit h t he m.<br />

T h e n e x t r e q u i r e m e n t i s t h e i n t e n t i o n t o c h a n n e l t h e -c J ao lle h r d e ‘tuning-in i , a n d ’. t h e f i n a l o n e i s<br />

M et a p ho r i c a l l y s p e a king, t he s ou r ce <strong>of</strong> th e lig h t ke e p s s en d in g t h e LI GHT like a r a dio st at io n .<br />

Li ke a r a d io o r a T V, t her e a re a lwa ys wa ve s b u t yo u ca n n ot se e n o r s e ns e .<br />

M okic hi Oka d a s a id t ha t e ve r y o n e <strong>of</strong> us h as go t a n a nt en n a t o r e ce ive it .<br />

Once you have tuned it in the r igh t c h a nn e l, th e n yo u wil l b e a ble t o pra ct is e Jo h re i a s on c e yo u t u n e d a<br />

T V t uner in a r ight c ha nne l t he n yo u c a n ge t b e a ut if u l s ou n d an d pict u re . I t c o n st an t ly f lo ws .<br />

T his is it .<br />

Three requirements for practice<br />

• TR US T (although you do not have to believe if you practise)<br />

– i n t h e p o w e r o f t h e s o u r c e o f L I<br />

– i n t h e A B I L I T Y o f y o u r S E L F<br />

• I N T E N T I O N t o c h a n n e l t h e J O H R E I<br />

• T U N I N -I G N w i t h a p p r e c i a t i o n<br />

Wh e n yo u a r e c o m f o r t a b l e t o a c ce p t t he s e t hr e e r e q u i r e m e n t s , i t i s me t i whe n yo u c a n pr ac tis e J ohr e i.<br />

I t is ve r y imp ort a nt to be c omf ort a ble yo ur s elf t o be gin wit h , s o ma ke s ur e t ha t yo u ar e c omf ort a ble<br />

enough.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 67 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Five principles for Johrei practice<br />

‘ T o x i n s ’ a n d ‘ C l o u d s i n t h e s p i r i t ’<br />

T h e p r o c e s s o f ‘ P u r i f i c a t i o n ’<br />

‘ I Z U N O M E ’<br />

‘ S p i r i t ’ p r e c e d e ‘ P h y s i c a l ’<br />

‘ S p i r i t u a l C o r d ’<br />

N e x t , I w o u l d l i k e t o s h o w a s u m m a r y o f c o r e p r i n c i p l e s f o r J o h r howing e i p r a c t it t le i c ne a me b y s s .<br />

T he s e a re th e cor e f ive pr inc iple s o f J o hr e i p ra c t ice .<br />

Ea c h will b e c ove r e d in det a il in t he tr a in in g s e s s io n .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 68 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Five Fingers Rule<br />

Thumb (T) TUNING IN the source / your self<br />

Index Finger (I) INTENTION and inspiration<br />

Middle Finger (M) Middle way & balance (IZUNOME)<br />

Ring Finger (R) Relax so that you can ENJOY!<br />

Little Finger (L) Let the LIGHT flow<br />

Open palm and receive gratitude with appreciation<br />

T he s e a re f ive pra ct ic a l c onc e pt s in or d er t o me mo r is e an d t o re min d yo ur se lf wh e n yo u ar e ap p lyin g<br />

J ohre i in e a ch s es s ion a nd a ls o in e ve r yd a y lif e .<br />

T he s e a re th e t it le na mes whic h yo u wi ll ma s t e r in th e t ra in in g s e s s io n .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 69 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

We are determined by our intentions<br />

“Gratitude attracts gratitude”<br />

‘Ingratitude attracts ingratitude’<br />

Our life is altered by the way we think<br />

A s m a n y p s y c h o l o g y o r s e -r l f e a l i s a t i o n t e x t b o o k s s a y n o w a d a y s , M o k i c h i O k a d a ing w ta his s e m p h a s i z<br />

c onc ept a lmo s t a ce ntur y a go.<br />

We a r e wh a t we think a nd wha t we wis h t o b e .<br />

I t i s e x a c t l y t h e s a m e t o t h e J o h r e i p r a c t i c e , o f c o u r s e !<br />

Ar e you r e a d y t o t r y one s imple e xe r c ise , wh ic h is th e f ir st st e p f or t he J ohre i pr ac t ic e ?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 70 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Tuning in<br />

Feel the ‘Flow <strong>of</strong> Light’<br />

T h e f i r s t s t e p f o r t -I h N e x e r J c i o s e h . r S h e a l i l w p e r b e a g i c n ? t i c e i s t h i s<br />

Ha ve yo u go t a ny e xpe r ienc e in med it at io n , vis ua lis a t io n , or e ve n s ome s pir it ua l pr ac t ic e like Spir it ua l<br />

H e a l i n g , T h e r a p e u t i c T o u c h , T a i C h i o r ha R ve e i s uk ch i ? kind T h <strong>of</strong> o s exper e w h ie nce , ple a s e us e yo ur t e c hniq ue if yo u f e e l comf or ta ble a nd wa nt to, bu t ple a se c omb in e t his ‘L I G H T’ c on c ep t wit h it .<br />

I t hink t his FLOWI NG LI GHT is a ver y po we r fu l me t ap ho r, s o be ar t his in min d , ple as e .<br />

Those who have got no expe r ien c e , yo u ma y wa n t t o us e on e vis u a lis a t io n t ec h niq u e I us u all y t e a c h .<br />

I ma gine a b e au t iful pla c e you ha ve b e e n b ef or e , sa y like a b e a c h or p ar k o n a s u n n y b ut n ot a t oo h ot d a y.<br />

You a re s itt in g t her e ha ving t he s u n s h in in g b e h in d yo u . T h e ligh t c o mes fr om t h e Su n a nd yo u c a n fe e l<br />

wa r mt h o n t h e ba c k <strong>of</strong> your nec k a n d s ho u ld er s . Ho w a b o ut th is ?<br />

Tr y t o FEEL t he light , ple a s e . By t his ‘Fe e l ’ I me a n , an y f ive s e ns e yo u c a n e xp er ie nce , br ight ne s s<br />

( s e e i n g ) , w a r m t h ( t o u c h ) , o r e v e n s o u n d s ( h e a r i n g me ) , ll) s c , e an n t d f( la s vour (t as t e) <strong>of</strong> the li gh t if yo u<br />

can.<br />

I t is t ot a lly u p t o you whe t her yo u h a ve yo u r e ye s o p e n o r c lo s e d.<br />

Sha ll we b e gin ? P le a se ma ke yo u r se lf c o mf o rt a b le f ir st , an d t hin k T HE LI GHT .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 71 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

D a i l y J o h r e i T e c h n i q u e H a n d b o o k<br />

for Home P r a c t i c e<br />

D r . A k i r a N A I T O<br />

I m p e r i a l C o l l e g e L o n d o n<br />

Johr ei Ac a dem y ©<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 72 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

I n t r o d u c t i o n<br />

Wel co me t o Jo h r ei p r a ct ice! S o me o f yo u ma y b e n ew to h ea ling o r s pi r itua lity, a n d s o me o f<br />

y o u m a y a l r e a d y b e a n e x p e r i e n c e d h e a l e r er , w ah y, o w e v he op r , e yo e u i fi t nd h in Jo h r ei an<br />

in s p ira t i on a nd s i mp l e mea ns to a cces s ing th e in tima te an d s p ir itua l s pa ce in to w hich yo u ma y<br />

b r ing h ea l in g an d b ea u t y.<br />

Th i s h a nd b oo k i s t o r emind yo u va r iou s tech n iq u es tau gh t o n th e cou r s e, an d pr a ctica l w a ys<br />

<strong>of</strong> a pp l yi n g Joh r ei ph i l o so ph y. On ce yo u h a ve ma s ter ed th em, n a tu ra lly, yo u w ill no lo ng er<br />

r eq u ir e t h is h an db o o k.<br />

Jo h r ei i s a w o n d er fu l w a y o f ma in ta in in g h ea lth a n d h ap p in es s , b u t a ls o a us efu l s kill fo r<br />

h elp ing p eop l e yo u ca r e ab ou t o u t o f th e g o od n ess o f y o u r h e a r t. ( Rememb er you ca n h ea l<br />

y o u r s e l f b y h e a l i n g o , t if h yo e r u s wan , a t , n yo d u ca n lear n to pr a ctice Jo h r ei pr o fes s io na lly w ith<br />

t h e J o h r e i p r a c t i t i o n e r t r a i n i n g a t t h e J o h r e i A c a d e m y . P l e a s e n o t e s yo t u h a t J o h r e i t e c h n i q<br />

h a v e l e a r n e d i s er n o ap t eu a ti c t tech h n iqu e, a n d you w ill n o t b e a b le to eith er medica lly<br />

d ia gn o s e o r t r ea t p eo p l e.)<br />

We ver y mu ch h o p e t h a t you w ill con tin u e w ith th e Jo hr ei p r a ctice, a nd in w hich ever w a y<br />

yo u ch os e to p r a ct is e it , yo u w ill b e co n trib u ting , little by little fr o m y o u r s u r r o u n d i n g , s to<br />

ma kin g t h is w o r ld b et t er , b eau tifu l an d ha r mo n io us p la ce to live.<br />

M a y t h e l i g h t a n d b e a u t y b e a l w a y s w i t h y o u !<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 73 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

W h a t i s J o h r e i ?<br />

1 O v e r v i e w o f J o h r e i p r i n c i p l e s a n d p r a c t i c e<br />

J o h r e i i s a t h e r a p e u t i c a , r t a n d i n o t h e r w o r d s : a n A r t o f L , i f o v u i n d n e g d i n 1 9 2 0 ’ s<br />

b y a J a p a n e s e a r t i s t , h e al e r a n d s p i r i t u al l e a d e r, M o k i c h i O k a d a .<br />

J o h r e i l i t e r a l l y m e a n s p u r i f i c a t i o n o f s p i r i t . I t s p r i m a r y a i m i s t o f ac i l i t a t e t h e<br />

e l i m i n a t i o n o f t o x i n s f r o m o u r b o d y a n d d i s p e r s i n g o f ‘ c o l m o u o d u s r ’ s p f i r i t i n o r d e r t o<br />

r e v i ta l i s e u s a n d u p l i f t o u r s ou l , th u s r e s to r i n g h a r mo n y a n d we l l -b e i n g .<br />

J o h r e i c a n b e p r a c t i s e d a s a t h e r a p y t h a t t r e a t s i l l n e s s f r o m al l l e v e l s ( m i n d , b o d y<br />

a n d s p i r i t ) o r a s a w o n d e r f u l a n d s i m p l p e r o v w i d a e y u s t w o i t h r e l i e v e s t r e s s<br />

s p i r i t u a l o a w s i t h s i n o u r h e c t i c l i v e s .<br />

W h a t i s u n i q u e a b o u t J o h r e i i s t h a t -t o-l i e a t r n t h e a c s h n i q a u e s f i o r m p l i f i e d , e a s<br />

y o u to p r a c ti s e a t h o me i n o r d e r to ma i n ta i n h e al th a n d we l l -b e i n g . T h e s e h a n d o u t s<br />

o u t l i n e t h e s e t e c h n i q u e s f o r y o u t o l e ar n a n d p r a c t i s e .<br />

J o h r e i al s o e x t e n d s b e y o n d i ts h e al i n g p r a c t i c e . I t i s a n A r t o f L i v i n g t h a t c o v e r s<br />

t h e f o l l o w i n g t h r e e as p e c t s :-<br />

1 . H E A L I N (Ar G t <strong>of</strong> lif e) - T r u s t t h e a b i l i t y o f h u m a n b e i n g<br />

2 . B E A U T Y - A p p r e c i a t i o n o f B e a u t y , e n l j i o f y e b e a u t y i n<br />

3 . N A T U R E - L i v i n g i n h a r m o n y w i t h n a t u r e , N a t u r a l f a r m i n g , d i e t a n d n u t r i t i o<br />

J o h r e i a c t i v i t y o v e r t h e d e c a d e s g av e r i s e t o i t s o w n u n i q u e f l o w e r a r r a n g e m e n t<br />

s ch o ol , SA N G ET S U , i ts o wn c h e mi c al -f r e e f a r m i n g t e c h n i q u e , N A T U R E F A R M I N G , i t s o w n<br />

t e a c e re m o n y , B O N T E M A E , a n d v a r i o u s a r t m u s e u m s , g a r d e n s o f e x q u i s i t e b e a u t y a n d<br />

s a c r e d g r o u n d s . A s a p r a c t i t i o n e r o f J o h r e i y o u w i l l h a v e a c c e s s t o a l l o f t h e s e .<br />

P r i n c i p l e s o f J o h r e i<br />

T o x i n s<br />

T h es e a r e e n ti ti e s ( ch e mi c al s , i n ap p r op r i a te me d i c i n e, p ol l u ti o n , e tc . ) t h a t a r e n o t<br />

i n t e n d e d f o r o u r n a t u r a l c o n s u m p t i o n . P r o b l e m s b e g i n t o o c c u r w h e n t h e y e x c e e d<br />

b e y o n d o u r n a t u r a l c a p a c i t y a n d b e g i n t o a c c u m u l a t e i n o u r b o d y as t o x i n s . In t h i s<br />

s e n s e , f o o d i n e x c e s s c a n b e c o m e t o x i c .<br />

C l o u d s<br />

T h i n k o f t h e s e a s t h e g l o o m t h a l t o o m s o v e r u s i n o u r s p i r i t w h e n w e a r e ‘ u n d e r t h e<br />

w e a t h e r ’ . T h e y m a n i f e s t w h e n w e a r e u n d e r s t r e s s , e m o t i o n a l l y c h al l e n g e d o r<br />

b e c o m e t o x i n i n f e s t e d .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 74 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T h e P r o c e s s o f P u r i f i c a t i o n<br />

T h e T o x i n s a n d C l o u d s a r e c o n s t a n t l y u n d e r g o i n g a n t i a n t g . u r a l p r o c e s s<br />

T h i s i s c al l e d t h e p r o c e s s o f p u ri f i c a t i o n . T h i s i s a n a t u r a l l y o c c u r r i n g p r o c e s s o f<br />

d e t o x i f i c a t i o n a n d s p i r i t u al u p l if t . J o h re i e n c o u r a g e s t h i s p r o c e s s i n a d i r e c t e d w a y<br />

a n d al l e v i a t e s d i s c o mf o r t .<br />

S p i r i t p r e c e d e p h y s i c a l<br />

W e a r e w h a t w e t h i n k el . a O n u d r me f e n ta l , e mo ti o n al a n d s p i r i tu al wel l -b e i n g i s o f<br />

u t m o s t i m p o r t a n c e . T h e p r o b l e m b e g i n s i f w e i g n o r e t h i s s i m p l e t r u t h a n d l e t o u r<br />

mi n d a n d s p i r i t g o o u t <strong>of</strong> s y n ch wi th o u r b od y . ( S e e al s o n e x t p a g e )<br />

I Z U N O M E<br />

I Z U N O M E i s a s t a t e o f b a l a n c e, h a r m o n y d a n p p r o p r i a t e n . e I s t s i s t h e m i d d l e w a y<br />

w h i c g h i v e s u s t h e a b i l i t y t o l o o k a t b o t h s i d e s o f a s i t u a t i o n s o t h a t y o u c a n<br />

m a i n t a i n t h e b al an c e . S o m e t i m e s w e n e e d t o t r u s t a n d l e t g o , o t h e r t i m e s w e n e e d t o<br />

t a k e o u r d e s t i n y i n t o o u r o w n h a n d s a n d w h a e c n t . o a c K t n o r w i h n e g n t o l e t g o<br />

i s n o t e a s y u n l e s s y o u c a n s e n s e t h a t . Y o u w i l l b e ab l e t o s e n s e i t b y b e i n g i n t h e<br />

s t a t e o f Iz u n o m e w h i c h p r a c t i c e s o f J o h r e i l e a d y o u t o .<br />

T h e P r o c e s s o f P u r i f i c a t i o n<br />

T h i s i s a n a t u r a l l y o c c u r r i n g p r o c e s s t s h t o a x t i n e s l a i n m d i c l n o a u t d e s f r o m t h e<br />

b o d y a n d t h e s p i r i . t<br />

I t o c c u r s i n t w o s t a g e s :<br />

( 1 ) A c c u m u l a t i o n<br />

T o x i n s a c c u m u l a t e a r o u n d d i f f e r e n t a r e a s o f t h e b o d y , w h i c h a r e u s e d f r e q u e n t l y .<br />

T h i s m e a n s t h a t t h e a r e a s o f t o x i n a c c u m u l a t i o n v a r y f r o m p e r s a o s n t o p e r s o n . A r e<br />

o f s t i f f n e s s , ‘ k n o t s ’ i n t h e m u s c l e s , s w e l l i n g , a n d t h e a r e a s o f p a i n a r e s a i d t o b e d u e<br />

t o t h e t o x i n a c c u m u l a t i o n . T o x i n s a l s o a c c u m u l a t e d e e p w i t h i n o u r b o d y a n d a f f e c t<br />

o u r i n t e r n a l o r g a n s .<br />

( 2 ) E l i m i n a t i o n<br />

W h e n w e a r e w e l l , o u r b o d y n a t u t r e s a l t o l x i y n s . e T l h i s m h i a n p a p e n s w h e n w e g o<br />

t o t h e t o i l e t , s n e e z e , c o u g h , a n d s w e a t o r s h e d s k i n s . W h e n t h e t o x i n a c c u m u l a t i o n<br />

i s s e v e r e , e l i m i n a t i o n p r o c e s s m a y a l s o b e p r o n o u n c e d a n d a c c o m p a n i e d w i t h<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 75 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

d i s c o m f o r t . F o r -l e i k x e a m s y p m l p t e o , m s f o r d l i u a r r h o e a a r e m s y p t o m s o c c u r r i n g a s<br />

t h e r e s u l t o f t o x i n e l i m i n a t i o n . W e t e n d t o s e e t h i s e l i m i n a t i o n p r o c e s s a s a n<br />

i n c i d e n t o f m i n o r i l l n e s s , h o w e v e r , t h e y a r e o u r b o d y ’ s w a y o f m a i n t a i n i n g o u r<br />

h e a l . t h<br />

H o w J o h r e i W o r k s<br />

J o h r e i w o r k s b y d i s p e r s i n g t h e c l o u d s i n t h e s p i r i t . T h i s e l i m i n a t e s t h e n e g a t i v i t i e s<br />

w i t h i n u s , t h u s g i v i n g u s g r e a t e r v i t a l i t y a n d e n c o u r a g i n g o u r b o d y ’ s n a t u r a l a b i l i t y<br />

t o e l i m i n a t e t o x i n s .<br />

F u r t h e r m o r e , i t i s t h o u g h t t h a t J o h r e i i t s e l f h e l p s t o d i s s o l v e a w a y t h e<br />

a c c u m u l a t e d t o x i n s o r ‘ b u r n a w a y ’ t h o e x i t n s t h e m s e l v e s , t h u s h e l p i n g t o s u p p o r t<br />

t h e b o d y ’ s i m m u n e f u n c t i o n a n d t h e f u n c t i o n o f o t h e r o r g a n s e s p e c i a l l y k i d n e y s<br />

w h i c h f i l t e r s o u t t o x i n s f r o m o u r b l o o d .<br />

J o h r e i<br />

T o x i n s B o d y S p i r i t C l o u d s<br />

U s<br />

I n t e r a c t i o n b e t w e e n B o d y a n d S p i r i t<br />

I n J o h r e i i t i s b e l i e v e d t h a t t h e s p i r i t a n d b o d y i n t e r a c t i n s u c h w a y t h a t<br />

a c c u m u l a t e d t o x i n s c a s t ‘ c l o u d s ’ i n o u r s p i r i t , a n d t h e ‘ c l o u d s ’ t h e m s e l v e s c a u s e<br />

i m p u r i t i e s i n o u r b l o o d t h a t l e a d s c e t i o l l t n . o e s x s i n b u i l d u p a n d h e<br />

S p ir i t p r e c e d e s P h ys i c a l<br />

O n t h e o t h e r h a n d , w h e n t h e ‘ c l o u d s ’ i n t h e s p i r i t a r e d i s p e r s e d t h i s e n c o u r a g e s<br />

t o x i n s i n t h e b o d y t o b e e l i m i n a t e d . J u s t a s o u r w i l l l e a d s t o t h e a c t i o n i n o u r b o d y ,<br />

i t i s b e l i e v e d t h a t t h e s t a t e o f o u r s p i r i t ( m d i a n d e m o t i o n ) i n f l u e n c e s o u r p h y s i c a l<br />

w e l l -b e i n g . T h i s p r i n c i p l e i s c a l l e d t h e S p i r i t p r e c ed es P h y s i c al . B a s e d o n t h i s<br />

p r i n c i p l e , J o h r e i p r a c t i t i o n e r w o r k s b y c h a n n e l l i n g t h e U n i v e r s a l E n e r g y ( r e f e r r e d t o<br />

a s “ t h e L i g h t ” ) w i t h t h e i n t e n t i o n o f d i s p e r s i h n e g ‘ t c l o u d s ’ i n t h e s p i r i t a n d<br />

e l i m i n a t i n g t o x i n s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 76 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

2 . T h e F i n g e r R u l e f o r p r e p a r i n g y o u r s e l f f o r t h e J o h r e i e x p e r i e n c e<br />

You can use the following rules to help you not only with Johrei practice but to prepare yourself<br />

consciously for anything, from flower arranging, art, music, sports to the life in general.<br />

V i s u a l i s e t h e s e r u l e s a s y o u c o u n t t h e m o u t w i t h t h e f i n g e r s o f y o u r h a n d ,<br />

s t a r t i n g : w i t h<br />

T h u m b ( T ) -T u n i n g i n<br />

F i r s t , t u n e i n t o . t h e s o u r c e<br />

Tune into the source <strong>of</strong> your energy, with love, inspiration and your very being. <strong>The</strong> source<br />

exists at the centre <strong>of</strong> the Universe and it is up to you whether you think <strong>of</strong> it as your higher self,<br />

God, the Spirit <strong>of</strong> the Sun, Nature or the Cosmic Consciousness.<br />

T h i s p r o c e s s i s l i k e a T V o r a r a d i o ; i f y o u d o n o t t u n e i n , y o u c a n n o t o b t a i n a<br />

b e a u t i f u l p i c t u r e o r c l e a r s o u n d s a l t h o u g h y o u h a v e a n a n t e n n a t o r e c e i v e i t . Y o u a l s o<br />

e m p o w e r t h e a n t e n n a b y p r a c t i s i n g J o h r e i .<br />

I n d e x f i n g e r ( I ) –I n s p i r a t i o n a n d I n t e n t i o n<br />

B e I n s p i r e d a n d h o l d h e a l i n g i n t e n t i o n<br />

Let the source <strong>of</strong> Universal Love inspire you by your loving intention for the healing <strong>of</strong> yourself<br />

and others.<br />

M i d d l e f i n g e r ( M ) (w i t h I n d e x f i n g e ( I r ) )<br />

–M e n t a l i t y ; t h e M i d d l e w a y ( I Z U N O M E )<br />

S t i l l t ba l h a n e c e a m n d i h n a r d mo n y & wi t h t i mi n g : Tr y h a r d f i r s t t h e n t r u s t!<br />

If your intentions are always for the good <strong>of</strong> mankind, there is nothing to be afraid <strong>of</strong>. Allow<br />

your stress to melt away and clear your mind. Everything that happens to you is enable you t o<br />

help you become happier, healthier and stronger. A raw diamond has to be polished to shine.<br />

You will find your soul is purified & enlightened by these processes. Keep a smile on your face<br />

always.<br />

R i n g f i n g e r ( R )<br />

–R e l a x s o t h a t y o u c a n E N J O Y y o u r s e l f<br />

R e l a x y o u r b o d y a n d t a k s e o t i h a t y o e u a s c y a n e n j o y y o u r s e l f !<br />

Rocks can be crushed if the force is strong enough, but free flowing water is adaptable to its<br />

surroundings. Always keep the body relaxed and flowing and you will never be crushed. It is all<br />

about learning to trust and let go. Relaxing your body will also improve your Johrei practice.<br />

L i t t l e f i n g e r ( L ) –L e t t h e L i g h t f l o w !<br />

i t h L w o v e & M A K O T O ( i n t e g r i , s t i y n c e r i t y , l o v e )<br />

T r u s t in t h e u n i v e r s a l f l o w & t r u s t y o u r s e l f. L o v e f o r o t h e r s & M . A K O T O t o y o u<br />

Let go and let the light flow. Once you are relaxed, open and tuned in, you can flow with the<br />

light.<br />

Opening your palm to receive gratitude!<br />

G r a t i t u d e a t t r a c t s g r a t i t u d e !<br />

E v e r y t h i n g t h a t h a p p e n s l e a d s t o y o u r e l e v a t i o n . I f y o u a r e i n t h e s t a t e o f g r a t i t u d e<br />

a n d a p p r e c i a t i o n , t h i n g s y o u d e s i r e , w i l l a l w a y s c o a m y .<br />

e y o u r w<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 77 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

3 . P o i n t s t o n o t e b e f o r e g i v i n g J o h r e i<br />

1. Take note <strong>of</strong> how you are feeling before you give Johrei.<br />

2. Choose comfortable surrounding where you will not be interrupted or disturbed during<br />

Johrei. Try choosing an area where there is harmony or beauty, possible nears a flower<br />

arrangement.<br />

3. Choose two comfortable seats, if possible stools with swivelling seats. However, seating<br />

must be chosen to suit the person receiving Johrei. If the person cannot remain seated<br />

for more than 10-20 minutes, adapt your Johrei accordingly. It is important that person<br />

who is receiving Johrei is informed that it will take this long before hand.<br />

4. A guide to the positioning <strong>of</strong> your self and your partner is as follows:-<br />

T h e L i g h t i s s a i d t o f l o w f r o m t h e n o r t h yo e a us r se t lf ws o it h i yo d ue r a back l l y t o p to he s i t i o n<br />

no r t heast .<br />

It is more important that you do not have your back to the door. Position your<br />

self so that you are in the opposite part <strong>of</strong> the room from the door.<br />

5. Take care to note if the person about to receive Johrei is already undergoing some sort <strong>of</strong><br />

Purification Process or the person is known to undergo pronounced Purification when<br />

receiving Johrei or other forms <strong>of</strong> healing. Remember that Johrei is about encouraging<br />

the Process <strong>of</strong> Purification. Although, Johrei will generally alleviate any discomfort, use<br />

your best judgment to decide whether it is best to proceed with Johrei or allow the<br />

process to take its own course and support it with Johrei at a later stage. If you decide to<br />

give Johrei in such a situation, it may be more advisable to adapt or shorten your Johrei<br />

accordingly, rather than doing the whole sequence. If in any doubt seek pr<strong>of</strong>essional help<br />

before proceeding.<br />

6. If the person to whom you are intending to give Johrei is suffering from acute pain,<br />

severe discomfort or very high fever, especially if the person is a child or pregnant please<br />

seek pr<strong>of</strong>essional help without delay.<br />

7. Be prepared for emerging emotions. Even though the person you are giving Johrei may be<br />

suffering from physical discomfort or no obvious discomfort at all, you may find that<br />

there are underlying emotions needing to be expressed, Johrei <strong>of</strong>ten allows these<br />

emotions to emerge. It can be the case that such emotions are dispersed by Johrei<br />

however, you should be ready to talk. Talking can sometimes be hard amongst friends or<br />

family. Ask yourself if you are prepared to handle it. If the person wishes to talk or cry,<br />

let the person lead the situation. Humility and sincerity is the key. Be there, listen with<br />

an open heart but do not advise or judge. I f in doubt seek pr<strong>of</strong>essional help.<br />

8. Heal your self by healing others. Johrei can benefit you when you give it to others. This is<br />

because you receive the Light before you channel it, and through the healing in your<br />

partner you are also healed. <strong>The</strong> feeling <strong>of</strong> appreciation and gratitude from your partner<br />

will also provide you with an up-lift.<br />

9. Make sure you are comfortable when you give Johrei. If you cannot remain in a seated<br />

position for a long time, arrange your seating or length <strong>of</strong> Johrei accordingly. If you<br />

cannot raise your arm for a long time support it with the other arm or rest it on an<br />

armrest or a table.<br />

10. You must feel comfortable to give Johrei. If you are too unwell, just receive Johrei from<br />

whoever is <strong>of</strong>fering to give it to you and then rest, don’t feel you are obliged to give Johrei<br />

each time.<br />

11. JUST ENJOY the feeling <strong>of</strong> intimacy, happiness and joy <strong>of</strong> returning the love and care<br />

you have received from others. Empower your self to help others and in so doing, help<br />

yourself.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 78 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

4 . a s i B c J r e o i h s e q u e n c e f o r f a m i l y p r a c t i c e<br />

1. Sit facing each other.<br />

2. Take a moment to relax and prepare yourself (with the 5 finger guide)<br />

3. Greet and acknowledge each other.<br />

4. Tune in by visualising the source <strong>of</strong> the Light. Channeling the Light is like ‘playing the<br />

music <strong>of</strong> the universe’. Appreciate the occasion and if you can, fill your self with gratitude<br />

and joy. Sense <strong>of</strong> gratitude will allow yourself to be healed in the process <strong>of</strong> giving Johrei<br />

and you will feel less tired during Johrei. <strong>The</strong> effect may be further enhanced if you can<br />

feel and visualise the happiness and the positive outcome for the person you are giving<br />

Johrei.<br />

5. Gently raise your hand, relax your arm, cup your palm and begin by channelling to the<br />

forehead (2 minutes)<br />

6. Gently lower your hand to the area near the heart and give Johrei there. (2 minutes)<br />

7. Ask your partner to turn around. Take a moment to tune in again.<br />

Stand up, and steady your partner. <strong>The</strong>n gently proceed to channel to the crown <strong>of</strong> your<br />

partner’s head. (2 minutes)<br />

8. Channel to the both sides <strong>of</strong> the neck with your hand (left side first and then right).<br />

Remember to cup them.<br />

(2 minutes (1 minute each))<br />

9. Cup your hand and place them on the shoulders (left side first and then right again). (2<br />

minutes (1 minute each))<br />

10. <strong>The</strong>n proceed by cupping your hands and giving Johrei to the centre <strong>of</strong> your partner’s<br />

back so as to channel to the liver, pancreas and stomach. (2 minutes)<br />

11. Place your hands on either sides <strong>of</strong> your partner’s lower back and give Johrei. This<br />

stimulates the kidneys. <strong>The</strong> Kidneys are important organs for purifying the blood.<br />

General fatigue can also be supported by energising the kidneys.<br />

(4 minutes (2 minutes each))<br />

12. Finish <strong>of</strong>f by raising one hand as if to give a shower <strong>of</strong> Light. (1-2 m i n u ) t e<br />

13. Signal your partner that you have finished with a gentle tap on the shoulders and ask<br />

your partner to face you once more. Thank each other. (Remember you have benefited<br />

by giving Johrei too).<br />

14. If your partner also practised Johrei then do not hesitate in proceeding to receive Johrei<br />

because Johrei is something to be shared!<br />

P o i n t s t o n o t e a f t e r J o h r e i :<br />

I t d o e s n o t m a t t e r w h e t h e r y o u r p a r t n e r o r y o u r s e l f d i d n o t f e e l a n y t h i n g d u r i n g<br />

J o h r e i , o r e v e n t h a t y o u r p a r t n e r d i d n o t i m m e d i a t e l y f e e l a n y e f f e c t o f i t . T h e e f f e c t o f<br />

J o h r e i c a n j u s t a s w e l l t b l e o r d u e n l n a o y t i e c e d a , b l e . s u b<br />

R e f l e c t m o r e h o w i t w a s l i k e f o r y o u , h o w y o u f e l t a f t e r w a r d s . A n d t h i n k o f h o w y o u<br />

m i g h t d o i t d i f f e r e n t l y fo i r n e v e f n u t b u e t r t e r r e s u l t s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 79 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

5 . a s i B c t e c h n i q u e o f S e l f J o h r e i<br />

1. Sit on a comfortable chair. It will be more effective if you sit upright.<br />

2. Close your eyes and take a moment to relax and tune in with the Five-finger guide.<br />

3. Tune into the source <strong>of</strong> the Light by visualising the spirit <strong>of</strong> the Sun over and above you<br />

shining down a beautiful Light.<br />

4. When you can feel the flow <strong>of</strong> the Light reaching down to you, slowly raise one hand and<br />

channel to your forehead. Your arm should be relaxed, as it would be when channelling<br />

Johrei in pairs. (2 minutes)<br />

5. Slowly move your hand down to your chest area passing through the throat. Channel Johrei<br />

to your heart. Enjoy the warmth & any alleviation <strong>of</strong> tension. (2 minutes)<br />

6. Lower your hand further to your stomach area. This area is related to anger and irritation.<br />

Channel Johrei here in order to calm you and make you feel more positive. (2minutes)<br />

7. With one hand at a time, channel Johrei to your groin (left side first then right). (1 minutes<br />

each side)<br />

8. Cover your tailbone with one hand and channel Johrei to the sacrum. This will help the<br />

womb in women, and also your intestines and digestive system. If you have a particularly<br />

problematic digestive system, you may also combine this with channelling Johrei to the<br />

lower abdomen from the front.<br />

9. If you are suffering from period pains, irregular period cycles, menopause or fertility<br />

problems you can follow this up with channelling Johrei with two hands placed on either<br />

side <strong>of</strong> your abdomen followed by one hand three finger width below your belly button. (in<br />

this occation1-2 minutes each position)<br />

10. <strong>The</strong>n from the front, channel to the kidneys (left side first) or cup you hand and place it on<br />

your lower back (left first then right). (2 minutes each) Your lower back is related to your<br />

kidneys. Kidneys are important organs for eliminating toxins and filtering blood. Stiffness<br />

in your lower back indicates that kidneys are weakened and that excessive toxins have<br />

accumulated there. If the kidneys are over worked, it will take extra energy to filter your<br />

blood hence you will feel physically drained. Use your hands to press away the stiffness<br />

and then channel Johrei if you feel comfortable.<br />

11. Cup your hands and gently place them on your shoulders. You may prefer to do this one<br />

shoulder at a time. Your shoulder is a barometer for your general health. Make sure they<br />

are always free <strong>of</strong> stiffness and tension. Your left shoulder is closely associated to your<br />

heart. Spend more time channelling to your left shoulder if you have a heart condition. (1-2<br />

minutes each side)<br />

12. With one hand at a time, channel Johrei to both sides <strong>of</strong> your neck (left side first the right).<br />

(1-2 minutes each side) This will help the toxins to move down from your head and support<br />

the alleviation <strong>of</strong> headache.<br />

13. Finally, channel to the forehead like a shower <strong>of</strong> Johrei! (1 minute)<br />

14. Please note that Johrei, just like every other healing, is effective both when you give it and<br />

receive it. So treat Self-Johrei as a daily self-maintenance practice for improving your<br />

Johrei. Always try to look out for anyone who will receive Johrei.<br />

R e m e m b e r , w i t h J o h r e i ,<br />

Y O U H E A L Y O U R S E L F B Y H E A L I N G O T H E R S<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 80 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

6. V i s u a l i s a t i o h n r e i f p o r ac t J i c e<br />

T h e f o u n d e r <strong>of</strong> J o h r e i , M o k i c h i O k a d a s a i d t h a t w e a r e w h a t w e t h i n k a n d o u r<br />

i n t e n t i o n a l t e r s o u r l i f e , a n d a l s o t h a t w h i a t s e c v r e r a t e d i n t h e s p i r i t u a l d -i<br />

m e n s i o n p r e<br />

e m p t s t h e c h a n g e s t a k i n g p l a c e i n t h e p h y s i e c s a p l h y s i d c i al m ) . e n s i o n ( S p i r i<br />

T h e s e c o n c e p t s p a r al l e l t h e w o r k c a r r i e d o u t b y t h e S i m o n t o n s i n t h e U S A . B a s e d o n t h i s ,<br />

i t i s o b v i o u s t h a t v i s u a l i z a p t l a i y s o a n n i m p o r t a n t r o l e i n w h a t e v e r w e d o . V i s u al i s a t i o n<br />

i s s o p o w e r f u l s u c h t h a t i t c a n e v e n d e t e r m i n e t h e d i r e c t i o n t h o f e f l o w o f L i g h t o r t h e<br />

o u tc o me <strong>of</strong> J o h r ei .<br />

D i r e c t i n g t h e f l o w<br />

I n J o h r e i , y o u t u n e i n b y v i s u a l i z i t h n e g s o u r c e o f t h e L i g h t a n d a s k i n g i t t o h e l p y o u<br />

b y c h a n n e ll i n t g h e L i g h t t o t h e r e c e i v e r . T h e c h a n n e l l e r v i s u a l i s z t e h e f l o w o f t h e L i g h t<br />

f r o m t h e s o u c r e , t h r o u g h h i m / h e r t o t h e r e c e i v e r .<br />

T h e c h a n n e l l e r c a n i n t e n s i f y t h e e f f e c t o f t h e L i g h t b y v i s u a l i z i t n b g e i n g f o c u s e d b y<br />

t h e c u p p e d h a n d a s i f i t i s a m a g n i f y i n g l e n s a n d b e a m e d t h r o u g h t h e b o d y o f t h e<br />

r e c e i v e r t o t h e o t h e r s i d e .<br />

T h o s e w h o a r e s e n s i e t t i o v p e o p ’s l e n e r g y a n d i n t e r n a l e m o t i o n a l s t a t e s , v i s u a l i z e<br />

y o u r s e l f a s a r i v e r r a t h e r t h a n a b o w l o f w a t e r . W h e n p e o p l e w a s h t h e i r d i r t y l i n e n i n<br />

y o u r b o w l o f w a t e r , i t l e a v e s t h e w a t e r d i r t y . H o w e v e r , i f y o u a r e a f r e e f l o w i n g r i v e r ,<br />

t h e d i r t i s w d a s w h e a y a n d t h e w a t e r i s a l w a y s p u r e a n d c l e a n .<br />

V i s u a l i s i n g t h e o u t c o m e<br />

I t i s h e l p f u l t o k n o w b e f o r e h a n d t h e h o p e a n d t h e w i s h e s o f t h e r e c e i v e r . A s a<br />

c h a n n e l l e r , y o u c a n v i s u a l i t z h e e w i s h e s o f t h e r e c e i v e r w h i l e y o u g i v e J o h r e i . I t m a y<br />

b e h e l p f u l t o v i s a l u i z a e f i l m s c r e e n o n t o w h i c h t h e f i l m s o f t h e f u t u r e e v e n t s a s w i s h e d<br />

b y t h e r e c e i v e r a r e s c r e e n e d .<br />

T h e r e c e i v e r c a n b e e n c o u r a g e d t o v i s u a l i z t h e e f u t u r e o u t c o m e s i n t h e s a m e w a y i f<br />

y o u w a n t , b u t d o n o t c o m p e l h i m / h e r t o d o s o p l e a s e .<br />

V i s u a l i s a t i t o h n e r b e y c e i v e r<br />

I t i s o f t e n f o u n d t h a t t h e r e c e i v e r i s u n s u r e h o w t o s i t d u r i n g J o h r e i a n d a l s o a s k s<br />

t h e c h a n n e l l e r w h e t h e r i t i s n e c e s s a r y f o r t h e m t o m a k e h i s / h e r m i n d b l a n k . I t i s<br />

u n d e s i r a b l e f o r t h e r e c e i v e r a s w e l l a s t h e c h a n n e l l e r t o b e s t r u g g l i n g t o v i s u a l i z o e r t o<br />

b l a n k t h e i r m i n d s .<br />

I t i s f a r m o r e i m p o r t a n t t o r e m a i n i n a n a t u r a l s t a t e . V i s u a l i s e o n l y i f i t b e c o m e s<br />

n a t u r a l t o y o u a n d t o t h e r e c e i v e r . A u s e f u l w a y o f q u i e t e n i n g t h e m i n d J o h r e i w a y i s<br />

t o a l l o w a n y t h o u g h t s t o a r i s e i n t g h i n e t h e a m d t o a n b d e c l i o u m d a s w h i c h a r e<br />

d i s p e r s e d b y t h e L i g h t o f J o h r e i . M o r e J o h r e i y o u p r a c t i c e , y o u w i l l f i n d t h a t t h e m i n d<br />

q u i e t e n s n a t u r a l l y w i t h o u t m a k i n g a c o n s c i o u s e f f o r t .<br />

V i s u a l i s i n g t h e p a s t a n d t h e f u t u r e<br />

I n J o h r e i , i t i s s a i d t h a h t y s i s c p a i l . r B y i u t p l i p f ti r n e g c t e h d e e p s a s t p a n d t h e f u tu r e<br />

w i t h J o h r e i , y o u c a n u p l i f t t h e p r e s e n t.<br />

W h e n y o u a r e g i v i n g J o h r e i f r o m t h e f r o n t o f t h e r e c e i v e r e s p e c i a l l y a t f o r e h e a d ,<br />

v i s u a l i a z e p a t h w a y f r o m t h e p a s t b e h i n d t h e r e c e i v e r , a l o n g w h i c h h e / s h e h a d t o<br />

t r a ve l . I t i s h i s / h e r p a s s a g e f r o m t h e p a s t . V i s u a l i s e t o c l e a r t h e h u r d l e s i n i t w i t h<br />

y o u r J o h r e i . W h e n t h e r e c e i v e r t u r n s a n d y o u a r e g i v i n g J o h r e i f r o m b e h i n d , v i s u a l i z e<br />

a p a s s a g e i n f r o n t o f t h e r e c e i v e r . I t i s h i s / h e r p a t h i n t o t h e f u t u r e . V i s u a l i s e t h a t y o u<br />

e n l i g h , t e n e n r g i s e a n d h e a l t h e p a t h f o r y o u r r e c e i v e r w i t h J o h r e i .<br />

I t i s u p t o y o u a s a J o h r e i oo s e p w r h a i c t h i v i t s i u o a n l e i r z a t o t o u i s e o c n o h r n o t t o u s e<br />

v i s u a l i z a t a i l l o . n<br />

W i t h p r a c t i c e , y o u w i l l f i n d t h e s e c o m e t o y o u n a t u r a l l<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 81 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

7. S e n s a ti o n s f e l t d u r i n g J o h r e i<br />

T he f ollowin g is a guide t o und er st a nd in g t he me a nin g <strong>of</strong> s ome <strong>of</strong> t he s e ns a t io ns fe lt by th e c han ne lle r<br />

or t he re c e ive r dur ing the J ohr e i pr oc e ss . I t mu s t be not e d th a t t he se a r e not <strong>of</strong>f ic ia l t ea c hings a s t a ught by M o k i c h i O k a d a e , f ound t h er <strong>of</strong> J ohr e i. Use this inf or mat io n as e xa mp le s .<br />

H e a t<br />

I n t he Jo hr e i pr inc ip le o f t he pu r ific at io n pr o cess, it is u nder st oo d t hat when t he accu mu lat ed and so lid if ied t o xins beg in t o ‘me lt ’, t he pro cess is ac co mp a nied by a lo ca lis ed t emper at ur e r is e. T he char act er ist ic o f t his i s t hat yo u w il l<br />

fee l t he heat up o n co nt act as well as awa y fr o m t he bo dy. I f yo u fee l t he heat fr o m t he r ece iver yet yo u fe e l<br />

COLDNE S S in yo ur ha nd whe n c ha nne l l ing Jo hr e i, it usua l l y ind icat es t hat t he pur ific at io n pr o cess <strong>of</strong> me lt in g t o xin s<br />

is t ak ing p la ce in t he ar ea and it is dr aw ing in t he L ig ht fr o m yo ur ha nd t o su ppo rt it ( see co ld nes s be lo w) .<br />

T he he at fe lt by t he r ece iver is t he L ig ht whic h is be ing c ha nne l led. I t is usu a ll y fe lt be lo w t he su r fac e . Ho w deep<br />

t h e r e c e i v e r ee f ls t he heat dep end s o n ho w far awa y t he cha nne ller 's ha nd is. T he fur t her awa y t he ha nd fr o m t he<br />

r ece iver , t he DE EP E R t he heat o f r ece iver . Tr y no t t o co nfuse t he c ha nne l ler 's bo d y heat w it h t he heat sen sat io n o f<br />

t h e L i g h t ( i t h a s b e e n k n o w n w it t h co a t ld ha a nd p s e r ca s n o st il l pr o du ce t he heat sensat io n w it hin t he r ece iver ) .<br />

I f t he c ha nne l ler fee ls t he heat co ming fr o m t he r ece iver w it h no r esult ing t o t emp er at ur e r ise, it usu a ll y in d ic at es t hat<br />

t he ar ea r eq uir es no fu r t her cha nne l l ing.<br />

C o l d n e s s<br />

T h e mo st well r eco gn ised se nsat io n ot her t han t he heat is t he se nsat io n o f co ld ne ss. T he ar eas w it h co ld se ns at io n<br />

ar e t he ar eas in need o f hea l in g . I f t he cha nne ller fee ls t he co ld ne ss in his/ her ha nd whe n g iv in g Jo hr e i, it ind ic at es<br />

t h a t t h e a r e a i ts he d Lr ig a ht w i in n ag nd hea lin g is t ak ing p lace. Not ice if t he ar ea beco me s war mer as Jo hr e i is g ive n.<br />

I f t he r ece iv er fee ls t he co ld ne ss in t he ar ea be ing g ive n Jo hr e i, find o ut if t he c ha nne l ler is fee l in g t he heat in his/ her<br />

ha nd . I f so , it usu a ll y ind ic at es t hat t he L ig ht is flo w ing in t he wr o ng d ir ect io n. S t o p , t une in ag a in a nd cha nne l by visu a lis in g t he L ig ht be in g fo cu sed by t he cha nne ll er 's ha nd a nd flo w in g fr o m t he c ha nne l ler t o t he r ece iver .<br />

I t w i l l h e l p t o v i s u a l i s e t h a t t h e b r oe ug a m h t he o f r ece L i iver g h 't s bo p di y e tr o c t he i n og t her t h s ide. Ot her co ld<br />

se nsat io ns ma y e xist su ch as t he se ns at io n o f co ld ness at t he co r e o f t he r ece iver 's bo d y, wh ic h me lt s awa y l ik e<br />

me lt in g ic e. T his in t he past has in d icat ed a pro fo und hea l ing.<br />

T i n g l i n g , m a g n e t u l i s io c n r a e n d p th e s e n s a t i o n o f m o v e m e n t<br />

T ing l in g se nsat io n in t he ha nd o f t he cha nne l ler ca n o ccur t o var ying deg r ees. S uch t ing lin g se nsat io n ind ic at es t hat<br />

a he a l in g p r o c e s s in w h ic h t he L ig ht is d r a w n t hr o u g h t he c ha n n e lle r t o t he a r e a w he r e t he p u r if ic a ot n i pr o cess is<br />

t aking p lace. Fo r Jo hr e i, an y t ing l ing se nsat io n ind icat es t hat t o xins ar e o n t he mo ve. S o t he t ing l in g sen sat io n in t he<br />

cha nn e ller 's bo d y ma y mea n t hat t he pur ificat io n p r o cess is t aking p lace t her e.<br />

T he se ns at io n o f mag net ic r ep u ls io n mea n t hat t he po lar it y o f t he cha nne l ler 's ha nd a nd t he ar ea r ece iv in g Jo hr e i<br />

ma y be t he sa me, he nce t he r ep u ls io n. Jo hr e i is a bo ut cha nne l l ing t he L ig ht fr o m t he Un iv er se a nd no t t he mag net ic<br />

ener g y o f t he ch a nne l ler 's bo d y. T her e fo r e, if t he c ha nne l ler fe e ls t he se nsat io n o f mag net ic r ep u ls io n in Jo hr e i, t hen<br />

st o p and t une in ag a in.<br />

P a i n<br />

Whe n t he e li m in at io n t ak es p lace a nd t he t o xins be g in t o me lt and mo ve awa y fr o m t he ar ea be ing g iv en Jo hr e i, t he<br />

r e c e ive r ma y f e e l t he s e ns a t io n o f t o xin s f lo w in g a w a y. I f he t r ece iver fee ls su c h se nsat io n, it can o nly be a po sit ive<br />

ind icat io n. I f su c h se nsat io n is unco mfo r t able o r pa infu l, fur t her Jo hr e i ma y be g ive n t o make t he pr ocess mo r e<br />

co mfo r t ab le.<br />

P a i n i n d i c a t e s t h a t t h e t o x i n s i n t h a t a r e a a r e m e l y. t i Du n g r in a g n d Jo hr m o e i, v i it n ma g a y w be a fo un d t hat t he<br />

ar ea o f pa in, kno t s and st iffn e ss pr o gr ess ive l y mo ves do wn t o war ds t he kid ne ys. I f it do es, t he pu r if ic at io n pr o cess is<br />

p r o c e e d i n g a s i t s h o u l d . E n c o u r a g e t h e r e c e i v e r b y l e t t i n g t h . e Im f t he k n ar o ea w ot f ph a in t is t no h t i s i s a g o o d s i g<br />

mo vin g , is beco min g int en se o r is mo ving in t he w r o ng dir ect io n ( upwar ds awa y fr o m t he k id ne ys) , use st ro king t o<br />

enco ur ag e t he t o xin flo w do wnwar ds.<br />

C o l d d r a f t<br />

I f t h e c h a n n e l l e r o r t h e ing ho r izo e c nt ae ll y i acr v oe ss r t he ar f ea e r ece e ivi l ng s Jo hr a e i, it d is r a f t o f c<br />

sa id t o ind ic at e t hat t he ar ea r eq uir es no fur t her Johr e i at t hat t ime.<br />

<strong>The</strong> s e a r e g ui d el ine s only and tr ue u n d er st a nd i n g c a n on ly c o me fr o m y ou r o wn e x p e ri e nce g a in e d<br />

t hr ough r e p ea te d pr act ic e .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 82 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

8. T a k i n g C a r e o f S y m p t o m s o f P u r i f i c a t i o<br />

It is likely that through the Johrei practice, toxins within your system start to be eliminated. This<br />

will lead to better health and improvement <strong>of</strong> your current condition. <strong>The</strong> symptoms <strong>of</strong> elimination<br />

(process <strong>of</strong> purification) vary from cold like symptoms to diarrhoea. <strong>The</strong> severity depends <strong>upon</strong><br />

various factors. <strong>The</strong> following may be a useful to note.<br />

1. History <strong>of</strong> illness, (how long have you suffered from your current condition, how severe is it,<br />

what other illness have you had in the past)?<br />

2. Symptomatic medication you have been using (medicine is useful in suppressing the<br />

discomfort, however, later your body will need to eliminate it if it is not appropriate.)<br />

3. Your general well being. As your health improves, you may find that your body will start to<br />

eliminate the toxins that were accumulated in the past.<br />

<strong>The</strong> above will take place irrespective <strong>of</strong> whether you give or receive Johrei or not. With Johrei<br />

you will find that the elimination process is quicker, with less discomfort. You will also find that<br />

more toxins are eliminated; the elimination process will be less prolonged and less intense.<br />

H o w t o m a n a g e t h e ‘ p u r i f i c a t i o n ’ s y m p t o m s<br />

F e v e r :<br />

We know that our immune system can be most activated at the body temperature <strong>of</strong> 38 to 40<br />

degrees Celsius. If you are feverish, just take a rest, relax and sleep well in peace (ideally with<br />

supportive Johrei to the kidneys).<br />

When fever causes you to be unable to drink or sleep, an antipyretic such as aspirin helps to<br />

prevent dehydration or exhaustion.<br />

D i a r r h o e a :<br />

Warm water is the best thing to take at this time as well as keeping your stomach warm.<br />

Diarrhoea is usually a self-limiting symptom, it should last at most about 1-2 days with or<br />

without a severe period <strong>of</strong> less than 12 hours. What a doctor worries about is dehydration and<br />

exhaustion. Consequently, if you cannot drink water for 12 hours, you should go and see a<br />

doctor to have fluid supplied intravenously.<br />

S w e a t i n g o r c h i l l i n g<br />

Once again, warm water is the best thing to take at these times. Keep yourself comfortable by<br />

changing your clothes, wearing warm clothes etc.<br />

C o u g h i n g<br />

Coughing is the way to throw sputum out. In Johrei philosophy, toxins can gather in sputum<br />

or in other discharges as well as into urine. When it hurts, give Johrei from the middle <strong>of</strong> back<br />

to alleviate it.<br />

P a i n<br />

If you or your partner gets acute discomfort, contact a doctor without delay.<br />

In Johrei philosophy, it is thought that accumulating or melting toxins cause some discomfort.<br />

This can be a sign that the elimination process is taking place. Johrei, however, is a wonderful<br />

and simple way to alleviate discomfort and help your body to detoxificate.<br />

9 . h T e k e y a r e a s<br />

1 . F o r e h e a d<br />

2 . C r o w n<br />

3 . T e m p l e s<br />

4 . B a c k o f t h e n e c k a n d t h e b a s e o f s k u l l ( m e d u l l a o b l o n g a t a )<br />

5 . B o t h s i d e s o f t h e n e c k f r o m t h e d i p b e h i n d t h e e a r s d o w n t o t h e c o l l a r b o n e o r<br />

s h i r t c o l l ar ( l y m p h a t i c n o d e s )<br />

6 . K i d n e y s : T h e m o t i o n i s a l w a y s d o w n f r o m t h e h e a d t o w a r d s t h e k i d n e y s .<br />

7 . A n d l y m p h a r e a s ( s u c h a s h e a r t a r e a , a r m p i t s , g r o i n ) .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 83 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 0 . B r i e f h i s t o r i c a l o f J b o a h c r k e i g r o u n d<br />

Johrei is a philosophy and practice, which has its foundation in a Japanese therapeutic art<br />

developed by Mokichi Okada (1882-1955) in the early part <strong>of</strong> the last century.<br />

Mokichi Okada was born into a poor family Okada was not a healthy youth and indeed his<br />

various afflictions and life threatening diseases kept him from fulfilling his potential <strong>of</strong> becoming<br />

a pr<strong>of</strong>essional artist. Following a vegetarian diet, he gradually recovered and with the death <strong>of</strong><br />

his father in 1905, he became the sole supporter <strong>of</strong> his family.<br />

He opened a small retail store in Tokyo where his artistic ability contributed to his success,<br />

however, he was again forced to abandon this business due to illness.<br />

During the next twenty years, the periods <strong>of</strong> success alternated with times <strong>of</strong> abysmal tragedy<br />

and disappointment. He lost his wife and their baby due to complications during childbirth.<br />

At one point, the failure <strong>of</strong> his main bank plunged his firm into bankruptcy, and the Great<br />

Kanto earthquake <strong>of</strong> 1923, in addition to destroying much <strong>of</strong> Tokyo, ruined Okada financially,<br />

along with thousands <strong>of</strong> others.<br />

Around this time, Okada, who had been an atheist, began to search for a spiritual meaning<br />

to life. He became acquainted with various religions and beliefs that were popular at the time,<br />

and in this vein, in 1920, he attended a lecture on Omoto at a movie theatre, which he regularly<br />

visited. Omoto was one <strong>of</strong> the New Religions making the headlines at the time. It is based on<br />

Shinto, which is the oldest national religion <strong>of</strong> Japan, and much <strong>of</strong> what the lecturer said<br />

seemed to be refreshingly straight to the point. Okada later joined Omoto and began studying<br />

its teachings. One thing unique about Omoto was that it had its own healing ministry called<br />

Chikon kishinho, Okada made it his own and began practicing it in 1929. However, by 1934,<br />

dissatisfied with the limitations <strong>of</strong> religious activities and desperately wanting to reach out to all<br />

those who needs help, he left Omoto in order to develop his gift as a healer and a therapeutic<br />

artist.<br />

<strong>The</strong> major influence Omoto had on Okada, was to make him realise the importance <strong>of</strong> the<br />

Spiritual. During his time in Omoto, he also discovered that he had a special ability to heal the<br />

sick.<br />

He had closely studied the way in which people became ill and the way in which people<br />

recovered from illness. He also closely studied medical writings <strong>of</strong> the day including those on<br />

traditional medicine, and had collaborated closely with the leading medical practitioners <strong>of</strong> the<br />

day. Through this process, he developed and perfected the unique spiritual therapy, which he<br />

called JOHREI, meaning purification (joh) <strong>of</strong> spirit (rei)<br />

Okada was passionate about promoting a life style, free from disease, through the use <strong>of</strong><br />

natural methods <strong>of</strong> preventing ourselves from becoming seriously ill. Based on his own<br />

experience, he knew our food played a crucial role in our health.<br />

In 1935 he began research into the possibility <strong>of</strong> realising a chemical free farming technique,<br />

which he called Nature Farming. By the 1950’s he was able to set up experimental farms and the<br />

Nature Farming Society.<br />

During that period, he also created the basis for the Sangetsu School <strong>of</strong> Flower<br />

Arrangement, which emphasised the freedom and the natural beauty <strong>of</strong> flowers. As a way <strong>of</strong><br />

bringing beauty into daily life, Sangetsu Flower Arrangement is also practiced alongside the<br />

therapy <strong>of</strong> Johrei healing.<br />

As an artist he knew that both artistic and natural beauty could inspire us and uplift our<br />

soul. He looked for a way to bring beauty into our daily lives, and he devoted the later part <strong>of</strong> his<br />

life to creating art museums and inspiringly beautiful gardens. <strong>The</strong> museums and the sacred<br />

gardens he created near Mount Fuji in Hakone and the seaside resort <strong>of</strong> Atami are enjoyed by<br />

millions <strong>of</strong> visitors today. His vision was to inspire and encourage everyone, in making this<br />

world an Earthly paradise.<br />

Back in 1936, Okada set up the H e a l t -care h Society <strong>of</strong> Japan and invited medical<br />

pr<strong>of</strong>essionals <strong>of</strong> the day, to contribute, to its promotion <strong>of</strong> a natural form <strong>of</strong> health maintenance.<br />

This was based on a way <strong>of</strong> living that respects our body’s natural ability, to heal itself and<br />

stresses the importance <strong>of</strong> truth, virtue and b e a u t y within health care.<br />

<strong>The</strong> Authorities <strong>of</strong> the day did not appreciate his vision, and he was discouraged from<br />

practicing Johrei as a therapy and healthcare measure. In order to be allowed to promote Johrei<br />

and both the medicinal and the spiritual aspects <strong>of</strong> its teaching, he decided, in 1950, to set it up,<br />

as a religious organisation, Sekai-Kyusei-Kyo in a style that everyone can practise Johrei.<br />

Following his death in 1955, his teachings spread around the world, and, today, there are 3<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 84 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

million people practicing Johrei within families, as a natural method <strong>of</strong> maintaining health and<br />

happiness.<br />

This also helped the development <strong>of</strong> Nature Farming technique in countries such as Japan,<br />

the USA, Brazil, Thailand and encouraged further research into the possibility <strong>of</strong> totally<br />

fertiliser- and chemical - free farming techniques.<br />

In 1996, Dr Rosy Daniel, former Medical Director <strong>of</strong> Bristol Cancer Help Centre and a<br />

leading proponent <strong>of</strong> the holistic approach to health creation in the UK, encountered Johrei in<br />

Japan and on her return to England, called for the formation <strong>of</strong> a Johrei society in the UK that<br />

would re-focus its attention on the original integrity <strong>of</strong> the Johrei philosophy and teach and<br />

promote Johrei practice, not as religion but as an individual’s truly holistic journey towards<br />

healing and health creation.<br />

<strong>The</strong> British Johrei Society and the Johrei Academy was formed by Dr. Rosy Daniel, Sue Boyd,<br />

Koichi Sakakibara and Junichi Imura, as a secular organization, and on 15t h May 2001, the<br />

British Johrei Society and the Johrei Academy were <strong>of</strong>ficially launched, commemorating 65t h<br />

Anniversary <strong>of</strong> the launch <strong>of</strong> Mokichi Okada’s H e a l t -care h Society <strong>of</strong> Japan.<br />

<strong>The</strong> British Johrei Society is currently helping to oversee scientific research, taking place<br />

around the world, on the efficacy <strong>of</strong> Johrei. <strong>The</strong> main research is being directed by Pr<strong>of</strong>. John<br />

Gruzelier <strong>of</strong> Imperial College, University <strong>of</strong> London.<br />

1 1 . J o h r e i p r a c t i c e<br />

It is useful to be aware that their area three distinct styles in which Johrei is practiced:<br />

( 1 ) J o h r e i a s d a i l y p r a c t i c e<br />

This is the style <strong>of</strong> Johrei, which you will learn in these workshops as a way to maintain<br />

health on daily basis. It is derived from the <strong>The</strong>rapeutic Johrei technique, which is made short<br />

and simple so that it is easy for you to practice anywhere and at any time. By itself, it does not<br />

constitute a therapy, however, it is a wonderful way to maintain health, prevent illness and also<br />

to support those with chronic conditions at home.<br />

( 2 ) T h e r a p e u t i c J o h r e i<br />

This is the style <strong>of</strong> Johrei, which is practiced as a therapeutic intervention. A <strong>The</strong>rapeutic<br />

Johrei practitioner will scan with hands, and use gentle touch and pressure to find the areas <strong>of</strong><br />

toxin accumulation and then channel the “Light” from the hand. If the toxin accumulation is<br />

severe, <strong>The</strong>rapeutic Johrei practitioner will also use the application <strong>of</strong> finger pressure and<br />

stroking action to encourage the movement <strong>of</strong> toxins to the kidneys, followed by channelling to<br />

the kidneys to affect the elimination process.<br />

<strong>The</strong> Johrei treatment is carried out with as much understanding <strong>of</strong> patient/client’s past medical<br />

history and lifestyle as possible, so that the application <strong>of</strong> Johrei is matched to the course <strong>of</strong> the<br />

possible Purification Process unique to the patient/client.<br />

( 3 ) S p i r i tu al J o h r ei<br />

This style <strong>of</strong> Johrei is practiced by those wishing to obtain closer union with their inner<br />

spirituality and the divine. It can be likened to the induced meditation for two. It involves<br />

channelling ‘the Light’ from the hand to the front and the back <strong>of</strong> the receiver’s body without<br />

guiding the hand to specific areas. It is totally hands <strong>of</strong>f and carried out with sincerity, love and<br />

faith. This style <strong>of</strong> Johrei is sometimes referred as Prayer in Action.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 85 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Appe ndi x 3 : S e l f-r e p o r t u e s q t i o n n a i r e s<br />

S t r e s s p e r c e p t i o n<br />

P e r c e i v e d S t r e s s S c a l e ( P S S )<br />

S t a t e a n x i e t y s c a l e i n t h e S t a t e a n d T r a i t A n x i e t y I n v e n t o r y ( S T A I ) 288<br />

I m p a c t o f E v e n t S c a l e E ( S I ) 289<br />

S e n s e o f t a k i n g c o n t r o l ’s o own f o ln ife e s cal e<br />

L o c u s o f C o n t r o l ( L o C )<br />

Q u a l i t y o f l i f e<br />

M e n t a l C o m p o n e n t s o f S u m m -3 a 6 r ( M y C S i ) n t h e S F 292<br />

S l e e p q u a l i t y<br />

P i t t s b u r g h S l e e p Q u a l i t y I n v e n t o r y ( P S Q I )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 86 - I m p e r i a l C o l l e g e L o n d o n<br />

287<br />

290<br />

295


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Pe r c e i v e St d r e s s Sc a l e<br />

1 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u b een<br />

u p s et b ecaus e <strong>of</strong> s o met h i n g th at h ap p en ed<br />

u n e x p e c t e d l y ?<br />

2 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u felt th at<br />

yo u we re u n ab l e t o c on t rol t h e i mp ortan t th in gs in<br />

y o u r l i f e ?<br />

3 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u felt<br />

n e r v o u s a n d s t r e s s e d ?<br />

4 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u d ealt<br />

w i t h i r r i t a t i n g l i f e h a s s l e s ?<br />

5 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u felt th at<br />

yo u we re ef fect i v el y cop i n g with imp o rta n t<br />

c h a n g e s t h a t w e r e o c c u r r i n g i n y o u r l i f e ?<br />

6 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u felt<br />

con fid en t ab ou t you r ab i l i t y to h an d le yo u r<br />

p e r s o n a l p r o b l e m s ?<br />

7 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u felt th at<br />

th in gs were g oi n g you r wa y?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 87 - I m p e r i a l C o l l e g e L o n d o n<br />

Never<br />

0<br />

8 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u fou n d<br />

th at you cou l d n ot c op e wi t h all th e th in g s you h ad<br />

t o d o ?<br />

9 . In th e l as t few d a ys , h ow <strong>of</strong>ten h ave yo u b een<br />

a b l e t o c o n t r o l i r r i t a t i o n s i n y o u r l i f e ?<br />

1 0 . In t h e l as t few d a ys , h o w o ften h ave you felt<br />

th at you wer e on t op <strong>of</strong> t h i n gs ?<br />

1 1 . In t h e l as t few d a ys , h o w o ften h ave you b een<br />

an gered b ecau s e <strong>of</strong> t h i n gs t h at h ap p en ed th at were<br />

o u t s i d e y o u r c o n t r o l ?<br />

1 2 . In t h e l as t few d a ys , h o w o ften h ave you fou n d<br />

yo u rs el f t h i n ki n g ab ou t t h i n gs th at you h a ve to<br />

a c c o m p l i s h ?<br />

1 3 . In th e l as t few d a ys , h o w o ften h ave you b een<br />

a b l e t o c o n t r o l t h e w a y y o u s p e n d y o u r t i m e ?<br />

1 4 . In t h e l as t few d a ys , h o w o ften h ave you felt<br />

d ifficu l t i es were p i l i n g u p s o h igh th at yo u cou ld<br />

n o t o v e r c o m e t h e m ?<br />

Almost never<br />

1<br />

Sometimes<br />

2<br />

Fairly <strong>of</strong>ten<br />

3<br />

Very <strong>of</strong>ten<br />

4


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S e l f-E v a l u a t i o n Q u e s t i o n n a i r e ( Y )<br />

Dev elo p ed b y Ch a rle s D. S p i elb erge r i n col lab o rat i on wi t h R. L. G o rsu ch , R. Lu sh en e, P. R. Vag g ,<br />

a n d G . A . J a c o b s<br />

S T A I (-S ) F o r m -1 Y<br />

NAME : DATE :<br />

AGE :<br />

T :<br />

S E X : M / F<br />

D I R E C T I O N S : A n u m b e r o f s t a t e m e n t s op w le h i h ave c h up se ed<br />

to d es cri b e th ems el ves are given b elo w. R ead each s tatemen t an d<br />

th en b lacken in th e ap p rop ri ate circle to t h e righ t o f th e s tatemen t<br />

to in d icat e h ow you feel R I G H T , th at N is O , A W T T HIS<br />

M O M E N T . Th ere are n o ri gh t or w ron g an s wers . Do n ot s p en d<br />

too mu ch ti me on an y on e s tatemen t b u t give th e an s wer, wh ich<br />

s eems to d es cri b e you r p res en t feelin g b e s t.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 88 - I m p e r i a l C o l l e g e L o n d o n<br />

Not at all<br />

1 . I feel cal m. ………………………………………………………… 1 2 3 4<br />

2 . I f e e l s e c ………….. u r e .…………………………………………… 1 2 3 4<br />

3 . I a m t e n …………………………………………………………. s e<br />

. 1 2 3 4<br />

4 . I am s t rai n ed . ……………………………………………………… 1 2 3 4<br />

5 . I feel at eas e. ………………………………………………………. 1 2 3 4<br />

6 . I feel u p s et . ………………………………………………………. .. 1 2 3 4<br />

7 . I a m p r e s e n t l y w o r e r py os i sn ig b le o m v i s f o r t u n e .………………. s<br />

1 2 3 4<br />

8 . I feel s at i s fi ed ...……………………………………………………. 1 2 3 4<br />

9 . I f e e l f r i …………………………………………….……… g h t e n e d<br />

1 2 3 4<br />

1 0 . I feel c om fo rt ab l e. …………………………………………………. 1 2 3 4<br />

1 1 . I f e e l s e -con l f fid en t . ……………………………….………………. 1 2 3 4<br />

1 2 . I feel n er vou s . ……………………………………………………... 1 2 3 4<br />

1 3 . I a m j i t t e r y. ……………………………………….…………….…. 1 2 3 4<br />

1 4 . I feel i n d e .………………………………………………… c i s i v e …<br />

1 2 3 4<br />

1 5 . I a m rel axed . …………………………………….………………… 1 2 3 4<br />

1 6 . I feel c on t en t ..……………………………………………………… 1 2 3 4<br />

1 7 . I a w m o r r i …….……………………………….………………… e d<br />

1 2 3 4<br />

1 8 . I feel c on fu s ed ..……………………………………………………. 1 2 3 4<br />

1 9 . I feel s t ead y. ………………….………………….………………… 1 2 3 4<br />

20. I f e e l p lea s ant . …………………………………..………………… 1 2 3 4<br />

S :<br />

Somewhat<br />

Moderately so<br />

Very much so


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Impa c t Ev e nt Sc a l e<br />

Name __________________________ Date ___________________<br />

Belo w i s a l i s t <strong>of</strong> co mmen t s mad e b y p eo p le<br />

d is tres s ed ab ou t s ome as p ect <strong>of</strong> livin g wit h<br />

can cer. P l eas e ch eck each i te m, in d icatin g h ow<br />

freq u en t l y t h es e c om men t s were tru e f or yo u<br />

DUR IN G T HE P AS T S EVEN D AYS. If th e y<br />

d i d n o t o c c u r d u r in g t h at t i me, p leas e mar k th e<br />

‘n ot at al l ’ col u mn .<br />

1 I thought about it when I didn’t want to.<br />

2 I a vo i d e d l e t t i n g m ys e l f ge t upset when I<br />

t hought a b o ut it or wa s re minde d <strong>of</strong> it .<br />

3 I tr ie d t o re move it fr om me mo r y.<br />

4 I h a d tr o uble f a lling a s le e p o r st a yin g a s le e p .<br />

5 I h a d w a v e s o f s t r o n g f e e l ai bout n g s it .<br />

6 I h a d d re a ms a bout it .<br />

7 I st a ye d a wa y f r om re min d e rs <strong>of</strong> it .<br />

8 I f e lt a s if it ha dn’t ha ppe n e d o r it wa s n ’t r ea l.<br />

9 I t r i e d tn ao lk t a bo t uo t it .<br />

10 P ict u re s a bout it popped in t o my min d .<br />

11 Ot h er t h ings ke pt ma king me t h in k a b o u t it .<br />

12 I wa s a wa r e that I s t ill ha d a lot <strong>of</strong> fe e lin gs<br />

a b o u t i t , idn’t b u t de I a l wit d h t he m.<br />

13 I tr ie d n ot t o t hink a bout it .<br />

14 An y r e minde r br ought ba c k f ee lin gs a b o ut it .<br />

15 M y f e e lings a bout it we r e kin d o f n u mb .<br />

F r e q u e n c y<br />

d u r i n g t h e p a s t w e e k<br />

� � N o t a t a l l R a r e l y S o m e t i m e s O f t e n<br />

0 1 3 5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 89 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

1 5 a . I n my ca se ge t t ing wh at I wa nt h a s<br />

lit t le o r n ot h ing to do with lu c k.<br />

1 6 a . Who g et s t o be t he bo s s o ft en<br />

d epe nd s on who wa s lu c ky e nou gh t o<br />

b e in th e righ t p lac e f irs t.<br />

1 7 a . A s fa r as wo rld a ff a irs a re con ce rne d,<br />

mo s t <strong>of</strong> u s a re th e v ic t ims <strong>of</strong> fo rce s<br />

we can n e it he r u nde rs ta nd , no r<br />

c on t ro l.<br />

1 8 a . Mo st p eop le don ' t rea liz e th e e xt en t to<br />

wh ich the ir liv e s a re c on t ro lled b y<br />

a c c id en ta l ha ppe n in gs .<br />

1 9 a . On e s hou ld a lwa y s be willin g to a d mit<br />

mis t a ke s.<br />

2 0 a . I t is ha rd to kno w whe th e r o r no t a<br />

p e rson re a lly lik e s yo u.<br />

2 1 a . I n th e long run t he ba d th ing s th at<br />

h app en t o us a re ba lan ced b y the<br />

g ood th in g s.<br />

2 2 a . Wit h eno ugh e f fo rt we c an wipe o ut<br />

p o lit ic a l c o rru pt ion .<br />

2 3 a . So met imes I c an 't u nde rs ta nd ho w<br />

t ea ch e rs a rrive a t t he g ra de s t he y<br />

g iv e.<br />

2 4 a . A go od lea de r e xp e ct s pe op le to<br />

d e c i d e f o r t eh lve e m s wha t t he y<br />

s ho u ld d o.<br />

2 5 a . Man y t ime s 1 fe e l th at I ha ve litt le<br />

in f luen ce o ve r th e th ing s t ha t hap pen<br />

t o me .<br />

2 6 a . Pe op le a re lon e ly be cau s e th ey d on 't<br />

t ry to b e f riend ly .<br />

o r b . M a n y t i m e s w e m t i ag s h we t ll j de u s c ide wha t<br />

t o do b y f lipp ing a co in .<br />

o r b . Ge t t in g peo p le t o do t he rig ht th in g dep end s<br />

u p o n a b i l i t y ; l u c k h a s l i t o t wit l h e o r n o t h i n g t o d<br />

it .<br />

o r b . B y ta k ing an a c t ive pa rt in p o lit ic a l an d so c ia l<br />

a f fa irs t he pe op le ca n co nt ro l wo rld e v en ts .<br />

o r b . <strong>The</strong> re rea lly is no su ch t h ing a s "lu c k . "<br />

o r b . I t is us ua lly be s t to co ve r up on e' s mist ak es .<br />

o r b . Ho w man y f riend s you h av e dep end s u pon h ow<br />

n ic e a pe rso n yo u a re .<br />

o r b . Mo st mis fo rtun e s a re t he re su lt o f la ck o f ab ilit y ,<br />

ig no ran ce , la z ine s s , o r a ll t h re e.<br />

o r b . I t is d if f icu lt f o r pe op le to ha ve mu ch co nt ro l<br />

o v e r t h e t h i n g s ia p no s l do i t in i c o ff ic e.<br />

o r b . <strong>The</strong> re is a d ire ct con ne c t ion b et we en ho w h a rd<br />

I s tud y a nd t he g ra de s I ge t .<br />

o r b . A go od lea de r ma ke s it c lea r t o ev e rybo dy wh at<br />

t he ir job s a re .<br />

o r b . I t is impo s s ib le fo r me to be lie ve t ha t ch an ce o r<br />

lu c k p la y s an imp o rtan t ro le in my life .<br />

o r b . <strong>The</strong> re' s no t mu ch u se in t ry in g to o ha rd to<br />

p lea se p eop le, if th e y lik e yo u, the y like you .<br />

2 7 a . T h e r e i s t o o m u c h e m p h a s i s o r o n b . Tea m spo rt s a re a n ex c e llen t wa y to b u ild<br />

a th let ic s in h igh s c hoo l.<br />

c ha ra ct e r.<br />

2 8 a . Wha t ha ppe ns to me is my o wn o r b . So met imes I fe e l t ha t I do n' t ha ve e nou gh<br />

d o ing .<br />

c on t ro l o ve r t he d irec t ion my life is ta k ing .<br />

2 9 a . Mo st o f t he t ime I can ' t und e rst and o r b . I n th e long run t he pe op le a re re spo n s ib le fo r<br />

wh y po lit ic ian s beh av e th e way the y<br />

b ad go ve rn me nt o n a na t ion a l a s we ll as o n a<br />

d o.<br />

lo c a l le ve l.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 91 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S F -3 6 Q u a l i t y o f L i f e ( r eS v ic s ea d l v e r s i o n )<br />

1. I n ge n e r a l wo u ld you say your health is:� e x c e l l e n t v e r y g o o d g o o d f a i r p o o r<br />

T i c k o n e b o x: 5 4 3 2 � 1<br />

2 . C o m p a r e d t o o n e y e , a r h o a w g o w o u l d y o u r a t e y o u r h e a l t h i n g (T e i n e c r k a l o n n e o w b ) o ? x<br />

M u c h b e t t e r t h a n o n e y e a r a g o<br />

5<br />

S o m e w h a t b e t t e r t h a n ao r n ae go y e<br />

4<br />

About t he s a me a s one ye ar a go<br />

3<br />

Some wh a t wo r s e t ha n one ye ar a go<br />

2<br />

M uc h wo r s e t ha n one ye ar a go<br />

1<br />

3 . T he f o llowing it e ms a re ab o ut a ct ivit ie s yo u migh t d o d u r in g a t yp ic a l d a y. D o es yo u r hea l t h l i m i t<br />

you i n t h e s e a c t i v i t i e s ? I f s o , h o w m u c h ?<br />

a ) Vigor o u s a ct ivit ie s s uc h a s r u n n in g, lif t in g h e a vy o b j e ct s ,<br />

pa rt ic ip a t in g in s tr e nuous s por ts .<br />

b ) M o d e r a t e a c t i v i st uc i e h s as mo vin g a t a ble , pus hing a<br />

va c uum c le a ner , bowlin g or golf .<br />

c ) Lif t in g or c ar r ying gr oc e r ie s .<br />

d) Climb in g s e ve r a l f light s <strong>of</strong> st a irs .<br />

e ) Climb in g o n e f light <strong>of</strong> st a ir s.<br />

f ) Bendin g, kn e e ling or s t oopin g.<br />

g ) W a or l e k t ha i n a n mile g . m<br />

h) Wa lkin g s e ve r a l hundr e d ya r d s .<br />

i) Wa lkin g 1 0 0 ya r ds .<br />

j ) Bat hin g o r dr es s ing your s e lf .<br />

Ye s ,<br />

lim it e d<br />

a lot 1<br />

Ye s ,<br />

T i c k o n e b . o x<br />

No, not<br />

lim it e d lim it e d<br />

2<br />

a l i t t l e a t a l l 3<br />

4. Dur in g t he p a s t 4 w e e k , s ha ve yo u ha d a ny <strong>of</strong> t he f ollowin g pr ob le ms wit h yo ur wo r k or oth e r<br />

r e gu l a r d a i l y a c t i vit ie s a s a r e s u l t o f y o u r p h ? y s i c a l h e a l t h<br />

Y e s 1<br />

a ) C u t d o w n t h e a m o u n t o f t i m e s p e n t o n w o r k o r o t h e r a c t i v i t i e s<br />

b ) A c c o m p l i s h e d l e s s t h a n y o u w o u l d l i k e<br />

c ) W e r e l i m i t e d i n t h e k i n d o f w o r k o r o t h e r a c t i v i t i e s<br />

d ) H a d d i f f i c u l t y p e r f o r m<br />

ing wor k o r o t h er act ivit ie s<br />

( f o r e x a m p l e , i t t o o k e x t r a e f f o r t )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 92 - I m p e r i a l C o l l e g e L o n d o n<br />

N o 2


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

5 . Dur in g t he p a s t 4 w e e k , s ha ve yo u ha d a ny <strong>of</strong> t he f ollowin g pr ob le ms wit h yo ur wo r k or oth e r<br />

r e gula r da ily a c t ivit ie s a s a r e s u l t o f a n y e m o t i o n a l p r o ( b s l u e c m h s a s f e e l i pre n g s se d e d or a nx ious) .<br />

Y e s 1<br />

N o 2<br />

a ) C u t d o w n t h e a m o u n t o f t i m e s p e n t o n w o r k o r o t h e r a c t i v i t i e s<br />

b ) A c c o m p l i s h e d l e s s t h a n y o u w o u l d l i k e<br />

c ) D i d n ’ t do wo r k o r o t he r a ct i vi t i e s a s ca r ef ul l y a s u s u a l<br />

6 . Du ri n g th e p a s t 4 w e e k , s t o w h a t he ave x t e you n r p h ys ical h eal th o r e moti on al p ro b lems<br />

i n t e r f e r e d w i t h y o u r n o r m a l s o c i a l a c t i v i t i e s w i t h f a m i l y , f r i e n d s , n e i g h b o u r s o r<br />

N o t at a l l 5<br />

4<br />

S l i g h t l y<br />

3<br />

M o d e r a t e l y<br />

7. How much bodily pain have you had in the p a s t 4 w e e k ? s<br />

None 6<br />

5<br />

V e r y m i l d<br />

M i l d<br />

4<br />

M o d e r a t e 3<br />

Q u i t e a b it 2<br />

S e v e r e 2<br />

1<br />

E x t r e m e l y<br />

1<br />

V e r y s e v e r e<br />

8 . Du ri n g th e p a s t 4 w e e k , s h ow mu ch d id p a i n in terfere with you r n o rmal wo rk (in clu d in g<br />

b o t h w o r k o u t s i d e t h e h o m e a n d h o u s e w o r k ) ?<br />

N o t at a l l 5<br />

A l i t t l e b i t 4<br />

3<br />

M o d e r a t e l y<br />

Q u i t e a b it 2<br />

1<br />

E x t r e m e l y<br />

9 . Th es e q u es ti on s are ab ou t h ow you feel a n d h ow th in gs h ave b een with you d u rin g th e p as t<br />

4 w e e k s, f or each q u es ti on , p leas e give on e an s wer th at co mes cl os es t to th e wa y you<br />

h a v e b e e n f e e l i n g . H o w m ri u nc g h th t e i p a m s t e 4 d u w e e k s…<br />

T i c k o n e b . o x<br />

Al l o f Mo st o f A go o d<br />

6<br />

5<br />

t h e t i m e t h e t i m e bit o f t he<br />

t i m e<br />

4<br />

S o me o f A lit t le<br />

3<br />

t h e t i m e o f t he<br />

t i m e<br />

2<br />

No ne o f<br />

1<br />

t h e t i m e<br />

a ) D i d y o u f e e l f u l l o f e n e r g y ?<br />

b) Ha ve yo u b e en a ve r y ner vou s<br />

person?<br />

c ) Ha ve yo u fe lt s o down in t he<br />

dumps t h at n ot hing c ould c he er<br />

you up?<br />

d ) H a v e y o u f e l t c a l m a n d p e a c e f u l ?<br />

e ) D i d y o u h a v e a l o t o f e n e r g y ?<br />

f ) Ha ve yo u fe lt downhe ar te d a n d<br />

s a d ?<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 93 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

g) Did you feel worn out?<br />

h) Ha ve yo u b e en a ve r y ha ppy<br />

person?<br />

i ) D i d y o u f e e l t i r e d ?<br />

j ) Ha ve yo u h ad diff ic ult y r e as o n in g<br />

a nd solvin g p r oble ms , e .g. ma kin g<br />

pla ns , ma kin g de c is ions , le ar nin g<br />

n e w t h i n g s ?<br />

k) Did yo u f o r ge t things t hat<br />

ha ppene d r e ce nt ly e .g. whe r e yo u<br />

p u t t h i n g s , a p p o i n t m e n t s ?<br />

l) Did yo u h a ve t r ouble ke e ping<br />

yo u r a t t e nt i o n on a n y a ct i vi ty f o r<br />

long?<br />

m) Did yo u h a ve dif f ic ult y doin g<br />

a c t ivit ie s in vo lving c onc e ntr a t io n<br />

and thinking?<br />

Al l o f<br />

6<br />

t h e t i m e<br />

Mo st o f A go o d<br />

5<br />

t h e t i m e<br />

bit o f t he<br />

t i m e<br />

4<br />

S o me o f A lit t le<br />

3<br />

t h e t i m e o f t he<br />

t i m e<br />

2<br />

No ne o f<br />

1<br />

t h e t i m e<br />

1 0 . Du ri n g th e p a s t 4 w e e k , s h ow mu ch o f th e ti me h as you r p h ys ical or em otion al p rob lems<br />

i n t e r f e r e d w i t h y o u r s o c i a l a c t i v i s t i t e i s n g ( l f i r k i e n d s , r e l a t i v e s e t c ) ?<br />

1<br />

2<br />

3<br />

A l l o f t h e t i m M e o s t o f t h e t i m S e o m e o f t h e t i m e<br />

A l it t le <strong>of</strong> t he t i m e<br />

4<br />

11. How T R U E or F A L S E i s e a c h o f t h e f o l l o w i n g s t a t e m e n t s f o r y o u ?<br />

a ) I s ee m t o get s ic k a lit t le ea s ier th a n<br />

ot her pe o p le .<br />

b) I a m a s h e a lt hy a s anybody I kn o w.<br />

c ) I e xpe ct my he a lt h t o ge t wor se .<br />

d) M y h ea lt h is e xce lle nt .<br />

De fin it e l y<br />

t r u e 1<br />

Mo st ly<br />

t r u e 2<br />

Do n’t<br />

k n o w<br />

3<br />

Mo st ly<br />

f a l s e<br />

4<br />

5<br />

N o n e o f t h e t i m e<br />

T i c k o n e b o x :<br />

De fin it e l y<br />

f a l s e<br />

5<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 94 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

P i t t s b u r g h S l e e p Q u a l i t y I n d e x<br />

N a m e : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ A g e : _ _ _ _ _ D a t e : _ _ _ _ _ _ _ _ _ _ _ _ _<br />

Th e fol l owi n g q u es ti on s rel ate t o you r u s u al s leep h ab its d u r i n g t h e p a s t . You m o n r t h<br />

a n s w e r s s h o u l d i n d e i mos c a t e accu t rat h e rep l y for th e m a j o r i t <strong>of</strong> y d a ys o r n igh ts in th e p as t<br />

mon th . P leas e an s wer A L L Q U E S T I O N . S<br />

1 D u r i n g t h e p a s t m o n t h , w h e n h a v e y o u u s u a l l y g o n e t o b e d a t n i g h t ?<br />

2 D u r i n g t h e p a s t m o n t h , h o w l o n g ( i n m i n u t e s ) h a s ? i t t a k e n y o u t o f a l l a s l e e p<br />

3 D u r i n g t h e p a s t m o n t h , w h e n h a v e y o u u s u a l l y g o t u p i n t h e m o r n i n g ?<br />

4 D u r i n g t h e p a s t m o n t h , h o w m a n y h o u r s o f a c t u a l s l e e p d i d y o u g e t a t n i g h t ?<br />

( t h is m a y be d if f e r e nt f r o m t h e n u mb e r o f hou r s y o u s p e n t in be d )<br />

5 D u r i n g t h e p a s t m o n t uld h , you h o w rate w your o sleep quality overall?<br />

v e r y g o o d = 1 , f a i r l y g o o d = 2 , f a i r l y b a d = 3 , v e r y b a d = 4<br />

6 D u r i n g t h e p a s t m o n t h , h o w m u c h o f a p r r o b y ol u e tm o k ee h a p s u p i t b e e n f o<br />

e n o u g h e n t h u s ia sm t o g e t th in g s d o n e ?<br />

No p r o b le m a t a ll = 0 ; O n ly a s lig h t p r o b lem = 1 ; So m e wh a t o f a pr o b le m =<br />

2 ; A v e r y b ig pr o b le m = 3<br />

7 D u r i n g t h e p a s t , m o n h t h o w o f t e n h a v e y o u h a d t<br />

P l e a s e c h e c k t h e c o r r e c t b o x :<br />

A C o u l d n o t g e t t o s l e e p i n 3 0 m i n u t e s<br />

not at all<br />

B Wo ke u p in t he midd le <strong>of</strong> t h e n i g h t o r t o o e a r l y<br />

C Ha d to g et u p to u se the lo o.<br />

d C o u l d n o t b r e a t h e c o m f o r t a b l y<br />

E C o u g h e d o r s n o r e d l o u d l y<br />

F F e l t t o o c o l d<br />

G Fe lt t oo ho t<br />

H H a d b a d d r e a m s<br />

I H a d p a i n<br />

J Ha d s we at i n g<br />

K W e r e d i s t u r b e d b y p a r t n e r / c h i l d r e n / p e t s<br />

l O t h e r r e a s o n s : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _<br />

8 I n pa s t mon th , ho w o ft en d id you ta ke<br />

m e d i c a t i o n t o h e l p y o u s l e e p ?<br />

9 I n pa s t mon th , ho w o ft en ha ve you h ad t rou b le<br />

s t a y ing a wak e wh ile d riv ing , ea t ing , wo rk in g o r<br />

e n g a g i n g i n s o c i a l a c t i v i t i e s ?<br />

less than<br />

once a<br />

week<br />

1 or 2<br />

times a<br />

week<br />

3 or more<br />

times a<br />

week<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 95 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Ap pe ndi x 4 : S t a n d a r d o p e r a t i n g p r o c e d u r e s ( S O P s )<br />

M a t e r i a l s :<br />

S O P -1: [ 3 H ] -t h y m i d i n e i n c o r p o r a t i o n u s i n g w h o l e b l o o d f o r p r o l i 296 f e r a t i o n a s s a y<br />

S O P -2 : F l o w c y t o m e t r y a s s a y f o r l y m p h o c y t e p r o l i f e r a t i o n r e 297 s p o n s e i n w h o l e b l<br />

S O P -3 : N K c e l l c y t o t o x e t i r y c a c t i v i t y 302 a s s a y b y<br />

[ 3 H ] -T h y m i d i n e i n c o r p o r a t i o n p r o l i f e r a t i o n a s s a y p r o t o c o l i n<br />

S O P -1 w r i t t e n b y D r . A k i r a N a i t o O c t . 2 0 0 3<br />

B u f f e r s :<br />

T is sue cu lt ur e me dium (T CM) c ons is ts <strong>of</strong> RPM I 16 40 s up ple men te d wit h 1 % g l u t a m i n ( e 200 mM ),<br />

1 % p e n i c i l l 0 i 0 n I ( U 5 / 0 m l ) / s t r e p t o m y c i n ( 5 0 0 0 m -es c g s/ ent m ia l ) a, min 1 o % ac ids n o n (100 x) , 1 %<br />

s odium pyr uva t e ( 100 mM) .<br />

F re s h ( 1-4 hours) 1:5 d i l u t h e d p a r i n i z e d w h o l se a mples b l o ar o e d us e d f or p r o l i f e r a t i o . n T he a s s a y<br />

blood is 1 :5 wit h t is s ue c ulture me diu m a nd 20 0 l c u l t u r e d i n t r i p l i c a -we t e l l w pla e l t e l . s o f a 9 6<br />

M i t o g en s / A nt i gens : t h e S t a p h y l o c o c c a l e n t e r o t o x i n B -4881, ( S E Sigma-A B ) ( l p r d r o i d ®) c u h c t n o . S<br />

and the Phytoh a e m a g g l u t i n i n A ( P -L H A ) ; ( L e c u t c i n o : a g -4144, p g r l o d u t c i t n n i o n . L P H A<br />

S i g m a-A l d r i ®) c h a re use d as st imuli f or pr olif e ra t io n r ea ct io n (ex per ime nta l solution is t itra t e d 50 g/ ml.) .<br />

- Fol lowin g c onc e ntr a t ion is fr om a s t oc k ( wh i c h me a ns th e REAL c on c . in t he we ll is 1/4) .<br />

- Che mic a l ( SEB/P HA) t it r at io n : or igin a l c on ce ntr at io n is 5 mg/ ml 500, 250, to 0.78 g/ m l<br />

D r u g p r e p a r a t i o n :<br />

- Hyd r oc ort is one ( cort is ol) 25 0 nM (1 i n t h e a d d i n g s o l u t i o n<br />

-<br />

Hydr oc ort is on e t i t r a : t ( ai ddin o n g c on c entr at ions : r e a l c on ce ntr at io n in we lls a r e 1/ 4) 32 , 16 , 8 , 4 ,<br />

2, 1, 0.5, 0.25, 0.125, 0.062, 0.031 m o l / L (underlined conce nt r at io ns a r e p h y s i o l o g i c a l . )<br />

M e l a t o n i n<br />

- D H E A -S<br />

M e t h o : d<br />

10 ml <strong>of</strong> h e p a r i n i z blood, e d 10 ml <strong>of</strong> 1 M c or t is ol, 7 ml <strong>of</strong> pre vio us ly t it r a te d ( 50 g/ L) s t imu lu s f or<br />

1 s ubj e ct .<br />

Pr e pa r at io n <strong>of</strong> 96 we lls p l a t e s ( o n e p l a t e f o r t w o s u b j e c t s P H A / S E r B s ) i n c u b a t i n g 7 2 h<br />

�� �� � �� �� � �� �� � �� �� �<br />

T C M / T C M T C M / / T C M C o Tr CM t / C o r t / M T e l C T M C 5 M 0 / C o r t / M e l 5 0 0<br />

S E B / T C S M E B / / T C M C o SEB r / t C o r t / M e T l C S E 5 M 0 B / C o r t / M e l 5 0 0<br />

P H A / T C P M H A / / T C M C o P HA r t / C o r t / M T e l C P H 5 M 0 A / C o r t / M e l 5 0 0<br />

a . 50 l <strong>of</strong> stimulus (12.5 g/ m l P H A/ SE B ) i n t o a l l we l l s e x c e pt f i r s t b a c kgr o u n d we l . l<br />

b. 50 l <strong>of</strong> e a c h dr ugs ( 0, 1 M c o r t i s o l + 0 , 2 0 0 o r 2 0 0 0 p g / m l o f m e l a t o n i n ) i n t o a l l w e l l s<br />

c . B l o o d p r e p a r a t i o n : k e e p 5 m l E D T A t u b e f l o r y m p oc f h l yt o e w subse c y t o t s m ae na t lys r y is a s i d e<br />

d. Mix 2 ml Li-heparinised blood with 3 ml TCM into 1:2.5 dilutions. ( 5 m l )<br />

e . P l a c e 5 0 l <strong>of</strong> diluted whole blood o n t o e a c h w e l l ( a t t h e e n d s t e p o f p r e p a r a t i o n o f .<br />

p l a t e s )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 96 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

[ 3 H ] -T h y m i d i n e i n c o r p o r a t i o n p r o l i f e r a t i o n a s s a y p r o t o c o l i n<br />

f o r -54 th d a y o f P P D s t i m u l a t -3 i o n a n d 2<br />

r d d a y o f P H A s t i m u l a t i o n<br />

M a t e r i a l s :<br />

S O P -1 b w r i t t e n b y D r . A k i r a N a i t o A p r . 2 0 0 4<br />

B u f f e r s :<br />

T is sue cu lt ur e me dium (T CM) c ons is ts <strong>of</strong> RPM I 16 40 s up ple men te d wit h 1 % g l u t a m i n ( e 200 mM ),<br />

1 % p e n i c i l l i n ( 5 0 0 0 I U / m l ) / ( 5 s 0 t 0 0 r e m p t c o g m / y m c l i ) n , -es 1 % s ent n ia o l n a min o ac ids (100 x) , 1 %<br />

s odium pyr uva t e ( 100 mM) .<br />

F re s h ( 1-4 hours) 1:5 d i l u t h e d p a r i n i z e d w h o l se a mples b l o ar o e d us e d f or p r o l i f e r a t i o . n T he a s s a y<br />

blood is 1 :5 wit h t is s ue c ulture me diu m a nd 20 0 l c u l t u r e d i n t r i p l i c ate w e l l s o -we f la l pla 9 6 t e .<br />

M i t o g en s / A nt i gens : t he Phytoh a e m a g g l u t i n i n A ( P -L) H A ( ; Le c t in L : e pr oduc u c t o no. a g g l u t i n i n<br />

L-4144, Sigma-A l d r i ®: c h e xper ime nta l solution is t itr at e d 50 g / m l . ) a nd P ur if ie d pr ote in (PP D) ar e<br />

u s e d a s s t i m u l i f o r pr o l i f er ati o n r e a c . t i o n<br />

- Fol lowin g c onc e ntr a t ion is fr om a s t oc k ( wh i c h me a ns th e REAL c on c . in t he we ll is 1/4) .<br />

- Che mic a l (P HA) t it ra t ion: or igin a l c on c e nt ra tio n is 5 mg/ ml 500, 250, to 0.78 g/ m l<br />

D r u g p r e p a r a t i o n :<br />

- Hyd r o c o rt is one ( cort is ol) 25 0 nM (1 i n t h e a d d i n g s o l u t i o n<br />

- M e l a t o n i n 5 0 p g / m l ( 4 0 0 p g / m l i n t h<br />

- D H E A -S<br />

M e t h o : d<br />

4 ml <strong>of</strong> h e p a r i n i z blood e d (10 ml <strong>of</strong> 1:2.5 diluted blood), 3 ml <strong>of</strong> 1 M c o r t i s o l 3 ml a n <strong>of</strong> d 50 pg/ml<br />

M e la ton in , 3 ml <strong>of</strong> pre vious ly t it r a te d (5 0 g/ L P HA, 1 / 10 0 PP D) st imulus f or 1 su bj e ct .<br />

Pr e pa r at io n <strong>of</strong> 96 we lls p l a t e s (o n e p la t e f or fo u r su b je ct s P HA / PP D) 4 p l a t e s ( 2 , 3 , 4 & 5 d a y s )<br />

�� �� � �� �� � �� �� � �� �� �<br />

T C M / T C M T CM / M e l T a t C o n M i n C o r t i s o l / M e l a T t o C n i M n / C o r t i s o l<br />

P P D / T C P M P D / / T CM / T M e C l M PP D / C or t / M e l P P D / C o r t / T<br />

�� �� � �� �� � �� �� � �� �� �<br />

T C M / T C M T C M / M T e l C a t M o n i C n o r t i s o l / M e l a T t o C n i M n / C o r t i s o l<br />

P H A / T C M P H A / T C M / T M C e l M PHA / C o r t / Me l P H A / C o r t / T<br />

a . 50 l <strong>of</strong> stimulus (12.5 g/ m l P H A, o r P P D ) in t o a l l we l l s e x c e pt f i r s t b a c kgr o u n d we . l l<br />

b. 50 l <strong>of</strong> e a c h dr ugs ( 0, 1.0 M o f c o r t i s o l a n d 0 , 2 0 0 p g / m l o f m e l a t o n i n ) i n t o a l l w e l l s<br />

c . Bloo d pr ep a ra t ion: ( ke e p 5 ml EDT A t ub e f or f l o w c y t o m e t l r y m p oc h yt e subs e t s a n a l y s i s a s i d e )<br />

d. Mix 2 ml Li-heparinised blood with 3 ml TCM into 1:2.5 dilutions. ( 5 m l )<br />

e . P l a c e 5 0 l <strong>of</strong> diluted whole blood o n t o e a c h w e l l ( a t t h e e n d s t e p o f p r e p a r a t i o n o f . p l a t e s )<br />

n d rd th th<br />

f . P r e p a r e and 2 3 d a y p l a t e s f o r nd P H 4A a d a y p l a t e s da ( y + pla 5 t e s) f or PPD.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 97 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

F l o w c y to me t r y a n a l y si s o f p r o l i f e r a t i o n r e s po n s e i n w ho l e b l o o d a s s a y p r o t o c o l<br />

M a t e r i a l s :<br />

S O P -2 w r i t t e n b y D r . A k i r a N a i t o O c t . 2 0 0 3<br />

B u f f e r s :<br />

T is sue cu lt ur e me dium (T CM) : RPMI 16 40 su pp le me nt e d wit h 1% g l ut a m i n e ( 200 mM) , 1%<br />

p e n i c i l l i n ( 5 0 0 0 I U / m l ) / s t r e p t o m y c i n ( -e 5 0 s0 se 0 nt ia m l c ag min / m o l a) c, ids 1 ( 100 % x) n o , n 1%<br />

s odium pyr uva t e ( 100 mM) .<br />

F re s h ( 1-4 hou rs ) 1:5 diluted h e p a r i n i z e d w h o l se a mples b l o ar o e d us e d f or p r o l i f e r a t i o . n a s s a y<br />

M i t o g en s / A nt i gens : t h e S t a p h y l o c o c c a l e n t e r o t o x i n B -4881, ( S E Sigma-A B ) ( l p r d r o i d ®) c u h c t n o . S<br />

and the Phytoh a e m a g g l u t i n i n A ( P -L H A ) ; ( L e c u t c i n o : a g -4144, p g r l o d u t c i t n n i o n . L P H A<br />

S i g m a-A l d r i ®) c h a r e use d as st imuli f or pr olif e ra t io n r ea ct io n (ex per ime nta l solution is titra t e d 50 g/ ml.) .<br />

- Fol lowin g c onc e ntr a t ion is fr om a s t oc k ( wh i c h me a ns th e REAL c on c . in t he we ll is 1/4) .<br />

- Che mic a l ( SEB/P HA) t it r at io n : or igin a l c on ce ntr at io n is 5 mg/ ml 500, 250, to 0.78 g/ m l<br />

D r u g p r e p a r a t i o n :<br />

- Hyd r oc ort is one ( cort is ol) 25 0 nM (1 i n t h e a d d i n g s o l u t i o n<br />

-<br />

Hydr oc ort is on e t i t r a : t ( ai ddin o n g c on c entr at ions : r e a l c on ce ntr at io n in we lls a r e 1/ 4) 32 , 16 , 8 , 4 ,<br />

2, 1, 0.5, 0.25, 0.125, 0.062, 0.031 m o l / L (u n d e r l i n e d c o n c e n t r a t i o a n r e s p h y s i o l o g i c a l . )<br />

M e l a t o n i n 5 0 p g / m l i s u p p e i r o p l h o y g s i c a l l e v e l s<br />

- D H E A -S<br />

M e t h o : d<br />

T i m e c o u r s e C D 9 5 / ( A -DR) n n e xp x re i s s io n a t V CD4/ ) / CD8/ C D 2 CD5 5 / 6 in ( 0/ H 2L 4/ A 48 / 72 hr<br />

1.<br />

w i t h / w i t h o u t 2 5 0 n M o f H y d r o c o r t i s o n e ( c o r t i s o l ) a n d w i t h / o u t 5 0 / 5 0 0 p g / m l o f m<br />

Pr e pa r at io n <strong>of</strong> 24 we lls p l a t e s ( o n e p l a t e f s u o b r j e ct t s w SE o B / P H A) wi t h / wi t h o u t c or t i so l<br />

� � � �<br />

T C M / T C M T C / M / T C M C o Tr CM t / C o r / t / T M e C l M T 5 C 0 M / C o r t / M e l 5 0 0<br />

S E B / T C M S E / B / T C M C o SEB r t / C o r t / M T e l C S M 5 E 0 B / C o r t / M e l 5 0 0<br />

P H A / T C M P H / A / T C M C o Pr HA t / C o r t / M T e C l M P 5 H 0 A / C o r t / M e l 5 0 0<br />

a . 400 l o f s t i m u .5 l u s g/ m ( l 1 P 2 H A/ SE B ) i n t o a l l we l l s e x c e pt f ir s t b ac kgr o u n d we l l<br />

b. 400 l <strong>of</strong> drug 1 (1 M c o r t i s o l / T C M ) i n t o a l l w e l l s<br />

c . 400 l o f d r u g 2 ( 2 0 0 o r 2 0 0 0 p g / m l m e l a t o n i n / T C M ) i n t o a l l w e l l s<br />

d. P l a c e 4 0 0 l 1:2.5 diluted whole blood ont o ea c h we ll ( 40 0 x 12 we lls = 4.8 ml needed)<br />

2. Colle c t io n <strong>of</strong> s upe r na nt fr om c ult ure d we lls : 50 0 l f r o m e a c h w e -we l l l -pla o f t e s 2 . 4<br />

3. Allo c a t e 500 l <strong>of</strong> mixe d s olut io n <strong>of</strong> c ult ur ed c e lls in t o 2 FAC S t ub e s .<br />

4. S t a i n i n g<br />

a . 5 l o f a n t i b o d i e s ( C D -C 3 D / 9 C 5 D / 8 A / n C n D e 5 x 6 i , n a -C V n D d 2 o 5 r F / I H -D F T L R C I A ) T a re C<br />

b.<br />

adde d to 500 l <strong>of</strong> 1:5 diluted cultured bloods.<br />

O n e t u b e f o r i s o t y p e c o n t r o l s<br />

c . I nc ub a te 20 min in r oom t e m p e r a t u r e<br />

5. L y s i n g : add R B 500 C l <strong>of</strong> l y s i n g s o l u t i not o n 10x) ( 5 x a n d i n c u b a t e 2 0 m i n<br />

F l o w c y t o m e t r y : a l w a y s m e a s u r e w i t h ( use t h s e a v e s d a m f i l e s e t t i t n g i ! s ) n g<br />

a . R 1 i s g a t e d f o r -S SC l y s c m a t p t e h r d o ot-plot. c y t At e le as b t y 6, 0 0 F 0 S t C a r g e t c e (in l l s R1) ar e<br />

b.<br />

c olle c t ed per sa mple .<br />

T h e f l u o r e s c e n c e -1 i ( F n I t T C e ) n peaks s i t a y r ce ompar o f e d F bL y ove r la ying t he his t ogr ams <strong>of</strong> d i f f e r e n t l y m p h o c p y u t l e a p t i o n s ( b y -2 g +, a FL-3+, t i n g F L -4 t + h c e lls ) F . L<br />

c . All s a mp le s a r e te s te d in du plic a t e a nd t he re su lt s a r e pr es e nt e d a s a ve r a ge va lu e s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 98 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Fl owc y to me tr y a nal y si s <strong>of</strong> prol if er ati o n r e spo nse i n w ho le bloo d a ssay pr o toco l<br />

M a t e r i a l s :<br />

S O P -2 b w r i t t e n b y D r . A k J i u r l a y N 2 0 a 0 i 4 t o<br />

B u f f e r s :<br />

T is sue cu lt ur e me dium (T CM) : RPMI 16 40 su pp le me nt e d wit h 1% g l u t a m i n ( e 200 mM) , 1%<br />

p e n i c i l l i n ( 5 0 0 0 I U / m l ) / s t r e p t o m y c i n ( -e 5 0 s0 se 0 nt ia m l c ag min / m o l a) c, ids 1 ( 100 % x) n o , n 1%<br />

s odium pyr uva t e ( 100 mM) .<br />

F re s h ( 1-4 hou rs ) 1:2.5 diluted h e p a r i n i z e d w h o l se a mples b l o ar o e d us e d f or p r o l i f e r a t i o . n a s s a y<br />

M i t o g en s / A nt i gens : t he Phytoh a e m a g g l u t i n i n A ( P -L) H A ( ; Le c t in L : e pr oduc u c t o no. a g g l u t i n i<br />

L-4144, Sigma-A l d r i ®) c h ar e us e d a s s t imuli f or pr olif er at io n re a ct io n (e x p e r i m ent a l s olut io n is<br />

t it ra t ed 50 g/ ml.) .<br />

- Fol lowin g c onc e ntr a t ion is fr om a s t oc k ( wh i c h me a ns th e REAL c on c . in t he we ll is 1/4) .<br />

- Che mic a l (P HA) t it ra t ion: or igin a l c on c e nt ra tio n is 5 mg/ ml 500, 250, to 0.78 g/ m l<br />

D r u g p r e p a r a t i o n :<br />

- H yd r o c o r t i s o n e ( co r t i s o l) 250 nM (1 i n t h e a d d i n g s o l u t i o n<br />

-<br />

Hydr oc ort is on e t i t r a : t ( ai ddin o n g c on c entr at ions : r e a l c on ce ntr at io n in we lls a r e 1/ 4) 32 , 16 , 8 , 4 ,<br />

2, 1, 0.5, 0.25, 0.125, 0.062, 0.031 m o l / L (u n d e r l i n e d c o n c e n t r a t i o a n r e s p h y s i o l o g i c a l . )<br />

M e l a t o n i n 5 0 p g/ m l i s u p p e r p h y s i o l o g i c a l l e v e l s<br />

- D H E A -S<br />

M e t h o : d<br />

rd<br />

A n n e x i n V & P I s t a i n i n g o n C D 4 / C D 8 T c e l l s i n p r o l i f e r a t da i o y n <strong>of</strong> r e s p o n s e t o t h e P H<br />

incubation with/out 250 nM h y d r o c o r t i s o n ( c e o r t i s o l )<br />

H L A -D R e x p r e s s i o n a t C D 4 / C D 8 T c e l l s i n w i t h / w i t h o u t 2 5 0 n H M y d r o f c o r t i s o n e ( c o r t i s o l )<br />

6. Pr e pa r at io n <strong>of</strong> 24 we lls p l a t e s ( o n e p l a t e f or f o u r su b j e ct s P H A) wi t h / wi t h o u t c or t i s o l<br />

� � � � � � � �<br />

T C M / T C T M C M / T C T M C / M M e l T CM 5 0 / C o r t / M e l 5 T 0 C M / C o r t / T<br />

P H A / T C P M H A / T C M T C / M e l P HA 5 0 / C o r t / M e l 5 P 0 H A / C o r t /<br />

e . 50 l <strong>of</strong> stimulus (12.5 g/ m l P H A) i n t o a l l we l l s e x c e pt f i r st b ac kgr o u n d we l l<br />

f . 50 l <strong>of</strong> drug 1 (1 M c o r t i s o l / T C M ) i n t o a l l w e l l s<br />

g. 50 l o f d r u g 2 ( 2 0 0 p g / m l m e l a t o n i n / T C M ) i n t o a l l w e l l s<br />

h. P l a c e 5 0 l 1:2.5 diluted whole blood o n t o e ac h we l l<br />

7. Allo c a t e 5 l <strong>of</strong> mixe d solu t io n <strong>of</strong> cu lt ure d c ells in t o 2 FAC S t ub e s .<br />

8. S t a i n i n g<br />

d. 5 l o f a n t i b o d i e /CD8, s ( C and D 3 CD95/Annexin V-F I T C<br />

l <strong>of</strong> 1:5 dilu t e d c ult ur ed bloods.<br />

o -D r R -F H I T L C A ) a r e e a d to d 500<br />

e . O n e t u b e f o r i s o t y p e c o n t r o l s<br />

f . I nc ub a te 20 min in r oom t e m p e r a t u r e<br />

F l o w c y t o m e t r y : a l w a y s m e a s u r e w i t h ( u t s e h e s a v s e d a m f i e l e s e t t i t n i ! g s n ) g<br />

d. R 1 i s g a t f e d o r<br />

c olle c t ed per sa mple .<br />

l y m p h o -S c SC y t s c a e t t e r b d ot-plot. y F S At C le as t 6, 0 0 0 t a r g e t c e (in l l s R1) ar e<br />

e . T h e f l u o r e s c e n c e -1 i ( F n I t T C e ) n peaks s i t a y r ce ompar o f e d F bL y ove r la ying t he his t ogr ams <strong>of</strong> d i f f e r e n t l y m p h o c y t e p o p u l -2 a +, t FL-3+, i o n s F L -4 ( + b cy e lls g ) . a t i n g t h e F L<br />

f . All s a mp le s a r e te s te d in du plic a t e a nd t he re su lt s a r e pr es e nt e d a s a ve r a ge va lu e s .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 2 99 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

M a t e r i a l s :<br />

N K c y t o t o x i c a c t i v i t y a s s a y p r o t o c o l u s i n g f l o w c y t o m e t r y<br />

S O P -3 w r i t t e n b y D r . A k i r a N a i t o F e b . 2 0 0 4<br />

B u f f e r s :<br />

T i s s u e c u l t u M) r e : RPMI m e 1d 640 i supple u m me ( T nt C e d wit h 1% g l u t a m i n ( e 200 mM) , 1%<br />

pe nic illin ( 50 00 I U/ ml) / s tr e pt omyc in ( 500 0 g / m l ) , 1 % -e s se n o nt n ia l a min o a c ids ( 100 x), 1 %<br />

s odium pyr uva t e ( 100 mM) , Lymp hP r e p (I nvit r oge n ) I n ac t iva t ed fe ta l c a lf se ru m & hu man AB<br />

s e r u m ( -4522): S i g 56 m a H<br />

o C fo r 35 min pr ior t o be fr oze n .<br />

C h e m i c a l s / a n t i b o d : i e s<br />

1 g / m l o f p r o p i d i u m i o d i n e ( P st I ) oc ( k s olu t io n wa s 1 mg/ m l : S i g m -A a l d r i ® c h p r o d u c t -4170) n o . P<br />

and 0.05% <strong>of</strong> Eosin Y (Sigma-A l d r i ®, c h HT 1 1 0 ) f or d ye s , an t i-C D 4 5 -F I T C ®) ( , a B nt D i-C D 5 6 -P E<br />

( B D® 555516), anti-C D 3 -A P C<br />

M a t e r i a l s n e e d e d :<br />

( ®) B , D H y d r o c o r t i s o n e ( -A S i l g d m r a i ® c h H-0135)<br />

Unive r s a ls , 1 ml pipe tt es , 20 ml pip et te s , T ips ( 1ml, ye llo w) , Fla s ks ( 40 , 10 0 ml) 5 , FAC S t ub e s ,<br />

2 4 w e l l s p l a t -b e o t t , o m , f l 9 a t-bottom), 6 w e CytoTox l l s 96® p l kit a (Pr t ome e ga ( G1 U 78 0 ) , ELI SA<br />

k i t f o r c o r t i s o l ( p l -I a 8 8 s 7 ) m , a I s c e b & o x a s n d u i p c e<br />

r n a t a n t s ) ( D R G<br />

D r u g p r e p a r a t i o n :<br />

- Hyd r oc ort is one ( cort is ol) 25 0 nM (1 M i n t h e a d d i n g s o l u t i o n<br />

-<br />

Hydr oc ort is on e t i t r a : t ( ai ddin o n g c on c entr at ions : r e a l c on ce ntr at io n in we lls a r e 1/ 4) 32 , 16 , 8 , 4 ,<br />

2, 1, 0.5, 0.25, 0.125, 0.062, 0.031 m o l / L (u n d e r l i n e d c o n c e n t r a t i o a n r e s p h y s i o l o g i c a l . )<br />

M e l a t o n i n 5 0 p g / m L i s y s i u o p l o p g e i r c a l p h c o n c e n t r a t i o n ( 2 0 0 p g / m L i n t h e a d d i n g s o l u t i o n )<br />

- D H E A -S<br />

C e l l p r e p a r a t i o n :<br />

- P e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s ( P B M C s )<br />

1. Ce ntr if uge fr e sh blood a t 15 00 r pm 10 min ( 4 t ub es <strong>of</strong> 10 ml h e p a r i n i z whole e d blood)<br />

2. Colle c t t he super nat a nt p l a s m a into 1 tube ( s t o c k i n a f r e e z e r f o r f u r t h e r s t u d y )<br />

3. Ad d T CM t o ea c h and get t he se blo od s ont o Lymp h P re p g e n t l y w i t h g r e a . t c a r e<br />

4. Ce ntr if uge 1500 rpm 25 min<br />

5. C o l l e c t t h e l a y e r o f P B w M i C t h s u p p e r l a y e r<br />

6. W a s h w C i e n t r i f h u g 1500 e T rpm C 10 M min ( w i t h K 5 6 2 f t i r c s e n t r i f u g e )<br />

7. W a s h w i t h C e n 1 t r 0 i f % u g 1500 e F rpm C 10 S min i n ( w i t h T K 5 C 6 2 M s e c o n d c e n t r i f u g e )<br />

8. De c a nt th e super nat a nt a nd ad d 2 m l <strong>of</strong> foe t a l c a l f s ) e + r 18 u m ml ( <strong>of</strong> F C S T C M<br />

9. Tr a ns f er re d t o a 250 ml c ultu r e f la s k f or ‘m o n o c y t e d e p l e ’ t , i o i n c u b a 1 t HOU e R<br />

10. C o l l e c t -a n d o h n e r e n t c e l l s f r o m f l a s k , 0 rpm c e n t 10 r min i f u g e 1 5 0<br />

11. Add 1000 L <strong>of</strong> T CM a nd ge t 10 L <strong>of</strong> that + 90 L o f E o s i n<br />

12. Count in microscope ( i n 1 0 o r d e : r m i n i m u m > 1 5 0 )<br />

150 x 10 x 10 4 /ml =1.5 x 10 7 / m l add 500(=1500-1000) L <strong>of</strong> T CM<br />

1.0 x10 7 / ml ( x1.3m l ) < P B M C s 1 ><br />

1 t ube (T ime 0 da ta ) : 0.6 m l o f t h i < s P B M C s + 1 0.3 > m l o C f M T + 0 . 1 m l o f F C S<br />

5.0 x 10 6 / m l ( .0ml) x 1 or 1.25 x 10 6 / m l ( x 4 . 0 m l ) c o l l e c t i n F A C S t u b e s<br />

24-we l l -p l a t e ( i n c ub a t e ) : 0.6 ml <strong>of</strong> < P B M C s 1 > + .4 0 m l o f T C M + 0 . 3 m l o f F C S<br />

+ 0.8 ml <strong>of</strong> 0, 50, 500 p g / m L M E L A T O N + I 0.8 N ml <strong>of</strong> 0, 250, 2500 nM CO RT I SO L<br />

T a ke 1 ml <strong>of</strong> s upe r na nt t o s toc k a t –80 o C f o r f u r t h e r c o r t i s o l E L I S A a n a l y s i s<br />

add 95 l o f -45 a (80 n t L i + 7 2 0 C D L o f P BS) a nd in cu bat e 20 min<br />

13. Wa s h w i t h T C M , c e n t r 0 i rpm f u g e 6 min 1 5 0<br />

14. Add 450 l <strong>of</strong> TCM (t o ma ke 50 0 l) and get 10 l <strong>of</strong> that + 90 l o f E o s i n ( 0 . 0 5 % E o s i n Y )<br />

15. Count in microscope ( i n 5 o r d e r )<br />

65 x 10 x 10 4 / m l 5 = x 6 10 5 / m l add 150 (= 65/50 x 500 -500) l o f T C M<br />

50 x10 5 � T C M C o r t i s o C l (250 nM) 2 5 C 0 (250) 0 + Mel. n M 50 pg C (250) + Mel. 500 pg<br />

(1) 4<br />

/ m l o f P B M C s * (100 l ha s 50 x10 c e l l : s minimum volume needed > 600 l )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 00 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S O P -3 : ( c o n t i n u e d )<br />

- K 5 6 2 t u m o u r c e l l (re s q u i r 2. e 0-5.0 x 10 6 c e l l s / t o t a l )<br />

1.<br />

6 o<br />

U n f r o z e n s t o c k K 5 6 2 c e l l ce s lls ( / ml 5 in x 1 0% 0 DSM O, 20% FCS, 70 % T CM at –80 C) and<br />

c u l t u r e t h -2 e m we e 1 ks p r i o r e x pe r i m e nt st ar t . ( p as s c el s e v e r -3 y days) 2<br />

2. Culture 10 ml <strong>of</strong> 2 x 10 5 c e l l s / m l c o n c e n t r a t i o n 2 t he d a ey xp s er p ime r i no t. r t o<br />

3.<br />

rd<br />

A f t e r wash, 3 de c a n t t h e s u p e r n a t a n t a 0 n d L a <strong>of</strong> d d TCM 1 0 0<br />

4. Get 10 L <strong>of</strong> K562 + 90 L <strong>of</strong> dye (0.05 % Eosin Y)<br />

5. Count in microscope<br />

50 x10 x10 4 /ml = 5 x10 6 /ml add 4(=5-1 ) m l 1.0 o x10f T C M<br />

6 / m l < K ><br />

1 m l o f < K > + 2 m l o f F C S + 7 m l TCM o f =1.0 x10 5 2<br />

/ m l o f K 5 6 ) 2 i ( n * 4 0 m l c u l t u r e f l a s k<br />

0 . 5 m l o f < K > + + 1 3.5ml m <strong>of</strong> l TCM o = f 1.0 x10 H u m a n A B s e r u m<br />

5 3<br />

/ m l o f K 5 6 ) 2 ( *<br />

2 4 (2)<br />

take 100 L o f t h i ) s ( = 1.0 ( * x10 c e l l ) s i n t o e a c h i n c u b a t i o n * * t u ( b d e u p l i c a t i o n )<br />

ta ke 50 L <strong>of</strong> this (* 3 (3)<br />

) into each w e l l s i -w n e l 9 6 l p l a t e ( d * u * p l i c a t i o n )<br />

M e t h o : d<br />

a . Fl o w a s s a y: T u b e s ( -4 1 ) f o r s e -u t p t f o i r n ac g q u i s i t i o n ( ga t i n g K 5 6 2 r e gi o n & C D 5 6 c u -o t f f )<br />

Tube 1: take 100 L for lymph only ( f or ne ga t ive c on tr ol) + 80 L <strong>of</strong> T CM + 20 L o f F C S<br />

Tube 2: take 100 L f or lymph on ly ( f or po s itive c on t r ol) + 80 L <strong>of</strong> T CM + 20 L o f F C S<br />

Tube 3: take 200 L for K562** (2) o n l y f o r f l o w c y t o m e t r i c a s s a y<br />

Tube 4: take 200 L for K562** (2) only for dupli c a t i o n<br />

(1) (2)<br />

E x p e r i m e n t a l t u b e s : f r om 5: M ix 100 L o f P B M C s int * o ea c h FAC S tube with K562* *<br />

( E : T r ; a t K i 5 o 6 2 : P B M C s : 50; = * 1<br />

(1) has 50 x10 4 c e l l ) s<br />

1. C e n t r i f u g e a t 2 5 0 x g f o r 1 m i n<br />

o<br />

2. I nc ub a te 4 H O U R S i n h u m i d i f i e d i n c u b a C t , o r a f a t e r 3 7 ut t th he e n m on p I C E ! !<br />

3. Add 3 L <strong>of</strong> CD56-P E a nt ib od y in t o e ve r y t ub e a nd in c uba t e 20 min<br />

4. 20 L o f P I g/ ml) ( 1 a r e ad de d a n d i n c u b a t e m 1 i 0 n j u s t b e f o r e a c q u i s i t i o n<br />

5. Add 150 l o f P B F S l o w c y t o m e t r y a c q u i s i t i o within n ( 75 s e c a c q u i s i t i o n t i m e )<br />

b. C y t o T o x 9 6 a -b s o s t t o a m y 9 : 6 w e l u l s p l a i t e n . ( g 1 p l a U t e f o r 3 s u b j e c t s )<br />

W e l l s : t a1 ke 50 L <strong>of</strong> K562** (3) for Max, with 50 L o f T C M ( q u a d r u p l i c a t e )<br />

W e l l s : t a2 ke 50 L for K562** (3) only with 50 L o f T C M ( q u a d r u p l i c a t e )<br />

We lls 3: t a ke 50 L f o r m e d i u m o n l y ( 1 0 % H u m a n A u B a d r u s p e l r i c u a m t e ) ( q<br />

W e l l s : t a4 ke 50 L for lymph only with 50 L <strong>of</strong> T CM ( du plic a te )<br />

(1) (3)<br />

E x p e r i m e n t a l w e l l s : Mix 50 L o f P B M C s i * n t o e h a c we ll ha vi ng with K562* *<br />

o<br />

1. Centrifuge at 250 x g for 3 min and inc ub at e 4 H O U R S i n h u m i d i f i e d i n c u b a C t o r a t 3 7<br />

2. C e n t r i e f u at g 250 x g for 3 min (600 rpm)<br />

3. T a ke 50 L o f s u p e r n a n t a n d t r a n s f e r t o f l a t 9 6 w e l l s p l a t e ®) ( f o r L D H a s s a y :<br />

a. F l ow c yt om e tr i c a c q u i s i t i o n :<br />

1.<br />

st<br />

U s e s a v e d t e m p l a f t o r e s N K 1 C A , ( t h e n C D 5 6 d i m & b r i g h t m e a s u r e m e n t )<br />

2. A r e g i o n 1 ( R 1 ) : S S r C e s c v e s n . c e-1 f (CD45-FI l u o T C : Fl-1 ) , t h e c l u s t e r o f t a r g e t c e l l s<br />

3. AT LEA S T 3,000 T A R G E T C E L L (IN S R1) c o l l e c t e d p e r s a m p l e<br />

4. T e s t e d i n d u p l i c a t e a n d t h e r e s u l t s p r e s e n t e d a s m e a n v a l u e s<br />

b. CytoTox96® L D H m e a s u r e m e n t : s<br />

1. De f r os t Su bs tr a te M ix, & Ad d 10 l <strong>of</strong> lysing so lu t io n in M AX qu a dr uplic a t es 45 min pr io r t o 2 .<br />

2. Ce ntr if uge a t 250 x g f or 3 min ( 600 r pm) a nd t ra nsf er 50 l <strong>of</strong> supernant and add 50 l <strong>of</strong><br />

Subs t r at e M ix , t he n inc ubat e 30 min at r oo m te mp in t he dar k.<br />

3. Add 50 l o f s t o p s o l u t i o n , a est n d #30 m on e a the s u m r a c e h i n a e t p r o g 4 r a 9 m 0 m e )<br />

n m ! ( T<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 01 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

CD5 6 NK ce ll s (di m & bri g ht) a naly si s co nc urr e ntly wi th<br />

N K c y to t o xi c a c ti v i t y ( L D H ) a s sa y p r o t o c o l<br />

S O P -3 b w r i t t e n b y D r . A k i r a N a i t o J u n . 2 0 0 4<br />

M a t e r i a l s :<br />

B u f f e r s :<br />

T is sue cu lt ur e me dium (T CM) : RPMI 16 40 su pp le me nt e d wit h 1% g l u t a m i n ( e 200 mM) , 1%<br />

pe nic illin ( 50 00 I U/ ml) / s tr e pt omyc in ( 500 0 g / m l ) , 1 % -e s se n o nt n ia l a min o a c ids ( 100 x), 1 %<br />

s odium pyr uva t e ( 100 mM) , Lymp hP r e p (I nvit r oge n ) I n ac t iva t ed fe ta l c a lf se ru m & hu man AB<br />

s e r u m ( -4522): S i g 56 m a H<br />

o C fo r 35 min pr ior t o be fr oze n .<br />

C h e m i c a l s / a n t i b o d : i e s<br />

0 . 0 5 % o f E o s i n Y ( -A S i l g d m r a i ®, c h H T 1 1 0) f o r d ye s , a nt i-C D 1 6 -F I T C ®) ( , a B nt D i-C D 5 6 -P E<br />

( B D® 555516), anti-C D 3 -C y -C h r o m e ®) , ( H B y D d r o c o r t i s o n e ( -A S i l g d m r a i ® c h H-0135),<br />

M e l a t o n i n ( S i -A g m l a d r i ® c h -) M<br />

M a t e r i a l s n e e d e d :<br />

Unive r s a ls , 1 ml pipe tt es , 20 ml pip et te s , T ips ( 1ml, ye llo w) , Fla s ks ( 40 , 10 0 ml) , FAC S t ub e s ,<br />

2 4 w e l l s p l a t -b e o t t , o m , f l 9 a t-bottom), 6 w e CytoTox l l s 96® p l kit a (Pr t ome e ga ( G1 U 78 0 ) , ELI SA<br />

k i t f o r c o r t i s o l a n d m e l a t -I887, o n i #EIA-I n ) ( p l a s m a s & s u p e<br />

D r u g p r e p a r a t i o n :<br />

- Hyd r oc ort is one ( cort is ol) 25 0 nM (1 i n t h e a d d i n g s o l u t i o n )<br />

- M e l a t o n i n 5 0 p g / m L i s u p p e r p h y s i o l o g i c a l c o n c e n t r a t i o n ( 2 0 0 p g / m L i n t h e a d d i n g s o l u t i o n )<br />

- D H E A -S<br />

C e l l p r e p a r a t i o n :<br />

- P e r i p h e r a l b l o o d m o n o n u c l e a r c e l l s ( P B M C s )<br />

1. Ce ntr if uge fr e sh blood a t 15 00 r pm 10 min ( 3. 5 t ube s <strong>of</strong> 10 ml he p a r i n i z whole e d blood)<br />

2. Colle c t t he super nat a nt p l a s m a into 1 tube ( s t o c k i n a f r e e z e r f o r f u r t h e r s t u d y )<br />

3. Ad d T CM t o ea c h and get t he se blo od s ont o Lymp h P re p g e n t l y w i t h g r e a . t c a r e<br />

4. Ce ntr if uge 1500 rpm 25 min<br />

5. C o l l e c t t h e l a y e r o f P B w M i C t h s u p p e r l a y e r<br />

6. Wa s h w C i e n t r i f h u g 1500 e T rpm C 10 M min ( w i t h K 5 6 2 f i r s t c e n t r i f u g e )<br />

7. W a s h w i t h C e n 1 t r 0 i f % u g 1500 e F rpm C 10 S min i n ( w i t h T K 5 C 6 2 M s e c o n d c e n t r i f u g e )<br />

8. De c a nt th e super nat a nt a nd ad d 2 m l <strong>of</strong> foe t a l c a l f s ) e + r 18 u m ml ( <strong>of</strong> F C S T C M<br />

9. Tr a ns f er re d t o a 250 ml c ultu r e f la s k f or ‘m o n o c y t e d e p l e ’ t , i o i n c u b a 1 t HOU e R<br />

10. C o l l e c t -a n d o h n e r e n t c e l l s f r o m f l a s k , 0 rpm c e n t 10 r min i f u g e 1 5 0<br />

11. Add 3000 L <strong>of</strong> T CM a nd ge t 10 L <strong>of</strong> that + 90 L o f E o s i n<br />

12. Count in microscope ( i n 1 0 o r d e : r m i n i m u m > 1 5 0 )<br />

150 x 10 x 10 4 / m l 1.5 = x 10 7 / m l add 1500(= (1500-1000) x 3) L <strong>of</strong> T CM<br />

1.0 x10 7 / ml ( x1.5m l ) < P B M C s 1 ><br />

1 t ube (T ime 0 da ta ) : 0.5 ml <strong>of</strong> < P B M C s + 1 0.5 > m l o f T C M<br />

5.0 x 10 6 / m l ( .6ml) x 0 c o l l e c t i n F A C S t u b e s<br />

24-we l l -p l a t e ( i n c ub a t e ) : 0.7 ml <strong>of</strong> < P B M C s 1 > + .4 0 m l o M f + T C 0 . 3 m l o f F C S<br />

+ 0.7 ml <strong>of</strong> 0, 50 p g / m L M E L A T O N + I 0.7 N ml <strong>of</strong> 0, 250 nM C O R T I S O L<br />

� � � �<br />

T C M / C T o C r M t i s o l T CM 2 5 / M 0 e l at o n i n M 50 p g/ / m l C T o r C t i M s o l + M e l a t o n i n<br />

T a ke 1 ml <strong>of</strong> s upe r na nt t o s to c k a t –80 o C f o r f u r t h e r c o r t i s o l E L I S A a n a l y s i s<br />

13. Wa s h w i t h T C M , c e n t r 0 i rpm f u g e 6 min 1 5 0<br />

14. Add 450 l <strong>of</strong> TCM and get 10 l <strong>of</strong> th a t + 90 l <strong>of</strong> Eosin (0.05% Eosin Y)<br />

15. Count in microscope ( i n 5 o r d e r )<br />

65 x 10 x 10 4 / m l 5 = x 6 10 5 / m l add 150 (= 65/50 x 500 -500) l o f T C M<br />

50 x10 5 (1) 4<br />

/ m l o f P B M C s * (100 l ha s 50 x10 c e l l : s minimum volume needed > 500 l )<br />

T a ke 20 0 l <strong>of</strong> *( 1) a nd a dd 10 l o f -3-A a P n C, t CD-56-C i C D y -C h r o m e, CD1 6 = FIT C,<br />

and N k p3 0 -P E or N k p46-P E a n t i b o d i e as nd inc ub at e 20 min ( C o n t r o l s -CD45, : N o n , F I T C<br />

P E -CD56, Cy-C h r o m e-C D 3 , -C A P D C 8 s i n g l e s t d a i t u n b e e s )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 02 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

S O P -3 : ( c o n t i n u e d )<br />

- K 5 6 2 t u m o u r c e l l (re s q u i r 2. e 0-5.0 x 10 6 c e l l s / t o t a l )<br />

6.<br />

6 o<br />

U n f r o z e n s t o c k K 5 6 2 c e l l ce s lls ( / ml 5 in x 1 0% 0 DSM O, 20% FCS, 70 % T CM at –80 C) and<br />

c u l t u r e t h -2 e m w e 1 e k s p r i o r e x p e r i m e n t s t a r t . -3 ( p days) a s s c e l l s e v e r y 2<br />

7. C u l t re u 10 ml <strong>of</strong> 2 x 10 5 c e l l s / m l c o n c e n t r a t i o n 2 t he d a ey xp s er p ime r i no t. r t o<br />

8.<br />

rd<br />

A f t e r wash, 3 de c a n t t h e s u p e r n a t a n t a 0 n d L a <strong>of</strong> d d TCM 1 0 0<br />

9. Get 10 L <strong>of</strong> K562 + 90 L <strong>of</strong> dye (0.05 % Eosin Y)<br />

10. Count in microscope<br />

50 x10 x10 4 /ml = 5 x10 6 / ml add 4(=5-1 ) m l 1.0 o x10f T C M<br />

6 / m l < K ><br />

1 m l o f < K > + 2 m l o f F C S + 7 m l TCM o f =1.0 x10 5 2<br />

/ m l o f K 5 6 ) 2 i ( n * 4 0 m l c u l t u r e f l a s k<br />

0 . 5 m l o f < K > + f 1 m H l u m o a n + A 3.5ml B <strong>of</strong> s TCM e r = u 1.0 m x10 5 3<br />

/ m l o f K 5 6 ) 2 ( *<br />

2 4 (2)<br />

take 100 L o f t h i ) s ( = 1.0 ( * x10 c e l l ) s i n t o e a c h i n c u b a t i o * n * t u ( d b u e p l i c a t i o n )<br />

ta ke 50 L <strong>of</strong> this (* 3 (3)<br />

) into each w e l l s i -w n e l 9 6 l p l a t e ( d * u * p l i c a t i o n )<br />

M e t h o : d<br />

b. Fl o w a s s a y: T ube s ( 1-4 ) f o r s e -u t p t f o i r n ac g q u i s i t i o n ( ga t i n g K 5 6 2 r e gi o n & C D 5 6 c u -o t f f )<br />

Tube 1: take 100 L f or lymph on ly ( f or ne ga t ive c on tr ol) + 80 L <strong>of</strong> T CM + 20 L o f F C S<br />

Tube 2: take 100 L f or lymph on ly ( f or po s itive c on t r ol) + 80 L <strong>of</strong> T CM + 20 L o f F C S<br />

Tube 3: take 200 L for K562** (2) o n l y f o r f l o w c y t o m e t r i c a s s a y<br />

Tube 4: take 200 L for K562** (2) o n l y f o r d u p l i c a t i o n<br />

(1) (2)<br />

E x p e r i m e n t a l t u b e s : f r om 5: M ix 100 L o f P B M C s int * o ea c h FAC S tube with K562* *<br />

( E : T r ; a t K i 5 o 6 2 : P B M C s : 50; = * 1<br />

(1) has 50 x10 4 c e l l ) s<br />

6. C e n t r i f u g e a t 2 5 0 x g f o r 1 m i n<br />

o<br />

7. I nc ub a te 4 H O U R S i n h u m i d i f i e d i n c u b a C t , o r a f a t e r 3 7 ut t th he e n m on p I C E ! !<br />

8. Add 3 L <strong>of</strong> CD56-P E a nt ib od y in t o e ve r y t ub e a nd in c uba t e 20 min<br />

9. 20 L o f P I g/ ml) ( 1 a r e ad de d a n d i n c u b a t e m 1 i 0 n j u s t b e f o r e a c q u i s i t i o n<br />

10. Add 150 l o f P B F S l o w c y t o m e t r y a c q u i s i t i o within n ( 75 s e c a c q u i s i t i o n t i m e )<br />

b. C y t o T o x 9 6 a -b s o s t t o a m y 9 : 6 w e l u l s p l a i t e n . ( g 1 p l a U t e f o r 3 s u b j e c t s )<br />

W e l l s : t a1 ke 50 L <strong>of</strong> K562** (3) for Max, with 50 L o f T C M ( q u a d r u p l i c a t e )<br />

W e l l s : t a2 ke 50 L for K562** (3) only with 50 L o f T C M ( q u a d r u p l i c a t e )<br />

We lls 3: t a ke 50 L f o r m e d i u m o n l y ( 1 0 % H u m a n A B s e r u m ) ( q u a d r u p l i c a t e )<br />

W e l l s : t a4 ke 50 L for lymph only with 50 L <strong>of</strong> T CM ( du plic a te )<br />

(1) (3)<br />

E x p e r i m e n t a l w e l l s : Mix 50 L o f P B M C s i * n t o e h a c we ll ha vi ng wit h K562* *<br />

o<br />

4. Centrifuge at 250 x g for 3 min and inc ub at e 4 H O U R S i n h u m i d i f i e d i n c u b a C t o r a t 3 7<br />

5. C e n t r i f u g e a t 2 5 0 x g f o r 3 m i n ( 6 0 0 r p m )<br />

6. T a ke 50 L o f s u p e r n a n t a n d t r a n s f e r t o f l a t 9 6 w e l l s p l a t e ®) ( f o r L D H a s s a y :<br />

a. F l ow c yt om e tr i c a c q ui si t i on:<br />

5.<br />

st<br />

U s e s a v e d t e m p l a f t o r e s N K 1 C A , ( t h e n C D 5 6 d i m & b r i g h t m e a s u r e m e n t )<br />

6. A r e g i o n 1 ( R 1 ) : S S C v s . f l -1 u o (CD45-FI r e s c e n c e T C : Fl-1 ) , t h e c l u s t e r o f t a r g e t c e l l s<br />

7. AT LEA S T 3,000 T A R G E T C E L L (IN S R1) c o l l e c t e d p e r s a m p l e<br />

8. T es te d in duplic a t e a nd t he re s ults p r e s e n t e d a s m e a n v a l u e s<br />

b. CytoTox96® L D H m e a s u r e m e n t : s<br />

16. De f r os t Su bs tr a te M ix, & Ad d 10 l <strong>of</strong> lys in g s olu t io n in M AX qu a dr uplic a t es 45 min pr io r t o 2 .<br />

17. Ce ntr if uge a t 250 x g f or 3 min ( 600 r pm) a nd t ra nsf er 50 l <strong>of</strong> supernant and add 50 l <strong>of</strong><br />

Subs t r at e M ix , t he n inc ubat e 30 min at r oo m te mp in t he dar k.<br />

18. Add 50 l o f s t o p s o l u t i o n , a n d a t m 490 e a s nm! u r e ( T e st #30 on the m a c h i n e p r o g r a m m e )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 03 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Appe ndi x 5: P a p e r s<br />

i. P e e r r e v i e w e d p u b l i c a t i o n s<br />

(1) B e n n e t t , B . M ., Lai d l aw , T. M. , Dwe vid i, P ., Naito, A., Gru zelier, J . H. (2 0 0 6 ). "A<br />

q u a l i t a t i v e s t u d y o f t h e e x p e r i e n c e o f -h s e y l p f n o s i s o r J o h r e i i n m tatic e t a s b re as t c an cer<br />

u s i n g i n t e r p r e t a t i v e p h e n o m e n o l o g i c a l a n a l y s i s . " C o n t e m p o - r a r y H y p n o s i s 2<br />

1 4 0 .<br />

(2) Lai d l aw, T. M., Nai t o, A. , Dwi ved i P ., Han s i N. K., Hen d ers on D. C ., Gru zelier J . H.<br />

(2 0 0 6 ). "Th e In fl u en ce o f 1 0 min <strong>of</strong> th e J o h rei h ealin g met h od on lab orat or y s t res s . "<br />

C o m p l e m e n t a r y T h e r a p i e s i n M , e d 1 i 4 c ( i 2 n ) e : -3 1 2 . 7<br />

(3) L a i d l a w , T . , D w i v e d i , P . , N a i t o , A . , G r u z e 2 l i 0 e 0 r 5 , ). J . L o ( w s e l f-d i rect ed n es s (T C I) ,<br />

m o o d , s c h i z o t y p y a n d h y p n o t i c s . u P s e c r e s p o t n a i l b i t l y i a t n y d I n d i v i d u a l D , i 3 f 9 f , e r e n c e<br />

4 6 9 -4 8 0<br />

(4) Lai d l aw, T. M., Ben n et t , B. M. , Dwe vid i, P ., Naito, A., Gru zelier, J . H. (2 0 0 5 ). Qu alit y<br />

o f L i f e a n d M o o d C h a n g e s i n M e t a s t a t i c B r e a s t C a n c e r a f t e r t r a i n i n g -h i n yp S ne os l f is or<br />

J oh rei. C o n t e m p o r a r y H y p n o s i s, 2 ( 2 ) : -9 8 3 4 .<br />

(5) Gru zel i e r, J . H., De P as calis , V., J a mies on , G., Laid law, T., Naito, A. D wived i, P . ( 2 0 04 ).<br />

R elation s b et ween h yp n ot i s ab ilit y an d p s ych op ath olo g y revis ited . C o n temp o r a r y<br />

Hyp n o s is , 2 1 , 1 -1 6 7 9 0<br />

(6) Lai d l aw, T. , Kers t ei n , R . , Ben n ett, B . M ., Naito, A., Dwived i , P ., Gru zelier, J . (2 0 0 4 ).<br />

H y p n o t i zab i l i t y an d i mmu n ol ogical res p o n s e to p s ych olo gical in ter ven tion in HIV.<br />

C o n t e m p o r a r y H y p n o s i ( s 3 , ) : 2 1 -1 1 2 36 5 .<br />

(7) Nai t o, A., Lai d l aw, T . M. , Hen d ers on , D . C ., Farah an i, L. , D wived i, P ., Gru zelier, J . H.<br />

( 2 0 0 3 ) . T h e i m p a c t o f s e -h l f y p n o s i s a n d J o h r e i o oc n yte l y sm u b p ph op u lat ion s at exam<br />

time : a c on trol led s tu d y. B r a i n R e s e a r c h B u l 6 l 2 ( e t 3 ) i : n -2 2 54 3 1 .<br />

(8) Lai d l aw, T. M., Nai t o, A. , Dwi ved i, P ., E n zor, N . A., Brin cat , C . E. Gru zelier, J . H.<br />

( 2 0 0 3 ) . M o o d C h a n g e s a f t e r s e -H l f yp n o s i s a n d th e J o h r e i h e a l in g m e t h o d P r ior to Exa ms .<br />

C o n t e m p o r a r y H y p n o s i ( s 1 , ) , 2 -4 0 2 0 5 .<br />

(9) Nai t o, A., S u ga wara, H., Sh imu ra, M., A zu ma, T. , Hu jis awa, K., Ku b o, C . (2 0 0 0 )<br />

B e h a v i o u r-t h erap eu t i c ap p roach to a p ati en t <strong>of</strong> p ain d is ord er, with a re mar kab le<br />

a v o i d a n t -b e h a v i o u r c a u s i n g d -a i s t u s r e d o p u sh cle. y Ps yo ch <strong>of</strong> s o ma m ti c M ed icin e, 4 , 2 - 9 5<br />

2 9 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 04 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

i i . P r e s e n t a t i o n a n d w o r k s h o p g i v e n u n ( d e r l i n e d p e r s o n i s t h e m a i n ): s p e a k e r<br />

1 ) You n g S ci en t i s t Da y at th e Grad u ate Sch ool <strong>of</strong> Life Scien ce an d Med icin e Stu d en t<br />

S ymp os i u m, Lon d on , U . K. Ma y. 2 0 0 6 , “Th e in flu en ce <strong>of</strong> p s ych ol ogical in terven ti on<br />

u p o n d i s e a s e p r o -i g n f r e c e t e s d p s a t i e o ”, n t n Naito, s i A., n Lai H d lI aw, V T ., Be n n e t t , B ,<br />

Ba r t o n , S . , G r u z e l i e r , J . , H e n d e r s o n , D . P o s t e r s e s s i o n<br />

2 ) 1 8 t h Worl d C on g res s on P s ych os om atic Med icin e, Kob e, J ap an . Au g. 2 0 0 5 “Th e<br />

in flu en ce <strong>of</strong> ps ych ol o gi cal in t e r v e n t s i o up n o n s tres s rel at ed ch an ges 1 . In exa m<br />

a s s o c i a t e d s t r n e i s v s e r s i t n y u s t u d e ” n t Naito, s A., Lai d law, T., Dwived i, P ., Gru z elier, J . ,<br />

Hen d ers on , D . P os t er s es s i on an d p u b lished in th e J ou rn al <strong>of</strong> P s ych os om atic R es ea rch 5 8<br />

( 2 0 0 5) , S -6 6 4 3<br />

3 ) 1 8 t h Worl d C on g res s on P s ych os om atic Med icin e, Kob e, J ap an . Au g. 2 0 0 5 “Th e<br />

in flu en ce <strong>of</strong> ps ych ol o gi cal in t e r v e n t s i o up n o n s tres s rel at ed ch an ges 2 . In d is eas e<br />

a s s o c i a t e d -i n f e s c t e d r p a e t i s e ” n s t Naito, s i A., n La H i d I l a w V , T . , B e n n e t t , B . , Gr u z e er, l i<br />

J ., Ba rt on , S ., Hen d ers on , D. P os ter s es s i on an d p u b lis h ed in th e J ou rn al <strong>of</strong><br />

P s y c h o s o m a t i c R e s e a r c h 5 8 ( -6 2 0 4 0 5 ) , S 6 3<br />

4 ) 1 8 t h Worl d C on g res s on P s ych os om atic Med icin e, Kob e, J ap an . Au g. 2 0 0 5 “Stress<br />

related ch an ges as s oci at ed with in vitr o e x p o s u r e t o c o rtis ol 1 . Effect s u p on Natu ra l<br />

Killer cells” Nai t o, A., U g w u-O n u o h a , I., Hen d ers on , D. P os ter s es s ion an d p u b lish ed in<br />

t h e J o u r n a l o f P s y c h o s o m a t i c R e s e a r c h -6 4 5 8 ( 2 0 0 5 ) , S 6 3<br />

5 ) 1 8 t h Worl d C on g res s on P s ych os om atic Med icin e, Kob e, J ap an . Au g. 2 0 0 5 “Stress<br />

r e l ated ch an ges as s oci at ed with in vitr o e x p o s u r e t o c o r t i s o - l 2 . E f f e c t s u<br />

l y m p h o c y t e s” Nai t o , A. , Hen d ers on , D . P os ter s es s ion an d p u b li sh ed in th e J ou rn al <strong>of</strong><br />

P s y c h o s o m a t i c R e s e a r c h 5 8 ( -6 2 0 4 0 5 ) , S 6 3<br />

6 ) Y o u n g S c i e n t i s t D a y a t t h e Gr a d u a t e S c h o o l o f Li f e S c ien ce an d Med icin e Stu d en t<br />

S ymp os i u m, Lon d on , U . K. Ma y. 2 0 0 5 , “Th e in flu en ce <strong>of</strong> P s ych olo gical In ter ven ti on<br />

u p o n N e u r -E o n d o c r i n e-I m m u n e i n t e r a ”, c t Nait i o o, n A. , Lai d law, T. , Gru zelie r, J .,<br />

Hen d ers on , D . P os t er s es s i on<br />

7 ) Y o u n g S c i e n t i s t D a y a t t h e ool G r <strong>of</strong> a d Li u a fe t Se ci en S c ce h an d Med icin e Stu d en t<br />

S ymp os i u m, Lon d on , U . K. Ma y. 2 0 0 5 , “Th e in flu en ce <strong>of</strong> P s ych olo gical In ter ven ti on<br />

u p o n d i s e a s e -i p n r f e c o t e g d r p a e t i s e ”, n s t Naito, s i o n A., Lai i dn law, T H ., I Ben V n ett, B .,<br />

B a r t o n , S . , H e n d e r s o n , D . a n d s G t r e r u z e s l e i s e s r i , o n<br />

J . P o<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 05 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

8 ) Th e Med i cal R es earch So ciet y, th e Acad em y <strong>of</strong> Med i cal Scien ces an d th e R o ya l C ollege<br />

<strong>of</strong> P h ys i ci an s j oi n t f ou rt h an n u al meetin g fo r C lin ician an d Scien ti s ts in Train in g,<br />

Lon d on , U. K. Feb . 2 0 0 5 , “T h e i n f l u e n c e o f P s y c h o l o g i c a l I n t e N r e v u e r -n<br />

o t i o n u p o n<br />

E n d o c r i n e-Im mu n e i n t eract i on .” N aito, A., Laid law, T. M., Gru zelier , J . H., Hen d e rs on ,<br />

D . C . P o s t e r s e s s i o n<br />

9 ) Bri t i s h S oci et y <strong>of</strong> Im mu n olog y an n u al C on gres s , Ha rr ogate , U. K. Dec . 2 0 0 4 , “Th e<br />

effects <strong>of</strong> 2 4 h ou rs in cu b at ion <strong>of</strong> h u man p e r i p h e r a l b l o o d u clear m o n o cel n ls wi th c ort is ol<br />

u p on Nat u ral Ki l l e r c e l l c y t o t o x i c Naito a c t i v , i A. t , y U . g ” w u -On u oh a, I. C ., Hen d e rs on ,<br />

D . C . P o s t e r s e s s i o n Nait ( o, A., et al . (2 0 0 4 ). Immu n ol og y 1 1 3 S u p . : 1 3 3 .<br />

1 0 ) B r i t i s h S o c i e t y o f I m m u n o l o g y a n n u a l C o n g r e s s , H a r c r . o 2 g 0 a 0 t 4 e , “Th U e . K . D e<br />

effects <strong>of</strong> i n cu b at i on <strong>of</strong> h u m a n p erip h eral b lood m on on u clear cell s with th e s tres s r elated<br />

h o r m o n es, c o r t i s o l a n d m e l a t , o un pi on n i n v i t l y r m o p h o c y t e p r o l i f e r a t i v e r e s p .” o n s e s<br />

Naito, A., H e n d e r s o n , D . C . P o s t e r s e s s i Naito, o n ( A., et al . ( 2 0 0 4). Immu n olo g y 1 1 3<br />

S u p . 1: 1 3 3 .<br />

1 1 ) Bri t i s h S oci et y <strong>of</strong> Exp eri men tal an d C lin ical Hyp n os is con fe ren ce, Lo n d on , J u l y 2 0 0 3 .<br />

“H y p n o t i s a b i l i t y a n d P r o b l e m P e r s o n ” a l Laid i t i le aw, s T . M ., Dwi ved i , P ., Nait o, A.,<br />

G r u z e l i e r , J . H . F r e e p a p e r<br />

1 2 ) Ninth C o n g r e s s o f t h e E an u r Soci o p e et y <strong>of</strong> H yp n os is an d P s ych os omatic Med icin e,<br />

R ome, Sep t . 2 0 0 2 , “Self-h y p n o s i s a n d J o h r e i p r a c t i c e o n i m m u n o l o g i c a l m ” e a s u r e s<br />

Naito, A., L a i d l a w , T . M . , D w i v e d i , P . , F a r a h a n i , L . , G r u z e l i e r , J . H . F r e e p a p e r<br />

1 3 ) N i n t h C o n g r e s s o f yp t nh os e is an d E Pu s ych r os o omat p e ia c Med n icin S o e, c i e t y o f H<br />

R ome, Sep t . 2 0 0 2 , “P s y c h o l o g i c a l e f f e c t o f S e -h l f y p n o s i s , J o h r e i a n d R ” e l a x a t i o n<br />

Laid law, T. M., Nai t o, A. , Dwi ved i, P ., B rin cat, C ., En zor, N., Gru zelier , J . H. Free<br />

p a p e r<br />

1 4 ) N i n t h C o n g r e s s o f t h e E u r o p e a n S o c si is e an t d y Po s ych f os H y omat p n o ic Med icin e,<br />

R ome, Sep t . 2 0 0 2 , “A c o m p a r i s o n , u s i n g E E G m e a s u r e s , b e t w e e n -h S e yp l f n os is an d a<br />

J a p a n e s e h e a l i n g ” m Dwived e t h o d i , P ., Lyn ch , C . , Laid law, T. M., Naito , A. , Gru z elier,<br />

J . H . F r e e p a p e r<br />

1 5 ) Nin t h C on gres s <strong>of</strong> t h e Eu rop ean Societ y <strong>of</strong> H yp n os is an d P s ych os omatic Med icin e,<br />

R ome, Sep t . 2 0 0 2 , works h op : “J o h r e i : I n t r o d u c t o r y ” W Nait o r o, k s A. h o , p Lai d law, T.<br />

M., Dwi ved i , P ., G r u z e l i e r , J . H . F r e e p a p e r<br />

1 6 ) Bri t i s h S oci et y <strong>of</strong> Exp eri men tal an d C lin ical Hyp n os is con fe ren ce, Le amin gt on Sp a,<br />

M a y 2 0 2 . “S e l f h y p n o s i s , t h e J o h r e i h e a l i n g m e t -c h on o d trol a gr n d ou r p s e : l A a x a t i o n<br />

c o m p a r i s ” o Laid n law, T. M ., N a i t o , A . , D w i v e d i , P . , G r u z e l i e r , J . H . F r e e p a p e r<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 06 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

i i i. S u p e r v i s o r f o r r e s e a r c h s t u d e n t s :<br />

M a s t e r o f S c i e n c e r e s e a r c h p r o j e c t :<br />

1 ) A l e x G a l e (Ev a l u a t n i <strong>of</strong> o n a ï ve, me mo r y an d regu lator y C D4 + T-c e l l s h ui man n<br />

immu n od efi ci en c y vi ru s i n f e c t ion . K i n g s C o l l e / g e Un ive rs it y <strong>of</strong> Lon d on , MSc<br />

I m m u n o l o g y 2 0 0 6 ).<br />

2 ) Ije o ma U g w u -On u oh a (Th e e ffect <strong>of</strong> Str es s h ormon e, c ortis ol , on Natu ral Kille r<br />

c e l l c yt o t o x i c a c t i v i t y a g a in s t K5 6 2 cells , i n v i . t Un r o ivers it y o f E as t Lon d on ,<br />

M S c I m m u n o l o g y 2 0 0 4 ) . *<br />

B a c h e l o r o f S c i e n c e r e s e a r c h p r o j e c t s :<br />

1 ) L i n d a F a r a h a n i ( T h e E f f e c t o f S -h e l yp f n os is , J oh rei an d St res s on P erip h eral<br />

B l o o d I m m u n e P a r a m e t e r s , I m p e r i a l C / o l U l n e i g e v e r L s o f i n d t Lon o y n d on o ,<br />

B S c M e d i c i n e 2 0 0 2 ) . *<br />

2 ) C h r i s t i n e B r i n c a t ( I m p a c t o f S -h e l yp f n os is an d J oh rei on P s ych ol ogical<br />

P aramet ers in th e He al th y P op u lation , I m p e r i a l C o l l e L g o e n d o n / Un ivers it y o f<br />

L o n d o n , B S c M e d i c i n e 2 0 0 2 ) . *<br />

3 ) N i c k E n z o r ( I n d i v i d u a l d i f f e r e n c e s i Flexib n C o g in li i t y t an i v d e it s R el at ion s h ip to<br />

P r<strong>of</strong>ou n d St at e <strong>of</strong> R el a xat i on , I m p e r i a l C o l l e L g o e n d o n / Un ive rs it y <strong>of</strong> Lon d on ,<br />

B S c M e d i c i n e 2 0 0 2 ) . *<br />

4 ) Navj ot Han s i (C ort i s ol an d Mood C h anges with J oh rei after an acu te Stres s or,<br />

I m p e r i a l C o l l L e g o e n d o n / U n i v e r s i t y d o n f , L B o S n c M e d i c i n e 2 0 0 3 ) . *<br />

5 ) An i l Kar mal i ( An E E G s tu d y <strong>of</strong> th e J ap an es e Healin g M eth od : J oh rei, Imp erial<br />

C o l l e g e L o n d o n / Un i ve rs i t y <strong>of</strong> Lon d on , BSc M ed icin e 2 0 03 ).<br />

6 ) R yan Kers t ei n ( Hyp n ot is ab ilit y an d Im mu n e Statu s in HIV b lo od res u lts after<br />

Self-h y p n o s i s o r h rei J , o I m p e r i a l C o l l e L g o e n d o n / Un ivers it y <strong>of</strong> Lo n d on , BSc<br />

M e d i c i n e 2 0 0 4 ) . *<br />

P ap ers h ave b een res u l t ed from th e p r oje cts mar ked with an as teri s k.<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 07 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Appe ndi x 6: A d d i t i o n a l r e s u l t s<br />

A n a l y si s <strong>of</strong> the co mpa r i so n be tw ee n Co hor ts A a n d i n B t h e s t u d e n t (3. 1. s 1 t ) u d y<br />

T able A-1: M e a n ( 95% C.I .) P SS le ve ls <strong>of</strong> t h e C o h o r t s A and B a t t h e -e N xa o n m a nd E x am t i m e p o i n ts<br />

Pe r c e i v e d S t r e s s S c a l e<br />

Non-e x a m<br />

Ex a ms<br />

Cohort A Cohort B Cohort A Cohort B<br />

Me a n l e ve l 19.9<br />

22.4<br />

24.5<br />

27.1<br />

( 9 5 % C . I . ) (12.7 – 27.1) (15.0 – 29.8) (18.1 – 30.9) (20.4 – 33.8)<br />

n 8 14 8 14<br />

T able A-2: M e a n ( 95% C.I .) St a te a nx ie t y le ve ls <strong>of</strong> the C o h o r t s o f A and B a t t h e -e N xam o n a nd Ex a m<br />

t i m e p o i n t s<br />

S t a t e a n x i e t y s c o r e<br />

Non-e x a m<br />

Ex ams Cohort A Cohort B Cohort A Cohort B<br />

Me a n l e ve l 34.0<br />

36.7<br />

34.9<br />

46.9<br />

( 9 5 % C . I . ) (29.8 – 38.2) (33.1 – 40.3) (30.3 – 39.5) (43.7 – 50.1)<br />

n 8 14 8 14<br />

Table A-3: M e a n ( 9 c 5 y t % o t o x C i . c a c I t i . v i ) t y i N n C K o t h o h r e t s A a n d B a t Non-e t h e x a m a n Exa d m<br />

t i m e p o i n ts<br />

N K c y t o t o x i c a c t i v i t y ( % K i l l i n g )<br />

Non-e x a m<br />

Ex a ms<br />

Cohort A Cohort B Cohort A Cohort B<br />

Me a n<br />

6.07<br />

9.37<br />

3.21<br />

10.38<br />

( 9 5 % C . I . ) (0 – 12.35) (3.88 – 14.87) (0 – 7.33) (3.09 – 17.67)<br />

N 9 12 9 12<br />

T able A-4: M e a n ( 9 -c 5 e ll % p e r c C e . n t a I g e . s in ) the C N o K h o r t s A and B at the Non-e x a and m Exa m<br />

t i m e p o i n ts<br />

N K -c e ll p e r c en t a g e<br />

Non-e x a m<br />

Ex a ms<br />

Cohort A Cohort B Cohort A Cohort B<br />

Me a n<br />

6.36<br />

8.86<br />

7.34<br />

8.71<br />

( 9 5 % C . I . ) (3.476 – 8.87) (6.66 - 11.05) (4.20 – 10.48) (6.72 – 10. 69)<br />

n 10 16 10 16<br />

T able A-5: M e a n ( 9 5 % C -c . e l I l . e r ) c p e n t C a g D e 4 s i T n C t h o e h o r t s A and B at th e N o n -e xa m and Exa m<br />

t i m e p o i n ts<br />

CD4 T-c e l l p e r c e n t a g e<br />

Non-e x a m<br />

Ex a ms<br />

Cohort A Cohort B Cohort A Cohort B<br />

Me a n<br />

48.54<br />

43.88<br />

48.29<br />

43.24<br />

( 9 5 % C . I . ) (43.04 – 56.04) (40.15 - 47.61) (36.72 – 54.80) (39.68 – 46.79)<br />

n 10 16 10 16<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 08 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-6: M e a n ( 95% C.I .) 8 C D T-c e ll pe rce nt a ge s in t he Cohor ts A a n d B a t t -e h e xa m N and o n Exa m<br />

t i m e p o i n ts<br />

C D 8 T-c e l l p e r c e n t a g e<br />

Non-e x a m<br />

Ex a ms<br />

Cohort A Cohort B Cohort A Cohort B<br />

Me a n<br />

26.26<br />

28.90<br />

26.34<br />

28.74<br />

( 9 5 % C . I . ) (22.64 – 29.88) (26.0 6 - 31.74) (22.1 1 – 30.57) (26.0 6 – 31.43)<br />

N 10 16 10 16<br />

Ana ly si s <strong>of</strong> the co mpa r i so n be tw ee n S t r e s s a e nd d N o n -s t r e s s e t d u d e n ts ( 3 . 1 . 2 )<br />

Table A-7: M e a n ( 9 5 % C . I . ) N K C A l e v e l -e s xa a m t a nd t E h e x a m N o t n i m e p o i n t s<br />

N K C A ( % k i l l i n g )<br />

Non-e x a m Ex ams<br />

Me a n l e ve l<br />

7.96<br />

7.31<br />

( 9 5 % C . I . ) (3.86 - 12.05) (2.61 – 12.01)<br />

N 21 21<br />

T a b l e A-8: M e a n ( 9 5 % -c C . e l I l . ) a n d N K C D 4 -c a e l n l d ( C % D ) 8 a T t -e t xa h m e a nd N o Ex n a m t ime<br />

points<br />

( % )<br />

Non-e x a m Ex ams<br />

Me a n NK-c e l l p e r c e n t a g e s 7.90<br />

8.18<br />

( 9 5 % C . I . )<br />

(6.20 – 9.60) (6.48 - 9.88)<br />

Me a n C D 4 -c eT ll p e r c e n t a g e s 45.7<br />

45.2<br />

( 9 5 % C . I . )<br />

(42.5 – 48.9) (41.8 - 48.6)<br />

Me a n C D 8 -c e T l l p e r c e n t a g e s 27.9<br />

27.8<br />

( 9 5 % C . I . )<br />

(25.6 – 30.1) (25.5 – 30.1)<br />

N 26 26<br />

T a b l e A-9: Numbe r <strong>of</strong> st ude nts in th e N ot -s tre s s ed a nd S t r e s s se ubgr d ou ps wit h r e g a r to d gender who<br />

f ille d i n t h e P S S a n d h a d b l o o d c o l l e c t i o n f o r a n d l y N m K p h C o A c y t l e v e l a n a l y s e s<br />

( N o t e : f i g u r e s i S n t r t e h s e s e u b d g r o u p i n c l u d e o n e m a l e w h o s e r e s u l t f a i l e d t o o b t a i n f o r l y m p h o c y t e )<br />

m a l e f e m a l e Total<br />

N o t -s t r e s s e d 1 1 9 2 0<br />

S t r e s s e d<br />

1 0 1 1 2 1<br />

T o t a l 2 1 2 0 4 1<br />

T able A-10: M e a n (95% C.I .) N K -c e l l p e r c e n t a the g e s N ot i -s n tr e ss e d and S t r e s s subgr e d ou ps N K -c e l l (%)<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 10.0<br />

9.1<br />

( 9 5 % C . I . ) (7.6 – 11.7) (6.8 – 11.4)<br />

n 20 20<br />

T able A-11: M e a n ( 9 5 % -c C e. ll pe I rc . e nt ) a ge s N in K the N ot -s tr e ss e d and S t r e s s m e d a l e s t u d e n t s<br />

N K -c e l l (%)<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 10.2<br />

12.0<br />

( 9 5 % C . I . ) (7.1 – 13.4) (7.9 – 16.1)<br />

n 11 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 09 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-12: M e a n ( 9 5 % -c C e. ll pe I rc . e nt ) a ge s N in K the N ot -s t r e s s and e d S t r e s s f e m d a l e s t u d e n t s<br />

N K -c e l l (%)<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 9.7<br />

6.7<br />

( 9 5 % C . I . ) (6.0 - 13.4) (5.2 – 8.1)<br />

n 9 11<br />

T a b l e A-13: M e a (95% n C. I .) le ve ls <strong>of</strong> NKCA ( % kil lin g) in t he N ot -s t r e s sed and S t r e s s f e ma d le<br />

s t u d e n t s<br />

N K C A (% k i l l ) i n g<br />

Not-s t r e s s e d St re s se d<br />

Me a n l e ve l 10.9<br />

6.7<br />

( 95% C . I . ) (4.9 – 16.9) (2.1 – 11.4)<br />

n 9 11<br />

T able A-14: M e a n ( 9 5 % C . I . ) l e v e l s o f N K C A ( % k i l l i n g ) o f m a l e a n d f e m a l e<br />

N K C A (% k i l l ) i n g<br />

Ma l e Fe m a l e<br />

Me a n l e ve l 9.0<br />

8.6<br />

( 9 5 % C . I . ) (4.9 – 13.0) (4.9 – 12.3)<br />

n 21 20<br />

T able A-15: M e a ( 9 n 5% C . I .) r a ti o s o f N -c K eC ll A in t ht e Not-s o tr N es K s ed and S t r e s s f e ma d le<br />

s t u d e n t s<br />

N K C A to NK-c e l l r a t i o<br />

Not-s t r e s s e d St re s se d<br />

Me a n r a t i o 1.18<br />

0.91<br />

( 9 5 % C . I . ) (0.50 – 1.87) (0.23 – 1.60)<br />

n 9 11<br />

T able A-16: M e a n ( 9 5 % C . I . ) r -c a e t l l i o i n s m a o l f f e m a l n e N d K s t C u A d e n t t s o N K<br />

N K C A to NK-c e l l r a t i o<br />

m a l e f e m a l e<br />

Me a n r a t i o 0.88<br />

1.04<br />

( 9 5 % C . I . ) (0.38 – 1.38) (0.56 – 1.52)<br />

N 21 20<br />

T a b l -17: e M eA a n (9 5% C.I .) CD4 and CD8 T-c e l l l e v e l s ( % i ) n the N ot -s t r e s s e a d n d S t r e s s subgroups e d<br />

(%)<br />

Not-s t r e s s e d S t r e s s e d<br />

Me a n C D 4 -c e T l l l e ve l 44.1<br />

47.8<br />

( 9 5 % C . I . ) (40.0 – 48.3) (45.5 – 50.1)<br />

Me a n C D 8 -c e T l l l e ve l 27.8<br />

26.1<br />

( 9 5 % C . I . ) (25.4 – 30.2) (23.7 – 28.6)<br />

n 20 20<br />

T able A-18: M e a n ( 9 5 % C . I . ) C D -c 4 e ll le a ve n ls d ( %) C D in 8 the T N ot -s tr e ss e d and S t r e s s ma e d le<br />

s t ud e n t s<br />

(%)<br />

Not-s t r e s s e d St re s se d<br />

Me a n C D 4 -c e T l l l e ve l 40.8<br />

46.1<br />

( 9 5 % C . I . ) (35.9 – 45.7) (42.7 – 49.5)<br />

Me a n C D 8 -c e T l l l e ve l 28.5<br />

25.2<br />

( 9 5 % C . I . ) (24.3 – 32.6) (21.2 – 29.2)<br />

n 11 9<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 10 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-19: M e a n ( 9 5 % C . I . ) C D -c 4 e ll le a ve n ls d ( %) C D in 8 the T Not -s tr e ss e d and S t r e s s f e ma d le<br />

s t u d e n t s<br />

(%)<br />

Not-s t r e s s e d St re s se d<br />

Me a n C D 4 -c e T l l l e ve l 48.2<br />

49.2<br />

( 9 5 % C . I . )<br />

(41.9 - 54.6) (46.2 – 52.2)<br />

Me a n C D 8 -c e T l l l e ve l 27.0<br />

26.9<br />

( 9 5 % C . I . )<br />

(24.9 - 29.1) (23.7 – 30.1)<br />

n 9 11<br />

T able A-20: M e a n (95% C.I .) C D 8 T-c e l l l e v e l s ( % ) o f m a l e a n d f e m a l e s t u d e n t s<br />

CD8 T-c e l l l e v e (%) l s<br />

m a l e Fe m a l e<br />

Me a n<br />

27.0<br />

26.9<br />

( 9 5 % C . I . ) (24.1 – 29.9) (25.0 – 28.8)<br />

n 20 20<br />

A n a l y s i s o f t h e c o m p a r i t s h e o n i n b t e r t v w e n e t e i n o n g r o u p s a n d c o n t r o l i n t h e<br />

s t u d e n t s t u d y ( 3 . 1 . 3 )<br />

T a ble A-21: M e a ( 9 n 5% C . I .) P SS l e ve l s i n t h e t hr ee gr o u ps at t h e E xa m t i m e p o i nt<br />

P S S s c o r e<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 24.5<br />

22.8<br />

26.3<br />

( 9 5 % C . I . ) (20.4 - 28.6) (17.5 – 28.1) (21.9 - 30.8)<br />

N 12 11 9<br />

T able A-22: M e a ( 9 n 5% C . I .) P SS s c o r es in m a l e s u bj e ct s i n t h e t hr e e gr o u p s a t t he E x a m t i m e p o i n t<br />

P S S s c o r e<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 25.3<br />

21.1<br />

22.0<br />

( 9 5 % C . I . ) (19.5 - 31.0) (16.6 – 25.7) (11.9 - 32.1)<br />

N 7 7 3<br />

T able A-23: M e a n ( 9 5 % C . I . ) P S S s c o r e s i n f e m e a t l h r e ee s gr u o b u j ps e c at t s t h e i E n xam t h t i m e p o i n t<br />

P S S s c o r e<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 23.4<br />

25.8<br />

28.5<br />

( 9 5 % C . I . ) (17.0 - 29.8) (12.9 – 38.6) (24.5 - 32.5)<br />

N 5 4 6<br />

T able A-24: M e a n (95% C.I .) S t a t e a n x i e t y s c t o h r e m e s a l e i s n u b j e c t s o f t h e S -hypnosis, e l f Johrei and<br />

R e l a x a t i o n c o n t r o l g r o au t p b s a s e l i n and e t h e E x a m t i m e p o i nt<br />

S t a t e s c o r e s i n t h e S T A I<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 37.8 35.9 34.3 44.4 43.8<br />

37.0<br />

( 9 5 % C . I . ) (32.7 - 42.8) (29.6 – 42.1) (30.2 - 38.3) (40.1 - 48.7) (39.6 – 47.9) (28.7 - 45.3)<br />

n 8 8 4 8 8 4<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 11 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-25: M e a n (95% C.I .) S t a t e s c o r e t s h e f i e n m a l e s u b j e c t s S i e n l f-hypnosis, t h e Johrei and<br />

Re la xa t io n c ont rol gr oup at b a s e l i n and e the E x a m t i m e p o i nt<br />

St a t e sc or e in t h e S T A I<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n s c o r e 36.6 32.8 29.7 38.8 29.5<br />

39.2<br />

( 9 5 % C . I . ) (33.0 - 40.2) (23.1 – 42.4) (25.9 - 33.4) (35.9 - 41.7) (24.1 – 34.9) (29.5 - 48.9)<br />

n 5 4 6 5 4 6<br />

T able A-26: M e a n ( 9 5% C . I .) N K C A l e ve l s ( % ki l l i n g) i n t h e t hr ee gr o u p s a t t he E x a m t i m e p o i n t<br />

N K C A ( % k i l l i n g )<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n<br />

6.0<br />

12.9<br />

12.2<br />

( 9 5 % C . I . ) (0.3 - 11.7) (6.3 – 19.6) (4.4 - 19.9)<br />

N 11 11 9<br />

T able A-27: M e a (95% n C. I .) NKCA le ve ls ( % kill in g) in ma le s ub j ec ts in t he th r ee gr ou ps a t t he Ex a m<br />

t i m e p o i n t<br />

N K C A ( % k i l l i n g )<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n<br />

7.3<br />

16.2<br />

9.8<br />

( 9 5 % C . I . ) (0.0 - 16.0) (7.9 – 24.6) (0.0 - 23.9)<br />

n 6 7 4<br />

T able A-28: M e a n ( 9 5 % C . I . ) N K C A l e v e l s f( e ma % le k si ul bj l e ct i s n g in ) t he i tn hr ee gr oup s at th e Exa m<br />

t i m e p o i n t<br />

N K C A ( % k i l l i n g )<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n<br />

4.4<br />

7.1<br />

14.0<br />

( 9 5 % C . I . ) (0.0 - 12.2) (0.0 – 16.8) (4.6 - 23.4)<br />

n 5 4 5<br />

T able A-29: M e a n (95% C.I .) l e v e l -c s e l l o ( % f ) o f N K m a l e s t u d in e n t he t s gr ou ps o f t h e S e l -hypnosis, f<br />

J o h r e i a n d C o n t r o at l s b a s e l i n and e t he Ex a m t i m e p o i n t<br />

N K -c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 8.9<br />

9.5 11.8 9.4<br />

12.6<br />

6.6<br />

( 9 5 % C . I . ) (6.4 - 11.3) (3.5 – 12.5) (8.4 - 15.3) (7.0 - 11.8) (9.5 – 15.8) (4.2 - 9.1)<br />

n 7 7 5 7 7 5<br />

T able A-30: M e a n (95% C.I .) l e v e l -c s e l l o s f ( % the N ) K f e i m n a l e s u b j e c t s i n t h e S -hypnosis, e l f Johrei<br />

a n d R e l a x a t i o n c o n t r o l g r at o u b p a s s e l i n ae nd t he Ex a m t i m e p o i n t<br />

N K -c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 10.6 4.4<br />

6.3<br />

7.5<br />

7.7<br />

6.8<br />

( 9 5 % C . I . ) (7.4 - 13.9) (1.0 – 7.8) (4.4 - 8.3) (1.2 - 13.9) (3.8 – 11.6) (3.4 - 10.1)<br />

n 5 4 6 5 4 6<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 12 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-31: M e a n (95% C.I .) l e v e l s f o C D 4 -c e l T l ( % ) o f m a l e t s h t e u S d e l f-h n t yp s no i s is n , J ohr e i a nd<br />

R e l a x a t i o n c o n t r o l g r o au t p b s a s e l i n and e t he E x a m t i m e p o i nt<br />

CD4 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 44.8 43.8 43.6 44.9 38.2<br />

46.2<br />

( 9 5 % C . I . )<br />

n<br />

(40.0 - 49.6)<br />

7<br />

(39.9 – 47.7)<br />

7<br />

(38.9 - 48.4)<br />

5<br />

(38.2 - 51.6)<br />

7<br />

(33.8 – 42.6)<br />

7<br />

(38.9 - 53.4)<br />

5<br />

T able A-32: M e a n (95% C.I .) l e v e l s o -c f e l l C D s 4 ( % T t ) h e f e i m n a l e s t u d e n t s i n t h e S -hypnosis, e l f<br />

J o h r e i a n d R e l a x a t i o n c ps o n t a t r b o a l s e l g i r n o and e u t he E x a m t i m e p o i nt<br />

CD4 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 46.8 51.3 46.6 47.0 51.7<br />

47.5<br />

( 9 5 % C . I . ) (42.4 - 51.2) (46.4. – 56.3) (41.6 – 51.6) (40.3 - 53.7) (44.4 – 58.9) (42.0 -52 9.)<br />

n 5 4 6 5 4 6<br />

T able A-33: M e a n (95% C.I .) l e v e l s o -c f e l l C D 8 ( % ) T o f m a l e t s h t e u S d e l f-h n t yp s no i s is n , J ohr e i a nd<br />

R e l a x a t i o n c o n t r o l g r o au t p b s a s e l i n and e t he E x a m t i m e p o i nt<br />

CD8 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 25.0 26.7 26.6 27.7 28.8<br />

26.8<br />

( 9 5 % C . I . ) (18.3 - 31.6) (22.3 – 31.1) (23.5 - 29.6) (22.3 - 33.2) (23.8 – 33.8) (22.2 - 31.5)<br />

n 7 7 5 7 7 5<br />

T able A-34: M e a n (95% C.I .) l e v e l s o -c f e l l C D s 8 ( % T t ) h fem e i n a l e s t u d e n t s i n t h e S -hypnosis, e l f<br />

J o h r e i a n d R e l a x a t i o n c o n t r o l g ar t o b u a p s e l i n and e t he E x a m t i m e p o i nt<br />

CD8 T-c e l l s ( % )<br />

B a s e l i n e<br />

E x a m s<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n l e ve l 25.4 26.9 27.8 27.4 25.4<br />

26.9<br />

( 9 5 % C . I . ) (17.6 - 33.4) (24.6 – 29.3) (23.0 – 32.5) (22.5 - 32.3) (23.6 – 27.3) (22.7 - 31.1)<br />

n 5 4 6 5 4 6<br />

Ana ly si s <strong>of</strong> the co mpa r i so n be tw ee n Str e ss pe rc e ptio n a nd the di sea se pa ra me te r s<br />

i n -i H n I f e c V t e d i n d i v i d u a l s ( 3 . 2 . 1 )<br />

T able A-35: C o r r e l a t i o n b e t w e e n CD4 t h g e r a d i e n t ( c e l per l s l pe r m o n t h ) a n d t st h re e s s pe r ce pt ion<br />

s c o r e s a n d t h e p e r c e i v e d q u -<strong>of</strong>-l a l i f t e y a t r e c r u i t m e n t t i m e p o i n t ( p r e ) a n d -mont f o u r hs af te r t he<br />

r e c r u i t m e n t ( p o s t )<br />

S t a t e a n x i e t y I E S P S S LoC MC S P S Q I<br />

pre post pre post pre post pre post pre post pr e post<br />

R .15 .28 .28 .19 .14 .18 .32 .02 - .24 .15 .22 - .03<br />

2-t a ile d p N S N S N S N S N S N S 0.085 N S N S N S N S N S<br />

N 30 30 30 30 30 30 30 30 30 30 30 30<br />

NS: p > 0 . 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 13 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

T able A-36: C o r r e l s a t b e i t o w n e e n t h e C D 4 g r a d i e n t per ( c e l l s pe r m o n t h ) a n d t h e c h a s n c g o e r e s <strong>of</strong><br />

s t re ss p er c ep t i o n s c a l es i n :<br />

S t a t e a n x i e t y I E S P S S<br />

R .13 - .18 .02<br />

2-t a ile d p N S N S N S<br />

n 30 30 30<br />

NS: p > 0 . 1<br />

T able A-37: Number <strong>of</strong> H I V-i n f e c t e d i n d i vi d u a ls who had vi r a l l o a d l e ve l c he c k<br />

a t t h e m o n t h l y e r i t o i d s m f e r m p o t h e R e cr u i t m e n t t o four months af te r t he re c ru it me nt (Ter m 4)<br />

V a l i d n u m b e r<br />

N P er ce n t<br />

T e r m 4 ( f o u r m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 10 15.9%<br />

T e r m 3 ( t h r e e m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 17 27.0%<br />

T e r m 2 ( t w o m o n t h s a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 17 27.0%<br />

T e r m ( 1 o n e m o n t h a f t e r t h e R e c r u i t m e n t t i m e p o i n t ) 14 22.2%<br />

B a s e l i n e ( 2 w e e k s b e f o r e a n d a f t e r t h e r e c r u i t m e n t ) 18 28.6%<br />

T able A-38: Co r r e la t ion be t we e n t he vi r a l l o a d l e ve l gr a d i e n ts (log-t r a nsf or med vir a l c op ies per l pe r<br />

m o n t h ) a n d t h s e t r e s s p e r c and e p t the i o n p e r c e i v e d q u -<strong>of</strong>-l a l i t f e y s c o r e at s re c ru it me nt t ime point ( pr e )<br />

a n d f o u r m o n t h s l a t e r ( p o s t )<br />

S t a t e a n x i e t y I E S P S S LoC MC S P S Q I<br />

pre post pre post pre post pre post pre post pre post<br />

R .04 .04 .25 .04 - .02 - .01 .21 .03 - .09 .08 .20 .11<br />

2-t aile d p N S N S N S N S N S N S N S N S N S N S N S N S<br />

n 29 29 29 29 29 29 29 29 29 29 29 29<br />

NS: p > 0.1<br />

T able A-39: Co r r e la t ion be t we e n t he vi r a l l o a d l e ve l g r a d i e n t log-t ( r a ns f or me d c opie s per l pe r mo nt h )<br />

a n d t h e c h a n g e s c o r e s o f p e r c e i v e d s t r e s s a -<strong>of</strong>-l n d q i u f a e l i s t c y o r : e s i n<br />

S t a t e a n x i e t I y E S P S S LoC M C S P S Q I<br />

R - .02 - .30 - .08 - .13 .29 - .15<br />

2-t a ile d p N S N S N S N S N S N S<br />

n 29 29 29 29 29 29<br />

NS: p > 0 . 1<br />

T able A-40: C o r r e l a t i o n b e tt he w N e K e n g r a d i e n t ( c e per l l s l pe r m o n t h ) a n d t s h t e r e s s p e r c e p t i o n s c o r e s<br />

and the p e r c e i v e d q u -<strong>of</strong>-l a l i f t e y a t r e c r u i t m e n t t i m e p o i n t ( p r e ) a n d -mont f o u r hs af te r t he re c r uit me nt<br />

( p o s t )<br />

S t a t e a n x i e t y I E S P S S LoC MC S P S Q I<br />

pre post pre post pre post pre post pre post pr e* post<br />

R .26 .19 .01 - .04 .20 .11 .28 .17 - .30 - .24 .44 .28<br />

2-t a ile d p N S N S N S N S N S N S N S N S N S N S 0.017 N S<br />

N 29 29 29 29 29 29 29 29 29 29 29 29<br />

NS: p > 0.1; *: p < 0.05<br />

T able A-41: Co r r e la t ion be t we e n t he N K g r a d i e n t ( c e per l l s l pe r m o n t h ) a n d t h e c h a n g e s c o r e s o f<br />

p e r c e i v e d s t r e q s u s a l a i n -<strong>of</strong>-l t d y i f e s c o r : e s i n<br />

S t a t e a n x i e t y I E S P S S LoC M C S P S Q I<br />

R - .19 - .07 - .23 - .16 .11 - .22<br />

2-t a ile d p N S N S N S N S N S N S<br />

N 29 29 29 29 29 29<br />

NS: p > 0 . 1<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 14 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

A n a l y s i s o f t h ee e n t h c e o m p i a n r t i e s r o v n e n b t e i t o w n g -r<br />

o u p s a n d<br />

i n f e c t e d i n d i v i d u a l s ( 3 . 2 . 2 )<br />

Table A-42: M e a n (95% C.I .) le ve ls <strong>of</strong> t he St a t e a nx iet y a n d P S s S c o r e s -individ i n ua t ls h in e t he H I V<br />

S e l f-h y p n o s i s , J o h r e wa i i t-l a n i d s t co e d n t r o l g r o u p s a t t h e B ost-i a s e n t l e r i v n e n e t i o a n d t i m t e h p e o i n P t s<br />

B a s e l i n e<br />

P os t -i n t e r v e n t i o n<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n A n x i e t y 41.5<br />

( 9 5 % C . I . ) (24.6 - 5 8 . 4)<br />

35.7<br />

(25.0 - 4 6 . 4)<br />

43.4<br />

(30.2 - 5 5 . ) 6<br />

37.6<br />

(25.0 - 5 0 . 2)<br />

35.9<br />

(24.8 - 4 7 . 0)<br />

42.4<br />

(29.2 - 5 5 . 6)<br />

Me a n P S S<br />

( 9 5 % C . I . )<br />

31.8<br />

(24.5 - 3 9 . 1)<br />

31.3<br />

(24.8 - 3 7 . 8)<br />

31.7<br />

(24.4- 39.0)<br />

30.6<br />

(24.9 - 3 6 . 3)<br />

32.1<br />

(27.2 - 3 7 . 0)<br />

31.8<br />

(26.7 - 3 8 . 7)<br />

N 21 12 18 21 12 18<br />

T able A-43: M e a n (95% C.I .) le ve ls <strong>of</strong> t he L o C , M C S a n d P S Q in I the HIV-i n d i v i d u a l s i n t h e S -e<br />

l f<br />

hyp n o s i s , J oh r e i an d wa i t-l i s t e d c o n t r o l g r o au t p t s h e B a s e l i and n e P o st -i n t e r v e n t i o n t i m e p o i n t s<br />

B a s e l i n e<br />

P os t -i n t e r v e n t i o n<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Mean LoC 10.2 12.0 11.2<br />

9.4 11.3 11.2<br />

( 9 5 % C . I . ) (9.3 - 1 1 . 1) (10.8 - 1 3 . ) 2 (10.2 - 1 2 . 2) (8.4 - 1 0 . 4) (10.0 - 1 2 . 6) (10.2 - 1 2 . 2)<br />

Me a n M C S 43.0 46.7 39.7 47.4 48.0 39.5<br />

( 9 5 % C . I . ) (40.0 - 4 6 . 0) (42.8 - 5 0 . 6) (36.5 - 4 2 . 9) (44.6 - 5 0 . 2) (44.5 - 5 1 . 5) (36.6 - 4 3 . 4)<br />

Me a n P S Q I 9.2<br />

8.6 9.4<br />

8.5<br />

7.5 9.6<br />

( 9 5 % C . I . ) (8.4 - 1 0 . 0 ) (7.6 - 9 . 6) (8.6 - 1 0 . 2) (7.8 - 9 . 2) (6.6 - 8 . 4) (8.9 - 1 0 . 3)<br />

n 21 12 18 21 12 18<br />

T able A-44: M e a n (95% C.I .) le ve ls <strong>of</strong> r e g r e s s i o n g r a d i v e i n r t a s l i l n o a d l e v -t e rl a ns s fo ( r me L o g d) i n<br />

H I V-i n f e c t e d i n d i v i d u a l s i n t h e S -hypnosis, e l f J o hr e i a nd wa i t -l i s t e d c o n t r o l g r o u p s<br />

H I V-v i r a l l o a d l e -t v e r l a n s f o ( r m l e o d g )<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n c h a n g e - .016<br />

- . 0 2 1 - . 0 3 1<br />

( 9 5 % C . I . ) (- .053 t o + .019) (- .082 t o + .040) (- .077 t o + .014)<br />

N 14 12 12<br />

T able A-45: M e a n (95% C.I .) le ve ls <strong>of</strong> r e g r e s sio n gr a die nt s in N K -c e l l (counts per l p e r m o n ) t i h n<br />

i n f e c t e d i n d i v i d u a l s i n t h e S -hypnosis, e l f J ohre i a nd wa i t -l i s t e d c o n t r o l g r o u p s<br />

N K -gr a die nt (counts pe r l p e r m o n ) t h<br />

H I - V<br />

S e l f-h y p n o s i s J o h r e i C o n t r o l s<br />

Me a n c h a n g e - 2.4<br />

+ 2 . 8 - 1 . 3<br />

( 9 5 % C . I . ) (- 9.4 t o + 4.7) (- 5.9 t o + 11.4) (- 9.1 to + 6.5)<br />

n 15 10 12<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 15 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

Appe ndi x 7: R e s e a r c h p r o p o s a l f o r p o s -d t o c t o r i a l p r o j e c t<br />

I n v e s t i g a t i o n o f s t r e s s m a n a g e m e n t i n , HIV J o pat h r i e nt i s , u p o n H e a<br />

n o t r e c e i v i n g a n t i-re t r o v i r a l tr e a t m e nt ( A R T ) : A n O p e n S t u d y<br />

B a c k g r o u n d<br />

A k i r A a I T O N M . D . 2 0 0 6<br />

Johrei i s a J a p a n e s e s t r e s s m a n a g e m e n t s y s t e m w h i c h p t ra r o ining v i d e a s n d e n c o u r a g i n g t pra h e ct ic e<br />

o f s e l f-h e lp c op ing st r at e gie s f o r d e a l i n g w i t h s . t r O e s u s r r e c e n t r e s e a r c h s t u [ N d i a e i t s o e t a l . , 2 0 0 ha 5 ] ve<br />

s h o w n t h a t t h e p r o g r e s -c s ei ll cv oe unt s d in e HI c l V i inf n ee ct e d i pat n ie nC ts D , wh 4 ic T h is a s s oc ia te d<br />

w i t h 'i l l-h e a l t h ' , w a s i n ru t e p r t e d i n p a t i e n t s t r a i n e d i n a n d p r a c t i s i n g J o h r e i s . Io t v e r a p e r i o d o<br />

i s b e l i [ e C v a e t d a l a n e t a l . , 1 9 9 5 ] t h a t t h e m a i n t -c e en lls a ove n c r e t his o f ive f months C D 4 per T io d wil l<br />

h a v e b e n e f i t e d t h e p a t i e n t s b y p r o l o n g i n g t h e p e r i o d ing o f t he ' og no se o t d <strong>of</strong> h HI e a V l t h ' a n d d e l a y<br />

r e l a t e d c o m p l i c a t i o n s a n d e d t for h e s pn ec e if ic HI V tr ea t ment .<br />

P u r p o s e<br />

T he c ur r e n t st u d y i s p r op o se d t o :<br />

M e t h o d<br />

Su b j e c t s<br />

Conf ir m th e p r e v i o u s f i n d i n ; g s<br />

D e m o n s t r a t e i n H I V p a t i e n t s t h a t J o h r e i i m p r o v ; e s q u a l i t y o f l i f e<br />

D e t er m i n e i f J oh r e i p a r t i c u l a r l y a f f e s c t u -p b s o p u C l D a 4 t i o n s s u c h a e, s n m a e ï m v o r y a n d<br />

r e g u l a t -c e o l r l s; y a T n d<br />

I de nt if y o n the ba s is <strong>of</strong> spe c if ic p s yc h o lo gic a l a n d immu n o lo gic a l p r o f ile s wh ic h p a t ien t s wo u ld<br />

b e n ef i t f r o m pr a ct i s i n g J o h r e i.<br />

P at i e nt s w i t h H I V w h o -c h e a l v l e c o C u n D t 4 m T o r e t h a n 2 0 0 c e l l s p e r m a ri e c not r o l i t t r e a n d w h o<br />

r e ce i vi n g a n t i-r e t r o vi r a l tr e a t me n t ( ART ) wil l b e re c ru it e d b y c omple t in g t h e wr it t e n c o ns ent for m.<br />

S t u d y d e s i g n<br />

O p e n cohort s t u d y c o m p a r e d w i t h c o n c u r r e n t a n d h i s -ma t o r t che i c a d l ( a ge c a , s ge e nder a nd CD4<br />

c o u n t s ) c o n t r o l p a t i e n t s s e l c linic e c t ae l d da tf ab r ao se m <strong>of</strong> t re h s ults .<br />

J o h r e i i n t e r v e n t i o n<br />

T r a i n i n g o f J oh r e i , a J ap a n es e s t r es s m a na ge m e n t s yst e m wh i c h p r o vi d e s :<br />

C o r e p h i l o s o p h i e s a n d p r i n c i p l e s f o r J o ; h r a e n i d p r a c t i c e<br />

B a s i c t e c h n i q u e s : m e n t a l i m a g e o f h e a l i n g l i g h t ing a n td he t ligh a k t i fn rom g t he u r n s a t r e c e i v<br />

i m a g i n a r y s o u r c e a n d c h a n n e l l i n g i t t o t h e -touching r e c i p i hand. e n t w i t h t h e n o n<br />

J ohre i c a n b e pr ac t is ed individu a ll y b u t is b et te r in p a ir s an d h en c e p at ie n ts wil l b e e n c ou r age d t o<br />

a t t e n d t h e t r a i n i n g s e s s i o n w i t h d t o h i pra s / c th ise e r J ohre p a r i wit t n h e r his / a he n r par t ne r .<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 16 - I m p e r i a l C o l l e g e L o n d o n


P s ych ol o gi cal in ter ven ti on an d psy c h o -n e u r o-e n d o c r i n -i o mmu n e n et wo rk. A k i r A a I T O N<br />

O n e w e e k e n d t r a i n i n g t ( e n hours e x cluding two one-hour lunch b r e a k s) a n d f i v e - m o n t h l y f<br />

ups (1.5-2 hours e ac h) wit h pr a ct ic e at ho me a min imu m o f f o ur 2 0 min s e ss io n s pe r we e k mo nit o r ed<br />

b y a s e l f-r e p o r t r e c o rd.<br />

M e a s u r e s<br />

P r i m a r y o u t c o m e<br />

As s e s s m e n t -c o f e l l C D 4 d e T c l i n e r a t e f r o m -c p er ll o c os unt p e s ac t t one i to v e t wo r o u t i n e C D 4<br />

m o n t h i n t e r v a l s d u r i n g t h e s t u d y p e r i o d a n d , w h -e<br />

r e a p p r o p r i<br />

c e ll c ou nt s o ve r t he pre c eding s ix to 12 months.<br />

S e c o n d a r y o u t c o m e s<br />

1. I m m u n o l o g i c a l p a r a m e t e r s on ( t hr e e oc ca s ions a longs ide r ou t in e c l i n i l c a m o n i t o ) r i n g<br />

N a ï v e and M e m o r y CD4 T-c e l l s and R e g u l a t -c o e r l y l T s u b p o p u l a t i o n<br />

2. P s yc ho l o gi c a l que s t ionna ir es ( be fo r e a nd t h r e e a n d m s o i n t x h s a f t e r t h e t r a i n i n g : )<br />

S t r e s s p e r c e p t : i o P n e r c e i v e d S t r e s s [ S C c o h r e n e t a 83] l . , 1 9<br />

P er ce i ve d s o c i a l s up p o r t : K e ss e l e r P er c e i ve d So c i a l Su p p o r t [ C o v e n t r y e t a l . , 2 0 0 4 ]<br />

Q u a l i t y o f L i f e ( e r m p e o n w t e ) : S e n s e o f C o h e [Antonovsky, r e n c e 1993]<br />

Q u a l i t y o f L i f e ( s p i r i t u a l : i t S y p ) i r i t u a l I n v o l v e m e n t a n d B e l i [ H e f a s t c h S c e a t l a e l . , 1 9 9 8 ]<br />

Sleep qual i t y : P i b t u t r s g h S l e e p Q u a l i t [ y B u I y s n s d e e e x t a l . , 1 9 8 9 ]<br />

3. P er so n a lit y que st ionna ir e ( o n ly a t r e cr u i t m e nt ) :<br />

C l o n i n g e r T e m p e r a m e n t a n d C h a r a c t [ e C r l o n I i n g v e r n t e t o r a l y . , 1 9 9 3 ]<br />

4. Fi n a n c i a l / Ec onomic a l a na lys e s (o ve r th e s i x m o n t h s) :<br />

R e c r u i t m e n t<br />

T h e c o s t e f f e c t i v e r a t i o a n a [ H l y l s a e t s k y e t a l . , 2 0 0 4 ]<br />

84 J ohr e i p a r t i c i p a n t s w i l l b a e n d r c e o c m r p u a i r e t d e d w i t h d a t a b a s e c o n . t Tr his o l s numb er wa s<br />

c a lc ula te d at 5% s ignif ic a nce a nd 9 0% po we r o n t he ba s is <strong>of</strong> th e pr e vio us f in din g t ha t 5 8% <strong>of</strong><br />

s ubje ct s in t he J o h r e i g r o u p s t a y e d t h e s a m e -ce o ll r c ou nt i c n o c m r p a e r a e d s e w d i t h i n t h e i r<br />

33% o f s u bj e cts in t h e c o n t r o l . g r o u p<br />

D a t a c o l l e c t i o n<br />

Q u e s t i o nn a i r es : b e f o r e a n d t a t h r e o n e t h s a f n t d e r J s o h i r e x i t m r a i n i n g<br />

B l o o d s a m p l e s : an a d d i t i o n a l 1 7 m l b l o o d s a m p l e w i l t l t he b se a me t a tk ime e n pa a t ie nt s c ome for<br />

A n a l y s e s<br />

mont hly r o u t ine monit or ing c he c ks , at mo nt h z e r o, t hr ee a nd s ix .<br />

T he re s u lts wil l be s ta t ist ic a lly a n a lys e d b y r egr e s s io n , co rr e la t ion , a na lys e s o f va r ia n c es<br />

( AN O V A) a n d s t u d e nt t-t e s t u s i n g t h e S t a t i s t i c a l P a c k a g e f o r S o c i a l S c i e n c e s ( and S P S S the )<br />

S t a t i s t i c a l A n a l y s i s S o f t w a r e ( S A .<br />

S )<br />

P h . D . a t U n i v e r s i t y o f L o n d o n - 3 17 - I m p e r i a l C o l l e g e L o n d o n

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!